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Flexible Manufacturing Facility for Biopharmaceuticals
Abstract
Monoclonal antibodies (mAbs) have the potential to treat a wide range of diseases. They possess the ability to
bind target molecules in a highly specific and effective manner. Recently, great technological advances have
been made to enhance the therapeutic effects of these drugs, making treatment cheaper, easier, and more
effective while allowing companies to profit significantly. As a Contract Manufacturing Organization (CMO)
for these products, we offer the newest technology and many flexible options for producing these proteins.
Our facility is designed to produce protein products in Chinese Hamster Ovary (CHO) cells, followed by
modification and purification steps. We present the option to cleave smaller antigen binding fragments (Fab)
from the mAb product, removing the crystallizable fragment (Fc) which can interfere with the binding
specificity of the drug. We also offer the option for polyethylene glycosylation (PEGylation), which has been
shown to improve the effectiveness of these drugs. The attachment of a polyethylene glycol (PEG) molecule
to the protein enhances its circulation time in the human body so that less frequent doses are needed.
To demonstrate the capabilities of this flexible facility, we have modeled the production of an innovative
PEGylated anti-TNF-α mAb. Celltech and Pfizer currently have similar products in Phase III clinical trials;
and UCB Incorporated’s Cimzia® recently received FDA approval for the first humanized PEGylated anti-
TNF-α Fab’ therapeutic protein. Many non- PEGylated TNF-α inhibitor mAbs are currently on the market to
treat pathologies including rheumatoid arthritis and Crohn’s disease. PEGylated products have a clear
advantage over these drugs.
Our facility can produce up to 55 batches of protein product a year for a maximum yield of 993 kg. For
economic analysis of this product, sales from the first year of Cimzia® were considered since this product is
almost identical to the one being modeled. Producing at 75% of the total design capacity, this facility has a
NPV of $1,319,592,100, an IRR of 33.51% and an ROI of 53.0%. This level of production would leave a
significant amount of time remaining for other products to be manufactured as well. The additional products
that the facility will produce will be mAbs of all forms (i.e. cleaved, uncleaved, PEGylated, non-PEGylated)
that are protected under IP for small biotech firms that do not have the capital to build such facilities.
Currently, small biotech firms are producing 81 mAbs and are looking to license production for their Phase III
molecules. Clearly, this will become a very profitable CMO as we would be able to capture much of this
demand. A major threat looming over the mAb market, however, is the production of small molecular
inhibitors, which are currently in Phase I and Phase II clinical trials. Such molecules may be able to capture
the full market since they would not only have significant delivery advantages over TNF-α inhibitors, which
require injection, but also might have an enhanced side effect profile compared with biologics.
Disciplines
Chemical Engineering
This working paper is available at ScholarlyCommons: http://repository.upenn.edu/cbe_sdr/3
 
 
 
 
Chemical and Biomolecular Engineering 459 
University of Pennsylvania 
Spring 2009 
 
Ryan J. Dunn 
Kevin Hsu 
Melanie Hullings 
Maria Lobikin 
Project Advisor: Dr. Matthew J. Lazzara 
Project Recommendation: Dr. Tiffany D. Rau 
 
 
 
Flexible Manufacturing Facility for Biopharmaceuticals 
 
-i- 
 
 
Table of Contents 
Table of Contents ........................................................................................................................................... i 
1.0 Abstract ................................................................................................................................................... 1 
2.0 Introduction ............................................................................................................................................. 3 
2.1 Project Charter ................................................................................................................................... 10 
2.2 Technology-Readiness Assessment .................................................................................................. 11 
3.0 Concept Stage .................................................................................................................................... 12 
3.1 Market and Competitive Analysis ..................................................................................................... 12 
3.1.1 Principle Competition Production Levels and Sales .................................................................. 13 
3.1.2 Customer Requirements ............................................................................................................. 14 
3.2 Block Flow Diagram ......................................................................................................................... 15 
4.0 Process Flow Diagrams ......................................................................................................................... 16 
4.1 PFD-01 .............................................................................................................................................. 17 
4.1.1 Overall Material Balance PFD-01 .................................................................................................. 18 
4.2 PFD-02 .............................................................................................................................................. 19 
4.2.1 Overall Material Balance PFD-02 .................................................................................................. 20 
4.3 PFD-02a ............................................................................................................................................ 21 
4.3.1 Overall Material Balance PFD-02a ................................................................................................ 22 
4.4 PFD-03a ............................................................................................................................................ 23 
4.4.1 Overall Material Balance PFD-03a ................................................................................................ 24 
4.5 PFD-03b ............................................................................................................................................ 25 
4.5.1 Overall Material Balance PFD-03b ................................................................................................ 26 
4.6 PFD-04 .............................................................................................................................................. 27 
4.6.1 Overall Material Balance PFD-04 .................................................................................................. 28 
4.7 PFD-05 .............................................................................................................................................. 29 
4.7.1 Overall Material Balance PFD-05 .................................................................................................. 30 
4.8 PFD-06 .............................................................................................................................................. 31 
4.8.1 Overall Material Balance PFD-06 .................................................................................................. 32 
5.0 Production Process Description ............................................................................................................ 33 
5.1 Preliminary Steps (BFD-01) .............................................................................................................. 33 
5.1.1 Buffer Preparation ...................................................................................................................... 33 
5.1.2 Media Preparation ...................................................................................................................... 33 
5.2 Inoculum Prep Section (BFD-01) ..................................................................................................... 34 
Flexible Manufacturing Facility for Biopharmaceuticals 
 
-ii- 
 
5.2.1 T-Flasks (TFR-101) .................................................................................................................... 34 
5.2.2 Roller Bottles (RBR-101) ........................................................................................................... 34 
5.2.3 Bag Bioreactor 1 (BBS-101) ...................................................................................................... 35 
5.2.4 Bag Bioreactor 2 (BBS-102) ...................................................................................................... 35 
5.3 Seed Bioreactor Sections (BFD-02 / BFD-03) .................................................................................. 36 
5.3.1 Seed Bioreactor 1 (SBR-101) ..................................................................................................... 36 
5.3.2 Seed Bioreactor 2 (SBR-102) ..................................................................................................... 36 
5.4 Production Bioreactor Section (BFD-04) .......................................................................................... 36 
5.4.1 Production Bioreactor (PBR-101) .............................................................................................. 36 
5.5 Primary Recovery Section (BFD-05) ................................................................................................ 37 
5.5.1 Harvest Tank (P-26/V-201) ........................................................................................................ 37 
5.5.2 Centrifugation (P-28/DS-201) .................................................................................................... 37 
5.6 Pepsin Cleavage (BFD-06a) .............................................................................................................. 38 
5.6.1 Diafiltration (P-35/DF-201) ....................................................................................................... 38 
5.6.2 Pepsin Cleavage (P-36/R-201) ................................................................................................... 38 
5.6.3 Plate and Frame Filtration (P-38/PFF-201) ................................................................................ 38 
5.6.4 Diafiltration (P-42/DF-202) ....................................................................................................... 39 
5.6.5 Disulfide Reduction (P-44/R-202) ............................................................................................. 39 
5.6.7 Diafiltration (P-47/DF-203) ....................................................................................................... 40 
5.7 Protein A Chromatography (BFD-07) ............................................................................................... 40 
5.7.1 Protein A Chromatography (P-49/C-201) .................................................................................. 40 
5.8 Chemical Virus Inactivation (BFD-08) ............................................................................................. 41 
5.8.1 Diafiltration (P-54/DF-204) ....................................................................................................... 41 
5.8.2 Chemical Virus Inactivation (P-56/V-207) ................................................................................ 41 
5.9 Ion Exchange Chromatography (BFD-09/BFD-10) .......................................................................... 41 
5.9.1 Cation Exchange Chromatography (P-68/C-301) ...................................................................... 42 
5.9.2 Anion Exchange Chromatography (P-71/C-302) ....................................................................... 43 
5.10 PEGylation: Thiol Reduction (BFD-11) ......................................................................................... 44 
5.10.1 Diafiltration (P-81/DF-401) ..................................................................................................... 44 
5.10.2 Thiol Reduction (P-83/R-401) ................................................................................................. 44 
5.11 PEGylation Reaction (BFD-12) ...................................................................................................... 45 
5.11.1 Diafiltration (P-86/DF-402) ..................................................................................................... 45 
5.11.2 PEGylation Reaction (P-88 / R-402) ........................................................................................ 45 
5.11.3 Diafiltration (P-91/DF-403) ..................................................................................................... 45 
Flexible Manufacturing Facility for Biopharmaceuticals 
 
-iii- 
 
5.12 Cation Exchange Chromatography (BFD-13) ................................................................................. 46 
5.12.1 Cation Exchange Chromatography Column (P-101/C-401) .................................................... 46 
5.13 Final Filtration and Packaging (BFD-14) ........................................................................................ 47 
5.13.1 Diafiltration (P-104/DF-501) ................................................................................................... 47 
5.13.2 Viral Exclusion Filtration (P-106/DE-501, P-107/DE-502) .................................................... 47 
5.13.3 Packaging/Freezing (P-108/DCS-101) ..................................................................................... 48 
6.0 Plant Utility Requirements .................................................................................................................... 50 
6.1 Electricity Requirements for Equipment ........................................................................................... 51 
7.0 Major Unit Descriptions ........................................................................................................................ 53 
7.1 Inoculum Prep Section (BFD-01) ..................................................................................................... 53 
7.1.1 T-Flasks (P-1/TFR-101) ............................................................................................................. 53 
7.1.2 Roller Bottles (P-2/RBR-101) .................................................................................................... 53 
7.1.3 Bag Bioreactor 1 (P-3/BBS-101) ............................................................................................... 53 
7.1.4 Bag Bioreactor 2 (P-4/BBS-101) ............................................................................................... 54 
7.1.5 Storage/Mixing Tank (P-5/MP-101) .......................................................................................... 54 
7.1.6 Pump (P-6/PM-101) ................................................................................................................... 54 
7.1.7 Sterilization Filter (P-7/DE-101) ................................................................................................ 54 
7.2 Seed Bioreactor Section (BFD-02/BFD-03) ..................................................................................... 55 
7.2.1 Pump (P-8/PM-102) ................................................................................................................... 55 
7.2.2 Seed Bioreactor 1 (P-9/SBR-101) .............................................................................................. 55 
7.2.3 Pump (P-10/PM-103) ................................................................................................................. 56 
7.2.4 Storage/Mixing Tank (P-11/MP-102) ........................................................................................ 56 
7.2.5 Pump (P-12/PM-104) ................................................................................................................. 56 
7.2.6 Sterilization Filter (P-13/DE-102) .............................................................................................. 56 
7.2.7 Pump (P-14/PM-105) ................................................................................................................. 57 
7.2.8 Seed Bioreactor 2 (P-15/SBR-102) ............................................................................................ 57 
7.2.9 Pump (P-16/PM-106) ................................................................................................................. 57 
7.2.10 Storage/Mixing Tank (P-17/MP-103) ...................................................................................... 58 
7.2.11 Pump (P-18/PM-107) ............................................................................................................... 58 
7.2.12 Sterilization Filter (P-19/DE-103) ............................................................................................ 58 
7.2.22 Pump (P-20/PM-108) ............................................................................................................... 59 
7.2.23 Storage/Mixing Tank (P-21/MP-104) ...................................................................................... 59 
7.2.24 Pump (P-22/PM-109) ............................................................................................................... 59 
7.2.25 Sterilization Filter (P-23/DE-104) ............................................................................................ 59 
Flexible Manufacturing Facility for Biopharmaceuticals 
 
-iv- 
 
7.3 Production Bioreactor Section (BFD-04) .......................................................................................... 60 
7.3.1 Pump (P-24/PM-110) ................................................................................................................. 60 
7.3.2 Production Bioreactor (P-25/PBR-101) X 2 .............................................................................. 60 
7.4 Primary Recovery (BFD-05) ............................................................................................................. 61 
7.4.1 Surge Tank (P-26/V-201) ........................................................................................................... 61 
7.4.2 Pump (P-27/PM-201) ................................................................................................................. 61 
7.4.3 Centrifuge (P-28/DS-201) .......................................................................................................... 61 
7.4.4 Pump (P-29/PM-202) ................................................................................................................. 62 
7.4.5 Sterilization Filter (P-30/DE-201) .............................................................................................. 62 
7.4.6 Pump (P-31/PM-203) ................................................................................................................. 62 
7.4.7 Centrifugation Pool Tank (P-32/V-202) .................................................................................... 62 
7.5 Pepsin Cleavage (BFD-06a) .............................................................................................................. 63 
7.5.1 Pump (P-33/PM-204) ................................................................................................................. 63 
7.5.2 Diafiltration Storage Tank (P-34/V-203) ................................................................................... 63 
7.5.3 Diafiltration Unit (P-35/DF-201) X2 ......................................................................................... 63 
7.5.4 Pump (P-36/PM-205) ................................................................................................................. 64 
7.5.5 Pepsin Cleavage Bioreactor (P-37/R-201) ................................................................................. 64 
7.5.6 Pump (P-38/PM-206) ................................................................................................................. 64 
7.5.7 Plate and Frame Filtration Unit (P-38/PFF-201) ........................................................................ 65 
7.6 Disulfide Reduction (BFD-06a) ........................................................................................................ 65 
7.6.1 Pump (P-40/PM-206) ................................................................................................................. 65 
7.6.2 Diafiltration Storage Tank (P-41 / V-204) ................................................................................. 65 
7.6.3 Diafiltration Unit (P-42 / DF-202) ............................................................................................. 66 
7.6.4 Pump (P-43 / PM-208) ............................................................................................................... 66 
7.6.5 Disulfide Reduction Reactor (P-44 / R-202) .............................................................................. 66 
7.6.6 Pump (P-45 / PM-209) ............................................................................................................... 67 
7.6.7 Diafiltration Storage Tank (P-46 / V-205) ................................................................................. 67 
7.6.8 Diafiltration Unit (P-47 / DF-203) ............................................................................................. 67 
7.7 Protein A Chromatography (BFD-07) ............................................................................................... 68 
7.7.1 Pump (P-48 / PM-210) ............................................................................................................... 68 
7.7.2 Protein A Chromatography Column (P-49/C-201) .................................................................... 68 
7.7.3 Pump (P-50/PM-211) ................................................................................................................. 69 
7.7.4 Sterilizing Filter (P-51/DE-202) ................................................................................................. 69 
7.8 Chemical Virus Inactivation (BFD-08) ............................................................................................. 69 
Flexible Manufacturing Facility for Biopharmaceuticals 
 
-v- 
 
7.8.1 Pump (P-52/PM-212) ................................................................................................................. 69 
7.8.2 Diafiltration Storage Tank (P-53 / V-206) ................................................................................. 69 
7.8.3 Diafiltration Unit (P-54/DF-204) ............................................................................................... 70 
7.8.4 Pump (P-55/PM-213) ................................................................................................................. 70 
7.8.5 Virus Inactivation Tank (P-56/V-207) ....................................................................................... 70 
7.8.6 Pump (P-57/PM-213) ................................................................................................................. 71 
7.8.7 Sterilizing Filter (P-58/DE-202) ................................................................................................. 71 
7.9 Cation Exchange Chromatography (BFD-09) ................................................................................... 71 
7.9.1 Storage Tank (P-59/V-301) ........................................................................................................ 71 
7.9.2 Storage Tank (P-60/V-302) ........................................................................................................ 72 
7.9.3 Pump (P-61/PM-301) ................................................................................................................. 72 
7.9.4 Pump (P-62/PM-302) ................................................................................................................. 72 
7.9.5 Pump (P-63/PM-303, P-64/PM-304) ......................................................................................... 72 
7.9.6 Pump (P-65/PM-305, P-66/PM-306) ......................................................................................... 73 
7.9.7 Mixer (P-67/MX-301) ................................................................................................................ 73 
7.9.8 Chromatography Column (P-68/C-301) ..................................................................................... 73 
7.10 Anion Exchange Chromatography (BFD-10) ................................................................................. 74 
7.10.1 Holding Tank (P-69/V-303) ..................................................................................................... 74 
7.10.2 Pump (P-70/PM-307) ............................................................................................................... 74 
7.10.3 Chromatography Column (P-71/C-302) ................................................................................... 74 
7.10.4 Storage Tank (P-72/V-306) ...................................................................................................... 75 
7.10.5 Pump (P-73/PM-308) ............................................................................................................... 75 
7.10.6 Pump (P-74/PM-309, P-75/PM-310) ....................................................................................... 75 
7.10.7 Pump (P-76/PM-311) ............................................................................................................... 75 
7.10.8 Storage Tank (P-77/V-304) ...................................................................................................... 76 
7.10.9 Storage Tank (P-78/V-305) ...................................................................................................... 76 
7.10.10 Pump (P-79/PM-312) ............................................................................................................. 76 
7.11 Thiol Reduction (BFD-11) .............................................................................................................. 76 
7.11.1 Diafiltration Storage Tank (P-80 / V-203) ............................................................................... 76 
7.11.2 Diafiltration Unit (P-81 / DF-401) ........................................................................................... 77 
7.11.3 Pump (P-82 / PM-401) ............................................................................................................. 77 
7.11.4 Thiol Reduction Reactor (P-83 / R-401) .................................................................................. 78 
7.11.5 Pump (P-84 / PM-402) ............................................................................................................. 78 
7.12 PEGylation Reaction (BFD-12) ...................................................................................................... 78 
Flexible Manufacturing Facility for Biopharmaceuticals 
 
-vi- 
 
7.12.1 Diafiltration Storage Tank (P-85 / V-402) ............................................................................... 78 
7.12.2 Diafiltration Unit (P-86 / DF-402) ........................................................................................... 79 
7.12.3 Pump (P-87 / PM-403) ............................................................................................................. 79 
7.12.4 PEGylation Reactor (P-88 / R-402) ......................................................................................... 79 
7.12.5 Pump (P-89 / PM-404) ............................................................................................................. 80 
7.12.6 Diafiltration Storage Tank (P-90 / V-403) ............................................................................... 80 
7.12.7 Diafiltration Unit (P-91 / DF-403) ........................................................................................... 81 
7.13 Cation Exchange Chromatography (BFD-13) ................................................................................. 81 
7.13.1 Cation Buffer 2 Storage Tank (P-92 / V-405) .......................................................................... 81 
7.13.2 Cation Buffer 1 Storage Tank (P-93 / V-404) .......................................................................... 81 
7.13.3 Pump (P-94 / PM-405) ............................................................................................................. 82 
7.13.4 Pump (P-95 / PM-406) ............................................................................................................. 82 
7.13.5 Pump (P-96 / PM-410) ............................................................................................................. 82 
7.13.6 Pump (P-97 / PM-411) ............................................................................................................. 83 
7.13.7 Pump (P-98 / PM-409) ............................................................................................................. 83 
7.13.8 Pump (P-99 / PM-407) ............................................................................................................. 83 
7.13.9 Mixer (P-100 / MX-102) .......................................................................................................... 84 
7.13.10 Chromatography Column (P-101 / C-401) ............................................................................. 84 
7.14 Final Filtration (BFD-14) ................................................................................................................ 84 
7.14.1Pump (P-102/PM-501) .............................................................................................................. 84 
7.14.2 Holding Tank (P-103/V-501) ................................................................................................... 85 
7.14.3 Diafiltration (P-104/DF-501) ................................................................................................... 85 
7.14.4 Peristaltic Pump (P-105/PM-502) ............................................................................................ 85 
7.14.5 Retrovirus Filtration (P-106/DE-501) ...................................................................................... 85 
7.14.6 Parvovirus Filtration (P-107/DE-502) ...................................................................................... 86 
7.14.7 Disposable Container Storage (P-108/DCS-101) ..................................................................... 86 
7.14.8 Refrigeration (P-109/EC-501) .................................................................................................. 86 
8.0 Additional Equipment and Pricing ........................................................................................................ 87 
8.1 Incubators for T-flasks and Roller Bottles ........................................................................................ 87 
8.2 Roller Bottle Apparatus ..................................................................................................................... 87 
8.3 Biosafety Cabinet .............................................................................................................................. 87 
8.4 Air Generator (HVAC Equipment) ................................................................................................... 87 
8.5 Clean Steam Generator ...................................................................................................................... 88 
8.7 Buffer Transfer Bags ......................................................................................................................... 88 
Flexible Manufacturing Facility for Biopharmaceuticals 
 
-vii- 
 
8.8 Filter Integrity Tester ........................................................................................................................ 88 
8.9 Tube Fuser ......................................................................................................................................... 88 
8.10 Tube Sealer ...................................................................................................................................... 89 
8.11 Water Treatment Package ............................................................................................................... 89 
8.12 WFI Still .......................................................................................................................................... 89 
8.13 Biowaste and Neutralization Waste Tanks ...................................................................................... 89 
8.14 Biowaste Inactivation System ......................................................................................................... 89 
8.15 Waste Neutralization System .......................................................................................................... 90 
8.16 Blood Gas Analyzer ........................................................................................................................ 90 
8.17 Laboratory Information Management System (LIMS) ................................................................... 90 
8.19 Portable Pump on Cart .................................................................................................................... 90 
8.20 Final Packaging ............................................................................................................................... 90 
9.0 Unit Specification Sheets ...................................................................................................................... 91 
T-Flask (P-1 / TFR-101) ......................................................................................................................... 92 
Roller Bottle (P-2 / RBR-101) ................................................................................................................ 93 
Bag Bioreactor (P-3 / BBS-101) ............................................................................................................. 94 
Bag Bioreactor (P-4 / BBS-102) ............................................................................................................. 95 
Storage/Mixing Tank (P-5 / MP-101) ..................................................................................................... 96 
Pump (P-6 / PM-101) .............................................................................................................................. 97 
Sterilization Filter (P-7 / DE-101) ........................................................................................................... 98 
Pump (P-8 / PM-102) .............................................................................................................................. 99 
Seed Bioreactor (P-9 / SBR-101) .......................................................................................................... 100 
Pump (P-10 / PM-103) .......................................................................................................................... 101 
Storage/Mixing Tank (P-11 / MP-102) ................................................................................................. 102 
Pump (P-12 / PM-104) .......................................................................................................................... 103 
Sterilization Filter (P-13 / DE-102) ....................................................................................................... 104 
Pump (P-14 / PM-105) .......................................................................................................................... 105 
Seed Bioreactor (P-15 / SBR-102) ........................................................................................................ 106 
Pump (P-16 / PM-106) .......................................................................................................................... 107 
Storage/Mixing Tank (P-17 / MP-103) ................................................................................................. 108 
Pump (P-18 / PM-107) .......................................................................................................................... 109 
Sterilization Filter (P-19 / DE-103) ....................................................................................................... 110 
Pump (P-20 / PM-108) .......................................................................................................................... 111 
Storage/Mixing Tank (P-21 / MP-104) ................................................................................................. 112 
Flexible Manufacturing Facility for Biopharmaceuticals 
 
-viii- 
 
Pump (P-22 / PM-109) .......................................................................................................................... 113 
Sterilization Filter (P-23 / DE-104) ....................................................................................................... 114 
Pump (P-24 / PM-110) .......................................................................................................................... 115 
Production Bioreactor (P-25 / PBR-101) .............................................................................................. 116 
Surge Tank (P-26 / V-201) .................................................................................................................... 117 
Pump (P-27 / PM-201) .......................................................................................................................... 118 
Centrifuge (P-28 / DS-201) ................................................................................................................... 119 
Pump (P-29 / PM-202) .......................................................................................................................... 120 
Sterilizing Filter (P-30 / DE-201) .......................................................................................................... 121 
Pump (P-31 / PM-203) .......................................................................................................................... 122 
Centrifugation Pool Tank (P-32 / V-202) ............................................................................................. 123 
Pump (P-33 / PM-204) .......................................................................................................................... 124 
Diafiltration Storage Tank (P-34 / V-203) ............................................................................................ 125 
Diafiltration Unit (P-35 / DF-201) ........................................................................................................ 126 
Pump (P-36 / PM-205) .......................................................................................................................... 127 
Pepsin Cleavage Bioreactor (P-37 / R-201) .......................................................................................... 128 
Pump (P-38 / PM-206) .......................................................................................................................... 129 
Plate and Frame Filtration Unit (P-39 / PFF-201) ................................................................................. 130 
Pump (P-40 / PM-207) .......................................................................................................................... 131 
Diafiltration Storage Tank (P-41 / V-204) ............................................................................................ 132 
Diafiltration Unit (P-42 / DF-202) ........................................................................................................ 133 
Pump (P-43 / PM-208) .......................................................................................................................... 134 
Disulfide Reduction Reactor (P-44 / R-202) ......................................................................................... 135 
Pump (P-45 / PM-209) .......................................................................................................................... 136 
Diafiltration Storage Tank (P-46 / V-205) ............................................................................................ 137 
Diafiltration Unit (P-47 / DF-203) ........................................................................................................ 138 
Pump (P-48 / PM-210) .......................................................................................................................... 139 
Protein A Chromatography Column (P-49 / C-201) ............................................................................. 140 
Pump (P-50 / PM-211) .......................................................................................................................... 141 
Sterilizing Filter (P-51 / DE-202) .......................................................................................................... 142 
Pump (P-52/ PM-209) ........................................................................................................................... 143 
Diafiltration Storage Tank (P-53 / V-206) ............................................................................................ 144 
Diafiltration Unit (P-54 / DF-204) ........................................................................................................ 145 
Pump (P-55/ PM-213) ........................................................................................................................... 146 
Flexible Manufacturing Facility for Biopharmaceuticals 
 
-ix- 
 
Virus Inactivation Tank (P-56/ V-207) ................................................................................................. 147 
Pump (P-57/ PM-214) ........................................................................................................................... 148 
Sterilizing Filter (P-58 / DE-203) .......................................................................................................... 149 
Storage Tank (P-59 / V-301) ................................................................................................................. 150 
Storage Tank (P-60 / V-302) ................................................................................................................. 151 
Pump (P-61 / PM-301) .......................................................................................................................... 152 
Pump (P-62 / PM-302) .......................................................................................................................... 153 
Pump (P-63 / PM-303, P-64 / PM-304) ................................................................................................ 154 
Pump (P-65 / PM-305, P-66 / PM-306) ................................................................................................ 155 
Cation Chromatography Column (P-68 /C-301) ................................................................................... 156 
Holding Tank (P-69 / V-303) ................................................................................................................ 157 
Pump (P-70 / PM-307) .......................................................................................................................... 158 
Anion Exchange Chromatography Column (P-71 / C-302) .................................................................. 159 
Anion Exchange Pool Tank (P-72 / V-306) .......................................................................................... 160 
Pump (P-73 / PM-308) .......................................................................................................................... 161 
Pump (P-74 / PM-309, P-75 / PM-310) ................................................................................................ 162 
Pump (P-76 / PM-311) .......................................................................................................................... 163 
Storage Tank (P-77 / V-304) ................................................................................................................. 164 
Storage Tank (P-78 / V-305) ................................................................................................................. 165 
Pump (P-79 / PM-312) .......................................................................................................................... 166 
Diafiltration Storage Tank (P-80 / V-401) ............................................................................................ 167 
Diafiltration Unit (P-81 / DF-401) ........................................................................................................ 168 
Pump (P-82 / PM-401) .......................................................................................................................... 169 
Thiol Reduction Reactor (P-83 / R-401) ............................................................................................... 170 
Pump (P-84 / PM-402) .......................................................................................................................... 171 
Diafiltration Storage Tank (P-85 / V-402) ............................................................................................ 172 
Diafiltration Unit (P-86 / DF-402) ........................................................................................................ 173 
Pump (P-87 / PM-403) .......................................................................................................................... 174 
PEGylation Reactor (P-88 / R-402) ...................................................................................................... 175 
Pump (P-89 / PM-404) .......................................................................................................................... 176 
Diafiltration Storage Tank (P-90 / V-403) ............................................................................................ 177 
Diafiltration Unit (P-91 / DF-403) ........................................................................................................ 178 
Cation Buffer 2 Storage Tank (P-92 / V-405) ....................................................................................... 179 
Cation Buffer 1 Storage Tank (P-93 / V-404) ....................................................................................... 180 
Flexible Manufacturing Facility for Biopharmaceuticals 
 
-x- 
 
Pump (P-94 / PM-405) .......................................................................................................................... 181 
Pump (P-95 / PM-406) .......................................................................................................................... 182 
Pump (P-96 / PM-410) .......................................................................................................................... 183 
Pump (P-97 / PM-411) .......................................................................................................................... 184 
Pump (P-98 / PM-408) .......................................................................................................................... 185 
Pump (P-99 / PM-407) .......................................................................................................................... 186 
Ion Exchange Chromatography (P-101 / C-401) .................................................................................. 187 
Pump (P-102 / PM-501) ........................................................................................................................ 188 
Diafiltration Storage Tank (P-103 / V-501) .......................................................................................... 189 
Diafiltration Unit (P-104 / DF-501) ...................................................................................................... 190 
Pump (P-105 / PM-502) ........................................................................................................................ 191 
Retrovirus Filter (P-106 / DE-501) ....................................................................................................... 192 
Parvovirus Filter (P-107 / DE-502) ....................................................................................................... 193 
Bag Dispenser (P-108 / DCS-501) ........................................................................................................ 194 
Ultra Cold Freezer (P-109 / EC-501) .................................................................................................... 195 
10.0 Cost Summary ................................................................................................................................... 196 
10.1 Inoculum Prep and Bioreaction ..................................................................................................... 196 
10.2 Primary Recovery – Disulfide Reduction ..................................................................................... 197 
10.3 Protein A – Chemical Virus Inactivation ...................................................................................... 198 
10.4 Cation and Anion Exchange Chromatography .............................................................................. 199 
10.5 PEGylation .................................................................................................................................... 200 
10.6 Final Filtration ............................................................................................................................... 201 
10.7 Additional Equipment ................................................................................................................... 202 
11.0 Other Important Considerations ........................................................................................................ 203 
11.1 Scheduling ..................................................................................................................................... 203 
11.1.1 Gantt Chart ............................................................................................................................. 204 
11.2 Environmental Concerns ............................................................................................................... 205 
11.3 Current Good Manufacturing Practices ......................................................................................... 206 
11.4 Plant Layout .................................................................................................................................. 208 
12.0 Economic Analysis ............................................................................................................................ 210 
12.1 Market Analysis ............................................................................................................................ 210 
12.2 Profitability Analysis ..................................................................................................................... 211 
12.2.1 Price of PEGylated Monoclonal Antibody ............................................................................. 211 
12.2.2 Plant Life ................................................................................................................................ 211 
Flexible Manufacturing Facility for Biopharmaceuticals 
 
-xi- 
 
12.2.3 Raw Materials and Equipment Costs ..................................................................................... 212 
12.2.4 Total Permanent Investment ................................................................................................... 212 
12.2.5 Working Capital ..................................................................................................................... 212 
12.2.6 Utilities ................................................................................................................................... 212 
12.2.7 Other Variable Costs .............................................................................................................. 213 
12.2.8 Fixed Costs ............................................................................................................................. 213 
12.2.9 Depreciation ........................................................................................................................... 213 
12.3 Input Summary .............................................................................................................................. 214 
12.4 Profitability Analysis ..................................................................................................................... 218 
12.4.1 Profitability Analysis Results ................................................................................................. 219 
12.5 Sensitivity Analysis ....................................................................................................................... 226 
12.5.1 Selling Price ........................................................................................................................... 226 
12.5.2 Plant Life ................................................................................................................................ 227 
12.5.3 Cost of Polyethylene Glycol .................................................................................................. 227 
12.5.4 Cost of Chromatography Resins ............................................................................................ 228 
13.0 Conclusions and Recommendations .................................................................................................. 229 
14.0 Acknowledgements ........................................................................................................................... 230 
15.0 Bibliography ...................................................................................................................................... 232 
Appendix A – Calculations ....................................................................................................................... 237 
Growth Rate .......................................................................................................................................... 237 
Growth Curves ...................................................................................................................................... 237 
Antibody Production Rate ..................................................................................................................... 239 
Media Calculation ................................................................................................................................. 239 
Ammonia Levels ................................................................................................................................... 239 
CHO Cell Data ...................................................................................................................................... 239 
Calculation of Product Amount ............................................................................................................. 240 
Vessel Sizing ......................................................................................................................................... 241 
Stoichiometry of the Batch and Fed-Batch Bioreactors ........................................................................ 242 
Clean-in-Place (CIP) and Steam-in-Place (SIP) Procedures ................................................................. 244 
Appendix B – PEGylation ......................................................................................................................... 247 
PEGylation Overview ........................................................................................................................... 247 
Pepsin Cleavage and Disulphide Reduction Protocol and Calculations ............................................... 249 
PEGylation Protocol and Calculations .................................................................................................. 250 
Appendix C – Glossary ............................................................................................................................. 253 
Flexible Manufacturing Facility for Biopharmaceuticals 
 
-xii- 
 
Appendix D – SuperPro Designer Stream Reports ................................................................................... 256 
Appendix E – SuperPro Validation Calculations ...................................................................................... 308 
Appendix E – Material Safety Data Sheets ............................................................................................... 321 
Appendix F – Vendor Specification Sheets .............................................................................................. 465 
Flexible Manufacturing Facility for Biopharmaceuticals 
 
-1- 
 
1.0 Abstract  
Monoclonal antibodies (mAbs) have the potential to treat a wide range of diseases. They 
possess the ability to bind target molecules in a highly specific and effective manner. Recently, 
great technological advances have been made to enhance the therapeutic effects of these drugs, 
making treatment cheaper, easier, and more effective while allowing companies to profit 
significantly. As a Contract Manufacturing Organization (CMO) for these products, we offer the 
newest technology and many flexible options for producing these proteins. Our facility is 
designed to produce protein products in Chinese Hamster Ovary (CHO) cells, followed by 
modification and purification steps. We present the option to cleave smaller antigen binding 
fragments (Fab) from the mAb product, removing the crystallizable fragment (Fc) which can 
interfere with the binding specificity of the drug. We also offer the option for polyethylene 
glycosylation (PEGylation), which has been shown to improve the effectiveness of these drugs. 
The attachment of a polyethylene glycol (PEG) molecule to the protein enhances its circulation 
time in the human body so that less frequent doses are needed.   
 To demonstrate the capabilities of this flexible facility, we have modeled the production 
of an innovative PEGylated anti-TNF-α mAb. Celltech and Pfizer currently have similar 
products in Phase III clinical trials; and UCB Incorporated’s Cimzia® recently received FDA 
approval for the first humanized PEGylated anti-TNF-α Fab’ therapeutic protein. Many non-
PEGylated TNF-α inhibitor mAbs are currently on the market to treat pathologies including 
rheumatoid arthritis and Crohn’s disease. PEGylated products have a clear advantage over these 
drugs.  
Our facility can produce up to 55 batches of protein product a year for a maximum yield 
of 993 kg. For economic analysis of this product, sales from the first year of Cimzia® were 
considered since this product is almost identical to the one being modeled. Producing at 75% of 
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the total design capacity, this facility has a NPV of $1,319,592,100, an IRR of 33.51% and an 
ROI of 53.0%. This level of production would leave a significant amount of time remaining for 
other products to be manufactured as well. The additional products that the facility will produce 
will be mAbs of all forms (i.e. cleaved, uncleaved, PEGylated, non-PEGylated) that are protected 
under IP for small biotech firms that do not have the capital to build such facilities. Currently, 
small biotech firms are producing 81 mAbs and are looking to license production for their Phase 
III molecules. Clearly, this will become a very profitable CMO as we would be able to capture 
much of this demand. A major threat looming over the mAb market, however, is the production 
of small molecular inhibitors, which are currently in Phase I and Phase II clinical trials. Such 
molecules may be able to capture the full market since they would not only have significant 
delivery advantages over TNF-α inhibitors, which require injection, but also might have an 
enhanced side effect profile compared with biologics. 
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2.0 Introduction 
Monoclonal antibodies (mAbs) are a class of biological agents currently used for 
therapeutics (see Figure 2.1). Their binding to target molecules is highly specific, which makes 
them useful for treating many human diseases including autoimmune and inflammatory 
conditions, cancers, and viral diseases (Sauer et al. 2000). Monoclonal antibodies are all 
identical to one another because they are produced by one single type of immune cell which are 
all clones of a single parent cell. While the mechanism by which mAbs achieve therapeutic 
effects is not very clear in all situations, some validated mechanisms include: the blocking or 
steric hindrance of a target antigen’s function (i.e. tumor necrosis factor-alpha (TNF-α)), 
cytotoxicity to cells with specific receptors, and the inhibition of certain growth factor molecules 
(Bogard et al. 1989).  
 
 
TNF-α is a cytokine, or cell-signaling molecule, that is involved in inflammatory 
response pathways seen in patients with Crohn’s, rheumatoid arthritis, and psoriatic arthritis. 
TNF-α is mainly produced by immune cells in response to bacteria, bacterial products, or other 
Figure 2.1: Three monoclonal antibodies currently used for treatment of 
Crohn’s Disease. (Melmed et.al, 2008) 
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inflammatory signals upstream. When TNF-α binds to TNF-R1, a membrane-bound TNF 
receptor found in almost all cells, it changes the conformation of the receptor and leads to an 
inflammatory response from the cell. As shown in Figure 2.2, anti-TNF-α antibodies bind to 
TNF-α and prevent it from binding to TNF-R1 through steric hindrance, inhibiting an 
inflammatory response (Magnani et al. 2005).  
 
 
This company is a large Contract Research Organization (CRO) with plans to expand into 
contract manufacturing. The company specializes in biopharmaceuticals produced in mammalian 
cell culture systems, specifically monoclonal antibodies. The goal of the company was to design 
a facility capable of producing the next wave of mAb/Fab biopharmaceuticals, demonstrating the 
potential of this facility by modeling production of a humanized monoclonal antibody that 
inhibits TNF- α. This type of mAb is manufactured by enzymatically cleaving mAb fragments to 
form Fab fragments which are then polyethylene glycosylated (PEGylated), a process which 
attaches a polyethylene glycol (PEG) molecule to the protein. Since two-thirds of 
biopharmaceutical companies have revenues of less than one billion dollars, there is a great 
demand for Contract Manufacturing Organizations (CMOs) such as this. This is due to the fact 
Figure 2.2: An Anti TNF-α binds to TNF-α, preventing it from signaling an 
inflammatory response through TNF-R1. (Magnani et al. 2005) 
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that many biopharmaceutical companies do not typically have the cash reserves to build a 
manufacturing facility outright. 
This facility offers many levels of flexibility in the products that can be manufactured. 
For mAbs and other proteins, the Fc region must be enzymatically cleaved off, as it interferes 
with Fab binding to the TNF-α target. In the case of the anti-TNF-α drug that is modeled, the 
mAb is enzymatically cleaved with pepsin and PEGylated. Depending on whether the protein 
will be PEGylated or not, this facility is capable of cleaving 150 kDa mAbs with the enzyme 
papain to produce 50 kDa Fab fragments, or cleaving with the enzyme pepsin to produce 100 
kDa F(ab’)2 molecules. F(ab’)2 molecules retain the hinge region disulfide bonds between the 
Fab and Fc fragments, which hold the two Fab fragments together when the 50 kDa Fc region is 
cleaved off (see Figure 2.3).  
 
Figure 2.3: Depiction of a typical monoclonal antibody and its  
pepsin and papain cleavage products (Sigma-Aldrich). 
 
These disulfide bonds holding the two Fab fragments together are then reduced using 2-
Mercaptoethylamine·HCl (2-MEA) to yield two 50 kDa Fab’ fragments (see Figure 2.4). Fab’ 
fragments are Fab fragments with an additional cysteine attached, which is retained from the 
hinge region of the mAb. This cysteine contains a thiol group that can specifically react with the 
PEG molecule (see Figure 2.4). The PEGylation of the Fab product results in a very innovative 
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drug, as PEGylation has been shown to result in longer circulation time of the Fab in the 
bloodstream, reducing the amount and frequency of injections needed by patients (Filpula 2006). 
 
Figure 2.4: Reduction with 2-MEA (Thermo Scientific Pierce). 
 
 
Figure 2.4:  Schematic illustration of site-specific Fab’ PEGylation  
through the attachment of PEG-maleimide to a thiol (Chapman 2002). 
 
A Fab fragment that is not PEGylated has a blood half-life of 28 minutes, meaning that in 
this short amount of time it will lose half of its pharmacologic effect, and it has a hydrodynamic 
diameter of 6.0nm (Choi 2007).  It has been experimentally determined that a particle with a 
hydrodynamic diameter less than or equal to 5.5 nm will be completely cleared from the body 
(Choi 2007).  Above a molecular weight of 20 kDa, renal filtration decreases in favor of bile 
excretion, and above 50 kDa, hepatobiliary (liver) clearance dominates (Fishburn 2007).  Since 
PEG molecules are highly hydrated, with two water molecules per ethylene glycol unit, they 
have a very large hydrodynamic diameter (Fishburn 2007).  In experiments testing a range of 
molecular weights and configurations of PEG molecules, the optimal PEG to be added to a Fab’ 
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fragment was found to be a 40 kDa branched molecule (Humphreys 2007).  The hydrodynamic 
diameter of a 40 kDa PEG molecule has been proven to be about 20nm (Dhalluin 2005). 
Attaching a single 40 kDa branched PEG molecule significantly increases the hydrodynamic 
diameter of the protein and almost doubles the molecular weight of the 40 kDa Fab’ fragment, 
resulting in a 90 kDa product. Therefore, PEGylated proteins will be much greater in size and 
mass, remain in the body much longer, and allow for less frequent injections (Humphreys 2007). 
In April of 2008, the FDA approved UCB’s certolizumab pegol (Cimzia®), a product 
nearly identical to the biopharmaceutical being modeled. Cimzia® was the first humanized 
PEGylated anti-TNF-α Fab’ therapeutic. Currently Cimzia® only has an indication to treat 
Crohn’s disease, yet it is possible that it will be able to obtain an indication for rheumatoid 
arthritis in the future. Analyst expectations for the sales of Cimzia® were $50 million for its 
launch year (Melmed 2008). Cimzia® is administered by a healthcare provider in 400 mg doses 
every four weeks via subcutaneous injections in the abdominal region or upper thigh. This differs 
from other biological TNF- α inhibitors on the market which must be intravenously injected. 
For this facility, Chinese hamster ovary cells (CHO) were selected to produce anti-TNF-α 
antibodies. CHO cells are widely used in the expression of recombinant proteins, including 
monoclonal antibodies. Since they are mammalian cells, CHO cells are able to express and 
secrete a target antibody with proper post-translational modifications (PTMs), such as 
glycosylation and protein folding. Since the desired product is secreted, the purification is less 
complicated due to the fact that the intercellular proteins do not have to be separated out. CHO 
cells also grow quickly and can survive in dense populations, allowing for the recovery of 
concentrations of anti-TNF-α antibodies up to 5 g/L (Jayapal, Karthik P. et al 2007). CHO cells 
can also grow in suspension without serum, which allows for the cells to grow in large-scale 
stirred-tank bioreactors (>10,000 L) without the cost of expensive serums. In addition, the 
contamination of serum with viruses is a well known and established risk, which is why it will 
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not be used in this plant. Despite the testing of batches of serum, agents such as transmissible 
spongiform encephalopathies (TSEs) can escape detection and contaminate production cell 
cultures. The cells routinely used for production of biological medicines do not support the 
replication or amplification of TSEs. The only cell lines known to do so are of neuronal origin 
and use of such cells for production requires special justification (Castle 1998). 
Safety and industrial acceptance were other important reasons for the selection of CHO 
cells to produce anti-TNF-α antibodies. CHO cells have been used in industry to produce 
biopharmaceuticals for 20 years, and have proven to be safe hosts for the synthesis of biologics. 
Their ability to consistently express stable and biologically active proteins is a chief reason why 
they are so commonly used. Another major benefit is that many of the major human pathogenic 
viruses, including HIV, influenza, polio, herpes, and measles, do not replicate inside CHO cells. 
This means that dangerous viruses will not propagate and thrive in these cells. 
Since Massachusetts is currently a hotspot for biotechnology, this would be a practical 
and economic location for our manufacturing facility. Being on the East Coast, and particularly 
in the New England area, would put our facility at a great advantage. This location is close to 
cutting-edge academic research being done at local universities as well as suppliers, clients, and 
other companies with whom this facility might do business. This location would also decrease 
the cost associated with packaging and distributing our product. With the current shortage of 
cell-culture capacity and a large demand for antibody production in the biotech industry, a 
rapidly expanding state such as Massachusetts would give us the potential for expansion and 
collaboration with other companies in the future. The state government is also offering grants 
and other incentives to move into this area through the Massachusetts Development Emerging 
Technology Fund. Over the next ten years, Massachusetts plans to spend $1 billion on 
subsidizing research and attracting and retaining biotech companies in the area. Many 
companies, both domestic and international, are taking advantage of this and in turn building 
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plants in Massachusetts (News Report 2005; Philippidis 2007). We also plan to take advantage 
of the opportunities that 
 
of TNF
with biologics such as the ones being produced at our facility, which can c
infections. An oral inhibitor would also have delivery advantages over TNF
require injections by healthcare providers.
Phase I and II clinical trials
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Table 2.1 Current small molecule
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2.1 Project Charter 
 
 
Project Name Humanized anti-TNF-alpha Antibody Production using a Flexible 
Biopharmaceutical Manufacturing Facility 
 
Project Champions Business Director of Biopharmaceutical Companies 
 
Project Leaders Ryan Dunn, Kevin Hsu, Melanie Hullings, Maria Lobikin 
 
Specific Goals Design a biopharmaceutical plant and a process to produce humanized 
monoclonal antibodies against TNF-alpha (Tumor Necrosis Factor)  
 
Project Scope In-scope: 
· Enzymatic cleavage of antibody to produce Fab fragments 
o Using papain digestion, antibody will be cleaved into two Fab 
fragments and an Fc fragment 
o Using pepsin digestion, cleaving the antibody into an F(ab)2’ and 
Fc fragment 
· PEGylation of fragments cleaved by pepsin for enhanced delivery  
o Increases size, reducing renal clearance 
o Masks product from immune response 
· Meets current safety and health regulations 
· Maintain profit margin 
· Facility may be used to produce other biopharmaceuticals (i.e. non-
cleaved, non-PEGylated antibodies) 
Out-of-scope: 
· Process design of other biopharmaceuticals 
· Cell line development 
· Clinical Trials 
· Distribution of product 
· Research and development of monoclonal antibodies 
 
Deliverables · Business opportunity assessment: 
o How great is the business opportunity for biopharmaceutical 
contract manufacturing organizations? 
o What is the market space for anti-TNF-alpha antibodies? 
· Technical feasibility assessment: 
o Is it technically feasible to manufacture anti-TNF-alpha 
antibodies on a large scale? 
· Manufacturing capability assessment: 
o Can this facility be built and can this process be executed 
without significant capital investment?  
· Product life-cycle assessment: 
o Would the facility and process satisfy current regulatory 
requirements? 
 
Timeline Facility and process design within 3 months 
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2.2 Technology-Readiness Assessment 
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3.0 Concept Stage 
3.1 Market and Competitive Analysis 
While monoclonal antibodies (mAbs) made up only 20% of biologics sales in 2000, this 
segment is growing more rapidly than biologics in total. In 2007, total global monoclonal 
antibody sales reached $26 billion and are forecast to almost double to $49 billion by 2013. 
While small molecule drug sales will continue to make up the majority of total market sales, the 
mAb market, with a compound annual growth rate (CAGR) of almost 11% will continue to grow 
at a much greater rate than their small molecule counterpart (DataMonitor 2008). With the 
expanding development and approval of mAbs comes the demand for production capacity by 
pharmaceutical companies.  
As of today, there is a distinct shortage in cell culture capacity (Mallik 2006). There is 
currently a wealth of biopharmaceuticals that are either in Phase III of clinical trials or have been 
already approved. However, much of the world’s cell-culture capacity is currently being utilized, 
and there is a lack of plant space for these newer drugs. Therefore, our plans to create a flexible 
biopharmaceutical manufacturing plant will help to address this demand. Not only is there a 
demand for manufacturing space in our facility, but there are also growing demands for the 
specific anti-TNF-α that the process described herein plans to manufacture. 
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3.1.1 Principle Competition Production Levels and Sales 
Currently, the majority of drugs on the market which are similar to the anti-TNF-α 
protein being produced in this facility are non-PEGylated proteins which are very expensive and 
require frequent large-volume injections. Leading competitors for rheumatoid arthritis/Crohn’s 
therapeutic proteins include J&J Centocor/Schering Plough’s Remicade®, Abbott’s Humira®, 
and Amgen/Wyeth’s Enbrel®. As seen in Table 3.1 these products, as well as other monoclonal 
antibodies currently in the market) generate very large revenues. However, we can expect our 
product to generate similar revenues, as our product will be more effective and more appealing to 
patients than existing therapies. There are two known major competitors for this PEGylated 
product, as Celltech and Pfizer currently have a similar product in Phase III clinical trials and 
Cimzia just had the first humanized PEGylated anti-TNF-α Fab’ protein approved by the FDA. 
  
 
 
 
Table 3.1 Production levels and sales for principle competition (Jagschies 2009) 
Flexible Manufacturing Facility for Biopharmaceuticals 
 
-14- 
 
3.1.2 Customer Requirements 
 The customer requirements for this manufacturing facility fit a design concept that is 
new-unique-difficult (NUD). The primary customers of this CMO facility will be the 
biotechnology firms who wish to produce these drugs; and the primary focus of the facility 
should be to provide the technology required to produce the drugs these companies currently 
wish to manufacture. It is important that this facility is equipped with the newest technology in 
order to produce innovative drugs that fulfill the needs of the patients buying these products from 
the biotechnology companies. In either case, production capabilities must meet the requirements 
of the most current technologies, as well as anticipate the next generation of drugs. As there are 
available therapies for the same target as the drug being modeled, this facility focuses on 
providing flexible options in order to offer the capability to make innovative new products and 
replace existing ones. The PEGylated anti-TNF-α mAb being modeled will have enhanced 
effects over existing non-PEGylated products, as it will remain in the body longer, require 
smaller volume and less frequent injections, and potentially can be offered at a lower cost to the 
customer than the highly expensive therapies that exist in the market (Schlesselman, 2008).  
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3.2 Block Flow Diagram 
 The diagram below depicts the overall process, as well as the three different possible 
production routes that can be implemented in creating the final product. 
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4.0 Process Flow Diagrams 
 The following pages contain the process flow diagrams and material balances describing 
the flexible manufacturing facility for the production of monoclonal antibodies. Flexibility in the 
facility is provided by the ability to create three different products through the utilization and/or 
bypass of certain unit(s). The final monoclonal antibody produced can be either cleaved and 
PEGylated, cleaved and not PEGylated, or neither cleaved nor PEGylated (see block flow 
diagram, p.11).   
 
 
 
 
 
 
Flexible Manufacturing Facility for Biopharmaceuticals 
 
-17- 
 
P-
1 
/ T
FR
-1
01
T-
Fl
as
k 
(2
25
 m
L)
P-
2 
/ R
BR
-1
01
Ro
lle
r B
ot
tle
 (2
.2
 L
)
P-
9 
/ S
BR
-1
01
Fi
rs
t S
ee
d 
Bi
or
ea
ct
or
 (1
50
0 
L)
P-
5 
/ M
P-
10
1
M
ed
ia
 P
re
p 
(1
00
0 
L)
P-
7 
/ D
E-
10
1
St
er
ile
 F
iltr
at
io
n
P-
3 
/ B
BS
-1
01
Ba
g 
Bi
or
ea
ct
or
 (2
0 
L)
P-
4 
/ B
BS
-1
02
Ba
g 
Bi
or
ea
ct
or
 (1
00
 L
)
In
no
cu
lu
m
 M
ed
ia
-1
In
no
cu
lu
m
 M
ed
ia
-2
SF
 M
ed
ia
-1
A
ir 
St
re
am
-1
P-
11
 / 
M
P-
10
2
M
ed
ia
 P
re
p 
(3
00
0 
L)
P-
13
 / 
DE
-1
02
St
er
ile
 F
iltr
at
io
n
P-
15
 / 
SB
R-
10
2
Se
co
nd
 S
ee
d 
Bi
or
ea
ct
or
  (
45
00
 L
)
SF
 M
ed
ia
-2
W
as
te
-2
P-
17
 / 
M
P-
10
3
M
ed
ia
 P
re
p 
(7
70
0 
L)
P-
19
 / 
DE
-1
03
St
er
ile
 F
iltr
at
io
n
P-
21
 / 
M
P-
10
4
M
ed
ia
 P
re
p 
(1
60
0 
L)
P-
23
 / 
DE
-1
04
St
er
ile
 F
iltr
at
io
n
P-
25
 / 
PB
R-
10
1
Pr
od
uc
tio
n 
Bi
or
ea
ct
or
 (1
40
00
 L
)
W
FI
-3
SF
 M
ed
ia
-3 W
FI
-4
SF
 M
ed
ia
-4
A
ir 
St
re
am
-3
V
en
t-5
To
 P
rim
ar
y 
Re
co
ve
ry
In
oc
ul
um
 P
re
p
B
io
re
ac
tio
n
W
as
te
-3
W
as
te
-4
In
no
cu
lu
m
 M
ed
ia
-4
P-
6 
/ P
M
-1
01
Fl
ui
d 
Fl
ow
P-
8 
/ P
M
-1
02
Fl
ui
d 
Fl
ow
P-
10
 / 
PM
-1
03
Fl
ui
d 
Fl
ow
S-
10
9
S-
11
0
P-
12
 / 
PM
-1
04
Fl
ui
d 
Fl
ow
S-
11
1
S-
11
2
P-
14
 / 
PM
-1
05
Fl
ui
d 
Fl
ow
S-
11
3
P-
16
 / 
PM
-1
06
Fl
ui
d 
Fl
ow
S-
11
6
P-
18
 / 
PM
-1
07
Fl
ui
d 
Fl
ow
S-
11
7
S-
11
8
P-
20
 / 
PM
-1
08
Fl
ui
d 
Fl
ow
S-
11
9
P-
22
 / 
PM
-1
09
Fl
ui
d 
Fl
ow
S-
12
1
S-
12
2
P-
24
 / 
PM
-1
10
Fl
ui
d 
Fl
ow
S-
12
3
A
ir 
St
re
am
-2
In
no
cu
lu
m
 M
ed
ia
-3
S-
10
1
S-
10
4
S-
10
8
S-
10
6
S-
10
5
S-
10
7
S-
11
5
W
as
te
-1
S-
12
0
S-
12
4
S-
11
4
S-
10
3
S-
10
2
V
en
t-4
V
en
t-3
V
en
t-2
V
en
t-1
W
FI
-1
W
FI
-2
  
4.1 PFD-01  
Flexible Manufacturing Facility for Biopharmaceuticals 
 
-18- 
 
4.1.1 Overall Material Balance PFD-01 
OVERALL COMPONENT BALANCE (kg/batch) 
COMPONENT INITIAL INPUT OUTPUT FINAL OUT-IN 
Amino Acids 0.00 34.00 3.49 0.20 - 30.32 
Biomass   0.00* 0.00 167.26 0.00 167.26 
Carbon Dioxide 0.00 0.00 338.58 0.29 338.87 
Dead Biomass 0.00 0.00 17.14 0.00 17.14 
Glucose 0.00 143.88 14.75 0.83 - 128.30 
Glutamine 0.00 16.64 1.71 0.10 - 14.84 
Inorganic Salts 0.00 348.53 35.72 2.01 - 310.80 
Lactate 0.00 0.00 118.59 0.00 118.59 
MAB 0.00 0.00 34.32 0.00 34.32 
Nitrogen 30.74 16763.30 16776.38 17.66 0.00 
Other Media Components 0.00 3.01 0.31 0.02 - 2.69 
Oxygen 9.33 5089.01 4605.18 4.94 - 488.22 
Phosphoric Acid 0.00 233.54 233.54 0.00 0.00 
Sodium Hydroxide 0.00 44.51 44.51 0.00 0.00 
Vitamins 0.00 1.42 0.15 0.01 - 1.27 
Water 0.00 0.00 300.26 0.00 300.26 
WFI 0.00 41604.18 41593.90 10.28 0.00 
TOTAL 40.07 64282.02 64285.77 36.32 0.00 
 
*Refers to a low inoculum concentration of initial biomass at the start of the process. 
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4.2.1 Overall Material Balance PFD-02 
OVERALL COMPONENT BALANCE (kg/batch) 
COMPONENT INITIAL INPUT OUTPUT FINAL OUT-IN 
Amino Acids 0.00 3.49 3.49 0.00 0.00 
Acetic-Acid 0.00 15.80 15.80 0.00 0.00 
Biomass 0.00 167.26 167.26 0.00 0.00 
Cysteine-HCl 0.00 5.45 5.45 0.00 0.00 
Dead Biomass 0.00 17.14 17.14 0.00 0.00 
EDTA, Disodium 0.00 9.02 9.02 0.00 0.00 
EDTA, Sodium 0.00 11.59 11.59 0.00 0.00 
Glucose 0.00 14.75 14.75 0.00 0.00 
Glutamine 0.00 1.71 1.71 0.00 0.00 
Impurities 0.00 0.00 0.54 0.00 0.54 
Inorganic Salts 0.00 35.72 35.72 0.00 0.00 
Lactate 0.00 118.59 118.59 0.00 0.00 
MAB 0.00 34.32 4.87 0.00 - 29.45 
mAb Fab 0.00 0.00 19.09 0.00 19.09 
mAb Fc 0.00 0.00 9.82 0.00 9.82 
Nitrogen 30.56 13.97 13.80 30.73 0.00 
Other Media Components 0.00 0.31 0.31 0.00 0.00 
Oxygen 9.28 4.24 4.19 9.33 0.00 
Papain 0.00 1540.43 1540.43 0.00 0.00 
Phosphoric Acid 0.00 240.08 240.08 0.00 0.00 
Polysorbate 80 0.00 0.10 0.10 0.00 0.00 
Sodium Chloride 0.00 5.79 5.79 0.00 0.00 
Sodium Citrate 0.00 2.85 2.85 0.00 0.00 
Sodium Hydroxide 0.00 87.33 87.33 0.00 0.00 
Sodium Phosphate 0.00 4.20 4.20 0.00 0.00 
TRIS Base 0.00 5.79 5.79 0.00 0.00 
TRIS HCl 0.00 224.16 224.16 0.00 0.00 
Vitamins 0.00 0.15 0.15 0.00 0.00 
Water 0.00 19696.99 19696.99 0.00 0.00 
WFI 0.00 48806.42 48806.42 0.00 0.00 
TOTAL 39.84 71067.63 71067.41 40.06 0.00 
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4.3.1 Overall Material Balance PFD-02a 
OVERALL COMPONENT BALANCE (kg/batch) 
COMPONENT INITIAL INPUT OUTPUT FINAL OUT-IN 
Amino Acids 0.00 0.29 0.29 0.00 0.00 
Acetic-Acid 0.00 67.11 67.11 0.00 0.00 
Biomass 0.00 184.88 184.88 0.00 0.00 
Dead Biomass 0.00 18.94 18.94 0.00 0.00 
EDTA, Sodium 0.00 49.20 49.20 0.00 0.00 
Glucose 0.00 1.23 1.23 0.00 0.00 
Glutamine 0.00 0.14 0.14 0.00 0.00 
Impurities 0.00 0.00 0.95 0.00 0.95 
Inorganic Salts 0.00 2.98 2.98 0.00 0.00 
Lactate 0.00 131.08 131.08 0.00 0.00 
mAb 0.00 37.94 36.98 0.00 - 0.954 
Nitrogen 33.52 18.21 17.81 33.92 0.00 
Other Media Components 0.00 0.03 0.03 0.00 0.00 
Oxygen 10.18 5.53 5.41 10.30 0.00 
Phosphoric Acid 0.00 199.19 199.19 0.00 0.00 
Polysorbate 80 0.00 0.09 0.09 0.00 0.00 
Sodium Chloride 0.00 24.60 24.60 0.00 0.00 
Sodium Citrate 0.00 12.09 12.09 0.00 0.00 
Sodium Hydroxide 0.00 112.27 112.27 0.00 0.00 
TRIS Base 0.00 24.60 24.60 0.00 0.00 
TRIS HCl 0.00 73.81 73.81 0.00 0.00 
Vitamins 0.00 0.01 0.01 0.00 0.00 
Water 0.00 19728.62 19728.62 0.00 0.00 
WFI 0.00 80412.48 80412.48 0.00 0.00 
TOTAL 43.69 101105.34 101104.81 44.22 0.00 
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4.4.1 Overall Material Balance PFD-03a 
OVERALL COMPONENT BALANCE (kg/batch) 
COMPONENT INITIAL INPUT OUTPUT FINAL OUT-IN 
2-MEA 0.00 0.08 0.08 0.00 0.00 
Amino Acids 0.00 3.49 3.49 0.00 0.00 
Biomass 0.00 167.26 167.26 0.00 0.00 
Dead Biomass 0.00 17.14 17.14 0.00 0.00 
EDTA, Sodium 0.00 432.20 432.20 0.00 - 0.00 
F(ab')2 Fragments 0.00 0.00 0.92 0.00 0.92 
Glucose 0.00 14.75 14.75 0.00 0.00 
Glutamine 0.00 1.71 1.71 0.00 0.00 
HCl 0.00 0.02 0.02 0.00 0.00 
Impurities 0.00 0.00 0.98 0.00 0.98 
Inorganic Salts 0.00 35.77 35.77 0.00 0.00 
Lactate 0.00 118.59 118.59 0.00 - 0.000 
mAb 0.00 34.32 4.77 0.00 - 29.55 
mAb Fab  0.00 0.00 14.31 0.00 14.31 
mAb Fc  0.00 0.00 13.33 0.00 13.33 
Nitrogen 49.10 33.83 34.81 48.11 - 0.00 
Other Media Components 0.00 0.31 0.31 0.00 0.00 
Oxygen 14.91 10.27 10.57 14.61 - 0.00 
Pepsin 0.00 1540.43 1540.43 0.00 0.00 
Phosphoric Acid 0.00 400.60 400.60 0.00 0.00 
Sodium Acetate 0.00 51.17 51.17 0.00 - 0.00 
Sodium Chloride 0.00 12965.87 12965.87 0.00 - 0.00 
Sodium Hydroxide 0.00 93.39 93.39 0.00 0.00 
Sodium Phosphate 0.00 4082.05 4082.05 0.00 - 0.00 
TRIS HCl 0.00 206.78 206.78 0.00 0.00 
Vitamins 0.00 0.15 0.15 0.00 0.00 
Water 0.00 15220.82 15220.82 0.00 - 0.00 
WFI 0.00 75680.08 75680.08 0.00 - 0.00 
TOTAL 64.00 111111.03 111112.31 62.73 0.00 
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4.5.1 Overall Material Balance PFD-03b 
OVERALL COMPONENT BALANCE (kg/batch) 
COMPONENT INITIAL INPUT OUTPUT FINAL OUT-IN 
2-MEA 0.00 0.01 0.01 0.00 0.00 
Amino Acids 0.00 0.00 0.00 0.00 0.00 
Acetic-Acid 0.00 0.51 0.51 0.00 0.00 
Dead Biomass 0.00 0.01 0.01 0.00 0.00 
EDTA, Sodium 0.00 25.57 25.57 0.00 0.00 
Glucose 0.00 0.01 0.01 0.00 0.00 
Glutamine 0.00 0.00 0.00 0.00 0.00 
Impurities 0.00 0.23 0.23 0.00 0.00 
Inorganic Salts 0.00 0.03 0.03 0.00 0.00 
Lactate 0.00 0.08 0.08 0.00 0.00 
mAb 0.00 0.02 0.02 0.00 0.00 
MAb Fab Fragments 0.00 14.31 14.31 0.00 0.00 
MAb Fc Fragments 0.00 0.23 0.23 0.00 0.00 
Nitrogen 5.21 5.58 5.43 5.37 0.00 
Other Media Components 0.00 0.00 0.00 0.00 0.00 
Oxygen 1.58 1.70 1.65 1.63 0.00 
Phosphoric Acid 0.00 82.73 82.73 0.00 0.00 
Polysorbate 80 0.00 0.09 0.09 0.00 0.00 
Sodium Acetate 0.00 0.19 0.19 0.00 0.00 
Sodium Chloride 0.00 756.15 756.15 0.00 0.00 
Sodium Citrate 0.00 0.09 0.09 0.00 0.00 
Sodium hydroxide 0.00 50.31 50.31 0.00 0.00 
Sodium Phosphate 0.00 238.00 238.00 0.00 0.00 
TRIS Base 0.00 0.19 0.19 0.00 0.00 
TRIS HCl 0.00 3.50 3.50 0.00 0.00 
Vitamins 0.00 0.00 0.00 0.00 0.00 
Water 0.00 7460.49 7460.49 0.00 0.00 
WFI 0.00 15557.20 15557.20 0.00 0.00 
TOTAL 6.79 24197.25 24197.04 7.00 0.00 
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4.6.1 Overall Material Balance PFD-04 
OVERALL COMPONENT BALANCE (kg/batch) 
COMPONENT INITIAL INPUT OUTPUT FINAL OUT-IN 
2-MEA 0.00 0.00 0.00 0.00 0.00 
Amino Acids 0.00 0.00 0.00 0.00 0.00 
Acetic-Acid 0.00 0.01 0.01 0.00 0.00 
EDTA, Sodium 0.00 0.67 0.67 0.00 0.00 
Glucose 0.00 0.00 0.00 0.00 0.00 
Glutamine 0.00 0.00 0.00 0.00 0.00 
Impurities 0.00 0.09 0.09 0.00 0.00 
Inorganic Salts 0.00 0.00 0.00 0.00 0.00 
Lactate 0.00 0.00 0.00 0.00 0.00 
mAb Fab Fragments 0.00 14.31 14.31 0.00 0.00 
MES 0.00 104.52 104.52 0.00 0.00 
Nitrogen 22.80 0.00 20.52 2.28 0.00 
Other Media Components 0.00 0.00 0.00 0.00 0.00 
Oxygen 6.92 0.00 6.23 0.69 0.00 
Phosphoric Acid 0.00 84.26 84.26 0.00 0.00 
Polysorbate 80 0.00 0.09 0.09 0.00 0.00 
Sodium Acetate 0.00 0.01 0.01 0.00 0.00 
Sodium Chloride 0.00 102.81 102.81 0.00 0.00 
Sodium Hydroxide 0.00 48.08 48.08 0.00 0.00 
Sodium Phosphate 0.00 6.36 6.36 0.00 0.00 
TRIS Base 0.00 18.71 18.71 0.00 - 0.000 
TRIS HCl 0.00 0.08 0.08 0.00 0.00 
Vitamins 0.00 0.00 0.00 0.00 0.00 
Water 0.00 28322.06 28322.06 0.00 0.00 
WFI 0.00 22975.18 22975.18 0.00 - 0.000 
TOTAL 29.72 51677.23 51703.98 2.97 0.00 
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4.7.1 Overall Material Balance PFD-05 
OVERALL COMPONENT BALANCE (kg/batch) 
COMPONENT INITIAL INPUT OUTPUT FINAL OUT-IN 
2-MEA 0.00 8.90 8.90 0.00 0.00 
EDTA, Disodium 0.00 2.21 2.21 0.00 0.00 
EDTA, Sodium 0.00 5.64 5.64 0.00 0.00 
Impurities 0.00 0.00 0.00 0.00 0.00 
mAb Fab Fragments 0.00 12.89 0.64 0.00 - 12.242 
MacroCap SP 2026.87 0.00 2026.87 0.00 0.00 
MES 0.00 0.46 0.46 0.00 0.00 
Nitrogen 14.53 5.63 5.36 14.79 - 0.000 
Oxygen 4.41 1.71 1.63 4.49 - 0.000 
PEG 0.00 225.48 216.17 0.00 - 9.304 
PEGylated mAb Fragments 0.00 0.00 20.93 0.00 20.93 
Phosphate 0.00 109.60 109.60 0.00 0.00 
Phosphoric Acid 0.00 231.33 231.33 0.00 0.00 
Reduced mAb Fab Fragments 0.00 0.00 0.61 0.00 0.61 
Sodium Chloride 0.00 103.85 103.85 0.00 - 0.000 
Sodium hydroxide 0.00 76.62 76.62 0.00 0.00 
TRIS Base 0.00 15.25 15.25 0.00 0.00 
Water 0.00 23242.95 23242.95 0.00 0.00 
WFI 0.00 43496.39 43496.39 0.00 - 0.000 
TOTAL 2045.81 67538.89 69565.42 19.29 0.00 
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4.8.1 Overall Material Balance PFD-06 
OVERALL COMPONENT BALANCE (kg/batch) 
COMPONENT INITIAL INPUT OUTPUT FINAL OUT-IN 
Impurities 0.00 0.00 0.00 0.00 0.00 
KCl 0.00 0.00 0.00 0.00 0.00 
KH2PO4 0.00 0.00 0.00 0.00 0.00 
mAb Fab Fragments 0.00 0.00 0.00 0.00 0.00 
Na2HPO4 0.00 0.42 0.42 0.00 0.00 
Nitrogen 1.24 0.43 0.43 1.24 0.00 
Oxygen 0.38 0.13 0.13 0.38 0.00 
PEGylated mAb Fragments 0.00 18.89 18.42 0.00 - 0.472 
Phosphate 0.00 0.24 0.24 0.00 0.00 
Phosphoric Acid 0.00 30.85 30.85 0.00 0.00 
Sodium Chloride 0.00 10.32 10.32 0.00 0.00 
Sodium Hydroxide 0.00 8.38 8.38 0.00 0.00 
Water 0.00 5968.23 5968.23 0.00 0.00 
WFI 0.00 4301.37 4301.85 0.00 0.47 
TOTAL 1.61 10339.26 10339.26 1.61 0.00 
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5.0 Production Process Description 
5.1 Preliminary Steps (BFD-01) 
 5.1.1 Buffer Preparation 
 Buffers needed for the process are prepared in sterile disposable containers located in a 
buffer prep room. This greatly aids in quality and compliance. Disposable containers eliminate 
the requirements for clean in place (CIP) and steam in place (SIP) validation (See Appendix A), 
especially in-process quality control (QC) documentation, service, and calibration requirements. 
In addition, disposables eliminate the possibility of residual carryover from batch to batch and 
contamination with CIP agents.  
Buffers, in most cases, will be diluted in-line with water for injection (WFI). Once at full 
volume, the buffers will be tested and verified to make sure that they are at the proper pH. If the 
buffers are incorrectly prepared, they will need to be adjusted before a calculated amount is 
placed in individual transfer bags for use in the process.  Before any buffer is added to any of the 
bioreactors, it must first pass through a 0.2 µm sterile filter to ensure that any bacteria or other 
contaminants have been properly removed. 
5.1.2 Media Preparation 
 EX-CELL® ACF CHO Serum Free Medium purchased from Sigma-Aldrich® is used 
exclusively for this process. For the initial inoculum steps in which small volumes of media are 
needed, a liquid form of the media purchased directly from Sigma-Aldrich® is used, while a 
powdered version of the media mixed with WFI in storage/mixing tanks is used for the seed 
bioreactor sections through the production bioreactor section. The solution will be 2% by mass 
powdered media and 98% by mass WFI. Both forms of media come from the same lot of 
material so the cells will experience no changes due to the use of powdered versus liquid media 
as they travel through the process. Before any media is added to any of the bioreactors, it must 
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first pass through a 0.2 µm sterile filter to ensure that any bacteria or other contaminants have 
been properly removed. 
5.2 Inoculum Prep Section (BFD-01) 
5.2.1 T-Flasks (TFR-101) 
 First, a provided vial of cells from R&D is removed from a freezer and stored in a 
biosafety cabinet until fully thawed. Once thawed, the cells are resuspended in fresh media and 
centrifuged. The supernatant is discarded. Twenty 225 mL Nunc non-treated, sterile t-flasks are 
then each initially inoculated with one million of these cells and 106 mL of serum free media 
using serological pipettes. Each t-flask thus has a working volume of 50% to allow for proper 
agitation as recommended by Nunc International from which these t-flasks are being purchased. 
The t-flasks are stored on rockers in an incubator at 37°C over the course of 4 days. The media 
will equilibrate around a neutral pH of 7.0. However, this is considered to be an uncontrolled 
system so the pH may range anywhere from 6.5 to 7.5. The incubator allows for necessary 
aeration so that the cells can obtain the oxygen they need for growth. However, limitations due to 
oxygen are expected. 
5.2.2 Roller Bottles (RBR-101) 
 Next, the cultures from the t-flasks are pooled together in a sterile glass vessel. A sterile 
serological pipette is used to transfer about 196 mL of culture to each of eleven 2.2 L standard 
roller bottles. An additional 800 mL of fresh serum free media is added to each of these bottles 
such that each roller bottle has a working volume of 50% to allow for proper agitation as 
recommended by the manufacturer Nunc International. The roller bottles are stored in a 
rotational incubator at 37°C over the course of 4 days. Again, the media will equilibrate around a 
neutral pH of 7.0 despite this being an uncontrolled system with a pH that may range anywhere 
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from 6.5 to 7.5. The incubator allows for necessary aeration so that the cells can obtain the 
oxygen they need for growth. However, limitations due to oxygen are expected. 
5.2.3 Bag Bioreactor 1 (BBS-101) 
 The cultures are then pooled two at a time in a sterile glass vessel. 1.38 L of culture are 
transferred from this vessel with connected tubing via a peristaltic pump on a movable cart to 
each of eight 20 L bag bioreactors. An additional 7.5 L of fresh serum free media is added to 
each of these disposable bags such that each has a working volume of 50% to allow for proper 
mixing as recommended by Sartorius Stedim Biotech. Process control is achieved through 
disposable optical chemical pH and dissolved oxygen (DO) sensors with feedback control of 
both values being available for the process. The temperature is kept at 37°C over the course of 4 
days. The pH is maintained at 7.0, which is recommended for CHO cell growth, while the 
dissolved oxygen level is maintained at 50%. The bag bioreactor allows for necessary aeration so 
that the cells can obtain the oxygen they need for growth. 
5.2.4 Bag Bioreactor 2 (BBS-102) 
 Next, the cultures are transferred from the eight 20 L bag bioreactors via a peristaltic 
pump on a movable cart to seven 100 L bag bioreactors. An additional 35.7 L of fresh serum free 
media is added to each of these disposable bags such that each has a working volume of 50% to 
allow for proper agitation as recommended by Sartorius Stedim Biotech. Process control is 
achieved through disposable optical chemical pH and DO sensors with feedback control of both 
values being available for the process. The temperature is kept at 37°C over the course of 4 days. 
The pH is maintained at 7.0, while the dissolved oxygen level is maintained at 50%. The package 
allows for necessary aeration so that the cells can obtain the oxygen they need for growth. 
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5.3 Seed Bioreactor Sections (BFD-02 / BFD-03) 
5.3.1 Seed Bioreactor 1 (SBR-101) 
 Following the 4 days of time in the second set of bag bioreactors, the cells are transferred 
from the seven 100 L bag bioreactors via a peristaltic pump on a movable cart to a 1500 L seed 
bioreactor. As described in the media preparation section (5.1.2), about 667 L of fresh serum free 
media is prepared and added to the bioreactor after passing through a sterile filter to remove 
possible contaminants such as bacteria. Seed bioreactor 1 has a working volume of 70% to allow 
for proper agitation with an installed agitator. Process control is achieved using a package 
provided by ABEC. The temperature is kept at 37°C over the course of 4 days with a pH of 7.0 
and a DO level of 50%.  
5.3.2 Seed Bioreactor 2 (SBR-102) 
The cells must then be transferred from the 1500 L bioreactor, via a permanent peristaltic 
pump, to a 4500 L seed bioreactor for additional scale up. About 2066 L of fresh serum free 
media is prepared and added to the bioreactor after passing through a sterile filter to remove 
possible contaminants such as bacteria. Seed bioreactor 2 has a working volume of 70% to allow 
for proper agitation with an installed agitator. Process control is achieved using a control 
package provided by ABEC. The temperature is kept at 37°C over the course of 4 days with a pH 
of 7.0 and a DO level of 50%.  
5.4 Production Bioreactor Section (BFD-04) 
5.4.1 Production Bioreactor (PBR-101) 
In order to obtain a 3.5 g/L titer of monoclonal antibodies in solution, the cells must be 
transferred to a 14,000 L fed-batch production bioreactor, via a permanent peristaltic pump, 
where they are allowed to continue to grow and secrete this valuable product. Serum free media 
and glucose will be incrementally added throughout the process in order to obtain the desired 
Flexible Manufacturing Facility for Biopharmaceuticals 
 
-37- 
 
titer level. About 2066 L of fresh serum free media is prepared and added to the bioreactor at the 
very start of fermentation while additional amounts will be added over the course of 12 days. 
The production bioreactor has a working volume of 70% to allow for proper agitation with an 
installed agitator. Process control is achieved using a control package provided by ABEC, and 
the temperature will be maintained at 37°C with a set point pH of 7.0. Two production 
bioreactors of equal size are staggered in order to provide a greater capacity and output of 
monoclonal antibodies that also reduces the amount of idle cycle time. See the scheduling 
section for more information. 
5.5 Primary Recovery Section (BFD-05) 
5.5.1 Harvest Tank (P-26/V-201) 
 After the harvest tank is initially sterilized with SIP operations, the contents of the 
production bioreactor are transferred to this unit though a peristaltic pump. The tank is 
maintained at 1-2 psig and 25ºC. The pH of the harvest tanks is adjusted to 7.0 with 0.1 M 
H3PO4. Once these measures have taken place, the product is ready to be purified. As a safety 
precaution, all wastes removed from this section of the process are collected in a biowaste tank, 
and sterilized by heating to 180 ºC. After the product stream fully exits the harvest tank, this unit 
is cleaned with CIP operations. 
5.5.2 Centrifugation (P-28/DS-201) 
 The generated biomass and other suspended components are removed using a Disc-Stack 
centrifuge (DS-201). The centrifuge is operated at 25ºC, with a throughput of 2,000 L/h. During 
this step, roughly 2% of the monoclonal antibody is lost in the solids waste stream, resulting in a 
product yield of 98%. The supernatant containing the monoclonal antibody then passes through a 
0.2 μm sterile filter before entering a centrifugation pool tank (P-32/V-202) to await further 
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processing. The centrifuge and centrifugation holding tank are sterilized through SIP and CIP 
operations. The sterile filtration membranes are disposed of after each batch. 
5.6 Pepsin Cleavage (BFD-06a) 
5.6.1 Diafiltration (P-35/DF-201) 
 Following centrifugation, the product-containing stream is split and passes through two 
diafiltration units to concentrate the stream from 3.56 g/L to 10.36 g/L of mAb, thus preparing it 
for pepsin cleavage. Filters are used with a pore size which correlates to a molecular weight 
cutoff (MWCO) of 30 kDa so that 150 kDa mAbs are retained. The diafiltration unit is 
maintained at 25ºC, and has a pressure change of 43.5 psig associated with it. This diafiltration 
system, including reusable membranes, is sterilized through SIP and CIP operations after each 
batch. 
5.6.2 Pepsin Cleavage (P-36/R-201) 
 Upon entering the cleavage reactor, the concentrated monoclonal antibody stream is 
mixed with an equal amount of digestion buffer (made up of 20 mM sodium acetate and pH 
adjusted to 4.5 using hydrogen chloride). Pepsin (immobilized on 6% cross-linked beaded 
agarose) is then transferred into the reactor, and the reaction vessel is heated to 37ºC. The reactor 
is maintained at this temperature with constant agitation for 5 hours. The cleavage reaction 
produces one F(ab’)2 fragment and one Fc fragment from each individual antibody (see figure 
2.3). The reaction vessel is sterilized with SIP and CIP operations. 
5.6.3 Plate and Frame Filtration (P-38/PFF-201) 
 Following the cleavage reaction, the immobilized pepsin is removed from the product 
stream through plate and frame (P&F) filtration. The plate and frame filtration system operates at 
25ºC and has a total filter area of 23.23 m2. Following the initial filtration, the filter cake is 
washed with 2322.94 L of 10 mM Tris-HCl, pH 7.5 for maximum product recovery. The pepsin 
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removed from this filtration can be washed and reused for additional cleavage reactions, but for 
the purposes of this analysis this has not been model. The enclosed P&F filtration unit is 
sterilized with SIP and CIP procedures. 
5.6.4 Diafiltration (P-42/DF-202) 
 Following P&F filtration, the product stream passes through another diafiltration unit. 
This diafiltration step is used to exchange the buffer of this stream to that necessary for the 
disulfide reduction reaction and concentrate the F(ab’)2 from 4.6 mg/mL to 10 mg/mL. The 
reduction protocol indicates that any similar buffer to that given with a concentration of EDTA 
between 1-10 mM is acceptable for this reaction, so the same buffer is used as that given in the 
protocol and used later in the process for the PEGylation reaction. This reduction buffer is made 
up of 2.0 mM EDTA and 0.1 M sodium phosphate at a pH of 6.0. Filters are used with a MWCO 
of 30 kDa so that 100 kDa F(ab’)2 fragments are retained, while some of the very small degraded 
Fc fragments (< 50 kDa) created during the cleavage reaction are filtered out. The diafiltration 
unit is maintained at 25ºC, and has a pressure change of 43.5 psig associated with it. Cleaning is 
performed before and after every batch using CIP and SIP procedures. 
5.6.5 Disulfide Reduction (P-44/R-202) 
 Once the F(ab’)2 fragments are produced in the cleavage reaction and transferred to 
reduction buffer in the diafiltration step, they are ready to go into the disulfide reduction reactor. 
The hinge region disulfide bonds are broken by the mild reducing agent 
2-Mercaptoethylamine·HCl (2-MEA), which will only reduce these bonds unlike stronger thiols 
which may also reduce the disulfide bonds between the heavy and light chains of the Fab’ 
fragments (Humphreys et al., 2007). This reaction then gives two 50 kDa Fab fragments from 
each F(ab’)2 molecule, each of which retains a portion of the hinge region, including a cysteine 
(See Figure 2.4). This cysteine contains a thiol group which can then be specifically PEGylated 
later in the process (Humphreys et al., 2007). 2-MEA at a concentration of 50 mM is reacted 
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with the F(ab’)2 stream in reduction buffer at 37ºC for 90 minutes in order for this reaction to 
occur. The reactor is then returned to room temperature (25ºC). Validated cleaning is performed 
before and after every batch using CIP and SIP procedures.  
5.6.7 Diafiltration (P-47/DF-203) 
 After the reduction reaction goes to completion, the product stream is split and passes 
through another diafiltration unit. This diafiltration step is used to exchange the reduction buffer 
with WFI so that the Fab’ fragments can go into the Protein-A chromatography column, while 
maintaining the same Fab’ concentration of 10 mg/ml. Filters are used with a MWCO of 10 kDa 
so that 50 kDa Fab’ fragments are retained, while any remaining 2-MEA (114 Da) from the 
reduction reaction are filtered out. The diafiltration unit is maintained at 25ºC, and has a pressure 
change of 14.5 psig associated with it. Cleaning is performed before and after every batch using 
CIP and SIP procedures. 
5.7 Protein A Chromatography (BFD-07) 
5.7.1 Protein A Chromatography (P-49/C-201) 
 This chromatography step is used to purify the monoclonal antibody Fab’ fragments and 
remove the bulk of contaminant (unwanted) proteins in the production stream. The Fc fragments 
produced during the cleavage reaction bind to this affinity chromatography column, and can thus 
be separated from the Fab’ products. Before loading the product stream onto the column, the 
column and skid undergo some preparatory steps. First, the system is drained to remove the 
storage solution (regeneration buffer). The skid and column are cleaned by flushing with WFI, 
and then equilibrated by flushing with equilibration buffer. All wastes are drained into the 
neutralization waste tank.  
 The product stream is then loaded into the column with a linear velocity of 200 cm/h. The 
resin in use, nProtein A sepharose, has a binding capacity of 50 g/l. After loading, the column is 
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washed with Wash Buffer. The column is then eluted isocratically with an eluant volume five 
packed bed volumes. The yield for the mAb Fab’ fragments for this step is 90%. 
 The column is regenerated with regeneration buffer, and then cleaned in place using a 
separate chromatographic rig CIP, which involves a wash with 0.1M NaOH, followed by a wash 
with WFI.  
5.8 Chemical Virus Inactivation (BFD-08) 
5.8.1 Diafiltration (P-54/DF-204) 
 The protein solution then passes through a sterile filtration unit to a diafiltration system. 
The stream is concentrated 5X and diafiltered 2X. The yield on product is 97%, as a small 
percentage is denatured in the process. This diafiltration step removes salts, solvents and other 
unwanted components from the solution, resulting in a higher concentration of cleaved 
monoclonal antibody. Filters are used with a MWCO of 10 kDa so that 50 kDa Fab’ fragments 
are retained. This diafiltration is operated at 25°C. The diafiltration system is cleaned with SIP 
and CIP procedures.  
5.8.2 Chemical Virus Inactivation (P-56/V-207) 
 The concentrated protein solution is chemically treated for 1.5 hours with polysorbate 80 
to inactivate enveloped viruses. Polysorbate 80 (also known as Tween 80) is an extremely mild 
and effective oil-in-water emulsifier and solubilizer. This chemical disrupts the interactions 
between molecules in the lipid coat of viruses, rendering the coat dysfunctional and impeding 
replication. This process operates at 25°C. The chemical virus inactivation tank is later cleaned 
with SIP and CIP procedures. 
5.9 Ion Exchange Chromatography (BFD-09/BFD-10) 
Ion exchange chromatography makes use of the charge properties of molecules to 
separate them. By changing both the ionic concentration and the pH of a solution, the charge of a 
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molecule can be manipulated, allowing it to bind to opposite charged resins that are packed in a 
column.  
5.9.1 Cation Exchange Chromatography (P-68/C-301) 
Cation exchange chromatography is used to bind positively charged molecules to its 
negatively charged resins. The Fab is positively charged under acidic conditions, such as Cation 
Buffer A (pH 5.5), and binds to the cation exchange resin, Toyopearl Gigacap S-650M. The 
column is manufactured by GE-Healthcare and is a Chromaflow 1000 column. The column is 1.0 
m in diameter, 0.50 m tall, and has a bed height of 0.137 m and a column volume of 392.7 L. 
The distributor is made of polypropylene; the seals are made of FEP-encapsulated silicone; and 
the remaining parts are made of 316L stainless steel.  
After loading the column with the resin, the column is equilibrated with five column 
volumes of Cation Buffer A using the Cat-Equil stream from tank V-301. Cation Buffer A 
contains MES (2-(N-morpholino)ethanesulfonic acid) at a pH of 5.5. MES was chosen instead of 
the more common acetate buffers because acetate buffers need to be used at a pH of 4.5, which 
can lead to insolubility, denaturation, and loss of activity of the Fab. The incoming solution 
containing the Fab will first be mixed online in a 1:9 ratio with Cation Buffer A and loaded into 
the column. At lower pH, the monoclonal antibody fragment has a positive net charge, allowing 
it to bind to the negatively charged resin. Because only the monoclonal antibody fragments bind, 
other impurities, such as host cell proteins and any leached Protein A particles flow through to a 
waste stream (Waste-15). The beads are then washed with 5 column volumes of Cation Buffer A 
using the Cat-Wash stream to remove any extra waste still in the resin. The Fab fragments are 
then eluted in a gradient with 15 column volumes of Cation Buffer B (stream Cat-Elute from 
tank V-302, diluted with Cat-WFI), which contains sodium chloride, a salt that disrupts the ionic 
binding between the resin and the fragments. Complete stripping and regeneration of the column 
is then performed with 5 column volumes of Cation Buffer B to completely remove all 
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substances bound to the column, allowing it to be reused. Clean-In-Place is then performed using 
a separate chromatographic rig, which involves a wash with 0.1M NaOH, followed by a wash 
with WFI. 
5.9.2 Anion Exchange Chromatography (P-71/C-302) 
Anion exchange chromatography is then used to bind negatively-charged molecules to its 
positively charged resin (Toyopearl SuperQ-650M). The column is run in flow-through mode, 
meaning the monoclonal antibody fragments will not bind, but will instead flow through the 
column due to its positive charge. The molecules that do bind to the column are negatively-
charged and include DNA, retrovirus, and endotoxins, all of which are extremely undesirable 
molecules. The column is manufactured be GE-Healthcare and is a Chromaflow 600 column. It 
is 0.6 m in diameter, 0.5 m tall, with a bed height of 0.205 m. It is a smaller version of the cation 
exchange column, and is made of the same materials: 316L stainless steel body, polypropylene 
distributor, and silicone seals.  
With the resin already loaded into the chromatography column, the column is then 
equilibrated with 5 column volumes of Anion Buffer A fed from stream Anion-Equil from tank 
V-304. Anion Buffer A, which contains Tris and NaCl at a pH of 7.5, changes the conductivity 
of the monoclonal antibody solution to ensure the proper conditions for flow-through. Stream S-
302 will first be mixed in tank V-303 with Anion Buffer A from stream Anion-Load and then 
loaded into anion exchange column C-302. The column binds any negatively charged particles, 
such as DNA, endotoxin, and retrovirus. The flow-through contains the monoclonal antibody 
fragment and is collected in storage tank V-306. The beads are then eluted with 2 column 
volumes of Anion Buffer A to ensure no product is retained in the resin. The column is then 
stripped and regenerated with 8 column volumes of Anion Buffer B, which contains a higher 
concentration of sodium chloride than Anion Buffer A and is used to disrupt the ionic 
interactions between the resin and any bound particles. The waste from stripping and 
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regeneration is output through Waste-16. CIP procedures are then performed using a separate 
chromatographic rig, which involves a wash with 0.1M NaOH, followed by a wash with WFI. 
5.10 PEGylation: Thiol Reduction (BFD-11) 
5.10.1 Diafiltration (P-81/DF-401) 
 Following the ion exchange chromatography steps, the product stream is split and passes 
through another diafiltration unit. This diafiltration step is used to exchange the buffer of this 
stream to the buffer that is necessary for the disulfide reduction reaction. In addition, this 
diafiltration process will concentrate the Fab’ fragments from 3.9 mg/ml to 10 mg/ml. The 
reduction protocol indicates that any similar buffer to that given, with a concentration of EDTA 
between 1-10mM, is acceptable for this reaction. Therefore, the same buffer is used for this 
reaction as that which is utilized for the PEGylation reaction (Humphreys 2007). This reduction 
buffer is made up of 2.0 mM EDTA and 0.1 M Sodium Phosphate, pH 6.0. Filters are used with 
a MWCO of 30 kDa so that 50 kDa Fab’ fragments are retained. The diafiltration unit is 
maintained at 25ºC, and has a pressure change of 14.5 psig associated with it. Cleaning is 
performed before and after every batch using CIP and SIP procedures. 
5.10.2 Thiol Reduction (P-83/R-401) 
 Now that the Fab’ fragments are purified using chromatography, any thiols that may have 
become attached to the available cysteine during these steps must be reduced. 2-
Mercaptoethylamine·HCl (2-MEA) can also be used for this purpose (Carter et al., 1992). 
Cysteine contains a thiol group which can then be specifically PEGylated later in the process 
(Humphreys et al., 2007). 2-MEA at a concentration of 50 mM is reacted with the F(ab’)2 stream 
in reduction buffer at 37ºC for 90 minutes in order for this reaction to occur. The reactor is then 
returned to 25ºC. Validated cleaning is performed before and after every batch using CIP and 
SIP procedures. 
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5.11 PEGylation Reaction (BFD-12) 
5.11.1 Diafiltration (P-86/DF-402) 
 After the reduction reaction goes to completion, the product stream is split and passes 
through another diafiltration unit. This diafiltration step is used to remove any remaining 2-MEA 
(114 Da) from the reduction reaction while maintaining the same Fab’ concentration of 10 mg/ml 
in PEGylation reaction buffer (which is the same as reduction reaction buffer). Filters are used 
with a MWCO of 10 kDa so that 50 kDa Fab’ fragments are retained. The diafiltration unit is 
maintained at 25ºC, and has a pressure change of 14.5 psig associated with it. Cleaning is 
performed before and after every batch using CIP and SIP procedures. 
5.11.2 PEGylation Reaction (P-88 / R-402) 
 Once any thiols attached to the Fab’ fragments are reduced, the molecules are ready to go 
into the PEGylation reactor. The hinge region cysteine that remains on the 50 kDa Fab’ 
fragments after pepsin cleavage and disulfide reduction is available to be specifically PEGylated 
with a 40 kDa thiol-reactive PEG molecule. The reaction occurs in PEGylation buffer containing 
the Fab’ fragments and a 1:2 molar excess of PEG at 25ºC for 2 hours. Validated cleaning is 
performed before and after every batch using CIP and SIP procedures. 
5.11.3 Diafiltration (P-91/DF-403) 
 After the PEGylation reaction goes to completion, the product stream is split and passes 
through another diafiltration unit. This diafiltration step is used maintain the same Fab’ 
concentration of 10 mg/ml, but switch buffers from PEGylation reaction buffer to WFI. Filters 
are used with a MWCO of 30 kDa so that 90 kDa PEGylated Fab’ products are retained. The 
diafiltration unit is maintained at 25ºC, and has a pressure change of 14.5 psig associated with it. 
Cleaning is performed before and after every batch using CIP and SIP procedures. 
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5.12 Cation Exchange Chromatography (BFD-13) 
5.12.1 Cation Exchange Chromatography Column (P-101/C-401) 
This cation exchange chromatography column contains a negatively charged, 
biopharmaceutical-grade MacroCap SP resin which specifically binds PEGylated proteins, which 
are positive under acidic conditions. This resin exploits the fact that PEG molecules are neutral, 
meaning that the mono-PEGylated proteins will have a lower charge than any unreacted (non-
PEGylated) Fab’ fragments while having a higher charge than the excess PEG molecules. This 
column will be used to separate the PEGylated Fab’ fragments with a very high specificity, 
resulting in 99% recovery of the desired protein product. 
The resin consists of a matrix made of a cross-linked copolymer of allyl dextran and N,N-
methylene bisacrylamide, which has a binding capacity of 150 mg/ml and a total ionic capacity 
of 0.10 to 0.13 mmol H+/ml medium. The matrix is very porous, so there is a large amount of 
surface area for the large protein product to bind. The resin will be packed in a bed of volume 
154.46 L in a Chromaflow 1000 Stainless Steel 316L column of volume 617.85 L total. The 
linear velocity in the column is 120 cm/h. Cation Buffer 1 is used for equilibration, loading, and 
washing and consists of 0.2 M phosphate in WFI. Cation Buffer 2 is used for elution and 
stripping and consists of 0.02 M phosphate (pH 6.8) and 1 M NaCl in WFI.  
After the resin bed is packed in the column, it is equilibrated with Cation Buffer 1 from 
the holding tank where this buffer is prepared and stored. Before loading the PEG-Fab’ stream 
into the column, this stream is mixed with acidic Cation Buffer 1, in which Fab’ fragments will 
exhibit positive charge. The beads are washed with Cation Buffer 1 to remove any waste or 
unbound particles still in the resin. The PEG-Fab’ fragments (and non-PEGylated Fab’ 
fragments) are eluted in a gradient with 20 column volumes of Cation Buffer 2, which contains 
sodium chloride, a salt that disrupts the ionic binding between the resin and the fragments. Since 
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PEG-Fab’ fragments are less positively charged than PEG molecules, but more positively 
charged than non-PEGylated proteins, the desired protein will elute in between the PEG and 
Fabs. This is why a gradient must be used to collect the desired product, after it is experimentally 
determined which column volumes the PEG-Fab’ will elute into. Once the product is recovered, 
the column is stripped and regenerated with Cation Buffer 2 to completely remove anything still 
bound to the resin. Once this is validated, the column and resin can be reused for the next batch. 
Finally, the column is Cleaned-In-Place using a chromatographic rig that will wash the 
equipment with 0.1M NaOH and then rinse it with WFI. 
5.13 Final Filtration and Packaging (BFD-14) 
5.13.1 Diafiltration (P-104/DF-501) 
Diafiltration is a process used to filter out different substances by molecular weight, 
while exchanging buffers. In this case, the reagents and impurities from previous downstream 
purification processes such as PEGylation and Ion Exchange Chromatography will be filtered 
out, leaving the PEGylated monoclonal antibody fragment in its final buffer. Using filters with a 
30 kDa MWCO, purified water flushes small ions and molecules through the membrane, leaving 
the larger PEGylated antibody fragment (90 kDa). The cassette is then diafiltered with phosphate 
buffered saline (PBS). PBS is a buffer solution and its ion and osmolarity concentrations match 
those of the human body and helps maintain a constant pH. Therefore, it is the most ideal final 
buffer solution for any injectable therapeutic. This process is also called a buffer exchange, as 
the previous solution is removed and replaced with PBS.  
5.13.2 Viral Exclusion Filtration (P-106/DE-501, P-107/DE-502) 
While ion exchange chromatography removes some virus particles, a final viral filtration 
step is still necessary to eliminate any possible virus particles from being packaged with the 
monoclonal antibody fragment. Viral filtration is necessary because the mammalian cell line that 
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is used to produce monoclonal antibodies may contain endogenous viruses that may be harmful 
to humans. Also, because viruses are extremely small and can survive for long periods without a 
host, they may also enter the system through raw materials or feed streams. For this reason, viral 
filtration is performed at the end of the process to ensure that all viruses are cleared from the 
system.  
Filtration of viruses is split into two steps: retrovirus filtration and parvovirus filtration. 
Retrovirus filters are capable of removing retroviruses that are generally about 50 nm or larger. 
Parvoviruses, which are about 20 nm, need to be filtered out using filters that are much more 
size-selective. Since the PEGylated monoclonal antibody fragment is about 10 nm, both of these 
filters will allow the desired product to pass through.  
Both retrovirus filtration systems and parvovirus filtration systems consist of normal-flow 
filters that remove the potentially harmful viruses from the product stream. Normal-flow 
filtration, or dead-end filtration, is a filtration mode where the fluid runs perpendicular to the 
filter membrane, trapping the virus in the filter while allowing the target protein to pass through. 
These filters are manufactured by Millipore and are contained within filter housings. A removal 
of a log of virus means that the viral load of the stream will be reduced by a factor of 10. The 
Millipore Viresolve filters remove over 6 logs of retrovirus (or a reduction factor of one million) 
and over 4 logs of parvovirus (a reduction factor of ten thousand), while allowing for greater 
than 98% yield of protein. The filters themselves are disposed of and replaced after each batch to 
ensure sterility. 
5.13.3 Packaging/Freezing (P-108/DCS-101) 
The purified PEGylated monoclonal antibody fragment contained in PBS will need to be 
transported to another company for formulation. However, proteins can denature, become 
unstable or inactive if they are allowed to sit at room temperature. The easiest way to ensure the 
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long term stability of the product is to freeze them down to very cold temperatures (anywhere 
between -20°C to -85°C).  
The product is dispensed into 50 L sterile plastic bags for storage. This is done by the 
SciLog Fillmaster system, which is a pump and valve system that allows for accurate distribution 
of the product. The bags are made of HyQ CX5-14 film, which are sterile, disposable bags 
manufactured by HyClone that can protect the product in ultra low temperatures. The filled bags 
are then frozen in an ultra cold freezer that can operate at temperatures down to -85°C. This will 
ensure long-term stability and prevent denaturation or damage to the product. The frozen product 
will be sent to another facility where it will be lyophilized and bottled for increased shelf life and 
patient delivery.  
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6.0 Plant Utility Requirements 
 The major utility needs of the plant consist of electricity, process water, and steam. 
Electricity is the most expensive of the three and costs approximately $98,000 a year. These 
calculations are based off a $0.08 per kWh rate obtained from NSTAR, a Massachusetts energy 
provider. Operation of process machinery costs roughly $5300 a year, with much of the energy 
consumed by the production bioreactors. The additional equipment actually consumes most of 
the energy in the plant. The HVAC system uses 71% of the electricity in the plant, while the WFI 
still and clean steam generator are the other significant consumers. The table shown in section 
6.1 displays the electricity requirements and related costs. 
 Process water is the other major utility that will be used to produce monoclonal 
antibodies. The plant will require approximately 2.7 million liters of process water a year. This 
water will also be used to generate WFI and steam for buffers and SIP. At a rate of $0.543 per 
1000 liters, a rate obtained from the Aquarion Water Company of Massachusetts, the cost of the 
process water will be approximately $1470 a year.  The cost greatly increases when purifying to 
WFI using WFI stills.  This cost is accounted for in the electricity costs. 
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6.1 Electricity Requirements for Equipment 
Electricity Costs Unit Cost 
 ($/kWh) 
Amount 
(kWh/batch) 
Cost 
 ($/batch) 
Cost/Year ($) 
Upstream     
P-1 0.08 0.08 $0.01 $0.35 
P-3 0.08 1.37 $0.11 $6.03 
P-4 0.08 6.2 $0.50 $27.28 
P-6 0.08 0.03 $0.00 $0.13 
P-8 0.08 0.03 $0.00 $0.13 
P-9 0.08 28.54 $2.28 $125.58 
P-10 0.08 0.07 $0.01 $0.31 
P-12 0.08 0.08 $0.01 $0.35 
P-14 0.08 0.08 $0.01 $0.35 
P-15 0.08 88.52 $7.08 $389.49 
P-16 0.08 0.12 $0.01 $0.53 
P-18 0.08 0.21 $0.02 $0.92 
P-20 0.08 0.21 $0.02 $0.92 
P-22 0.08 0.04 $0.00 $0.18 
P-24 0.08 0.04 $0.00 $0.18 
P-25 0.08 620.11 $49.61 $2,728.48 
Total 0.08 745.73 59.6584 3281.212 
Primary Recovery/Pepsin     
P-27 0.08 0.67 $0.05 $2.95 
P-28 0.08 143.8 $11.50 $632.72 
P-29 0.08 0.6 $0.05 $2.64 
P-31 0.08 0.6 $0.05 $2.64 
P-33 0.08 0.6 $0.05 $2.64 
P-35 0.08 92.78 $7.42 $408.23 
P-36 0.08 0.79 $0.06 $3.48 
P-38 0.08 3.97 $0.32 $17.47 
P-40 0.08 1.15 $0.09 $5.06 
P-42 0.08 33.7 $2.70 $148.28 
P-43 0.08 1.16 $0.09 $5.10 
P-45 0.08 0.17 $0.01 $0.75 
P-47 0.08 34.17 $2.73 $150.35 
P-48 0.08 0.59 $0.05 $2.60 
P-50 0.08 0.59 $0.05 $2.60 
P-52 0.08 0.59 $0.05 $2.60 
P-54 0.08 20.72 $1.66 $91.17 
P-55 0.08 0.12 $0.01 $0.53 
P-57 0.08 0.12 $0.01 $0.53 
Total 0.08 336.89 26.9512 1482.316 
IEX Chromatography     
P-61 0.08 0.01 $0.00 $0.04 
P-62 0.08 0.1 $0.01 $0.44 
P-63 0.08 0.02 $0.00 $0.09 
P-64 0.08 0.02 $0.00 $0.09 
P-65 0.08 0.02 $0.00 $0.09 
P-66 0.08 0.02 $0.00 $0.09 
P-70 0.08 0.15 $0.01 $0.66 
P-73 0.08 0.14 $0.01 $0.62 
P-74 0.08 0.01 $0.00 $0.04 
P-75 0.08 0.01 $0.00 $0.04 
P-76 0.08 0.02 $0.00 $0.09 
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P-79 0.08 0.04 $0.00 $0.18 
Total 0.08 0.56 0.0448 2.464 
PEGylation     
P-81 0.08 39.93 $3.19 $175.69 
P-82 0.08 0.06 $0.00 $0.26 
P-84 0.08 0.06 $0.00 $0.26 
P-86 0.08 11.94 $0.96 $52.54 
P-87 0.08 0.06 $0.00 $0.26 
P-89 0.08 0.03 $0.00 $0.13 
P-91 0.08 6.78 $0.54 $29.83 
P-94 0.08 0.03 $0.00 $0.13 
P-95 0.08 0.08 $0.01 $0.35 
P-96 0.08 0.03 $0.00 $0.13 
P-97 0.08 0.04 $0.00 $0.18 
P-98 0.08 0.03 $0.00 $0.13 
P-99 0.08 0.03 $0.00 $0.13 
Total 0.08 59.1 4.728 260.04 
Final Filtration     
P-104 0.08 2.00 $0.16 $8.80 
P-102 0.08 0.02 $0.00 $0.09 
P-105 0.08 0.04 $0.00 $0.18 
P-109 0.08 44.00 $3.52 $193.60 
P-108 0.08 0.03 $0.00 $0.13 
Total 0.08 46.09 3.69 202.80 
     
Process Equipment Total 1188.37 95.07 5228.83 
     
Incubators 0.08 49.92 3.9936 $219.65 
HVAC 0.08 15927.3 1274.184 $70,080.12 
Steam Generator 0.08 938.48 $75.08 $4,129.30 
CIP Skids 0.08 87.84 $7.03 $386.50 
Water Treatment Package 0.08 734.09 $58.73 $3,230.00 
WFI Still 0.08 2,391.59 $191.33 $10,523.00 
Biowaste Inactivation 0.08 233.30 $18.66 $1,026.53 
Waste Neutralization 0.08 911.90 $72.95 $4,012.35 
     
Additional Equipment Total 21274.42 1701.954 $93,607.45 
     
     
Grand Total  22462.79 1797.02 $98,836.28 
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7.0 Major Unit Descriptions 
7.1 Inoculum Prep Section (BFD-01) 
7.1.1 T-Flasks (P-1/TFR-101) 
 The T-flasks used for initial inoculation are purchased from Nunc International for the 
cost of $205.01 for a case of 30 flasks. These flasks are non-treated and are provided in sterile 
condition so that the cells will not be contaminated in any way when they come into contact with 
the surface of the flask. The flasks are made of polystyrene with a filter cap and can hold up to 
225 mL of volume, but the suggested working volume is 70-100 mL. The T-flasks are easily 
disposed of after use. Twenty T-flasks will be utilized per batch. The flasks will be manipulated 
in a Bio hood. 
7.1.2 Roller Bottles (P-2/RBR-101) 
 The roller bottles used for the second step of the seed train are also purchased from Nunc 
International. The cost for a case of 22 bottles is $426.75. These roller bottles, like the T-flasks, 
are non-treated and are provided in sterile condition. The bottles are made of Polyethylene 
terephthalate (PETG) and have a culture area of 1800 cm2 with a suggested working volume of 
200-1000 ml. Eleven roller bottles will be used per batch. 
7.1.3 Bag Bioreactor 1 (P-3/BBS-101) 
 The pre-sterilized disposable bioreactor chamber is equipped with ports for sterile 
aeration, seeding, harvesting, sampling and analysis. The rocker unit is used to control and 
monitor temperature, aeration rate, and rocking speed to obtain proper cell growth. Each bag 
bioreactor unit for this stage of the process is able to hold one 20 L bag. The unit is purchased 
from Sartorius Stedim Biotech for $33,000. This, however, is based on a quote from Applikon 
who produces a similar product. The name of the model is the BIOSTAT® CultiBag RM Rocker 
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20/50 Optical Package. Disposable bags with sensors and ports for oxygen, media, and buffer 
flow are also purchased from Sartorius and retail for $447 per bag.  
7.1.4 Bag Bioreactor 2 (P-4/BBS-101) 
 The second set of bag bioreactors has the same functions as the first set which were 
described in the previous section. Each bag bioreactor unit for this stage of the process is able to 
hold one 100 L bag. The unit is purchased from Sartorius Stedim Biotech for $39,000. This, 
however, is based on a quote from Applikon who produces a similar product. The name of the 
model is the BIOSTAT® CultiBag RM Rocker 200 Optical Package. Disposable bags with 
sensors and ports for oxygen, media, and buffer flow are also purchased from Sartorius and retail 
for $447 per bag.  
7.1.5 Storage/Mixing Tank (P-5/MP-101) 
 This tank is used to store and mix powdered serum free media before it is fed through a 
sterile filter and into the first seed bioreactor. The tank is made from stainless steel 316, has a 
volume of 1000 L, and has a working capacity of 70%. It stands 2.2 m tall and is 0.8 m in 
diameter. For sterilization, CIP and SIP are used after each batch. The tank operates at room 
temperature and at 1 bar. The tank is fabricated by Sharpsville Container and costs $117,000. 
7.1.6 Pump (P-6/PM-101) 
 This pump is used to transfer fluid from the first media prep storage tank to the first 
sterile filter of the process. This is a very low powered 1 kW (1.34 hp) peristaltic pump. It 
operates at room temperature with an approximate pressure drop of 25 psi. The pump is sterilized 
via CIP and SIP after every batch. It can handle flow rates up to 33.3 LPM. The pump is 
purchased from Watson Marlow (model 825) for the cost of $12,350. 
7.1.7 Sterilization Filter (P-7/DE-101) 
 This 0.2 µm filter is used to remove bacteria and other impurities from the serum free 
media prior to feeding the first seed bioreactor. It is approximately 30 inches in size with a 
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filtration area of 1.8 m2. The filter operates at room temperature with a differential pressure of 
0.5 bar. The filters require a type of housing for security that requires a one time purchase from 
Sartorius Stedim Biotech for the cost of $1908. The filters are disposable, and therefore need to 
be replaced after every batch. These filters are also purchased from Sartorius under the model 
name Sartopore 2 for the cost of $608 per unit. 
7.2 Seed Bioreactor Section (BFD-02/BFD-03) 
7.2.1 Pump (P-8/PM-102) 
 This pump is used to transfer fluid from the first sterilization filter to the first seed 
bioreactor. This pump is exactly the same as (PM-101) described previously. This is a very low 
powered 1 kW (1.34 hp) peristaltic pump. It operates at room temperature with an approximate 
pressure drop of 25 psi. The pump is sterilized via CIP and SIP after every batch. It can handle 
flow rates up to 33.3 LPM. The pump is purchased from Watson Marlow (model 825) for the 
cost of $12,350. 
7.2.2 Seed Bioreactor 1 (P-9/SBR-101) 
 This is a 1500 L jacketed seed bioreactor with agitator and control package used for 
continued cell growth and production of monoclonal antibodies. The bioreactor is purchased 
from ABEC. The bioreactor is 2.3 m tall and 0.9 m in diameter. It has a working capacity of 70% 
and CIP and SIP are necessary for validated cleaning following each batch. The bioreactor 
operates at 37°C and 1 bar over the course of 4 days. This temperature is maintained by filling 
the water jacket with water at 37°C at an average flow rate of approximately 0.04 kg/s. This 
bioreactor also comes with an add-on control system that provides automated control of 
environmental conditions and feed scheduling. The purchase cost from ABEC for this bioreactor 
is $495,000. 
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7.2.3 Pump (P-10/PM-103) 
 This pump is used to transfer fluid from the first seed bioreactor to the second seed 
bioreactor. This pump is similar to both PM-101 and PM-102 which were described previously. 
This is a very low powered 1 kW (1.34 hp) peristaltic pump. It operates at room temperature 
with an approximate pressure drop of 25 psi. The pump is sterilized via CIP and SIP after every 
batch. It can handle flow rates up to 33.3 LPM. The pump is purchased from Watson Marlow 
(model 825) for the cost of $12,350. 
7.2.4 Storage/Mixing Tank (P-11/MP-102) 
 This tank is used to store and mix powdered serum free media before it is fed through a 
sterile filter and into the second seed bioreactor. The tank is made from stainless steel 316, has a 
volume of 3000 L, and has a working capacity of 70%. It stands 3.3 m tall and is 1.1 m in 
diameter. For sterilization, CIP and SIP are used after each batch. The tank operates at room 
temperature and at 1 bar. The tank is fabricated by Sharpsville Container and has a purchase cost 
of $120,000. 
7.2.5 Pump (P-12/PM-104) 
 This pump is used to transfer fluid from the second media prep storage tank to the second 
sterile filter of the process. Like the others described previously, it is a very low powered 1 kW 
(1.34 hp) peristaltic pump. It operates at room temperature with an approximate pressure drop of 
25 psi. The pump is sterilized via CIP and SIP after every batch. It can handle flow rates up to 
33.3 LPM. The pump is purchased from Watson Marlow (model 825) for the cost of $12,350. 
7.2.6 Sterilization Filter (P-13/DE-102) 
 This 0.2 µm filter is used to remove bacteria and other impurities from the serum free 
media prior to feeding the second seed bioreactor. It is approximately 30 inches in size with a 
filtration area of 1.8 m2. The filter operates at room temperature with a differential pressure of 
0.5 bar. The filters require a type of housing for security that requires a one-time purchase from 
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Sartorius Stedim Biotech for the cost of $1908. The filters are disposable, and therefore need to 
be replaced after every batch. These filters are also purchased from Sartorius under the model 
name Sartopore 2 for the cost of $608 per unit. 
7.2.7 Pump (P-14/PM-105) 
 This pump is used to transfer fluid from the second sterilization filter to the second seed 
bioreactor. This pump is exactly the same as (PM-104) described previously. This is a very low 
powered 1 kW (1.34 hp) peristaltic pump. It operates at room temperature with an approximate 
pressure drop of 25 psi. The pump is sterilized via CIP and SIP after every batch. It can handle 
flow rates up to 33.3 LPM. The pump is purchased from Watson Marlow (model 825) for the 
cost of $12,350. 
7.2.8 Seed Bioreactor 2 (P-15/SBR-102) 
 This is a 4500 L jacketed seed bioreactor with agitator and control package. The 
bioreactor package is fabricated by ABEC. The bioreactor is 3.3 m tall and 1.3 m in diameter. It 
has a working capacity of 70% and CIP and SIP are necessary for validated cleaning following 
each batch. The bioreactor operates at 37°C and 1 bar over the course of 4 days. This 
temperature is maintained by filling the water jacket with water at 37°C at an average flow rate 
of approximately 0.08 kg/s. This bioreactor also comes with an add-on control system that 
provides automated control of environmental conditions and feed scheduling. The purchase cost 
from ABEC for this bioreactor is $585,000. 
7.2.9 Pump (P-16/PM-106) 
 This pump is used to transfer fluid from the second seed bioreactor to the production 
bioreactor. This pump is similar to both PM-104 and PM-105 which were described previously. 
This is a very low powered 1 kW (1.34 hp) peristaltic pump. It operates at room temperature 
with an approximate pressure drop of 25 psi. The pump is sterilized via CIP and SIP after every 
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batch. It can handle flow rates up to 33.3 LPM. The pump is purchased from Watson Marlow 
(model 825) for the cost of $12,350. 
7.2.10 Storage/Mixing Tank (P-17/MP-103) 
 This tank is used to store and mix powdered serum free media before it is fed through a 
sterile filter and into the production bioreactor. The tank is made from stainless steel 316, has a 
volume of 7700 L, and has a working capacity of 70%. It stands 4.5 m tall and is 1.5 m in 
diameter. For sterilization, CIP and SIP are used after each batch. The tank operates at room 
temperature and at 1 bar. The tank is fabricated by Sharpsville Container and has a purchase cost 
of $130,000. 
7.2.11 Pump (P-18/PM-107) 
 This pump is used to transfer fluid from the third media prep storage tank to the third 
sterile filter of the process. Like the others described previously, it is a very low powered 1 kW 
(1.34 hp) peristaltic pump. It operates at room temperature with an approximate pressure drop of 
25 psi. The pump is sterilized via CIP and SIP after every batch. It can handle flow rates up to 
33.3 LPM. The pump is purchased from Watson Marlow (model 825) for the cost of $12,350. 
7.2.12 Sterilization Filter (P-19/DE-103) 
 This 0.2 µm filter is used to remove bacteria and other impurities from the serum free 
media prior to feeding the production bioreactor. It the same as the filters that were previously 
described in that it is approximately 30 inches in size with a filtration area of 1.8 m2. The filter 
operates at room temperature with a differential pressure of 0.5 bar. The filters require a type of 
housing for security that requires a one-time purchase from Sartorius Stedim Biotech for the cost 
of $1908. The filters are disposable, and therefore need to be replaced after every batch. These 
filters are also purchased from Sartorius under the model name Sartopore 2 for the cost of $608 
per unit. 
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7.2.22 Pump (P-20/PM-108) 
 This pump is used to transfer fluid from the third sterilization filter to the production 
bioreactor. This pump is exactly the same as (PM-107) described previously. This is a very low 
powered 1 kW (1.34 hp) peristaltic pump. It operates at room temperature with an approximate 
pressure drop of 25 psi. The pump is sterilized via CIP and SIP after every batch. It can handle 
flow rates up to 33.3 LPM. The pump is purchased from Watson Marlow (model 825) for the 
cost of $12,350. 
7.2.23 Storage/Mixing Tank (P-21/MP-104) 
 This tank is used to store and mix powdered serum free media that is used for fed batch in 
the production bioreactor before it is fed through another sterile filter and into the production 
bioreactor. The tank is made from stainless steel 316, has a volume of 1600 L, and has a working 
capacity of 70%. It stands 2.6 m tall and is 0.9 m in diameter. For sterilization, CIP and SIP are 
used after each batch. The tank operates at room temperature and at 1 bar. The tank is fabricated 
by Sharpsville Container and has a purchase cost of $117,000. 
7.2.24 Pump (P-22/PM-109) 
 This pump is used to transfer fluid from the fourth media prep storage tank to the fourth 
sterile filter of the process. Like the others described previously, it is a very low powered 1 kW 
(1.34 hp) peristaltic pump. It operates at room temperature with an approximate pressure drop of 
25 psi. The pump is sterilized via CIP and SIP after every batch. It can handle flow rates up to 
33.3 LPM. The pump is purchased from Watson Marlow (model 825) for the cost of $12,350. 
7.2.25 Sterilization Filter (P-23/DE-104) 
 This 0.2 µm filter is used to remove bacteria and other impurities from the serum free 
media prior to feeding the production bioreactor. It is approximately 30 inches in size with a 
filtration area of 1.8 m2. The filter operates at room temperature with a differential pressure of 
0.5 bar. The filters require a type of housing for security that requires a one-time purchase from 
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Sartorius Stedim Biotech for the cost of $1908. The filters are disposable, and therefore need to 
be replaced after every batch. These filters are also purchased from Sartorius under the model 
name Sartopore 2 for the cost of $608 per unit. 
7.3 Production Bioreactor Section (BFD-04) 
7.3.1 Pump (P-24/PM-110) 
 This pump is used to transfer fluid from the first sterilization filter to the first seed 
bioreactor. This pump is exactly the same as (PM-109) described previously. This is a very low 
powered 1 kW (1.34 hp) peristaltic pump. It operates at room temperature with an approximate 
pressure drop of 25 psi. The pump is sterilized via CIP and SIP after every batch. It can handle 
flow rates up to 33.3 LPM. The pump is purchased from Watson Marlow (model 825) for the 
cost of $12,350. 
7.3.2 Production Bioreactor (P-25/PBR-101) X 2 
 There are two production bioreactors used for this process that are staggered in order to 
provide a greater output of monoclonal antibodies and reduce the amount of idle time that would 
otherwise occur if two units were not used. See the scheduling section (p. 187) for further 
information. Each unit is a 14000 L jacketed bioreactor with agitator. The bioreactor package is 
fabricated by ABEC. Each is 4.8 m tall and 2.0 m in diameter. They have a working capacity of 
70%. CIP and SIP are mandatory for validated cleaning following each batch. Each operates at 
37°C and 1 bar over the course of 9 days. The temperature in each bioreactor is maintained by 
filling the water jacket with water at 37°C at an average flow rate of approximately 0.25 kg/s. 
This bioreactor also comes with an add-on control system that provides automated control of 
environmental conditions and feed scheduling. The purchase cost from ABEC for each 
bioreactor is $661,000. 
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7.4 Primary Recovery (BFD-05) 
7.4.1 Surge Tank (P-26/V-201) 
 The storage tank is used to store the output of the production bioreactor prior to further 
processing. This unit is an 11,000 L jacketed blending tank made of 316L Stainless Steel with an 
electropolished finish. The unit is 5.0 m tall, has a diameter of 1.67 m and has a working capacity 
of 90%. It operates at 25°C and 1.103 bar. This unit is sterilized via CIP and SIP procedures 
following every batch. This surge tank is manufactured by Sharpsville Container, with a 
purchase cost of $117,000. 
7.4.2 Pump (P-27/PM-201) 
This pump is used to transfer fluid from the bioreaction surge tank to the centrifugation 
unit. This is a very low powered 1 kW (1.34 hp) peristaltic pump. It operates at room 
temperature with an approximate pressure drop of 25 psi. The pump is sterilized via CIP and SIP 
after every batch. It can handle flow rates up to 33.3 LPM. The pump is purchased from Watson 
Marlow (model 825) for the cost of $12,350. 
7.4.3 Centrifuge (P-28/DS-201) 
 The generated biomass and other suspended compounds are removed using a Disc-Stack 
Centrifuge. The centrifuge in use the BTAX 215H-31 CEP produced by Alfa-Laval. This unit is 
constructed from 316L Stainless Steel with an electropolished finish. The maximum bowl speed 
of the centrifuge is 6,065 rpm, and requires a power input of 13-28 kW (depending on centrifuge 
speed selected). This unit operates at 25°C, with a throughput of 2,000 L/h. The centrifuge is 
sterilized after each batch with CIP and SIP procedures. The purchase cost of this centrifuge 
from Alfa-laval is $421,000. 
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7.4.4 Pump (P-29/PM-202) 
This pump is used to transfer fluid from the centrifugation unit to a sterile filtration unit. 
This, as the previously described pump, operates at a very low powered 1 kW (1.34 hp) 
peristaltic pump. Operation is maintained at room temperature with an approximate pressure 
drop of 25 psi. The pump is sterilized via CIP and SIP after every batch. It can handle flow rates 
up to 33.3 LPM. The pump is purchased from Watson Marlow (model 825) for the cost of 
$12,350. 
7.4.5 Sterilization Filter (P-30/DE-201) 
 This 0.2 µm filter is used to remove bacteria and other impurities from the supernatant of 
the centrifugation process. It is approximately 30 inches in size with a filtration area of 1.8 m2. 
The filter operates at room temperature with a differential pressure of 0.5 bar. The filters require 
a type of housing for security that requires a one-time purchase from Sartorius Stedim Biotech 
for the cost of $1908. The filters are disposable, and therefore need to be replaced after every 
batch. These filters are also purchased from Sartorius under the model name Sartopore 2 for the 
cost of $608 per unit. 
7.4.6 Pump (P-31/PM-203) 
This pump is used to transfer fluid through the sterile filtration unit to the centrifugation 
pool tank. This, as the other previously described pumps, operates at a very low powered 1 kW 
(1.34 hp) peristaltic pump. The pump is maintained at room temperature and has approximate 
pressure drop of 25 psi associated with it. The pump is sterilized via CIP and SIP after every 
batch. It can handle flow rates up to 33.3 LPM. The pump is purchased from Watson Marlow 
(model 825) for the cost of $12,350. 
7.4.7 Centrifugation Pool Tank (P-32/V-202) 
 This jacketed storage tank is used to store the supernatant of the centrifugation procedure 
prior to further processing. This unit is a 10,000 L blending tank made of 316L Stainless Steel 
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with an electropolished finish. The unit is 4.8 m tall and has a diameter of 1.6 m. The working 
capacity of this tank is 90%. It operates at 25°C and 1.103 bar. This unit is sterilized via CIP and 
SIP procedures following every batch. This surge tank is manufactured by Sharpsville Container, 
with a purchase cost of $117,000. 
7.5 Pepsin Cleavage (BFD-06a) 
7.5.1 Pump (P-33/PM-204) 
This pump is used to transfer fluid from the centrifugation pool tank to the diafiltration 
system. This, as the other previously described pumps, operates at a very low powered 1 kW 
(1.34 hp) peristaltic pump. The pump is maintained at room temperature and has approximate 
pressure drop of 25 psi associated with it. The pump is sterilized via CIP and SIP after every 
batch. It can handle flow rates up to 33.3 LPM. The pump is purchased from Watson Marlow 
(model 825) for the cost of $12,350. 
7.5.2 Diafiltration Storage Tank (P-34/V-203) 
 This jacketed storage tank is used to store the production stream during the diafiltration 
process. This unit is a 10,000 L blending tank made of 316L Stainless Steel with an 
electropolished finish. The unit is 4.8 m tall and has a diameter of 1.6 m. The working capacity 
of this tank is 90%. It operates at 25°C and 1.103 bar. This unit is sterilized via CIP and SIP 
procedures following every batch. This surge tank is manufactured by Sharpsville Container, 
with a purchase cost of $117,000. 
7.5.3 Diafiltration Unit (P-35/DF-201) X2 
 This diafiltration system is used to concentrate the monoclonal antibody containing 
stream to prepare it for cleavage by immobilized pepsin. The stream is split and passed through 
two diafiltration units to concentrate the stream from 3.56 g/L to 10.36 g/L. The diafiltration 
system is manufactured by Sartorius Stedim Biotechnology. This system is comprised of 
Flexible Manufacturing Facility for Biopharmaceuticals 
 
-64- 
 
stabilized cellulose based filters (Sartocube® 302 144 59 30 E-BSW), which are each 3.0 m2 
with a MWCO of 30 kDa. The filter housing unit to be used is the Sartocon 2 Plus. The total 
filter area needed for each diafiltration system is 14.901 m2. These diafiltration systems operate 
at 25°C and are associated with a pressure drop of 43.5 psi. The diafiltration housing costs 
$11,141, which each diafiltration cartridge costs $8,374 for a 3m2 filter. The filters are replaced 
every 30 days. 
7.5.4 Pump (P-36/PM-205) 
This pump is used to transfer the antibody-containing stream from the diafiltration system 
to the pepsin cleavage reactor. This pump operates at 9.0 kW (12.07 hp). The pump is 
maintained at room temperature and has approximate pressure drop of 25 psi associated with it. 
The pump is sterilized via CIP and SIP after every batch. It can handle flow rates up to 33.3 
LPM. The pump is purchased from Watson Marlow (model 825) for the cost of $12,350. 
7.5.5 Pepsin Cleavage Bioreactor (P-37/R-201) 
 Cleavage of the monoclonal antibody by pepsin occurs in this bioreactor. This unit is a 
9,000L jacketed bioreactor with agitator made of 316L stainless steel with an electropolish 
finish. This reactor package is fabricated by ABEC. The unit is 4.06 m tall and 1.62 m in 
diameter. The operation of the unit occurs at 37°C and 1 bar over the course of 5 hours. Agitation 
is provided through a backward curved impeller, and control is provided through a DCS control 
system. CIP and SIP are mandatory for validated cleaning following each batch. The purchase 
cost from ABEC for this bioreactor is $622,000. 
7.5.6 Pump (P-38/PM-206) 
This pump is used to transfer the antibody-containing stream from the pepsin cleavage 
reactor to the plate and frame filtration system. This, as the previously described pump, operates 
at 9.0 kW (12.07 hp) using a peristaltic pump. The pump is maintained at room temperature and 
has approximate pressure drop of 25 psi associated with it. The pump is sterilized via CIP and 
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SIP after every batch. It can handle flow rates up to 33.3 LPM. The pump is purchased from 
Watson Marlow (model 825) for the cost of $12,350. 
7.5.7 Plate and Frame Filtration Unit (P-38/PFF-201) 
 The plate and frame filtration system is used to remove and wash the immobilized pepsin 
used in the cleavage reaction. This filter system is the MEMBRAplan® DGM (model number 
800 K 100), manufactured by Pall Corporation. The system is comprised of 29 sheet filter plates, 
each 1000 mm x 1000 mm, stacked horizontally in a 316L stainless steel housing unit. The unit 
has a total filtration area of 24.4 m2, and operation occurs at 25°C. The filter unit is sterilizable 
via SIP and CIP operations. The purchase cost of this filtration system is $74,000. 
7.6 Disulfide Reduction (BFD-06a) 
7.6.1 Pump (P-40/PM-206) 
This pump is used to transfer the antibody-containing stream from the pepsin cleavage 
reactor to the plate and frame filtration system. This, as with the two previously described 
pumps, operates at 9.0 kW (12.07 hp) using a peristaltic pump. The pump is maintained at room 
temperature and has approximate pressure drop of 25 psi associated with it. The pump is 
sterilized via CIP and SIP after every batch. It can handle flow rates up to 33.3 LPM. The pump 
is purchased from Watson Marlow (model 825) for the cost of $12,350. 
7.6.2 Diafiltration Storage Tank (P-41 / V-204) 
 This unit is a 4500 L jacketed storage tank with a 90% working capacity volume of 
4027.01 L (height = 3.587 m, diameter = 1.196 m) to be used during the diafiltration process 
between P&F Filtration and the Disulfide Reduction Reaction. It is a blending tank made of 
electropolished 316L Stainless Steel by Sharpsville Container for a purchase cost of $117,000. 
Operating conditions are 25°C and 22.038 psi. Cleaning is performed before and after every 
batch using CIP and SIP procedures. 
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7.6.3 Diafiltration Unit (P-42 / DF-202) 
 This diafiltration unit will concentrate the F(ab’)2 fragments from 3.68 mg/ml in pepsin 
Digestion Buffer to 10 mg/ml in Reduction Reaction Buffer for the Disulfide Reduction 
Reaction. This unit consists of 15 diafiltration filters, each with a membrane area of 3.0 m2 to 
fulfill the 43.185 m2 total membrane area requirement for this diafiltration process. The unit will 
use Sartorius Stedim Biotechnology's Sartocube® 302 144 59 30 E-BSW stabilized cellulose 
based filters in a Sartocon 2 Plus filter housing unit. The cutoff molecular weight for this filter is 
30 kDa in order to retain the 100 kDa F(ab’)2 fragments in the retentate. The housing unit costs 
$11,141 and each filter costs $8,374, so the total cost for this unit will be $136,751. Operating 
conditions are 25°C with a pressure drop of 14.5 psi. Cleaning is performed before and after 
every batch using CIP and SIP procedures. 
7.6.4 Pump (P-43 / PM-208) 
This peristaltic pump is used to transport the F(ab’)2 fragments concentrated in the 
Reduction Reaction Buffer from the Diafiltration Unit to the Disulfide Reduction Reactor. This 
pump operates at 0.12 kW (0.15 hp) and 186.80 L/min. Operating conditions are 25°C with a 
pressure drop of 50 psi. The pump is model 840 manufactured by Watson Marlow and costs 
$18,135. This model has a maximum flow rate of 133.3 L/min and maximum power of 3.1 kW 
(4.11 hp). It is made of electropolished Stainless Steel 316L and will be used with Bioprene 40 
mm tubing. Cleaning is performed before and after every batch using CIP and SIP procedures. 
7.6.5 Disulfide Reduction Reactor (P-44 / R-202) 
 In this bioreactor, the reduction reaction will take place to break the hinge region bonds 
of the F(ab’)2 to give 2 Fab’ fragments with a retained cysteine from the hinge region per every 
F(ab’)2. This unit is an 1800 L jacketed bioreactor with a backward curved impeller for agitation 
and a DCS control system. It has a volume of 1589.93 L with a height of 2.330 m, a diameter of 
0.932 m and a 90% working capacity. It is made of electropolished 316L Stainless Steel by 
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ABEC for a purchase cost of $508,000. The reaction is run at operating conditions of 37°C for 
90 minutes. Validated cleaning is performed before and after every batch using CIP and SIP 
procedures. 
7.6.6 Pump (P-45 / PM-209) 
This peristaltic pump is used to transport the Fab’ fragments concentrated in the 
Reduction Reaction Buffer from the Disulfide Reduction Reactor to the next Diafiltration Unit. 
This pump operates at 0.11 kW (0.15 hp) and 46.65 L/min. Operating conditions are 25°C with a 
pressure drop of 14.5 psi. The pump is model 840 manufactured by Watson Marlow and costs 
$18,135. This model has a maximum flow rate of 133.3 L/min and maximum power of 3.0 kW 
(2.2 hp). It is made of electropolished Stainless Steel 316L and will be used with Bioprene 40 
mm tubing. Cleaning is performed before and after every batch using CIP and SIP procedures. 
7.6.7 Diafiltration Storage Tank (P-46 / V-205) 
 This unit is a 1800 L jacketed storage tank with a 90% working capacity volume of 
1597.92 L (height = 2.636 m, diameter = 0.879 m) to be used during the diafiltration process 
between Disulfide Reduction and the next Diafiltration Unit. It is a blending tank made of 
electropolished 316L Stainless Steel by Sharpsville Container for a purchase cost of $117,000. 
Operating conditions are 25°C and 22.038 psi. Cleaning is performed before and after every 
batch using CIP and SIP procedures. 
7.6.8 Diafiltration Unit (P-47 / DF-203) 
 This diafiltration unit will separate out the 2-MEA and any very small Fc fragments, 
while maintaining a concentration of Fab’ of 10 mg/ml and switching buffers from the reduction 
reaction buffer to WFI. This unit consists of 5 diafiltration filters, each with a membrane area of 
3.0 m2 to fulfill the 12.415 m2 total membrane area requirement for this diafiltration process. The 
unit will use Sartorius Stedim Biotechnology's Sartocube® 302 144 59 30 E-BSW stabilized 
cellulose based filters in a Sartocon 2 Plus filter housing unit. The cutoff molecular weight for 
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this filter is 10 kDa in order to retain the 50 kDa Fab’ fragments in the retentate. The housing 
unit costs $11,141 and each filter costs $8,374, so the total cost for this unit will be $53,011. 
Operating conditions are 25°C with a pressure drop of 14.5 psi. Cleaning is performed before 
and after every batch using CIP and SIP procedures. 
7.7 Protein A Chromatography (BFD-07) 
7.7.1 Pump (P-48 / PM-210) 
This peristaltic pump is used to transport the Fab’ fragments concentrated in WFI from 
the Diafiltration Unit to the Protein-A Chromatography. This pump operates at 0.21 kW (0.28 
hp) and 25.09 L/min. Operating conditions are 25°C with a pressure drop of 14.5 psi. The pump 
is model 825 manufactured by Watson Marlow and costs $12,350. This model has a maximum 
flow rate of 33.3 L/min and maximum power of 1.1 kW (1.6 hp). It is made of electropolished 
Stainless Steel 316L and will be used with Bioprene 25 mm tubing. Cleaning is performed before 
and after every batch using CIP and SIP procedures. 
7.7.2 Protein A Chromatography Column (P-49/C-201) 
 The Protein A affinity chromatography column is used to further purify the mainstream 
fluid, removing the Fc fragments. The chromatography column in use is a Chromaflow® column 
made by GE Healthcare Life Sciences (formerly Amersham Biosciences). This system consists 
of a column tube, column lid, distributor, bed support, Chromaflow nozzle, seals and a stand. 
The distributor is made of polypropylene, the seals are made of fluoride ethylene propylene 
(FEP) encapsulated silicone, and the remaining parts are all made of 316L stainless steel. The 
column is packed with nProtein A sepharose 4 Fast Flow resin, also distributed by GE 
Healthcare Life Sciences. This resin has a binding capacity of 50 mg/ml and a working velocity 
of 30-300 cm/h. The column is operated at 25°C, at 1 bar. The cost of the column is $190,000, 
and the resin is $7,000 per liter. 
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7.7.3 Pump (P-50/PM-211) 
This pump is used to transfer fluid from protein A chromatography column to a sterile 
filtration unit. This pump operates at 1 kW (1.34 hp). The pump is maintained at room 
temperature and has approximate pressure drop of 25 psi associated with it. The pump is 
sterilized via CIP and SIP after every batch. It can handle flow rates up to 33.3 LPM. The pump 
is purchased from Watson Marlow (model 825) for the cost of $12,350. 
7.7.4 Sterilizing Filter (P-51/DE-202) 
 This 0.2 µm filter is used to remove bacteria and other impurities from the clarified 
product stream. It is approximately 30 inches in size with a filtration area of 1.8 m2. The filter 
operates at room temperature with a differential pressure of 0.5 bar. The filters require a type of 
housing for security that requires a one-time purchase from Sartorius Stedim Biotech for the cost 
of $1908. The filters are disposable, and therefore need to be replaced after every batch. These 
filters are also purchased from Sartorius under the model name Sartopore 2 for the cost of $608 
per unit. 
7.8 Chemical Virus Inactivation (BFD-08) 
7.8.1 Pump (P-52/PM-212) 
This pump is used to transfer fluid from the sterile filtration unit to the diafiltration 
system. This pump operates at 1 kW (1.34 hp). The pump is maintained at room temperature and 
has approximate pressure drop of 25 psi associated with it. The pump is sterilized via CIP and 
SIP after every batch. It can handle flow rates up to 33.3 LPM. The pump is purchased from 
Watson Marlow (model 825) for the cost of $12,350. 
7.8.2 Diafiltration Storage Tank (P-53 / V-206) 
 This jacketed storage tank is used to store the production stream during the diafiltration 
process. This unit is a 10,000 L blending tank made of 316L Stainless Steel with an 
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electropolished finish. The unit is 4.8 m tall and has a diameter of 1.6 m. The working capacity 
of this tank is 90%. It operates at 25°C and 1.103 bar. This unit is sterilized via CIP and SIP 
procedures following every batch. This surge tank is manufactured by Sharpsville Container, 
with a purchase cost of $117,000. 
7.8.3 Diafiltration Unit (P-54/DF-204) 
 This diafiltration system is used to concentrate the monoclonal antibody Fab fragments 
5x. The diafiltration system is manufactured by Sartorius Stedim Biotechnology. This system is 
comprised of stabilized cellulose based filters (Sartocube® 302 144 59 30 E-BSW), which are 
each 3.0 m2. A 10 kDa molecular weight cutoff filter is used in order to retain the 50 kDa Fab’ 
fragments in the retentate. The filter housing unit to be used is the Sartocon 2 Plus. The total 
filter area needed for each diafiltration system is 22.23 m2. These diafiltration systems operate at 
25°C and are associated with a pressure drop of 43.5 psi. The diafiltration housing costs $11,141, 
which each diafiltration cartridge costs $8374 for a 3m2 filter. 
7.8.4 Pump (P-55/PM-213) 
This pump is used to transfer fluid from the sterile filtration unit to the diafiltration 
system. This pump, as with previous pumps, operates at 1 kW (1.34 hp). The pump is maintained 
at room temperature and has approximate pressure drop of 25 psi associated with it. The pump is 
sterilized via CIP and SIP after every batch. It can handle flow rates up to 33.3 LPM. The pump 
is purchased from Watson Marlow (model 825) for the cost of $12,350. 
7.8.5 Virus Inactivation Tank (P-56/V-207) 
 This jacketed blending tank is used to treat the product stream with Polysorbate 80 in 
order to inactivate viruses in the stream. This unit is a 1,000 L blending tank made of 316L 
Stainless Steel with an electropolished finish. The unit is 2.2 m tall and has a diameter of 0.75 m. 
The working capacity of this tank is 90%. It operates at 25°C and 1.103 bar. This unit is 
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sterilized via CIP and SIP procedures following every batch. This surge tank is manufactured by 
Sharpsville Container, with a purchase cost of $130,000. 
7.8.6 Pump (P-57/PM-213) 
This pump is used to transfer fluid from chemical virus inactivation tank to another sterile 
filtration unit. This pump, as with previous pumps, operates at 1 kW (1.34 hp). The pump is 
maintained at room temperature and has approximate pressure drop of 25 psi associated with it. 
The pump is sterilized via CIP and SIP after every batch. It can handle flow rates up to 33.3 
LPM. The pump is purchased from Watson Marlow (model 825) for the cost of $12,350. 
7.8.7 Sterilizing Filter (P-58/DE-202) 
 This 0.2 µm filter is used to remove bacteria and other impurities from the treated 
product stream. It is approximately 30 inches in size with a filtration area of 1.8 m2. The filter 
operates at room temperature with a differential pressure of 0.5 bar. The filters require a type of 
housing for security that requires a one-time purchase from Sartorius Stedim Biotech for the cost 
of $1908. The filters are disposable, and therefore need to be replaced after every batch. These 
filters are also purchased from Sartorius under the model name Sartopore 2 for the cost of $608 
per unit. 
7.9 Cation Exchange Chromatography (BFD-09) 
7.9.1 Storage Tank (P-59/V-301) 
This storage tank is where Cation Buffer A is stored for use in C-301. The tank size is 
4500L and made of 316L stainless steel tank with an 83% working capacity (3700L). It is 2.28 m 
tall and 1.52 m in diameter (1:1.5 diameter to height ratio). Operating temperature is maintained 
at around room temperature (25°C). The tank is sterilized using CIP and SIP techniques. The 
tank is manufactured by Sharpsville Container and has a purchase cost of $117,000. 
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7.9.2 Storage Tank (P-60/V-302) 
This storage tank is where Cation Buffer B is stored for use in C-301. The tank size is 
1200L and is made of 316L stainless steel tank with an 83% working capacity (1000L). It is 1.46 
m tall and 0.97 m in diameter (1:1.5 diameter to height ratio). Operating temperature is 
maintained at around room temperature (25°C). The tank is sterilized using CIP and SIP 
techniques. The tank is manufactured by Sharpsville Container and has a purchase cost of 
$117,000. 
7.9.3 Pump (P-61/PM-301) 
This pump delivers the fluid containing the monoclonal antibody fragment from viral 
inactivation to MX-301 via stream S-301. It is a 316L stainless steel peristaltic pump and uses 
0.01 kW of power per batch. The pump is a Watson-Marlow Bredel 825, and provides a 
maximum flow rate of 33.3 LPM and enough power to overcome the 45.5 ft of head required for 
transport. It has a purchase cost of $12,350.  
7.9.4 Pump (P-62/PM-302) 
This pump delivers Cation Buffer A from V-301 to MX-301. It is a 316L stainless steel 
peristaltic pump and uses 0.06 kW of power per batch. The pump is a Watson-Marlow Bredel 
825, and provides a maximum flow rate of 33.3 LPM and enough power to overcome the 45.5 ft 
of head required for transport. It has a purchase cost of $12,350.  
7.9.5 Pump (P-63/PM-303, P-64/PM-304) 
This pump transports Cation Buffer B from V-302 to C-301 for elution and 
stripping/column regeneration. It is a 316L stainless steel peristaltic pump and uses 0.09 kW of 
power per batch. The pump is a Watson-Marlow Bredel 825, and provides a maximum flow rate 
of 33.3 LPM and enough power to overcome the 45.5 ft of head required for transport. It has a 
purchase cost of $12,350.  
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7.9.6 Pump (P-65/PM-305, P-66/PM-306) 
This pump delivers Cation Buffer A from V-301 to equilibrate and wash C-301. It is a 
316L stainless steel peristaltic pump and uses 0.11 kW of power per batch (0.06 kW for 
equilibration, 0.05 kW for wash). The pump is a Watson-Marlow Bredel 825, and provides a 
maximum flow rate of 33.3 LPM and enough power to overcome the 45.5 ft of head required for 
transport. It has a purchase cost of $12,350.  
7.9.7 Mixer (P-67/MX-301) 
This mixer forces stream S-301 and Cat-Load 2 to mix. The mixing of the antibody 
fragment with Cation Buffer A must be done right before entry into the column to prevent any 
undue denaturation or precipitation. The mixer is a joint that allows the piping of the two streams 
to merge. The cost is included in pricing calculations for piping.  
7.9.8 Chromatography Column (P-68/C-301) 
This chromatography column is operated as a cation exchange chromatography column. 
It is a ChromaflowTM 1000 column made by GE-Healthcare. It is made of a column tube, lid, 
distributor, bed support, nozzles, seals, and a stand. The distributor is made of polypropylene, the 
seals are made of FEP-encapsulated silicone, and the remaining parts are made of 316L stainless 
steel. The column has an inner diameter of 1.0m and a height of 0.5 m, giving it a column 
volume of 392.7 L. The cost of this chromatography column is approximately $245,000. This 
cation exchange column is packed with Tosoh Toyopearl Gigacap S-650M beads, which have 
dynamic binding capacities of 145 mg/ml. The resin costs $182,490 for the 110 L needed.  
The column and the beads can be washed using standard CIP procedures.  
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7.10 Anion Exchange Chromatography (BFD-10) 
7.10.1 Holding Tank (P-69/V-303) 
This holding tank is where the partially purified monoclonal antibody fragment (eluted 
product from C-301) is mixed with Anion Buffer A for use in C-302. The tank is made of 316L 
stainless steel and holds up to 4,200 L of fluid with an 88.8% working capacity (3730L). It is 
2.3m in tall and 1.5 m in diameter. Operating temperature is maintained at around room 
temperature (25°C). The tank is sterilized using CIP and SIP techniques. The tank is 
manufactured by Sharpsville Container and has a purchase cost of $117,000. 
7.10.2 Pump (P-70/PM-307) 
This pump transfers a mixed solution containing Anion Buffer A and monoclonal 
antibody fragments from V-303 to C-302 for further purification. It is a 316L stainless steel 
peristaltic pump and uses 0.11 kW of power per batch. The pump is a Watson-Marlow Bredel 
840, and provides a maximum flow rate of 133.3 LPM and enough power to overcome the 45.5 
ft of head required for transport. It has a purchase cost of $18,135. 
7.10.3 Chromatography Column (P-71/C-302) 
This chromatography column is operated as an anion exchange chromatography column. 
It is a ChromaflowTM 600 column made by GE-Healthcare. It is made of a column tube, lid, 
distributor, bed support, nozzles, seals, and a stand. The distributor is made of polypropylene, the 
seals are made of FEP-encapsulated silicone, and the remaining parts are made of 316L stainless 
steel. The column has an inner diameter of 0.6 m and a height of 0.5 m, giving it a column 
volume of 141.2 L. The cost of this chromatography column is approximately $177,000. This 
anion exchange column is packed with Tosoh Toyopearl SuperQ-650M beads, which have 
dynamic binding capacities of 140 mg/ml. The resin costs $64,870 for the 65 L needed. Both the 
column and the beads can be washed using standard CIP procedures.  
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7.10.4 Storage Tank (P-72/V-306) 
This storage tank is where the flow-through from C-302 collected. The tank is made of 
316L stainless steel and holds up to 4,300 L of fluid with an 89.5% working capacity (3850L). It 
is 2.3 m tall and 1.5 m in diameter. Operating temperature is maintained at around room 
temperature (25°C). The tank is sterilized using CIP and SIP techniques. The tank is 
manufactured by Sharpsville Container and has a purchase cost of $117,000. 
7.10.5 Pump (P-73/PM-308) 
This pump transports Anion Buffer A to V-303 from V-304 for mixing with the 
monoclonal antibody fragments in preparation for anion exchange chromatography. It is a 316L 
stainless steel peristaltic pump and uses 0.14 kW of power per batch. The pump is a Watson-
Marlow Bredel 840, and provides a maximum flow rate of 133.3 LPM and enough power to 
overcome the 44.1 ft of head required for transport. It has a purchase cost of $18,135. 
7.10.6 Pump (P-74/PM-309, P-75/PM-310) 
This pump transports Anion Buffer A to C-302 from V-304 for equilibration and washing 
in anion exchange chromatography. It is a 316L stainless steel peristaltic pump and uses 0.05 kW 
of power per batch. The pump is a Watson-Marlow Bredel 825, and provides a maximum flow 
rate of 33.3 LPM and enough power to overcome the 45.5 ft of head required for transport. It has 
a purchase cost of $12,350.  
7.10.7 Pump (P-76/PM-311) 
This pump transports Anion Buffer B to C-302 from V-305 for stripping and regeneration 
in anion exchange chromatography. It is a 316L stainless steel peristaltic pump and uses 0.05 kW 
of power per batch. The pump is a Watson-Marlow Bredel 825, and provides a maximum flow 
rate of 33.3 LPM and enough power to overcome the 45.5 ft of head required for transport. It has 
a purchase cost of $12,350.  
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7.10.8 Storage Tank (P-77/V-304) 
This mixing tank is where Anion Buffer A is stored for use in anion exchange 
chromatography. The tank is made of 316L stainless steel and holds up to 4,400 L of fluid with 
an 88.6% working capacity (3900L). It is 2.3m tall and 1.5 m in diameter. Operating temperature 
is maintained at around room temperature (25°C). The tank is sterilized using CIP and SIP 
techniques. The tank is manufactured by Sharpsville Container and has a purchase cost of 
$117,000. 
7.10.9 Storage Tank (P-78/V-305) 
This mixing tank is where Anion Buffer B is stored for use in anion exchange 
chromatography. The tank is made of 316L stainless steel and holds up to 550 L of fluid with an 
86.4% working capacity (475.2L). It is 1.14m tall and 0.76 m in diameter. Operating temperature 
is maintained at around room temperature (25°C). The tank is sterilized using CIP and SIP 
techniques. The tank is manufactured by Sharpsville Container and has a purchase cost of 
$117,000. 
7.10.10 Pump (P-79/PM-312) 
This pump transports the purified monoclonal antibody stream from V-306 to the 
PEGylation section (PFD -010A), where the monoclonal antibody fragments are PEGylated. It is 
a 316L stainless steel peristaltic pump and uses 0.04 kW of power per batch. The pump is a 
Watson-Marlow Bredel 825, and provides a maximum flow rate of 33.3 LPM and enough power 
to overcome the 50.1 ft of head required for transport. It has a purchase cost of $12,350. 
7.11 Thiol Reduction (BFD-11) 
7.11.1 Diafiltration Storage Tank (P-80 / V-203) 
 This unit is a 4800 L jacketed storage tank with a 90% working capacity volume of 
4277.24 L (height = 2.305 m, diameter = 1.537 m) to be used during the diafiltration process 
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between Ion Exchange Chromatography and Thiol Reduction. It is a blending tank made of 
electropolished 316L Stainless Steel by Sharpsville Container for a purchase cost of $117,000. 
Operating conditions are 25°C and 22.038 psi. Cleaning is performed before and after every 
batch using CIP and SIP procedures. 
7.11.2 Diafiltration Unit (P-81 / DF-401) 
 This diafiltration unit will concentrate the Fab’ fragments from 3.9 mg/ml in Anion 
Buffer 2 to 10 mg/ml in Reduction Reaction Buffer for the Thiol Reduction Reaction. This unit 
consists of 15 diafiltration filters, each with a membrane area of 3.0 m2 to fulfill the 43.56 m2 
total membrane area requirement for this diafiltration process. The unit will use Sartorius Stedim 
Biotechnology's Sartocube® 302 144 59 30 E-BSW stabilized cellulose based filters in a 
Sartocon 2 Plus filter housing unit. The cutoff molecular weight for this filter is 10 kDa, and is 
used in order to retain the 50 kDa Fab’ fragments in the retentate. The housing unit costs $11,141 
and each filter costs $8,374, so the total cost for this unit will be $136,751. Operating conditions 
are 25°C with a pressure drop of 14.5 psi. Cleaning is performed before and after every batch 
using CIP and SIP procedures. 
7.11.3 Pump (P-82 / PM-401) 
This peristaltic pump is used to transport the Fab’ fragments concentrated in the 
Reduction Reaction Buffer from the Diafiltration Unit to the Thiol Reduction Reactor. This 
pump operates at 0.12 kW (0.15 hp) and 48.36 L/min. Operating conditions are 25°C with a 
pressure drop of 50 psi. The pump is model 840 manufactured by Watson Marlow and costs 
$18,135. This model has a maximum flow rate of 133.3 L/min and maximum power of 3.0 kW 
(2.2 hp). It is made of electropolished Stainless Steel 316L and will be used with Bioprene 40 
mm tubing. Cleaning is performed before and after every batch using CIP and SIP procedures. 
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7.11.4 Thiol Reduction Reactor (P-83 / R-401) 
 The  reduction reaction takes place in this reactor in order to reduce any thiols that attach 
to the cysteine on the hinge-region end of the Fab’ fragments during the purification processes. 
This will ensure that the thiols are available for the site-specific PEGylation reaction.  This unit 
is a 1900 L jacketed bioreactor with a backward curved impeller for agitation and a DCS control 
system. It has a 90% working capacity volume of 1673.93 L (height = 2.371 m, diameter = 0.948 
m). It is made of electropolished 316L Stainless Steel by ABEC for a purchase cost of $511,000. 
The reaction is run at operating conditions of 37°C for 90 minutes. Validated cleaning is 
performed before and after every batch using CIP and SIP procedures. 
7.11.5 Pump (P-84 / PM-402) 
This peristaltic pump is used to transport the Fab’ fragments concentrated in the 
Reduction Reaction Buffer from the Thiol Reduction Reactor to the next Diafiltration Unit. This 
pump operates at 0.12 kW (0.16 hp) and 49.11 L/min. Operating conditions are 25°C with a 
pressure drop of 14.5 psi. The pump is model 840 manufactured by Watson Marlow and costs 
$18,135. This model has a maximum flow rate of 133.3 L/min and maximum power of 3.0 kW 
(2.2 hp). It is made of electropolished Stainless Steel 316L and will be used with Bioprene 40 
mm tubing. Cleaning is performed before and after every batch using CIP and SIP procedures. 
7.12 PEGylation Reaction (BFD-12) 
7.12.1 Diafiltration Storage Tank (P-85 / V-402)  
This unit is a 1900 L jacketed storage tank with a 90% working capacity volume of 
1678.37 L (height = 2.679 m, diameter = 0.893 m) to be used during the diafiltration process 
between Thiol Reduction and the PEGylation Reaction. It is a blending tank made of 
electropolished 316L Stainless Steel by Sharpsville Container for a purchase cost of $117,000. 
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Operating conditions are 25°C and 22.046 psi. Cleaning is performed before and after every 
batch using CIP and SIP procedures. 
7.12.2 Diafiltration Unit (P-86 / DF-402)  
This diafiltration unit will filter out the 2-MEA from the Reduction Reaction and keep the 
Fab’ fragments at a concentration of 10 mg/ml in Reduction Reaction Buffer (PEGylation 
Reaction Buffer). This unit consists of 5 diafiltration filters, each with a membrane area of 3.0 
m2 to fulfill the 13.03 m2 total membrane area requirement for this diafiltration process. The unit 
will use Sartorius Stedim Biotechnology's Sartocube® 302 144 59 30 E-BSW stabilized 
cellulose based filters in a Sartocon 2 Plus filter housing unit. The cutoff molecular weight for 
this filter is 10 kDa, and is used in order to retain the 50 kDa Fab’ fragments in the retentate. The 
housing unit costs $11,141 and each filter costs $8,374, so the total cost for this unit will be 
$53,011. Operating conditions are 25°C with a pressure drop of 152.68 psi. Cleaning is 
performed before and after every batch using CIP and SIP procedures. 
7.12.3 Pump (P-87 / PM-403) 
This peristaltic pump is used to transport the Fab’ fragments concentrated in the 
PEGylation Reaction Buffer from the Diafiltration Unit to the PEGylation Reactor. This pump 
operates at 0.12 kW (0.16 hp) and 49.24 L/min. Operating conditions are 25°C with a pressure 
drop of 14.5 psi. The pump is model 840 manufactured by Watson Marlow and costs $18,135. 
This model has a maximum flow rate of 133.3 L/min and maximum power of 3.0 kW (2.2 hp). It 
is made of electropolished Stainless Steel 316L and will be used with Bioprene 40 mm tubing. 
Cleaning is performed before and after every batch using CIP and SIP procedures. 
7.12.4 PEGylation Reactor (P-88 / R-402) 
 In this bioreactor, the PEGylation reaction will take place to site-specifically PEGylate 
the Fab’ fragments with a 40 kDa PEG molecule. This unit is a 2200 L jacketed bioreactor with a 
backward curved impeller for agitation and a DCS control system. It has a 90% working capacity 
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volume of 1947.83 L (height = 2.493 m, diameter = 0.997 m). It is made of electropolished 316L 
Stainless Steel by ABEC for a purchase cost of $522,000. The reaction is run at operating 
conditions of 25°C for 2 hours. Validated cleaning is performed before and after every batch 
using CIP and SIP procedures. The PEG molecule that will be used is a branched maleimide 
polyethylene glycol molecule that will react with thiols. It is purchased from JenKem 
Technology USA at a bulk price of $144/g, costing a total of $3,285,350 per batch for the 
22,814.95 g of the PEG molecular required to react with the Fab’ fragments. 
7.12.5 Pump (P-89 / PM-404) 
This peristaltic pump is used to transport the PEGylated Fab’ fragments, as well as the 
remaining PEG molecules and non-PEGylated Fab’ fragments concentrated in the PEGylation 
Reaction Buffer from the PEGylation Reactor to the next Diafiltration Unit. This pump operates 
at 0.07 kW (0.09 hp) and 27.84 L/min. Operating conditions are 25°C with a pressure drop of 
14.5 psi. The pump is model 825 manufactured by Watson Marlow and costs $12,350. This 
model has a maximum flow rate of 33.3 L/min and maximum power of 1.1 kW (1.6 hp). It is 
made of electropolished Stainless Steel 316L and will be used with Bioprene 25 mm tubing. 
Cleaning is performed before and after every batch using CIP and SIP procedures. 
7.12.6 Diafiltration Storage Tank (P-90 / V-403) 
 This unit is an 1100 L jacketed storage tank with a 90% working capacity volume of 
950.09 L (height = 2.216 m, diameter = 0.739 m) to be used during the diafiltration process 
between the PEGylation Reaction and Cation Exchange Chromatography. It is a blending tank 
made of electropolished 316L Stainless Steel by Sharpsville Container for a purchase cost of 
$117,000. Operating conditions are 25°C and 26.1 psi. Cleaning is performed before and after 
every batch using CIP and SIP procedures. 
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7.12.7 Diafiltration Unit (P-91 / DF-403)  
This diafiltration unit will filter out the PEGylation Reaction Buffer and give a retentate 
of PEGylated Fab’ fragments, excess PEG molecules, and non-PEGylated Fab’ fragments in 
WFI to go into the Cation Exchange Chromatography. This unit consists of 3 diafiltration filters, 
each with a membrane area of 3.0 m2 to fulfill the 7.39 m2 total membrane area requirement for 
this diafiltration process. The unit will use Sartorius Stedim Biotechnology's Sartocube® 302 
144 59 30 E-BSW stabilized cellulose based filters in a Sartocon 2 Plus filter housing unit. The 
cutoff molecular weight for this filter is 30 kDa, and is used in order to be sure to retain the 90 
kDa PEGylated Fab’ fragments in the retentate. The housing unit costs $11,141 and each filter 
costs $8,374, so the total cost for this unit will be $36,263. Operating conditions are 25°C with a 
pressure drop of 26.1 psi. Cleaning is performed before and after every batch using CIP and SIP 
procedures. 
7.13 Cation Exchange Chromatography (BFD-13) 
7.13.1 Cation Buffer 2 Storage Tank (P-92 / V-405) 
This unit is a 2400 L jacketed storage tank with a 90% working capacity volume of 
2113.64 L (height = 2.89 m, diameter = 0.96 m) which will be used to store prepared Cation 
Buffer 2 for the Elution and Stripping steps of the Cation Ion Exchange Chromatography. It is a 
blending tank made of electropolished 316L Stainless Steel by Sharpsville Container for a 
purchase cost of $117,000. Operating conditions are 25°C and 132.2 psi. Cleaning is performed 
before and after every batch using CIP and SIP procedures. 
7.13.2 Cation Buffer 1 Storage Tank (P-93 / V-404) 
This unit is a 2400 L jacketed storage tank with a 90% working capacity volume of 
2113.64 L (height = 2.89 m, diameter = 0.96 m) which will be used to store prepared Cation 
Buffer 2 for the Elution and Stripping steps of the Cation Ion Exchange Chromatography. It is a 
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blending tank made of electropolished 316L Stainless Steel by Sharpsville Container for a 
purchase cost of $117,000. Operating conditions are 25°C and 132.226 psi. Cleaning is 
performed before and after every batch using CIP and SIP procedures. 
7.13.3 Pump (P-94 / PM-405) 
This peristaltic pump is used to transport the mixture of PEGylated Fab’ fragments, 
excess PEG molecules, and non-PEGylated Fab’ fragments in WFI during the Load step of the 
Cation Exchange Chromatography. This pump operates at 0.12 kW (0.16 hp) and 48.79 L/min. 
Operating conditions are 25°C with a pressure drop of 14.5 psi. The pump is model 840 
manufactured by Watson Marlow and costs $18,135. This model has a maximum flow rate of 
133.3 L/min and maximum power of 3.0 kW (2.2 hp). It is made of electropolished Stainless 
Steel 316L and will be used with Bioprene 40 mm tubing. Cleaning is performed before and after 
every batch using CIP and SIP procedures. 
7.13.4 Pump (P-95 / PM-406) 
This peristaltic pump is used to transport Cation Buffer 1 from the storage tank in order 
to be mixed with the incoming PEGylated Fab’ stream before the Load step of the Cation 
Exchange Chromatography. This pump operates at 0.29 kW (0.38 hp) and 119.83 L/min. 
Operating conditions are 25°C with a pressure drop of 14.5 psi. The pump is model 840 
manufactured by Watson Marlow and costs $18,135. This model has a maximum flow rate of 
133.3 L/min and maximum power of 3.0 kW (2.2 hp). It is made of electropolished Stainless 
Steel 316L and will be used with Bioprene 40 mm tubing. Cleaning is performed before and after 
every batch using CIP and SIP procedures. 
7.13.5 Pump (P-96 / PM-410) 
This peristaltic pump is used to transport Cation Buffer 2 from the storage tank to the 
Cation Exchange Chromatography Column during the Stripping step. This pump operates at 0.06 
kW (0.08 hp) and 25.18 L/min. Operating conditions are 25°C with a pressure drop of 14.5 psi. 
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The pump is model 825 manufactured by Watson Marlow and costs $12,350. This model has a 
maximum flow rate of 33.3 L/min and maximum power of 1.6 kW (1.1 hp). It is made of 
electropolished Stainless Steel 316L and will be used with Bioprene 25 mm tubing. Cleaning is 
performed before and after every batch using CIP and SIP procedures. 
7.13.6 Pump (P-97 / PM-411) 
This peristaltic pump is used to transport Cation Buffer 2 from the storage tank to the 
Chromatography Column during the Elution step. This pump operates at 0.02 kW (0.03 hp) and 
9.21 L/min. Operating conditions are 25°C with a pressure drop of 14.5 psi. The pump is model 
825 manufactured by Watson Marlow and costs $12,350. This model has a maximum flow rate 
of 33.3 L/min and maximum power of 1.6 kW (1.1 hp). It is made of electropolished Stainless 
Steel 316L and will be used with Bioprene 25 mm tubing. Cleaning is performed before and after 
every batch using CIP and SIP procedures. 
7.13.7 Pump (P-98 / PM-409) 
This peristaltic pump is used to transport Cation Buffer 1 from the storage tank to the 
Cation Exchange Chromatography Column during the Washing step. This pump operates at 0.04 
kW (0.06 hp) and 18.88 L/min. Operating conditions are 25°C with a pressure drop of 14.5 psi. 
The pump is model 825 manufactured by Watson Marlow and costs $12,350. This model has a 
maximum flow rate of 33.3 L/min and maximum power of 1.6 kW (1.1 hp). It is made of 
electropolished Stainless Steel 316L and will be used with Bioprene 25 mm tubing. Cleaning is 
performed before and after every batch using CIP and SIP procedures. 
7.13.8 Pump (P-99 / PM-407) 
This peristaltic pump is used to transport Cation Buffer 1 from the storage tank to the 
Cation Exchange Chromatography Column during the Equilibration step. This pump operates at 
0.06 kW (0.08 hp) and 25.18 L/min. Operating conditions are 25°C with a pressure drop of 14.5 
psi. The pump is model 825 manufactured by Watson Marlow and costs $12,350. This model has 
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a maximum flow rate of 33.3 L/min and maximum power of 1.6 kW (1.1 hp). It is made of 
electropolished Stainless Steel 316L and will be used with Bioprene 25 mm tubing. Cleaning is 
performed before and after every batch using CIP and SIP procedures. 
7.13.9 Mixer (P-100 / MX-102) 
This mixing step will be a joint in the piping of the system which will mix the incoming 
Fab’ stream with Cation Buffer 1 from the storage tank immediately before the Loading step of 
the Cation Exchange Chromatograph. This must be done to ensure that the PEGylated Fab’ 
fragments do not denature. Price will be incorporated into the cost of piping.  
7.13.10 Chromatography Column (P-101 / C-401) 
This unit is a Cation Exchange Chromatography Column which goes through a process of 
Equilibration, Washing, Loading, Elution and Stripping. It is a 154.46 L (height = 0.787 m, 
diameter = 1.0 m) ChromaflowTM 1000 column made by GE Healthcare which will be purchased 
for $249,000. The distributor is made of polypropylene, the seals are made of FEP-encapsulated 
silicone, and the column, lid, bed support, nozzles, and stand are made of 316L stainless steel. 
The 154.46 L bed will be packed with GE Healthcare MacroCap SP Resin with a dynamic 
binding capacity of 150 mg/ml and a linear velocity of 120 cm/h, which will cost $290,230 at a 
price of $1,879 per liter. Cleaning is performed before and after every batch using CIP and SIP 
procedures. 
7.14 Final Filtration (BFD-14) 
7.14.1Pump (P-102/PM-501) 
This pump transports the purified monoclonal antibody stream from the PEGylation 
section (PFD -010A) to the diafiltration holding tank V-501. It is a 316L stainless steel peristaltic 
pump and uses 0.02 kW of power per batch. The pump is a Watson-Marlow Bredel 825, and 
Flexible Manufacturing Facility for Biopharmaceuticals 
 
-85- 
 
provides a maximum flow rate of 33.3 LPM and enough power to overcome the 45.5 ft of head 
required for transport. It has a purchase cost of $12,350. 
7.14.2 Holding Tank (P-103/V-501) 
This holding tank is used to store fluid for diafiltration. The tank is made of 316L 
stainless steel and holds up to 370 L of fluid with a 90% working capacity (333L). It is 1.0m tall 
and 0.68m in diameter. Operating temperature is maintained at around room temperature (25°C). 
The tank is sterilized using CIP and SIP techniques. The tank is manufactured by Sharpsville 
Container and has a purchase cost of $117,000. 
7.14.3 Diafiltration (P-104/DF-501) 
Diafiltration cassettes will be provided by Sartorius Stedim Biotechnology. The 
membrane is composed of the cellulose-based Hydrosart, is about 3.0 m2 in area. The cutoff 
molecular weight for this filter is 30 kDa, and is used in order to retain the 90 kDa PEGylated 
Fab’ fragments in the retentate. The housing unit costs $11,141 and each filter costs $8,374, so 
the total cost for this unit will be $36,263. Operating conditions are 25°C with a pressure drop of 
26.1 psi. Cleaning is performed before and after every batch using CIP and SIP procedures. 
7.14.4 Peristaltic Pump (P-105/PM-502) 
This pump transports the purified monoclonal antibody stream diafiltration to viral 
filtration. It is a 316L stainless steel peristaltic pump and uses 0.036 kW of power per batch. The 
pump is a Watson-Marlow Bredel 825, and provides a maximum flow rate of 33.3 LPM. It has a 
purchase cost of $12,350. 
7.14.5 Retrovirus Filtration (P-106/DE-501) 
This 50 nm normal flow filter is used to remove larger viral particles, such as retroviruses 
and certain bacteriophages, while allowing the PEGylated monoclonal antibody fragment (10nm) 
to pass through. The Viresolve NFR Cartridge filter is manufactured by Millipore and is made of 
polyethersulfone with a filtration area of 0.43m2. The filter costs $1,459 and the housing for it 
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costs $1,340. A new filter will be used for each batch to ensure sterility and to maximize 
filtration of the virus. 
7.14.6 Parvovirus Filtration (P-107/DE-502) 
This 20 nm normal flow filter is used to remove parvoviruses from the product stream, 
while allowing the PEGylated monoclonal antibody fragment (10nm) to pass through. The 
Viresolve NFP Cartridge filter is manufactured by Millipore and is made of modified 
polyvinylidene fluoride (PVDF) with a filtration area of 0.42m2. The filter costs $3,963 and the 
housing for it costs $1,340. A new filter will be used for each batch to ensure sterility and to 
maximize filtration of the virus. 
7.14.7 Disposable Container Storage (P-108/DCS-101) 
Dispensing the final product into 50 L bags is done by the SciLog Fillmaster system. It 
contains a peristaltic pump, whose maximum flow rate is 14.6 LPM, and distributes liquid 
accurately into sterile 50 L HyClone Labtainer Bags made of a special HyQ CX5-14 film. The 
SciLog Fillmaster system costs $10,000 and the sterile bags cost $49.05 each. 
7.14.8 Refrigeration (P-109/EC-501) 
Freezing down of the PEGylated monoclonal antibody is necessary to keep the product 
stable for as long as possible. Effective temperatures for long term storage range from -20°C to -
80°C. The freezing is done using an ultra cold freezer, which can reach temperatures up to -
85°C. The freezer can hold up to 1050 L (or 21 bags) and requires 10.85 kW per batch. 
Manufactured by Cincinnati Sub-Zero, the freezer is made of 304 grade stainless steel and costs 
$45,000.  
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8.0 Additional Equipment and Pricing 
 There are several pieces of equipment that are integral to the operation of the monoclonal 
antibody production plant, but are not found on the process flow diagrams. These pieces of 
equipment are described in this section, along with a description of the spare equipment that will 
be purchased. 
8.1 Incubators for T-flasks and Roller Bottles 
 Mammalian cells need to live at a very specific temperature to survive and proliferate. 
The incubators are used to control the temperature of the t-flasks and roller bottles. The total cost 
of the incubators, which are manufactured by Thermo Scientific, is $15,000. Electricity 
consumption per batch for the incubators is 49.9 kWh.  
8.2 Roller Bottle Apparatus 
The roller bottle apparatus is a system that is used to rotate the roller bottles to ensure the 
cultures receive enough oxygen to grow. The apparatus is used inside the roller bottle incubator. 
Manufactured by Cole-Parmer, the total cost of the apparatus costs $6500.  
8.3 Biosafety Cabinet 
A biosafety cabinet is needed to provide a sterile environment for aseptic handling and 
transfer of mammalian cells into T-flasks and roller bottles. Manufactured by Thermo Scientific, 
the biosafety cabinet costs $10,000.  
8.4 Air Generator (HVAC Equipment) 
 Purified air will be provided by an HVAC system, supplying pure air to bioreactors, clean 
rooms, and other process equipment. This cost of the system is $1.2 million and requires 100 kW 
of power per hour.  
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8.5 Clean Steam Generator 
 The clean steam generator is used to produce steam from WFI and clean process 
equipment with steam-in-place procedures. It has a power requirement of 4.1 kW and costs 
$200,000.  
8.6 CIP Skids 
 CIP, or Clean-In-Place, is a technique used to clean process equipment. A CIP skid 
contains the cleaning solutions and equipment and is portable, as it can be wheeled around to 
different pieces of process equipment. Three CIP skids, manufactured by Sani-matic, will be 
needed for this process and each one will cost $80,000. Power consumption totals to about 7.5 
kW per batch. 
8.7 Buffer Transfer Bags 
 Buffer transfer bags are used to transfer media or buffer to certain processing steps. 
These disposable bags are manufactured by HyClone and will cost approximately $70,000 a 
year. 
8.8 Filter Integrity Tester 
 The filter integrity tester is used to test sterile and viral filters before use to ensure that 
they are not clogged, torn, or unusable. Even though the filters used are single-use, filter testing 
is performed to prevent loss of product and time. The filter integrity tester from Millipore, or the 
Integritest Exacta Automatic Filter Integrity Test Instrument, has a purchase cost of $16,500. 
8.9 Tube Fuser 
 In using sterile, single-use, equipment, it is necessary to connect tubing of process 
equipment, sterile containers, and bags to transfer liquid. Sartorius Stedim Biotech’s Sterile Tube 
Fuser is a fully automatic device that cuts and fuses tube ends together to ensure sterility. It costs 
$15,300. 
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8.10 Tube Sealer 
 The tube sealer is used to seal plastic tubing to prevent leaks from the bags that are used 
throughout the process. It is a fully automated unit and can be used on many types of plastic 
tubing. It is produced by Sartorius Stedim Biotech and the cost of the tube sealer is $10,200.  
8.11 Water Treatment Package 
The water treatment package is used to generate USP grade water from tap water. The 
package costs $100,000 and uses 7.5 kW per batch.  
8.12 WFI Still 
The WFI still further purifies the water from the water treatment package to produce 
WFI. WFI is used throughout the process to ensure sterility of the product and process 
equipment. The still costs $350,000 and is manufactured by the Paul Mueller Co. It requires 37.3 
kW per batch. 
8.13 Biowaste and Neutralization Waste Tanks 
 Two separate tanks are necessary to collect the wastes generated by the process. All 
wastes potentially carrying living cells are sent to the biowaste tank, while the rest are sent to the 
neutralization tank. The biowaste tank is 5,000 L, while the neutralization tank is 35,000 L. 
These tanks will be made of 316L stainless steel and manufactured by Sharpsville Container for 
$125,000 each.   
8.14 Biowaste Inactivation System 
 This system kills any remaining biomass in the biowaste tank. This includes all CIP and 
SIP washes, from the main bioreactors and primary recovery. The system costs $270,000 and 
uses 12 kW per batch.   
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8.15 Waste Neutralization System 
 The waste neutralization system operates by adjusting the pH of process waste in the 
neutralization tank to 7.0. This allows the wastes to be sent to the sewer. The cost of the system 
is $100,000 and requires 12kW for operation.  
8.16 Blood Gas Analyzer  
 A blood gas analyzer is needed to analyze the contents of the media. This includes 
nutrients, metabolites, gases, cell density, cell viability, osmolality, and even IgG concentration. 
With the BioProfile Flex, manufactured by Nova Biomedical, up to 16 assays can be performed 
within minutes. The total cost of the system is $45,000 
8.17 Laboratory Information Management System (LIMS)  
 The Laboratory Information Management system, or LIMS, is software that is used to 
manage a laboratory. It manages samples, users, instruments, and many laboratory functions. 
The cost of a LIMS is $450,000 and is provided by STARLIMS.  
8.19 Portable Pump on Cart 
 A portable pump on cart is used in case a connected pump breaks down or malfunctions. 
This pump will easily replace the broken pump until it can be fixed. An extra Watson-Marlow 
Bredel 840 pump and a cart will cost $12,500.  
8.20 Final Packaging 
 The monoclonal antibody produced by plant will not be ready for dosing of patients, as 
the product requires further packaging. The product will be shipped out to a facility that will 
lyophilize the frozen antibodies in septum bottles, allowing the longer shelf-life at room 
temperature. Final packaging, including both shipping and lyophilization, will be performed by 
Quality BioResources, Inc., and costs $270,000 per batch.  
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9.0 Unit Specification Sheets 
 The following pages contain the unit specification sheets for the equipment used in our 
manufacturing facility. Equipment models and prices have been obtained through direct contact 
with vendors.  
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T-Flask (P-1 / TFR-101) 
Function: Non-treated, sterile flasks for the suspension and growth of cell cultures. 
Vendor: Nunc International 
PFD Reference: PFD-01 
Operation: Batch 
Materials Handled: 
 
Input:  
Amino Acids 
Glucose 
Glutamine 
Inorganic Salts 
Other Media 
Vitamins 
WFI 
Total 
 
 
Quantity (kg/batch):  
0.00267 
0.01132 
0.00131 
0.02742 
0.00024 
0.00011 
2.11021 
2.15309 
 
Characteristics: 
Model: 
Material of Construction: 
Cap: 
Flask Type: 
Total Volume: 
Suggested Working Volume: 
Additional Features: 
Nunc EasyFlask 159933 
Polystyrene 
Filter 
Non-treated, Sterile 
225 ml 
70 ml 
Disposable 
Operating Conditions: 
Temp: 
Pressure: 
Duration: 
Number of Containers: 
37 °C 
1 bar 
4 days 
20 
Purchase Cost: $205.01/(30 flasks) 
Reference Page: 466 
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Roller Bottle (P-2 / RBR-101) 
Function: Non-treated, sterile bottles for the suspension and growth of cell cultures. 
Vendor: Nunc International 
PFD Reference: PFD-01 
Operation: Batch 
Materials Handled: 
Input:  
Amino Acids 
Biomass 
Dead Biomass 
Glucose 
Glutamine 
Inorganic Salts 
Lactate 
MAB 
Other Media 
Vitamins 
Water 
WFI 
Total 
 
Quantity (kg/batch):  
0.01363 
0.00030 
0.00003 
0.05770 
0.00667 
0.13976 
0.00021 
0.00006 
0.00121 
0.00057 
0.00053 
10.80021 
11.02088 
 
Characteristics: 
Model: 
Material of Construction: 
Flask Type: 
Culture Area: 
Suggested Working Volume: 
Additional Features: 
Nunc Standard Roller Bottle 186022 
PETG 
Non-treated, Sterile 
1800 cm2 
200-1000 
Disposable 
Operating Conditions: 
Temp: 
Pressure: 
Duration: 
Number of Containers: 
37 °C 
1 bar 
4 days 
11 
Purchase Cost: $426.75/(22 bottles) 
Reference Page: 468 
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Bag Bioreactor (P-3 / BBS-101) 
Function: 
A pre-sterilized disposable bioreactor chamber equipped with ports for 
sterile aeration, seeding, harvesting, sampling and analysis. The rocker 
unit is used to control and monitor temperature, pH, aeration rate, and 
rocking speed to obtain proper cell growth. 
Vendor: Sartorius Stedim Biotech 
PFD Reference: PFD-01 
Operation: Batch 
Materials Handled: 
Input:  
Amino Acids 
Biomass 
Dead Biomass 
Glucose 
Glutamine 
Inorganic Salts 
Lactate 
MAB 
Other Media 
Vitamins 
Water 
WFI 
Total 
 
Quantity (kg/batch):  
0.08843 
0.00189 
0.00019 
0.37423 
0.04329 
0.90654 
0.00134 
0.00039 
0.00783 
0.00370 
0.00339 
70.04777 
71.47899 
 
Characteristics: 
Model: 
Type: 
Bag Size: 
Max Working Volume: 
Min Working Volume: 
Sterilization: 
BIOSTAT® CultiBag RM 
Rocker 20/50 (Optical Package) 
20 L 
10 L 
2 L 
Disposable Bags 
Operating Conditions: 
Temp: 
Pressure: 
pH: 
DO: 
Duration: 
Number In Use Per Batch: 
37 °C 
1 bar 
7.0 
50% 
4 Days 
8 
Purchase Cost: Rocker and Control Unit: $33,000 (Quote from Applikon) Disposable Bag: $447/bag (Quote from Applikon) 
Reference Page: 483 
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Bag Bioreactor (P-4 / BBS-102) 
Function: 
A pre-sterilized disposable bioreactor chamber equipped with ports for 
sterile aeration, seeding, harvesting, sampling and analysis. The rocker 
unit is used to control and monitor temperature, pH, aeration rate, and 
rocking speed to obtain proper cell growth. 
Vendor: Sartorius Stedim Biotech 
PFD Reference: PFD-01 
Operation: Batch 
Materials Handled: 
Input:  
Amino Acids 
Biomass 
Dead Biomass 
Glucose 
Glutamine 
Inorganic Salts 
Lactate 
MAB 
Other Media 
Vitamins 
Water 
WFI 
Total 
 
Quantity (kg/batch):  
0.39911 
0.01393 
0.00143 
1.68901 
0.19538 
4.09140 
0.00988 
0.00286 
0.03535 
0.01671 
0.02501 
316.91374 
323.39381 
 
Characteristics: 
Model: 
Type: 
Bag Size: 
Max Working Volume: 
Min Working Volume: 
Sterilization: 
BIOSTAT® CultiBag RM 
Rocker 200 (Optical Package) 
100 L 
50 L 
10 L 
Disposable Bags 
Operating Conditions: 
Temp: 
Pressure: 
pH: 
DO: 
Duration: 
Number In Use Per Batch: 
37 °C 
1 bar 
7.0 
50% 
4 Days 
7 
Purchase Cost: Rocker and Control Unit: $39,000 (Quote from Applikon) Disposable Bag: $447/bag (Quote from Applikon) 
Reference Page: 483 
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Storage/Mixing Tank (P-5 / MP-101) 
Function: Tank used to store and mix powdered serum free media with water for injection prior to being pumped through a sterile filter. 
Vendor: Sharpsville Container 
PFD Reference: PFD-02 
Operation: Batch 
Materials Handled: 
Input:  
Amino Acids 
Glucose 
Glutamine 
Inorganic Salts 
Other Media 
Vitamins 
WFI 
Total 
 
Quantity (kg/batch):  
1.36298 
5.76797 
0.66722 
13.97219 
0.12071 
0.05707 
648.69449 
670.64263 
 
Characteristics: 
Material of Construction: 
Volume: 
Height: 
Diameter: 
Working Capacity: 
Sterilization: 
Stainless Steel 316 
1000 L 
2.2 m 
0.8 m 
70% 
SIP/CIP 
Operating Conditions: Temp: Pressure: 
25 °C 
1 bar 
Purchase Cost: $117,000 
Reference Page: 508 
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Pump (P-6 / PM-101) 
Function: Pump to transfer fluid from first media prep storage tank to first sterile filter. 
Vendor: Watson Marlow 
PFD Reference: PFD-02 
Operation: Batch 
Materials Handled: 
Input:  
Amino Acids 
Glucose 
Glutamine 
Inorganic Salts 
Other Media 
Vitamins 
WFI 
Total  
 
Quantity (kg/batch):  
1.36298 
5.76797 
0.66722 
13.97219 
0.12071 
0.05707 
648.69449 
670.64263 
 
Characteristics: 
Model: 
Pump Type: 
Material of Construction: 
Flow Rate: 
Power: 
Sterilization: 
Watson-Marlow Bredel 825 
Peristaltic 
Stainless Steel 316 
33.3 LPM 
1.5 – 5.0 hp 
SIP/CIP 
Operating Conditions: 
Temp: 
Power: 
Pressure Change 
25 °C 
1.34 hp/ 1 kW 
25 psi 
Purchase Cost: $12,350 
Reference Pages: 493, 505 
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Sterilization Filter (P-7 / DE-101) 
Function: 0.2 µm filter to remove bacteria and other impurities from the serum free media prior to feeding the first seed bioreactor. 
Vendor: Sartorius Stedim Biotech 
PFD Reference: PFD-02 
Operation: Batch 
Materials Handled: 
Input:  
Amino Acids 
Glucose 
Glutamine 
Inorganic Salts 
Other Media 
Vitamins 
WFI 
Total  
 
Quantity (kg/batch):  
1.36298 
5.76797 
0.66722 
13.97219 
0.12071 
0.05707 
648.69449 
670.64263 
 
Characteristics: 
Model: 
Size: 
Filtration Area: 
Max. Differential Pressure: 
Sartopore 2 0.2 µm 
30’’ 
1.8 m2 (18 ft2) 
5 bar (75 psi) at 20°C 
Operating Conditions: Temp: Differential Pressure: 
25 °C 
0.5 bar (7.5 psi) 
Purchase Cost: Filter Housing:   $1,908  Filter Membrane: $608/unit 
Reference Page: 491 
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Pump (P-8 / PM-102) 
Function: Pump to transfer fluid from first sterile filter to first seed bioreactor. 
Vendor: Watson Marlow 
PFD Reference: PFD-02 
Operation: Batch 
Materials Handled: 
Input:  
Amino Acids 
Glucose 
Glutamine 
Inorganic Salts 
Other Media 
Vitamins 
WFI 
Total 
 
Quantity (kg/batch):  
1.36298 
5.76797 
0.66722 
13.97219 
0.12071 
0.05707 
648.69449 
670.64263 
 
Characteristics: 
Model: 
Pump Type: 
Material of Construction: 
Flow Rate: 
Power: 
Sterilization: 
Watson-Marlow Bredel 825 
Peristaltic 
Stainless Steel 316 
33.3 LPM 
1.5 – 5.0 hp 
SIP/CIP 
Operating Conditions: 
Temp: 
Power: 
Pressure Change 
25 °C 
1.34 hp/ 1 kW 
25 psi 
Purchase Cost: $12,350 
Reference Pages: 493, 505 
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Seed Bioreactor (P-9 / SBR-101) 
Function: Bioreactor used for continued cell growth and production of monoclonal antibodies. 
Vendor: ABEC 
PFD Reference: PFD-02 
Operation: Batch 
Materials Handled: 
Input:  
Amino Acids 
Biomass 
Dead Biomass 
Glucose 
Glutamine 
Inorganic Salts 
Lactate 
MAB 
Other Media 
Vitamins 
Water 
WFI 
Total 
 
Quantity (kg/batch):  
1.75135 
0.07321 
0.0075 
7.41151 
0.85734 
17.95346 
0.0519 
0.01502 
0.15511 
0.07333 
0.13141 
965.60863 
994.08977 
 
Characteristics: 
Material of Construction: 
Volume: 
Height: 
Diameter: 
Working Capacity: 
Sterilization: 
Stainless Steel 316 
1500 L 
2.3 m 
0.9 m 
70% 
SIP/CIP 
Operating Conditions: 
Temp: 
Pressure: 
pH: 
DO: 
Duration: 
37°C 
1 bar 
7.0 
50% 
4 days 
Purchase Cost: $495,000 
Reference Page: 507 
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Pump (P-10 / PM-103) 
Function: Pump to transfer fluid from first seed bioreactor to second seed bioreactor. 
Vendor: Watson Marlow 
PFD Reference: PFD-03 
Operation: Batch 
Materials Handled: 
Input:  
Amino Acids 
Biomass 
Dead Biomass 
Glucose 
Glutamine 
Inorganic Salts 
Lactate 
MAB 
Other Media 
Oxygen 
Vitamins 
Water 
WFI 
Total 
 
Quantity (kg/batch):  
0.18 
8.77 
0.90 
0.74 
0.09 
1.80 
6.22 
1.80 
0.00 
0.02 
0.01 
15.74 
969.06 
1005.31 
 
Characteristics: 
Model: 
Pump Type: 
Material of Construction: 
Flow Rate: 
Power: 
Sterilization: 
Watson-Marlow Bredel 825 
Peristaltic 
Stainless Steel 316 
33.3 LPM 
1.5 – 5.0 hp 
SIP/CIP 
Operating Conditions: 
Temp: 
Power: 
Pressure Change 
25 °C (Room Temperature) 
1.34 hp/ 1 kW 
25 psi 
Purchase Cost: $12,350 
Reference Pages: 493, 505 
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Storage/Mixing Tank (P-11 / MP-102) 
Function: Tank used to store and mix powdered serum free media with water for injection prior to being pumped to a sterile filter. 
Vendor: Sharpsville Container 
PFD Reference: PFD-03 
Operation: Batch 
Materials Handled: 
Input:  
Amino Acids 
Glucose 
Glutamine 
Inorganic Salts 
Other Media 
Vitamins 
WFI 
Total 
 
Quantity (kg/batch):  
4.17654 
17.67465 
2.04456 
42.81462 
0.3699 
0.17486 
2011.29215 
2078.54728 
 
Characteristics: 
Material of Construction: 
Volume: 
Height: 
Diameter: 
Working Capacity: 
Sterilization: 
Stainless Steel 316 
3000 L 
3.3 m 
1.1 m 
70% 
SIP/CIP 
Operating Conditions: Temp: Pressure: 
25 °C 
1 bar 
Purchase Cost: $120,000 
Reference Page: 508 
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Pump (P-12 / PM-104) 
Function: Pump to transfer fluid from second media prep storage tank to second sterile filter. 
Vendor: Watson Marlow 
PFD Reference: PFD-03 
Operation: Batch 
Materials Handled: 
Input:  
Amino Acids 
Glucose 
Glutamine 
Inorganic Salts 
Other Media 
Vitamins 
WFI 
Total (kg/batch) 
 
Quantity (kg/batch):  
4.17654 
17.67465 
2.04456 
42.81462 
0.3699 
0.17486 
2011.29215 
2078.54728 
 
Characteristics: 
Model: 
Pump Type: 
Material of Construction: 
Flow Rate: 
Power: 
Sterilization: 
Watson-Marlow Bredel 825 
Peristaltic 
Stainless Steel 316 
33.3 LPM 
1.5 – 5.0 hp 
SIP/CIP 
Operating Conditions: 
Temp: 
Power: 
Pressure Change 
25 °C 
1.34 hp/ 1 kW 
25 psi 
Purchase Cost: $12,350 
Reference Pages: 493, 505 
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Sterilization Filter (P-13 / DE-102) 
Function: 0.2 µm filter to remove bacteria and other impurities from the serum free media prior to feeding the second seed bioreactor. 
Vendor: Sartorius Stedim Biotech 
PFD Reference: PFD-03 
Operation: Batch 
Materials Handled: 
Input:  
Amino Acids 
Glucose 
Glutamine 
Inorganic Salts 
Other Media 
Vitamins 
WFI 
Total 
 
Quantity (kg/batch):  
4.17654 
17.67465 
2.04456 
42.81462 
0.3699 
0.17486 
2011.29215 
2078.54728 
 
Characteristics: 
Model: 
Size: 
Filtration Area: 
Max. Differential Pressure: 
Sartopore 2 0.2 µm 
30’’ 
1.8 m2 (18 ft2) 
5 bar (75 psi) at 20°C 
Operating Conditions: Temp: Differential Pressure: 
25 °C 
0.5 bar (7.5 psi) 
Purchase Cost: Filter Housing:   $1,908  Filter Membrane: $608/unit 
Reference Page: 491 
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Pump (P-14 / PM-105) 
Function: Pump to transfer fluid from second sterile filter to second seed bioreactor. 
Vendor: Watson Marlow 
PFD Reference: PFD-03 
Operation: Batch 
Materials Handled: 
Input:  
Amino Acids 
Glucose 
Glutamine 
Inorganic Salts 
Other Media 
Vitamins 
WFI 
Total 
 
Quantity (kg/batch):  
4.17654 
17.67465 
2.04456 
42.81462 
0.3699 
0.17486 
2011.29215 
2078.54728 
 
Characteristics: 
Model: 
Pump Type: 
Material of Construction: 
Flow Rate: 
Power: 
Sterilization: 
Watson-Marlow Bredel 825 
Peristaltic 
Stainless Steel 316 
33.3 LPM 
1.5 – 5.0 hp 
SIP/CIP 
Operating Conditions: 
Temp: 
Power: 
Pressure Change 
25 °C 
1.34 hp/ 1 kW 
25 psi 
Purchase Cost: $12,350 
Reference Pages: 493, 505 
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Seed Bioreactor (P-15 / SBR-102) 
Function: Bioreactor used for continued cell growth and production of monoclonal antibodies. 
Vendor: ABEC 
PFD Reference: PFD-03 
Operation: Batch 
Materials Handled: 
Input:  
Amino Acids 
Biomass 
Dead Biomass 
Glucose 
Glutamine 
Inorganic Salts 
Lactate 
MAB 
Other Media 
Vitamins 
Water 
WFI 
Total 
 
Quantity (kg/batch):  
4.52681 
7.80284 
0.79941 
19.15695 
2.21603 
46.40531 
5.53213 
1.60111 
0.40092 
0.18953 
14.00684 
2976.90078 
3079.53866 
 
Characteristics: 
Material of Construction: 
Volume: 
Height: 
Diameter: 
Working Capacity: 
Sterilization: 
Stainless Steel 316 
4500 L 
3.3 m 
1.3 m 
70% 
SIP/CIP 
Operating Conditions: 
Temp: 
Pressure: 
pH: 
DO: 
Duration: 
37°C 
1 bar 
7.0 
50% 
4 days 
Purchase Cost: $585,000 
Reference Page: 507 
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Pump (P-16 / PM-106) 
Function: Pump to transfer fluid from second seed bioreactor to production bioreactor. 
Vendor: Watson Marlow 
PFD Reference: PFD-04 
Operation: Batch 
Materials Handled: 
Input:  
Amino Acids 
Biomass 
Dead Biomass 
Glucose 
Glutamine 
Inorganic Salts 
Lactate 
MAB 
Other Media 
Vitamins 
Water 
WFI 
Total 
 
Quantity (kg/batch):  
0.90536 
27.78205 
2.84632 
3.83139 
0.4432 
9.28106 
19.6972 
5.70075 
0.08019 
0.03791 
49.87146 
2976.90077 
3097.37766 
 
Characteristics: 
Model: 
Pump Type: 
Material of Construction: 
Flow Rate: 
Power: 
Sterilization: 
Watson-Marlow Bredel 825 
Peristaltic 
Stainless Steel 316 
33.3 LPM 
1.5 – 5.0 hp 
SIP/CIP 
Operating Conditions: 
Temp: 
Power: 
Pressure Change 
25 °C (Room Temperature) 
1.34 hp/ 1 kW 
25 psi 
Purchase Cost: $12,350 
Reference Pages: 493, 505 
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Storage/Mixing Tank (P-17 / MP-103) 
Function: Tank used to store and mix powdered serum free media with water for injection prior to being pumped to a sterile filter (P-19). 
Vendor: Sharpsville Container 
PFD Reference: PFD-04 
Operation: Batch 
Materials Handled: 
Input:  
Amino Acids 
Glucose 
Glutamine 
Inorganic Salts 
Other Media 
Vitamins 
WFI 
Total 
 
Quantity (kg/batch):  
10.74057 
45.45284 
5.25786 
110.10379 
0.95126 
0.44969 
5222.19771 
5395.15372 
 
Characteristics: 
Material of Construction: 
Volume: 
Height: 
Diameter: 
Working Capacity: 
Sterilization: 
Stainless Steel 316 
7700 L 
4.5 m 
1.5 m 
70% 
SIP/CIP 
Operating Conditions: Temp: Pressure: 
25 °C 
1 bar 
Purchase Cost: $130,000 
Reference Page: 508 
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Pump (P-18 / PM-107) 
Function: Pump to transfer fluid from storage tank (P-17) to sterile filter (P-19). 
Vendor: Watson Marlow 
PFD Reference: PFD-04 
Operation: Batch 
Materials Handled: 
Input:  
Amino Acids 
Glucose 
Glutamine 
Inorganic Salts 
Other Media 
Vitamins 
WFI 
Total 
 
Quantity (kg/batch):  
10.74057 
45.45284 
5.25786 
110.10379 
0.95126 
0.44969 
5222.19771 
5395.15372 
 
Characteristics: 
Model: 
Pump Type: 
Material of Construction: 
Flow Rate: 
Power: 
Sterilization: 
Watson-Marlow Bredel 825 
Peristaltic 
Stainless Steel 316 
33.3 LPM 
1.5 – 5.0 hp 
SIP/CIP 
Operating Conditions: 
Temp: 
Power: 
Pressure Change 
25 °C 
1.34 hp/ 1 kW 
25 psi 
Purchase Cost: $12,350 
Reference Pages: 493, 505 
 
Flexible Manufacturing Facility for Biopharmaceuticals 
 
-110- 
 
Sterilization Filter (P-19 / DE-103) 
Function: 0.2 µm filter to remove bacteria and other impurities from the serum free media prior to feeding the production bioreactor. 
Vendor: Sartorius Stedim Biotech 
PFD Reference: PFD-04 
Operation: Batch 
Materials Handled: 
Input:  
Amino Acids 
Glucose 
Glutamine 
Inorganic Salts 
Other Media 
Vitamins 
WFI 
Total 
 
Quantity (kg/batch):  
10.74057 
45.45284 
5.25786 
110.10379 
0.95126 
0.44969 
5222.19771 
5395.15372 
 
Characteristics: 
Model: 
Size: 
Filtration Area: 
Max. Differential Pressure: 
Sartopore 2 0.2 µm 
30’’ 
1.8 m2 (18 ft2) 
5 bar (75 psi) at 20°C 
Operating Conditions: Temp: Differential Pressure: 
25 °C 
0.5 bar (7.5 psi) 
Purchase Cost: Filter Housing:   $1,908  Filter Membrane: $608/unit 
Reference Page: 491 
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Pump (P-20 / PM-108) 
Function: Pump to transfer fluid from sterile filter (P-19) to the production bioreactor. 
Vendor: Watson Marlow 
PFD Reference: PFD-04 
Operation: Batch 
Materials Handled: 
Input:  
Amino Acids 
Glucose 
Glutamine 
Inorganic Salts 
Other Media 
Vitamins 
WFI 
Total 
 
Quantity (kg/batch):  
10.74057 
45.45284 
5.25786 
110.10379 
0.95126 
0.44969 
5222.19771 
5395.15372 
 
Characteristics: 
Model: 
Pump Type: 
Material of Construction: 
Flow Rate: 
Power: 
Sterilization: 
Watson-Marlow Bredel 825 
Peristaltic 
Stainless Steel 316 
33.3 LPM 
1.5 – 5.0 hp 
SIP/CIP 
Operating Conditions: 
Temp: 
Power: 
Pressure Change 
25 °C 
1.34 hp/ 1 kW 
25 psi 
Purchase Cost: $12,350 
Reference Pages: 493, 505 
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Storage/Mixing Tank (P-21 / MP-104) 
Function: 
Tank used to store and mix powdered serum free media with water for 
injection for fed batch considerations prior to being pumped to a sterile 
filter (P-23). 
Vendor: Sharpsville Container 
PFD Reference: PFD-04 
Operation: Batch 
Materials Handled: 
Input:  
Amino Acids 
Glucose 
Glutamine 
Inorganic Salts 
Other Media Components 
Vitamins 
WFI 
Total 
 
Quantity (kg/batch):  
1.36 
5.77 
0.67 
13.97 
0.12 
0.06 
908.165 
674.10 
 
Characteristics: 
Material of Construction: 
Volume: 
Height: 
Diameter: 
Working Capacity: 
Sterilization: 
Stainless Steel 316 
1600 L 
2.6 m 
0.9 m 
70% 
SIP/CIP 
Operating Conditions: Temp: Pressure: 
25 °C 
1 bar 
Purchase Cost: $117,000 
Reference Page: 508 
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Pump (P-22 / PM-109) 
Function: Pump to transfer fluid from media prep storage tank (P-21) to sterile filter (P-23). 
Vendor: Watson Marlow 
PFD Reference: PFD-04 
Operation: Batch 
Materials Handled: 
Input:  
Amino Acids 
Glucose 
Glutamine 
Inorganic Salts 
Other Media 
Vitamins 
WFI 
Total 
 
Quantity (kg/batch):  
17.12144 
72.45596 
8.38151 
175.5155 
1.51639 
0.71684 
897.8898 
1173.597 
 
Characteristics: 
Model: 
Pump Type: 
Material of Construction: 
Flow Rate: 
Power: 
Sterilization: 
Watson-Marlow Bredel 825 
Peristaltic 
Stainless Steel 316 
33.3 LPM 
1.5 – 5.0 hp 
SIP/CIP 
Operating Conditions: 
Temp: 
Power: 
Pressure Change 
25 °C 
1.34 hp/ 1 kW 
25 psi 
Purchase Cost: $12,350 
Reference Pages: 493, 505 
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Sterilization Filter (P-23 / DE-104) 
Function: 0.2 µm filter to remove bacteria and other impurities from the serum free media prior to feeding the production bioreactor (fed batch). 
Vendor: Sartorius Stedim Biotech 
PFD Reference: PFD-04 
Operation: Batch 
Materials Handled: 
Input:  
Amino Acids 
Glucose 
Glutamine 
Inorganic Salts 
Other Media 
Vitamins 
WFI 
Total 
 
Quantity (kg/batch):  
17.12144 
72.45596 
8.38151 
175.5155 
1.51639 
0.71684 
897.8898 
1173.597 
 
Characteristics: 
Model: 
Size: 
Filtration Area: 
Max. Differential Pressure: 
Sartopore 2 0.2 µm 
30’’ 
1.8 m2 (18 ft2) 
5 bar (75 psi) at 20°C 
Operating Conditions: Temp: Differential Pressure: 
25 °C 
0.5 bar (7.5 psi) 
Purchase Cost: Filter Housing:   $1,908  Filter Membrane: $608/unit 
Reference Page: 491 
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Pump (P-24 / PM-110) 
Function: Pump to transfer fluid from the sterile filter (P-23) tank to production bioreactor. 
Vendor: Watson Marlow 
PFD Reference: PFD-04 
Operation: Batch 
Materials Handled: 
Input:  
Amino Acids 
Glucose 
Glutamine 
Inorganic Salts 
Other Media 
Vitamins 
WFI 
Total 
 
Quantity (kg/batch):  
17.12144 
72.45596 
8.38151 
175.5155 
1.51639 
0.71684 
897.8898 
1173.597 
 
Characteristics: 
Model: 
Pump Type: 
Material of Construction: 
Flow Rate: 
Power: 
Sterilization: 
Watson-Marlow Bredel 825 
Peristaltic 
Stainless Steel 316 
33.3 LPM 
1.5 – 5.0 hp 
SIP/CIP 
Operating Conditions: 
Temp: 
Power: 
Pressure Change 
25 °C 
1.34 hp/ 1 kW 
25 psi 
Purchase Cost: $12,350 
Reference Pages: 493, 505 
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Production Bioreactor (P-25 / PBR-101) 
Function: Fed batch bioreactor used for continued cell growth and production of monoclonal antibodies at a 3.5 g/l titer. 
Vendor: ABEC 
PFD Reference: PFD-04 
Operation: Fed Batch 
Materials Handled: 
Input:  
Amino Acids 
Biomass 
Dead Biomass 
Glucose 
Glutamine 
Inorganic Salts 
Lactate 
MAB 
Other Media 
Vitamins 
Water 
WFI 
Total 
 
Quantity (kg/batch):  
28.76737 
27.78205 
2.84632 
121.74019 
14.08257 
294.90032 
19.6972 
5.70075 
2.54784 
1.20444 
49.87146 
9096.9883 
9666.12881 
 
Characteristics: 
Material of Construction: 
Volume: 
Height: 
Diameter: 
Working Capacity: 
Sterilization: 
Number of Staggered Vessels: 
Stainless Steel 316 
14000 L 
4.8 m 
2.0 m 
70% 
SIP/CIP 
2  
Operating Conditions: 
Temp: 
Pressure: 
pH: 
DO: 
Duration: 
37 °C 
1 bar 
7.0 
50% 
9 days 
Purchase Cost: $661,000 (x2) 
Reference Page: 507 
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Surge Tank (P-26 / V-201) 
Function: To store output of production bioreactor (P-25 / PBR-101) 
Vendor: Sharpsville Container 
PFD Reference: PFD-05 
Operation: Batch 
Materials Handled: 
Input:  
Amino Acids 
Biomass 
Dead Biomass 
Glucose 
Glutamine 
Inorganic Salts 
Lactate 
Monoclonal Antibodies 
Other Media Components 
Vitamins 
Water 
WFI 
Total  
 
Quantity (kg/batch):  
3.48470 
167.26423 
17.13653 
14.74685 
1.70588 
35.72240 
118.58868 
34.32188 
0.30863  
0.14590 
300.25541 
9096.98830 
9790.669 
 
Characteristics: 
Capacity: 
Inside Diameter: 
Height: 
Interior Construction: 
Sterilization: 
11,000 L 
1.67 m 
5.00 m 
316L Electropolished Stainless Steel 
SIP / CIP 
Operating Conditions: Temperature: Pressure: 
25°C  
1.103 bar 
Purchase Cost: $ 129,000 
Reference Page: 508 
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Pump (P-27 / PM-201) 
Function: To transfer fluid from bioreaction surge tank (P-26 / V-201) to centrifugation unit (P-28 / DS-201) 
Vendor: Watson Marlow 
PFD Reference: PFD-05 
Operation: Batch 
Materials Handled: 
Input:  
Amino Acids 
Biomass 
Dead Biomass 
Glucose 
Glutamine 
Inorganic Salts 
Lactate 
Monoclonal Antibodies 
Other Media Components 
Vitamins 
Water 
WFI 
Total  
 
Quantity (kg/batch):  
3.49 
167.26 
17.14 
14.75 
1.71 
35.72 
118.59 
34.32 
0.31 
0.15 
300.26 
9096.99 
9790.67 
 
Characteristics: 
Model: 
Pump Type: 
Material of Construction: 
Flow Rate: 
Power: 
Sterilization: 
Watson-Marlow Bredel 825 
Peristaltic 
Stainless Steel 316 
33.3 LPM 
1.5 – 5.0 hp 
SIP/CIP 
Operating Conditions: 
Temp: 
Power: 
Pressure Change 
25 °C 
1.34 hp/ 1 kW 
25 psi 
Purchase Cost: $ 12,350 
Reference Pages: 493, 505 
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Centrifuge (P-28 / DS-201) 
Function: To remove cells from the stream containing the monoclonal antibody product 
Vendor: Alfa-Laval 
PFD Reference: PFD-05 
Operation: Batch 
Materials Handled: 
Input:  
Amino Acids 
Biomass 
Dead Biomass 
Glucose 
Glutamine 
Inorganic Salts 
Lactate 
Monoclonal Antibodies 
Other Media Components 
Vitamins 
Water 
WFI 
Total  
 
Quantity (kg/batch):  
3.49 
167.26 
17.14 
14.75 
1.71 
35.72 
118.59 
34.32 
0.31 
0.15 
300.26 
9096.99 
9790.67 
 
Characteristics: 
Model: 
Centrifuge Type: 
Material of Construction: 
Max bowl speed: 
Power: 
Sterilization: 
BTAX 215H-31 CEP 
Hermetic 
Stainless Steel 316 
6,065 rpm 
13-28 kW 
SIP/CIP 
Operating Conditions: Temp: Throughput: 
25 °C 
2,000 L/h 
Purchase Cost: $ 421,000 
Reference Page: 510 
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Pump (P-29 / PM-202) 
Function: To transfer fluid from centrifugation unit (P-28 / DS-201) to sterile filter (P-30 / DE – 201) 
Vendor: Watson Marlow 
PFD Reference: PFD-05 
Operation: Batch 
Materials Handled: 
Input:  
Amino Acids 
Biomass 
Dead Biomass 
Glucose 
Glutamine 
Inorganic Salts 
Lactate 
Monoclonal Antibodies 
Other Media Components 
Vitamins 
Water 
WFI 
Total  
 
Quantity (kg/batch):  
3.15 
3.35 
15.49 
13.33 
1.54 
32.28 
107.16 
31.02 
0.28 
0.13 
271.33 
8220.53 
8699.58 
 
Characteristics: 
Model: 
Pump Type: 
Material of Construction: 
Flow Rate: 
Power: 
Sterilization: 
Watson-Marlow Bredel 825 
Peristaltic 
Stainless Steel 316 
33.3 LPM 
1.5 – 5.0 hp 
SIP/CIP 
Operating Conditions: 
Temp: 
Power: 
Pressure Change 
25 °C 
1.34 hp/ 1 kW 
25 psi 
Purchase Cost: $ 12,350 
Reference Pages: 493, 505 
 
Flexible Manufacturing Facility for Biopharmaceuticals 
 
-121- 
 
Sterilizing Filter (P-30 / DE-201) 
Function: To sterilize supernatant of centrifugation process and remove bacteria from stream  
Vendor: Sartorius Stedim Biotech 
PFD Reference: PFD-05 
Operation: Batch 
Materials Handled: 
Input:  
Amino Acids 
Biomass 
Dead Biomass 
Glucose 
Glutamine 
Inorganic Salts 
Lactate 
Monoclonal Antibodies 
Other Media Components 
Vitamins 
Water 
WFI 
Total  
 
Quantity (kg/batch):  
3.15 
3.35 
15.49 
13.33 
1.54 
32.28 
107.16 
31.02 
0.28 
0.13 
271.33 
8220.53 
8699.58 
 
Characteristics: 
Model: 
Size: 
Filtration Area: 
Max. Differential Pressure: 
Sartopore 2 0.2 µm 
30’’ 
1.8 m2 (18 ft2) 
5 bar (75 psi) at 20°C 
Operating Conditions: Temp: Differential Pressure: 
25 °C 
0.5 bar (7.5 psi) 
Purchase Cost: Filter Housing:   $1908 Filter Membrane: $ 608/ unit 
Reference Page: 491 
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Pump (P-31 / PM-203) 
Function: To transfer fluid from sterile filter (P-30 / DE-201) to centrifugation pool tank (P-32 / V-202) 
Vendor: Watson Marlow 
PFD Reference: PFD-05 
Operation: Batch 
Materials Handled: 
Input:  
Amino Acids 
Biomass 
Dead Biomass 
Glucose 
Glutamine 
Inorganic Salts 
Lactate 
Monoclonal Antibodies 
Other Media Components 
Vitamins 
Water 
WFI 
Total  
 
Quantity (kg/batch):  
3.15 
0.00 
15.48 
13.32 
1.54 
32.27 
107.12 
31.00 
0.28 
0.13 
271.22 
8217.36 
8692.87 
 
Characteristics: 
Model: 
Pump Type: 
Material of Construction: 
Flow Rate: 
Power: 
Sterilization: 
Watson-Marlow Bredel 825 
Peristaltic 
Stainless Steel 316 
33.3 LPM 
1.5 – 5.0 hp 
SIP/CIP 
Operating Conditions: 
Temp: 
Power: 
Pressure Change 
25 °C 
1.34 hp/ 1 kW 
25 psi 
Purchase Cost: $ 12,350 
Reference Pages: 493, 505 
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Centrifugation Pool Tank (P-32 / V-202) 
Function: To store sterilized supernatant from centrifugation process  
Vendor: Sharpsville Container 
PFD Reference: PFD-05 
Operation: Batch 
Materials Handled: 
Input:  
Amino Acids 
Dead Biomass 
Glucose 
Glutamine 
Inorganic Salts 
Lactate 
Monoclonal Antibodies 
Other Media Components 
Vitamins 
Water 
WFI 
Total  
 
Quantity (kg/batch):  
3.15 
15.48 
13.32 
1.54 
32.27 
107.12 
31.00 
0.28 
0.13 
271.22 
8217.36 
8692.87 
 
Characteristics: 
Capacity: 
Inside Diameter: 
Height: 
Interior Construction: 
Sterilization: 
10,000 L 
1.6 m 
4.8 m 
316L Electropolished Stainless Steel  
SIP / CIP 
Operating Conditions: Temperature: Pressure: 
25°C 
1.103 bar 
Purchase Cost: $ 17,000 
Reference Page: 508 
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Pump (P-33 / PM-204) 
Function: To transfer fluid from centrifugation pool tank (P-32 / V-202) to the diafiltration storage tank (P-35 / DF-201) 
Vendor: Watson Marlow 
PFD Reference: PFD-06 
Operation: Batch 
Materials Handled: 
Input:  
Amino Acids 
Dead Biomass 
Glucose 
Glutamine 
Inorganic Salts 
Lactate 
Monoclonal Antibodies 
Other Media Components 
Vitamins 
Water 
WFI 
Total  
 
Quantity (kg/batch):  
3.15 
15.48 
13.32 
1.54 
32.27 
107.12 
31.00 
0.28 
0.13 
271.22 
8217.36 
8692.87 
 
Characteristics: 
Model: 
Pump Type: 
Material of Construction: 
Flow Rate: 
Power: 
Sterilization: 
Watson-Marlow Bredel 825 
Peristaltic 
Stainless Steel 316 
33.3 LPM 
1.5 – 5.0 hp 
SIP/CIP 
Operating Conditions: 
Temp: 
Power: 
Pressure Change 
25 °C 
1.34 hp/ 1 kW 
25 psi 
Purchase Cost: $ 12,350 
Reference Pages: 493, 505 
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Diafiltration Storage Tank (P-34 / V-203) 
Function: To store sterilized supernatant from centrifugation process prior to diafiltration. 
Vendor: Sharpsville Container 
PFD Reference: PFD-06A 
Operation: Batch 
Materials Handled: 
Input:  
Amino Acids 
Dead Biomass 
Glucose 
Glutamine 
Inorganic Salts 
Lactate 
Monoclonal Antibodies 
Other Media Components 
Vitamins 
Water 
WFI 
Total  
 
Quantity (kg/batch):  
3.15 
15.48 
13.32 
1.54 
32.27 
107.12 
31.00 
0.28 
0.13 
271.22 
8217.36 
8692.87 
 
Characteristics: 
Capacity: 
Inside Diameter: 
Height: 
Interior Construction: 
Sterilization: 
10,000 L 
1.6 m 
4.8 m 
316L Electropolished Stainless Steel  
SIP / CIP 
Operating Conditions: Temperature: Pressure: 
25°C 
1.103 bar 
Purchase Cost: $ 117,000 
Reference Page: 508 
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Diafiltration Unit (P-35 / DF-201) 
Function: To concentrate the monoclonal antibody-containing stream to prepare it for the cleavage reaction 
Vendor: Sartorius Stedim Biotechnology 
PFD Reference: PFD-06 
Operation: Batch 
Materials Handled: 
Input:  
Amino Acids 
Dead Biomass 
Glucose 
Glutamine 
HCl 
Impurities 
Inorganic Salts 
Lactate 
MAB 
Other Media 
Components 
Sodium Acetate 
Vitamins 
Water 
WFI 
TOTAL (kg/batch) 
 
Quantity (kg/batch):  
3.15 
15.48 
13.32 
1.54 
0.00 
0.00 
32.31 
107.12 
31.00 
0.28 
0.00 
0.13 
271.22 
8217.36 
8692.92 
 
Characteristics: 
Cassette Model: 
Membrane: 
Filter Area per Cassette: 
Filter holder: 
Maximum feed pressure: 
Sterilization: 
Sartocube® 302 144 59 30 E-BSW 
Hydrosart (stabilized cellulose based) 
3.0 m2 
Sartocon 2 Plus 
58 psi (4 bar) 
SIP/CIP 
Operating Conditions: 
Number of units: 
Total Filter area: 
Filter MWCO: 
Temp: 
Pressure Change: 
2 
14.901 m2 
30 kDa 
25 °C 
43.5 psi 
Purchase Cost: Diafiltration Housing:   $ 11,141 Diafiltration Cartridges: $ 8374 / 3m2  
Reference Pages: 514, 516, 518, 520 
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Pump (P-36 / PM-205) 
Function: 
To transport the concentrated monoclonal-antibody containing-stream from 
the diafiltration unit (P-35 / DF-201) to the Pepsin Cleavage Reactor (P-37 
/ R-201) 
Vendor: Watson-Marlow Bredel 
PFD Reference: PFD-06 
Operation: Batch 
Materials Handled: 
Input:  
Amino Acids 
Dead Biomass 
Glucose 
Glutamine 
Impurities 
Inorganic Salts 
Lactate 
MAB 
Other Media Components 
Sodium Acetate 
Vitamins 
Water 
WFI 
TOTAL (kg/batch) 
 
Quantity (kg/batch):  
0.14 
0.69 
0.60 
0.07 
0.50 
1.45 
4.80 
30.07 
0.01 
6.70 
0.01 
12.14 
2833.00 
2890.17 
 
Characteristics: 
Model: 
Pump Type: 
Material of Construction: 
Flow Rate: 
Power: 
Sterilization: 
Watson-Marlow Bredel 825 
Peristaltic 
Stainless Steel 316 
33.3 LPM 
1.5 – 5.0 hp 
SIP/CIP 
Operating Conditions: 
Temp: 
Power: 
Pressure Change 
25 °C 
1.34 hp/ 1 kW 
50 psi 
Purchase Cost: $ 12,350 
Reference Pages: 493, 505 
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Pepsin Cleavage Bioreactor (P-37 / R-201) 
Function: To cleave the monoclonal antibody into F(ab)2 and Fc fragments using immobilized pepsin 
Vendor: Abec 
PFD Reference: PFD-06 
Operation: Batch 
Materials Handled: 
Input:  
Amino Acids 
Dead Biomass 
Glucose 
Glutamine 
Impurities 
Inorganic Salts 
Lactate 
MAB 
Other Media Components 
Sodium Acetate 
Vitamins 
Water 
WFI 
TOTAL (kg/batch) 
 
Quantity (kg/batch):  
0.14 
0.69 
0.60 
0.07 
0.50 
1.45 
4.80 
30.07 
0.01 
6.70 
0.01 
12.14 
2833.00 
2890.17 
 
Characteristics: 
Material of Construction: 
Mode of agitation 
Mode of Drive: 
Mode of Control: 
Volume: 
Height: 
Diameter 
Sterilization: 
316L Stainless Steel, Electropolished 
Backward curved impeller 
Top mechanical agitation 
DCS control sistem 
9,000 L 
4.06 m 
1.62 m 
SIP/CIP 
Operating Conditions: Temperature: 37°C 
Purchase Cost: $ 622,000 
Reference Page: 507 
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Pump (P-38 / PM-206) 
Function: Transport product-containing stream from the cleavage bioreactor (P-37 / R-201) to the plate and frame filtration unit (P-39/ PFF-201) 
Vendor: Watson-Marlow Bredel 
PFD Reference: PFD-06 
Operation: Batch 
Materials Handled: 
Input:  
Amino Acids 
Dead Biomass 
F(ab')2 
Glucose 
Glutamine 
Impurities 
Inorganic Salts 
Lactate 
MAB 
MAb Fc Fragments 
Other Media Components 
Pepsin 
Sodium Acetate 
TRIS HCl 
Vitamins 
Water 
WFI 
TOTAL (kg/batch) 
 
Quantity (kg/batch):  
0.14 
0.69 
15.24 
0.60 
0.07 
0.50 
1.45 
4.80 
1.50 
13.33 
0.01 
1540.43 
10.88 
0.00 
0.01 
12.14 
2364.28 
3966.06 
 
Characteristics: 
Model: 
Pump Type: 
Material of Construction: 
Flow Rate: 
Power: 
Sterilization: 
Watson-Marlow Bredel 825 
Peristaltic 
Stainless Steel 316 
33.3 LPM 
1.5 – 5.0 hp 
SIP/CIP 
Operating Conditions: 
Temperature: 
Power: 
Pressure Change: 
25 °C 
12.07 hp/ 9 kW 
25 psi 
Purchase Cost: $ 12,350 
Reference Pages: 493, 505 
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Plate and Frame Filtration Unit (P-39 / PFF-201) 
Function: To remove the immobilized pepsin from the product stream 
Vendor: Pall Corporation 
PFD Reference: PFD-06 
Operation: Batch 
Materials Handled: 
Input:  
Amino Acids 
Dead Biomass 
F(ab')2 
Glucose 
Glutamine 
Impurities 
Inorganic Salts 
Lactate 
MAB 
MAb Fc Fragments 
Other Media Components 
Pepsin 
Sodium Acetate 
TRIS HCl 
Vitamins 
Water 
WFI 
TOTAL (kg/batch) 
 
Quantity (kg/batch):  
0.14 
0.69 
15.24 
0.60 
0.07 
0.50 
1.45 
4.80 
1.50 
13.33 
0.01 
1540.43 
10.88 
0.00 
0.01 
12.14 
2364.28 
3966.06 
 
Characteristics: 
Model: 
Plate size: 
Material of Construction: 
Chassis Size: 
No. Filter Plates 
Sterilization: 
MEMBRAplan® DGM 
1000 mm x 1000 mm 
Stainless Steel 316L 
800 K 100 
29 
SIP/CIP 
Operating Conditions: Temperature:  Filter Area: 
25 °C 
24.4 m2 
Purchase Cost: $ 74,000 
Reference Page: 522 
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Pump (P-40 / PM-207) 
Function: 
To transport the concentrated monoclonal-antibody containing-stream 
from the P&F filter (P-39 / UF-201) to the protein A chromatography 
column (P-40 / C-201) 
Vendor: Watson-Marlow Bredel 
PFD Reference: PFD-07 
Operation: Batch 
Materials Handled: 
Input:  
Amino Acids 
Dead Biomass 
F(ab')2 
Glucose 
Glutamine 
Impurities 
Inorganic Salts 
Lactate 
MAB 
MAb Fc Fragments 
Other Media Components 
Sodium Acetate 
TRIS HCl 
Vitamins 
Water 
WFI 
TOTAL (kg/batch) 
 
Quantity (kg/batch):  
0.13 
0.65 
14.31 
0.56 
0.07 
0.47 
1.36 
4.51 
1.41 
12.53 
0.01 
10.22 
160.75 
0.01 
11.41 
4040.65 
4259.03 
 
Characteristics: 
Model: 
Pump Type: 
Material of Construction: 
Flow Rate: 
Power: 
Sterilization: 
Watson-Marlow Bredel 825 
Peristaltic 
Stainless Steel 316 
33.3 LPM 
1.5 – 5.0 hp 
SIP/CIP 
Operating Conditions: 
Temperature: 
Power: 
Pressure Change 
25 °C 
9 kW/ 12.07 hp 
25 psi 
Purchase Cost: $ 12,350 
Reference Pages: 493, 505 
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Diafiltration Storage Tank (P-41 / V-204) 
Function: To store F(ab’)2 fragments from P&F Filtration prior to Diafiltration process. 
Vendor: Sharpsville Container 
PFD Reference: PFD-10A 
Operation: Batch 
Materials Handled: 
Input:  
Amino Acids 
Dead Biomass 
F(ab')2 
Glucose 
Glutamine 
Impurities 
Inorganic Salts 
Lactate 
MAB 
MAb Fc Fragments 
Other Media Components 
Oxygen 
Sodium Acetate 
TRIS HCl 
Vitamins 
Water 
WFI 
TOTAL (kg/batch) 
 
 
Quantity (kg/batch):  
0.13 
0.65 
16.67 
0.56 
0.07 
0.44 
1.35 
4.48 
1.32 
8.34 
0.01 
0.00 
6.27 
147.46 
0.01 
11.35 
3486.58 
3685.68 
 
Characteristics: 
Capacity: 
Inside Diameter: 
Height: 
Interior Construction: 
Sterilization: 
4027.01 L 
1.196 m 
3.587 m 
316L Electropolished Stainless Steel  
SIP / CIP 
Operating Conditions: 
 
Temp: 
Pressure: 
 
 
25 °C 
22.04 psi 
 
Purchase Cost: $1 17,000 
Reference Page: 508 
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Diafiltration Unit (P-42 / DF-202) 
Function: To concentrate the F(ab’)2 fragments from 3.56 mg/ml to 10 mg/ml in Reduction Reaction Buffer to prepare for the Thiol Reduction Reaction. 
Vendor: Sartorius Stedim Biotechnology 
PFD Reference: PFD-10A 
Operation: Batch 
Materials Handled: 
Input:  
Amino Acids 
Dead Biomass 
Glucose 
Glutamine 
Phosphate 
Impurities 
Inorganic Salts 
Lactate 
MAB 
Other Media Components 
EDTA, Sodium 
Vitamins 
Water 
WFI 
TOTAL (kg/batch) 
 
Quantity (kg/batch):  
3.15 
15.48 
13.32 
1.54 
14477.03 
0.00 
32.31 
107.12 
31.00 
0.28 
1134.87 
0.13 
271.22 
10242.90 
26330.40 
 
Characteristics: 
Cassette Model: 
Membrane: 
Filter Area per Cassette: 
Filter holder: 
Maximum feed pressure: 
Sterilization: 
Sartocube® 302 144 59 30 E-BSW 
Hydrosart (stabilized cellulose based) 
3.0 m2 
Sartocon 3 
58 psi (4 bar) 
SIP/CIP 
Operating Conditions: 
Number of units: 
Total Filter area: 
Filter MWCO: 
Temp: 
Pressure Change: 
15 
43.185 m2 
30 kDa 
25 °C 
14.5 psi 
Purchase Cost: Ultrafiltration Housing:    $ 11,141 Ultrafiltration Cartridges: $ 125,610  
Reference Pages: 514, 516, 518, 520 
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Pump (P-43 / PM-208) 
Function: To transport F(ab’)2 fragments from the Diafiltration System (P-41 / V-402, P-42 /DF-202) to the Thiol Reduction Reactor (P-44 / R-202). 
Vendor: Watson-Marlow Bredel 
PFD Reference: PFD-10A 
Operation: Batch 
Materials Handled: 
Input:  
Amino Acids 
Dead Biomass 
EDTA, Sodium 
F(ab')2 
Glucose 
Impurities 
Inorganic Salts 
Lactate 
MAB 
MAb Fc Fragments 
Sodium Acetate 
Sodium Phosphate 
TRIS HCl 
Water 
WFI 
TOTAL (kg/batch) 
 
Quantity (kg/batch):  
0.01 
0.03 
178.18 
16.67 
0.03 
0.27 
0.07 
0.22 
0.06 
0.41 
0.31 
2272.91 
7.28 
0.56 
411.49 
2888.50 
 
Characteristics: 
Model: 
Pump Type: 
Material of Construction: 
Flow Rate: 
Power: 
Tubing: 
Sterilization: 
Watson-Marlow Bredel 840  
Peristaltic 
Stainless Steel 316L 
133.3 L/min 
2.2 hp / 3.0 kW 
Bioprene 40 mm 
SIP/CIP 
Operating Conditions: 
Temp: 
Power: 
Volumetric Throughput: 
Pressure Change 
25 °C 
4.11 hp/3.07 kW 
186.80 L/min 
14.5 psi 
Purchase Cost: $18,135 
Reference Pages: 
 493, 505 
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Disulfide Reduction Reactor (P-44 / R-202) 
Function: 
To reduce the hinge region disulfide bonds in the F(ab’)2 molecules to 
produce Fab’ molecules, which retain a hinge region cysteine that 
facilitates site-specific PEGylation. 
Vendor: Abec 
PFD Reference: PFD-10A 
Operation: Batch 
Materials Handled: 
Input:  
2-MEA 
Amino Acids 
Dead Biomass 
EDTA, Sodium 
F(ab')2 
Glucose 
Glutamine 
Impurities 
Inorganic Salts 
Lactate 
MAB 
MAb Fab Fragments 
Other Media Components 
Sodium Acetate 
Sodium Phosphate 
TRIS HCl 
Water 
WFI 
TOTAL (kg/batch) 
 
Quantity (kg/batch):  
8.00 
0.01 
0.03 
178.18 
16.67 
0.03 
0.00 
0.27 
0.07 
0.22 
0.06 
0.00 
0.41 
0.31 
2272.91 
7.28 
0.56 
411.49 
2896.50 
 
Characteristics: 
Material of Construction: 
Mode of agitation 
Mode of Drive: 
Mode of Control: 
Volume: 
Height: 
Diameter 
Sterilization: 
316L Stainless Steel, Electropolished 
Backward curved impeller 
Top mechanical agitation 
DCS control system 
1589.93 L 
2.330 m 
0.932 m 
SIP/CIP 
Operating Conditions: Temperature: Incubation Time: 
37°C 
90 minutes 
Purchase Cost: $ 508,000 
Reference Page: 507 
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Pump (P-45 / PM-209) 
Function: To transport Fab’ molecules in Reduction Reactor Buffer from the Thiol Reduction Reactor (P-44 / R-202) to the Diafiltration System (P-46 / V-205). 
Vendor: Watson-Marlow Bredel 
PFD Reference: PFD-10A 
Operation: Batch 
Materials Handled: 
Input:  
2-MEA 
Amino Acids 
Dead Biomass 
EDTA, Sodium 
F(ab')2 
Glucose 
Impurities 
Inorganic Salts 
Lactate 
MAB 
Other Media Components 
Sodium Acetate 
Sodium Phosphate 
TRIS HCl 
Water 
WFI 
TOTAL (kg/batch) 
 
  
 
Quantity (kg/batch):  
8.00 
0.01 
0.03 
178.18 
16.67 
0.03 
0.27 
0.07 
0.22 
0.06 
0.41 
0.31 
2272.91 
7.28 
0.56 
411.49 
2896.50 
 
Characteristics: 
Model: 
Pump Type: 
Material of Construction: 
Flow Rate: 
Power: 
Tubing: 
Sterilization: 
Watson-Marlow Bredel 840  
Peristaltic 
Stainless Steel 316L 
133.3 L/min 
2.2 hp / 3.0 kW 
Bioprene 40 mm 
SIP/CIP 
Operating Conditions: 
Temp: 
Power: 
Volumetric Throughput: 
Pressure Change 
25 °C 
0.15 hp/ 0.11 kW 
46.65 L/min 
14.5 psi 
Purchase Cost: $18,135 
Reference Pages:  493, 505 
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Diafiltration Storage Tank (P-46 / V-205) 
Function: To store Fab’ fragments from the Thiol Reduction Reaction prior to Protein-A Chromatography. 
Vendor: Sharpsville Container 
PFD Reference: PFD-10A 
Operation: Batch 
Materials Handled: 
Input:  
2-MEA 
Amino Acids 
Dead Biomass 
EDTA, Sodium 
Glucose 
Glutamine 
Impurities 
Inorganic Salts 
Lactate 
MAB 
MAb Fab Fragments 
MAb Fc Fragments 
Sodium Acetate 
Sodium Phosphate 
TRIS HCl 
Water 
WFI 
TOTAL (kg/batch) 
 
Quantity (kg/batch):  
8.00 
0.01 
0.03 
178.18 
0.03 
0.00 
0.27 
0.07 
0.22 
0.06 
16.67 
0.41 
0.31 
2272.91 
7.28 
0.56 
411.49 
2896.50 
 
Characteristics: 
Capacity: 
Inside Diameter: 
Height: 
Interior Construction: 
Sterilization: 
1597.82 L 
0.879 m 
2.636 m 
316L Electropolished Stainless Steel  
SIP / CIP 
Operating Conditions: 
 
Temp: 
Pressure: 
 
 
25 °C 
22.04 psi 
 
Purchase Cost: $117,000 
Reference Page: 508 
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Diafiltration Unit (P-47 / DF-203) 
Function: 
To filter out 2-MEA and small Fc fragments and to switch the Fab’ 
fragments from Reduction Reaction Buffer to WFI while maintaining a 
concentration of 10 mg/ml. 
Vendor: Sartorius Stedim Biotechnology 
PFD Reference: PFD-10A 
Operation: Batch 
Materials Handled: 
Input:  
2-MEA 
Dead Biomass 
EDTA, Sodium 
Glucose 
Glutamine 
Impurities 
Inorganic Salts 
Lactate 
MAB 
MAb Fab Fragments 
MAb Fc Fragments 
Sodium Acetate 
Sodium Phosphate 
TRIS HCl 
Water 
WFI 
TOTAL (kg/batch) 
 
Quantity (kg/batch):  
8.00 
0.03 
178.18 
0.03 
0.00 
0.27 
0.07 
0.22 
0.06 
16.67 
0.41 
0.31 
2272.91 
7.28 
0.56 
3781.30 
6266.31 
 
Characteristics: 
Cassette Model: 
Membrane: 
Filter Area per Cassette: 
Filter holder: 
Maximum feed pressure: 
Sterilization: 
Sartocube® 302 144 59 30 E-BSW 
Hydrosart (stabilized cellulose based) 
3.0 m2 
Sartocon 3 
58 psi (4 bar) 
SIP/CIP 
Operating Conditions: 
Number of units: 
Total Filter area: 
Filter MWCO: 
Temp: 
Pressure Change: 
5 
12.415 m2 
10 kDa 
25 °C 
14.5 psi 
Purchase Cost: Diafiltration Housing:   $ 11,141 Diafiltration Cartridges: $ 41,870 
Reference Pages: 514, 516, 518, 520 
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Pump (P-48 / PM-210) 
Function: To transport the Fab’ fragments from the Diafiltration System (P-46 / V-205, P-47 / DF-203) to the Protein-A Chromatography (P-49 / C-201). 
Vendor: Watson-Marlow Bredel 
PFD Reference: PFD-10A 
Operation: Batch 
Materials Handled: 
Input:  
2-MEA 
Amino Acids 
Dead Biomass 
EDTA, Sodium 
Glucose 
Glutamine 
Impurities 
Inorganic Salts 
Lactate 
MAB 
MAb Fab Fragments 
MAb Fc Fragments 
Sodium Phosphate 
TRIS HCl 
Vitamins 
Water 
WFI 
TOTAL (kg/batch) 
 
 
Quantity (kg/batch):  
1.08 
0.00 
0.00 
24.11 
0.00 
0.00 
0.18 
0.01 
0.03 
0.01 
16.67 
0.06 
307.61 
0.99 
0.00 
0.08 
1281.16 
1632.02 
 
Characteristics: 
Model: 
Pump Type: 
Material of Construction: 
Max Flow Rate: 
Max Power: 
Tubing: 
Sterilization: 
Watson-Marlow Bredel 825 
Peristaltic 
Stainless Steel 316L 
33.3 L/min 
1.6 hp / 1.1 kW 
Bioprene 25 mm 
SIP/CIP 
Operating Conditions: 
Temp: 
Power: 
Volumetric Throughput: 
Pressure Change 
25 °C 
0.28 hp/ 0.21 kW 
25.09 L/min 
14.5 psi 
Purchase Cost: $12,350 
Reference Pages:  493, 505 
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Protein A Chromatography Column (P-49 / C-201) 
Function: To purify the antibody Fab fragments from the mainstream fluid 
Vendor: Amersham biosciences (GE corporation) 
PFD Reference: PFD-07 
Operation: Batch 
Materials Handled: 
Input:  
2-MEA 
Dead Biomass 
EDTA, Sodium 
Glucose 
Impurities 
Inorganic Salts 
Lactate 
MAB 
MAb Fab Fragments 
MAb Fc Fragments 
Sodium Acetate 
Sodium Chloride 
Sodium Phosphate 
TRIS Base 
TRIS HCl 
Water 
WFI 
TOTAL (kg/batch) 
 
Quantity (kg/batch):  
0.01 
0.01 
25.57 
0.01 
0.23 
0.03 
0.08 
0.02 
14.31 
0.23 
0.19 
756.15 
238.00 
0.19 
3.50 
0.21 
3942.67 
4981.43 
 
Characteristics: 
Column Model: 
Inner Diameter: 
Tube Height: 
Material of Construction: 
Max. Bed Volume: 
Max Pressure: 
Column Media: 
Binding Capacity: 
Working Flow Velocity: 
Temperature stability:  
BPG 450 
450 mm 
1000 mm 
Stainless Steel 316 
90.6 L 
2.5 bar 
nProtein A Sepharose Fast Flow 
50 mg antibody / ml media 
30–300 cm/h 
4-40ºC 
Operating Conditions: Temperature: Pressure: 
4 ºC 
1.01 bar 
Purchase Cost: $ 190,000 for BPG column, $7,000 / L Protein A Media  
Reference Pages: 529, 537 
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Pump (P-50 / PM-211) 
Function: 
To transport the concentrated antibody solution from the protein A 
chromatography column (P-49/ C-201) to the sterile filtration unit (P-51 / 
DE-202) 
Vendor: Watson-Marlow Bredel 
PFD Reference: PFD-07 
Operation: Batch 
Materials Handled: 
Input:  
2-MEA 
Acetic-Acid 
Dead Biomass 
EDTA, Sodium 
Glucose 
Impurities 
Inorganic Salts 
Lactate 
MAb Fab Fragments 
Sodium Acetate 
Sodium Chloride 
Sodium Phosphate 
TRIS HCl 
Water 
WFI 
TOTAL (kg/batch) 
 
Quantity (kg/batch):  
0.01 
0.20 
0.01 
25.20 
0.01 
0.18 
0.03 
0.08 
14.31 
0.19 
755.97 
238.00 
2.94 
0.21 
3791.15 
4828.50 
 
Characteristics: 
Model: 
Pump Type: 
Material of Construction: 
Flow Rate: 
Power: 
Sterilization: 
Watson-Marlow Bredel 825 
Peristaltic 
Stainless Steel 316 
33.3 LPM 
1.5 – 5.0 hp 
SIP/CIP 
Operating Conditions: 
Temperature: 
Power: 
Pressure Change 
25 °C 
1.34 hp/ 1kW 
25 psi 
Purchase Cost: $ 12,350 
Reference Pages: 493, 505 
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Sterilizing Filter (P-51 / DE-202) 
Function: To sterilize supernatant of Protein A chromatography and remove bacteria from stream  
Vendor: Sartorius Stedim Biotech 
PFD Reference: PFD-05 
Operation: Batch 
Materials Handled: 
Input:  
2-MEA 
Acetic-Acid 
Dead Biomass 
EDTA, Sodium 
Glucose 
Impurities 
Inorganic Salts 
Lactate 
MAb Fab Fragments 
Sodium Acetate 
Sodium Chloride 
Sodium Phosphate 
TRIS HCl 
Water 
WFI 
TOTAL (kg/batch) 
 
Quantity (kg/batch):  
0.01 
0.20 
0.01 
25.20 
0.01 
0.18 
0.03 
0.08 
14.31 
0.19 
755.97 
238.00 
2.94 
0.21 
3791.15 
4828.50 
 
Characteristics: 
Model: 
Size: 
Filtration Area: 
Max. Differential Pressure: 
Sartopore 2 0.2 µm 
30’’ 
1.8 m2 (18 ft2) 
5 bar (75 psi) at 20°C 
Operating Conditions: Temp: Differential Pressure: 
25 °C 
0.5 bar (7.5 psi) 
Purchase Cost: Filter Housing:   $1908 Filter Membrane: $ 608/ unit 
Reference Page: 491 
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Pump (P-52/ PM-209) 
Function: To transport the product containing-stream from the sterile filtration unit (P-51 / DE-202) to the diafiltration system 
Vendor: Watson-Marlow Bredel 
PFD Reference: PFD-07 
Operation: Batch 
Materials Handled: 
Input:  
2-MEA 
Acetic-Acid 
EDTA, Sodium 
Glucose 
Impurities 
Inorganic Salts 
Lactate 
MAb Fab Fragments 
Sodium Acetate 
Sodium Chloride 
Sodium Phosphate 
TRIS HCl 
Water 
WFI 
TOTAL (kg/batch) 
 
Quantity (kg/batch):  
0.01 
0.20 
25.20 
0.01 
0.18 
0.03 
0.08 
14.31 
0.19 
755.97 
238.00 
2.94 
0.21 
3791.14 
4828.48 
 
Characteristics: 
Model: 
Pump Type: 
Material of Construction: 
Flow Rate: 
Power: 
Sterilization: 
Watson-Marlow Bredel 825 
Peristaltic 
Stainless Steel 316 
33.3 LPM 
1.5 – 5.0 hp 
SIP/CIP 
Operating Conditions: 
Temperature: 
Power: 
Pressure Change 
25 °C 
1.34 hp/ 1kW 
25 psi 
Purchase Cost: $ 12,350 
Reference Pages: 493, 505 
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Diafiltration Storage Tank (P-53 / V-206) 
Function: To store product containing stream prior to diafiltration 
Vendor: Sharpsville Container 
PFD Reference: PFD-06A 
Operation: Batch 
Materials Handled: 
Input:  
2-MEA 
Acetic-Acid 
EDTA, Sodium 
Glucose 
Impurities 
Inorganic Salts 
Lactate 
MAb Fab Fragments 
Sodium Acetate 
Sodium Chloride 
Sodium Phosphate 
TRIS HCl 
Water 
WFI 
TOTAL (kg/batch) 
 
Quantity (kg/batch):  
0.01 
0.20 
25.20 
0.01 
0.18 
0.03 
0.08 
14.31 
0.19 
755.97 
238.00 
2.94 
0.21 
3791.14 
4828.48 
 
Characteristics: 
Capacity: 
Inside Diameter: 
Height: 
Interior Construction: 
Sterilization: 
10,000 L 
1.6 m 
4.8 m 
316L Electropolished Stainless Steel  
SIP / CIP 
Operating Conditions: Temperature: Pressure: 
25°C 
1.103 bar 
Purchase Cost: $ 117,000 
Reference Page: 508 
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Diafiltration Unit (P-54 / DF-204) 
Function: To concentrate the monoclonal antibody-containing stream to prepare it for the cleavage reaction 
Vendor: Sartorius Stedim Biotechnology 
PFD Reference: PFD-06 
Operation: Batch 
Materials Handled: 
Input:  
2-MEA 
Acetic-Acid 
EDTA, Sodium 
Glucose 
Impurities 
Inorganic Salts 
Lactate 
MAb Fab Fragments 
Sodium Acetate 
Sodium Chloride 
Sodium Phosphate 
TRIS HCl 
Water 
WFI 
TOTAL (kg/batch) 
 
Quantity (kg/batch):  
0.01 
0.20 
25.20 
0.01 
0.18 
0.03 
0.08 
14.31 
0.19 
755.97 
238.00 
2.94 
0.21 
3791.14 
4828.48 
 
Characteristics: 
Cassette Model: 
Membrane: 
Filter Area per Cassette: 
Filter holder: 
Maximum feed pressure: 
Sterilization: 
Sartocube® 302 144 59 30 E-BSW 
Hydrosart (stabilized cellulose based) 
3.0 m2 
Sartocon 3 
58 psi (4 bar) 
SIP/CIP 
Operating Conditions: 
Number of units: 
Total Filter area: 
Filter MWCO: 
Temp: 
Pressure Change: 
6 
14.901 m2 
10 kDa 
25 °C 
43.5 psi 
Purchase Cost: Ultrafiltration Housing:   $ 11,141 Ultrafiltration Cartridges: $ 8374 / 3m2  
Reference Page: 514, 516, 518, 520 
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Pump (P-55/ PM-213) 
Function: To transport the product containing-stream from diafiltration system to the chemical inactivation tank (P-56 / V-207) 
Vendor: Watson-Marlow Bredel 
PFD Reference: PFD-07 
Operation: Batch 
Materials Handled: 
Input:  
Acetic-Acid 
Dead Biomass 
EDTA, Sodium 
Impurities 
MAb Fab Fragments 
Sodium Acetate 
Sodium Chloride 
Sodium Phosphate 
TRIS HCl 
Water 
WFI 
TOTAL (kg/batch) 
 
Quantity (kg/batch):  
0.01 
0.00 
0.67 
0.09 
14.31 
0.01 
20.19 
6.36 
0.08 
0.01 
837.19 
878.90 
 
Characteristics: 
Model: 
Pump Type: 
Material of Construction: 
Flow Rate: 
Power: 
Sterilization: 
Watson-Marlow Bredel 825 
Peristaltic 
Stainless Steel 316 
33.3 LPM 
1.5 – 5.0 hp 
SIP/CIP 
Operating Conditions: 
Temperature: 
Power: 
Pressure Change 
25 °C 
1.34 hp/ 1kW 
25 psi 
Purchase Cost: $ 12,350 
Reference Pages: 493, 505 
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Virus Inactivation Tank (P-56/ V-207) 
Function: To treat the product stream with Polysorbate 80 to inactivate viruses 
Vendor: Sharpsville Container 
PFD Reference: PFD-06A 
Operation: Batch 
Materials Handled: 
Input:  
Acetic-Acid 
Dead Biomass 
EDTA, Sodium 
Impurities 
MAb Fab Fragments 
Sodium Acetate 
Sodium Chloride 
Sodium Phosphate 
TRIS HCl 
Water 
WFI 
TOTAL (kg/batch) 
 
Quantity (kg/batch):  
0.01 
0.00 
0.67 
0.09 
14.31 
0.01 
20.19 
6.36 
0.08 
0.01 
837.19 
878.90 
 
Characteristics: 
Capacity: 
Inside Diameter: 
Height: 
Interior Construction: 
Sterilization: 
1,000 L 
0.75 m 
2.2 m 
316L Electropolished Stainless Steel  
SIP / CIP 
Operating Conditions: Temperature: Pressure: 
25°C 
1.103 bar 
Purchase Cost: $ 117,000 
Reference Page: 508 
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Pump (P-57/ PM-214) 
Function: To transport the product containing-stream virus inactivation tank to the sterile filtration unit (P-58/DE-203) 
Vendor: Watson-Marlow Bredel 
PFD Reference: PFD-07 
Operation: Batch 
Materials Handled: 
Input:  
Acetic-Acid 
EDTA, Sodium 
Impurities 
MAb Fab Fragments 
Polysorbate 80 
Sodium Acetate 
Sodium Chloride 
Sodium Phosphate 
TRIS HCl 
Water 
WFI 
TOTAL (kg/batch) 
 
Quantity (kg/batch):  
0.01 
0.67 
0.09 
14.31 
0.09 
0.01 
20.19 
6.36 
0.08 
0.01 
837.28 
879.08 
 
Characteristics: 
Model: 
Pump Type: 
Material of Construction: 
Flow Rate: 
Power: 
Sterilization: 
Watson-Marlow Bredel 825 
Peristaltic 
Stainless Steel 316 
33.3 LPM 
1.5 – 5.0 hp 
SIP/CIP 
Operating Conditions: 
Temperature: 
Power: 
Pressure Change 
25 °C 
1.34 hp/ 1kW 
25 psi 
Purchase Cost: $ 12,350 
Reference Pages: 493, 505 
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Sterilizing Filter (P-58 / DE-203) 
Function: To sterilize supernatant of centrifugation process and remove bacteria from stream  
Vendor: Sartorius Stedim Biotech 
PFD Reference: PFD-05 
Operation: Batch 
Materials Handled: 
Input:  
Acetic-Acid 
EDTA, Sodium 
Impurities 
MAb Fab Fragments 
Polysorbate 80 
Sodium Acetate 
Sodium Chloride 
Sodium Phosphate 
TRIS HCl 
Water 
WFI 
TOTAL (kg/batch) 
 
Quantity (kg/batch):  
0.01 
0.67 
0.09 
14.31 
0.09 
0.01 
20.19 
6.36 
0.08 
0.01 
837.28 
879.08 
 
Characteristics: 
Model: 
Size: 
Filtration Area: 
Max. Differential Pressure: 
Sartopore 2 0.2 µm 
30’’ 
1.8 m2 (18 ft2) 
5 bar (75 psi) at 20°C 
Operating Conditions: Temp: Differential Pressure: 
25 °C 
0.5 bar (7.5 psi) 
Purchase Cost: Filter Housing:   $1908 Filter Membrane: $ 608/ unit 
Reference Page: 491 
Flexible Manufacturing Facility for Biopharmaceuticals 
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Storage Tank (P-59 / V-301) 
Function: To hold buffer solution for cation exchange chromatography  
Vendor:  Sharpsville Container 
PFD Reference: PFD-09 
Operation: Batch 
Materials Handled: 
Input:  
MES Buffer 
WFI 
 Total 
Quantity (kg/batch):  
36.0861 
3660.4993 
3716.2655 
 
Characteristics: 
Material of Construction: 
Total Volume: 
Sterilization: 
Stainless Steel 316L 
4129.18 L 
SIP/CIP 
Operating Conditions: Temperature: Pressure: 
25 °C 
 1 bar 
Purchase Cost: $ 110,000 
Reference Page: 508 
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Storage Tank (P-60 / V-302) 
Function: To hold buffer solution for cation exchange chromatography 
Vendor: Sharpsville Container 
PFD Reference: PFD-09 
Operation: Batch 
Materials Handled: 
Input:  
MES Buffer 
Sodium Chloride 
WFI 
Total 
 
Quantity (kg/batch):  
9.0985 
54.4783 
932.2062 
974.4692 
 
Characteristics: 
Material of Construction: 
Total Volume: 
Sterilization: 
Stainless Steel 316L 
1082.75 L 
SIP/CIP 
Operating Conditions: Temperature: Operating Pressure: 
25 °C 
1 bar 
Purchase Cost: $ 114,000  
Reference Page: 508 
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Pump (P-61 / PM-301) 
Function: To transfer fluid from chemical virus inactivation to cation chromatography column 
Vendor: Watson –Marlow Bredel 
PFD Reference: PFD-09 
Operation: Batch 
Materials Handled: 
Input:  
2-MEA 
Amino Acids 
Acetic Acid 
EDTA, Sodium 
Glucose 
Glutamine 
Impurities 
Inorganic Salts 
Lactate 
MAb Fab Fragments 
Polysorbate 80 
Sodium Acetate 
Sodium Phosphatee 
Tris HCl 
Water 
WFI 
Total 
Quantity (kg/batch):  
0.028 
0.00002 
0.00132 
0.62195 
0.0001 
0.00001 
0.06612 
0.00023 
0.00077 
16.67308 
0.02949 
0.00108 
7.93396 
0.02542 
0.00196 
269.4751 
294.859 
 
Characteristics: 
Model: 
Pump Type: 
Material of Construction: 
Flow Rate: 
Tubing: 
Sterilization: 
Watson-Marlow Bredel 825 
Peristaltic 
Stainless Steel 316L 
Up to 33.33 LPM 
Bioprene, 25 mm 
SIP 
Operating Conditions: 
Pressure Change: 
Pump Head: 
Max. Flow Rate: 
Power Consumption: 
1 bar 
45.5 ft 
2.61 LPM 
0.0134 hp 
Purchase Cost: $ 12,350 
Reference Pages: 493, 505 
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Pump (P-62 / PM-302) 
Function: To transfer buffer solution from storage tank to cation exchange chromatography column 
Vendor: Watson-Marlow Bredel 
PFD Reference: PFD-09 
Operation: Batch 
Materials Handled: 
Input:  
MES Buffer 
WFI 
Total  
 
Quantity (kg/batch):  
25.47882 
2584.52118 
2610.0 
 
Characteristics: 
Model: 
Pump Type: 
Material of Construction: 
Flow Rate: 
Tubing: 
Sterilization: 
Watson-Marlow Bredel 825 
Peristaltic 
Stainless Steel 316L 
Up to 33.33 LPM 
Bioprene, 25 mm 
SIP 
Operating Conditions: 
Pressure Change: 
Pump Head: 
Max. Flow Rate: 
Power Consumption: 
1 bar 
45.5 ft 
23.57 LPM 
0.056 kW 
Purchase Cost: $ 12,350 
Reference Pages: 493, 505 
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Pump (P-63 / PM-303, P-64 / PM-304) 
Function: To transfer buffer solution from storage tank to cation exchange chromatography column 
Vendor: Watson-Marlow Bredel 
PFD Reference: PFD-09 
Operation: Batch 
Materials Handled: 
Input:  
 MES Buffer 
 Sodium Chloride 
 WFI 
 Total 
Quantity (kg/batch):  
9.10 
54.48 
932.21 
995.78 
 
Characteristics: 
Model: 
Pump Type: 
Material of Construction: 
Flow Rate: 
Tubing: 
Sterilization: 
Watson-Marlow Bredel 825 
Peristaltic 
Stainless Steel 316L 
Up to 33.33 LPM 
Bioprene, 25 mm 
SIP 
Operating Conditions: 
Pressure Change: 
Pump Head: 
Max. Flow Rate: 
Power Consumption: 
1 bar 
45.5 ft 
26.18 LPM 
0.09 kW 
Purchase Cost: $12,350 
Reference Pages: 493, 505 
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Pump (P-65 / PM-305, P-66 / PM-306) 
Function: To transfer buffer solution from storage tank to cation exchange chromatography column 
Vendor: Watson-Marlow Bredel 
PFD Reference: PFD-09 
Operation: Batch 
Materials Handled: 
Input:  
 MES Buffer 
 WFI 
 Total 
Quantity (kg/batch):  
10.61 
1075.98 
1086.59 
 
Characteristics: 
Model: 
Pump Type: 
Material of Construction: 
Flow Rate: 
Tubing: 
Sterilization: 
Watson-Marlow Bredel 825 
Peristaltic 
Stainless Steel 316L 
Up to 33.33 LPM 
Bioprene, 25 mm 
SIP 
Operating Conditions: 
Pressure Change: 
Pump Head: 
Max. Flow Rate: 
Power Consumption: 
1 bar 
45.5 ft 
26.18 LPM 
0.11 kW 
Purchase Cost: $ 12,350 
Reference Pages: 493, 505 
Flexible Manufacturing Facility for Biopharmaceuticals 
 
-156- 
 
Cation Chromatography Column (P-68 /C-301) 
Function: To purify and isolate antigen binding fragments from impurities 
Vendor: GE-Amersham 
PFD Reference: PFD-09 
Operation: Batch 
Materials Handled: 
Input:  
2-MEA 
Amino Acids 
Acetic-Acid 
EDTA, Sodium 
Glucose 
Glutamine 
Impurities 
Inorganic Salts 
Lactate 
MAb Fab Fragments 
MES 
Other Media Components 
Polysorbate 80 
Sodium Acetate 
Sodium Phosphate 
TRIS HCl 
Vitamins 
Water 
WFI 
Total  
 
Quantity (kg/batch):  
0.0279 
0.0000 
0.0013 
0.6220 
0.0001 
0.0000 
0.0661 
0.0002 
0.0008 
16.6731 
25.4788 
0.0000 
0.0295 
0.0011 
7.9340 
0.0254 
0.0000 
0.0020 
2853.9963 
2904.8586 
 
Characteristics: 
Model: 
Material of Construction: 
Column Volume: 
Sterilization: 
Chromaflow 1000 
Stainless Steel 316, PE 
436.95 L 
SIP/CIP 
Operating Conditions: Bed Volume: Resin: 
109.24L 
Toyopearl Gigacap S-650M 
Purchase Cost: $ 245,000 
Reference Page: 529 
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Holding Tank (P-69 / V-303) 
Function: To hold and mix product from cation exchange chromatography with buffer solutions in preparation for anion exchange chromatography 
Vendor: Sharpsville Container 
PFD Reference: PFD-09 
Operation: Batch 
Materials Handled: 
Input:  
 Impurities 
 MAb Fab Fragments 
 MES 
 Sodium Chloride 
 WFI 
 TRIS Base 
Total  
 
Quantity (kg/batch):  
0.0079 
15.0475 
0.5332 
11.9266 
3685.3208 
14.7608 
3728.0859 
 
Characteristics: 
Material of Construction: 
Total Volume: 
Sterilization: 
Stainless Steel 316L 
4148.45 L 
SIP/CIP 
Operating Conditions: Temperature: Operating Pressure: 
25 °C 
1 bar 
Purchase Cost: $ 117,000 
Reference Page: 508 
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Pump (P-70 / PM-307) 
Function: To transfer mixed solution from storage tank to anion exchange chromatography column 
Vendor: Watson-Marlow Bredel 
PFD Reference: PFD-09 
Operation: Batch 
Materials Handled: 
Input:  
 Impurities 
 MAb Fab Fragments 
 MES Buffer 
 Sodium Chloride 
 WFI 
 TRIS Base 
Total  
 
Quantity (kg/batch):  
0.0079 
15.0475 
0.5332 
11.9266 
3685.3208 
14.7608 
3728.0859 
 
Characteristics: 
Model: 
Pump Type: 
Material of Construction: 
Flow Rate: 
Tubing: 
Sterilization: 
Watson-Marlow Bredel 840 
Peristaltic 
Stainless Steel 316L 
Up to 133.33 LPM 
Bioprene, 40mm 
SIP 
Operating Conditions: 
Pressure Change: 
Pump Head: 
Max. Flow Rate: 
Power Consumption: 
1 bar 
44.1 ft 
44.74 LPM 
0.143 hp 
Purchase Cost: $ 18,135 
Reference Pages: 493, 505 
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Anion Exchange Chromatography Column (P-71 / C-302) 
Function: To remove impurities and purify antigen binding fragments 
Vendor: GE-Amersham 
PFD Reference: PFD-09 
Operation: Batch 
Materials Handled: 
Input:  
 Impurities 
 MAb Fab Fragments 
 MES Buffer 
 Sodium Chloride 
 TRIS Base 
 WFI 
 Total 
 
 
Quantity (kg/batch):  
 0.0079 
 15.0475 
 0.5332 
 11.9266 
 14.7608 
 3685.3208 
 3727.5968 
 
 
Characteristics: 
Model: 
Material of Construction: 
Sterilization: 
Chromaflow 600 
Stainless Steel 316L, PE 
SIP/CIP 
Operating Conditions: Temperature: Resin: 
25 °C 
Toyopearl SuperQ-650M 
Purchase Cost: $ 177,000 
Reference Page: 529 
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Anion Exchange Pool Tank (P-72 / V-306) 
Function: To collect product from anion exchange chromatography 
Vendor: Sharpsville Container 
PFD Reference: PFD-09 
Operation: Batch 
Materials Handled: 
Input:  
 Impurities 
 MAb Fab Fragments 
 MES 
 Sodium Chloride 
 TRIS Base 
 WFI 
 Total 
Quantity (kg/batch):  
 0.0004 
 15.0098 
 0.5332 
 12.2159 
 15.2497 
 3800.2578 
 3843.7711 
 
Characteristics: 
Material of Construction: 
Total Volume: 
Sterilization: 
Stainless Steel 316L 
4277.22 L 
SIP/CIP 
Operating Conditions: Temperature: Operating Pressure: 
25 °C 
1 bar 
Purchase Cost: $ 121,000  
Reference Page: 508 
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Pump (P-73 / PM-308) 
Function: To transfer buffer solution from storage tank to mixing tank 
Vendor: Watson-Marlow Bredel 
PFD Reference: PFD-09 
Operation: Batch 
Materials Handled: 
Input:  
 Sodium Chloride 
 Tris Base 
 WFI 
 Total 
Quantity (kg/batch):  
8.7342 
14.761 
3470.177 
3493.672 
 
Characteristics: 
Model: 
Pump Type: 
Material of Construction: 
Flow Rate: 
Tubing: 
Sterilization: 
Watson-Marlow Bredel 840 
Peristaltic 
Stainless Steel 316L 
Up to 133.33 LPM 
Bioprene, 40mm 
SIP 
Operating Conditions: 
Pressure Change: 
Pump Head: 
Max. Flow Rate: 
Power Consumption: 
1 bar 
44.1 ft 
58.33 LPM 
0.14 kW 
Purchase Cost: $ 18,135 
Reference Pages: 493, 505 
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Pump (P-74 / PM-309, P-75 / PM-310) 
Function: To transfer buffer solution from storage tank to anion exchange chromatography column 
Vendor: Watson-Marlow Bredel 
PFD Reference: PFD-09 
Operation: Batch 
Materials Handled: 
Input:  
 Sodium Chloride 
 Tris Base 
 WFI 
 Total 
Quantity (kg/batch):  
1.0125 
1.7111 
402.279 
405.0026 
 
Characteristics: 
Model: 
Pump Type: 
Material of Construction: 
Flow Rate: 
Tubing: 
Sterilization: 
Watson-Marlow Bredel 825 
Peristaltic 
Stainless Steel 316L 
Up to 33.33 LPM 
Bioprene, 25 mm 
SIP 
Operating Conditions: 
Pressure Change: 
Pump Head: 
Max. Flow Rate: 
Power Consumption: 
1 bar 
44.1 ft 
14.14 LPM 
0.075 hp 
Purchase Cost: $ 12,350 
Reference Pages: 493, 505 
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Pump (P-76 / PM-311) 
Function: To transfer buffer solution from storage tank to anion exchange chromatography column 
Vendor: Watson-Marlow Bredel 
PFD Reference: PFD-09 
Operation: Batch 
Materials Handled: 
Input:  
 Sodium Chloride 
 Tris Base 
 WFI 
 Total 
Quantity (kg/batch):  
 26.11021 
 2.23362 
 446.79333 
 475.137 
 
Characteristics: 
Model: 
Pump Type: 
Material of Construction: 
Flow Rate: 
Tubing: 
Sterilization: 
Watson-Marlow Bredel 825 
Peristaltic 
Stainless Steel 316L 
Up to 33.33 LPM 
Bioprene, 25 mm 
SIP 
Operating Conditions: 
Pressure Change: 
Pump Head: 
Max. Flow Rate: 
Power Consumption: 
1 bar 
44.1 ft 
9.42 LPM 
0.0295 hp 
Purchase Cost: $ 12,350 
Reference Pages: 493, 505 
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Storage Tank (P-77 / V-304) 
Function: To mix and hold buffer solution for anion exchange chromatography 
Vendor: Sharpsville Container 
PFD Reference: PFD-09 
Operation: Batch 
Materials Handled: 
Input:  
Sodium Chloride 
Tris Base 
WFI 
Total  
 
Quantity (kg/batch):  
9.7467 
16.4719 
3872.4568 
3899.19 
 
Characteristics: 
Material of Construction: 
Total Volume: 
Sterilization: 
Stainless Steel 316L 
4339.69 L 
SIP/CIP 
Operating Conditions: Temperature: Operating Pressure: 
25 °C 
1 bar 
Purchase Cost: $117,000 
Reference Page: 508 
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Storage Tank (P-78 / V-305) 
Function: To mix and hold buffer solution for anion exchange chromatography 
Vendor: Sharpsville Container 
PFD Reference: PFD-09 
Operation: Batch 
Materials Handled: 
Input:  
Sodium Chloride 
TRIS Base 
WFI 
Total 
Quantity (kg/batch):  
26.1102 
 2.2336 
 446.7933 
 475.2 
 
Characteristics: 
Material of Construction: 
Total Volume: 
Sterilization: 
Stainless Steel 316L 
515.22 L 
SIP/CIP 
Operating Conditions: Temperature: Operating Pressure: 
25 °C 
1 bar 
Purchase Cost: $ 117,000 
Reference Page: 508 
 
Flexible Manufacturing Facility for Biopharmaceuticals 
 
-166- 
 
Pump (P-79 / PM-312) 
Function: To transfer solution for to PEGylation section 
Vendor: Watson-Marlow Bredel 
PFD Reference: PFD-09 
Operation: Batch 
Materials Handled: 
Input:  
Impurities 
MAb Fab Fragments 
MES 
Sodium Chloride 
Tris Base 
WFI 
Total 
Quantity (kg/batch):  
 0.00040 
 15.00984  
 0.53318 
 12.21593 
 15.24966 
 3800.25778 
 3843.267 
 
Characteristics: 
Model: 
Pump Type: 
Material of Construction: 
Flow Rate: 
Tubing: 
Sterilization: 
Watson-Marlow Bredel 825 
Peristaltic 
Stainless Steel 316L 
Up to 33.33 LPM 
Bioprene, 25 mm 
SIP 
Operating Conditions: 
Pressure Change: 
Pump Head: 
Max. Flow Rate: 
Power Consumption: 
1 bar 
50.1 ft 
16.04 LPM 
0.038 kW 
Purchase Cost: $ 12,350 
Reference Pages: 493, 505 
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Diafiltration Storage Tank (P-80 / V-401) 
Function: To store purified Fab fragments from Ion Exchange Chromatography prior to Diafiltration 1 process. 
Vendor: Sharpsville Container 
PFD Reference: PFD-10A 
Operation: Batch 
Materials Handled: 
Input:  
MAb Fab Fragments 
MES 
Sodium Chloride 
TRIS Base 
WFI 
TOTAL (kg/batch) 
 
Quantity (kg/batch):  
15.01 
0.53 
12.22 
15.25 
3800.26 
3843.27 
 
Characteristics: 
Capacity: 
Inside Diameter: 
Height: 
Interior Construction: 
Sterilization: 
4277.24 L 
1.537 m 
2.305 m 
316L Electropolished Stainless Steel  
SIP / CIP 
Operating Conditions: 
 
Temp: 
Pressure: 
 
 
25 °C 
22.04 psi 
 
Purchase Cost: $ 111,000 
Reference Page: 508 
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Diafiltration Unit (P-81 / DF-401) 
Function: To concentrate the Fab fragments from 3.9 mg/ml to 10 mg/ml in Reduction Reaction Buffer to prepare for the Reduction Reaction. 
Vendor: Sartorius Stedim Biotechnology 
PFD Reference: PFD-10A 
Operation: Batch 
Materials Handled: 
Input:  
EDTA, Sodium 
MAb Fab Fragments 
MES 
Phosphate 
Sodium Chloride 
TRIS Base 
WFI 
TOTAL (kg/batch) 
 
Quantity (kg/batch):  
5.69 
15.01 
0.53 
72.60 
12.22 
15.25 
12948.40 
13069.70 
 
Characteristics: 
Cassette Model: 
Membrane: 
Filter Area per Cassette: 
Filter holder: 
Maximum feed pressure: 
Sterilization: 
Sartocube® 302 144 59 30 E-BSW 
Hydrosart (stabilized cellulose based) 
3.0 m2 
Sartocon 3 
58 psi (4 bar) 
SIP/CIP 
Operating Conditions: 
Number of units: 
Total Filter area: 
Filter MWCO: 
Temp: 
Pressure Change: 
15 
43.56 m2 
10 kDa 
25 °C 
14.5 psi 
Purchase Cost: Ultrafiltration Housing:   $ 11,141 Ultrafiltration Cartridges: $ 125,610 
Reference Pages: 514, 516, 518, 520 
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Pump (P-82 / PM-401) 
Function: 
To transport the Fab fragments concentrated in the Reduction Reaction 
Buffer from Diafiltration Unit (P-81 / DF-401) to the Thiol Reduction 
Reactor (P-83 / R-401). 
Vendor: Watson-Marlow Bredel 
PFD Reference: PFD-10A 
Operation: Batch 
Materials Handled: 
Input:  
EDTA, Sodium 
MAb Fab Fragments 
MES 
Phosphate 
Sodium Chloride 
TRIS Base 
WFI 
TOTAL (kg/batch) 
 
Quantity (kg/batch):  
0.94 
15.01 
0.03 
11.95 
0.63 
0.79 
1454.82 
1484.17 
 
Characteristics: 
Model: 
Pump Type: 
Material of Construction: 
Flow Rate: 
Power: 
Tubing: 
Sterilization: 
Watson-Marlow Bredel 840  
Peristaltic 
Stainless Steel 316L 
133.3 L/min 
2.2 hp / 3.0 kW 
Bioprene 40 mm 
SIP/CIP 
Operating Conditions: 
Temp: 
Power: 
Volumetric Throughput: 
Pressure Change 
25 °C 
0.15 hp/ 0.12 kW 
48.36 L/min 
50 psi 
Purchase Cost: $18,135 
Reference Pages: 493, 505 
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Thiol Reduction Reactor (P-83 / R-401) 
Function: To reduce any thiols attached to the cysteine which will then be specifically PEGylated during the PEGylation Reaction. 
Vendor: Abec 
PFD Reference: PFD-10A 
Operation: Batch 
Materials Handled: 
Input:  
2-MEA 
EDTA, Sodium 
MAb Fab Fragments 
MES 
Phosphate 
Sodium Chloride 
TRIS Base 
WFI 
TOTAL (kg/batch) 
 
Quantity (kg/batch):  
5593.00 
0.94 
15.01 
0.03 
11.95 
0.63 
0.79 
1454.82 
7077.17 
 
Characteristics: 
Material of Construction: 
Mode of agitation 
Mode of Drive: 
Mode of Control: 
Volume: 
Height: 
Diameter 
Sterilization: 
316L Stainless Steel, Electropolished 
Backward curved impeller 
Top mechanical agitation 
DCS control system 
1673.93 L 
2.371 m 
0.948 m 
SIP/CIP 
Operating Conditions: Temperature: Incubation Time: 
37°C 
90 minutes 
Purchase Cost: $ 511,000 
Reference Page: 507 
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Pump (P-84 / PM-402) 
Function: 
To transport the reduced Fab fragments in the Reduction Reaction Buffer 
from the Thiol Reduction Reactor (P-83 / R-401) to Diafiltration Unit (P-
86 / DF-402). 
Vendor: Watson-Marlow Bredel 
PFD Reference: PFD-10A 
Operation: Batch 
Materials Handled: 
Input:  
2-MEA 
EDTA, Sodium 
MAb Fab Fragments 
MES 
Phosphate 
Reduced MAb Fab Fragments 
Sodium Chloride 
TRIS Base 
WFI 
TOTAL (kg/batch) 
 
 
 
Quantity (kg/batch):  
9.01 
0.94 
0.75 
0.03 
11.95 
14.26 
0.63 
0.79 
1454.82 
1493.17 
 
Characteristics: 
Model: 
Pump Type: 
Material of Construction: 
Flow Rate: 
Power: 
Tubing: 
Sterilization: 
Watson-Marlow Bredel 840  
Peristaltic 
Stainless Steel 316L 
133.3 L/min 
2.2 hp / 3.0 kW 
Bioprene 40 mm 
SIP/CIP 
Operating Conditions: 
Temp: 
Power: 
Volumetric Throughput: 
Pressure Change 
25 °C 
0.16 hp/ 0.12 kW 
49.11 L/min 
14.5 psi 
Purchase Cost: $ 18,135 
Reference Pages: 493, 505 
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Diafiltration Storage Tank (P-85 / V-402) 
Function: To store reduced Fab fragments from Thiol Reduction Reaction prior to Diafiltration process. 
Vendor: Sharpsville Container 
PFD Reference: PFD-10A 
Operation: Batch 
Materials Handled: 
 
Input:  
2-MEA 
EDTA, Sodium 
MAb Fab Fragments 
MES 
Phosphate 
Reduced MAb Fab Fragments 
Sodium Chloride 
TRIS Base 
WFI 
TOTAL (kg/batch) 
 
 
 
 
 
Quantity (kg/batch): 
9.01 
0.94 
0.75 
0.03 
11.95 
14.26 
0.63 
0.79 
1454.82 
1493.17 
 
Characteristics: 
Capacity: 
Inside Diameter: 
Height: 
Interior Construction: 
Sterilization: 
1678.37 L 
0.893 m 
2.679 m 
316L Electropolished Stainless Steel  
SIP / CIP 
Operating Conditions: 
 
Temp: 
Pressure: 
 
 
25 °C 
22.046 bar 
 
Purchase Cost: $ 115,000 
Reference Page: 508 
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Diafiltration Unit (P-86 / DF-402) 
Function: 
To filter out 2-MEA and switch the reduced Fab fragments to PEGylation 
Reaction Buffer while maintaining a concentration of 10 mg/ml to prepare 
for the PEGylation Reaction. 
Vendor: Sartorius Stedim Biotechnology 
PFD Reference: PFD-10A 
Operation: Batch 
Materials Handled: 
 
 
Input:  
2-MEA 
EDTA, Disodium 
EDTA, Sodium 
MAb Fab Fragments 
MES 
Phosphate 
Reduced MAb Fab Fragments 
Sodium Chloride 
TRIS Base 
WFI 
TOTAL (kg/batch) 
 
 
 
Quantity (kg/batch):  
9.01 
2.23 
0.94 
0.75 
0.03 
40.36 
14.26 
0.63 
0.79 
4947.76 
5016.75 
 
Characteristics: 
Cassette Model: 
Membrane: 
Filter Area per Cassette: 
Filter holder: 
Maximum feed pressure: 
Sterilization: 
Sartocube® 302 144 59 30 E-BSW 
Hydrosart (stabilized cellulose based) 
3.0 m2 
Sartocon 3 
58 psi (4 bar) 
SIP/CIP 
Operating Conditions: 
Number of units: 
Total Filter area: 
Filter MWCO: 
Temp: 
Pressure Change: 
5 
13.03 m2 
10 kDa 
25 °C 
152.68 psi 
Purchase Cost: Ultrafiltration Housing:   $ 11,141 Ultrafiltration Cartridges: $ 41,870 
Reference Pages: 514, 516, 518, 520 
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Pump (P-87 / PM-403) 
Function: 
To transport the reduced Fab fragments in the PEGylation Reaction 
Buffer from Diafiltration Unit (P-86 / DF-402) to the PEGylation Reactor 
(P-88 / R-402). 
Vendor: Watson-Marlow Bredel 
PFD Reference: PFD-10A 
Operation: Batch 
Materials Handled: 
 
 
Input:  
2-MEA 
EDTA Disodium 
EDTA, Sodium 
MAb Fab Fragments 
Phosphate 
Reduced MAb Fab Fragments 
Sodium Chloride 
TRIS Base 
WFI 
TOTAL (kg/batch) 
 
 
 
 
 
Quantity (kg/batch):  
1.22 
0.95 
0.13 
0.75 
13.78 
14.26 
0.09 
0.11 
1477.31 
1508.59 
 
Characteristics: 
Model: 
Pump Type: 
Material of Construction: 
Flow Rate: 
Power: 
Tubing: 
Sterilization: 
Watson-Marlow Bredel 840  
Peristaltic 
Stainless Steel 316L 
133.3 L/min 
2.2 hp / 3.0 kW 
Bioprene 40 mm 
SIP/CIP 
Operating Conditions: 
Temp: 
Power: 
Volumetric Throughput: 
Pressure Change 
25 °C 
0.16 hp/ 0.12 kW 
49.24 L/min 
14.5 psi 
Purchase Cost: $ 18,135 
Reference Pages: 493, 505 
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PEGylation Reactor (P-88 / R-402) 
Function: To site-specifically PEGylate the 50 kDa Fab fragments with a 40 kDa PEG molecule to enhance therapeutic effects of the drug. 
Vendor: Abec 
PFD Reference: PFD-10A 
Operation: Batch 
Materials Handled: 
 
Input:  
2-MEA 
EDTA, Disodium 
EDTA, Sodium 
MAb Fab Fragments 
Phosphate 
Reduced MAb Fab Fragments 
Sodium Chloride 
TRIS Base 
WFI 
PEG 
TOTAL (kg/batch) 
 
 
Quantity (kg/batch):  
1.22 
0.95 
0.13 
0.75 
13.78 
14.26 
0.09 
0.11 
1477.31 
228.15 
1745.59 
 
Characteristics: 
Material of Construction: 
Mode of agitation 
Mode of Drive: 
Mode of Control: 
Volume: 
Height: 
Diameter 
Sterilization: 
316L Stainless Steel, Electropolished 
Backward curved impeller 
Top mechanical agitation 
DCS control system 
1947.83 L 
2.493 m 
0.997 m 
SIP/CIP 
Operating Conditions: Temperature: Incubation Time: 
25°C 
120 minutes 
Purchase Cost: $ 522,000 
Reference Page: 507 
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Pump (P-89 / PM-404) 
Function: 
To transport the PEGylated Fab fragments, excess PEG molecules, and 
non-PEGylated Fab fragments in PEGylation Reaction Buffer from the 
PEGylation Reactor (P-88 / R-402) to Diafiltration Unit (P-91 / DF-403). 
Vendor: Watson-Marlow Bredel 
PFD Reference: PFD-10A 
Operation: Batch 
Materials Handled: 
Input:  
2-MEA 
EDTA, Disodium 
EDTA, Sodium 
MAb Fab Fragments 
PEG 
PEGylated MAb F 
Phosphate 
Reduced MAb Fab Fragments 
Sodium Chloride 
TRIS Base 
WFI 
TOTAL (kg/batch) 
 
 
 
Quantity (kg/batch):  
1.22 
0.95 
0.13 
0.75 
217.31 
24.38 
13.78 
0.71 
0.09 
0.11 
590.92 
850.36 
 
Characteristics: 
Model: 
Pump Type: 
Material of Construction: 
Max Flow Rate: 
Max Power: 
Tubing: 
Sterilization: 
Watson-Marlow Bredel 825 
Peristaltic 
Stainless Steel 316L 
33.3 L/min 
1.6 hp / 1.1 kW 
Bioprene 25 mm 
SIP/CIP 
Operating Conditions: 
Temp: 
Power: 
Volumetric Throughput: 
Pressure Change 
25 °C 
0.09 hp/ 0.07 kW 
27.84 L/min 
14.5 psi 
Purchase Cost: $ 12,135 
Reference Pages:  493, 505 
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Diafiltration Storage Tank (P-90 / V-403) 
Function: To store PEGylated Fab fragments mixed with non-PEGylated Fab fragments and excess PEG molecules prior to Diafiltration process. 
Vendor: Sharpsville Container 
PFD Reference: PFD-10A 
Operation: Batch 
Materials Handled: 
Input:  
2-MEA 
EDTA, Disodium 
EDTA, Sodium 
MAb Fab Fragments 
PEG 
PEGylated MAb F 
Phosphate 
Reduced MAb Fab Fragments 
Sodium Chloride 
TRIS Base 
WFI 
TOTAL (kg/batch) 
 
 
 
Quantity (kg/batch):  
1.22 
0.95 
0.13 
0.75 
217.31 
24.38 
13.78 
0.71 
0.09 
0.11 
590.92 
850.36 
 
Characteristics: 
Capacity: 
Inside Diameter: 
Height: 
Interior Construction: 
Sterilization: 
950.09 L 
0.739 m 
2.216 m 
316L Electropolished Stainless Steel  
SIP / CIP 
Operating Conditions: 
 
Temp: 
Pressure: 
 
 
25 °C 
26.1 psi 
 
Purchase Cost: $ 117,000 
Reference Page: 508 
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Diafiltration Unit (P-91 / DF-403) 
Function: 
To switch the PEGylated Fab fragments, non-PEGylated Fab fragments, 
and excess PEG molecules from PEGylation Reaction Buffer to WFI 
while maintaining a concentration of 10 mg/ml to prepare for the cation 
exchange chromatography. 
Vendor: Sartorius Stedim Biotechnology 
PFD Reference: PFD-10A 
Operation: Batch 
Materials Handled: 
 
 
Input:  
2-MEA 
EDTA, Disodium 
EDTA, Sodium 
MAb Fab Fragments 
PEG 
PEGylated MAb F 
Phosphate 
Reduced MAb Fab Fragments 
Sodium Chloride 
TRIS Base 
WFI 
TOTAL (kg/batch) 
. 
 
 
Quantity (kg/batch):  
1.22 
0.95 
0.13 
0.75 
217.31 
24.38 
13.78 
0.71 
0.09 
0.11 
2812.17 
3071.61 
 
Characteristics: 
Cassette Model: 
Membrane: 
Filter Area per Cassette: 
Filter holder: 
Maximum feed pressure: 
Sterilization: 
Sartocube® 302 144 59 30 E-BSW 
Hydrosart (stabilized cellulose based) 
3.0 m2 
Sartocon 3 
58 psi (4 bar) 
SIP/CIP 
Operating Conditions: 
Number of units: 
Total Filter area: 
Filter MWCO: 
Temp: 
Pressure Change: 
3 
7.39 m2 
30 kDa 
25 °C 
26.1 psi 
Purchase Cost: Ultrafiltration Housing:   $ 11,141 Ultrafiltration Cartridges: $ 25,122 / 3m2 
Reference Page: 514, 516, 518, 520  
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Cation Buffer 2 Storage Tank (P-92 / V-405) 
Function: To store Cation Buffer 1 for Cation Exchange Chromatography Elution and Stripping steps. 
Vendor: Sharpsville Container 
PFD Reference: PFD-10A 
Operation: Batch 
Materials Handled: 
 
Input:  
Phosphate 
Sodium Chloride 
WFI 
TOTAL (kg/batch) 
 
 
Quantity (kg/batch):  
3.48 
107.26 
1833.58 
1944.33 
 
Characteristics: 
Capacity: 
Inside Diameter: 
Height: 
Interior Construction: 
Sterilization: 
2113.64 L 
0.96 m 
2.89 m 
316L Electropolished Stainless Steel  
SIP / CIP 
Operating Conditions: 
Temp: 
Pressure: 
 
25 °C 
132.23 psi 
 
Purchase Cost: $ 119,000 
Reference Page: 508 
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Cation Buffer 1 Storage Tank (P-93 / V-404) 
Function: To store Cation Buffer 2 for Cation Exchange Chromatography Equilibration, Wash, and Load steps. 
Vendor: Sharpsville Container 
PFD Reference: PFD-10A 
Operation: Batch 
Materials Handled: 
Input:  
Phosphate 
WFI 
TOTAL (kg/batch) 
 
 
Quantity (kg/batch):  
6.87 
3618.45 
3625.32 
. 
Characteristics: 
Capacity: 
Inside Diameter: 
Height: 
Interior Construction: 
Sterilization: 
4049.58 L 
1.198 m 
3.594 m 
316L Electropolished Stainless Steel  
SIP / CIP 
Operating Conditions: 
Temp: 
Pressure: 
 
25 °C 
132.23 psi 
 
Purchase Cost: $ 109,000 
Reference Page: 508 
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Pump (P-94 / PM-405) 
Function: 
To transport the PEGylated Fab fragments, excess PEG molecules, and 
non-PEGylated Fab fragments in WFI from Diafiltration Unit (P-91 / DF-
403) to Cation Exchange Chromatography (P-101 / C-401). 
Vendor: Watson-Marlow Bredel 
PFD Reference: PFD-10A 
Operation: Batch 
Materials Handled: 
Input:  
2-MEA 
EDTA, Disodium 
EDTA, Sodium 
MAb Fab Fragments 
PEG 
PEGylated MAb F 
Phosphate 
Reduced MAb Fab Fragments 
Sodium Chloride 
TRIS Base 
WFI 
TOTAL (kg/batch) 
 
  
 
Quantity (kg/batch):  
0.17 
0.13 
0.02 
0.10 
29.41 
24.38 
1.87 
0.10 
0.01 
0.01 
802.27 
858.47 
 
Characteristics: 
Model: 
Pump Type: 
Material of Construction: 
Flow Rate: 
Power: 
Tubing: 
Sterilization: 
Watson-Marlow Bredel 840  
Peristaltic 
Stainless Steel 316L 
133.3 L/min 
2.2 hp / 3.0 kW 
Bioprene 40 mm 
SIP/CIP 
Operating Conditions: 
Temp: 
Power: 
Volumetric Throughput: 
Pressure Change 
25 °C 
0.16 hp/ 0.12 kW 
48.79 L/min 
14.5 psi 
Purchase Cost: $18,135  
Reference Pages:  493, 505 
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Pump (P-95 / PM-406) 
Function: 
To transport Cation Buffer 1 from the Storage Tank (P-93 / V-404) to 
Cation Exchange Chromatography (P-101 / C-401) for the loading step 
after mixing with the main Fab stream. 
Vendor: Watson-Marlow Bredel 
PFD Reference: PFD-10A 
Operation: Batch 
Materials Handled: 
Input:  
Phosphate 
WFI 
TOTAL (kg/batch) 
 
  
 
 
 
 
 
 
Quantity (kg/batch):  
3.96 
2084.92 
2088.88 
 
Characteristics: 
Model: 
Pump Type: 
Material of Construction: 
Flow Rate: 
Power: 
Tubing: 
Sterilization: 
Watson-Marlow Bredel 840  
Peristaltic 
Stainless Steel 316L 
133.3 L/min 
2.2 hp / 3.0 kW 
Bioprene 40 mm 
SIP/CIP 
Operating Conditions: 
Temp: 
Power: 
Volumetric Throughput: 
Pressure Change 
25 °C 
0.38 hp/ 0.29 kW 
119.83 L/min 
14.5 psi 
Purchase Cost: $18,135 
Reference Pages:  493, 505 
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Pump (P-96 / PM-410) 
Function: To transport Cation Buffer 2 from the Storage Tank (P-92 / V-405) to Cation Exchange Chromatography (P-101 / C-401) for the Stripping step. 
Vendor: Watson-Marlow Bredel 
PFD Reference: PFD-10A 
Operation: Batch 
Materials Handled: 
Input:  
Phosphate 
Sodium Chloride 
WFI 
TOTAL (kg/batch) 
  
 
 
 
 
 
 
Quantity (kg/batch):  
1.41 
43.55 
744.42 
789.38 
 
Characteristics: 
Model: 
Pump Type: 
Material of Construction: 
Max Flow Rate: 
Max Power: 
Tubing: 
Sterilization: 
Watson-Marlow Bredel 825 
Peristaltic 
Stainless Steel 316L 
33.3 L/min 
1.6 hp / 1.1 kW 
Bioprene 25 mm 
SIP/CIP 
Operating Conditions: 
Temp: 
Power: 
Volumetric Throughput: 
Pressure Change 
25 °C 
0.08 hp/ 0.06 kW 
25.18 L/min 
14.5 psi 
Purchase Cost: $ 12,350 
Reference Pages:  493, 505 
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Pump (P-97 / PM-411) 
Function: To transport Cation Buffer 2 from the Storage Tank (P-92 / V-405) to Cation Exchange Chromatography (P-101 / C-401) for the Elution step. 
Vendor: Watson-Marlow Bredel 
PFD Reference: PFD-10A 
Operation: Batch 
Materials Handled: 
Input:  
Phosphate 
Sodium Chloride 
WFI 
TOTAL (kg/batch) 
  
 
 
 
 
 
 
Quantity (kg/batch):  
2.07 
63.72 
1089.16 
1154.94 
 
Characteristics: 
Model: 
Pump Type: 
Material of Construction: 
Max Flow Rate: 
Max Power: 
Tubing: 
Sterilization: 
Watson-Marlow Bredel 825 
Peristaltic 
Stainless Steel 316L 
33.3 L/min 
1.6 hp / 1.1 kW 
Bioprene 25 mm 
SIP/CIP 
Operating Conditions: 
Temp: 
Power: 
Volumetric Throughput: 
Pressure Change 
25 °C 
0.03 hp/ 0.02 kW 
9.21 L/min 
14.5 psi 
Purchase Cost: $ 12,350 
Reference Pages:  493, 505 
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Pump (P-98 / PM-408) 
Function: To transport Cation Buffer 1 from the Storage Tank (P-93 / V-404) to Cation Exchange Chromatography (P-101 / C-401) for the Wash step. 
Vendor: Watson-Marlow Bredel 
PFD Reference: PFD-10A 
Operation: Batch 
Materials Handled: 
 
Input:  
2-MEA 
EDTA, Disodium 
EDTA, Sodium 
MAb Fab Fragments 
PEG 
PEGylated MAb F 
Phosphate 
Reduced MAb Fab Fragments 
Sodium Chloride 
TRIS Base 
WFI 
TOTAL (kg/batch) 
 
  
 
Quantity (kg/batch):  
0.17 
0.13 
0.02 
0.10 
29.41 
24.38 
1.87 
0.10 
0.01 
0.01 
802.27 
858.47 
 
Characteristics: 
Model: 
Pump Type: 
Material of Construction: 
Max Flow Rate: 
Max Power: 
Tubing: 
Sterilization: 
Watson-Marlow Bredel 825 
Peristaltic 
Stainless Steel 316L 
33.3 L/min 
1.6 hp / 1.1 kW 
Bioprene 25 mm 
SIP/CIP 
Operating Conditions: 
Temp: 
Power: 
Volumetric Throughput: 
Pressure Change 
25 °C 
0.06 hp/ 0.04 kW 
18.88 L/min 
14.5 psi 
Purchase Cost: $ 12,350 
Reference Pages:  493, 505 
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Pump (P-99 / PM-407) 
Function: 
To transport Cation Buffer 1 from the Storage Tank (P-93 / V-404) to 
Cation Exchange Chromatography (P-101 / C-401) for the Equilibration 
step. 
Vendor: Watson-Marlow Bredel 
PFD Reference: PFD-10A 
Operation: Batch 
Materials Handled: 
Input:  
Phosphate 
WFI 
TOTAL (kg/batch) 
 
 
 
Quantity (kg/batch): 
1.46 
766.76 
768.22 
 
 
Characteristics: 
Model: 
Pump Type: 
Material of Construction: 
Max Flow Rate: 
Max Power: 
Tubing: 
Sterilization: 
Watson-Marlow Bredel 825 
Peristaltic 
Stainless Steel 316L 
33.3 L/min 
1.6 hp / 1.1 kW 
Bioprene 25 mm 
SIP/CIP 
Operating Conditions: 
Temp: 
Power: 
Volumetric Throughput: 
Pressure Change 
25 °C 
0.08 hp/ 0.06 kW 
25.18 L/min 
14.5 psi 
Purchase Cost: $12,350 
Reference Pages:  493, 505 
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Ion Exchange Chromatography (P-101 / C-401) 
Function: To specifically bind and elute the PEGylated Fab’ fragments in Cation Buffer 2. 
Vendor: GE Amersham 
PFD Reference: PFD-10A 
Operation: Batch 
Materials Handled: 
Input:  
2-MEA 
EDTA, Disodium 
EDTA, Sodium 
MAb Fab Fragments 
PEG 
PEGylated MAb F 
Phosphate 
Reduced MAb Fab Fragments 
Sodium Chloride 
TRIS Base 
Water 
WFI 
TOTAL (kg/batch) 
 
 
Quantity (kg/batch):  
0.17 
0.13 
0.02 
0.10 
29.41 
24.38 
5.83 
0.10 
0.01 
0.01 
2084.92 
802.27 
2947.35 
 
Characteristics: 
Model: 
Material of Construction: 
Column Volume: 
Column Height: 
Column Diameter: 
Sterilization: 
Chromaflow 1000 
Stainless Steel 316L 
617.85 L 
0.787 m 
1.0 m 
SIP/CIP 
Operating Conditions: 
Temp: 
Bed Volume: 
Resin: 
Binding Capacity: 
25 °C 
154.46 L 
MacroCap SP 
150 mg/ml 
Purchase Cost: Column: $ 249,000 MacroCap SP Resin: $ 290,230 
Reference Page:  529 
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Pump (P-102 / PM-501) 
Function: To transfer solution from to PEGylation to diafiltration 
Vendor: Watson-Marlow Bredel 
PFD Reference: PFD-11 
Operation: Batch 
Materials Handled: 
Input:  
Impurities 
MAb Fab Fragments 
PEGylated MAb Fab Fragments 
Phosphate 
Sodium Chloride 
WFI 
Total 
 
 
Quantity (kg/batch):  
0.00001 
 0.00025 
 22.00609 
 0.27583 
 8.49544 
 302.64578 
 333.423 
 
 
Characteristics: 
Model: 
Pump Type: 
Material of Construction: 
Flow Rate: 
Tubing: 
Sterilization: 
Watson-Marlow Bredel 825 
Peristaltic 
Stainless Steel 316L 
Up to 33.33 LPM 
Bioprene, 25 mm 
SIP 
Operating Conditions: 
Pressure Change: 
Pump Head: 
Max. Flow Rate: 
Power Consumption: 
1 bar 
45.9 
5.52 LPM 
0.005 kW 
Purchase Cost: $ 12,350 
Reference Pages: 493, 505 
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Diafiltration Storage Tank (P-103 / V-501) 
Function: To store product containing stream prior to diafiltration 
Vendor: Sharpsville Container 
PFD Reference: PFD-11 
Operation: Batch 
Materials Handled: 
Input:  
Impurities 
MAb Fab Fragments 
PEGylated MAb Fab Fragments 
Phosphate 
Sodium Chloride 
WFI 
Total 
 
 
Quantity (kg/batch):  
0.00001 
 0.00025 
 22.0061 
 0.2758 
 8.4954 
 302.6458 
 333.4668 
 
 
Characteristics: 
Material of Construction: 
Total Volume: 
Sterilization: 
Stainless Steel 316L 
367.82 L 
SIP/CIP 
Operating Conditions: Temperature: Operating Pressure: 
25 °C 
1 bar 
Purchase Cost: $ 117,000  
Reference Page: 508 
 
Flexible Manufacturing Facility for Biopharmaceuticals 
 
-190- 
 
Diafiltration Unit (P-104 / DF-501) 
Function: To concentrate monoclonal antibody stream and exchange buffer solution to PBS 
Vendor: Sartorius Stedim Biotechnology 
PFD Reference: PFD-11 
Operation: Batch 
Materials Handled: 
Input:  
Impurities 
MAb Fab Fragments 
PBS 
PEGylated MAb Fab Fragments 
Phosphate 
Sodium Chloride 
WFI 
Total 
Quantity (kg/batch):  
 0.00001 
 0.00025 
 440.95913 
 22.0061 
 0.2758 
 8.4954 
 800.000 
 1271.73 
 
Characteristics: 
Cassette Model: 
Membrane: 
Filter Area per Cassette: 
Filter holder: 
Maximum feed pressure: 
Sterilization: 
Sartocube® 302 144 59 30 E-BSW 
Hydrosart (stabilized cellulose based) 
3.0 m2 
Sartocon 3 
58 psi (4 bar) 
SIP/CIP 
Operating Conditions: 
Number of units: 
Total Filter area: 
Filter MWCO: 
Temperature: 
1 
2.759 m2 
30 kDa 
25 °C 
Purchase Cost: Ultrafiltration Housing:   $ 11,141 Ultrafiltration Cartridge:  $ 8374 / 3m2 
Reference Page: 514, 516, 518, 520 
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Pump (P-105 / PM-502) 
Function: To transfer solution from diafiltration to viral filtration 
Vendor: Watson-Marlow Bredel 
PFD Reference: PFD-11 
Operation: Batch 
Materials Handled: 
Input:  
KCl 
KH2PO4 
MAb Fab Fragments 
Na2HPO4 
PEGylated MAb Fab Fragments 
Phosphate 
Sodium Chloride 
WFI 
Total 
 
 
Quantity (kg/batch):  
0.00034 
 0.00034 
 0.00025 
 0.18291 
 21.45594 
 0.02402 
 2.11584 
 196.844 
 220.360 
 
 
Characteristics: 
Model: 
Pump Type: 
Material of Construction: 
Flow Rate: 
Tubing: 
Sterilization: 
Watson-Marlow Bredel 825 
Peristaltic 
Stainless Steel 316L 
Up to 33.33 LPM 
Bioprene, 25 mm 
SIP 
Operating Conditions: 
Pump Head: 
Max. Flow Rate: 
Power Consumption: 
50.1 ft 
3.68 LPM 
0.036 kW 
Purchase Cost: $ 12,350  
Reference Pages: 493, 505 
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Retrovirus Filter (P-106 / DE-501) 
Function: Removal of retrovirus from the monoclonal antibody stream 
Vendor: Millipore 
PFD Reference: PFD-11 
Operation: Batch 
Materials Handled: 
Input:  
KCl 
KH2PO4 
MAb Fab Fragments 
Na2HPO4 
PEGylated MAb Fab Fragments 
Phosphate 
Sodium Chloride 
WFI 
Total 
Quantity (kg/batch):  
 0.00034 
 0.00034 
 0.00025 
 0.18291 
 21.45594 
 0.02402 
 2.11584 
 196.844 
 220.360 
 
Characteristics: 
Filter Model: 
Filtration Area: 
Filter Material: 
Filter Size Cutoff: 
Process Volume: 
Viresolve NFR Cartridge Filter (10in) 
0.43 m2 
Polyethersulfone 
50 nm 
600-1200L 
Operating Conditions: Temperature: Filtration Mode: 
25°C 
Normal Flow Filtration (Dead-End) 
Purchase Cost: Filter:    $1,459 Housing  $1,340  
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Parvovirus Filter (P-107 / DE-502) 
Function: Removal of parvovirus from the monoclonal antibody stream 
Vendor: Millipore 
PFD Reference: PFD-11 
Operation: Batch 
Materials Handled: 
Input:  
KCl 
KH2PO4 
MAb Fab Fragments 
Na2HPO4 
PEGylated MAb Fab Fragments 
Phosphate 
Sodium Chloride 
WFI 
Total 
Quantity (kg/batch):  
0.00034 
 0.00034 
 0.00025 
 0.18900 
 21.24138 
 0.02399 
 2.11355 
 196.63112 
 220.200 
 
Characteristics: 
Filter Model: 
Filtration Area: 
Filter Material: 
Filter Size Cutoff: 
Process Volume: 
Viresolve NFP Cartridge Filter (10in) 
0.42 m2 
Modified PVDF 
20 nm 
250L 
Operating Conditions: Temperature: Filtration Mode: 
25°C 
Normal Flow Filtration (Dead-End) 
Purchase Cost: Filter:   $3,963 Housing: $1,340 
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Bag Dispenser (P-108 / DCS-501) 
Function: To transfer solution into 50 L bags 
Vendor: SciLog, HyClone 
PFD Reference: PFD-11 
Operation: Batch 
Materials Handled: 
Input:  
Impurities 
KCl 
KH2PO4 
MAb Fab Fragments 
Na2HPO4 
PEGylated MAb F 
Phosphate 
Sodium Chloride 
WFI 
Total 
Quantity (kg/batch):  
 0.0000 
 0.0003 
 0.0003 
 0.0002 
 0.1888 
 21.0290 
 0.0240 
 2.1113 
 196.4200 
 221.0122 
 
Characteristics: 
Dispenser Model: 
Pump Type: 
Max Flow Rate: 
Sterilization: 
 
Bag Material: 
Sterilization: 
SciLog Fillmaster 104B 
Peristaltic 
14.6 L/min 
SIP/CIP 
 
HyQ CX5-14 Film 
Pre-sterilized 
Operating Conditions: Temperature: 25°C 
Purchase Cost: Dispensing Pump Unit:    $10,000 Five 50L Sterile Bags:     $245.05 
Reference Page: 541 
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Ultra Cold Freezer (P-109 / EC-501) 
Function: To transfer solution for to PEGylation section 
Vendor: Watson-Marlow Bredel 
PFD Reference: PFD-11 
Operation: Batch 
Materials Handled: 
Input:  
KCl 
KH2PO4 
MAb Fab Fragments 
Na2HPO4 
PEGylated MAb F 
Phosphate 
Sodium Chloride 
WFI 
Total  
 
Quantity (kg/batch):  
0.00034 
 0.00034 
 0.00025 
 0.18880 
 21.02897 
 0.02397 
 2.11128 
 196.42002 
 219.774 
 
Characteristics: 
Model: 
Material of Construction: 
Temperature Range: 
Size 
TF-1050 
Stainless Steel 304 
-20°C to -85°C 
1050 L 
Operating Conditions: Temperature: Power Consumption: 
-80°C 
10.85 kW 
Purchase Cost: $ 45,000 
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10.0 Cost Summary 
10.1 Inoculum Prep and Bioreaction 
Inoculum Prep - Bioreaction 
Name Type Units Size (Capacity)  
Material of 
Construction Vendor 
Purchase 
Cost 
($/Unit) 
TFR-101 T-Flask 20.00 4.50 L  Nunc $6.83 
RBR-101 Roller Bottle 11.00 24.20 L CS Nunc $19.40 
SBR-101 Seed Reactor 1.00 1439.60 L SS316 ABEC $495,000.00 
MP-101 Blending Tank 1.00 952.15 L SS316 Sharpsville Container $117,000.00 
DE-101 Sterile Filter Housing 1.00 10.00 m2 SS316 
Sartorius Stedim 
Biotech $1,908.00 
 Filter Unit     
Sartorius Stedim 
Biotech $608.00 
BBS-101 Disposable Bioreactor Skid 8.00 160.00 L CS 
Sartorius Stedim 
Biotech $33,000.00 
 Bag 8.00    
Sartorius Stedim 
Biotech $447.00 
BBS-102 Disposable Bioreactor Skid 7.00 700.00 L CS 
Sartorius Stedim 
Biotech $39,000.00 
 Bag 7.00     $447.00 
MP-102 Blending Tank 1.00 2951.41 L SS316 Sharpsville Container $120,000.00 
DE-102 Sterile Filter Housing 1.00 10.00 m2 SS316 
Sartorius Stedim 
Biotech $1,908.00 
 Filter Unit     
Sartorius Stedim 
Biotech $608.00 
SBR-102 Stirred Reactor 1.00 4455.30 L SS316 ABEC $585,000.00 
MP-103 Blending Tank 1.00 7661.60 L SS316 Sharpsville Container $130,000.00 
DE-103 Dead-End Filter Housing 1.00 10.00 m2 SS316 
Sartorius Stedim 
Biotech $1,908.00 
 Filter     
Sartorius Stedim 
Biotech $608.00 
MP-104 Blending Tank 1.00 1564.84 L SS316 Sharpsville Container $117,000.00 
DE-104 Dead-End Filter Housing 1.00 10.00 m2 SS316 
Sartorius Stedim 
Biotech $1,908.00 
 Filter     
Sartorius Stedim 
Biotech $608.00 
PBR-101 Stirred Reactor 2.00 14062.54 L SS316 ABEC $661,000.00 
PM-101 Pump 1.00 0.05 kW SS316 Watson Marlow $12,500.00 
PM-102 Pump 1.00 0.05 kW SS316 Watson Marlow $12,500.00 
PM-103 Pump 1.00 0.04 kW SS316 Watson Marlow $12,500.00 
PM-104 Pump 1.00 0.08 kW SS316 Watson Marlow $12,500.00 
PM-105 Pump 1.00 0.08 kW SS316 Watson Marlow $12,500.00 
PM-106 Pump 1.00 0.02 kW SS316 Watson Marlow $12,500.00 
PM-107 Pump 1.00 0.21 kW SS316 Watson Marlow $12,500.00 
PM-108 Pump 1.00 0.21 kW SS316 Watson Marlow $12,500.00 
PM-109 Pump 1.00 0.04 kW SS316 Watson Marlow $12,500.00 
PM-110 Pump 1.00 0.04 kW SS316 Watson Marlow $12,500.00 
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10.2 Primary Recovery – Disulfide Reduction 
Primary Recovery - Disulfide Reduction 
Name Type Units Size (Capacity)  
Material of 
Construction Vendor 
Purchase 
Cost 
($/Unit) 
V-201 Blending Tank 1.00 10889.01 L SS316 Sharpsville Container $129,000.00 
V-202 Blending Tank 1.00 9667.46 L SS316 Sharpsville Container $117,000.00 
DS-201 Disk-Stack Centrifuge 1.00 1800.01 L/h SS316 Alfa-Laval $421,000.00 
DE-201 Dead-End Filter Housing 1.00 10.00 m2 SS316 
Sartorius Stedim 
Biotech $1,908.00 
 Filter     
Sartorius Stedim 
Biotech $608.00 
PM-201 Pump 1.00 0.12 kW SS316 Watson Marlow $12,500.00 
PM-202 Pump 1.00 0.11 kW SS316 Watson Marlow $12,500.00 
PM-203 Pump 1.00 0.11 kW SS316 Watson Marlow $12,500.00 
PM-204 Pump 1.00 0.54 kW SS316 Watson Marlow $12,500.00 
V-203 Blending Tank 1.00 9667.52 L SS316 Sharpsville Container $17,000.00 
DF-201 Diafilter 2.00 14.90 m2 SS316 Sartorius Stedim Biotech $41,870.00 
 Diafilter Housing     
Sartorius Stedim 
Biotech $11,141.00 
R-201 Stirred Reactor 1.00 8422.52 L SS316 ABEC $639,000.00 
PM-205 Pump 1.00 0.73 kW SS316 Watson Marlow $12,500.00 
PM-206 Pump 1.00 9.03 kW SS316 Watson Marlow $12,500.00 
PFF-201 Plate & Frame Filter 1.00 23.23 m2 SS316 Pall Corporation $74,000.00 
PM-207 Pump 1.00 9.06 kW SS316 Watson Marlow $12,500.00 
V-204 Blending Tank 1.00 4708.01 L SS316 Sharpsville Container $117,000.00 
DF-202 Diafiltration Housing 1.00 36.45 m2 SS316 Sartorius Stedim Biotech $83,000.00 
 Diafilter     
Sartorius Stedim 
Biotech  
R-202 Stirred Reactor 1.00 4738.43 L SS316 ABEC $590,000.00 
PM-209 Pump 1.00 0.33 kW SS316 Watson Marlow $18,135.00 
PM-208 Pump 1.00 9.16 kW SS316 Watson Marlow $18,135.00 
V-205 Blending Tank 1.00 4760.28 L SS316 Sharpsville Container $117,000.00 
DF-203 Diafiltration Housing 1.00 36.45 m2 SS316 Sartorius Stedim Biotech $83,000.00 
 Diafilter     
Sartorius Stedim 
Biotech  
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10.3 Protein A – Chemical Virus Inactivation 
Protein A - Chemical Virus Inactivation 
Name Type Units Size (Capacity)  
Material of 
Construction Vendor 
Purchase 
Cost 
($/Unit) 
DE-202 Sterile Filter Housing 1.00 --- --- SS316 Sartorius Stedim $1,908.00 
 Filter 
1 / 
batch 1.80 m2 Polyethersulfone Sartorius Stedim $608.00 
V-206 Blending Tank 1.00 4797.72 L SS316 Sharpsville Container $117,000.00 
DF-204 Diafiltration Housing 6.00 14.90 m2 SS316 Sartorius Stedim $49,000.00 
 
Diafiltration 
Cassettes 
5 / 
housing 3 m2 
stabilized 
cellulose based 
membrane 
Sartorius Stedim $1,200.00 
V-207 Blending Tank 1.00 963.24 L SS316 Sharpsville Container $117,000.00 
DE-203 Sterile Filter Housing 1.00 --- --- SS316 Sartorius Stedim $1,908.00 
 Filter 
1 / 
batch 1.80 m2 Polyethersulfone Sartorius Stedim $608.00 
PM-211 Pump 1.00 0.62 kW SS316 Watson Marlow $12,500.00 
PM-212 Pump 1.00 0.62 kW SS316 Watson Marlow $12,500.00 
PM-213 Pump 1.00 0.62 kW SS316 Watson Marlow $12,500.00 
PM-214 Pump 1.00 0.62 kW SS316 Watson Marlow $12,500.00 
C-201 
PBA 
Chromatography 
Column 
1.00 8.46 L SS316 GE LifeSciences $121,000.00 
 
Chromatography 
Resin     GE LifeSciences 7000/L 
PM-210 Pump 1.00 0.61 kW SS316 Watson Marlow $12,500.00 
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10.4 Cation and Anion Exchange Chromatography 
Cation and Anion Exchange Columns 
Name Type Units Size 
(Capacity) 
 Material of 
Construction 
Vendor Purchase 
Cost 
($/Unit) 
V-301 Blending Tank 1.00 11223.72 L SS316- Electropolished Sharpsville 
Container 
$125,000.00 
V-302 Blending Tank 1.00 1070.05 L SS316- Electropolished Sharpsville 
Container 
$115,000.00 
V-303 Blending Tank 1.00 4145.41 L SS316- Electropolished Sharpsville 
Container 
$120,000.00 
V-304 Blending Tank 1.00 4339.69 L SS316- Electropolished Sharpsville 
Container 
$120,000.00 
V-305 Blending Tank 1.00 515.22 L SS316- Electropolished Sharpsville 
Container 
$112,000.00 
V-306 Blending Tank 1.00 4275.00 L SS316- Electropolished Sharpsville 
Container 
$120,000.00 
C-301 Chrom. 
Column 
1.00 431.83 L PE/SS316 GE $245,000.00 
C-302 Chrom. 
Column 
1.00 141.37 L PE/SS316 GE $177,000.00 
 Cation Resin 1 110 L Toyopearl Gigacap S-650M Tosoh Bioscience $182,490.00 
 Anion Resin 1 65 L Toyopearl SuperQ-650M Tosoh Bioscience $64,870.00 
PM-
301 
Pump 1.00 0.01 kW SS316- Electropolished Watson-Marlow $12,500.00 
PM-
302 
Pump 1.00 0.06 kW SS316- Electropolished Watson-Marlow $12,500.00 
PM-
303 
Pump 1.00 0.06 kW SS316- Electropolished Watson-Marlow $12,500.00 
PM-
304 
Pump 1.00 0.01 kW SS316- Electropolished Watson-Marlow $12,500.00 
PM-
306 
Pump 1.00 0.11 kW SS316- Electropolished Watson-Marlow $12,500.00 
PM-
307 
Pump 1.00 0.11 kW SS316- Electropolished Watson-Marlow $18,135.00 
PM-
308 
Pump 1.00 0.14 kW SS316- Electropolished Watson-Marlow $18,135.00 
PM-
309 
Pump 1.00 0.06 kW SS316- Electropolished Watson-Marlow $12,500.00 
PM-
310 
Pump 1.00 0.05 kW SS316- Electropolished Watson-Marlow $12,500.00 
PM-
311 
Pump 1.00 0.02 kW SS316- Electropolished Watson-Marlow $12,500.00 
PM-
312 
Pump 1.00 0.01 kW SS316- Electropolished Watson-Marlow $12,500.00 
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10.5 PEGylation 
PEGylation 
Name Type Units Size 
(Capacity) 
 Material of 
Construction 
Vendor Purchase 
Cost 
($/Unit) 
R-401 Stirred Reactor 1.00 1659.53   L SS316 ABEC $511,000.00 
R-402 Stirred Reactor 1.00 1930.30   L SS316 ABEC $521,000.00 
V-402 Blending Tank 1.00 1663.96   L SS316 Sharpsville 
Container 
$117,000.00 
DF-402 Diafilter 1.00 12.91   m2 SS316 Sartorius Stedim $45,000.00 
V-401 Blending Tank 1.00 4240.52   L SS316 Sharpsville 
Container 
$117,000.00 
DF-401 Diafilter 3.00 14.40   m2 SS316 Sartorius Stedim $48,000.00 
V-403 Blending Tank 1.00 945.09   L SS316 Sharpsville 
Container 
$117,000.00 
DF-403 Diafilter 1.00 7.34   m2 SS316 Sartorius Stedim $32,000.00 
PM-401 Centrifugal Pump 1.00 0.11   
kW 
SS316 Watson Marlow $18,135.00 
PM-402 Centrifugal Pump 1.00 0.12   
kW 
SS316 Watson Marlow $18,135.00 
PM-404 Centrifugal Pump 1.00 0.07   
kW 
SS316 Watson Marlow $12,500.00 
PM-403 Centrifugal Pump 1.00 0.12   
kW 
SS316 Watson Marlow $18,135.00 
C-401 PBA 
Chromatography 
Column 
1.00 530.42   L SS316 GE Healthcare 
Life Sciences 
$121,000.00 
 Chromatography 
Resin 
1.00 154.46 L MacroCap SP GE LifeSciences $290,230.00 
MX-102 Mixer 1.00 10059.40   
kg/h 
SS316  $0.00 
V-404 Blending Tank 1.00 3806.73   L SS316 Sharpsville 
Container 
$117,000.00 
V-405 Blending Tank 1.00 1814.55   L SS316 Sharpsville 
Container 
$117,000.00 
PM-407 Centrifugal Pump 1.00 0.05   
kW 
SS316 Watson Marlow $12,500.00 
PM-408 Centrifugal Pump 1.00 0.04   
kW 
SS316 Watson Marlow $12,500.00 
PM-406 Centrifugal Pump 1.00 0.28   
kW 
SS316 Watson Marlow $18,135.00 
PM-405 Centrifugal Pump 1.00 0.12   
kW 
SS316 Watson Marlow $18,135.00 
PM-411 Centrifugal Pump 1.00 0.02   
kW 
SS316 Watson Marlow $12,500.00 
PM-410 Centrifugal Pump 1.00 0.05   
kW 
SS316 Watson Marlow $12,500.00 
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10.6 Final Filtration 
Final Filtration 
Name Type Units Size 
(Capacity) 
 Material of 
Construction 
Vendor Purchase 
Cost 
($/Unit) 
Extra Unit Sterile Liquid Dis. 1    SciLog $10,000.00 
Extra Unit 10 in. Filter 
Housing 
1.00   SS316- Electropolished Millipore $1,354.00 
Extra Unit 10 in. Filter 
Housing 
1.00   SS316- Electropolished Millipore $1,354.00 
 Diafilter Housing 1.00     $11,141.00 
V-501 Blending Tank 1.00 363.51 L SS316- Electropolished Sharpsville 
Container 
$12,000.00 
PM-501 Centrifugal Pump 1.00 0.02 kW SS316- Electropolished Watson-Marlow $12,500.00 
PM-502 Centrifugal Pump 1.00 0.04 kW SS316- Electropolished Watson-Marlow $12,500.00 
EC-501 Refrigerator 1.00 1050.00 L  Cincinnati Sub Zero $45,000.00 
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10.7 Additional Equipment 
Additional Equipment 
Type Units Vendor Purchase Cost ($/Unit) 
Incubators 2 Thermo Scientific $15,000.00  
Roller Bottle Apparatus 1 Cole-Parmer $6,500.00  
Biosafety Cabinet 1 Thermo Scientific $10,000.00  
HVAC Equipment 1 - $1,200,000.00  
Clean Steam Generator 1 - $200,000.00  
CIP Skids 3 Sani-matic $80,000.00  
Buffer Transfer Bags - HyClone $70,000/year 
Filter Integrity Tester 1 Millipore $16,500.00  
Tube Fuser 1 Sartorius Stedim Biotech $15,300.00  
Tube Sealer 1 Sartorius Stedim Biotech $10,200.00  
Water Treatment Package 1 - $100,000.00  
WFI Still 1 Paul Mueller Co. $350,000.00  
Biowaste and Neutralization Waste Tanks 2 Sartorius Stedim Biotech $125,000.00  
Biowaste Inactivation System 1 - $270,000.00  
Waste Neutralization System 1 - $100,000.00  
Blood Gas Analyzer 1 Nova Biomedical $45,000.00  
LIMS   Starlims $450,000.00  
Pump on Cart 1 Watson Marlow $12,500.00  
Final Packaging 1 Quality BioResources, Inc. $270,000/batch 
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11.0 Other Important Considerations 
11.1 Scheduling 
 The total amount of time that it takes for one batch of monoclonal antibodies to go 
through the longest option in this flexible manufacturing facility is 40 days. However, the 
slowest part of the process is the bioreaction section, in which the main production bioreactor has 
a procedure time of about 10 days. The downstream following the bioreactor, from primary 
recovery to final formulation, has a total process of time of about 5 days. Using two main 
production reactors, a new batch can be started about every 5 days, when the equipment 
upstream of the main production bioreactor becomes available as most units before the main 
reactor take about 4-5 days. By using two production bioreactors and slightly staggering the 
batches, the production efficiency of this process can be greatly increased over a process that 
only used one main production reactor (see figure 11.1). Not only does this result in significantly 
greater production capacity, it helps alleviate the problem of the entire downstream remaining 
unused for a large portion of the time.  
 The plant will be run for 330 days a year and 6 days will be allowed between batches to 
be sure that they are staggered sufficiently. This is done to account for cleaning and validation, 
any required maintenance, or other problems that may arise in such a sensitive process. 
According to this scheduling, the plant will be able to produce 55 batches of PEGylated 
monoclonal antibodies per year. Economic analysis was performed based on this production 
schedule.  
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Figure 11.1 Gantt chart for entire process 
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11.2 Environmental Concerns 
 In the production of monoclonal antibodies, the main environmental concerns are those 
that deal with waste disposal. Both biological and non-biological waste is produced and must be 
disposed of properly. Biological waste can be found in the waste streams of the bioreactors and 
primary recovery, as they may contain living cells, either bacterial or mammalian, and viruses 
that are considered biohazards. These biological waste streams will be sent to and treated by the 
biowaste inactivation package, which will heat the waste to 80°C for 1 minute and inactivate the 
mammalian cell cultures. The biowaste is combined with all other non-biological waste in the 
waste neutralization tank, which adjusts the pH to 7.0, and then released into the sewage system. 
T-flasks, roller bottles, and the Wave bags will contain living cells as well, and must be 
autoclaved before disposal.  
Plant emissions consist only of nitrogen, oxygen, and carbon dioxide, the major 
components of air. Although carbon dioxide emissions have come to be a large concern, 
emission from our plant is not deemed to be a considerable amount.  
Another environmental concern is the waste generated through use of disposables. These 
disposable bags, flasks, and bottles contribute to a large amount of the waste generated by the 
facility. This is an environmental concern because there is limited landfill space and they are 
made of plastic and not biodegradable. Generally, these plastic disposables are not recycled. As 
disposables become more and more popular, recycling systems or services should become 
available.  
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11.3 Current Good Manufacturing Practices 
Current Good Manufacturing Practices are enforced in the United States by the Food and 
Drug Administration (FDA). These guidelines ensure that drug products are safe and effective 
for human consumption, and therefore much care is needed to monitor the quality and sterility of 
them. In order to be assured of a product’s quality, the manufacturer must pay careful attention to 
a number of factors. These include that only quality parts and materials are used to produce a 
certain drug, that the product and process have been adequately designed, that the layout of the 
plant is conducive to sterile production (See Section 11.4), that the process is controlled and 
monitored by operators at all times, and that a form of in-process and end-product testing is 
routine for each batch. Manufacturers must not rely on end-product testing alone since these tests 
may have limited sensitivity (FDA). 
 Sterility assurance measures are used to make sure that no contaminants of any kind have 
entered the product. This is accomplished by using standard CIP and SIP techniques following 
each batch for most pieces of equipment used. See the CIP and SIP section in Appendix A. 
Disposable bags for bioreactors, media, and buffers are helpful in maintaining a sterile process 
since their sterility is certified by their manufacturers. Sterile tube sealers and tube fusers also 
help to make sure that tube connections remain sterile.  
 Quality assurance requires that the product be tested throughout the process by quality 
control inspectors. Miniscule samples of the streams flowing out of a piece of equipment are 
tested in a quality control lab to ensure that each batch is producing a uniform product. 
 Proper process documentation including a validation protocol must be written and 
maintained for the manufacturer and for the FDA. This is a written plan stating how validation 
will be conducted, including test parameters, product characteristics, production equipment, and 
decision points on what constitutes acceptable test results. Each batch process must be written 
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and authenticated with operator signatures when performed in order to make sure that each batch 
is producing an identical product and to keep a paper trail in case there are issues that arise with 
the drug later on. 
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11.4 Plant Layout 
 The issue of contamination plays an important role in designing the layout of a 
biotechnology plant. The FDA recommends that in order to decrease cross contamination of the 
product, the flow of materials and people must be unidirectional. Otherwise, there is a great risk 
of contamination from the backtracking of the product. In order to prevent backtracking, process 
sections (i.e. inoculum prep areas, bioreaction areas, etc.) should be arranged so that the 
equipment needed for the next downstream step should be adjacent to the equipment currently 
being used. Materials should not under any circumstances be transported across the facility so 
that it comes into contact with other parts of the process where contamination might occur. In 
other words, product that has passed through the viral exclusion part of the process should not 
pass by portions of the process in which viruses have not been inactivated or excluded. 
Figure 11.2 Typical schematic of a biotechnology production plant with “in-line” flow. 
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 The diagram shown on the previous page is the layout of a typical biotechnology 
production facility similar to the flexible process for PEGylated monoclonal antibodies described 
herein. The FDA recommends that the layout of such a plant should mimic that of an assembly 
line, consisting of steps that are “in line” in one direction such that production begins on one side 
of the facility and ends on the other side. There is a clean corridor that allows traffic to flow to 
the left and return to the right. The general flow of materials in the diagram is right to left. 
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12.0 Economic Analysis 
12.1 Market Analysis 
 According to the scheduling of our processes, as described in section 11.1, our facility is 
able to run a total of 55 batches per year, with each batch producing roughly 18 kg of our 
PEGylated monoclonal antibody. This results in the possibility to produce a total of 993 kg of 
product per year. However, the very competitive marketplace of biopharmaceuticals limits the 
potential market share of our product. This obstacle is overcome by the flexibility that is built 
into our manufacturing facility. Flexibility will allow for the production of various products each 
at amounts smaller than the maximum, thus allowing for profitability in the facility. The 
production capacity for the facility has nonetheless been estimated to be 75% of the design 
capacity in order to model the potential market share our facility will be able to capture from 
competing therapeutics. 
 In April 2008, Cimzia® (certolizumab pegol), an anti-TNF-α PEGylated Fab’ fragment, 
was approved by the U.S. FDA for treatment of adult patients with moderate to severe Crohn’s 
disease (Melmed, 2008). The current wholesale acquisition cost for Cimzia® is $1,316 per 400 
mg dose, administered every four weeks (Caremark®, 2008). According to Melmed et al, the 
projected first year sales for Cimzia® are $50,000,000. Therefore, a simple calculation gives 
3,166 patients in this first year and with each patient requiring 4.8 g per year, a yearly production 
amount of 15.2 kg/year is required. However, we predict that PEGylated mAb Fab’ therapeutics, 
like Cimzia®, are likely to be approved for other indications including rheumatoid arthritis. This 
would lead to an increase in the yearly production amount, and may also increase the retail price 
for this therapeutic.  
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12.2 Profitability Analysis 
 The profitability analysis worksheet (Version 1.1), developed by Nickish Consulting, was 
used to determine the profitability of the processing plant. The following sections describe the 
relevant sections of this worksheet. 
12.2.1 Price of PEGylated Monoclonal Antibody 
 While the PEGylation of the monoclonal antibody increases the price at which it should 
be sold to consumers, it also lowers the dosing requirements for this biopharmaceutical. Thus, 
instead of calculated consumer selling prices, the cost at which the product will be sold back to 
the client while maintaining profitability was determined. Competition in the market serves to 
drive down the price at which the facility can sell the product back to the client, and was taken 
into account for the pricing of our product. While the wholesale cost for Cimzia® is $3,290,000 
per kg, the retail cost can be assumed to be much more than this. Also, the flexibility of our 
facility will allow for the production of other antibodies, some which sell for as much as roughly 
$25,000,000 per kg. Thus, a conservative estimate of $5,000,000 per kg was used in profitability 
calculations.  
12.2.2 Plant Life 
The biopharmaceutical and bioprocess industries are continuously innovating and 
improving their products and processes. Patents may run out and competitive or superior 
treatments for the same disease may arise too. For these reasons, the plant life of many 
biopharmaceutical plants can vary, with a worst-case scenario of 5 years. However, this 
particular biopharmaceutical manufacturing facility is directly in line with the direction that the 
industry it taking. That is to say, that not only does this facility have the capability of producing 
PEGylated mAbs, but it is also flexible, allowing for the production of other mAbs. Therefore, a 
plant life of ten years has been used in economic calculations.   
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12.2.3 Raw Materials and Equipment Costs 
 The price of all raw materials and equipment units was gathered by direct contact with 
various vendors. The bare module factors for the equipment units were found in Product and 
Process Design Principles. Unfortunately, the profitability analysis worksheet has a maximum of 
15 allowable entries per section, thus some raw materials and equipment units were lumped 
together in order to perform the necessary calculations. Also, additional costs for packaging and 
various process consumables were input into the “utilities” section. 
12.2.4 Total Permanent Investment 
 The Total Permanent Investment accounts for the costs of site preparations, service 
facilities, contingencies and contractor fees, land and plant start up. The percentages used for 
profitability calculations were found in Product and Process Design Principles. 
12.2.5 Working Capital 
 The working capital of a facility is defined as the current assets less the current liabilities. 
More specifically, it is the sum of the cash reserves, inventory, and accounts receivable minus 
the accounts payable. In most cases, 30 days of cash reserved, accounts receivable, and accounts 
payable is sufficient in calculations. For the inventory of raw materials, 30 days of most items 
was assumed. For costly raw materials, specifically polyethylene glycol, an inventory of 7 days 
was assumed. For weekly shipping of product, 7 days of inventory of product is accounted for in 
the working capital. 
12.2.6 Utilities 
 The utility quantities were input into the worksheet as a ratio of utility to the product 
produced. These were calculated from the total utility requirements calculated in Section 5. 
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12.2.7 Other Variable Costs 
 These costs include the selling/transferring expenses, administrative expenses, and the 
management incentive compensation.  
12.2.8 Fixed Costs 
 According to a suggestion by Dr. Tiffany Rau, the total number of operators needed per 
shift was assumed to be 16, each with direct wages and benefits totaling $40.00/hr. The wages 
and benefits of maintenance, quality control, and technical assistants were also figured into the 
fixed costs. There are usually two maintenance personnel, two quality control experts on staff at 
any given time. The technical assistant category includes a small group of 2-3 engineers. 
 Operating overhead includes the general plant overhead, as well as the mechanical 
department services, employee relations department and business services. Once again, the 
percentages for these values were found in Product and Process Design Principles. 
12.2.9 Depreciation 
 The MACRS Tax-Basis Depreciation for 5 years is used in this process. The percentages 
of Total Depreciable Capital for 5 years, starting at year 1 are as follows, 20%, 32%, 19.20%, 
11.52%, 11.52%, 5.76% (Seider, 2004). 
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12.3 Input Summary   
General Information
Process Title: Flexible Manufacturing Facility for Biopharmaceuticals
Product: Anti-TNF-a PEGylated mAb
Plant Site Location: Northeast
Site Factor: 1.10
Operating Hours per Year: 7,920
Operating Days per Year: 330
Operating Factor: 0.9041
Chronology
Year Action
Start Year 2009 Design
2010 Construction
2011 Production
2012 Production
2013 Production
2014 Production
2015 Production
2016 Production
2017 Production
2018 Production
2019 Production
End Year 2020 Production
Product Information
The Process will yield: a 0 kg of Anti-TNF-a PEGylated mAb per hour.
a 3 kg of Anti-TNF-a PEGylated mAb per day.
a 993 kg of Anti-TNF-a PEGylated mAb per year.
The Price per kg of Anti-TNF-a PEGylated mAb is: $ 5,000,000
Raw Materials
Raw Material Unit of Measure Ratio to Product Cost of Raw Material
2-MEA kg 0.5028 kg per kg of Anti-TNF-a PEGylated mAb $136.0 per kg
Anion Buffers kg 242.3 kg per kg of Anti-TNF-a PEGylated mAb $0.5380 per kg
Cation Buffers kg 877.3 kg per kg of Anti-TNF-a PEGylated mAb $2.3700 per kg
H3PO4 kg 1,177.8 kg per kg of Anti-TNF-a PEGylated mAb $0.1430 per kg
NaOH (0.1M & 0.5M) kg 913.4 kg per kg of Anti-TNF-a PEGylated mAb $0.2321 per kg
Pepsin (Immobilized) kg 170.7 kg per kg of Anti-TNF-a PEGylated mAb $167.0 per kg
Polyethylene Glycol (PEG) g 22,814.0 g per kg of Anti-TNF-a PEGylated mAb $120.0 per g
Polysorbate 80 kg 0.0049 kg per kg of Anti-TNF-a PEGylated mAb $1.8330 per kg
Protein A Buffers kg 5.3176 kg per kg of Anti-TNF-a PEGylated mAb $0.5153 per kg
Reaction Buffers kg 2,604.5 kg per kg of Anti-TNF-a PEGylated mAb $9.8810 per kg
Serum Free Media kg 42.8176 kg per kg of Anti-TNF-a PEGylated mAb $1,749.9 per kg
NaH2PO4, NaCl, PBS kg 77.1049 kg per kg of Anti-TNF-a PEGylated mAb $2.5638 per kg
Tris HCl (1M & 10mM), Tris Base kg 142.1 kg per kg of Anti-TNF-a PEGylated mAb $0.0707 per kg
WFI L 2,657.8 L per kg of Anti-TNF-a PEGylated mAb $0.1500 per L
Production Capacity  (% 
of Design Capacity)
Percentage of Total 
Capital Investment for 
Depreciation
0.0%
0.0%
1.9%
38.4%
75.0%
75.0%
75.0%
20.0%
32.0%
19.2%
11.5%
11.5%
5.8%
0.0%
100.0%
75.0%
75.0%
75.0%
Input Summary
75.0%
75.0%
Distribution of Total 
Permanent Investment
Distribution of Total 
Working Capital
0.0%
100.0%
CLICK HERE FOR MENU
CLICK HERE FOR MENU
CLICK HERE FOR MENU
CLICK HERE FOR MENU
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Equipments Costs
Fabricated Equipment Purchase Cost Bare Module Factor Bare Module Cost
Chromatography Columns (4) $ 861,000 1.1 $ 947,100
Diafiltration Housings (7) $ 381,870 2.32 $ 885,938
Diafiltration Cassettes (35) $ 286,090 1.1 $ 314,699
Disposable Bag Bioreactor Systems (15) $ 537,000 1.1 $ 590,700
Disposable Reactor Bags (825) $ 368,775 1.1 $ 405,653
Plate and Frame Filter $ 74,000 1.4 $ 103,600
Sterile Filter Housings (7) $ 13,356 2.32 $ 30,986
Production Bioreactor (2) $ 1,322,000 4.16 $ 5,499,520
T-Flasks (1100) + Roller Bottles (605) $ 19,249 1 $ 19,249
Sterile Filters (385) $ 234,080 1.1 $ 257,488
Stirred Reactors (6) $ 3,341,000 4.16 $ 13,898,560
HVAC Equipment $ 1,200,000 1 $ 1,200,000
Process Machinery Purchase Cost Bare Module Factor Bare Module Cost
Centrifuge $ 421,000 2.03 $ 854,630
Peristaltic Pump with Cart $ 3,100 3.3 $ 10,230
Pump-825B/R (34) $ 419,900 3.3 $ 1,385,670
Pump-840B/R (8) $ 145,080 3.3 $ 478,764
Sterile Liquid Distributor $ 10,000 2.5 $ 25,000
Media Prep Blending Tanks (4) $ 71,000 4.16 $ 295,360
Virus Inactivation Tank $ 24,000 4.16 $ 99,840
Clean Steam Generator $ 200,000 2 $ 400,000
CIP Skids (3) $ 720,000 4 $ 2,880,000
WFI Still $ 350,000 4 $ 1,400,000
LIM System $ 450,000 1.1 $ 495,000
Spares Purchase Cost Bare Module Factor Bare Module Cost
Filter Integrity Tester $ 16,500 1 $ 16,500
Sterile Tube Fuser $ 15,300 1 $ 15,300
Sterile Tube Sealer $ 10,200 1 $ 10,200
Water Treatment Package $ 100,000 1.1 $ 110,000
Bioinactivation System $ 270,000 3.5 $ 945,000
Waste Neutralization System $ 100,000 3 $ 300,000
Autoclave $ 160,000 1.7 $ 272,000
Blood Gas Analyzer $ 45,000 1.1 $ 49,500
Portable Pump on Cart $ 12,500 3.3 $ 41,250
Storage Purchase Cost Bare Module Factor Bare Module Cost
Storage Tanks (18) $ 2,106,000 4.16 $ 8,760,960
Refrigeration Units $ 45,000 2.05 $ 92,250
Incubators (2) $ 15,000 1.74 $ 26,100
Biosafety Cabinet $ 10,000 1.1 $ 11,000
Biowaste/Neutralization Tank $ 50,000 4.16 $ 208,000
Roller Bottle Aparatus $ 6,500 1.1 $ 7,150
*Derived Bare Module Factor
Total Permanent Investment
Cost of Site Preparations: 5.0% of Total Bare Module Costs
Cost of Service Facilities: 5.0% of Total Bare Module Costs
Allocated Costs for utility plants and related facilities: $0
Cost of Contingencies and Contractor Fees: 18.0% of Direct Permanent Investment
Cost of Land: 2.0% of Total Depreciable Capital
Cost of Royalties: $0
Cost of Plant Start-Up: 10.0% of Total Depreciable Capital
CLICK HERE FOR MENU
CLICK HERE FOR MENU
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Working Capital
Anti-TNF-a PEGylated mAb a Inventory: 7 Days a 21.06 kg
2-MEA a Inventory: 30 Days a 45.38 kg
Anion Buffers a Inventory: 30 Days a 21,865.98 kg
Cation Buffers a Inventory: 30 Days a 79,180.43 kg
H3PO4 a Inventory: 30 Days a 106,300.45 kg
NaOH (0.1M & 0.5M) a Inventory: 30 Days a 82,434.84 kg
Pepsin (Immobilized) a Inventory: 30 Days a 15,402.16 kg
Polyethylene Glycol (PEG) a Inventory: 7 Days a 480,424.82 g
Polysorbate 80 a Inventory: 90 Days a 1.32 kg
Protein A Buffers a Inventory: 30 Days a 479.91 kg
Reaction Buffers a Inventory: 30 Days a 235,056.77 kg
Serum Free Media a Inventory: 30 Days a 3,864.29 kg
NaH2PO4, NaCl, PBS a Inventory: 30 Days a 6,958.72 kg
Tris HCl (1M & 10mM), Tris Basea Inventory: 30 Days a 12,822.64 kg
Chromatography Resins (all) a Inventory: 30 Days a 2,972.30 L
Accounts Receivable a 30 Days
Cash Reservces a 30 Days
Accounts Payable a 30 Days
Utilities
Utility Unit of Measure Ratio to Product Cost of Utility
Process Water L 2,724.1 L per kg of Anti-TNF-a PEGylated mAb $0.0005 per L
Electricity kW-hr 1,244.5 kW-hr per kg of Anti-TNF-a PEGylated mAb$0.0800 per kW-hr
Process Consumables unit 2.9358 unit per kg of Anti-TNF-a PEGylated mAb$213.2 per unit
Lyophilization/Packaging vials 2,500.0 vials per kg of Anti-TNF-a PEGylated mAb$1.2000 per vials
Byproducts
 - no Byproducts -
Other Variable Costs
General Expenses
Selling / Transfer Expenses: 3.00% of Sales
Direct Research: 0.00% of Sales
Allocated Research: 0.00% of Sales
Administrative Expense: 2.00% of Sales
Management Incentive Compensation: 1.25% of Sales
CLICK HERE FOR MENU
CLICK HERE FOR MENU
CLICK HERE FOR MENU
CLICK HERE FOR MENU
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Fixed Costs
Operations
Operators per Shift: 16 (Assuming 16 Shifts)
Direct Wages and Benefits: $40.00 per Operator Hour
Direct Salaries and Benefits: 15.00% of Direct Wages and Benefits
Operating Supplies and Services: 6.00% of Direct Wages and Benefits
Technical Assistance to Manufacturing: $4,125.00 per year, for each Operator per Shift
Control Laboratory: $7,525.00 per year, for each Operator per Shift
Maintenance
 Wages and Benefits: 4.50% of Total Depreciable Capital
Salaries and Benefits: 25.00% of Maintenance Wages and Benefits
Materials and Services: 100.00% of Maintenance Wages and Benefits
Maintenance Overhead: 5.00% of Maintenance Wages and Benefits
Operating Overhead
General Plant Overhead: 7.10% of Maintenance and Operations Wages and Benefits
Mechanical Department Services: 2.40% of Maintenance and Operations Wages and Benefits
Employee Relations Department: 5.90% of Maintenance and Operations Wages and Benefits
Business Services: 7.40% of Maintenance and Operations Wages and Benefits
Property Taxes and Insurance
Property Taxes and Insurance: 2.00% of Total Depreciable Capital
Straight Line Depreciation
Direct Plant: 8.00% of Total Depreciable Capital, less1.18 times the Allocated Costs for Utility Plants and Related Facilities 
Allocated Plant: 6.00% of  1.18 times the Allocated Costs for Utility Plants and Related Facilities 
Depletion Allowance
Annual Depletion Allowance: $0.00
CLICK HERE FOR MENU
CLICK HERE FOR MENU
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12.4 Profitability Analysis 
 There are several ways for estimating profitability, the easiest of which is Return on 
Investment (ROI). As described in Product and Process Design Principles, the ROI “is the 
annual interest rate made by the profits on the original investment” (Seider, 2004). This is the 
least accurate method for calculating profitability since it assumes straight line depreciation. The 
ROI for this process is 53.0%. 
 The second method for estimating profitability involves the Net Present Value (NPV), 
which “provides a quantitative measure for comparing the capital required for competing 
processes in current terms” (Seider,2004). The NPV of the process is $1,319,592,100 after a 
plant life of 10 years. 
 The third method used for estimating the profitability of this process is to use the 
Investor’s Rate of Return (IRR), which is the interest rate which gives a net present value of 
zero. The IRR for this facility has been calculated to be 33.51%. This high IRR, which is likely 
to be higher than the market interest rate, conveys the profitability of the process. The following 
pages contain the results of the profitability worksheet for a plant life of 10 years, a selling price 
of $5,000,000 per kg, modeled with an annual production of 744.6 kg/year (75% of the design 
capacity of 992.75 kg/year) of PEGylated mAb Fab’ therapeutics. 
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12.4.1 Profitability Analysis Results 
 
 
 
  
April, 2009
The Investor's Rate of Return (IRR) for this Project is: 33.51%
The Net Present Value (NPV) at 15% for this Project is: $1,319,592,100
ROI Analysis (Third Production Year)
Annual Sales:
Annual Costs:
Depreciation:
Income Tax:
Net Earnings:
Total Capital Investment:
ROI:
$652,887,900
$1,231,787,600
53.0%
Profitability Measures
Flexible Manufacturing Facility for Biopharmaceuticals
$3,722,812,500
-$2,689,125,700
-$4,500,700
-$380,798,900
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April, 2009
Bare Module Costs
Fabricated Equipment
Chromatography Columns (4) $947,100
Diafiltration Housings (7) $885,900
Diafiltration Cassettes (35) $314,700
Disposable Bag Bioreactor Systems (15) $590,700
Disposable Reactor Bags (825) $405,700
Plate and Frame Filter $103,600
Sterile Filter Housings (7) $31,000
Production Bioreactor (2) $5,499,500
T-Flasks (1100) + Roller Bottles (605) $19,200
Sterile Filters (385) $257,500
Stirred Reactors (6) $13,898,600
HVAC Equipment $1,200,000
Total Fabricated Equipment: $24,153,500
Process Machinery
Centrifuge $854,600
Peristaltic Pump with Cart $10,200
Pump-825B/R (34) $1,385,700
Pump-840B/R (8) $478,800
Sterile Liquid Distributor $25,000
Media Prep Blending Tanks (4) $295,400
Virus Inactivation Tank $99,800
Clean Steam Generator $400,000
CIP Skids (3) $2,880,000
WFI Still $1,400,000
LIM System $495,000
Total Process Machinery: $8,324,500
Spares
Filter Integrity Tester $16,500
Sterile Tube Fuser $15,300
Sterile Tube Sealer $10,200
Water Treatment Package $110,000
Bioinactivation System $945,000
Waste Neutralization System $300,000
Autoclave $272,000
Blood Gas Analyzer $49,500
Portable Pump on Cart $41,250
Total Spares: $1,759,800
Storage
Storage Tanks (18) $8,761,000
Refrigeration Units $92,300
Incubators (2) $26,100
Biosafety Cabinet $11,000
Biowaste/Neutralization Tank $208,000
Roller Bottle Aparatus $7,200
Total Storage: $9,105,500
Total Bare Module Costs:
Investment Summary
Flexible Manufacturing Facility for Biopharmaceuticals
TOTAL
$43,343,000
Flexible Manufacturing Facility for Biopharmaceuticals 
 
-221- 
 
  
Direct Permanent Investment
Cost of Site Preparation: $2,167,200
Cost of Service Facilities: $2,167,200
Allocated Costs for utility plants and related facilities:$0
Direct Permanent Investment:
Total Depreciable Capital
Cost of Contigencies and Contractor Fees: $8,581,900
Total Depreciable Capital:
Total Permanent Investment
Cost of Land: $1,125,200
Cost of Royalties: $0
Cost of Plant Start-Up: $5,625,900
Total Permanent Investment:
Working Capital
Inventory
Anti-TNF-a PEGylated mAba 0 kg $78,968,800
2-MEA a 0 kg $4,600
Anion Buffers a 16,000 kg $8,800
Cation Buffers a 59,000 kg $140,700
H3PO4 a 80,000 kg $11,400
NaOH (0.1M & 0.5M)a 62,000 kg $14,300
Pepsin (Immobilized) a 12,000 kg $1,929,100
Polyethylene Glycol (PEG)a 360,000 g $43,238,200
Polysorbate 80 a 0 kg $0
Protein A Buffers a 0 kg $200
Reaction Buffers a 176,000 kg $1,741,900
Serum Free Media a 3,000 kg $5,071,700
NaH2PO4, NaCl, PBSa 5,000 kg $13,400
Tris HCl (1M & 10mM), Tris Basea 10,000 kg $700
WFI a 0 L $0
Chromatography Resins (all)a 2,000 L $25,225,900
Total Inventory: $156,369,900
Accounts Receivable: $451,250,000
Cash Reservces: $268,495,600
Accounts Payable: $292,662,100
Total Working Capital: $1,168,777,600
TOTAL CAPITAL INVESTMENT
$63,010,000
$1,231,787,600
$47,677,000
$56,259,000
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April, 2009
Raw Materials
2-MEA
Anion Buffers
Cation Buffers
H3PO4
NaOH (0.1M & 0.5M)
Pepsin (Immobilized)
Polyethylene Glycol (PEG)
Polysorbate 80
Protein A Buffers
Reaction Buffers
Serum Free Media
NaH2PO4, NaCl, PBS
Tris HCl (1M & 10mM), Tris Base
WFI
Chromatography Resins (all)
Total Raw Materials:
Utilties
Process Water
Electricity
Process Consumables
Lyophilization/Packaging
Total Raw Materials:
Byproducts
General Expenses
Selling / Transfer:
Direct Research:
Allocated Research:
Administrative Expense:
Management Incentives:
Total Byproducts:
TOTAL
$68.38 per kg of Anti-TNF-a PEGylated mAb $67,900
Variable Cost Summary
Flexible Manufacturing Facility for Biopharmaceuticals
Per kg Anti-TNF-a PEGylated mAb TOTAL
$130.35 per kg of Anti-TNF-a PEGylated mAb $129,400
$2,079.31 per kg of Anti-TNF-a PEGylated mAb $2,064,200
$168.43 per kg of Anti-TNF-a PEGylated mAb $167,200
$212.00 per kg of Anti-TNF-a PEGylated mAb $210,500
$28,500.40 per kg of Anti-TNF-a PEGylated mAb $28,293,800
$2,737,680.00 per kg of Anti-TNF-a PEGylated mAb $2,717,831,800
$0.01 per kg of Anti-TNF-a PEGylated mAb $0
$2.74 per kg of Anti-TNF-a PEGylated mAb $2,700
$25,735.13 per kg of Anti-TNF-a PEGylated mAb $25,548,600
$74,927.88 per kg of Anti-TNF-a PEGylated mAb $74,384,600
$197.68 per kg of Anti-TNF-a PEGylated mAb $196,200
$10.04 per kg of Anti-TNF-a PEGylated mAb $10,000
$1.48 per kg of Anti-TNF-a PEGylated mAb $1,500
$3,219,283,100
$398.68 per kg of Anti-TNF-a PEGylated mAb $395,800
$372,682.28 per kg of Anti-TNF-a PEGylated mAb $369,980,300
$3,242,793.31 per kg of Anti-TNF-a PEGylated mAb $3,219,283,100
$3,222,983,100
$99.56 per kg of Anti-TNF-a PEGylated mAb $98,800
$625.96 per kg of Anti-TNF-a PEGylated mAb $621,400
$3,000.00 per kg of Anti-TNF-a PEGylated mAb $2,978,300
$150,000.00 per kg of Anti-TNF-a PEGylated mAb $148,912,500
$3,726.99 per kg of Anti-TNF-a PEGylated mAb $3,700,000
$3,559,020.31 per kg of Anti-TNF-a PEGylated mAb $3,533,217,400 $3,533,217,400
$0.00 per kg of Anti-TNF-a PEGylated mAb $0
$0.00 per kg of Anti-TNF-a PEGylated mAb $0
$100,000.00 per kg of Anti-TNF-a PEGylated mAb $99,275,000
$62,500.00 per kg of Anti-TNF-a PEGylated mAb $62,046,900
$312,500.00 per kg of Anti-TNF-a PEGylated mAb $310,234,400 $3,533,217,500
Flexible Manufacturing Facility for Biopharmaceuticals 
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April, 2009
Operations
Direct Wages and Benefits: $21,299,200
Direct Salaries and Benefits: $3,194,880
Operating Supplies and Services: $1,277,952
Technical Assistance to Manufacturing: $66,000
Control Laboratory: $120,400
Total Operations: $25,958,432
Maintenance
 Wages and Benefits: $2,531,655
Salaries and Benefits: $632,914
Materials and Services: $2,531,655
Maintenance Overhead: $126,583
Total Maintenance: $5,822,807
Operating Overhead
General Plant Overhead: $1,963,764
Mechanical Department Services: $663,808
Employee Relations Department: $1,631,860
Business Services: $2,046,740
Total Operating Overhead: $6,306,172
Property Insurance and Taxes
Total Property Insurance and Taxes: $1,125,180
TOTAL
$39,212,591
$39,212,591
Fixed Cost Summary
Flexible Manufacturing Facility for Biopharmaceuticals
TOTAL
$25,958,432
$31,781,239
$38,087,411
Flexible Manufacturing Facility for Biopharmaceuticals 
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12.5 Sensitivity Analysis 
 Several factors affect the profitability of this facility. Namely, the selling price of the 
PEGylated monoclonal antibody, the duration of the plant life, and the expenses of resins and the 
PEG molecule are all important to examine. 
12.5.1 Selling Price 
In order to determine the effect of selling price on profitability, various selling prices of 
PEGylated monoclonal antibodies produced at full capacity were varied while keeping all other 
variables constant. As shown in Figure 12.1, a gradual increase in selling price increases the IRR 
non-linearly. Effects on NPV and ROI are also shown in the table on the following page. Note 
how changes in prices drastically affect the return on investment. 
 
 
 
Figure 12.1: This is a single variable sensitivity analysis showing how changes 
in the selling price of the PEGylated monoclonal antibodies affects the IRR. 
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Product Price ($MM) IRR (%) NPV (At 15%) ROI (%) 
6.50 51.5 $3,396,412,000 94.4 
6.25 49.05 $3,050,275,500 88.1 
6.00 46.43 $2,704,138,500 81.7 
5.50 40.53 $2,011,865,400 67.9 
5.00 33.51 $1,319,592,100 53.0 
4.50 24.90 $627,318,800 36.7 
  Table 12.1 Selling price sensitivity analysis 
12.5.2 Plant Life  
The effect of plant life on profitability is can be seen in the table below. As plant life is 
increased from 5 to 15 years, IRR increases from 29.38% to 34.19%. NPV also increases and 
ranges from $629.4 MM to $1.66 billion.  
  Table 12.2 Plant life sensitivity analysis 
12.5.3 Cost of Polyethylene Glycol 
In order to determine the effect that the purchase cost for the raw material PEG has on 
profitability, various PEG prices were considered with production at full capacity while keeping 
all other variables constant. This was done because PEG is the most expensive raw material that 
is purchased for this process. Effects on IRR, NPV, and ROI are also shown in the following 
table. Note that significant decreases in the price of PEG greatly increase the IRR and ROI 
beyond reasonable expectations. In addition, significant increases in the price of PEG greatly 
decrease the IRR and ROI beyond the point where the facility would be profitable. 
 
 
 
Plant Life 
(years) 
Selling Price  
($/gram) 
IRR NPV  
(At 15%) 
ROI 
5 $5,000 29.38% $629,444,400 53% 
7 $5,000 32.03% $964,380,400 53% 
10 $5,000 33.51% $1,319,592,100 53% 
15 $5,000 34.19% $1,662,493,400 53% 
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  Table 12.3 Cost of polyethylene glycol sensitivity analysis 
12.5.4 Cost of Chromatography Resins 
The table below shows the effect of changing the cost of chromatography resins on the 
profitability of the process over 10 years. With the current calculated cost of resin, the IRR is 
33.51%, the NPV is $1,319,592,100, and the ROI is 53%. As the price of resin increases by 50%, 
the IRR drops 4.5 percent, the NPV decreases by more than $300 million, and the ROI drops by 
9%. On the other hand, as the price of resin decreases by 50%, the IRR increases to 37.96%, the 
NPV increases to $1.637 billion, and the ROI rise to 62.4%. The cost of the chromatography 
resins has a strong impact on the profitability of the monoclonal antibody. Fortunately, the price 
of these resins should only decrease over time, as newer resins with higher binding capacities 
will enter the market. 
 
  Table 12.4 Cost of chromatography resins sensitivity analysis 
 
 
  
% Inc/Dec Price of PEG ($/g) IRR (%) NPV (At 15%) ROI (%) 
-50 60 64.96 $3,610,659,700 132.8 
-20 96 45.89 $2,236,019,000 80.6 
0 120 33.51 $1,319,592,100 53.0 
20 144 20.82 $403,164,900 29.7 
Resin Cost 
Increase 
Resin Cost  
($/L) 
IRR NPV  
(At 15%) 
ROI 
-50% $5,658 37.96% $1,637,807,000 62.4% 
-20% $9,053 35.29% $1,440,866,700 56.7% 
0 $11,316 33.51% $1,319,592,100 53.0% 
20% $13,579 31.74% $1,192,317,500 49.4% 
50% $16,974 29.08% $1,001,377,300 44.3% 
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13.0 Conclusions and Recommendations 
 This report provides a detailed analysis of the production of PEGylated mAb Fab’ 
therapeutics, as well as the production of various other biopharmaceutical products. If this 
facility were to be run at full capacity (for 330 days) with production bioreactors that yield 3.5 
g/L titers, it would be able to produce 993 kg of PEGylated monoclonal antibodies. From 
economic analysis of this facility, it has been determined that a conservative selling price for 
PEGylated monoclonal antibodies would be $5,000/g. Under the assumption that we would be 
running at 1.9% of this design capacity for the first year and increase to 75% over two years, the 
profitability analysis shows an NPV of $1,319,592,100, an IRR of 33.51%, and a 53.0% ROI 
after three years. This design scheme was based on financial research of sales projections for the 
new therapeutic Cimzia® for its first year of production. 
The flexibility of this facility will allow for the production of other biopharmaceutical 
monoclonal antibodies. Small biotech firms are currently producing 81 mAbs and many are 
looking to license production for their Phase III molecules. Thus, CMO’s such as ours are 
working to capture much of this demand. Many of the mAbs generated by this facility will be 
able to yield great profit, especially since most, if not all, of the process equipment can be used 
to meet the demands of multiple products. It is for these reasons that we recommend that this 
facility be built, to not only meet the demands of the innovative PEGylated monoclonal antibody, 
but also a number of other biopharmaceuticals. 
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Appendix A – Calculations 
Growth Rate 
Time required to double = 
net
D m
t
2ln
=  
μnet = net specific growth rate (h-1) dt
dX
X
1
º , where X is the cell mass concentration (gL-1) 
(Sauer 2000) 
 
for CHO cells: τD = 14-17 hours 
04951.004077.0 -=\ netm  hr
-1 
Growth Curves 
 The cells grown up in the batch inoculum and seed bioreaction sections of the process 
typically proceed through various phases. These include a lag phase, exponential phase, 
stationary phase, and lastly a death phase.  
Figure A.1: This is a typical graph of the viable cell number versus time. Each 
phase of cell growth is labeled. 
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During the short-lived lag phase, cells in culture experience very little growth since they 
must adjust to their new environment. After this initial adjustment period, cells begin to actively 
divide themselves, leading into the exponential phase of growth. During this phase, the cell 
number increases exponentially with time. However, after a certain period of time, the cells use 
up all of their food and resources (namely glucose, vitamins, amino acids, and other nutrients 
from the serum free media) and growth slows down. This is considered to be the stationary 
phase. The number of cells that die is roughly equal to the number of cells that are created. Once 
a majority of the nutrients in the surrounding environment are used up, the cells move into the 
death phase. The cells in this phase have greater death rates than reproduction rates, so the 
number of viable cells decreases. If no new nutrients are added to the batch at this point, all the 
cells will eventually die.  
 For the batch reactors in this process, mammalian cells follow a similar growth curve. 
The lag phase generally lasts from 1-2 days. The exponential phase occurs anywhere from 2-3 
days after inoculation and lasts about 1.5 days. This is the period of time at which monoclonal 
antibody production is at its highest. Therefore, it is of interest to lengthen the period of time at 
which cells growth is in the exponential phase. This is generally done by setting the bioreactor to 
fed batch mode which has been implemented for the production bioreactor in this process. For 
this mode, the lag phase generally lasts the same amount of time as in batch mode, but the 
exponential phase is extended from anywhere between 3-5 days. Additional feeding at regular 
intervals allows the cells to continue dividing and producing monoclonal antibodies since 
nutrients are constantly being replenished. Despite this additional feeding, the accumulation of 
toxic waste products begins to decrease the viability of the cells. The stationary phase is short-
lived and only lasts for at the most 1 day until the death phase begins.  
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 For this process, it has been determined that for each batch process bioreactor will 
operate for 4 days, while the fed batch bioreactor will operate for 9 days in order to maximize 
growth and production of monoclonal antibodies. 
Antibody Production Rate 
ò
×-×
=
final
initial
initialinitialfinalfinal
t
t V
ttttave
Ab
VdtX
VAbVAb
q
)(
 , 
where Abt is the antibody concentration at time t, and XVV is the total number of viable cells 
(Sauer 2000) 
 
According to Kumar et. al, productivities today are ~90 pg/cell/day. 
 
Media Calculation 
Volume of the feed medium = Vfeed = Vglcglc
glcglc
tarfeed
tar ×÷
÷
ø
ö
ç
ç
è
æ
-
- ,  
where glctar is the post-feed target glucose concentration, glc is the pre-feed glucose 
concentration, and glcfeed is the medium’s glucose concentration. 
For a medium of 1:1: LgLgLgglc feed /401.1)/802.1()/1(2
1
=+=  
glctar = 4.5 g/L (time of feed addition is 30 minutes). 
Ammonia Levels 
For CHO cells, there was found to be 50% growth reduction at 8 mM ammonium, PEGylation 
effects by levels of ammonium between 3 to 9 mM, and observed dependence on the 
extracellular pH.  
CHO Cell Data 
Dry Cell Weight: 390 pg/cell 
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Oxygen Uptake Rate (OUR) = kLa (C* - CR) + D(CF – CR) 
kLa= liquid phase mass transfer coefficient for oxygen 
C* = liquid phase concentration of oxygen at equilibrium with the gas phase 
CR= concentration of oxygen in the liquid phase of the reactor 
D = dilution rate 
CF = concentration of oxygen in the liquid feed 
Carbon dioxide Evolution Rate (CER) = (ng/VR) (yRCO2 – yFCO2) + D(CRA – CFA) (Nyberg 1999) 
Calculation of Product Amount 
Calulations using Cimzia® (certolizumab pegol) for current sales projections: 
 
 
 
 
 
 
 
 
 
96.8 g = 15.1968 kg 
 
A 25% increase in production for the first year: 
 
 
 
 
Calculations using Humira® (adalimumab) as a basis for future sales projections: 
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Vessel Sizing  
SuperPro Designer was useful for sizing all of the vessels for this process, but as a validation the 
following equation was used on one of the bioreactors (“Reactor Considerations,” 1997) 
 
Let: 
D = diameter of the vessel (ft) 
WV = working volume in the tank (gal) 
F = fraction of total volume occupied by working volume 
a = factor for determining the capacity in gallons of the bottom head = 0.606 for ASME Standard 
F & D heads 
d = 5.875 gal/ft3 
R = aspect ratio = L/D = 2.5 
 
Then: 
 
 
 
Example (PBR-101): 
WV = 14,000 L = 3,698 gal 
F= 0.7 
a = 0.606 
d = 5.875 gal/ft3 
R = 2.5 
 
 
 
Note that this within 5% of the Superpro calculation of 2.0 m. 
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Stoichiometry of the Batch and Fed-Batch Bioreactors 
 A stoichiometric reaction for each batch bioreactor and for the fed-batch production 
bioreactor is used to model cell growth and monoclonal antibody production for this process. 
Note that for a more detailed analysis, a list of kinetically defined reactions detailing growth, 
maintenance, production, and death could have been used. However, it was determined that this 
single stoichiometric reaction listed below would provide a sufficient estimate for the growth of 
cells and production of monoclonal antibodies throughout the process. 
 
 
 
 
 
 
 
 
 
For the reactants side of the equation, 100 mass percent of serum free media is reacting 
with 100 mass percent of oxygen. The percentages of amino acids, glucose, glutamine, inorganic 
salts, other inactive components of the media, and vitamins are determined based on the 
percentage of each in the purchased media from Sigma-Aldrich and sum to 100 mass percent. 
Even though in reality the cells would not consume inorganic salts and the other inactive 
components of the media, these components are modeled in the equation for simplicity and 
assumed to convert into dead biomass and other impurities. The main purpose of the inorganic 
REACTANTS   PRODUCTS   
Components Mass Coeff % Components Mass Coeff% 
Amino Acids 6.21  Biomass 34.26  
Glucose 26.28  Carb. Dioxide 69.41  
Glutamine 3.04  Dead Biomass 3.51  
Inorganic Salts 63.66  MAB 7.03  
Other Media 0.55  Water 61.5  
Oxygen 100  Lactate 24.29  
Vitamins 0.26     
      
Total 200   200  
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salts is to control the pH of the media to about 7.2. This combined with the buffers will provide 
an effective environment for cell growth. 
For the product side of the equation, the total components are out of 200 mass percent in 
order to properly balance the equation. First, the percentage of lactate was determined. Glucose 
from the reactants goes to lactate via a 1:1 mole ratio. Therefore, a mass conversion using the 
molecular weights of each component gives a percentage of lactate in the products that is slightly 
less than that of glucose in the reactants. The remaining percentages of biomass, carbon dioxide, 
dead biomass, monoclonal antibodies, and water were based on a monoclonal antibody 
production example provided by Intelligen employee Dr. Demetri Petrides which used the 
equation for the bioreactors: 
REACTANTS   PRODUCTS  
Components Mass Coeff %  Components Mass Coeff % 
Oxygen 100  Biomass 39 
Serum Free Media 100  Carb. Dioxide 79 
   Impurities 4 
   MAB 8 
   Water 70 
 
The percentages of these products were thus adjusted to include lactate to give the equation 
shown on the previous page. 
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Clean-in-Place (CIP) and Steam-in-Place (SIP) Procedures 
CIP and SIP procedures are used in the manufacturing process to remove biologically 
active contaminants such as cells from all process units after each batch.  
The following CIP procedure will be used for all pipes, valves, and mixing tanks used 
throughout the process: 
1. Each vessel will be washed with an amount of sterile water equal to half its volume for 
10 minutes. 
2. Next, a cleaning solution of caustic (NaOH 0.5 M) equal to half the vessel’s volume will 
be sprayed into the tank for 30 minutes. 
3. Sterile water will then be used as in step 1 to wash away the cleaning solution for 10 
minutes. 
4. Next, a cleaning solution of acid (H3PO4 5% w/w) equal to half the vessel’s volume will 
be sprayed into the tank for 30 minutes. 
5. Sterile water will then be used as in step 1 to wash away the cleaning solution for 10 
minutes. 
6. Lastly, another half volume of sterile water will be used to wash the vessel once more 
before the next batch for 10 minutes. 
This washing regime will use approximately 2 vessel volumes of water. This includes the water 
to be used to make the sterile wash solution. 
CIP Calculations were performed by SuperPro Designer based on modified equations listed in 
(Stewart 1996) in which each vessel is sprayed in a certain number of bursts: 
Let: 
C= circumference of tank (ft) 
Vt = total volume used (gal) 
Vw = total water used (gal) 
Vcaustic = total concentrated caustic used (gal) 
Vacid = total concentrated acid used (gal) 
 
Then: 
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For filter units such as diafiltration and ultrafiltration, the cleaning procedure determined by the 
manufacturers is as follows: 
1. Flush each unit with sterile water at 50°C. 
2. Circulate for one hour sodium hypochlorite (NaOCl) at 50°C with a pH around 10 or 11. 
3. Repeat step 1. 
A procedure including steam-in-place is necessary for large, less sensitive equipment such as the 
bioreactors and final storage tanks. Therefore the procedure will be changed as follows: 
1. Each reactor will be washed with an amount of sterile water equal to half its volume for 
10 minutes. 
2. Next, a cleaning solution of caustic (NaOH 0.5 M) equal to half the vessel’s volume will 
be sprayed into the vessel for 30 minutes. 
3. Sterile water will then be used as in step 1 to wash away the cleaning solution. 
4. Next, a cleaning solution of acid (H3PO4 5% w/w) equal to half the vessel’s volume will 
be sprayed into the tank for 30 minutes. 
5. Sterile water will then be used as in step 1 to wash away the cleaning solution for 10 
minutes. 
6. 5 lb/hr of pure steam per cubic foot of vessel volume will be pumped into the vessel to 
heat it up to the temperature of the steam, 130°C. Note: The steam used in this procedure 
will be generated by a sterile steam generator at 130°C and 2 bars. 
7. Once the 130°C has been reached in the vessel, the steam flow rate will be reduced to 1 
lb/hr of pure steam per cubic foot of vessel volume and held at the flow rate for thirty 
minutes. 
8. Lastly, after thirty minutes, the flow rate of steam will be stopped and a half volume of 
sterile water will then be sprayed into the tank to wash it and cool it down to room 
temperature. (Burbano 2001) 
SIP calculations are also performed by Superpro Designer and are calculated with modified 
equations such as these: 
Let: 
V = volume of vessel or pump (ft3) 
St = total steam required (lb) 
Sc = volume of steam when condensed (L) 
Flexible Manufacturing Facility for Biopharmaceuticals 
 
-246- 
 
 
Then: 
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Appendix B – PEGylation 
PEGylation Overview 
Polyethylene glycol (PEG) is used often in the pharmaceutical industry to improve the 
pharmacokinetic effects of protein therapies (Knudson 2008).  Attaching PEG(s) to protein 
products has helped to solve the dilemma of the short half-lives of proteins and peptides, since 
these products are removed from the body so quickly through dialysis in the kidneys.  Not only 
does PEG conjugation increase retention time of a drug by slowing filtration in the kidneys, but 
it also helps protect against enzyme digestion of the drug and allows for less frequent injections 
for patients (Fishburn 2007).   
While papain can be used to efficiently cleave Fab fragments that will not be PEGylated, 
it was found that pepsin cleavage to produce Fab’ fragments is the better alternative for proteins 
that will be PEGylated.  Therefore, this option was added to the process so that PEGylation can 
be done more efficiently.  If the enzyme is not PEGylated, the enzyme papain is used since it 
requires fewer steps than pepsin cleavage and is the most efficient way to produce Fab 
fragments.  Cleaving the mAbs with the enzyme pepsin requires extra reduction steps, but this is 
what allows for the high-efficiency, site-specific PEGylation.  Traditionally, strong thiols were 
used to activate the disulphide bonds between the heavy and light chains of the Fab fragment and 
then these activated bonds were PEGylated.  However, this non-specific PEGylation method 
results in a heterogeneous mixture of conjugates, some with loss of functionality and some 
PEGylated an undesirable number of times or on less optimal bond(s) (Brocchini 2006).  
Processes were developed to separate the mono-PEGylated Fabs and determine which locations 
were best to PEGylate.  For Fab, the optimal PEGylation is mono-PEGylation furthest from the 
active end, which targets TNF-α, in order to avoid steric hindrance and maintain full function of 
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therapeutic effects.  This requires additional steps to separate out the desired molecule, resulting 
in significant loss of Fab (Humphreys 2007).   
To avoid these complications, methods have been discovered to site-specifically 
PEGylate.  While there are ways to distinctively PEGylate the disulphide bonds in the Fab 
fragments themselves, this is difficult and breaking these bonds can alter the therapeutic effects 
of the protein (Brocchini 2006).  For this reason, pepsin is used to cleave off fragments from the 
Fc region that consists of both Fabs linked by the hinge disulphide bonds, referred to as F(ab’)2 
(See Figure 2.3). Reduction of these species produces two Fab’ fragments, which are Fab 
fragments that retain a cysteine from the heavy-chain linking disulfide bonds in the hinge region.  
The thiol in this cysteine can then easily be PEGylated at high efficiency under mild conditions, 
allowing for site-specific PEGylation without interrupting the structure of the protein 
(Humphreys 2007) (See Figure 2.4).  Mild reduction of the hinge region disulfide bonds is 
performed with a thiol-based compound which will only break the inter-heavy chain disulphide 
bonds and leave the disulphide bonds between the light and heavy chains of the Fab fragments 
intact (See Figure B.1).  We cannot use stronger reducing agents or PEGylate on the disulfide 
bonds between the heavy and light chains of the Fab fragment as this would result in a decrease 
or loss of therapeutic effects of the protein. 
In this process, Thermo Scientific’s 2-Mercaptoethylamine·HCl (2-MEA) is used for the 
reduction.  This 2-MEA compound is used again later in the process, right before PEGylation, as 
a mild reductant is again required to remove any small thiol-reactive molecules that cap the thiol 
that needs to be PEGylated, which can accumulate during purification steps (Humphreys 2007). 
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3. Plate and Filter Filtration (P-39/PFF-201) removes suspended Immobilized Pepsin from 
the slurry. 
4. Diafiltration (P-42/DF-202) is performed to remove any very small Fc fragments and 
concentrates the  F(ab')2 in Reduction Reaction Buffer from  a concentration of 3.68 
mg/mL to 10 mg/mL.  Buffer calculations are based on the amount of F(ab')2 in the 
incoming stream. 
Reduction Reaction Buffer Mass (g/batch) 
Mass 
Fraction Mass % 
Phosphate (0.1 M, pH 6.0) 12667.57 0.8448176 84.48176 
EDTA (2 mM) 993.0246 0.0662262 6.622616 
Water 1333.85 0.0889563 8.895626 
Total 14994.45   
 
5. The Disulphide Reduction Reaction (P-44/R-202) will produce 2 Fab’ fragments from 
each F(ab')2 molecule.  As per the protocol for using Thermo Scientific’s 2-
Mercaptoethylamine·HCl, 6 mg of 2-MEA per mL of Fab' solution at 10 mg/ml is added 
to give 50 mM 2-MEA Solution.  This is incubates for 90 minutes at 37°C, and then 
returned to room temperature (25°C). 
6. Diafiltration (P-47/DF-203) is performed to separate out 2-MEA (114 Da) and exchange 
the Reduction Reaction Buffer with WFI while maintaining a concentration of 10 mg/ml 
for the Protein-A Chromatography which will specifically bind the Fab’ fragments and 
purify them further. 
PEGylation Protocol and Calculations 
For the PEGylation Reaction, the Fab’ fragments must first be reduced with Thermo 
Scientific/Pierce 2-Mercaptoethylamine·HCl, a mild reductant which will remove any thiols 
which became attached to the cysteine to be PEGylated during previous purification steps 
(Humphreys 2007).  Then the fragments are PEGylated with JenKem USA’s branched, thiol-
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reactive 40 kDa PEG maleimide molecule, following the protocol used in Humphreys for 
PEGylation on Fab’ fragments.   
1. Diafiltration (P-81/DF-401) is performed to concentrate the Fab’ fragments in Reduction 
Reaction Buffer from 3.9 mg/ml to 10 mg/ml.  Calculations are based on the amount of 
Fab’ in the incoming stream. 
Reduction Reaction 
Buffer 
Mass 
(g/batch) 
Mass 
Fraction Mass % 
Phosphate (0.1 M, pH 
6.0) 14254.85 0.009401 0.940072 
EDTA (2 mM) 1117.453 0.000737 0.073693 
Water 1500984 0.989862 98.98623 
Total 1516356   
 
2. The Thiol Reduction Reaction (P-83/R-401) will prepare the cysteine for PEGylation.  As 
per the protocol for using Thermo Scientific’s 2-Mercaptoethylamine·HCl, 6 mg of 2-
MEA per mL of Fab' solution at 10 mg/ml is added to give 50 mM 2-MEA Solution.  
This is incubates for 90 minutes at 37°C, and then returned to 25°C. 
3. Diafiltration (P-86/DF-402) is performed to separate out 2-MEA (114 Da) and keep 
Reduced Fab’ fragments at a concentration 10 mg/mL, though now in PEGylation 
Reaction Buffer.  The 2-MEA protocol requires a buffer with a concentration of EDTA 
between 1 and 10 mM, so the Reduction Reaction Buffer used is the same PEGylation 
Reaction Buffer used for the PEGylation protocol in Humphreys.  Calculations are based 
on the amount of Reduced Fab’ in the incoming stream. 
PEGylation Reaction 
Buffer Mass 
Mass 
Fraction Mass % 
NaOAc (2.72 g/L) 13542.1 0.009401 0.940072 
HCl (To pH 4.5) 1061.58 0.000737 0.073693 
WFI 1425935 0.989862 98.98623 
Total 1440539   
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4. As per the protocol followed by Humphreys, PEG is added to Fab' Solution and 
incubated at room temperature (~24°C) for 2 hours.  An excess of 2 moles of PEG are 
added per mole of Fab’ to ensure that the reaction goes to completion. 
5. Diafiltration (P-91/DF-403) is conducted to switch the PEG Reaction Buffer with WFI 
for Cation Exchange Chromatography.  A filter with a 30 kDa cutoff pore size is used to 
filter out excess PEG molecules (40 kDa) and non-PEGylated Fab’ fragments (40 kDa) 
while retaining the PEGylated proteins (90 kDa) in the retentate. 
6. Cation Exchange Chromatography (P-101/C-101) is performed to specifically isolate 
PEGylated Fab fragments.  Buffer calculations are based on the provided protocol for 
using the GE Healthcare MacroCap SP resin. 
Cation Buffer 1 Mass Mass Fraction Mass % 
Phosphate (0.02 M, pH 6.8) 1.8994 0.001896 0.189579912 
Water 1000 0.998104 99.81042009 
Total 1001.899   
Cation Buffer 2 Mass Mass Fraction Mass % 
Phosphate (0.02 M, pH 6.8) 1.8994 0.001791 0.179129634 
NaCl (1 M) 58.45 0.055123 5.512333953 
Water 1000 0.943085 94.30853641 
Total 1060.349   
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Appendix C – Glossary 
Antigen- Any foreign material that is specifically bound by a specific antibody. 
Antigen-binding site- Part of an immunoglobin molecule that binds an antigen specifically. 
Batch mode- the most commonly used type of fermentation, in which microbes are added to a 
sterile nutrient broth and allowed to ferment without the addition of further nutrients (except 
oxygen). 
Chromatography- a technique used to separate molecules based on their different physical or 
chemical properties. 
Crossflow- Flow of solution adjacent or parallel to the surface of the membrane. This contrasts 
with direct flow seen in traditional filters, in which the liquid flows perpendicular to the surface 
of the filter. In crossflow, only a fraction of the crossflow solution passes through the membrane. 
Diafiltration- A crossflow filtration process allowing for the transfer of low molecular weight 
species, water and/or solvents through a membrane without changing the solution volume. This 
process is used for purifying retained large molecular weight species, increasing the recovery of 
low molecular weight species, buffer exchange and simply changing the properties of a given 
solution. 
Dalton (Da)- A unit of mass that equals the weight of a hydrogen atom, or  g. 
Fab fragment- “fragment antigen binding”; Fragment of antibody containing the antigen 
binding site, generated by the cleavage of the antibody with the enzyme papain, which cuts at the 
hinge region N-terminally to the inter-H-chain disulphide bond and generates two Fab fragments 
from one antibody molecule. 
Fc fragment- “fragment crystalizable”; Fragment of the antibody without antigen-binding sites, 
generated by cleavage with papain; the Fc fragment contains the C-terminal domains of the 
heavy immunoglobin chains. 
Fed-batch mode- fermentation in which substrate is added incrementally throughout the 
process. 
Flux: The amount of solution that passes through a unit of membrane area in a given amount of 
time. For example, a filter might have a flux of 1 liter per minute per square centimeter. 
Fouling- Contamination (plugging) of the membrane, either decreasing flux, or increasing 
differential pressure or TMP. Membrane fouling may necessitate a flux maintenance procedure 
or a membrane cleaning. 
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Hinge Region- a flexible, open segment of an antibody that allows bending of the molecule. The 
hinge region is located between the Fab and Fc fragments and is susceptible to enzymatic 
cleavage. 
Hydrodynamic Diameter- the diameter of a hard sphere that diffuses at the same rate as the 
molecule, taking hydration and shape effects into account. 
Inoculation- a standard procedure to initialize the operation of a bioreactor by adding a small 
amount of cells. The initial amount of cells are cultured in a carefully controlled medium and are 
allowed to undergo division and growth to a desired cell density within the bioreactor. 
Ion Exchange Chromatography- utilizes charge properties to bind either negatively or 
postively charged ions. There are two types: 
Cation Exchange- column with negative charge, binds positively charged particles - used at a 
low enough pH that the desired antibody binds to the column while anions flow through. 
Anion Exchange- column with positive charge, binds negatively charged particles – binds DNA, 
endotoxin, retrovirus. 
Lactate (lactic acid)- a byproduct of carbohydrate metabolism (anaerobic metabolism) that 
plays a role in several biochemical processes; produced (for example) as a result of anaerobic 
respiration in muscles and red blood cells when glycogen rather than oxygen is used as an energy 
source for respiration. 
Membrane Filtration- Membrane filtration is a pressure driven process that uses a semi-
permeable (porous) membrane to separate particulate matter from soluble components in the 
carrier fluid such as water. 
Monoclonal- Literally, coming from a single clone. A clone is the progeny of a single cell. In 
immunology, monoclonal generally describes a preparation of antibody that is monogenous, or 
cells of a single specificity. 
Monoclonal Antibodies- antibodies that come from plasma cells that produce a single antibody 
of known specificity. 
Papain- a nonspecific, thiol-endopeptidase that has a sulfhydryl group in the active site, which 
must be in the reduced form for activity. When antibody molecules are incubated with papain in 
the presence of cysteine, one or more peptide bonds in the hinge region are split, producing three 
fragments of similar size: two Fab fragments and one Fc fragment. The Fc fragments can be 
separated from the Fab fragments using immobilized Protein A or by ion exchange 
chromatography. 
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Protein A- A 42-kDa monomeric protein from Staphylococcus aureus bacteria, protein A lacks 
cysteine residues and binds to the Fc portion of immunoglobulins. It is used extensively in 
affinity chromatography; ELISAs; and immunoblotting, -precipitation, and -histochemistry. 
PEGylation- the process of covalent attachment of poly(ethylene glycol) polymer chains to 
another molecule, normally a drug or therapeutic protein. PEGylation is routinely achieved by 
incubation of a reactive derivative of PEG with the target macromolecule. The covalent 
attachment of PEG to a drug or therapeutic protein can "mask" the agent from the host's immune 
system (reduced immunogenicity and antigenicity), increase the hydrodynamic size (size in 
solution) of the agent which prolongs its circulatory time by reducing renal clearance. 
PEGylation can also provide water solubility to hydrophobic drugs and proteins. 
Serum- fluid portion of blood; retains antibodies present in whole blood. 
Titer- the quantity of one substance required to produce a reaction with a specific volume of 
another; also the number/measure of antibodies detected in blood or media. 
TNF-alpha – “Tumor necrosis factor-alpha” is a cytokine involved in systemic inflammation and is a 
member of a group of cytokines that stimulate the acute phase reaction. The primary role of TNF is in the 
regulation of immune cells. TNF is also able to induce apoptotic cell death, to induce inflammation, and 
to inhibit tumorigenesis and viral replication. 
Ultrafiltration (UF)- high-level filtration system for the treatment of water and other liquids. Liquids are 
forced through a membrane with extremely fine pores to filter colloids and molecules between 0.002 and 
0.1 microns in size. Ultrafiltration is capable of removing solids, bacteria and viruses . 
Validation- Establishing documented evidence which provides a high degree of assurance that a 
specific process will consistently produce a product meeting its pre-determined specifications 
and quality attributes. 
Validation protocol- A written plan stating how validation will be conducted, including test 
parameters, product characteristics, production equipment, and decision points on what 
constitutes acceptable test results. 
Viral filtration- retrovirus and parvovirus filters remove small viruses of 50 nm and 20 nm sizes 
and larger, leaving target protein in stream. 
Water for Injection (WFI)- highly purified water used for medical purposes. 
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Appendix D – SuperPro Designer Stream Reports 
1. BIOREACTION OVERALL PROCESS DATA  
     
Annual Operating Time 7836.52 h 
Annual Throughput 1887.70 kg MP 
Batch Throughput 34.32 kg MP 
Recipe Batch Time 807.66 h 
Recipe Cycle Time 130.16 h 
Number of Batches per Year 55.00  
MP = Main Product = Flow of MAB in stream To Primary Recovery 
     
STREAM DETAILS 
     
Stream Name Innoculum Media-1 S-101 
Innoculum 
Media-2 S-102 
Source INPUT P-1 INPUT P-2 
Destination P-1 P-2 P-2 P-3 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 25.00 37.00 25.00 37.00 
Pressure (bar) 1.01 1.88 1.01 1.80 
Density (g/L) 1007.62 997.17 1007.62 997.14 
Component Flowrates (kg/batch) 
Amino Acids 0.00 0.00 0.01 0.01 
Biomass*  0.00 0.00 0.00 0.00 
Dead Biomass 0.00 0.00 0.00 0.00 
Glucose 0.01 0.01 0.05 0.06 
Glutamine 0.00 0.00 0.01 0.01 
Inorganic Salts 0.03 0.03 0.11 0.14 
Lactate 0.00 0.00 0.00 0.00 
MAB 0.00 0.00 0.00 0.00 
Other Media Components 0.00 0.00 0.00 0.00 
Vitamins 0.00 0.00 0.00 0.00 
Water 0.00 0.00 0.00 0.00 
WFI 2.11 2.11 8.69 10.80 
TOTAL (kg/batch) 2.15 2.15 8.87 11.02 
TOTAL (L/batch) 2.14 2.16 8.80 11.05 
   
Stream Name Innoculum Media-3 Vent-1 S-103 
Innoculum 
Media-4 
Source INPUT P-3 P-3 INPUT 
Destination P-3 OUTPUT P-4 P-4 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
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Temperature (°C) 25.00 37.00 37.00 25.00 
Pressure (bar) 1.01 1.01 1.01 1.01 
Density (g/L) 1007.62 1.17 997.12 1007.62 
Component Flowrates (kg/batch) 
Amino Acids 0.08 0.00 0.09 0.31 
Biomass 0.00 0.00 0.01 0.00 
Carb. Dioxide 0.00 0.01 0.00 0.00 
Dead Biomass 0.00 0.00 0.00 0.00 
Glucose 0.32 0.00 0.37 1.32 
Glutamine 0.04 0.00 0.04 0.15 
Inorganic Salts 0.77 0.00 0.88 3.21 
Lactate 0.00 0.00 0.01 0.00 
MAB 0.00 0.00 0.00 0.00 
Nitrogen 0.00 0.06 0.00 0.00 
Other Media Components 0.01 0.00 0.01 0.03 
Oxygen 0.00 0.00 0.00 0.00 
Vitamins 0.00 0.00 0.00 0.01 
Water 0.00 0.00 0.03 0.00 
WFI 59.25 0.00 70.05 246.87 
TOTAL (kg/batch) 60.46 0.08 71.49 251.90 
TOTAL (L/batch) 60.00 64.29 71.70 250.00 
   
Stream Name Vent-2 S-104 S-108 Air Stream-1 
Source P-4 P-4 P-8 INPUT 
Destination OUTPUT P-9 P-9 P-9 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 37.00 37.00 25.02 25.00 
Pressure (bar) 1.01 1.01 5.38 1.01 
Density (g/L) 1.17 997.09 1006.20 1.18 
Component Flowrates (kg/batch) 
Amino Acids 0.00 0.39 1.36 0.00 
Biomass 0.00 0.07 0.00 0.00 
Carb. Dioxide 0.05 0.00 0.00 0.00 
Dead Biomass 0.00 0.01 0.00 0.00 
Glucose 0.00 1.64 5.77 0.00 
Glutamine 0.00 0.19 0.67 0.00 
Inorganic Salts 0.00 3.98 13.97 0.00 
Lactate 0.00 0.05 0.00 0.00 
MAB 0.00 0.02 0.00 0.00 
Nitrogen 0.27 0.00 0.00 2780.96 
Other Media Components 0.00 0.03 0.12 0.00 
Oxygen 0.01 0.00 0.00 844.25 
Vitamins 0.00 0.02 0.06 0.00 
Water 0.00 0.13 0.00 0.00 
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WFI 0.00 316.91 648.69 0.00 
TOTAL (kg/batch) 0.33 323.45 670.64 3625.21 
TOTAL (L/batch) 284.41 324.39 666.51 3074994.50 
   
Stream Name Vent-3 S-109 WFI-1 SF Media-1 
Source P-9 P-9 INPUT INPUT 
Destination OUTPUT P-10 P-5 P-5 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 37.00 37.00 25.00 25.00 
Pressure (bar) 1.01 1.01 1.01 1.01 
Density (g/L) 1.13 993.33 994.70 1640.37 
Component Flowrates (kg/batch) 
Amino Acids 0.00 0.35 0.00 1.36 
Biomass 0.00 7.80 0.00 0.00 
Carb. Dioxide 15.66 0.00 0.00 0.00 
Dead Biomass 0.00 0.80 0.00 0.00 
Glucose 0.00 1.48 0.00 5.77 
Glutamine 0.00 0.17 0.00 0.67 
Inorganic Salts 0.00 3.59 0.00 13.97 
Lactate 0.00 5.53 0.00 0.00 
MAB 0.00 1.60 0.00 0.00 
Nitrogen 2781.89 0.00 0.00 0.00 
Other Media Components 0.00 0.03 0.00 0.12 
Oxygen 821.97 0.00 0.00 0.00 
Vitamins 0.00 0.02 0.00 0.06 
Water 0.00 14.01 0.00 0.00 
WFI 0.00 965.61 648.69 0.00 
TOTAL (kg/batch) 3619.51 1000.99 648.69 21.95 
TOTAL (L/batch) 3190145.66 1007.72 652.15 13.38 
   
Stream Name S-105 S-106 S-107 S-110 
Source P-5 P-6 P-7 P-10 
Destination P-6 P-7 P-8 P-15 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 25.00 25.01 25.01 37.02 
Pressure (bar) 3.38 4.38 4.38 2.74 
Density (g/L) 1006.21 1006.21 1006.21 993.32 
Component Flowrates (kg/batch) 
Amino Acids 1.36 1.36 1.36 0.35 
Biomass 0.00 0.00 0.00 7.80 
Dead Biomass 0.00 0.00 0.00 0.80 
Glucose 5.77 5.77 5.77 1.48 
Glutamine 0.67 0.67 0.67 0.17 
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Inorganic Salts 13.97 13.97 13.97 3.59 
Lactate 0.00 0.00 0.00 5.53 
MAB 0.00 0.00 0.00 1.60 
Other Media Components 0.12 0.12 0.12 0.03 
Vitamins 0.06 0.06 0.06 0.02 
Water 0.00 0.00 0.00 14.01 
WFI 648.69 648.69 648.69 965.61 
TOTAL (kg/batch) 670.64 670.64 670.64 1000.99 
TOTAL (L/batch) 666.50 666.51 666.51 1007.72 
   
Stream Name S-114 Air Stream-2 Vent-4 S-115 
Source P-14 INPUT P-15 P-15 
Destination P-15 P-15 OUTPUT P-16 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 25.02 25.00 37.00 37.00 
Pressure (bar) 5.38 1.01 1.01 1.01 
Density (g/L) 1006.07 1.18 1.13 993.16 
Component Flowrates (kg/batch) 
Amino Acids 4.18 0.00 0.00 0.91 
Biomass 0.00 0.00 0.00 27.78 
Carb. Dioxide 0.00 0.00 40.47 0.00 
Dead Biomass 0.00 0.00 0.00 2.85 
Glucose 17.68 0.00 0.00 3.83 
Glutamine 2.05 0.00 0.00 0.44 
Inorganic Salts 42.82 0.00 0.00 9.28 
Lactate 0.00 0.00 0.00 19.70 
MAB 0.00 0.00 0.00 5.70 
Nitrogen 0.00 8626.38 8629.25 0.00 
Other Media Components 0.37 0.00 0.00 0.08 
Oxygen 0.00 2618.80 2561.36 0.00 
Vitamins 0.18 0.00 0.00 0.04 
Water 0.00 0.00 0.00 49.87 
WFI 2011.29 0.00 0.00 2976.90 
TOTAL (kg/batch) 2078.55 11245.18 11231.08 3097.38 
TOTAL (L/batch) 2066.00 9536104.80 9900239.90 3118.71 
   
Stream Name S-111 S-112 S-113 WFI-2 
Source P-11 P-12 P-13 INPUT 
Destination P-12 P-13 P-14 P-11 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 25.00 25.01 25.01 25.00 
Pressure (bar) 3.38 4.38 4.38 1.01 
Density (g/L) 1006.08 1006.08 1006.08 994.70 
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Component Flowrates (kg/batch) 
Amino Acids 4.18 4.18 4.18 0.00 
Glucose 17.68 17.68 17.68 0.00 
Glutamine 2.05 2.05 2.05 0.00 
Inorganic Salts 42.82 42.82 42.82 0.00 
Other Media Components 0.37 0.37 0.37 0.00 
Vitamins 0.18 0.18 0.18 0.00 
WFI 2011.29 2011.29 2011.29 2011.29 
TOTAL (kg/batch) 2078.55 2078.55 2078.55 2011.29 
TOTAL (L/batch) 2065.99 2066.00 2066.00 2022.00 
   
Stream Name SF Media-2 S-116 S-120 S-124 
Source INPUT P-16 P-20 P-24 
Destination P-11 P-25 P-25 P-25 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 25.00 37.01 25.02 25.02 
Pressure (bar) 1.01 2.01 5.38 5.38 
Density (g/L) 1640.37 993.16 1005.97 1083.65 
Component Flowrates (kg/batch) 
Amino Acids 4.18 0.91 10.74 17.12 
Biomass 0.00 27.78 0.00 0.00 
Dead Biomass 0.00 2.85 0.00 0.00 
Glucose 17.68 3.83 45.45 72.46 
Glutamine 2.05 0.44 5.26 8.38 
Inorganic Salts 42.82 9.28 110.10 175.52 
Lactate 0.00 19.70 0.00 0.00 
MAB 0.00 5.70 0.00 0.00 
Other Media Components 0.37 0.08 0.95 1.52 
Vitamins 0.18 0.04 0.45 0.72 
Water 0.00 49.87 0.00 0.00 
WFI 0.00 2976.90 5222.20 897.89 
TOTAL (kg/batch) 67.26 3097.38 5395.15 1173.60 
TOTAL (L/batch) 41.00 3118.72 5363.16 1083.00 
   
Stream Name Air Stream-3 Vent-5 To Primary Recovery WFI-3 
Source INPUT P-25 P-25 INPUT 
Destination P-25 OUTPUT OUTPUT P-17 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 25.00 37.00 37.00 25.00 
Pressure (bar) 1.01 1.01 1.01 1.01 
Density (g/L) 1.18 1.14 994.61 994.70 
Component Flowrates (kg/batch) 
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Amino Acids 0.00 0.00 3.49 0.00 
Biomass 0.00 0.00 167.26 0.00 
Carb. Dioxide 0.00 282.39 0.00 0.00 
Dead Biomass 0.00 0.00 17.14 0.00 
Glucose 0.00 0.00 14.75 0.00 
Glutamine 0.00 0.00 1.71 0.00 
Inorganic Salts 0.00 0.00 35.72 0.00 
Lactate 0.00 0.00 118.59 0.00 
MAB 0.00 0.00 34.32 0.00 
Nitrogen 5355.96 5364.91 0.00 0.00 
Other Media Components 0.00 0.00 0.31 0.00 
Oxygen 1625.97 1221.84 0.00 0.00 
Vitamins 0.00 0.00 0.15 0.00 
Water 0.00 0.00 300.26 0.00 
WFI 0.00 0.00 9096.99 5222.20 
TOTAL (kg/batch) 6981.92 6869.14 9790.67 5222.20 
TOTAL (L/batch) 5920790.79 6009112.24 9843.78 5250.00 
   
Stream Name SF Media-3 S-117 S-118 S-119 
Source INPUT P-17 P-18 P-19 
Destination P-17 P-18 P-19 P-20 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 25.00 25.00 25.01 25.01 
Pressure (bar) 1.01 3.38 4.38 4.38 
Density (g/L) 1640.37 1005.97 1005.97 1005.97 
Component Flowrates (kg/batch) 
Amino Acids 10.74 10.74 10.74 10.74 
Glucose 45.45 45.45 45.45 45.45 
Glutamine 5.26 5.26 5.26 5.26 
Inorganic Salts 110.10 110.10 110.10 110.10 
Other Media Components 0.95 0.95 0.95 0.95 
Vitamins 0.45 0.45 0.45 0.45 
WFI 0.00 5222.20 5222.20 5222.20 
TOTAL (kg/batch) 172.96 5395.15 5395.15 5395.15 
TOTAL (L/batch) 105.44 5363.12 5363.14 5363.14 
   
Stream Name WFI-4 SF Media-4 S-121 S-122 
Source INPUT INPUT P-21 P-22 
Destination P-21 P-21 P-22 P-23 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 25.00 25.00 25.00 25.01 
Pressure (bar) 1.01 1.01 3.38 4.38 
Density (g/L) 994.70 1640.37 1083.66 1083.66 
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Component Flowrates (kg/batch) 
Amino Acids 0.00 17.32 17.12 17.12 
Glucose 0.00 73.29 72.46 72.46 
Glutamine 0.00 8.48 8.38 8.38 
Inorganic Salts 0.00 177.52 175.52 175.52 
Other Media Components 0.00 1.53 1.52 1.52 
Vitamins 0.00 0.73 0.72 0.72 
WFI 908.17 0.00 897.89 897.89 
TOTAL (kg/batch) 908.17 278.86 1173.60 1173.60 
TOTAL (L/batch) 913.00 170.00 1082.99 1083.00 
   
Stream Name S-123    
Source P-23    
Destination P-24    
Stream Properties 
Activity (U/ml) 0.00    
Temperature (°C) 25.01    
Pressure (bar) 4.38    
Density (g/L) 1083.66    
Component Flowrates (kg/batch) 
Amino Acids 17.12    
Glucose 72.46    
Glutamine 8.38    
Inorganic Salts 175.52    
Other Media Components 1.52    
Vitamins 0.72    
WFI 897.89    
TOTAL (kg/batch) 1173.60    
TOTAL (L/batch) 1083.00    
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2. PAPAIN CLEAVAGE OVERALL PROCESS DATA 
     
Annual Operating Time 7912.36 h 
Annual Throughput 8410.56 kg MP 
Batch Throughput 17.60 kg MP 
Recipe Batch Time 38.96 h 
Recipe Cycle Time 16.51 h 
Number of Batches per Year 478.00  
MP = Main Product = Flow of MAb Fab Fragments in stream To IEX 
     
STREAM DETAILS 
     
Stream Name From Bioreactor S-201 S-202 S-203 
Source INPUT P-26 P-27 P-28 
Destination P-26 P-27 P-28 P-29 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 25.00 25.00 25.02 25.00 
Pressure (bar) 1.01 1.01 2.74 2.74 
Density (g/L) 999.04 999.04 999.03 999.11 
Component Flowrates (kg/batch) 
Amino Acids 3.49 3.49 3.49 3.15 
Biomass 167.26 167.26 167.26 3.35 
Dead Biomass 17.14 17.14 17.14 15.49 
Glucose 14.75 14.75 14.75 13.33 
Glutamine 1.71 1.71 1.71 1.54 
Inorganic Salts 35.72 35.72 35.72 32.28 
Lactate 118.59 118.59 118.59 107.16 
MAB 34.32 34.32 34.32 31.02 
Other Media Components 0.31 0.31 0.31 0.28 
Vitamins 0.15 0.15 0.15 0.13 
Water 300.26 300.26 300.26 271.33 
WFI 9096.99 9096.99 9096.99 8220.53 
TOTAL (kg/batch) 9790.67 9790.67 9790.67 8699.58 
TOTAL (L/batch) 9800.09 9800.09 9800.15 8707.30 
   
Stream Name Waste-5 S-206 Vent-7 S-207 
Source P-28 P-31 P-32 P-32 
Destination OUTPUT P-32 OUTPUT P-33 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 25.00 25.04 25.04 25.04 
Pressure (bar) 2.74 6.18 1.01 1.01 
Density (g/L) 998.45 999.10 1.18 999.10 
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Component Flowrates (kg/batch) 
Amino Acids 0.34 3.15 0.00 3.15 
Biomass 163.92 0.00 0.00 0.00 
Dead Biomass 1.65 15.48 0.00 15.48 
Glucose 1.42 13.32 0.00 13.32 
Glutamine 0.16 1.54 0.00 1.54 
Inorganic Salts 3.44 32.27 0.00 32.27 
Lactate 11.43 107.12 0.00 107.12 
MAB 3.31 31.00 0.00 31.00 
Nitrogen 0.00 0.00 7.87 0.00 
Other Media Components 0.03 0.28 0.00 0.28 
Oxygen 0.00 0.00 2.39 0.00 
Vitamins 0.01 0.13 0.00 0.13 
Water 28.93 271.22 0.00 271.22 
WFI 876.46 8217.36 0.00 8217.36 
TOTAL (kg/batch) 1091.09 8692.87 10.26 8692.87 
TOTAL (L/batch) 1092.79 8700.69 8701.85 8700.69 
   
Stream Name S-204 S-205 Waste-6 S-208 
Source P-29 P-30 P-30 P-33 
Destination P-30 P-31 OUTPUT P-34 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 25.02 25.02 25.02 25.05 
Pressure (bar) 4.46 4.46 4.46 2.74 
Density (g/L) 999.11 999.11 996.90 999.10 
Component Flowrates (kg/batch) 
Amino Acids 3.15 3.15 0.00 3.15 
Biomass 3.35 0.00 3.35 0.00 
Dead Biomass 15.49 15.48 0.01 15.48 
Glucose 13.33 13.32 0.01 13.32 
Glutamine 1.54 1.54 0.00 1.54 
Inorganic Salts 32.28 32.27 0.01 32.27 
Lactate 107.16 107.12 0.04 107.12 
MAB 31.02 31.00 0.01 31.00 
Other Media Components 0.28 0.28 0.00 0.28 
Vitamins 0.13 0.13 0.00 0.13 
Water 271.33 271.22 0.11 271.22 
WFI 8220.53 8217.36 3.18 8217.36 
TOTAL (kg/batch) 8699.58 8692.87 6.71 8692.87 
TOTAL (L/batch) 8707.36 8700.63 6.73 8700.75 
   
Stream Name Waste-7 S-209 S-210 Digest Buffer 
Source P-34 P-34 P-35 INPUT 
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Destination OUTPUT P-35 P-36 P-36 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 25.77 25.77 25.84 25.00 
Pressure (bar) 2.74 2.74 9.63 1.01 
Density (g/L) 998.85 998.76 998.73 1004.70 
Component Flowrates (kg/batch) 
Amino Acids 2.60 0.55 0.55 0.00 
Cysteine-HCl 0.00 0.00 0.00 5.45 
Dead Biomass 12.77 2.71 2.71 0.00 
EDTA Disodium 0.00 0.00 0.00 9.02 
Glucose 10.99 2.33 2.33 0.00 
Glutamine 1.27 0.27 0.27 0.00 
Inorganic Salts 26.62 5.65 5.65 0.00 
Lactate 88.38 18.74 18.74 0.00 
MAB 0.00 31.00 31.00 0.00 
Other Media Components 0.23 0.05 0.05 0.00 
Sodium Phosphate 0.00 0.00 0.00 4.20 
Vitamins 0.11 0.02 0.02 0.00 
Water 223.76 47.46 47.46 0.00 
WFI 6779.48 1437.88 1437.88 1537.23 
TOTAL (kg/batch) 7146.21 1546.66 1546.66 1555.90 
TOTAL (L/batch) 7154.47 1548.59 1548.63 1548.63 
   
Stream Name Papain Waste-8 S-211 S-212 
Source INPUT P-36 P-36 P-37 
Destination P-36 OUTPUT P-37 P-38 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 25.00 37.00 37.00 37.26 
Pressure (bar) 1.01 10.54 2.13 27.13 
Density (g/L) 994.70 990.33 994.27 994.17 
Component Flowrates (kg/batch) 
Amino Acids 0.00 0.00 0.55 0.55 
Cysteine-HCl 0.00 0.00 5.45 5.45 
Dead Biomass 0.00 0.00 2.71 2.71 
EDTA Disodium 0.00 0.00 9.02 9.02 
Glucose 0.00 0.00 2.33 2.33 
Glutamine 0.00 0.00 0.27 0.27 
Inorganic Salts 0.00 0.00 5.65 5.65 
Lactate 0.00 0.00 18.74 18.74 
MAB 0.00 0.00 1.55 1.55 
MAb Fab Fragments 0.00 0.00 19.64 19.64 
MAb Fc Fragments 0.00 0.00 9.82 9.82 
Other Media Components 0.00 0.00 0.05 0.05 
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Papain 1540.43 0.00 1540.43 1540.43 
Sodium Phosphate 0.00 0.00 4.20 4.20 
Vitamins 0.00 0.00 0.02 0.02 
Water 0.00 0.00 47.46 47.46 
WFI 1540.43 2709.32 1806.21 1806.21 
TOTAL (kg/batch) 3080.85 2709.32 3474.09 3474.09 
TOTAL (L/batch) 3097.25 2735.77 3494.11 3494.45 
   
Stream Name Tris-HCl Waste-9 S-213 ProtA-Equiil. 
Source INPUT P-38 P-38 INPUT 
Destination P-38 OUTPUT P-39 P-40 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 4.00 28.92 25.44 25.00 
Pressure (bar) 1.01 1.01 1.01 1.01 
Density (g/L) 1096.65 1004.81 1021.57 998.35 
Component Flowrates (kg/batch) 
Amino Acids 0.00 0.04 0.51 0.00 
Cysteine-HCl 0.00 0.41 5.03 0.00 
Dead Biomass 0.00 0.21 2.50 0.00 
EDTA Disodium 0.00 0.68 8.34 0.00 
EDTA, Sodium 0.00 0.00 0.00 5.25 
Glucose 0.00 0.18 2.15 0.00 
Glutamine 0.00 0.02 0.25 0.00 
Inorganic Salts 0.00 0.43 5.22 0.00 
Lactate 0.00 1.42 17.33 0.00 
MAB 0.00 0.12 1.43 0.00 
MAb Fab Fragments 0.00 1.49 18.15 0.00 
MAb Fc Fragments 0.00 0.74 9.07 0.00 
Other Media Components 0.00 0.00 0.05 0.00 
Papain 0.00 1540.43 0.00 0.00 
Sodium Chloride 0.00 0.00 0.00 2.62 
Sodium Phosphate 0.00 0.32 3.88 0.00 
TRIS Base 0.00 0.00 0.00 2.62 
TRIS HCl 206.78 45.86 160.92 7.87 
Vitamins 0.00 0.00 0.02 0.00 
Water 0.00 3.59 43.87 0.00 
WFI 2340.66 655.84 3491.04 2604.09 
TOTAL (kg/batch) 2547.44 2251.77 3769.77 2622.45 
TOTAL (L/batch) 2322.93 2240.98 3690.18 2626.78 
   
Stream Name ProtA-Wash ProtA-Elut. ProtA-Reg. S-214 
Source INPUT INPUT INPUT P-39 
Destination P-40 P-40 P-40 P-40 
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Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 4.00 4.00 4.00 25.52 
Pressure (bar) 1.01 1.01 1.01 7.91 
Density (g/L) 1006.01 1002.70 1003.19 1021.54 
Component Flowrates (kg/batch) 
Amino Acids 0.00 0.00 0.00 0.51 
Acetic-Acid 0.00 15.80 0.00 0.00 
Cysteine-HCl 0.00 0.00 0.00 5.03 
Dead Biomass 0.00 0.00 0.00 2.50 
EDTA Disodium 0.00 0.00 0.00 8.34 
EDTA, Sodium 6.34 0.00 0.00 0.00 
Glucose 0.00 0.00 0.00 2.15 
Glutamine 0.00 0.00 0.00 0.25 
Inorganic Salts 0.00 0.00 0.00 5.22 
Lactate 0.00 0.00 0.00 17.33 
MAB 0.00 0.00 0.00 1.43 
MAb Fab Fragments 0.00 0.00 0.00 18.15 
MAb Fc Fragments 0.00 0.00 0.00 9.07 
Other Media Components 0.00 0.00 0.00 0.05 
Sodium Chloride 3.17 0.00 0.00 0.00 
Sodium Citrate 0.00 0.00 2.85 0.00 
Sodium Phosphate 0.00 0.00 0.00 3.88 
TRIS Base 3.17 0.00 0.00 0.00 
TRIS HCl 9.51 0.00 0.00 160.92 
Vitamins 0.00 0.00 0.00 0.02 
Water 0.00 0.00 0.00 43.87 
WFI 3148.88 2618.08 1578.25 3491.04 
TOTAL (kg/batch) 3171.08 2633.88 1581.09 3769.77 
TOTAL (L/batch) 3152.13 2626.78 1576.07 3690.28 
   
Stream Name S-215 Waste-11 WFI-5 S-219 
Source P-40 P-40 INPUT P-44 
Destination P-41 OUTPUT P-45 P-45 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 20.81 10.17 4.00 20.88 
Pressure (bar) 1.01 1.01 1.01 1.01 
Density (g/L) 1017.35 1002.67 1002.36 1017.31 
Component Flowrates (kg/batch) 
Amino Acids 0.51 0.00 0.00 0.51 
Acetic-Acid 6.32 9.48 0.00 6.32 
Cysteine-HCl 5.03 0.00 0.00 5.03 
Dead Biomass 2.50 0.00 0.00 0.00 
EDTA Disodium 8.34 0.00 0.00 8.34 
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EDTA, Sodium 0.00 11.59 0.00 0.00 
Glucose 2.15 0.00 0.00 2.15 
Glutamine 0.25 0.00 0.00 0.25 
Inorganic Salts 5.22 0.00 0.00 5.22 
Lactate 17.33 0.00 0.00 17.32 
MAB 0.00 1.43 0.00 0.00 
MAb Fab Fragments 18.15 0.00 0.00 18.14 
MAb Fc Fragments 0.00 9.07 0.00 0.00 
Other Media Components 0.05 0.00 0.00 0.05 
Sodium Chloride 0.00 5.79 0.00 0.00 
Sodium Citrate 0.00 2.85 0.00 0.00 
Sodium Phosphate 3.88 0.00 0.00 3.88 
TRIS Base 0.00 5.79 0.00 0.00 
TRIS HCl 160.92 17.38 0.00 160.84 
Vitamins 0.02 0.00 0.00 0.02 
Water 43.87 0.00 0.00 43.84 
WFI 4538.27 8902.06 1894.89 4535.98 
TOTAL (kg/batch) 4812.81 8965.45 1894.89 4807.88 
TOTAL (L/batch) 4730.72 8941.57 1890.43 4726.08 
   
Stream Name WFI-6 S-220 WFI-out Waste-13 
Source INPUT P-45 P-45 P-45 
Destination P-45 P-44 OUTPUT OUTPUT 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 4.00 16.41 4.00 16.41 
Pressure (bar) 1.01 1.01 1.01 1.01 
Density (g/L) 1002.36 1000.64 1002.36 1014.95 
Component Flowrates (kg/batch) 
Amino Acids 0.00 0.01 0.00 0.50 
Acetic-Acid 0.00 0.17 0.00 6.15 
Cysteine-HCl 0.00 0.13 0.00 4.90 
EDTA Disodium 0.00 0.22 0.00 8.12 
Glucose 0.00 0.06 0.00 2.10 
Glutamine 0.00 0.01 0.00 0.24 
Impurities 0.00 0.26 0.00 0.28 
Inorganic Salts 0.00 0.14 0.00 5.08 
Lactate 0.00 0.46 0.00 16.86 
MAb Fab Fragments 0.00 17.60 0.00 0.00 
Other Media Components 0.00 0.00 0.00 0.04 
Sodium Phosphate 0.00 0.10 0.00 3.78 
TRIS HCl 0.00 4.29 0.00 156.55 
Vitamins 0.00 0.00 0.00 0.02 
Water 0.00 1.17 0.00 42.68 
WFI 501.18 924.60 501.18 5506.27 
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TOTAL (kg/batch) 501.18 949.22 501.18 5753.55 
TOTAL (L/batch) 500.00 948.62 500.00 5668.83 
   
Stream Name S-218 Vent-10 S-221 S-216 
Source P-43 P-44 P-44 P-41 
Destination P-44 OUTPUT P-46 P-42 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 20.88 19.57 16.42 20.84 
Pressure (bar) 7.91 1.01 1.01 4.46 
Density (g/L) 1017.31 1.20 1000.63 1017.34 
Component Flowrates (kg/batch) 
Amino Acids 0.51 0.00 0.01 0.51 
Acetic-Acid 6.32 0.00 0.17 6.32 
Cysteine-HCl 5.03 0.00 0.13 5.03 
Dead Biomass 0.00 0.00 0.00 2.50 
EDTA Disodium 8.34 0.00 0.22 8.34 
Glucose 2.15 0.00 0.06 2.15 
Glutamine 0.25 0.00 0.01 0.25 
Impurities 0.00 0.00 0.26 0.00 
Inorganic Salts 5.22 0.00 0.14 5.22 
Lactate 17.32 0.00 0.46 17.33 
MAb Fab Fragments 18.14 0.00 17.60 18.15 
Nitrogen 0.00 5.08 0.00 0.00 
Other Media Components 0.05 0.00 0.00 0.05 
Oxygen 0.00 1.54 0.00 0.00 
Sodium Phosphate 3.88 0.00 0.10 3.88 
TRIS HCl 160.84 0.00 4.29 160.92 
Vitamins 0.02 0.00 0.00 0.02 
Water 43.84 0.00 1.17 43.87 
WFI 4535.98 0.00 924.60 4538.27 
TOTAL (kg/batch) 4807.88 6.62 949.22 4812.81 
TOTAL (L/batch) 4726.08 5511.15 948.62 4730.78 
   
Stream Name S-217 Waste-12 Polysorb80 S-222 
Source P-42 P-42 INPUT P-46 
Destination P-43 OUTPUT P-47 P-47 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 20.84 20.84 4.00 16.45 
Pressure (bar) 4.46 4.46 1.01 4.46 
Density (g/L) 1017.32 1033.66 881.61 1000.62 
Component Flowrates (kg/batch) 
Amino Acids 0.51 0.00 0.00 0.01 
Acetic-Acid 6.32 0.00 0.00 0.17 
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Cysteine-HCl 5.03 0.00 0.00 0.13 
Dead Biomass 0.00 2.50 0.00 0.00 
EDTA Disodium 8.34 0.00 0.00 0.22 
Glucose 2.15 0.00 0.00 0.06 
Glutamine 0.25 0.00 0.00 0.01 
Impurities 0.00 0.00 0.00 0.26 
Inorganic Salts 5.22 0.00 0.00 0.14 
Lactate 17.32 0.01 0.00 0.46 
MAb Fab Fragments 18.14 0.01 0.00 17.60 
Other Media Components 0.05 0.00 0.00 0.00 
Polysorbate 80 0.00 0.00 0.10 0.00 
Sodium Phosphate 3.88 0.00 0.00 0.10 
TRIS HCl 160.84 0.08 0.00 4.29 
Vitamins 0.02 0.00 0.00 0.00 
Water 43.84 0.02 0.00 1.17 
WFI 4535.98 2.29 0.10 924.60 
TOTAL (kg/batch) 4807.88 4.93 0.19 949.22 
TOTAL (L/batch) 4726.01 4.77 0.22 948.63 
   
Stream Name Vent-11 S-223 S-224 To IEX 
Source P-47 P-47 P-48 P-49 
Destination OUTPUT P-48 P-49 OUTPUT 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 16.46 16.45 16.49 16.49 
Pressure (bar) 1.01 1.01 4.46 4.46 
Density (g/L) 1.21 1000.59 1000.58 1000.58 
Component Flowrates (kg/batch) 
Amino Acids 0.00 0.01 0.01 0.01 
Acetic-Acid 0.00 0.17 0.17 0.17 
Cysteine-HCl 0.00 0.13 0.13 0.13 
EDTA Disodium 0.00 0.22 0.22 0.22 
Glucose 0.00 0.06 0.06 0.06 
Glutamine 0.00 0.01 0.01 0.01 
Impurities 0.00 0.26 0.26 0.26 
Inorganic Salts 0.00 0.14 0.14 0.14 
Lactate 0.00 0.46 0.46 0.46 
MAb Fab Fragments 0.00 17.60 17.60 17.60 
Nitrogen 0.86 0.00 0.00 0.00 
Other Media Components 0.00 0.00 0.00 0.00 
Oxygen 0.26 0.00 0.00 0.00 
Polysorbate 80 0.00 0.10 0.10 0.10 
Sodium Phosphate 0.00 0.10 0.10 0.10 
TRIS HCl 0.00 4.29 4.29 4.29 
Vitamins 0.00 0.00 0.00 0.00 
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Water 0.00 1.17 1.17 1.17 
WFI 0.00 924.69 924.69 924.69 
TOTAL (kg/batch) 1.12 949.41 949.41 949.41 
TOTAL (L/batch) 918.63 948.85 948.86 948.86 
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2A. NO CLEAVAGE OVERALL PROCESS DATA 
     
Annual Operating Time 7918.74 h 
Annual Throughput 0.00 kg MP 
Batch Throughput 0.00 kg MP 
Recipe Batch Time 20.87 h 
Recipe Cycle Time 15.92 h 
Number of Batches per Year 497.00  
MP = Main Product = Flow of MAb Fab Fragments in stream To IEX 
     
STREAM DETAILS 
     
Stream Name From Bioreactor S-201 
ProtA-
Equiil. 
ProtA-
Wash 
Source INPUT P-26 INPUT INPUT 
Destination P-26 P-27 P-36 P-36 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 25.00 25.00 25.00 4.00 
Pressure (bar) 1.01 1.01 1.01 1.01 
Density (g/L) 996.55 996.55 998.35 1006.01 
Component Flowrates (kg/batch) 
Amino Acids 0.29 0.29 0.00 0.00 
Biomass 184.88 184.88 0.00 0.00 
Dead Biomass 18.94 18.94 0.00 0.00 
EDTA, Sodium 0.00 0.00 22.27 26.93 
Glucose 1.23 1.23 0.00 0.00 
Glutamine 0.14 0.14 0.00 0.00 
Inorganic Salts 2.98 2.98 0.00 0.00 
Lactate 131.08 131.08 0.00 0.00 
MAB 37.94 37.94 0.00 0.00 
Other Media Components 0.03 0.03 0.00 0.00 
Sodium Chloride 0.00 0.00 11.14 13.47 
TRIS Base 0.00 0.00 11.14 13.47 
TRIS HCl 0.00 0.00 33.41 40.40 
Vitamins 0.01 0.01 0.00 0.00 
Water 331.88 331.88 0.00 0.00 
WFI 13825.29 13825.29 11058.22 13371.67 
TOTAL (kg/batch) 14534.70 14534.70 11136.17 13465.93 
TOTAL (L/batch) 14585.02 14585.02 11154.57 13385.48 
   
Stream Name ProtA-Elut. 
ProtA-
Reg. S-215 S-216 
Source INPUT INPUT P-35 P-36 
Destination P-36 P-36 P-36 P-37 
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Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 4.00 4.00 4.07 4.00 
Pressure (bar) 1.01 1.01 9.63 1.01 
Density (g/L) 1002.70 1003.19 1004.22 1002.70 
Component Flowrates (kg/batch) 
Amino Acids 0.00 0.00 0.03 0.00 
Acetic-Acid 67.11 0.00 0.00 26.84 
Dead Biomass 0.00 0.00 1.72 0.00 
Glucose 0.00 0.00 0.11 0.00 
Glutamine 0.00 0.00 0.01 0.00 
Inorganic Salts 0.00 0.00 0.27 0.00 
Lactate 0.00 0.00 11.88 0.00 
MAB 0.00 0.00 35.23 31.79 
Other Media Components 0.00 0.00 0.00 0.00 
Sodium Citrate 0.00 12.09 0.00 0.00 
Vitamins 0.00 0.00 0.00 0.00 
Water 0.00 0.00 30.08 0.00 
WFI 11117.62 6702.00 1253.00 4447.05 
TOTAL (kg/batch) 11184.73 6714.09 1332.33 4505.68 
TOTAL (L/batch) 11154.57 6692.74 1326.73 4493.54 
   
Stream Name Waste-8 WFI-5 S-220 WFI-6 
Source P-36 INPUT P-40 INPUT 
Destination OUTPUT P-41 P-41 P-41 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 9.95 4.00 4.08 4.00 
Pressure (bar) 1.01 1.01 1.01 1.01 
Density (g/L) 1002.73 1002.36 1002.67 1002.36 
Component Flowrates (kg/batch) 
Amino Acids 0.03 0.00 0.00 0.00 
Acetic-Acid 40.27 0.00 26.84 0.00 
Dead Biomass 1.72 0.00 0.00 0.00 
EDTA, Sodium 49.20 0.00 0.00 0.00 
Glucose 0.11 0.00 0.00 0.00 
Glutamine 0.01 0.00 0.00 0.00 
Inorganic Salts 0.27 0.00 0.00 0.00 
Lactate 11.88 0.00 0.00 0.00 
MAB 3.43 0.00 31.79 0.00 
Other Media Components 0.00 0.00 0.00 0.00 
Sodium Chloride 24.60 0.00 0.00 0.00 
Sodium Citrate 12.09 0.00 0.00 0.00 
TRIS Base 24.60 0.00 0.00 0.00 
TRIS HCl 73.81 0.00 0.00 0.00 
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Vitamins 0.00 0.00 0.00 0.00 
Water 30.08 0.00 0.00 0.00 
WFI 39055.46 1801.71 4447.05 501.18 
TOTAL (kg/batch) 39327.56 1801.71 4505.68 501.18 
TOTAL (L/batch) 39220.39 1797.47 4493.67 500.00 
   
Stream Name S-221 WFI-out Waste-10 S-219 
Source P-41 P-41 P-41 P-39 
Destination P-40 OUTPUT OUTPUT P-40 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 4.35 4.00 4.35 4.07 
Pressure (bar) 1.01 1.01 1.01 7.91 
Density (g/L) 1002.28 1002.36 1002.51 1002.68 
Component Flowrates (kg/batch) 
Acetic-Acid 0.71 0.00 26.14 26.84 
Impurities 0.46 0.00 0.49 0.00 
MAB 30.84 0.00 0.00 31.79 
WFI 868.88 501.18 5379.87 4447.05 
TOTAL (kg/batch) 900.89 501.18 5406.50 4505.68 
TOTAL (L/batch) 898.85 500.00 5392.97 4493.66 
   
Stream Name Vent-8 S-222 S-202 S-203 
Source P-40 P-40 P-27 P-28 
Destination OUTPUT P-42 P-28 P-29 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 4.17 4.35 25.02 25.00 
Pressure (bar) 1.01 1.01 2.74 2.74 
Density (g/L) 1.27 1002.28 996.54 996.57 
Component Flowrates (kg/batch) 
Amino Acids 0.00 0.00 0.29 0.27 
Acetic-Acid 0.00 0.71 0.00 0.00 
Biomass 0.00 0.00 184.88 3.70 
Dead Biomass 0.00 0.00 18.94 17.59 
Glucose 0.00 0.00 1.23 1.14 
Glutamine 0.00 0.00 0.14 0.13 
Impurities 0.00 0.46 0.00 0.00 
Inorganic Salts 0.00 0.00 2.98 2.77 
Lactate 0.00 0.00 131.08 121.74 
MAB 0.00 30.84 37.94 35.24 
Nitrogen 4.91 0.00 0.00 0.00 
Other Media Components 0.00 0.00 0.03 0.02 
Oxygen 1.49 0.00 0.00 0.00 
Vitamins 0.00 0.00 0.01 0.01 
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Water 0.00 0.00 331.88 308.24 
WFI 0.00 868.88 13825.29 12840.42 
TOTAL (kg/batch) 6.40 900.89 14534.70 13331.28 
TOTAL (L/batch) 5047.79 898.85 14585.11 13377.12 
   
Stream Name Waste-5 S-206 Vent-7 S-207 
Source P-28 P-31 P-32 P-32 
Destination OUTPUT P-32 OUTPUT P-33 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 25.00 25.04 25.04 25.04 
Pressure (bar) 1.01 6.18 1.01 1.01 
Density (g/L) 996.29 996.56 1.18 996.56 
Component Flowrates (kg/batch) 
Amino Acids 0.02 0.27 0.00 0.27 
Biomass 181.19 0.00 0.00 0.00 
Dead Biomass 1.35 17.59 0.00 17.59 
Glucose 0.09 1.14 0.00 1.14 
Glutamine 0.01 0.13 0.00 0.13 
Inorganic Salts 0.21 2.77 0.00 2.77 
Lactate 9.34 121.71 0.00 121.71 
MAB 2.70 35.23 0.00 35.23 
Nitrogen 0.00 0.00 12.10 0.00 
Other Media Components 0.00 0.02 0.00 0.02 
Oxygen 0.00 0.00 3.67 0.00 
Vitamins 0.00 0.01 0.00 0.01 
Water 23.64 308.16 0.00 308.16 
WFI 984.87 12836.85 0.00 12836.85 
TOTAL (kg/batch) 1203.42 13323.88 15.77 13323.88 
TOTAL (L/batch) 1207.90 13369.86 13371.64 13369.86 
   
Stream Name S-217 S-218 S-204 S-205 
Source P-37 P-38 P-29 P-30 
Destination P-38 P-39 P-30 P-31 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 4.04 4.04 25.02 25.02 
Pressure (bar) 4.46 4.46 4.46 4.46 
Density (g/L) 1002.69 1002.69 996.57 996.57 
Component Flowrates (kg/batch) 
Amino Acids 0.00 0.00 0.27 0.27 
Acetic-Acid 26.84 26.84 0.00 0.00 
Biomass 0.00 0.00 3.70 0.00 
Dead Biomass 0.00 0.00 17.59 17.59 
Glucose 0.00 0.00 1.14 1.14 
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Glutamine 0.00 0.00 0.13 0.13 
Inorganic Salts 0.00 0.00 2.77 2.77 
Lactate 0.00 0.00 121.74 121.71 
MAB 31.79 31.79 35.24 35.23 
Other Media Components 0.00 0.00 0.02 0.02 
Vitamins 0.00 0.00 0.01 0.01 
Water 0.00 0.00 308.24 308.16 
WFI 4447.05 4447.05 12840.42 12836.85 
TOTAL (kg/batch) 4505.68 4505.68 13331.28 13323.88 
TOTAL (L/batch) 4493.60 4493.60 13377.21 13369.77 
   
Stream Name Waste-6 Polysorb80 S-223 Vent-9 
Source P-30 INPUT P-42 P-43 
Destination OUTPUT P-43 P-43 OUTPUT 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 25.02 4.00 4.39 4.39 
Pressure (bar) 4.46 1.01 4.46 1.01 
Density (g/L) 995.63 881.61 1002.26 1.27 
Component Flowrates (kg/batch) 
Amino Acids 0.00 0.00 0.00 0.00 
Acetic-Acid 0.00 0.00 0.71 0.00 
Biomass 3.70 0.00 0.00 0.00 
Dead Biomass 0.01 0.00 0.00 0.00 
Glucose 0.00 0.00 0.00 0.00 
Glutamine 0.00 0.00 0.00 0.00 
Impurities 0.00 0.00 0.46 0.00 
Inorganic Salts 0.00 0.00 0.00 0.00 
Lactate 0.03 0.00 0.00 0.00 
MAB 0.01 0.00 30.84 0.00 
Nitrogen 0.00 0.00 0.00 0.81 
Other Media Components 0.00 0.00 0.00 0.00 
Oxygen 0.00 0.00 0.00 0.25 
Polysorbate 80 0.00 0.09 0.00 0.00 
Vitamins 0.00 0.00 0.00 0.00 
Water 0.09 0.00 0.00 0.00 
WFI 3.57 0.09 868.88 0.00 
TOTAL (kg/batch) 7.40 0.18 900.89 1.05 
TOTAL (L/batch) 7.44 0.20 898.86 830.02 
   
Stream Name S-224 S-225 To IEX S-208 
Source P-43 P-44 P-45 P-33 
Destination P-44 P-45 OUTPUT P-34 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
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Temperature (°C) 4.39 4.43 4.43 25.05 
Pressure (bar) 1.01 4.46 4.46 2.74 
Density (g/L) 1002.23 1002.22 1002.22 996.55 
Component Flowrates (kg/batch) 
Amino Acids 0.00 0.00 0.00 0.27 
Acetic-Acid 0.71 0.71 0.71 0.00 
Dead Biomass 0.00 0.00 0.00 17.59 
Glucose 0.00 0.00 0.00 1.14 
Glutamine 0.00 0.00 0.00 0.13 
Impurities 0.46 0.46 0.46 0.00 
Inorganic Salts 0.00 0.00 0.00 2.77 
Lactate 0.00 0.00 0.00 121.71 
MAB 30.84 30.84 30.84 35.23 
Other Media Components 0.00 0.00 0.00 0.02 
Polysorbate 80 0.09 0.09 0.09 0.00 
Vitamins 0.00 0.00 0.00 0.01 
Water 0.00 0.00 0.00 308.16 
WFI 868.97 868.97 868.97 12836.85 
TOTAL (kg/batch) 901.07 901.07 901.07 13323.88 
TOTAL (L/batch) 899.06 899.07 899.07 13369.95 
   
Stream Name Waste-7 S-214   
Source P-34 P-34   
Destination OUTPUT P-35   
Stream Properties 
Activity (U/ml) 0.00 0.00   
Temperature (°C) 4.00 4.00   
Pressure (bar) 2.74 2.74   
Density (g/L) 1004.30 1004.25   
Component Flowrates (kg/batch) 
Amino Acids 0.24 0.03   
Dead Biomass 15.87 1.72   
Glucose 1.03 0.11   
Glutamine 0.12 0.01   
Inorganic Salts 2.50 0.27   
Lactate 109.83 11.88   
MAB 0.00 35.23   
Other Media Components 0.02 0.00   
Vitamins 0.01 0.00   
Water 278.08 30.08   
WFI 11583.85 1253.00   
TOTAL (kg/batch) 11991.55 1332.33   
TOTAL (L/batch) 11940.22 1326.69   
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3A. Pepsin CLEAVAGE OVERALL PROCESS DATA 
     
Annual Operating Time 7915.92 h 
Annual Throughput 0.00 kg MP 
Batch Throughput 0.00 kg MP 
Recipe Batch Time 28.88 h 
Recipe Cycle Time 9.68 h 
Number of Batches per Year 816.00  
MP = Main Product = Undefined 
     
STREAM DETAILS 
     
Stream Name From Bioreactor S-201 S-206 Vent 7 
Source INPUT P-26 P-31 P-32 
Destination P-26 P-27 P-32 OUTPUT 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 25.00 25.00 25.04 25.04 
Pressure (bar) 1.01 1.01 6.18 1.01 
Density (g/L) 999.04 999.04 999.10 1.18 
Component Flowrates (kg/batch) 
Amino Acids 3.49 3.49 3.15 0.00 
Biomass 167.26 167.26 0.00 0.00 
Dead Biomass 17.14 17.14 15.48 0.00 
Glucose 14.75 14.75 13.32 0.00 
Glutamine 1.71 1.71 1.54 0.00 
Inorganic Salts 35.77 35.77 32.31 0.00 
Lactate 118.59 118.59 107.12 0.00 
MAB 34.32 34.32 31.00 0.00 
Nitrogen 0.00 0.00 0.00 7.87 
Other Media Components 0.31 0.31 0.28 0.00 
Oxygen 0.00 0.00 0.00 2.39 
Vitamins 0.15 0.15 0.13 0.00 
Water 300.26 300.26 271.22 0.00 
WFI 9096.99 9096.99 8217.36 0.00 
TOTAL (kg/batch) 9790.72 9790.72 8692.92 10.26 
TOTAL (L/batch) 9800.11 9800.11 8700.71 8701.88 
   
Stream Name S-207 From Dia1 S-208 Vent 8 
Source P-32 P-35 P-33 P-34 
Destination P-33 P-34 P-34 OUTPUT 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
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Temperature (°C) 25.04 25.33 25.05 25.17 
Pressure (bar) 1.01 1.01 2.74 1.01 
Density (g/L) 999.10 995.33 999.10 1.18 
Component Flowrates (kg/batch) 
Amino Acids 3.15 0.14 3.15 0.00 
Dead Biomass 15.48 0.69 15.48 0.00 
Glucose 13.32 0.60 13.32 0.00 
Glutamine 1.54 0.07 1.54 0.00 
HCl 0.00 0.00 0.00 0.00 
Impurities 0.00 0.50 0.00 0.00 
Inorganic Salts 32.31 1.45 32.31 0.00 
Lactate 107.12 4.80 107.12 0.00 
MAB 31.00 30.07 31.00 0.00 
Nitrogen 0.00 0.00 0.00 10.50 
Other Media Components 0.28 0.01 0.28 0.00 
Oxygen 0.00 0.00 0.00 3.19 
Sodium Acetate 0.00 6.70 0.00 0.00 
Vitamins 0.13 0.01 0.13 0.00 
Water 271.22 12.14 271.22 0.00 
WFI 8217.36 2833.00 8217.36 0.00 
TOTAL (kg/batch) 8692.92 2890.17 8692.92 13.69 
TOTAL (L/batch) 8700.71 2903.75 8700.77 11617.11 
   
Stream Name To Dia1 S-209 
Pepsin 
Dig 
Buffer 2-
1 
WFI In 
2-1 
Source P-34 P-34 INPUT INPUT 
Destination P-35 P-36 P-35 P-35 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 25.05 25.33 25.00 4.00 
Pressure (bar) 1.01 1.01 1.01 1.01 
Density (g/L) 999.10 995.98 995.37 1002.36 
Component Flowrates (kg/batch) 
Amino Acids 3.15 0.14 0.00 0.00 
Dead Biomass 15.48 0.69 0.00 0.00 
Glucose 13.32 0.60 0.00 0.00 
Glutamine 1.54 0.07 0.00 0.00 
HCl 0.00 0.00 0.02 0.00 
Impurities 0.00 0.50 0.00 0.00 
Inorganic Salts 32.31 1.45 0.00 0.00 
Lactate 107.12 4.80 0.00 0.00 
MAB 31.00 30.07 0.00 0.00 
Other Media Components 0.28 0.01 0.00 0.00 
Sodium Acetate 0.00 6.70 46.99 0.00 
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Vitamins 0.13 0.01 0.00 0.00 
Water 271.22 12.14 0.00 0.00 
WFI 8217.36 2833.00 17274.02 1002.36 
TOTAL (kg/batch) 8692.92 2890.17 17321.03 1002.36 
TOTAL (L/batch) 8700.77 2901.84 17401.54 1000.00 
   
Stream Name WFI Out 2-1 Waste 7 S-202 S-203 
Source P-35 P-35 P-27 P-28 
Destination OUTPUT OUTPUT P-28 P-29 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 4.00 25.33 25.02 25.00 
Pressure (bar) 1.01 1.01 2.74 2.74 
Density (g/L) 1002.36 996.28 999.04 999.12 
Component Flowrates (kg/batch) 
Amino Acids 0.00 3.01 3.49 3.15 
Biomass 0.00 0.00 167.26 3.35 
Dead Biomass 0.00 14.79 17.14 15.49 
Glucose 0.00 12.73 14.75 13.33 
Glutamine 0.00 1.47 1.71 1.54 
HCl 0.00 0.02 0.00 0.00 
Impurities 0.00 0.43 0.00 0.00 
Inorganic Salts 0.00 30.87 35.77 32.33 
Lactate 0.00 102.33 118.59 107.16 
MAB 0.00 0.00 34.32 31.02 
Other Media Components 0.00 0.27 0.31 0.28 
Sodium Acetate 0.00 40.29 0.00 0.00 
Vitamins 0.00 0.13 0.15 0.13 
Water 0.00 259.08 300.26 271.33 
WFI 1002.36 22658.39 9096.99 8220.54 
TOTAL (kg/batch) 1002.36 23123.78 9790.72 8699.62 
TOTAL (L/batch) 1000.00 23210.20 9800.18 8707.32 
   
Stream Name Waste 5 S-204 S-205 Waste 6 
Source P-28 P-29 P-30 P-30 
Destination OUTPUT P-30 P-31 OUTPUT 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 25.00 25.02 25.02 25.02 
Pressure (bar) 2.74 4.46 4.46 4.46 
Density (g/L) 998.45 999.11 999.11 996.90 
Component Flowrates (kg/batch) 
Amino Acids 0.34 3.15 3.15 0.00 
Biomass 163.92 3.35 0.00 3.35 
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Dead Biomass 1.65 15.49 15.48 0.01 
Glucose 1.42 13.33 13.32 0.01 
Glutamine 0.16 1.54 1.54 0.00 
Inorganic Salts 3.45 32.33 32.31 0.01 
Lactate 11.43 107.16 107.12 0.04 
MAB 3.31 31.02 31.00 0.01 
Other Media Components 0.03 0.28 0.28 0.00 
Vitamins 0.01 0.13 0.13 0.00 
Water 28.93 271.33 271.22 0.11 
WFI 876.45 8220.54 8217.36 3.18 
TOTAL (kg/batch) 1091.10 8699.62 8692.92 6.71 
TOTAL (L/batch) 1092.79 8707.38 8700.66 6.73 
   
Stream Name S-210 
Pepsin 
Dig 
Buffer 2-
2 
Pepsin Waste 8 
Source P-36 INPUT INPUT P-37 
Destination P-37 P-37 P-37 OUTPUT 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 25.40 25.00 25.00 37.00 
Pressure (bar) 7.91 1.01 1.01 10.54 
Density (g/L) 995.95 995.37 994.70 990.33 
Component Flowrates (kg/batch) 
Amino Acids 0.14 0.00 0.00 0.00 
Dead Biomass 0.69 0.00 0.00 0.00 
Glucose 0.60 0.00 0.00 0.00 
Glutamine 0.07 0.00 0.00 0.00 
HCl 0.00 0.00 0.00 0.00 
Impurities 0.50 0.00 0.00 0.00 
Inorganic Salts 1.45 0.00 0.00 0.00 
Lactate 4.80 0.00 0.00 0.00 
MAB 30.07 0.00 0.00 0.00 
Other Media Components 0.01 0.00 0.00 0.00 
Pepsin 0.00 0.00 1540.43 0.00 
Sodium Acetate 6.70 4.18 0.00 0.00 
Vitamins 0.01 0.00 0.00 0.00 
Water 12.14 0.00 0.00 0.00 
WFI 2833.00 1537.28 1540.43 3546.42 
TOTAL (kg/batch) 2890.17 1541.46 3080.85 3546.42 
TOTAL (L/batch) 2901.92 1548.63 3097.25 3581.05 
   
Stream Name S-211 S-212 Tris-HCl Waste 9 
Source P-37 P-38 INPUT P-39 
Destination P-38 P-39 P-39 OUTPUT 
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Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 37.00 37.26 4.00 28.89 
Pressure (bar) 2.01 27.01 1.01 1.01 
Density (g/L) 991.71 991.61 1096.65 1004.53 
Component Flowrates (kg/batch) 
Amino Acids 0.14 0.14 0.00 0.01 
Dead Biomass 0.69 0.69 0.00 0.04 
F(ab')2 15.24 15.24 0.00 0.92 
Glucose 0.60 0.60 0.00 0.04 
Glutamine 0.07 0.07 0.00 0.00 
Impurities 0.50 0.50 0.00 0.03 
Inorganic Salts 1.45 1.45 0.00 0.09 
Lactate 4.80 4.80 0.00 0.29 
MAB 1.50 1.50 0.00 0.09 
MAb Fc Fragments 13.33 13.33 0.00 0.81 
Other Media Components 0.01 0.01 0.00 0.00 
Pepsin 1540.43 1540.43 0.00 1540.43 
Sodium Acetate 10.88 10.88 0.00 0.66 
TRIS HCl 0.00 0.00 206.78 46.03 
Vitamins 0.01 0.01 0.00 0.00 
Water 12.14 12.14 0.00 0.74 
WFI 2364.28 2364.28 2340.66 664.30 
TOTAL (kg/batch) 3966.06 3966.06 2547.44 2254.47 
TOTAL (L/batch) 3999.22 3999.61 2322.93 2244.31 
   
Stream Name S-213 
RR 
Buffer 2-
1 
S-220 WFI In 2-2 
Source P-39 INPUT P-41 INPUT 
Destination P-40 P-42 P-42 P-42 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 26.81 4.00 26.89 4.00 
Pressure (bar) 1.01 1.01 1.01 1.01 
Density (g/L) 1016.01 2084.92 1015.98 1002.36 
Component Flowrates (kg/batch) 
Amino Acids 0.13 0.00 0.13 0.00 
Dead Biomass 0.65 0.00 0.65 0.00 
EDTA, Sodium 0.00 432.20 0.00 0.00 
F(ab')2 14.31 0.00 14.31 0.00 
Glucose 0.56 0.00 0.56 0.00 
Glutamine 0.07 0.00 0.07 0.00 
Impurities 0.47 0.00 0.47 0.00 
Inorganic Salts 1.36 0.00 1.36 0.00 
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Lactate 4.51 0.00 4.51 0.00 
MAB 1.41 0.00 1.41 0.00 
MAb Fc Fragments 12.53 0.00 12.53 0.00 
Other Media Components 0.01 0.00 0.01 0.00 
Sodium Acetate 10.22 0.00 10.22 0.00 
Sodium Chloride 0.00 12965.87 0.00 0.00 
Sodium Phosphate 0.00 4082.05 0.00 0.00 
TRIS HCl 160.75 0.00 160.75 0.00 
Vitamins 0.01 0.00 0.01 0.00 
Water 11.41 0.00 11.41 0.00 
WFI 4040.65 0.00 4040.65 501.18 
TOTAL (kg/batch) 4259.03 17480.11 4259.03 501.18 
TOTAL (L/batch) 4191.93 8384.08 4192.04 500.00 
   
Stream Name S-219 WFI Out 2-2 Waste 10 S-214 
Source P-42 P-42 P-42 P-40 
Destination P-41 OUTPUT OUTPUT P-41 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 8.70 4.00 8.70 26.89 
Pressure (bar) 1.01 1.01 1.01 7.91 
Density (g/L) 1916.29 1002.36 1616.50 1015.98 
Component Flowrates (kg/batch) 
Amino Acids 0.02 0.00 0.11 0.13 
Dead Biomass 0.09 0.00 0.56 0.65 
EDTA, Sodium 186.20 0.00 246.00 0.00 
F(ab')2 14.31 0.00 0.00 14.31 
Glucose 0.08 0.00 0.48 0.56 
Glutamine 0.01 0.00 0.06 0.07 
Impurities 0.34 0.00 0.17 0.47 
Inorganic Salts 0.18 0.00 1.18 1.36 
Lactate 0.61 0.00 3.90 4.51 
MAB 0.19 0.00 1.19 1.41 
MAb Fc Fragments 1.70 0.00 10.83 12.53 
Other Media Components 0.00 0.00 0.01 0.01 
Sodium Acetate 1.38 0.00 8.84 10.22 
Sodium Chloride 5585.88 0.00 7379.99 0.00 
Sodium Phosphate 1758.60 0.00 2323.44 0.00 
TRIS HCl 21.76 0.00 138.99 160.75 
Vitamins 0.00 0.00 0.01 0.01 
Water 1.54 0.00 9.86 11.41 
WFI 546.84 501.18 3493.81 4040.65 
TOTAL (kg/batch) 8119.73 501.18 13619.41 4259.03 
TOTAL (L/batch) 4237.21 500.00 8425.26 4192.04 
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Stream Name Vent 11 S-215 S-216 2-MEA 
Source P-41 P-41 P-43 INPUT 
Destination OUTPUT P-43 P-44 P-44 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 14.01 8.71 8.78 25.00 
Pressure (bar) 1.01 1.01 7.91 1.01 
Density (g/L) 1.22 1916.29 1916.26 994.70 
Component Flowrates (kg/batch) 
2-MEA 0.00 0.00 0.00 0.08 
Amino Acids 0.00 0.02 0.02 0.00 
Dead Biomass 0.00 0.09 0.09 0.00 
EDTA, Sodium 0.00 186.20 186.20 0.00 
F(ab')2 0.00 14.31 14.31 0.00 
Glucose 0.00 0.08 0.08 0.00 
Glutamine 0.00 0.01 0.01 0.00 
Impurities 0.00 0.34 0.34 0.00 
Inorganic Salts 0.00 0.18 0.18 0.00 
Lactate 0.00 0.61 0.61 0.00 
MAB 0.00 0.19 0.19 0.00 
MAb Fc Fragments 0.00 1.70 1.70 0.00 
Nitrogen 8.22 0.00 0.00 0.00 
Other Media Components 0.00 0.00 0.00 0.00 
Oxygen 2.49 0.00 0.00 0.00 
Sodium Acetate 0.00 1.38 1.38 0.00 
Sodium Chloride 0.00 5585.88 5585.88 0.00 
Sodium Phosphate 0.00 1758.60 1758.60 0.00 
TRIS HCl 0.00 21.76 21.76 0.00 
Vitamins 0.00 0.00 0.00 0.00 
Water 0.00 1.54 1.54 0.00 
WFI 0.00 546.84 546.84 0.00 
TOTAL (kg/batch) 10.71 8119.73 8119.73 0.08 
TOTAL (L/batch) 8748.17 4237.21 4237.28 0.08 
   
Stream Name S-217 WFI In 2-3 S-226 
WFI In 
2-4 
Source P-44 INPUT P-46 INPUT 
Destination P-45 P-47 P-47 P-47 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 37.00 4.00 37.01 4.00 
Pressure (bar) 10.54 1.01 1.01 1.01 
Density (g/L) 1904.01 1002.36 1904.00 1002.36 
Component Flowrates (kg/batch) 
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2-MEA 0.08 0.00 0.08 0.00 
Amino Acids 0.02 0.00 0.02 0.00 
Dead Biomass 0.09 0.00 0.09 0.00 
EDTA, Sodium 186.20 0.00 186.20 0.00 
Glucose 0.08 0.00 0.08 0.00 
Glutamine 0.01 0.00 0.01 0.00 
Impurities 0.34 0.00 0.34 0.00 
Inorganic Salts 0.18 0.00 0.18 0.00 
Lactate 0.61 0.00 0.61 0.00 
MAB 0.19 0.00 0.19 0.00 
MAb Fab Fragments 14.31 0.00 14.31 0.00 
MAb Fc Fragments 1.70 0.00 1.70 0.00 
Other Media Components 0.00 0.00 0.00 0.00 
Sodium Acetate 1.38 0.00 1.38 0.00 
Sodium Chloride 5585.88 0.00 5585.88 0.00 
Sodium Phosphate 1758.60 0.00 1758.60 0.00 
TRIS HCl 21.76 0.00 21.76 0.00 
Vitamins 0.00 0.00 0.00 0.00 
Water 1.54 0.00 1.54 0.00 
WFI 546.84 8549.31 546.84 501.18 
TOTAL (kg/batch) 8119.81 8549.31 8119.81 501.18 
TOTAL (L/batch) 4264.59 8529.19 4264.60 500.00 
   
Stream Name S-225 WFI Out 2-3 Waste 12 S-218 
Source P-47 P-47 P-47 P-45 
Destination P-46 OUTPUT OUTPUT P-46 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 20.30 4.00 20.30 37.01 
Pressure (bar) 1.01 1.01 1.01 11.54 
Density (g/L) 1119.19 1002.36 1389.74 1904.00 
Component Flowrates (kg/batch) 
2-MEA 0.01 0.00 0.07 0.08 
Amino Acids 0.00 0.00 0.02 0.02 
Dead Biomass 0.01 0.00 0.08 0.09 
EDTA, Sodium 25.20 0.00 161.00 186.20 
Glucose 0.01 0.00 0.07 0.08 
Glutamine 0.00 0.00 0.01 0.01 
Impurities 0.23 0.00 0.12 0.34 
Inorganic Salts 0.03 0.00 0.16 0.18 
Lactate 0.08 0.00 0.53 0.61 
MAB 0.02 0.00 0.16 0.19 
MAb Fab Fragments 14.31 0.00 0.00 14.31 
MAb Fc Fragments 0.23 0.00 1.47 1.70 
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Other Media Components 0.00 0.00 0.00 0.00 
Sodium Acetate 0.19 0.00 1.20 1.38 
Sodium Chloride 755.97 0.00 4829.92 5585.88 
Sodium Phosphate 238.00 0.00 1520.60 1758.60 
TRIS HCl 2.94 0.00 18.81 21.76 
Vitamins 0.00 0.00 0.00 0.00 
Water 0.21 0.00 1.34 1.54 
WFI 3757.43 501.18 5338.72 546.84 
TOTAL (kg/batch) 4794.89 501.18 11874.23 8119.81 
TOTAL (L/batch) 4284.25 500.00 8544.24 4264.60 
   
Stream Name Vent 13 To Protein A   
Source P-46 P-46   
Destination OUTPUT OUTPUT   
Stream Properties 
Activity (U/ml) 0.00 0.00   
Temperature (°C) 25.36 20.31   
Pressure (bar) 1.01 1.01   
Density (g/L) 1.18 1119.19   
Component Flowrates (kg/batch) 
2-MEA 0.00 0.01   
Amino Acids 0.00 0.00   
Dead Biomass 0.00 0.01   
EDTA, Sodium 0.00 25.20   
Glucose 0.00 0.01   
Glutamine 0.00 0.00   
Impurities 0.00 0.23   
Inorganic Salts 0.00 0.03   
Lactate 0.00 0.08   
MAB 0.00 0.02   
MAb Fab Fragments 0.00 14.31   
MAb Fc Fragments 0.00 0.23   
Nitrogen 8.22 0.00   
Other Media Components 0.00 0.00   
Oxygen 2.50 0.00   
Sodium Acetate 0.00 0.19   
Sodium Chloride 0.00 755.97   
Sodium Phosphate 0.00 238.00   
TRIS HCl 0.00 2.94   
Vitamins 0.00 0.00   
Water 0.00 0.21   
WFI 0.00 3757.43   
TOTAL (kg/batch) 10.72 4794.89   
TOTAL (L/batch) 9102.01 4284.25   
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3B. Pepsin CLEAVAGE OVERALL PROCESS DATA 
     
Annual Operating Time 7874.21 h 
Annual Throughput 100215.01 kg MP 
Batch Throughput 879.08 kg MP 
Recipe Batch Time 69.57 h 
Recipe Cycle Time 69.07 h 
Number of Batches per Year 114.00  
MP = Main Product = Total flow of stream To IEX 
     
STREAM DETAILS 
     
Stream Name 
From 
Pepsin 
Cleavage 
S-101 ProtA-Equiil. 
ProtA-
Wash 
Source INPUT P-48 INPUT INPUT 
Destination P-48 P-49 P-49 P-49 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 20.31 20.35 25.00 4.00 
Pressure (bar) 1.01 4.46 1.01 1.01 
Density (g/L) 1119.19 1119.17 998.35 1006.01 
Component Flowrates (kg/batch) 
2-MEA 0.01 0.01 0.00 0.00 
Amino Acids 0.00 0.00 0.00 0.00 
Dead Biomass 0.01 0.01 0.00 0.00 
EDTA, Sodium 25.20 25.20 0.17 0.20 
Glucose 0.01 0.01 0.00 0.00 
Glutamine 0.00 0.00 0.00 0.00 
Impurities 0.23 0.23 0.00 0.00 
Inorganic Salts 0.03 0.03 0.00 0.00 
Lactate 0.08 0.08 0.00 0.00 
MAB 0.02 0.02 0.00 0.00 
MAb Fab Fragments 14.31 14.31 0.00 0.00 
MAb Fc Fragments 0.23 0.23 0.00 0.00 
Other Media Components 0.00 0.00 0.00 0.00 
Sodium Acetate 0.19 0.19 0.00 0.00 
Sodium Chloride 755.97 755.97 0.08 0.10 
Sodium Phosphate 238.00 238.00 0.00 0.00 
TRIS Base 0.00 0.00 0.08 0.10 
TRIS HCl 2.94 2.94 0.25 0.31 
Vitamins 0.00 0.00 0.00 0.00 
Water 0.21 0.21 0.00 0.00 
WFI 3757.43 3757.43 83.85 101.39 
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TOTAL (kg/batch) 4794.89 4794.89 84.44 102.11 
TOTAL (L/batch) 4284.26 4284.31 84.58 101.50 
   
Stream Name ProtA-Elut. 
ProtA-
Reg. S-227 Waste 13 
Source INPUT INPUT P-49 P-49 
Destination P-49 P-49 P-50 OUTPUT 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 4.00 4.00 20.23 10.16 
Pressure (bar) 1.01 1.01 1.01 1.01 
Density (g/L) 1002.70 1003.19 1118.26 1002.67 
Component Flowrates (kg/batch) 
2-MEA 0.00 0.00 0.01 0.00 
Amino Acids 0.00 0.00 0.00 0.00 
Acetic-Acid 0.51 0.00 0.20 0.31 
Dead Biomass 0.00 0.00 0.01 0.00 
EDTA, Sodium 0.00 0.00 25.20 0.37 
Glucose 0.00 0.00 0.01 0.00 
Glutamine 0.00 0.00 0.00 0.00 
Impurities 0.00 0.00 0.18 0.06 
Inorganic Salts 0.00 0.00 0.03 0.00 
Lactate 0.00 0.00 0.08 0.00 
MAB 0.00 0.00 0.00 0.02 
MAb Fab Fragments 0.00 0.00 14.31 0.00 
MAb Fc Fragments 0.00 0.00 0.00 0.23 
Other Media Components 0.00 0.00 0.00 0.00 
Sodium Acetate 0.00 0.00 0.19 0.00 
Sodium Chloride 0.00 0.00 755.97 0.19 
Sodium Citrate 0.00 0.09 0.00 0.09 
Sodium Phosphate 0.00 0.00 238.00 0.00 
TRIS Base 0.00 0.00 0.00 0.19 
TRIS HCl 0.00 0.00 2.94 0.56 
Vitamins 0.00 0.00 0.00 0.00 
Water 0.00 0.00 0.21 0.00 
WFI 84.30 50.82 3791.15 286.64 
TOTAL (kg/batch) 84.81 50.91 4828.50 288.65 
TOTAL (L/batch) 84.58 50.75 4317.86 287.88 
   
Stream Name WFI 2-5 S-232 WFI 2-6 S-231 
Source INPUT P-53 INPUT P-54 
Destination P-54 P-54 P-54 P-53 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 4.00 20.30 4.00 16.29 
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Pressure (bar) 1.01 1.01 1.01 1.01 
Density (g/L) 1002.36 1118.23 1002.36 1014.07 
Component Flowrates (kg/batch) 
2-MEA 0.00 0.01 0.00 0.00 
Amino Acids 0.00 0.00 0.00 0.00 
Acetic-Acid 0.00 0.20 0.00 0.01 
EDTA, Sodium 0.00 25.20 0.00 0.67 
Glucose 0.00 0.01 0.00 0.00 
Glutamine 0.00 0.00 0.00 0.00 
Impurities 0.00 0.18 0.00 0.09 
Inorganic Salts 0.00 0.03 0.00 0.00 
Lactate 0.00 0.08 0.00 0.00 
MAb Fab Fragments 0.00 14.31 0.00 14.31 
Other Media Components 0.00 0.00 0.00 0.00 
Sodium Acetate 0.00 0.19 0.00 0.01 
Sodium Chloride 0.00 755.97 0.00 20.19 
Sodium Phosphate 0.00 238.00 0.00 6.36 
TRIS HCl 0.00 2.94 0.00 0.08 
Vitamins 0.00 0.00 0.00 0.00 
Water 0.00 0.21 0.00 0.01 
WFI 1731.25 3791.14 501.18 837.19 
TOTAL (kg/batch) 1731.25 4828.48 501.18 878.90 
TOTAL (L/batch) 1727.18 4317.95 500.00 866.71 
   
Stream Name WFI Out 2-4 Waste 15 S-230 Vent 14 
Source P-54 P-54 P-52 P-53 
Destination OUTPUT OUTPUT P-53 OUTPUT 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 4.00 16.29 20.30 19.12 
Pressure (bar) 1.01 1.01 7.91 1.01 
Density (g/L) 1002.36 1096.65 1118.24 1.20 
Component Flowrates (kg/batch) 
2-MEA 0.00 0.01 0.01 0.00 
Amino Acids 0.00 0.00 0.00 0.00 
Acetic-Acid 0.00 0.20 0.20 0.00 
EDTA, Sodium 0.00 24.53 25.20 0.00 
Glucose 0.00 0.01 0.01 0.00 
Glutamine 0.00 0.00 0.00 0.00 
Impurities 0.00 0.09 0.18 0.00 
Inorganic Salts 0.00 0.02 0.03 0.00 
Lactate 0.00 0.08 0.08 0.00 
MAb Fab Fragments 0.00 0.00 14.31 0.00 
Nitrogen 0.00 0.00 0.00 4.65 
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Other Media Components 0.00 0.00 0.00 0.00 
Oxygen 0.00 0.00 0.00 1.41 
Sodium Acetate 0.00 0.18 0.19 0.00 
Sodium Chloride 0.00 735.78 755.97 0.00 
Sodium Phosphate 0.00 231.65 238.00 0.00 
TRIS HCl 0.00 2.87 2.94 0.00 
Vitamins 0.00 0.00 0.00 0.00 
Water 0.00 0.20 0.21 0.00 
WFI 501.18 4685.21 3791.14 0.00 
TOTAL (kg/batch) 501.18 5680.83 4828.48 6.06 
TOTAL (L/batch) 500.00 5180.17 4317.94 5034.34 
   
Stream Name S-233 S-228 S-229 Waste 14 
Source P-53 P-50 P-51 P-51 
Destination P-55 P-51 P-52 OUTPUT 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 16.30 20.27 20.27 20.27 
Pressure (bar) 1.01 4.46 4.46 4.46 
Density (g/L) 1014.07 1118.25 1118.25 1084.12 
Component Flowrates (kg/batch) 
2-MEA 0.00 0.01 0.01 0.00 
Amino Acids 0.00 0.00 0.00 0.00 
Acetic-Acid 0.01 0.20 0.20 0.00 
Dead Biomass 0.00 0.01 0.00 0.01 
EDTA, Sodium 0.67 25.20 25.20 0.00 
Glucose 0.00 0.01 0.01 0.00 
Glutamine 0.00 0.00 0.00 0.00 
Impurities 0.09 0.18 0.18 0.00 
Inorganic Salts 0.00 0.03 0.03 0.00 
Lactate 0.00 0.08 0.08 0.00 
MAb Fab Fragments 14.31 14.31 14.31 0.00 
Other Media Components 0.00 0.00 0.00 0.00 
Sodium Acetate 0.01 0.19 0.19 0.00 
Sodium Chloride 20.19 755.97 755.97 0.00 
Sodium Phosphate 6.36 238.00 238.00 0.00 
TRIS HCl 0.08 2.94 2.94 0.00 
Vitamins 0.00 0.00 0.00 0.00 
Water 0.01 0.21 0.21 0.00 
WFI 837.19 3791.15 3791.14 0.01 
TOTAL (kg/batch) 878.90 4828.50 4828.48 0.03 
TOTAL (L/batch) 866.71 4317.91 4317.89 0.02 
   
Stream Name Polysorb80 S-234 Vent 15 S-235 
Source INPUT P-55 P-56 P-56 
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Destination P-56 P-56 OUTPUT P-57 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 4.00 16.34 16.34 16.34 
Pressure (bar) 1.01 4.46 1.01 1.01 
Density (g/L) 881.61 1014.06 1.21 1014.03 
Component Flowrates (kg/batch) 
2-MEA 0.00 0.00 0.00 0.00 
Amino Acids 0.00 0.00 0.00 0.00 
Acetic-Acid 0.00 0.01 0.00 0.01 
EDTA, Sodium 0.00 0.67 0.00 0.67 
Glucose 0.00 0.00 0.00 0.00 
Glutamine 0.00 0.00 0.00 0.00 
Impurities 0.00 0.09 0.00 0.09 
Inorganic Salts 0.00 0.00 0.00 0.00 
Lactate 0.00 0.00 0.00 0.00 
MAb Fab Fragments 0.00 14.31 0.00 14.31 
Nitrogen 0.00 0.00 0.78 0.00 
Other Media Components 0.00 0.00 0.00 0.00 
Oxygen 0.00 0.00 0.24 0.00 
Polysorbate 80 0.09 0.00 0.00 0.09 
Sodium Acetate 0.00 0.01 0.00 0.01 
Sodium Chloride 0.00 20.19 0.00 20.19 
Sodium Phosphate 0.00 6.36 0.00 6.36 
TRIS HCl 0.00 0.08 0.00 0.08 
Vitamins 0.00 0.00 0.00 0.00 
Water 0.00 0.01 0.00 0.01 
WFI 0.09 837.19 0.00 837.28 
TOTAL (kg/batch) 0.18 878.90 1.02 879.08 
TOTAL (L/batch) 0.20 866.72 838.94 866.92 
   
Stream Name S-236 To IEX   
Source P-57 P-58   
Destination P-58 OUTPUT   
Stream Properties 
Activity (U/ml) 0.00 0.00   
Temperature (°C) 16.37 16.37   
Pressure (bar) 4.46 4.46   
Density (g/L) 1014.01 1014.01   
Component Flowrates (kg/batch) 
2-MEA 0.00 0.00   
Amino Acids 0.00 0.00   
Acetic-Acid 0.01 0.01   
EDTA, Sodium 0.67 0.67   
Glucose 0.00 0.00   
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Glutamine 0.00 0.00   
Impurities 0.09 0.09   
Inorganic Salts 0.00 0.00   
Lactate 0.00 0.00   
MAb Fab Fragments 14.31 14.31   
Other Media Components 0.00 0.00   
Polysorbate 80 0.09 0.09   
Sodium Acetate 0.01 0.01   
Sodium Chloride 20.19 20.19   
Sodium Phosphate 6.36 6.36   
TRIS HCl 0.08 0.08   
Vitamins 0.00 0.00   
Water 0.01 0.01   
WFI 837.28 837.28   
TOTAL (kg/batch) 879.08 879.08   
TOTAL (L/batch) 866.93 866.93   
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4. IEX OVERALL PROCESS DATA 
     
Annual Operating Time 7916.33 h 
Annual Throughput 11064.57 kg MP 
Batch Throughput 14.31 kg MP 
Recipe Batch Time 15.37 h 
Recipe Cycle Time 10.23 h 
Number of Batches per Year 773.00  
MP = Main Product = Flow of MAb Fab Fragments in stream From Protein A 
     
STREAM DETAILS 
     
Stream Name Cat. Buffer B Vent20 
Cation 
Buffer A Vent19 
Source INPUT P-60 INPUT P-59 
Destination P-60 OUTPUT P-59 OUTPUT 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 25.00 25.00 25.00 25.00 
Pressure (bar) 1.01 1.01 1.01 1.01 
Density (g/L) 1046.15 1.18 994.70 1.18 
Component Flowrates (kg/batch) 
MES 7.81 0.00 96.71 0.00 
Nitrogen 0.00 0.76 0.00 9.01 
Oxygen 0.00 0.23 0.00 2.74 
Sodium Chloride 46.77 0.00 0.00 0.00 
WFI 800.30 0.00 9810.13 0.00 
TOTAL (kg/batch) 854.88 0.99 9906.84 11.75 
TOTAL (L/batch) 817.17 836.58 9959.58 9959.58 
   
Stream Name Cat-Wash1 
Cat-
Load1 
Cat-
Equil2 
Cat-
Wash2 
Source P-59 P-59 P-66 P-65 
Destination P-65 P-62 P-68 P-68 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 25.00 25.00 25.01 25.01 
Pressure (bar) 1.01 1.01 2.01 2.01 
Density (g/L) 994.70 994.70 994.70 994.70 
Component Flowrates (kg/batch) 
MES 4.55 87.60 4.55 4.55 
WFI 461.86 8886.41 461.86 461.86 
TOTAL (kg/batch) 466.42 8974.01 466.42 466.42 
TOTAL (L/batch) 468.90 9021.79 468.90 468.90 
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Stream Name Cat-WFI Cat-Elute2 
Cat-
Strip2 Fab Load 
Source INPUT P-64 P-63 P-67 
Destination P-68 P-68 P-68 P-68 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 25.00 25.01 25.01 24.25 
Pressure (bar) 1.01 2.01 2.01 2.01 
Density (g/L) 994.70 1021.87 1021.87 996.40 
Component Flowrates (kg/batch) 
2-MEA 0.00 0.00 0.00 0.00 
Amino Acids 0.00 0.00 0.00 0.00 
Acetic-Acid 0.00 0.00 0.00 0.01 
EDTA, Sodium 0.00 0.00 0.00 0.67 
Glucose 0.00 0.00 0.00 0.00 
Glutamine 0.00 0.00 0.00 0.00 
Impurities 0.00 0.00 0.00 0.09 
Inorganic Salts 0.00 0.00 0.00 0.00 
Lactate 0.00 0.00 0.00 0.00 
MAb Fab Fragments 0.00 0.00 0.00 14.31 
MES 0.00 3.43 4.38 87.60 
Other Media Components 0.00 0.00 0.00 0.00 
Polysorbate 80 0.00 0.00 0.00 0.09 
Sodium Acetate 0.00 0.00 0.00 0.01 
Sodium Chloride 0.00 20.56 26.21 20.19 
Sodium Phosphate 0.00 0.00 0.00 6.36 
TRIS HCl 0.00 0.00 0.00 0.08 
Vitamins 0.00 0.00 0.00 0.00 
Water 0.00 0.00 0.00 0.01 
WFI 1033.52 351.74 448.56 9723.68 
TOTAL (kg/batch) 1033.52 375.72 479.16 9853.09 
TOTAL (L/batch) 1039.02 367.68 468.90 9888.68 
   
Stream Name S-302 Waste 17 From Protein A 
Anion 
Buffer A 
Source P-68 P-68 INPUT INPUT 
Destination P-69 OUTPUT P-61 P-77 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 24.95 24.41 16.37 25.00 
Pressure (bar) 1.01 1.01 4.46 1.01 
Density (g/L) 1001.36 997.76 1014.04 1002.00 
Component Flowrates (kg/batch) 
2-MEA 0.00 0.00 0.00 0.00 
Amino Acids 0.00 0.00 0.00 0.00 
Acetic-Acid 0.00 0.01 0.01 0.00 
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EDTA, Sodium 0.00 0.67 0.67 0.00 
Glucose 0.00 0.00 0.00 0.00 
Glutamine 0.00 0.00 0.00 0.00 
Impurities 0.01 0.08 0.09 0.00 
Inorganic Salts 0.00 0.00 0.00 0.00 
Lactate 0.00 0.00 0.00 0.00 
MAb Fab Fragments 12.92 1.40 14.31 0.00 
MES 0.46 104.06 0.00 0.00 
Other Media Components 0.00 0.00 0.00 0.00 
Polysorbate 80 0.00 0.09 0.09 0.00 
Sodium Acetate 0.00 0.01 0.01 0.00 
Sodium Chloride 2.74 64.22 20.19 9.75 
Sodium Phosphate 0.00 6.36 6.36 0.00 
TRIS Base 0.00 0.00 0.00 16.47 
TRIS HCl 0.00 0.08 0.08 0.00 
Vitamins 0.00 0.00 0.00 0.00 
Water 0.00 0.01 0.01 0.00 
WFI 184.70 12296.52 837.28 3872.46 
TOTAL (kg/batch) 200.83 12473.49 879.08 3898.68 
TOTAL (L/batch) 200.55 12501.54 866.91 3890.91 
   
Stream Name Vent21 Anion-Load1 
Anion-
Wash1 
Anion-
Load2 
Source P-77 P-77 P-77 P-73 
Destination OUTPUT P-73 P-74 P-69 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 25.00 25.00 25.00 25.01 
Pressure (bar) 1.01 1.01 1.01 2.01 
Density (g/L) 1.18 998.20 998.20 998.19 
Component Flowrates (kg/batch) 
Nitrogen 3.53 0.00 0.00 0.00 
Oxygen 1.07 0.00 0.00 0.00 
Sodium Chloride 0.00 8.73 0.29 8.73 
TRIS Base 0.00 14.76 0.49 14.76 
WFI 0.00 3470.18 114.94 3470.18 
TOTAL (kg/batch) 4.61 3493.67 115.72 3493.67 
TOTAL (L/batch) 3905.72 3499.99 115.92 3500.00 
   
Stream Name Vent17 S-303 S-304 Anion-Equil2 
Source P-69 P-69 P-70 P-75 
Destination OUTPUT P-70 P-71 P-71 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 25.01 25.01 25.02 25.01 
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Pressure (bar) 1.01 1.01 2.01 2.01 
Density (g/L) 1.18 998.36 998.36 998.19 
Component Flowrates (kg/batch) 
Impurities 0.00 0.01 0.01 0.00 
MAb Fab Fragments 0.00 12.92 12.92 0.00 
MES 0.00 0.46 0.46 0.00 
Nitrogen 3.35 0.00 0.00 0.00 
Oxygen 1.02 0.00 0.00 0.00 
Sodium Chloride 0.00 11.48 11.48 0.72 
TRIS Base 0.00 14.76 14.76 1.22 
WFI 0.00 3654.88 3654.88 287.34 
TOTAL (kg/batch) 4.36 3694.50 3694.50 289.29 
TOTAL (L/batch) 3700.65 3700.55 3700.57 289.81 
   
Stream Name Anion-Wash2 
Anion-
Strip2 S-305 Waste 18 
Source P-74 P-76 P-71 P-71 
Destination P-71 P-71 P-72 OUTPUT 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 25.01 25.01 25.02 25.01 
Pressure (bar) 2.01 2.01 1.01 2.01 
Density (g/L) 998.19 1024.67 998.36 1014.48 
Component Flowrates (kg/batch) 
Impurities 0.00 0.00 0.00 0.01 
MAb Fab Fragments 0.00 0.00 12.89 0.03 
MES 0.00 0.00 0.46 0.00 
Sodium Chloride 0.29 26.11 11.76 26.83 
TRIS Base 0.49 2.23 15.25 3.46 
WFI 114.94 446.79 3769.82 734.14 
TOTAL (kg/batch) 115.72 475.14 3810.17 764.47 
TOTAL (L/batch) 115.93 463.70 3816.45 753.55 
   
Stream Name Vent18 S-306 To PEG Anion Buffer B 
Source P-72 P-72 P-79 INPUT 
Destination OUTPUT P-79 OUTPUT P-78 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 25.02 25.02 25.03 25.00 
Pressure (bar) 1.01 1.01 2.01 1.01 
Density (g/L) 1.18 998.36 998.35 1051.88 
Component Flowrates (kg/batch) 
Impurities 0.00 0.00 0.00 0.00 
MAb Fab Fragments 0.00 12.89 12.89 0.00 
MES 0.00 0.46 0.46 0.00 
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Nitrogen 3.45 0.00 0.00 0.00 
Oxygen 1.05 0.00 0.00 0.00 
Sodium Chloride 0.00 11.76 11.76 26.11 
TRIS Base 0.00 15.25 15.25 2.23 
WFI 0.00 3769.82 3769.82 446.79 
TOTAL (kg/batch) 4.50 3810.17 3810.17 475.14 
TOTAL (L/batch) 3816.70 3816.45 3816.47 451.70 
   
Stream Name Vent16    
Source P-78    
Destination OUTPUT    
Stream Properties 
Activity (U/ml) 0.00    
Temperature (°C) 25.00    
Pressure (bar) 1.01    
Density (g/L) 1.18    
Component Flowrates (kg/batch) 
Nitrogen 0.42    
Oxygen 0.13    
TOTAL (kg/batch) 0.55    
TOTAL (L/batch) 463.70    
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5. PEGylation OVERALL PROCESS DATA 
     
Annual Operating Time 7919.92 h 
Annual Throughput 0.00 kg MP 
Batch Throughput 0.00 kg MP 
Recipe Batch Time 13.28 h 
Recipe Cycle Time 12.37 h 
Number of Batches per Year 640.00  
MP = Main Product = Undefined 
     
STREAM DETAILS 
     
Stream Name From Dia1 S-401 Vent 22 To Dia1 
Source P-81 INPUT P-80 P-80 
Destination P-80 P-80 OUTPUT P-81 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 11.29 25.03 11.30 25.03 
Pressure (bar) 1.01 2.01 1.01 1.01 
Density (g/L) 1000.51 998.35 1.24 998.35 
Component Flowrates (kg/batch) 
EDTA, Sodium 0.93 0.00 0.00 0.00 
Impurities 0.00 0.00 0.00 0.00 
MAb Fab Fragments 12.89 12.89 0.00 12.89 
MES 0.02 0.46 0.00 0.46 
Nitrogen 0.00 0.00 1.21 0.00 
Oxygen 0.00 0.00 0.37 0.00 
Phosphate 11.86 0.00 0.00 0.00 
Sodium Chloride 0.61 11.76 0.00 11.76 
TRIS Base 0.79 15.25 0.00 15.25 
WFI 1444.33 3769.82 0.00 3769.82 
TOTAL (kg/batch) 1471.43 3810.17 1.58 3810.17 
TOTAL (L/batch) 1470.68 3816.47 1275.85 3816.47 
   
Stream Name S-402 
RR 
Buffer 4-
1 
WFI In 
4-1 
WFI Out 4-
1 
Source P-80 INPUT INPUT P-81 
Destination P-82 P-81 P-81 OUTPUT 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 11.30 4.00 4.00 4.00 
Pressure (bar) 1.01 1.01 1.01 1.01 
Density (g/L) 1000.50 1003.09 1002.36 1002.36 
Component Flowrates (kg/batch) 
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EDTA, Sodium 0.93 5.64 0.00 0.00 
Impurities 0.00 0.00 0.00 0.00 
MAb Fab Fragments 12.89 0.00 0.00 0.00 
MES 0.02 0.00 0.00 0.00 
Phosphate 11.86 71.98 0.00 0.00 
Sodium Chloride 0.61 0.00 0.00 0.00 
TRIS Base 0.79 0.00 0.00 0.00 
WFI 1444.33 7578.93 1503.54 1503.54 
TOTAL (kg/batch) 1471.43 7656.55 1503.54 1503.54 
TOTAL (L/batch) 1470.69 7632.93 1500.00 1500.00 
   
Stream Name Waste 19 S-403 2-MEA S-404 
Source P-81 P-82 INPUT P-83 
Destination OUTPUT P-83 P-83 P-84 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 11.29 11.31 25.00 37.00 
Pressure (bar) 1.01 2.01 1.01 10.54 
Density (g/L) 1001.26 1000.50 994.70 991.13 
Component Flowrates (kg/batch) 
2-MEA 0.00 0.00 8.90 8.90 
EDTA, Sodium 4.71 0.93 0.00 0.93 
Impurities 0.00 0.00 0.00 0.00 
MAb Fab Fragments 0.00 12.89 0.00 0.64 
MES 0.43 0.02 0.00 0.02 
Phosphate 60.11 11.86 0.00 11.86 
Reduced MAb Fab Fragments 0.00 0.00 0.00 12.24 
Sodium Chloride 11.16 0.61 0.00 0.61 
TRIS Base 14.46 0.79 0.00 0.79 
WFI 9904.42 1444.33 0.00 1444.33 
TOTAL (kg/batch) 9995.29 1471.43 8.90 1480.33 
TOTAL (L/batch) 9982.72 1470.69 8.95 1493.58 
   
Stream Name S-405 From Dia2 Vent 24 To Dia2 
Source P-84 P-86 P-85 P-85 
Destination P-85 P-85 OUTPUT P-86 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 37.01 15.15 20.89 37.01 
Pressure (bar) 11.54 1.01 1.01 1.01 
Density (g/L) 991.13 998.72 1.20 991.13 
Component Flowrates (kg/batch) 
2-MEA 8.90 1.21 0.00 8.90 
EDTA Disodium 0.00 0.95 0.00 0.00 
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EDTA, Sodium 0.93 0.13 0.00 0.93 
Impurities 0.00 0.00 0.00 0.00 
MAb Fab Fragments 0.64 0.64 0.00 0.64 
MES 0.02 0.00 0.00 0.02 
Nitrogen 0.00 0.00 2.65 0.00 
Oxygen 0.00 0.00 0.80 0.00 
Phosphate 11.86 13.68 0.00 11.86 
Reduced MAb Fab Fragments 12.24 12.24 0.00 12.24 
Sodium Chloride 0.61 0.08 0.00 0.61 
TRIS Base 0.79 0.11 0.00 0.79 
WFI 1444.33 1466.61 0.00 1444.33 
TOTAL (kg/batch) 1480.33 1495.64 3.45 1480.33 
TOTAL (L/batch) 1493.58 1497.56 2887.31 1493.58 
   
Stream Name S-406 
PR 
Buffer 4-
1 
WFI In 
4-2 
WFI Out 4-
2 
Source P-85 INPUT INPUT P-86 
Destination P-87 P-86 P-86 OUTPUT 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 15.15 4.00 4.00 4.00 
Pressure (bar) 1.01 1.01 1.01 1.01 
Density (g/L) 998.72 1003.09 1002.36 1002.36 
Component Flowrates (kg/batch) 
2-MEA 1.21 0.00 0.00 0.00 
EDTA Disodium 0.95 2.21 0.00 0.00 
EDTA, Sodium 0.13 0.00 0.00 0.00 
Impurities 0.00 0.00 0.00 0.00 
MAb Fab Fragments 0.64 0.00 0.00 0.00 
MES 0.00 0.00 0.00 0.00 
Phosphate 13.68 28.17 0.00 0.00 
Reduced MAb Fab Fragments 12.24 0.00 0.00 0.00 
Sodium Chloride 0.08 0.00 0.00 0.00 
TRIS Base 0.11 0.00 0.00 0.00 
WFI 1466.61 2966.03 501.18 501.18 
TOTAL (kg/batch) 1495.64 2996.40 501.18 501.18 
TOTAL (L/batch) 1497.56 2987.16 500.00 500.00 
   
Stream Name Waste 21 S-407 PEG Waste 22 
Source P-86 P-87 INPUT P-88 
Destination OUTPUT P-88 P-88 OUTPUT 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 15.15 15.16 25.00 37.00 
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Pressure (bar) 1.01 2.01 1.01 10.54 
Density (g/L) 998.85 998.71 994.70 990.33 
Component Flowrates (kg/batch) 
2-MEA 7.70 1.21 0.00 0.00 
EDTA Disodium 1.26 0.95 0.00 0.00 
EDTA, Sodium 0.80 0.13 0.00 0.00 
Impurities 0.00 0.00 0.00 0.00 
MAb Fab Fragments 0.00 0.64 0.00 0.00 
MES 0.02 0.00 0.00 0.00 
PEG 0.00 0.00 225.48 0.00 
Phosphate 26.35 13.68 0.00 0.00 
Reduced MAb Fab Fragments 0.00 12.24 0.00 0.00 
Sodium Chloride 0.53 0.08 0.00 0.00 
TRIS Base 0.68 0.11 0.00 0.00 
WFI 2943.75 1466.61 0.00 879.96 
TOTAL (kg/batch) 2981.09 1495.64 225.48 879.96 
TOTAL (L/batch) 2984.52 1497.57 226.68 888.56 
   
Stream Name S-408 S-409 From Dia3 Vent 26 
Source P-88 P-89 P-91 P-90 
Destination P-89 P-90 P-90 OUTPUT 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 37.00 37.01 15.18 20.92 
Pressure (bar) 1.88 2.88 1.01 1.01 
Density (g/L) 991.08 991.08 998.39 1.20 
Component Flowrates (kg/batch) 
2-MEA 1.21 1.21 0.16 0.00 
EDTA Disodium 0.95 0.95 0.13 0.00 
EDTA, Sodium 0.13 0.13 0.02 0.00 
Impurities 0.00 0.00 0.00 0.00 
MAb Fab Fragments 0.64 0.64 0.09 0.00 
MES 0.00 0.00 0.00 0.00 
Nitrogen 0.00 0.00 0.00 1.51 
Oxygen 0.00 0.00 0.00 0.46 
PEG 216.17 216.17 29.26 0.00 
PEGylated MAb F 20.93 20.93 20.93 0.00 
Phosphate 13.68 13.68 1.85 0.00 
Reduced MAb Fab Fragments 0.61 0.61 0.08 0.00 
Sodium Chloride 0.08 0.08 0.01 0.00 
TRIS Base 0.11 0.11 0.01 0.00 
WFI 586.64 586.64 796.66 0.00 
TOTAL (kg/batch) 841.15 841.15 849.21 1.96 
TOTAL (L/batch) 848.72 848.72 850.58 1640.44 
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Stream Name To Dia3 S-410 WFI In 4-4 WFI In 4-3 
Source P-90 P-90 INPUT INPUT 
Destination P-91 P-94 P-91 P-91 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 37.01 15.18 4.00 4.00 
Pressure (bar) 1.01 1.01 1.01 1.01 
Density (g/L) 991.08 998.38 1002.36 1002.36 
Component Flowrates (kg/batch) 
2-MEA 1.21 0.16 0.00 0.00 
EDTA Disodium 0.95 0.13 0.00 0.00 
EDTA, Sodium 0.13 0.02 0.00 0.00 
Impurities 0.00 0.00 0.00 0.00 
MAb Fab Fragments 0.64 0.09 0.00 0.00 
MES 0.00 0.00 0.00 0.00 
PEG 216.17 29.26 0.00 0.00 
PEGylated MAb F 20.93 20.93 0.00 0.00 
Phosphate 13.68 1.85 0.00 0.00 
Reduced MAb Fab Fragments 0.61 0.08 0.00 0.00 
Sodium Chloride 0.08 0.01 0.00 0.00 
TRIS Base 0.11 0.01 0.00 0.00 
WFI 586.64 796.66 1701.44 501.18 
TOTAL (kg/batch) 841.15 849.21 1701.44 501.18 
TOTAL (L/batch) 848.72 850.58 1697.44 500.00 
   
Stream Name WFI Out 4-3 Waste 23 
Cation 
Buffer 1 Load1 
Source P-91 P-91 INPUT P-93 
Destination OUTPUT OUTPUT P-93 P-95 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 4.00 15.18 25.00 25.00 
Pressure (bar) 1.01 1.01 1.01 3.70 
Density (g/L) 1002.36 998.61 994.70 994.70 
Component Flowrates (kg/batch) 
2-MEA 0.00 1.04 0.00 0.00 
EDTA Disodium 0.00 0.82 0.00 0.00 
EDTA, Sodium 0.00 0.11 0.00 0.00 
Impurities 0.00 0.00 0.00 0.00 
MAb Fab Fragments 0.00 0.56 0.00 0.00 
MES 0.00 0.00 0.00 0.00 
PEG 0.00 186.92 0.00 0.00 
Phosphate 0.00 11.83 6.46 3.96 
Reduced MAb Fab Fragments 0.00 0.53 0.00 0.00 
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Sodium Chloride 0.00 0.07 0.00 0.00 
TRIS Base 0.00 0.09 0.00 0.00 
Water 0.00 0.00 3401.45 2084.92 
WFI 501.18 1491.42 0.00 0.00 
TOTAL (kg/batch) 501.18 1693.39 3407.91 2088.88 
TOTAL (L/batch) 500.00 1695.75 3426.05 2100.00 
   
Stream Name Cation Buffer 2 Equil2 Wash2 WFI In 4-5 
Source INPUT P-99 P-98 INPUT 
Destination P-92 P-101 P-101 P-101 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 25.00 25.01 25.01 25.00 
Pressure (bar) 1.01 11.13 2.23 1.01 
Density (g/L) 1046.58 994.70 994.70 994.70 
Component Flowrates (kg/batch) 
Phosphate 2.99 1.25 1.25 0.00 
Sodium Chloride 92.09 0.00 0.00 0.00 
Water 0.00 658.27 658.27 0.00 
WFI 1574.12 0.00 0.00 1013.62 
TOTAL (kg/batch) 1669.20 659.52 659.52 1013.62 
TOTAL (L/batch) 1594.91 663.03 663.03 1019.01 
   
Stream Name Cat-Elute2 Cat-Strip Load 
Final 
Formulation 
Source P-97 P-96 P-100 P-101 
Destination P-101 P-101 P-101 OUTPUT 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 25.01 25.01 22.30 24.90 
Pressure (bar) 11.13 2.60 2.01 1.01 
Density (g/L) 1022.10 1022.10 995.72 1007.21 
Component Flowrates (kg/batch) 
2-MEA 0.00 0.00 0.16 0.00 
EDTA Disodium 0.00 0.00 0.13 0.00 
EDTA, Sodium 0.00 0.00 0.02 0.00 
Impurities 0.00 0.00 0.00 0.00 
MAb Fab Fragments 0.00 0.00 0.09 0.00 
MES 0.00 0.00 0.00 0.00 
PEG 0.00 0.00 29.26 0.00 
PEGylated MAb F 0.00 0.00 20.93 18.89 
Phosphate 1.78 1.21 5.81 0.24 
Reduced MAb Fab Fragments 0.00 0.00 0.08 0.00 
Sodium Chloride 54.70 37.39 0.01 7.29 
TRIS Base 0.00 0.00 0.01 0.00 
Flexible Manufacturing Facility for Biopharmaceuticals 
 
-304- 
 
Water 0.00 0.00 2084.92 0.00 
WFI 935.04 639.08 796.66 259.82 
TOTAL (kg/batch) 991.52 677.68 2938.09 286.24 
TOTAL (L/batch) 970.08 663.03 2950.72 284.19 
   
Stream Name Waste 24    
Source P-101    
Destination OUTPUT    
Stream Properties 
Activity (U/ml) 0.00    
Temperature (°C) 24.09    
Pressure (bar) 1.01    
Density (g/L) 999.79    
Component Flowrates (kg/batch) 
2-MEA 0.16    
EDTA Disodium 0.13    
EDTA, Sodium 0.02    
Impurities 0.00    
MAb Fab Fragments 0.09    
MacroCap SP 2026.87    
MES 0.00    
PEG 29.26    
PEGylated MAb F 2.04    
Phosphate 11.07    
Reduced MAb Fab Fragments 0.08    
Sodium Chloride 84.80    
TRIS Base 0.01    
Water 3401.45    
WFI 3124.58    
TOTAL (kg/batch) 8680.56    
TOTAL (L/batch) 8682.37    
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6. Final Formulation OVERALL PROCESS DATA 
     
Annual Operating Time 7914.09 h 
Annual Throughput 0.00 kg MP 
Batch Throughput 0.00 kg MP 
Recipe Batch Time 14.76 h 
Recipe Cycle Time 11.33 h 
Number of Batches per Year 698.00  
MP = Main Product = Undefined 
     
STREAM DETAILS 
     
Stream Name From PEG S-501 S-508 Vent-29 
Source INPUT P-102 P-104 P-103 
Destination P-102 P-103 P-103 OUTPUT 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 24.90 24.92 25.22 25.11 
Pressure (bar) 1.01 2.51 1.01 1.01 
Density (g/L) 1007.21 1007.21 999.63 1.18 
Component Flowrates (kg/batch) 
Impurities 0.00 0.00 0.00 0.00 
KCl 0.00 0.00 0.00 0.00 
KH2PO4 0.00 0.00 0.00 0.00 
MAb Fab Fragments 0.00 0.00 0.00 0.00 
Na2HPO4 0.00 0.00 0.16 0.00 
Nitrogen 0.00 0.00 0.00 0.43 
Oxygen 0.00 0.00 0.00 0.13 
PEGylated MAb F 18.89 18.89 18.42 0.00 
Phosphate 0.24 0.24 0.02 0.00 
Sodium Chloride 7.29 7.29 1.82 0.00 
WFI 259.82 259.82 168.99 0.00 
TOTAL (kg/batch) 286.24 286.24 189.41 0.56 
TOTAL (L/batch) 284.19 284.20 189.48 474.02 
   
Stream Name S-507 S-502 PBS Dia-WFI 
Source P-103 P-103 INPUT INPUT 
Destination P-104 P-105 P-104 P-104 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 24.92 25.22 25.00 25.00 
Pressure (bar) 1.01 1.01 1.01 1.01 
Density (g/L) 1007.21 999.63 999.04 994.70 
Component Flowrates (kg/batch) 
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Impurities 0.00 0.00 0.00 0.00 
KCl 0.00 0.00 0.00 0.00 
KH2PO4 0.00 0.00 0.00 0.00 
MAb Fab Fragments 0.00 0.00 0.00 0.00 
Na2HPO4 0.00 0.16 0.42 0.00 
PEGylated MAb F 18.89 18.42 0.00 0.00 
Phosphate 0.24 0.02 0.00 0.00 
Sodium Chloride 7.29 1.82 3.03 0.00 
WFI 259.82 168.99 375.12 497.35 
TOTAL (kg/batch) 286.24 189.41 378.56 497.35 
TOTAL (L/batch) 284.20 189.48 378.93 500.00 
   
Stream Name Waste-25 Waste-26 S-503 S-504 
Source P-104 P-104 P-105 P-106 
Destination OUTPUT OUTPUT P-106 P-107 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 25.00 25.22 25.27 25.27 
Pressure (bar) 1.01 1.01 5.15 5.15 
Density (g/L) 994.70 1003.57 999.62 999.62 
Component Flowrates (kg/batch) 
Impurities 0.00 0.00 0.00 0.00 
KCl 0.00 0.00 0.00 0.00 
KH2PO4 0.00 0.00 0.00 0.00 
MAb Fab Fragments 0.00 0.00 0.00 0.00 
Na2HPO4 0.00 0.25 0.16 0.16 
PEGylated MAb F 0.00 0.00 18.42 18.24 
Phosphate 0.00 0.22 0.02 0.02 
Sodium Chloride 0.00 8.51 1.82 1.81 
WFI 497.35 466.42 168.99 168.81 
TOTAL (kg/batch) 497.35 475.40 189.41 189.04 
TOTAL (L/batch) 500.00 473.70 189.48 189.11 
   
Stream Name Waste-27 S-505 Waste-28 S-506 
Source P-106 P-107 P-107 P-108 
Destination OUTPUT P-108 OUTPUT P-109 
Stream Properties 
Activity (U/ml) 0.00 0.00 0.00 0.00 
Temperature (°C) 25.27 25.27 25.27 25.27 
Pressure (bar) 5.15 5.15 5.15 1.24 
Density (g/L) 997.38 999.63 997.38 999.63 
Component Flowrates (kg/batch) 
Impurities 0.00 0.00 0.00 0.00 
KCl 0.00 0.00 0.00 0.00 
KH2PO4 0.00 0.00 0.00 0.00 
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MAb Fab Fragments 0.00 0.00 0.00 0.00 
Na2HPO4 0.00 0.16 0.00 0.16 
PEGylated MAb F 0.18 18.05 0.18 18.05 
Phosphate 0.00 0.02 0.00 0.02 
Sodium Chloride 0.00 1.81 0.00 1.81 
WFI 0.18 168.63 0.18 168.63 
TOTAL (kg/batch) 0.37 188.68 0.37 188.68 
TOTAL (L/batch) 0.37 188.75 0.37 188.75 
   
Stream Name Final Product    
Source P-109    
Destination OUTPUT    
Stream Properties 
Activity (U/ml) 0.00    
Temperature (°C) - 80.00    
Pressure (bar) 1.24    
Density (g/L) 1038.11    
Component Flowrates (kg/batch) 
Impurities 0.00    
KCl 0.00    
KH2PO4 0.00    
MAb Fab Fragments 0.00    
Na2HPO4 0.16    
PEGylated MAb F 18.05    
Phosphate 0.02    
Sodium Chloride 1.81    
WFI 168.63    
TOTAL (kg/batch) 188.68    
TOTAL (L/batch) 181.75    
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Appendix E – SuperPro Validation Calculations 
 
 
Unit: P-1/TFR-101 T-Flask
Process Description:
Inlet Components (kg/batch) Outlet Components (kg/batch) Theoretical SuperPro
AAs 0.00267 AAs 0.00262 0.00262
Glucose 0.01132 Biomass 0.00031 0.00031
Glutamine 0.00131 DeadBiomass 0.00003 0.00003
Inorganic Salts 0.02742 Glucose 0.01042 0.01109
OtherMedia 0.00024 Glutamine 0.00129 0.00128
Vitamins 0.00011 Inorganic Salts 0.02218 0.02686
WFI 2.11021 Lactate 0.00021 0.00021
TOTAL 2.15309 MAB 0.00006 0.00006
OtherMedia 0.00024 0.00023
Vitamins 0.00011 0.00011
Water 0.00053 0.00053
WFI 2.11021 2.11021
TOTAL 2.14822 2.15354
Reaction Extent: 70%
EQUATION
REACTANTS PRODUCTS
Components Mass Coeff % Components Mass Coeff %
AAs 6.21 Biomass 34.26
Glucose 26.28 Carb. Dioxide 69.41
Glutamine 3.04 DeadBiomass 3.51
Inorganic Salts 63.66 MAB 7.03
OtherMedia 0.55 Water 61.5
Oxygen 100 Lactate 24.29
Vitamins 0.26
Total 200 200
Main Components
Non-treated, sterile flasks for the suspension and growth of cell cultures.
Unit: P-2/RBR-101 Roller Bottle
Process Description:
Inlet Components (kg/batch) Outlet Components (kg/batch) Theoretical SuperPro
AAs 0.01363 AAs 0.01338 0.01334
Biomass 0.00031 Biomass 0.00187 0.00189
DeadBiomass 0.00003 DeadBiomass 0.00018 0.00019
Glucose 0.05771 Glucose 0.05651 0.05647
Glutamine 0.00667 Glutamine 0.00652 0.00653
Inorganic Salts 0.13976 Inorganic Salts 0.13692 0.1368
Lactate 0.00021 Lactate 0.00134 0.00134
MAB 0.00006 MAB 0.00397 0.00039
OtherMedia 0.00121 OtherMedia 0.00118 0.00118
Vitamins 0.00057 Vitamins 0.00055 0.00056
Water 0.00053 Water 0.00338 0.00339
WFI 10.80021 WFI 10.79991 10.79991
TOTAL (kg/batch) 11.02088 11.02571 11.02199
Reaction Extent: 70%
EQUATION
REACTANTS PRODUCTS
Components Mass Coeff % Components Mass Coeff %
AAs 6.21 Biomass 34.26
Glucose 26.28 Carb. Dioxide 69.41
Glutamine 3.04 DeadBiomass 3.51
Inorganic Salts 63.66 MAB 7.03
OtherMedia 0.55 Water 61.5
Oxygen 100 Lactate 24.29
Vitamins 0.26
Total 200 200
Main Components
Non-treated, sterile bottles for the suspension and growth of cell cultures.
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Unit: P-3/BBS-101
Process Description:
Inlet Components (kg/batch) Outlet Components (kg/batch) Theoretical SuperPro
AAs 0.08843 AAs 0.08733 0.08625
Biomass 0.00189 Biomass 0.01393 0.01393
DeadBiomass 0.00019 DeadBiomass 0.00143 0.00143
Glucose 0.37423 Glucose 0.36412 0.36514
Glutamine 0.04329 Glutamine 0.04222 0.04222
Inorganic Salts 0.90654 Inorganic Salts 0.88421 0.88416
Lactate 0.00134 Lactate 0.00989 0.00988
MAB 0.00039 MAB 0.00288 0.00286
OtherMedia 0.00783 OtherMedia 0.00765 0.00764
Vitamins 0.0037 Vitamins 0.00361 0.00361
Water 0.00339 Water 0.02501 0.02501
WFI 70.04777 WFI 70.04782 70.04782
TOTAL (kg/batch) 71.47899 71.49213 71.48995
Reaction Extent: 80%
EQUATION
REACTANTS PRODUCTS
Components Mass Coeff % Components Mass Coeff %
AAs 6.21 Biomass 34.26
Glucose 26.28 Carb. Dioxide 69.41
Glutamine 3.04 DeadBiomass 3.51
Inorganic Salts 63.66 MAB 7.03
OtherMedia 0.55 Water 61.5
Oxygen 100 Lactate 24.29
Vitamins 0.26
Total 200 200
Main Components
A pre-sterilized disposable bioreactor chamber equipped with ports for
sterile aeration, seeding, harvesting, sampling, and analysis. 
Bag Bioreactor 1
Unit: P-4/BBS-102
Process Description:
Inlet Components (kg/batch) Outlet Components (kg/batch) Theoretical SuperPro
AAs 0.39911 AAs 0.39415 0.38837
Biomass 0.01393 Biomass 0.07322 0.07321
DeadBiomass 0.00143 DeadBiomass 0.00741 0.00751
Glucose 1.68901 Glucose 1.65221 1.64354
Glutamine 0.19538 Glutamine 0.19012 0.19012
Inorganic Salts 4.0914 Inorganic Salts 3.98127 3.98127
Lactate 0.00988 Lactate 0.05192 0.05191
MAB 0.00286 MAB 0.01511 0.01502
OtherMedia 0.03535 OtherMedia 0.03444 0.03441
Vitamins 0.01671 Vitamins 0.01625 0.01626
Water 0.02501 Water 0.13141 0.13141
WFI 316.91374 WFI 316.9137 316.91414
TOTAL (kg/batch) 323.39381 323.4672331 323.44717
Reaction Extent: 80%
EQUATION
REACTANTS PRODUCTS
Components Mass Coeff % Components Mass Coeff %
AAs 6.21 Biomass 34.26
Glucose 26.28 Carb. Dioxide 69.41
Glutamine 3.04 DeadBiomass 3.51
Inorganic Salts 63.66 MAB 7.03
OtherMedia 0.55 Water 61.5
Oxygen 100 Lactate 24.29
Vitamins 0.26
Total 200 200
A pre-sterilized disposable bioreactor chamber equipped with ports for
sterile aeration, seeding, harvesting, sampling, and analysis. 
Bag Bioreactor 2
Main Components
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Unit: P-9/SBR-101
Process Description:
Inlet Components (kg/batch) Outlet Components (kg/batch) Theoretical SuperPro
AAs 1.75135 AAs 0.35023 0.35027
Biomass 0.07321 Biomass 7.81121 7.80284
DeadBiomass 0.00751 DeadBiomass 0.80002 0.79941
Glucose 7.41151 Glucose 1.49342 1.48231
Glutamine 0.85734 Glutamine 0.17122 0.17147
Inorganic Salts 17.95346 Inorganic Salts 3.59111 3.59069
Lactate 0.05191 Lactate 4.98001 5.53213
MAB 0.01502 MAB 1.61002 1.60111
OtherMedia 0.15511 OtherMedia 0.03112 0.03102
Vitamins 0.07333 Vitamins 0.01471 0.01467
Water 0.13141 Water 11.14202 14.00684
WFI 965.60863 WFI 965.60863 965.60863
TOTAL (kg/batch) 994.08977 997.60372 1000.99139
Reaction Extent: 80%
EQUATION
REACTANTS PRODUCTS
Components Mass Coeff % Components Mass Coeff %
AAs 6.21 Biomass 34.26
Glucose 26.28 Carb. Dioxide 69.41
Glutamine 3.04 DeadBiomass 3.51
Inorganic Salts 63.66 MAB 7.03
OtherMedia 0.55 Water 61.5
Oxygen 100 Lactate 24.29
Vitamins 0.26
Total 200 200
Main Components
Seed Bioreactor 1
Bioreactor used for continued cell growth and production of monoclonal antibodies.
Unit: P-15/SBR-102
Process Description:
Inlet Components (kg/batch) Outlet Components (kg/batch) Theoretical SuperPro
AAs 4.52681 AAs 0.90521 0.90536
Biomass 7.80284 Biomass 22.81032 22.78205
DeadBiomass 0.79941 DeadBiomass 2.85423 2.84632
Glucose 19.15695 Glucose 3.82002 3.83139
Glutamine 2.21603 Glutamine 0.44402 0.44321
Inorganic Salts 46.40531 Inorganic Salts 9.28221 9.28106
Lactate 5.53213 Lactate 19.69731 19.69721
MAB 1.60111 MAB 5.71001 5.70075
OtherMedia 0.40092 OtherMedia 0.08019 0.08019
Vitamins 0.18953 Vitamins 0.03791 0.03791
Water 14.00684 Water 38.43123 39.87146
WFI 2976.90078 WFI 2976.90077 2976.90077
TOTAL (kg/batch) 3079.53866 3080.97343 3082.37768
Reaction Extent: 80%
EQUATION
REACTANTS PRODUCTS
Components Mass Coeff % Components Mass Coeff %
AAs 6.21 Biomass 34.26
Glucose 26.28 Carb. Dioxide 69.41
Glutamine 3.04 DeadBiomass 3.51
Inorganic Salts 63.66 MAB 7.03
OtherMedia 0.55 Water 61.5
Oxygen 100 Lactate 24.29
Vitamins 0.26
Total 200 200
Main Components
Bioreactor used for continued cell growth and production of monoclonal antibodies.
Seed Bioreactor 2
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Unit: P-25/PBR-101
Process Description:
Inlet Components (kg/batch) Outlet Components (kg/batch) Theoretical SuperPro
AAs 51.76737 AAs 3.44222 3.48472
Biomass 27.78205 Biomass 166.12232 167.26415
DeadBiomass 2.84632 DeadBiomass 16.98743 17.13652
Glucose 194.74019 Glucose 14.98641 14.74692
Glutamine 22.08257 Glutamine 1.65321 1.70588
Inorganic Salts 320.90032 Inorganic Salts 33.42423 35.72256
Lactate 19.69721 Lactate 118.58712 118.58862
MAB 5.70075 MAB 34.32111 34.32186
OtherMedia 2.54784 OtherMedia 0.30863 0.30863
Vitamins 1.20444 Vitamins 0.15231 0.14591
Water 39.87146 Water 300.04222 300.25526
WFI 9096.98831 WFI 9096.98831 9096.98831
TOTAL (kg/batch) 9786.12881 9787.00523 9790.66934
Reaction Extent: 80%
EQUATION
REACTANTS PRODUCTS
Components Mass Coeff % Components Mass Coeff %
AAs 6.21 Biomass 34.26
Glucose 26.28 Carb. Dioxide 69.41
Glutamine 3.04 DeadBiomass 3.51
Inorganic Salts 63.66 MAB 7.03
OtherMedia 0.55 Water 61.5
Oxygen 100 Lactate 24.29
Vitamins 0.26
Total 200 200
Main Components
monoclonal antibodies at a 3.5 g/l titer.
Fed batch bioreactor used for continued cell growth and production of
Production Bioreactor
Unit: P-26/V-201 Blending Tank
Process Description:
Inlet Components (kg/batch) Outlet Components (kg/batch) Theoretical SuperPro
AAs 3.49 AAs 3.49 3.49
Biomass 167.26 Biomass 167.26 167.26
DeadBiomass 17.14 DeadBiomass 17.14 17.14
Glucose 14.75 Glucose 14.75 14.75
Glutamine 1.71 Glutamine 1.71 1.71
Inorganic Salts 35.72 Inorganic Salts 35.72 35.72
Lactate 118.59 Lactate 118.59 118.59
MAB 34.32 MAB 34.32 34.32
OtherMedia 0.31 OtherMedia 0.31 0.31
Vitamins 0.15 Vitamins 0.15 0.15
Water 300.26 Water 300.26 300.26
WFI 9096.99 WFI 9096.99 9096.99
TOTAL (kg/batch) 9790.67 9790.67 9790.67
Hold material from main bioreactor before transferring to centrifuge.
Main Components
Unit: P-28/DS-201
Process Description:
Inlet Components (kg/batch) Outlet Components (kg/batch) Theoretical SuperPro Theoretical SuperPro
AAs 3.49 AAs 3.14 3.15 0.35 0.34
Biomass 167.26 Biomass 3.35 3.35 163.92 163.92
DeadBiomass 17.14 DeadBiomass 15.42 15.49 1.71 1.65
Glucose 14.75 Glucose 13.27 13.33 1.47 1.42
Glutamine 1.71 Glutamine 1.54 1.54 0.17 0.16
Inorganic Salts 35.72 Inorganic Salts 32.15 32.28 3.57 3.44
Lactate 118.59 Lactate 106.73 107.16 11.86 11.43
MAB 34.32 MAB 30.89 31.02 3.43 3.31
OtherMedia 0.31 OtherMedia 0.28 0.28 0.03 0.03
Vitamins 0.15 Vitamins 0.13 0.13 0.01 0.01
Water 300.26 Water 270.23 271.33 30.03 28.93
WFI 9096.99 WFI 8187.29 8220.53 909.70 876.46
TOTAL (kg/batch) 9790.67 8664.41 8699.58 1126.26 1091.09
Centifuge to remove solids larger than 1 micron (98% of biomass removed).
Main Components Waste Components
Disk-Stack Centrifuge
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Unit: P-30/DE-201
Process Description:
Inlet Components (kg/batch) Outlet Components (kg/batch) Theoretical SuperPro Theoretical SuperPro
AAs 3.15 AAs 3.15 3.15 0.00 0.00
Biomass 3.35 Biomass 0.00 0.00 3.35 3.35
DeadBiomass 15.49 DeadBiomass 15.49 15.48 0.00 0.01
Glucose 13.33 Glucose 13.33 13.32 0.00 0.01
Glutamine 1.54 Glutamine 1.54 1.54 0.00 0.00
Inorganic Salts 32.28 Inorganic Salts 32.28 32.27 0.00 0.01
Lactate 107.16 Lactate 107.16 107.12 0.00 0.04
MAB 31.02 MAB 31.02 31.00 0.00 0.01
OtherMedia 0.28 OtherMedia 0.28 0.28 0.00 0.00
Vitamins 0.13 Vitamins 0.13 0.13 0.00 0.00
Water 271.33 Water 271.33 271.22 0.00 0.11
WFI 8220.53 WFI 8220.53 8217.36 0.00 3.18
TOTAL (kg/batch) 8699.58 8696.23 8692.87 3.35 6.71
Main Components Waste Components
Removes bacteria and biomass.
Sterile Filtration (Dead-end Filtration)
Unit: P-32/V-202 Centrifugation 
Process Description:
Inlet Components (kg/batch) Outlet Components (kg/batch) Theoretical SuperPro
AAs 3.15 AAs 3.15 3.15
Biomass 0.00 Biomass 0.00 0.00
DeadBiomass 15.48 DeadBiomass 15.48 15.48
Glucose 13.32 Glucose 13.32 13.32
Glutamine 1.54 Glutamine 1.54 1.54
Inorganic Salts 32.27 Inorganic Salts 32.27 32.27
Lactate 107.12 Lactate 107.12 107.12
MAB 31.00 MAB 31.00 31.00
Nitrogen 0.00 Nitrogen 0.00 0.00
OtherMedia 0.28 OtherMedia 0.28 0.28
Oxygen 0.00 Oxygen 0.00 0.00
Vitamins 0.13 Vitamins 0.13 0.13
Water 271.22 Water 271.22 271.22
WFI 8217.36 WFI 8217.36 8217.36
TOTAL (kg/batch) 8692.87 8692.87 8692.87
Hold outlet of centrifugation unit before entering cleavage bioreactor
Main Components
Unit: P-34/UF-201
Process Description:
Inlet Components (kg/batch) Outlet Components (kg/batch) Theoretical SuperPro Theoretical SuperPro
AAs 3.15 AAs 0.54 0.55 2.60 2.60
Cysteine-HCl 0.00 Cysteine-HCl 0.00 0.00 0.00 0.00
DeadBiomass 15.48 DeadBiomass 2.67 2.71 12.81 12.77
EDTA 0.00 EDTA 0.00 0.00 0.00 0.00
Glucose 13.32 Glucose 2.30 2.33 11.02 10.99
Glutamine 1.54 Glutamine 0.27 0.27 1.28 1.27
Inorganic Salts 32.27 Inorganic Salts 5.57 5.65 26.70 26.62
Lactate 107.12 Lactate 18.48 18.74 88.64 88.38
MAB 31.00 MAB 31.00 31.00 0.00 0.00
OtherMedia 0.28 OtherMedia 0.05 0.05 0.23 0.23
Sodium Phosphat 0.00 Sodium Phosphat 0.00 0.00 0.00 0.00
Vitamins 0.13 Vitamins 0.02 0.02 0.11 0.11
Water 271.22 Water 47.46 47.46 223.76 223.76
WFI 8217.36 WFI 1438.04 1437.88 6779.32 6779.48
TOTAL (kg/batch) 8692.87 1546.40 1546.66 7146.47 7146.21
Concentrate feed stream with a feed:retenate concentration of 17.5
Ultrafiltration (*Papain Process)
Main Components Waste Components
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Unit: P-37/R-201
Process Description:
Inlet Components (kg/batch) Outlet Theoretical SuperPro Theoretical SuperPro
Stream name: S-210 Dig Buf Papain Total
AAs 0.55 0.00 0.00 0.55 0.55 0.55 0.00 0.00
Cysteine-HCl 0.00 5.45 0.00 5.45 5.45 5.45 0.00 0.00
DeadBiomass 2.71 0.00 0.00 2.71 2.71 2.71 0.00 0.00
EDTA Disodium 0.00 9.02 0.00 9.02 9.02 9.02 0.00 0.00
Glucose 2.33 0.00 0.00 2.33 2.33 2.33 0.00 0.00
Glutamine 0.27 0.00 0.00 0.27 0.27 0.27 0.00 0.00
Inorganic Salts 5.65 0.00 0.00 5.65 5.65 5.65 0.00 0.00
Lactate 18.74 0.00 0.00 18.74 18.74 18.74 0.00 0.00
MAB 31.00 0.00 0.00 31.00 1.55 1.55 0.00 0.00
MAB Fab 0.00 0.00 0.00 0.00 58.91 58.91 0.00 0.00
Mab Fc 0.00 0.00 0.00 0.00 29.45 29.45 0.00 0.00
OtherMedia 0.05 0.00 0.00 0.05 0.05 0.05 0.00 0.00
Papain 0.00 0.00 1540.43 1540.43 1481.52 1481.52 0.00 0.00
Sodium Phosphat 0.00 4.20 0.00 4.20 4.20 4.20 0.00 0.00
Vitamins 0.02 0.00 0.00 0.02 0.02 0.02 0.00 0.00
Water 47.46 0.00 0.00 47.46 47.46 47.46 0.00 0.00
WFI 1437.88 1537.23 1540.43 4515.53 1806.21 1806.21 2709.32 2709.32
TOTAL (kg/batch) 1546.66 1555.90 3080.85 6183.41 3474.09 3474.09 2709.32 2709.32
Cleave the monoclonal antibody to 2 Fab' (or Fab) fragments and 1 Fc fragment with 95% efficiency, removing 60% of WFI.
Main Components Waste Components
Stirred Reactor
Unit: P-39/PFF-201
Process Description:
Inlet Components (kg/batch) Outlet Theoretical SuperPro Theoretical SuperPro
Stream name: S-211 Tris-HCl Total
AAs 0.55 0.00 0.55 0.51 0.51 0.04 0.04
Cysteine-HCl 5.45 0.00 5.45 5.06 5.03 0.38 0.41
DeadBiomass 2.71 0.00 2.71 2.52 2.50 0.19 0.21
EDTA Disodium 9.02 0.00 9.02 8.39 8.34 0.63 0.68
Glucose 2.33 0.00 2.33 2.16 2.15 0.17 0.18
Glutamine 0.27 0.00 0.27 0.25 0.25 0.02 0.02
Inorganic Salts 5.65 0.00 5.65 5.22 5.22 0.42 0.43
Lactate 18.74 0.00 18.74 17.34 17.33 1.41 1.42
MAB 1.55 0.00 1.55 1.44 1.43 0.11 0.12
MAB Fab 19.64 0.00 19.64 18.16 18.15 1.47 1.49
Mab Fc 9.82 0.00 9.82 9.08 9.07 0.74 0.74
OtherMedia 0.05 0.00 0.05 0.05 0.05 0.00 0.00
Papain 1540.43 0.00 1540.43 0.00 0.00 1540.43 1540.43
Sodium Phosphat 4.20 0.00 4.20 3.91 3.88 0.29 0.32
Tris HCl 0.00 206.78 206.78 160.25 160.92 46.53 45.86
Vitamins 0.02 0.00 0.02 0.02 0.02 0.00 0.00
Water 47.46 0.00 47.46 43.90 43.87 3.56 3.59
WFI 1806.21 2340.66 4146.88 3524.84 3491.04 622.03 655.84
TOTAL (kg/batch) 3474.09 2547.44 6021.53 3803.11 3769.77 2218.42 2251.77
Plate and Frame Filter
Waste Components
Removes unreacted Papain from the process stream.
Main Components
Unit: P-42/DF-202
Process Description:
Inlet Components (kg/batch) Outlet Components (kg/batch) Theoretical SuperPro Theoretical SuperPro
Stream name: S-214 RR Buffer 2-1
AAs 0.13 0.00 AAs 0.02 0.01 0.11 0.62
DeadBiomass 0.65 0.00 DeadBiomass 0.10 0.03 0.00 0.00
EDTA, Sodium 0.00 1134.87 EDTA, Sodium 170.23 178.18 964.64 956.69
F(ab')2 16.67 0.00 F(ab')2 16.67 16.67 16.67 0.53
Glucose 0.56 0.00 Glucose 0.08 0.03 0.47 0.06
Glutamine 0.07 0.00 Glutamine 0.01 0.00 0.06 0.22
Impurities 0.44 0.00 Impurities 0.07 0.27 0.38 1.29
Inorganic Salts 1.35 0.00 Inorganic Salts 0.20 0.07 1.15 4.26
Lactate 4.48 0.00 Lactate 0.67 0.22 3.81 1.21
MAB 1.32 0.00 MAB 0.20 0.06 1.12 7.93
Mab Fc 8.34 0.00 MAB Fab 0.00 0.00 0.00 0.00
Nitrogen 0.00 0.00 Mab Fc 1.25 0.41 7.09 0.01
OtherMedia 0.01 0.00 OtherMedia 0.00 0.00 0.00 0.00
Oxygen 0.00 0.00 Oxygen 0.00 0.00 0.00 0.00
Sodium Acetate 6.27 0.00 Sodium Acetate 0.94 0.31 5.33 5.96
Sodium Phosphat 0.00 14477.03 Sodium Phosphat 2171.55 2272.91 12305.47 12204.11
TRIS HCl 147.46 0.00 TRIS HCl 22.12 7.28 125.34 140.17
Vitamins 0.01 0.00 Vitamins 0.00 0.00 0.01 0.01
Water 11.35 0.00 Water 1.70 0.56 9.65 10.79
WFI 3486.58 1524.37 WFI 522.99 411.49 2963.59 4599.46
TOTAL (kg/batch) 3685.68 17136.27 TOTAL (kg/batch) 2908.81 2888.50 16404.88 17933.44
Main Components Waste Components
Diafiltration System
F(ab')2 must be dissolved in Reduction Reaction Buffer at 10 mg/mL before Reduction (Concentrate from 3.68 mg/ml).
Flexible Manufacturing Facility for Biopharmaceuticals 
 
-314- 
 
 
 
Unit: P-44/R-202
Process Description:
Inlet Components (kg/batch) Outlet Components (kg/batch) Theoretical SuperPro
Stream name: S-216 2-MEA
2-MEA 0.00 8.00 2-MEA 8.00 8.00
AAs 0.01 0.00 AAs 0.01 0.01
DeadBiomass 0.03 0.00 DeadBiomass 0.03 0.03
EDTA, Sodium 178.18 0.00 EDTA, Sodium 178.18 178.18
F(ab')2 16.67 0.00 F(ab')2 0.00 0.00
Glucose 0.03 0.00 Glucose 0.03 0.03
Glutamine 0.00 0.00 Glutamine 0.00 0.00
Impurities 0.27 0.00 Impurities 0.27 0.27
Inorganic Salts 0.07 0.00 Inorganic Salts 0.07 0.07
Lactate 0.22 0.00 Lactate 0.22 0.22
MAB 0.06 0.00 MAB 0.06 0.06
MAB Fab 0.00 0.00 MAB Fab 15.84 16.67
Mab Fc 0.41 0.00 Mab Fc 0.41 0.41
OtherMedia 0.00 0.00 OtherMedia 0.00 0.00
Sodium Acetate 0.31 0.00 Sodium Acetate 0.31 0.31
Sodium Phosphat 2272.91 0.00 Sodium Phosphat 2272.91 2272.91
TRIS HCl 7.28 0.00 TRIS HCl 7.28 7.28
Vitamins 0.00 0.00 Vitamins 0.00 0.00
Water 0.56 0.00 Water 0.56 0.56
WFI 411.49 0.00 WFI 411.49 411.49
TOTAL (kg/batch) 2888.50 8.00 TOTAL (kg/batch) 2895.67 2896.50
Disulfide Reaction
F(ab')2 fragments are reacted with Reduction Agent 2-MEA to Form 2 Fab' Fragments.
Main Components
Unit: P-47/DF-203
Process Description:
Inlet Components (kg/batch) Outlet Components (kg/batch) Theoretical SuperPro Theoretical SuperPro
Stream name: S-218 WFI In 2-3
2-MEA 8.00 0.00 2-MEA 1.20 1.08 6.80 6.92
AAs 0.01 0.00 AAs 0.00 0.00 0.01 0.01
DeadBiomass 0.03 0.00 DeadBiomass 0.00 0.00 0.03 0.03
EDTA, Sodium 178.18 0.00 EDTA, Sodium 26.73 24.11 151.45 154.06
Glucose 0.03 0.00 Glucose 0.00 0.00 0.02 0.02
Glutamine 0.00 0.00 Glutamine 0.00 0.00 0.00 0.00
Impurities 0.27 0.00 Impurities 0.04 0.18 0.23 0.09
Inorganic Salts 0.07 0.00 Inorganic Salts 0.01 0.01 0.06 0.06
Lactate 0.22 0.00 Lactate 0.03 0.03 0.19 0.19
MAB 0.06 0.00 MAB 0.01 0.01 0.05 0.05
MAB Fab 16.67 0.00 MAB Fab 16.67 16.67 0.00 0.00
Mab Fc 0.41 0.00 Mab Fc 0.06 0.06 0.35 0.36
Nitrogen 0.00 0.00 Nitrogen 0.00 0.00 0.00 0.00
OtherMedia 0.00 0.00 OtherMedia 0.00 0.00 0.00 0.00
Oxygen 0.00 0.00 Oxygen 0.00 0.00 0.00 0.00
Sodium Acetate 0.31 0.00 Sodium Acetate 0.05 0.04 0.26 0.27
Sodium Phosphat 2272.91 0.00 Sodium Phosphat 340.94 307.61 1931.97 1965.30
TRIS HCl 7.28 0.00 TRIS HCl 1.09 0.99 6.19 6.30
Vitamins 0.00 0.00 Vitamins 0.00 0.00 0.00 0.00
Water 0.56 0.00 Water 0.08 0.08 0.48 0.49
WFI 411.49 2868.63 WFI 492.02 1281.16 2788.10 1998.97
TOTAL (kg/batch) 2896.50 2868.63 TOTAL (kg/batch) 878.94 1632.02 4886.19 4133.11
Diafiltration System
2-MEA must be filtered out and Fab' must be dissolved in WFI at 10 mg/mL before Protein-A Chromatography.
Main Components Waste Components
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Unit: P-49/C-201
Process Description:
Inlet Components (kg/batch) Theoretical SuperPro Theoretica SuperPro
Stream name: S-214 ProtA-Equil ProtA-Wash ProtA-Elut ProtA-Reg Total
AAs 0.51 0.00 0.00 0.00 0.00 0.51 0.51 0.51 0.00 0.00
Acetic-Acid 0.00 0.00 0.00 15.80 0.00 15.80 6.32 6.32 9.48 9.48
Cysteine-HCl 5.03 0.00 0.00 0.00 0.00 5.03 5.03 5.03 0.00 0.00
DeadBiomass 2.50 0.00 0.00 0.00 0.00 2.50 2.50 2.50 0.00 0.00
EDTA Disodium 8.34 0.00 0.00 0.00 0.00 8.34 8.34 8.34 0.00 0.00
EDTA, Sodium 0.00 5.25 6.34 0.00 0.00 11.59 0.00 0.00 11.59 11.59
Glucose 2.15 0.00 0.00 0.00 0.00 2.15 2.15 2.15 0.00 0.00
Glutamine 0.25 0.00 0.00 0.00 0.00 0.25 0.25 0.25 0.00 0.00
Inorganic Salts 5.22 0.00 0.00 0.00 0.00 5.22 5.22 5.22 0.00 0.00
Lactate 17.33 0.00 0.00 0.00 0.00 17.33 17.33 17.33 0.00 0.00
MAB 1.43 0.00 0.00 0.00 0.00 1.43 0.00 0.00 1.43 1.43
MAB Fab 18.15 0.00 0.00 0.00 0.00 18.15 18.15 18.15 0.00 0.00
Mab Fc 9.07 0.00 0.00 0.00 0.00 9.07 0.00 0.00 9.07 9.07
OtherMedia 0.05 0.00 0.00 0.00 0.00 0.05 0.05 0.05 0.00 0.00
Sodium Chloride 0.00 0.00 3.17 0.00 0.00 3.17 0.00 0.00 3.17 5.79
Sodium Citrate 0.00 2.62 0.00 0.00 2.85 5.47 0.00 0.00 5.47 2.85
Sodium Phosphat 3.88 0.00 0.00 0.00 0.00 3.88 3.88 3.88 0.00 0.00
TRIS Base 0.00 2.62 3.17 0.00 0.00 5.79 0.00 0.00 5.79 5.79
TRIS HCl 160.92 7.87 9.51 0.00 0.00 178.30 160.47 160.92 17.83 17.38
Vitamins 0.02 0.00 0.00 0.00 0.00 0.02 0.02 0.02 0.00 0.00
Water 43.87 0.00 0.00 0.00 0.00 43.87 43.87 43.87 0.00 0.00
WFI 3491.04 2604.09 3148.88 2618.08 1578.25 13440.33 4475.63 4538.27 8964.70 8902.06
TOTAL (kg/batch) 3769.77 2622.45 3171.08 2633.88 1581.09 13778.26 4749.72 4812.81 9028.54 8965.45
Protein-A Chromatography column
Remove the Fc fragments from the product stream.
Main Components Waste Components
Outlet Components (kg/batch)
Unit: P-51/DE-202
Process Description:
Inlet Components (kg/batch) Outlet Components (kg/batch) Theoretical SuperPro Theoretical SuperPro
AAs 0.51 AAs 0.51 0.51 0.00 0.00
Acetic-Acid 6.32 Acetic-Acid 6.32 6.32 0.00 0.00
Cysteine-HCl 5.03 Cysteine-HCl 5.03 5.03 0.00 0.00
DeadBiomass 2.50 DeadBiomass 0.00 0.00 2.50 2.50
EDTA Disodium 8.34 EDTA Disodium 8.34 8.34 0.00 0.00
Glucose 2.15 Glucose 2.15 2.15 0.00 0.00
Glutamine 0.25 Glutamine 0.25 0.25 0.00 0.00
Impurities 0.00 Impurities 0.00 0.00 0.00 0.00
Inorganic Salts 5.22 Inorganic Salts 5.22 5.22 0.00 0.00
Lactate 17.33 Lactate 17.32 17.32 0.01 0.01
MAB Fab 18.15 MAB Fab 18.14 18.14 0.01 0.01
OtherMedia 0.05 OtherMedia 0.05 0.05 0.00 0.00
Oxygen 0.00 Oxygen 0.00 0.00 0.00 0.00
Sodium Phosphat 3.88 Sodium Phosphat 3.88 3.88 0.00 0.00
TRIS HCl 160.92 TRIS HCl 160.84 160.84 0.08 0.08
Vitamins 0.02 Vitamins 0.02 0.02 0.00 0.00
Water 43.87 Water 43.84 43.84 0.02 0.02
WFI 4538.27 WFI 4536.00 4535.98 2.27 2.29
TOTAL (kg/batch) 4812.81 TOTAL (kg/batch) 4812.81 4807.88 4.89 4.93
Main Components Waste Components
Sterile Filtration (Dead-end Filtration)
Removes bacteria and biomass.
Unit: P-54/DF-204 Diafiltration 
Process Description:
Inlet Components (kg/batch) Theoretical SuperPro Theoretical SuperPro
Stream Name: S-218 WFI-input Total
AAs 0.51 0.00 0.51 0.01 0.01 0.50 0.50
Acetic-Acid 6.32 0.00 6.32 0.16 0.17 6.16 6.15
Cysteine-HCl 5.03 0.00 5.03 0.13 0.13 4.91 4.90
DeadBiomass 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EDTA Disodium 8.34 0.00 8.34 0.21 0.22 8.13 8.12
Glucose 2.15 0.00 2.15 0.05 0.06 2.10 2.10
Glutamine 0.25 0.00 0.25 0.01 0.01 0.24 0.24
Inorganic Salts 0.00 0.00 0.00 0.00 0.26 0.00 0.28
Lactate 5.22 0.00 5.22 0.13 0.14 5.09 5.08
MAB Fab 17.32 0.00 17.32 0.43 0.46 16.88 16.86
Nitrogen 18.14 0.00 18.14 18.14 17.60 0.00 0.00
OtherMedia 0.05 0.00 0.05 0.00 0.00 0.04 0.04
Oxygen 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Sodium Phosphat 3.88 0.00 3.88 0.10 0.10 3.78 3.78
TRIS HCl 160.84 0.00 160.84 4.02 4.29 156.82 156.55
Vitamins 0.02 0.00 0.02 0.00 0.00 0.02 0.02
Water 43.84 0.00 43.84 1.10 1.17 42.75 42.68
WFI 4535.98 1894.89 6430.87 932.48 924.60 5498.39 5506.27
TOTAL (kg/batch) 4807.88 1894.89 6702.77 956.96 949.22 5745.81 5753.55
Further refine the product by exchanging buffer.
Main Components Waste Components
Outlet Components (kg/batch)
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Unit: P-56/V-207
Process Description:
Inlet Components (kg/batch) Theoretical SuperPro
Stream Name: S-222 Polysorb80 Total
AAs 0.01 0.00 0.01 0.01 0.01
Acetic-Acid 0.17 0.00 0.17 0.17 0.17
Cysteine-HCl 0.13 0.00 0.13 0.13 0.13
DeadBiomass 0.00 0.00 0.00 0.00 0.00
EDTA Disodium 0.22 0.00 0.22 0.22 0.22
Glucose 0.06 0.00 0.06 0.06 0.06
Glutamine 0.01 0.00 0.01 0.01 0.01
Impurities 0.26 0.00 0.26 0.26 0.26
Inorganic Salts 0.14 0.00 0.14 0.14 0.14
Lactate 0.46 0.00 0.46 0.46 0.46
MAB Fab 17.60 0.00 17.60 17.60 17.60
OtherMedia 0.00 0.00 0.00 0.00 0.10
Polysorbate 80 0.00 0.10 0.10 0.10 0.00
Sodium Phosphat 0.10 0.00 0.10 0.10 0.10
TRIS HCl 4.29 0.00 4.29 4.29 4.29
Vitamins 0.00 0.00 0.00 0.00 0.00
Water 1.17 0.00 1.17 1.17 1.17
WFI 924.60 0.10 924.69 924.69 924.69
TOTAL (kg/batch) 949.22 0.19 949.41 949.41 949.41
Inactivate possible viruses through treatment with polysorbate 80.
Outlet Components (kg/batch)
Main Components
Chemical Virus Inactivation Tank
Unit: P-58/DE-203
Process Description:
Inlet Components (kg/batch) Outlet Components (kg/batch) Theoretical SuperPro
AAs 0.01 AAs 0.01 0.01
Acetic-Acid 0.17 Acetic-Acid 0.17 0.17
Cysteine-HCl 0.13 Cysteine-HCl 0.13 0.13
EDTA Disodium 0.22 EDTA Disodium 0.22 0.22
Glucose 0.06 Glucose 0.06 0.06
Glutamine 0.01 Glutamine 0.01 0.01
Impurities 0.26 Impurities 0.26 0.26
Inorganic Salts 0.14 Inorganic Salts 0.14 0.14
Lactate 0.46 Lactate 0.46 0.46
MAB Fab 17.60 MAB Fab 17.60 17.60
Nitrogen 0.00 Nitrogen 0.00 0.00
OtherMedia 0.00 OtherMedia 0.00 0.00
Oxygen 0.00 Oxygen 0.00 0.00
Polysorbate 80 0.10 Polysorbate 80 0.10 0.10
Sodium Phosphat 0.10 Sodium Phosphat 0.10 0.10
TRIS HCl 4.29 TRIS HCl 4.29 4.29
Vitamins 0.00 Vitamins 0.00 0.00
Water 1.17 Water 1.17 1.17
WFI 924.69 WFI 924.69 924.69
TOTAL (kg/batch) 949.41 TOTAL (kg/batch) 949.41 949.41
Main Components
Further refines the stream.
Sterile Filtration (Dead-end Filtration)
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Unit: P-68/C-301 Cation Exchange Chromatography
Process Description:
Inlet Components (kg/batch) Theoretical SuperPro Theoretical SuperPro
Stream name: Fab Load Cat-Equil Cat Wash Cat Elute Cat-WFI Cat-Strip Total
2-MEA 0.02794 0.00 0.00 0.00 0.00 0.00 0.03 0.00 0.00 0.03 0.02794
AAs 0.00002 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00002
Acetic-Acid 0.00132 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00132
EDTA, Sodium 0.62195 0.00 0.00 0.00 0.00 0.00 0.62 0.00 0.00 0.62 0.62195
Glucose 0.0001 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.0001
Glutamine 0.00001 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00001
Impurities 0.06612 0.00 0.00 0.00 0.00 0.00 0.07 0.01 0.00793 0.06 0.05818
Inorganic Salts 0.00023 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00023
Lactate 0.00077 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0 0.00 0.00077
MAB Fab 16.67308 0 0 0 0 0 16.67 15.05 15.04746 1.63 1.62563
MES 25.47882 5.30362 5.30362 3.99882 0.00 5.09965 45.18 0.53 0.53318 44.65 44.65136
OtherMedia 0 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0
Polysorbate 80 0.02949 0.00 0.00 0 0.00 0 0.03 0.00 0 0.03 0.02949
Sodium Acetate 0.00108 0.00 0.00 0 0 0 0.00 0.00 0 0.00 0.00108
Sodium Chloride 0 0.00 0.00 23.94348 0 0 30.53481 3.19 3.19246 51.29 51.28582
Sodium Phosphat 7.93396 0.00 0.00 0.00 0.00 0.00 7.93 0.00 0.00 7.93 7.93396
TRIS HCl 0.02542 0.00 0.00 0.00 0.00 0.00 0.03 0.00 0.00 0.03 0.02542
Vitamins 0 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0
Water 0.00196 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00196
WFI 2853.99631 537.98904 537.98904 409.70927 1203.86659 1718.88173 522.49691 215.14 215.14345 5850.90 5850.9037
TOTAL (kg/batch) 2904.86 543.29 543.29 437.65 1203.87 1723.98 623.60 233.90 233.92 5957.20 5957.17
Waste Components
Outlet Components (kg/batch)
Binds Fab fragments, allowing impurities to flow through (95% binding, 95% yield).
Main Components
Unit: P-71/C-302 Anion Exchange Chromatography
Process Description:
Inlet Components (kg/batch) Theoretical SuperPro Theoretical SuperPro
Stream name: S-304 (Load) Anion-Equil Anion-Wash Anion-Strip Total
Impurities 0.00793 0 0 0 0.00793 0.00 0.0004 0.01 0.00754
MAB Fab 15.04746 0 0 0 15.04746 15.01 15.00984 0.04 0.03762
MES 0.53318 0 0 0 0.53318 0.53 0.53318 0.00 0
Sodium Chloride 11.92664 0.72322 0.28929 26.11021 39.04936 12.22 12.21593 26.83 26.83343
TRIS Base 14.76077 1.22224 0.4889 2.23362 18.70553 15.25 15.24966 3.46 3.45586
WFI 3685.32078 287.3425 114.937 446.79333 4534.39361 3800.26 3800.25778 734.14 734.13582
Total (kg/batch) 3727.59676 289.28796 115.71519 475.13716 4607.73707 3843.26 3843.26679 764.5 764.47027
Binds Impurities, allowing FAB to flow through (5% binding, 95% yield of FAB).
Main Components Waste Components
Outlet Components (kg/batch)
Unit: P-81/DF-401
Process Description: Fab' must be dissolved in Reduction Reaction Buffer at 10 mg/mL before Reduction (Concentrate from 6 mg/ml).
Main Components Waste Components
Inlet Components (kg/batch) Outlet Components (kg/batch) Theoretical SuperPro Theoretical SuperPro
Stream Name: S-401 RR Buffer
EDTA, Sodium 0.00 5.69 EDTA, Sodium 0.85 0.94 4.84 4.75
Impurities 0.00 0.00 Impurities 0.00 0.00 0.00 0.00
MAB Fab 15.01 0.00 MAB Fab 15.01 15.01 0.00 0.00
MES 0.53 0.00 MES 0.08 0.03 0.45 0.51
Nitrogen 0.00 0.00 Phosphate 10.89 11.95 61.71 60.65
Oxygen 0.00 0.00 Reduced Mab Fab 0.00 0.00 0.00 0.00
Phosphate 0.00 72.60 Sodium Chloride 1.83 0.63 10.38 11.58
Sodium Chloride 12.22 0.00 TRIS Base 2.29 0.79 12.96 14.46
TRIS Base 15.25 0.00 WFI 1716.72 1454.82 9728.09 9989.99
WFI 3800.26 7644.56 TOTAL (kg/batch) 1747.68 1484.17 9818.44 10081.95
TOTAL (kg/batch) 3843.27 7722.85
Diafiltration System
Unit: P-83 / R-401
Process Description: Remove any small-thiol reactive molecules which can cap cysteine during purification steps.
Inlet Components (kg/batch) Outlet Components (kg/batch) Theoretical SuperPro
Stream Name: S-403 2-MEA
2-MEA 0.00 9.01 2-MEA 9.01 9.01
EDTA, Sodium 0.94 0.00 EDTA Disodium 0.00 0.00
Impurities 0.00 0.00 EDTA, Sodium 0.94 0.94
MAB Fab 15.01 0.00 Impurities 0.00 0.00
MES 0.03 0.00 MAB Fab 0.75 0.75
Phosphate 11.95 0.00 MES 0.03 0.03
Reduced Mab Fab 0.00 0.00 Phosphate 11.95 11.95
Sodium Chloride 0.63 0.00 Reduced Mab Fab 14.26 14.26
TRIS Base 0.79 0.00 Sodium Chloride 0.63 0.63
WFI 1454.82 0.00 TRIS Base 0.79 0.79
TOTAL (kg/batch) 1484.17 9.01 WFI 1454.82 1454.82
TOTAL (kg/batch) 1493.18 1493.17
Thiol Reduction Reaction
Main Components
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Unit: P-86/DF-402
Process Description: Separate out 2-MEA and keep Fab' at 10 mg/mL in PEGylation Reaction Buffer.
Main Components Waste Components
Inlet Components (kg/batch) Outlet Components (kg/batch) Theoretical SuperPro Theoretical SuperPro
Stream Name: S-405 PR Buffer 4-1
2-MEA 9.01 0.00 2-MEA 1.35 1.22 7.66 7.79
EDTA Disodium 0.00 2.23 EDTA Disodium 0.33 0.95 1.89 1.27
EDTA, Sodium 0.94 0.00 EDTA, Sodium 0.14 0.13 0.14 0.81
Impurities 0.00 0.00 Impurities 0.00 0.00 0.00 0.00
MAB Fab 0.75 0.00 MAB Fab 0.75 0.75 0.00 0.00
MES 0.03 0.00 MES 0.00 0.00 0.02 0.02
Nitrogen 0.00 0.00 PEG 0.00 0.00 0.00 0.00
Oxygen 0.00 0.00 Phosphate 6.05 13.78 34.31 26.59
Phosphate 11.95 28.41 Reduced Mab Fab 14.26 14.26 0.00 0.00
Reduced Mab Fab 14.26 0.00 Sodium Chloride 0.09 0.09 0.54 0.55
Sodium Chloride 0.63 0.00 TRIS Base 0.12 0.11 0.67 0.68
TRIS Base 0.79 0.00 WFI 1111.65 1477.31 3334.94 2969.27
WFI 1454.82 2991.76 TOTAL (kg/batch) 1134.75 1508.59 3380.16 3006.98
TOTAL (kg/batch) 1493.17 3022.40
Diafiltration System
Unit: P-88/R-402
Process Description: PEGylate Fab' fragments at thiol in hinge region cysteine.
Main Components Waste Components
Inlet Components (kg/batch) Outlet Components (kg/batch) Theoretical SuperPro Theoretical SuperPro
Stream Name: S-407 PEG Reagent
2-MEA 1.22 0.00 2-MEA 1.22 1.22 0.00 0.00
EDTA Disodium 0.95 0.00 EDTA Disodium 0.95 0.95 0.00 0.00
EDTA, Sodium 0.13 0.00 EDTA, Sodium 0.13 0.13 0.00 0.00
Impurities 0.00 0.00 Impurities 0.00 0.00 0.00 0.00
MAB Fab 0.75 0.00 MAB Fab 0.75 0.75 0.00 0.00
MES 0.00 0.00 MES 0.00 0.00 0.00 0.00
PEG 0.00 228.15 Nitrogen 0.00 0.00 0.00 0.00
Phosphate 13.78 0.00 Oxygen 0.00 0.00 0.00 0.00
Reduced Mab Fab 14.26 0.00 PEG 216.74 217.31 0.00 0.00
Sodium Chloride 0.09 0.00 PEGylated Mab F 27.09 24.38 0.00 0.00
TRIS Base 0.11 0.00 Phosphate 13.78 13.78 0.00 0.00
WFI 1477.31 0.00 Reduced Mab Fab 1.43 0.71 0.00 0.00
TOTAL (kg/batch) 1508.59 228.15 Sodium Chloride 0.09 0.09 0.00 0.00
TRIS Base 0.11 0.11 0.00 0.00
WFI 590.92 590.92 886.39 886.39
TOTAL (kg/batch) 853.21 850.36 886.39 886.39
PEGylation Reaction
Unit: P-91/DF-403
Process Description: Filter out PEG Reagent and make sure pH between 3 and 12.
Main Components Waste Components
Inlet Components (kg/batch) Outlet Components (kg/batch): Theoretical SuperPro Theoretical SuperPro
Stream Name: S-409 WFI In 4-4
2-MEA 1.22 0.00 2-MEA 0.18 0.17 1.04 1.05
EDTA Disodium 0.95 0.00 EDTA Disodium 0.14 0.13 0.81 0.82
EDTA, Sodium 0.13 0.00 EDTA, Sodium 0.02 0.02 0.11 0.11
Impurities 0.00 0.00 Impurities 0.00 0.00 0.00 0.00
MAB Fab 0.75 0.00 MAB Fab 0.11 0.10 0.64 0.65
MES 0.00 0.00 MES 0.00 0.00 0.00 0.00
Nitrogen 0.00 0.00 PEG 32.60 29.41 184.72 187.90
Oxygen 0.00 0.00 PEGylated Mab F 24.38 24.38 0.00 0.00
PEG 217.31 0.00 Phosphate 2.07 1.87 11.71 11.91
PEGylated Mab F 24.38 0.00 Reduced Mab Fab 0.11 0.10 0.61 0.62
Phosphate 13.78 0.00 Sodium Chloride 0.01 0.01 0.07 0.07
Reduced Mab Fab 0.71 0.00 TRIS Base 0.02 0.01 0.09 0.09
Sodium Chloride 0.09 0.00 WFI 924.40 802.27 1386.60 1508.72
TRIS Base 0.11 0.00 TOTAL (kg/batch) 984.04 858.47 1586.39 1711.96
WFI 590.92 1720.07
TOTAL (kg/batch) 850.36 1720.07
Diafiltration System
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Unit: P-101 / C-401
Process Description:
Main Components Waste Components
Inlet Components (kg/batch) Outlet Components (kg/batch) Theoretical SuperPro Theoretical SuperPro
Stream Name: S-410
2-MEA 0.17 2-MEA 0.00 0.00 0.17 0.17
EDTA Disodium 0.13 EDTA Disodium 0.00 0.00 0.13 0.13
EDTA, Sodium 0.02 EDTA, Sodium 0.00 0.00 0.02 0.02
Impurities 0.00 Impurities 0.00 0.00 0.00 0.00
MAB Fab 0.10 MAB Fab 0.00 0.00 0.10 0.10
MES 0.00 MacroCap SP 0.00 0.00 0.00 2026.87
PEG 29.41 MES 0.00 0.00 0.00 0.00
PEGylated Mab F 24.38 PEG 0.00 0.00 29.41 29.41
Phosphate 5.83 PEGylated Mab F 21.94 22.01 2.44 2.38
Reduced Mab Fab 0.10 Phosphate 0.87 0.28 4.95 11.94
Sodium Chloride 0.01 Reduced Mab Fab 0.00 0.00 0.10 0.10
TRIS Base 0.01 Sodium Chloride 0.00 8.50 0.01 98.78
Water 2084.92 TRIS Base 0.00 0.00 0.01 0.01
WFI 802.27 Water 0.00 0.00 2084.92 3618.45
TOTAL (kg/batch) 2947.35 WFI 320.91 302.65 481.36 3513.89
TOTAL (kg/batch) 343.73 333.42 2603.62 9302.24
Specifically binds PEGylated Fab' fragments which are larger and have lower surface charge.
Separates unPEGylated Fab' fragments and excess PEG molecules from Pegylated Fab'.
Cation Exchange 
Unit: P-106/DE-501 RetroVirus Filtration
Process Description:
Main Components Waste Components
Inlet Components (kg/batch) Outlet Components (kg/batch) Theoretical SuperPro Theoretical SuperPro
Stream name: S-503
Impurities 0 Impurities 0.00 0 0.00 0
KCl 0.00034 KCl 0.00 0.00034 0.00 0
KH2PO4 0.00034 KH2PO4 0.00 0.00034 0.00 0
MAB Fab 0.00025 MAB Fab 0.00 0.00025 0.00 0
Na2HPO4 0.18921 Na2HPO4 0.19 0.189 0.00 0.0002
PEGylated Mab F 21.45594 PEGylated Mab F 21.24 21.24138 0.21 0.21456
Phosphate 0.02402 Phosphate 0.02 0.02399 0.00 0.00003
Sodium Chloride 2.11584 Sodium Chloride 2.11 2.11355 0.00 0.00229
WFI 196.84436 WFI 196.63 196.63112 0.21 0.21324
Total (kg/batch) 220.6303 Total (kg/batch) 220.20 220.19997 0.43 0.43032
Removes Retrovirus (lets 99% of protein pass through, virus not modeled).
Unit: P-107/DE-502 Parvovirus Filtration
Process Description:
Main Components Waste Components
Inlet Components (kg/batch) Outlet Components (kg/batch) Theoretical SuperPro Theoretical SuperPro
Stream name: S-504
Impurities 0 Impurities 0.00 0 0.00 0
KCl 0.00034 KCl 0.00 0.00034 0.00 0
KH2PO4 0.00034 KH2PO4 0.00 0.00034 0.00 0
MAB Fab 0.00025 MAB Fab 0.00 0.00025 0.00 0
Na2HPO4 0.189 Na2HPO4 0.19 0.1888 0.00 0.0002
PEGylated Mab F 21.24138 PEGylated Mab F 21.03 21.02897 0.21 0.21241
Phosphate 0.02399 Phosphate 0.02 0.02397 0.00 0.00003
Sodium Chloride 2.11355 Sodium Chloride 2.11 2.11128 0.00 0.00227
WFI 196.63112 WFI 196.42 196.42002 0.21 0.2111
Total (kg/batch) 220.19997 Total (kg/batch) 219.77 219.77397 0.43 0.42601
Removes Retrovirus (lets 99% of protein pass through, virus not modeled).
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Immobilized Pepsin 370 
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MES 390 
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PBS Phosphate Buffered Saline 402 
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Polyethylene glycol 416 
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http://www.sciencelab.com/msdsList.php
2-Mercaptoethylamine Hydrochloride
ethanethiol, 2-amino-, hydrochloride
3756
0020408 1854450 1885690
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Material Safety Data Sheet
Product name
Synonym
Manufacturer
Product No.
MSDS #
Validation date
Print date
In case of emergency
Product and company identification
Responsible name MSDS (Regulatory Affairs)
2-Mercaptoethylamine Hydrochloride
:
:
:
:
:
:
:
:
1 .
Chemical formula : C2-H7-N-S.Cl-H
CHEMTREC:
800.424.9300
OUTSIDE US:
202.483.7616
Supplier : Thermo Fisher Scientific
Pierce Biotechnology
P.O. Box 117
Rockford, IL 61105
United States
815.968.0747 or
800.874.3723
:Use of
Substance/Preparation
Refer to the instruction booklet for
proper and intended use.
Otherwise, contact supplier for
specific applications.
: Thermo Fisher Scientific
Pierce Biotechnology
P.O. Box 117
Rockford, IL 61105
United States
815.968.0747
800.874.3723
Eye contact. Inhalation. Ingestion.
Emergency overview
Hazards identification
Routes of entry
Potential acute health effects
Slightly irritating to the respiratory system.  Exposure to decomposition products may
cause a health hazard.  Serious effects may be delayed following exposure.
Slightly irritating to the eyes.
Harmful if swallowed.
Slightly irritating to the skin.
Eyes
Skin
Inhalation
Ingestion
Physical state Solid. [Crystalline solid]
CAUTION !
MAY BE HARMFUL IF SWALLOWED.  MAY CAUSE RESPIRATORY TRACT, EYE
AND SKIN IRRITATION.  CAN CAUSE TARGET ORGAN DAMAGE.
Harmful if swallowed.  Slightly irritating to the eyes, skin and respiratory system.  Do not
ingest.  Avoid contact with eyes, skin and clothing.  Can cause target organ damage.
Use only with adequate ventilation.  Keep container tightly closed and sealed until ready
for use.  Wash thoroughly after handling.
:
:
:
:
:
:
:
Odor : Disagreeable and choking.
OSHA/HCS status : This material is considered hazardous by the OSHA Hazard Communication Standard
(29 CFR 1910.1200).
2 .
Potential chronic health effects
Carcinogenicity : No known significant effects or critical hazards.
Mutagenicity : No known significant effects or critical hazards.
Teratogenicity : No known significant effects or critical hazards.
Developmental effects : No known significant effects or critical hazards.
Chronic effects : Can cause target organ damage.
Fertility effects : No known significant effects or critical hazards.
1/75/23/2008.
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2-Mercaptoethylamine Hydrochloride
Hazards identification2 .
See toxicological information (section 11)
Medical conditions
aggravated by over-
exposure
Pre-existing digestive disorders and disorders involving any other target organs
mentioned in this MSDS as being at risk may be aggravated by over-exposure to this
product.
:
Over-exposure signs/symptoms
Ingestion : No specific data.
Skin : Adverse symptoms may include the following:
irritation
redness
Eyes : Adverse symptoms may include the following:
irritation
watering
redness
Inhalation : Adverse symptoms may include the following:
respiratory tract irritation
coughing
Target organs : Causes damage to the following organs: gastrointestinal tract, skin.
The substance is not classified as dangerous according to Directive 67/548/EEC and its amendments.
Classification Not classified.:
2-Mercaptoethylamine Hydrochloride 156-57-0 98 - 100
Composition/information on ingredients
Name CAS number %
United States
3 .
There are no ingredients or additional ingredients present which, within the current knowledge of the supplier and
in the concentrations applicable, are classified as hazardous to health or the environment and hence require
reporting in this section.
Substance/preparation Substance:
Wash out mouth with water.  Remove dentures if any.  Move exposed person to fresh
air.  Keep person warm and at rest.  If material has been swallowed and the exposed
person is conscious, give small quantities of water to drink.  Stop if the exposed person
feels sick as vomiting may be dangerous.  Do not induce vomiting unless directed to do
so by medical personnel.  If vomiting occurs, the head should be kept low so that vomit
does not enter the lungs.  Get medical attention.  Never give anything by mouth to an
unconscious person.  If unconscious, place in recovery position and get medical
attention immediately.  Maintain an open airway.  Loosen tight clothing such as a collar,
tie, belt or waistband.
Flush contaminated skin with plenty of water.  Remove contaminated clothing and
shoes.  Continue to rinse for at least 10 minutes.  Get medical attention if symptoms
occur.  Wash clothing before reuse.  Clean shoes thoroughly before reuse.
Move exposed person to fresh air.  Keep person warm and at rest.  If not breathing, if
breathing is irregular or if respiratory arrest occurs, provide artificial respiration or oxygen
by trained personnel.  It may be dangerous to the person providing aid to give mouth-to-
mouth resuscitation.  Get medical attention.  If unconscious, place in recovery position
and get medical attention immediately.  Maintain an open airway.  Loosen tight clothing
such as a collar, tie, belt or waistband.  In case of inhalation of decomposition products
in a fire, symptoms may be delayed.  The exposed person may need to be kept under
medical surveillance for 48 hours.
First aid measures
Skin contact
Inhalation
Ingestion
:
:
:
4 .
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2-Mercaptoethylamine Hydrochloride
First aid measures4 .
Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting
the upper and lower eyelids.  Check for and remove any contact lenses.  Get medical
attention if irritation occurs.
Eye contact :
Protection of first-aiders : No action shall be taken involving any personal risk or without suitable training.  It may
be dangerous to the person providing aid to give mouth-to-mouth resuscitation.
See section 11 for more detailed information on health effects and symptoms.
Use an extinguishing agent suitable for the surrounding fire.
Emits highly corrosive fumes when heated to decomposition. Emits very toxic fumes
when heated to decomposition.
Fire-fighting measures
Extinguishing media
Special remarks on fire
hazards
Promptly isolate the scene by removing all persons from the vicinity of the incident if
there is a fire.  No action shall be taken involving any personal risk or without suitable
training.
No specific fire or explosion hazard.
Special protective
equipment for fire-fighters
Fire-fighters should wear appropriate protective equipment and self-contained breathing
apparatus (SCBA) with a full face-piece operated in positive pressure mode.
:
:
5 .
Special exposure hazards :
None known.
Suitable :
Not suitable :
Hazardous combustion
products
: Decomposition products may include the following materials:
carbon oxides
nitrogen oxides
sulfur oxides
halogenated compounds
Flammability of the product :
No action shall be taken involving any personal risk or without suitable training.
Evacuate surrounding areas.  Keep unnecessary and unprotected personnel from
entering.  Do not touch or walk through spilled material.  Provide adequate ventilation.
Wear appropriate respirator when ventilation is inadequate.  Put on appropriate personal
protective equipment (see section 8).
Move containers from spill area.  Approach release from upwind.  Prevent entry into
sewers, water courses, basements or confined areas.  Vacuum or sweep up material
and place in a designated, labeled waste container.  Dispose of via a licensed waste
disposal contractor.  Note: see section 1 for emergency contact information and section
13 for waste disposal.
Environmental precautions
Accidental release measures
: Avoid dispersal of spilled material and runoff and contact with soil, waterways, drains
and sewers.  Inform the relevant authorities if the product has caused environmental
pollution (sewers, waterways, soil or air).
Personal precautions :
Large spill :
6 .
Move containers from spill area.  Vacuum or sweep up material and place in a
designated, labeled waste container.  Dispose of via a licensed waste disposal
contractor.
Small spill :
Put on appropriate personal protective equipment (see section 8).  Eating, drinking and
smoking should be prohibited in areas where this material is handled, stored and
processed.  Workers should wash hands and face before eating, drinking and smoking.
Do not ingest.  Avoid contact with eyes, skin and clothing.  Use only with adequate
ventilation.  Wear appropriate respirator when ventilation is inadequate.  Keep in the
original container or an approved alternative made from a compatible material, kept
tightly closed when not in use.  Empty containers retain product residue and can be
hazardous.  Do not reuse container.
Handling and storage
Handling :
7 .
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2-Mercaptoethylamine Hydrochloride
Handling and storage7 .
Store between the following temperatures: 2 to 8°C (35.6 to 46.4°F).  Store in
accordance with local regulations.  Store in original container protected from direct
sunlight in a dry, cool and well-ventilated area, away from incompatible materials (see
section 10) and food and drink.  Keep container tightly closed and sealed until ready for
use.  Containers that have been opened must be carefully resealed and kept upright to
prevent leakage.  Do not store in unlabeled containers.  Use appropriate containment to
avoid environmental contamination.
Storage :
Exposure controls/personal protection
Use a properly fitted, air-purifying or air-fed respirator complying with an approved
standard if a risk assessment indicates this is necessary.  Respirator selection must be
based on known or anticipated exposure levels, the hazards of the product and the safe
working limits of the selected respirator.
Safety eyewear complying with an approved standard should be used when a risk
assessment indicates this is necessary to avoid exposure to liquid splashes, mists,
gases or dusts.
Personal protective equipment for the body should be selected based on the task being
performed and the risks involved and should be approved by a specialist before handling
this product.
Personal protection
Eyes
Skin
Respiratory
Consult local authorities for acceptable exposure limits.
:
:
:
Chemical-resistant, impervious gloves complying with an approved standard should be
worn at all times when handling chemical products if a risk assessment indicates this is
necessary.
Hands :
8 .
Engineering measures : Use only with adequate ventilation.  If user operations generate dust, fumes, gas, vapor
or mist, use process enclosures, local exhaust ventilation or other engineering controls
to keep worker exposure to airborne contaminants below any recommended or statutory
limits.
Hygiene measures : Wash hands, forearms and face thoroughly after handling chemical products, before
eating, smoking and using the lavatory and at the end of the working period.  Appropriate
techniques should be used to remove potentially contaminated clothing.  Wash
contaminated clothing before reusing.  Ensure that eyewash stations and safety showers
are close to the workstation location.
Recommended monitoring
procedures
: If this product contains ingredients with exposure limits, personal, workplace atmosphere
or biological monitoring may be required to determine the effectiveness of the ventilation
or other control measures and/or the necessity to use respiratory protective equipment.
Environmental exposure
controls
: Emissions from ventilation or work process equipment should be checked to ensure they
comply with the requirements of environmental protection legislation.  In some cases,
fume scrubbers, filters or engineering modifications to the process equipment will be
necessary to reduce emissions to acceptable levels.
Europe
No exposure limit value known.
Solid. [Crystalline solid]
3.5 to 5 [Conc. (% w/w): 11.4%]
67 to 71°C (152.6 to 159.8°F)
113.62 g/mole
Disagreeable and choking.
White.
Melting/freezing point
Physical and chemical properties
Physical state
Molecular weight
pH
Odor
Color
C2-H7-N-S.Cl-HMolecular formula
:
:
:
:
:
:
:
9 .
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2-Mercaptoethylamine Hydrochloride
Physical and chemical properties9 .
Easily soluble in the following materials: cold water and hot water.Solubility :
The product is stable.  Under normal conditions of storage and use, hazardous
polymerization will not occur.
No specific data.
Will not occur.
Under normal conditions of storage and use, hazardous decomposition products should
not be produced.
No specific data.
Stability and reactivity
Chemical stability
Conditions to avoid
Incompatible materials
Hazardous decomposition
products
Possibility of hazardous
reactions
:
:
:
:
:
10 .
Toxicological information
United States
11 .
Acute toxicity
ethanethiol, 2-amino-, hydrochloride TDLo Oral Rat 800 mg/kg -
Product/ingredient name Result Species Dose Exposure
Conclusion/Summary : Not available.
Chronic toxicity
Conclusion/Summary : Not available.
Carcinogenicity
Conclusion/Summary : Laboratory experiments have shown mutagenic effects. Can cause gastrointestinal
disturbances.
Mutagenicity
Conclusion/Summary : Not available.
Teratogenicity
Conclusion/Summary : Not available.
Reproductive toxicity
Classification
ethanethiol, 2-amino-, hydrochloride - - - None. - None.
Product/ingredient name ACGIH EPA NIOSH NTPIARC OSHA
No known significant effects or critical hazards.Chronic effects :
No known significant effects or critical hazards.Carcinogenicity :
No known significant effects or critical hazards.Mutagenicity
No known significant effects or critical hazards.Teratogenicity
Developmental effects : No known significant effects or critical hazards.
Fertility effects : No known significant effects or critical hazards.
:
:
Europe
Not available.Conclusion/Summary :
5/75/23/2008.
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2-Mercaptoethylamine Hydrochloride
Ecological information
United States
Environmental effects : No known significant effects or critical hazards.
12 .
Aquatic ecotoxicity
Conclusion/Summary : Not available.
Other adverse effects : No known significant effects or critical hazards.
The generation of waste should be avoided or minimized wherever possible.  Dispose of
surplus and non-recyclable products via a licensed waste disposal contractor.  Disposal
of this product, solutions and any by-products should at all times comply with the
requirements of environmental protection and waste disposal legislation and any regional
local authority requirements.  Avoid dispersal of spilled material and runoff and contact
with soil, waterways, drains and sewers.
Waste disposal
Disposal considerations
Disposal should be in accordance with applicable regional, national and local laws and regulations.
:
13 .
Refer to Section 7: HANDLING AND STORAGE and Section 8: EXPOSURE CONTROLS/PERSONAL PROTECTION
for additional handling information and protection of employees.
Hazardous waste : Within the present knowledge of the supplier, this product is not regarded as
hazardous waste, as defined by EU Directive 91/689/EEC.
Transport information
9DOT Classification Aviation Regulated
Solid, n.o.s. (2-
Aminoethanethiol
hydrochloride)
(ethanethiol, 2-amino-
, hydrochloride)
III
Not available.Not available.IATA-DGR Class Not available.
Regulatory
information
UN number Proper shipping
name
Classes PG*
-
UN3335
14 .
PG* : Packing group
Target organ effectsHCS Classification
Regulatory information
U.S. Federal regulations United States inventory (TSCA 8b): This material is listed or exempted.
Clean Water Act (CWA) 307: No products were found.
Clean Water Act (CWA) 311: No products were found.
Clean Air Act (CAA) 112 accidental release prevention: No products were found.
Clean Air Act (CAA) 112 regulated flammable substances: No products were found.
Clean Air Act (CAA) 112 regulated toxic substances: No products were found.
WHMIS (Canada) Class D-2B: Material causing other toxic effects (Toxic).
SARA 302/304/311/312 extremely hazardous substances: No products were found.
SARA 302/304 emergency planning and notification: No products were found.
SARA 302/304/311/312 hazardous chemicals: No products were found.
SARA 311/312 MSDS distribution - chemical inventory - hazard identification: No
products were found.
:
:
:
Canada
United States
15 .
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2-Mercaptoethylamine Hydrochloride
Regulatory information15 .
CEPA Toxic substances: This material is not listed.
Canadian ARET: This material is not listed.
Canadian NPRI: This material is not listed.
Alberta Designated Substances: This material is not listed.
Ontario Designated Substances: This material is not listed.
Quebec Designated Substances: This material is not listed.
Australia inventory (AICS): This material is listed or exempted.
China inventory (IECSC): This material is listed or exempted.
Korea inventory (KECI): This material is listed or exempted.
Philippines inventory (PICCS): This material is listed or exempted.
Japan inventory (ENCS): This material is listed or exempted.
International regulations
International lists :
EU regulations
Canadian lists :
Canada inventory : Canada inventory: This material is listed or exempted.
This product is not classified according to EU legislation.Risk phrases
:
:
Other information
Hazardous Material
Information System (U.S.A.)
1
0
1
1
0
1
National Fire Protection
Association (U.S.A.)
Health
Special
Instability
Flammability
Health
Flammability
Physical hazards
MAY BE HARMFUL IF SWALLOWED.  MAY CAUSE RESPIRATORY TRACT, EYE
AND SKIN IRRITATION.  CAN CAUSE TARGET ORGAN DAMAGE.
Label requirements :
Notice to reader
To the best of our knowledge, the information contained herein is accurate. However, neither the above-named
supplier, nor any of its subsidiaries, assumes any liability whatsoever for the accuracy or completeness of the
information contained herein.
Final determination of suitability of any material is the sole responsibility of the user. All materials may present
unknown hazards and should be used with caution. Although certain hazards are described herein, we cannot
guarantee that these are the only hazards that exist.
Date of printing
Date of issue
Date of previous issue
Version
5/23/2008.
5/23/2008.
1.01
1/25/2008.
:
:
:
:
:
:
16 .
The customer is responsible for determining the PPE code for this material.
Indicates information that has changed from previously issued version.
This product has been classified according to the hazard criteria of the CPR and the MSDS contains all the information required by the CPR.
7/75/23/2008.
-328-
Material Safety Data Sheet
Acetic acid MSDS
Section 1: Chemical Product and Company Identification
Product Name: Acetic acid
Catalog Codes: SLA3784, SLA1438, SLA2101, SLA3604,
SLA1258
CAS#: 64-19-7
RTECS: AF1225000
TSCA: TSCA 8(b) inventory: Acetic acid
CI#: Not applicable.
Synonym: Acetic acid; glacial acetic acid
Chemical Name: Acetic Acid, Glacial
Chemical Formula: C2-H4-O2
Contact Information:
Sciencelab.com, Inc.
14025 Smith Rd.
Houston, Texas 77396
US Sales: 1-800-901-7247
International Sales: 1-281-441-4400
Order Online: ScienceLab.com
CHEMTREC (24HR Emergency Telephone), call:
1-800-424-9300
International CHEMTREC, call: 1-703-527-3887
For non-emergency assistance, call: 1-281-441-4400
Section 2: Composition and Information on Ingredients
Composition:
Name CAS # % by Weight
Acetic acid 64-19-7 100
Toxicological Data on Ingredients: Acetic acid: ORAL (LD50): Acute: 3310 mg/kg [Rat]. 4960 mg/kg [Mouse]. 3530 mg/kg
[Rat]. DERMAL (LD50): Acute: 1060 mg/kg [Rabbit]. VAPOR (LC50): Acute: 5620 ppm 1 hours [Mouse].
Section 3: Hazards Identification
Potential Acute Health Effects:
Very hazardous in case of skin contact (irritant), of eye contact (irritant), of ingestion, of inhalation. Hazardous in
case of skin contact (corrosive, permeator), of eye contact (corrosive). Liquid or spray mist may produce tissue
damage particularly on mucous membranes of eyes, mouth and respiratory tract. Skin contact may produce
burns. Inhalation of the spray mist may produce severe irritation of respiratory tract, characterized by coughing,
choking, or shortness of breath. Inflammation of the eye is characterized by redness, watering, and itching. Skin
inflammation is characterized by itching, scaling, reddening, or, occasionally, blistering.
Potential Chronic Health Effects:
Hazardous in case of skin contact (irritant), of ingestion, of inhalation.
CARCINOGENIC EFFECTS: Not available.
MUTAGENIC EFFECTS: Mutagenic for mammalian somatic cells. Mutagenic for bacteria and/or yeast.
TERATOGENIC EFFECTS: Not available.
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DEVELOPMENTAL TOXICITY: Not available.
The substance may be toxic to kidneys, mucous membranes, skin, teeth.
Repeated or prolonged exposure to the substance can produce target organs damage. Repeated or prolonged
contact with spray mist may produce chronic eye irritation and severe skin irritation. Repeated or prolonged
exposure to spray mist may produce respiratory tract irritation leading to frequent attacks of bronchial infection.
Section 4: First Aid Measures
Eye Contact:
Check for and remove any contact lenses. In case of contact, immediately flush eyes with plenty of water for at
least 15 minutes. Cold water may be used. Get medical attention immediately.
Skin Contact:
In case of contact, immediately flush skin with plenty of water for at least 15 minutes while removing contaminated
clothing and shoes. Cover the irritated skin with an emollient. Cold water may be used.Wash clothing before
reuse. Thoroughly clean shoes before reuse. Get medical attention immediately.
Serious Skin Contact:
Wash with a disinfectant soap and cover the contaminated skin with an anti-bacterial cream. Seek immediate
medical attention.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get
medical attention immediately.
Serious Inhalation:
Evacuate the victim to a safe area as soon as possible. Loosen tight clothing such as a collar, tie, belt or
waistband. If breathing is difficult, administer oxygen. If the victim is not breathing, perform mouth-to-mouth
resuscitation. WARNING: It may be hazardous to the person providing aid to give mouth-to-mouth resuscitation
when the inhaled material is toxic, infectious or corrosive. Seek immediate medical attention.
Ingestion:
Do NOT induce vomiting unless directed to do so by medical personnel. Never give anything by mouth to an
unconscious person. Loosen tight clothing such as a collar, tie, belt or waistband. Get medical attention if
symptoms appear.
Serious Ingestion: Not available.
Section 5: Fire and Explosion Data
Flammability of the Product: Flammable.
Auto-Ignition Temperature: 463°C (865.4°F)
Flash Points: CLOSED CUP: 39°C (102.2°F). OPEN CUP: 43°C (109.4°F).
Flammable Limits: LOWER: 4% UPPER: 19.9%
Products of Combustion: These products are carbon oxides (CO, CO2).
Fire Hazards in Presence of Various Substances:
Flammable in presence of open flames and sparks, of heat.
Slightly flammable to flammable in presence of oxidizing materials, of metals.
Explosion Hazards in Presence of Various Substances:
Risks of explosion of the product in presence of mechanical impact: Not available.
Risks of explosion of the product in presence of static discharge: Not available.
Slightly explosive in presence of oxidizing materials.
Fire Fighting Media and Instructions:
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Flammable liquid, soluble or dispersed in water.
SMALL FIRE: Use DRY chemical powder.
LARGE FIRE: Use alcohol foam, water spray or fog. Cool containing vessels with water jet in order to prevent
pressure build-up, autoignition or explosion.
Special Remarks on Fire Hazards:
Reacts with metals to produces flammable hydrogen gas.
It will ignite on contact with potassium-tert-butoxide.
A mixture of ammonium nitrate and acetic acid ignites when warmed, especially if warmed.
Special Remarks on Explosion Hazards:
Acetic acid vapors may form explosive mixtures with air.
Reactions between acetic acid and the following materials are potentially explosive: 5-azidotetrazole, bromine
pentafluoride, chromium trioxide, hydrogen peroxide, potassium permanganate, sodium peroxide, and phorphorus
trichloride.
Dilute acetic acid and dilute hydrogen can undergo an exothermic reaction if heated, forming peracetic acid which
is explosive at 110 degrees C.
Reaction between chlorine trifluoride and acetic acid is very violent, sometimes explosive.
Section 6: Accidental Release Measures
Small Spill:
Dilute with water and mop up, or absorb with an inert dry material and place in an appropriate waste disposal
container. If necessary: Neutralize the residue with a dilute solution of sodium carbonate.
Large Spill:
Flammable liquid. Corrosive liquid.
Keep away from heat. Keep away from sources of ignition. Stop leak if without risk. If the product is in its solid
form: Use a shovel to put the material into a convenient waste disposal container. If the product is in its liquid
form: Absorb with DRY earth, sand or other non-combustible material. Do not get water inside container.
Absorb with an inert material and put the spilled material in an appropriate waste disposal. Do not touch spilled
material. Use water spray curtain to divert vapor drift. Prevent entry into sewers, basements or confined areas;
dike if needed. Call for assistance on disposal. Neutralize the residue with a dilute solution of sodium
carbonate. Be careful that the product is not present at a concentration level above TLV. Check TLV on the
MSDS and with local authorities.
Section 7: Handling and Storage
Precautions:
\Keep away from heat. Keep away from sources of ignition. Ground all equipment containing material. Do not
ingest. Do not breathe gas/fumes/ vapor/spray. Never add water to this product. In case of insufficient
ventilation, wear suitable respiratory equipment. If ingested, seek medical advice immediately and show the
container or the label. Avoid contact with skin and eyes. Keep away from incompatibles such as oxidizing agents,
reducing agents, metals, acids, alkalis.
Storage:
Store in a segregated and approved area. Keep container in a cool, well-ventilated area. Keep container tightly
closed and sealed until ready for use. Avoid all possible sources of ignition (spark or flame).
Section 8: Exposure Controls/Personal Protection
Engineering Controls:
Provide exhaust ventilation or other engineering controls to keep the airborne concentrations of vapors below their
respective threshold limit value. Ensure that eyewash stations and safety showers are proximal to the
work-station location.
Personal Protection:
Splash goggles. Synthetic apron. Vapor respirator. Be sure to use an approved/certified respirator or equivalent.
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Gloves (impervious).
Personal Protection in Case of a Large Spill:
Splash goggles. Full suit. Vapor respirator. Boots. Gloves. A self contained breathing apparatus should be
used to avoid inhalation of the product. Suggested protective clothing might not be sufficient; consult a specialist
BEFORE handling this product.
Exposure Limits:
TWA: 10 STEL: 15 (ppm) [Australia]
TWA: 25 STEL: 27 (mg/m3) [Australia]
TWA: 10 STEL: 15 (ppm) from NIOSH
TWA: 25 STEL: 37 (mg/m3) from NIOSH
TWA: 10 STEL: 15 (ppm) [Canada]
TWA: 26 STEL: 39 (mg/m3) [Canada]
TWA: 25 STEL: 37 (mg/m3)
TWA: 10 STEL: 15 (ppm) from ACGIH (TLV) [United States] [1999]
TWA: 10 (ppm) from OSHA (PEL) [United States]
TWA: 25 (mg/m3) from OSHA (PEL) [United States]Consult local authorities for acceptable exposure limits.
Section 9: Physical and Chemical Properties
Physical state and appearance: Liquid.
Odor: Pungent, vinegar-like, sour (Strong.)
Taste: Vinegar, sour (Strong.)
Molecular Weight: 60.05 g/mole
Color: Colorless. Clear (Light.)
pH (1% soln/water): 2 [Acidic.]
Boiling Point: 118.1°C (244.6°F)
Melting Point: 16.6°C (61.9°F)
Critical Temperature: 321.67°C (611°F)
Specific Gravity: 1.049 (Water = 1)
Vapor Pressure: 1.5 kPa (@ 20°C)
Vapor Density: 2.07 (Air = 1)
Volatility: Not available.
Odor Threshold: 0.48 ppm
Water/Oil Dist. Coeff.: The product is more soluble in water; log(oil/water) = -0.2
Ionicity (in Water): Not available.
Dispersion Properties: See solubility in water, diethyl ether, acetone.
Solubility:
Easily soluble in cold water, hot water.
Soluble in diethyl ether, acetone.
Miscible with Glycerol, alcohol, Benzene, Carbon Tetrachloride.
Practically insoluble in Carbon Disulfide.
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Section 10: Stability and Reactivity Data
Stability: The product is stable.
Instability Temperature: Not available.
Conditions of Instability: Heat, ignition sources, incompatible materials
Incompatibility with various substances: Reactive with oxidizing agents, reducing agents, metals, acids, alkalis.
Corrosivity:
Highly corrosive in presence of stainless steel(304).
Slightly corrosive in presence of aluminum, of copper.
Non-corrosive in presence of stainless steel(316).
Special Remarks on Reactivity:
Reacts violently with strong oxidizing agents, acetaldehyde, and acetic anhydride. Material can react with metals,
strong bases, amines, carbonates, hydroxides, phosphates, many oxides,cyanides, sulfides, chromic acid, nitric
acid, hydrogen peroxide, carbonates. ammonium nitrate, ammonium thiosulfate, chlorine trifluoride, chlorosulfonic
acid, perchloric acid, permanganates, xylene, oleum, potassium hydroxide, sodium hydroxide, phosphorus
isocyanate, ethylenediamine, ethylene imine.
Special Remarks on Corrosivity: Moderate corrosive effect on bronze. No corrosion data on brass
Polymerization: Will not occur.
Section 11: Toxicological Information
Routes of Entry: Absorbed through skin. Dermal contact. Eye contact. Inhalation. Ingestion.
Toxicity to Animals:
WARNING: THE LC50 VALUES HEREUNDER ARE ESTIMATED ON THE BASIS OF A 4-HOUR EXPOSURE.
Acute oral toxicity (LD50): 3310 mg/kg [Rat].
Acute dermal toxicity (LD50): 1060 mg/kg [Rabbit].
Acute toxicity of the vapor (LC50): 5620 1 hours [Mouse].
Chronic Effects on Humans:
MUTAGENIC EFFECTS: Mutagenic for mammalian somatic cells. Mutagenic for bacteria and/or yeast.
May cause damage to the following organs: kidneys, mucous membranes, skin, teeth.
Other Toxic Effects on Humans:
Extremely hazardous in case of inhalation (lung corrosive).
Very hazardous in case of skin contact (irritant), of ingestion, .
Hazardous in case of skin contact (corrosive, permeator), of eye contact (corrosive).
Special Remarks on Toxicity to Animals: Not available.
Special Remarks on Chronic Effects on Humans: May affect genetic material and may cause reproductive effects based on
animal data. No human data found.
Special Remarks on other Toxic Effects on Humans:
Acute Potential Health Effects:
Skin: Extremely irritating and corrosive. Causes skin irritation (reddening and itching, inflammation). May cause
blistering , tissue damage and burns.
Eyes: Extremely irritating and corrosive. Causes eye irritation, lacrimation, redness, and pain. May cause burns,
blurred vision, conjunctivitis, conjunctival and corneal destruction and permanent injury.
Inhalation: Causes severe respiratory tract irritation. Affects the sense organs (nose, ear, eye, taste), and blood.
May cause chemical pneumonitis, bronchitis, and pulmonary edema. Severe exposure may result in lung tissue
damage and corrosion (ulceration) of the mucous membranes. Inhalation may also cause rhinitis, sneezing,
coughing, oppressive feeling in the chest or chest pain, dyspnea, wheezing, tachypnea, cyanosis, salivation,
nausea, giddiness, muscular weakness.
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Ingestion: Moderately toxic. Corrosive. Causes gastrointestinal tract irritation (burning and pain of the mouth,
throat, and abdomen, coughing, ulceration, bleeding, nausea, abdomial spasms, vomiting, hematemesis, diarrhea.
May Also affect the liver (impaired liver function), behavior (convulsions, giddines, muscular weakness), and the
urinary system - kidneys (Hematuria, Albuminuria, Nephrosis, acute renal failure, acute tubular necrosis). May
also cause dyspnea or asphyxia. May also lead to shock, coma and death.
Chronic Potential Health Effects:
Chronic exposure via ingestion may cause blackening or erosion of the teeth and jaw necrosis, pharyngitis, and
gastritis. It may also behavior (similar to acute ingestion), and metabolism (weight loss).
Chronic exposure via inhalation may cause asthma and/or bronchitis with cough, phlegm, and/or shortness of
breath . It may also affect the blood (decreased leukocyte count), and urinary system (kidneys).
Repeated or prolonged skin contact may cause thickening, blackening, and cracking of the skin.
Section 12: Ecological Information
Ecotoxicity:
Ecotoxicity in water (LC50): 423 mg/l 24 hours [Fish (Goldfish)]. 88 ppm 96 hours [Fish (fathead minnow)]. 75
ppm 96 hours [Fish (bluegill sunfish)]. >100 ppm 96 hours [Daphnia].
BOD5 and COD: BOD-5: 0.34-0.88 g oxygen/g
Products of Biodegradation:
Possibly hazardous short term degradation products are not likely. However, long term degradation products may
arise.
Toxicity of the Products of Biodegradation: The products of degradation are less toxic than the product itself.
Special Remarks on the Products of Biodegradation: Not available.
Section 13: Disposal Considerations
Waste Disposal:
Waste must be disposed of in accordance with federal, state and local environmental
control regulations.
Section 14: Transport Information
DOT Classification:
CLASS 3: Flammable liquid.
Class 8: Corrosive material
Identification: : Acetic Acid, Glacial UNNA: 2789 PG: II
Special Provisions for Transport: Not available.
Section 15: Other Regulatory Information
Federal and State Regulations:
New York release reporting list: Acetic acid
Rhode Island RTK hazardous substances: Acetic acid
Pennsylvania RTK: Acetic acid
Florida: Acetic acid
Minnesota: Acetic acid
Massachusetts RTK: Acetic acid
New Jersey: Acetic acid
California Director's List of Hazardous Subtances (8 CCR 339): Acetic acid
TSCA 8(b) inventory: Acetic acid
CERCLA: Hazardous substances.: Acetic acid: 5000 lbs. (2268 kg)
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Other Regulations:
OSHA: Hazardous by definition of Hazard Communication Standard (29 CFR 1910.1200).
EINECS: This product is on the European Inventory of Existing Commercial Chemical Substances.
Other Classifications:
WHMIS (Canada):
CLASS B-3: Combustible liquid with a flash point between 37.8°C (100°F) and 93.3°C
(200°F).
CLASS E: Corrosive liquid.
DSCL (EEC):
R10- Flammable.
R35- Causes severe burns.
S23- Do not breathe gas/fumes/vapour/spray
[***]
S26- In case of contact with eyes, rinse
immediately with plenty of water and seek
medical advice.
S45- In case of accident or if you feel unwell,
seek medical advice immediately (show the
label where possible).
HMIS (U.S.A.):
Health Hazard: 3
Fire Hazard: 2
Reactivity: 0
Personal Protection: H
National Fire Protection Association (U.S.A.):
Health: 3
Flammability: 2
Reactivity: 0
Specific hazard:
Protective Equipment:
Gloves (impervious).
Synthetic apron.
Vapor respirator. Be sure to use an
approved/certified respirator or
equivalent. Wear appropriate respirator
when ventilation is inadequate.
Splash goggles.
Section 16: Other Information
References: Not available.
Other Special Considerations: Not available.
Created: 10/09/2005 03:35 PM
Last Updated: 11/06/2008 12:00 PM
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The information above is believed to be accurate and represents the best information currently available to us. However, we
make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we
assume no liability resulting from its use. Users should make their own investigations to determine the suitability of the
information for their particular purposes. In no event shall ScienceLab.com be liable for any claims, losses, or damages of any
third party or for lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even
if ScienceLab.com has been advised of the possibility of such damages.
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Material Safety Data Sheet
L-Cysteine HCl monohydrate MSDS
Section 1: Chemical Product and Company Identification
Product Name: L-Cysteine HCl monohydrate
Catalog Codes: SLC1114, SLC2905, SLC2695
CAS#: 7048-04-6
RTECS: HA2275000
TSCA: TSCA 8(b) inventory: L-Cysteine HCl monohydrate
CI#: Not available.
Synonym: 2-Amino-3-mercaptopropanoic acid
hydrochloride
Chemical Formula: C3H7NO2S.HCl.H2O
Contact Information:
Sciencelab.com, Inc.
14025 Smith Rd.
Houston, Texas 77396
US Sales: 1-800-901-7247
International Sales: 1-281-441-4400
Order Online: ScienceLab.com
CHEMTREC (24HR Emergency Telephone), call:
1-800-424-9300
International CHEMTREC, call: 1-703-527-3887
For non-emergency assistance, call: 1-281-441-4400
Section 2: Composition and Information on Ingredients
Composition:
Name CAS # % by Weight
{L-}Cysteine HCl monohydrate 7048-04-6 100
Toxicological Data on Ingredients: L-Cysteine HCl monohydrate: ORAL (LD50): Acute: 3550 mg/kg [Mouse]. 5580 mg/kg
[Rat]. 4200 mg/kg [Mouse].
Section 3: Hazards Identification
Potential Acute Health Effects:
Very hazardous in case of skin contact (irritant), of eye contact (irritant), of ingestion, of inhalation. Inflammation
of the eye is characterized by redness, watering, and itching. Skin inflammation is characterized by itching,
scaling, reddening, or, occasionally, blistering.
Potential Chronic Health Effects:
Very hazardous in case of skin contact (irritant), of eye contact (irritant), of ingestion, of inhalation.
CARCINOGENIC EFFECTS: Not available.
MUTAGENIC EFFECTS: Not available.
TERATOGENIC EFFECTS: Not available.
DEVELOPMENTAL TOXICITY: Not available.
Repeated or prolonged inhalation of dust may lead to chronic respiratory irritation.
Section 4: First Aid Measures
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Eye Contact:
Check for and remove any contact lenses. Immediately flush eyes with running water for at least 15 minutes,
keeping eyelids open. Cold water may be used. Do not use an eye ointment. Seek medical attention.
Skin Contact:
After contact with skin, wash immediately with plenty of water. Gently and thoroughly wash the contaminated skin
with running water and non-abrasive soap. Be particularly careful to clean folds, crevices, creases and groin.
Cold water may be used. Cover the irritated skin with an emollient. If irritation persists, seek medical attention.
Wash contaminated clothing before reusing.
Serious Skin Contact:
Wash with a disinfectant soap and cover the contaminated skin with an anti-bacterial cream. Seek medical
attention.
Inhalation: Allow the victim to rest in a well ventilated area. Seek immediate medical attention.
Serious Inhalation: Not available.
Ingestion:
Do not induce vomiting. Loosen tight clothing such as a collar, tie, belt or waistband. If the victim is not
breathing, perform mouth-to-mouth resuscitation. Seek immediate medical attention.
Serious Ingestion: Not available.
Section 5: Fire and Explosion Data
Flammability of the Product: May be combustible at high temperature.
Auto-Ignition Temperature: Not available.
Flash Points: Not available.
Flammable Limits: Not available.
Products of Combustion:
These products are carbon oxides (CO, CO2), nitrogen oxides (NO, NO2...), sulfur oxides (SO2, SO3...),
halogenated compounds.
Fire Hazards in Presence of Various Substances: Not available.
Explosion Hazards in Presence of Various Substances:
Risks of explosion of the product in presence of mechanical impact: Not available.
Risks of explosion of the product in presence of static discharge: Not available.
Fire Fighting Media and Instructions:
SMALL FIRE: Use DRY chemical powder.
LARGE FIRE: Use water spray, fog or foam. Do not use water jet.
Special Remarks on Fire Hazards: Not available.
Special Remarks on Explosion Hazards: Not available.
Section 6: Accidental Release Measures
Small Spill:
Use appropriate tools to put the spilled solid in a convenient waste disposal container. Finish cleaning by
spreading water on the contaminated surface and dispose of according to local and regional authority
requirements.
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Large Spill:
Use a shovel to put the material into a convenient waste disposal container. Finish cleaning by spreading water
on the contaminated surface and allow to evacuate through the sanitary system.
Section 7: Handling and Storage
Precautions:
Keep away from heat. Keep away from sources of ignition. Empty containers pose a fire risk, evaporate the
residue under a fume hood. Ground all equipment containing material. Do not ingest. Do not breathe dust. In
case of insufficient ventilation, wear suitable respiratory equipment If ingested, seek medical advice immediately
and show the container or the label. Avoid contact with skin and eyes
Storage:
Keep container dry. Keep in a cool place. Ground all equipment containing material. Keep container tightly
closed. Keep in a cool, well-ventilated place. Combustible materials should be stored away from extreme heat
and away from strong oxidizing agents.
Section 8: Exposure Controls/Personal Protection
Engineering Controls:
Use process enclosures, local exhaust ventilation, or other engineering controls to keep airborne levels below
recommended exposure limits. If user operations generate dust, fume or mist, use ventilation to keep exposure to
airborne contaminants below the exposure limit.
Personal Protection:
Splash goggles. Lab coat. Dust respirator. Be sure to use an approved/certified respirator or equivalent.
Gloves.
Personal Protection in Case of a Large Spill:
Splash goggles. Full suit. Dust respirator. Boots. Gloves. A self contained breathing apparatus should be used
to avoid inhalation of the product. Suggested protective clothing might not be sufficient; consult a specialist
BEFORE handling this product.
Exposure Limits: Not available.
Section 9: Physical and Chemical Properties
Physical state and appearance: Solid. (Solid crystalline powder.)
Odor: Not available.
Taste: Not available.
Molecular Weight: 175.64 g/mole
Color: White.
pH (1% soln/water): Not available.
Boiling Point: Not available.
Melting Point: Decomposes. (176°C or 348.8°F)
Critical Temperature: Not available.
Specific Gravity: Not available.
Vapor Pressure: Not applicable.
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Vapor Density: Not available.
Volatility: Not available.
Odor Threshold: Not available.
Water/Oil Dist. Coeff.: Not available.
Ionicity (in Water): Not available.
Dispersion Properties: See solubility in water.
Solubility: Soluble in cold water.
Section 10: Stability and Reactivity Data
Stability: The product is stable.
Instability Temperature: Not available.
Conditions of Instability: Not available.
Incompatibility with various substances: Not available.
Corrosivity: Non-corrosive in presence of glass.
Special Remarks on Reactivity: Not available.
Special Remarks on Corrosivity: Not available.
Polymerization: No.
Section 11: Toxicological Information
Routes of Entry: Eye contact. Inhalation. Ingestion.
Toxicity to Animals: Acute oral toxicity (LD50): 3550 mg/kg [Mouse].
Chronic Effects on Humans: Not available.
Other Toxic Effects on Humans: Very hazardous in case of skin contact (irritant), of ingestion, of inhalation.
Special Remarks on Toxicity to Animals: Not available.
Special Remarks on Chronic Effects on Humans: Not available.
Special Remarks on other Toxic Effects on Humans: Not available.
Section 12: Ecological Information
Ecotoxicity: Not available.
BOD5 and COD: Not available.
Products of Biodegradation:
Possibly hazardous short term degradation products are not likely. However, long term degradation products may
arise.
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Toxicity of the Products of Biodegradation: The products of degradation are more toxic.
Special Remarks on the Products of Biodegradation: Not available.
Section 13: Disposal Considerations
Waste Disposal:
Section 14: Transport Information
DOT Classification: Not a DOT controlled material (United States).
Identification: Not applicable.
Special Provisions for Transport: Not applicable.
Section 15: Other Regulatory Information
Federal and State Regulations: TSCA 8(b) inventory: L-Cysteine HCl monohydrate
Other Regulations: OSHA: Hazardous by definition of Hazard Communication Standard (29 CFR 1910.1200).
Other Classifications:
WHMIS (Canada): Not controlled under WHMIS (Canada).
DSCL (EEC):
R38- Irritating to skin.
R41- Risk of serious damage to eyes.
HMIS (U.S.A.):
Health Hazard: 2
Fire Hazard: 1
Reactivity: 0
Personal Protection: E
National Fire Protection Association (U.S.A.):
Health: 2
Flammability: 1
Reactivity: 0
Specific hazard:
Protective Equipment:
Gloves.
Lab coat.
Dust respirator. Be sure to use an
approved/certified respirator or
equivalent.
Splash goggles.
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Section 16: Other Information
References: Not available.
Other Special Considerations: Not available.
Created: 10/09/2005 05:03 PM
Last Updated: 11/06/2008 12:00 PM
The information above is believed to be accurate and represents the best information currently available to us. However, we
make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we
assume no liability resulting from its use. Users should make their own investigations to determine the suitability of the
information for their particular purposes. In no event shall ScienceLab.com be liable for any claims, losses, or damages of any
third party or for lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even
if ScienceLab.com has been advised of the possibility of such damages.
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Material Safety Data Sheet
EDTA Disodium, 0.5 M Solution MSDS
Section 1: Chemical Product and Company Identification
Product Name: EDTA Disodium, 0.5 M Solution
Catalog Codes: SLE2083
CAS#: Mixture.
RTECS: Not applicable.
TSCA: TSCA 8(b) inventory: Sodium hydroxide; Water
CI#: Not applicable.
Synonym:
Chemical Name: Not applicable.
Chemical Formula: Not applicable.
Contact Information:
Sciencelab.com, Inc.
14025 Smith Rd.
Houston, Texas 77396
US Sales: 1-800-901-7247
International Sales: 1-281-441-4400
Order Online: ScienceLab.com
CHEMTREC (24HR Emergency Telephone), call:
1-800-424-9300
International CHEMTREC, call: 1-703-527-3887
For non-emergency assistance, call: 1-281-441-4400
Section 2: Composition and Information on Ingredients
Composition:
Name CAS # % by Weight
Edetate disodium, dihydrate 6381-92-6 18.6
Sodium hydroxide 1310-73-2 2
Water 7732-18-5 79.4
Toxicological Data on Ingredients: Sodium hydroxide LD50: Not available. LC50: Not available.
Section 3: Hazards Identification
Potential Acute Health Effects: Slightly hazardous in case of skin contact (irritant, permeator), of eye contact (irritant,), of
ingestion.
Potential Chronic Health Effects:
CARCINOGENIC EFFECTS: Not available.
MUTAGENIC EFFECTS: Mutagenic for mammalian somatic cells. [Sodium hydroxide].
TERATOGENIC EFFECTS: Not available.
DEVELOPMENTAL TOXICITY: Not available.
The substance may be toxic to mucous membranes, upper respiratory tract, skin, eyes.
Repeated or prolonged exposure to the substance can produce target organs damage.
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Section 4: First Aid Measures
Eye Contact:
Check for and remove any contact lenses. In case of contact, immediately flush eyes with plenty of water for at
least 15 minutes. Cold water may be used. Get medical attention.
Skin Contact:
In case of contact, immediately flush skin with plenty of water. Cover the irritated skin with an emollient. Remove
contaminated clothing and shoes. Cold water may be used.Wash clothing before reuse. Thoroughly clean shoes
before reuse. Get medical attention.
Serious Skin Contact: Not available.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get
medical attention.
Serious Inhalation: Not available.
Ingestion:
Do NOT induce vomiting unless directed to do so by medical personnel. Never give anything by mouth to an
unconscious person. Loosen tight clothing such as a collar, tie, belt or waistband. Get medical attention if
symptoms appear.
Serious Ingestion: Not available.
Section 5: Fire and Explosion Data
Flammability of the Product: Non-flammable.
Auto-Ignition Temperature: Not applicable.
Flash Points: Not applicable.
Flammable Limits: Not applicable.
Products of Combustion: Not available.
Fire Hazards in Presence of Various Substances: Not applicable.
Explosion Hazards in Presence of Various Substances: Non-explosive in presence of open flames and sparks, of shocks.
Fire Fighting Media and Instructions: Not applicable.
Special Remarks on Fire Hazards: Not available.
Special Remarks on Explosion Hazards: Not Available
Section 6: Accidental Release Measures
Small Spill:
Dilute with water and mop up, or absorb with an inert dry material and place in an appropriate waste disposal
container. Finish cleaning by spreading water on the contaminated surface and dispose of according to local and
regional authority requirements.
Large Spill:
Absorb with an inert material and put the spilled material in an appropriate waste disposal. Finish cleaning by
spreading water on the contaminated surface and allow to evacuate through the sanitary system. Be careful that
the product is not present at a concentration level above TLV. Check TLV on the MSDS and with local authorities.
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Section 7: Handling and Storage
Precautions:
Do not ingest. Do not breathe gas/fumes/ vapor/spray. Never add water to this product. If ingested, seek
medical advice immediately and show the container or the label. Avoid contact with skin and eyes.
Storage: Keep container tightly closed. Keep container in a cool, well-ventilated area.
Section 8: Exposure Controls/Personal Protection
Engineering Controls:
Provide exhaust ventilation or other engineering controls to keep the airborne concentrations of vapors below their
respective threshold limit value.
Personal Protection: Splash goggles. Lab coat. Gloves.
Personal Protection in Case of a Large Spill:
Splash goggles. Full suit. Boots. Gloves. Suggested protective clothing might not be sufficient; consult a
specialist BEFORE handling this product.
Exposure Limits:
Sodium hydroxide
STEL: 2 (mg/m3) from ACGIH (TLV) [United States]
TWA: 2 CEIL: 2 (mg/m3) from OSHA (PEL) [United States]
CEIL: 2 (mg/m3) from NIOSHConsult local authorities for acceptable exposure limits.
Section 9: Physical and Chemical Properties
Physical state and appearance: Liquid.
Odor: Not available.
Taste: Not available.
Molecular Weight: Not applicable.
Color: Colorless.
pH (1% soln/water): pH of undiluted product: approx. 8 [Basic.]
Boiling Point: The lowest known value is 100°C (212°F) (Water).
Melting Point: Not available.
Critical Temperature: Not available.
Specific Gravity: Weighted average: 1.01 (Water = 1)
Vapor Pressure: The highest known value is 2.3 kPa (@ 20°C) (Water).
Vapor Density: The highest known value is 0.62 (Air = 1) (Water).
Volatility: Not available.
Odor Threshold: Not available.
Water/Oil Dist. Coeff.: Not available.
Ionicity (in Water): Not available.
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Dispersion Properties: See solubility in water.
Solubility: Easily soluble in cold water, hot water.
Section 10: Stability and Reactivity Data
Stability: The product is stable.
Instability Temperature: Not available.
Conditions of Instability: Incompatible materials
Incompatibility with various substances: Slightly reactive to reactive with oxidizing agents, reducing agents, metals, acids,
alkalis.
Corrosivity: Non-corrosive in presence of glass.
Special Remarks on Reactivity: No other information at this time. (Edetate disodium, dihydrate)
Special Remarks on Corrosivity: Not available.
Polymerization: Will not occur.
Section 11: Toxicological Information
Routes of Entry: Absorbed through skin. Eye contact.
Toxicity to Animals: Acute oral toxicity (LD50): >2000 mg/kg [Rat]. (Edetate disodium, dihydrate).
Chronic Effects on Humans:
MUTAGENIC EFFECTS: Mutagenic for mammalian somatic cells. [Sodium hydroxide].
Contains material which may cause damage to the following organs: mucous membranes, upper respiratory tract,
skin, eyes.
Other Toxic Effects on Humans: Slightly hazardous in case of skin contact (irritant, permeator), of ingestion, of inhalation.
Special Remarks on Toxicity to Animals:
Lowest Published Lethal Dose:
LDL [Rabbit] - Route: Oral; Dose: 500 mg/kg (Sodium hydroxide)
Special Remarks on Chronic Effects on Humans:
Genetic (Mutation) Effects (Cytogenic Analysis)cited (dust inhalation in hamsters) in "Registery of Toxic Effects of
Chemical Substances" (RTECS) database.
May cause adverse reproductive effects and birth defects (teratogenic) based on animal test data (Edetate
disodium, dihydrate)
Special Remarks on other Toxic Effects on Humans:
Acute Potential Health Effects:
May irritate eyes, skin, respiratory tract, and mucous membranes.
Ingestion: It may cause gastrointestinal tract irritation with nausea, vomiting, and diarrhea. It may affect
behavior/central nervous system (convulsions)
Chronic Potential Health Effects:
Ingestion: Prolonged or repeated ingestion may affect metabolism (weight loss), liver, urinary system.
Section 12: Ecological Information
Ecotoxicity: Not available.
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BOD5 and COD: Not available.
Products of Biodegradation:
Possibly hazardous short term degradation products are not likely. However, long term degradation products may
arise.
Toxicity of the Products of Biodegradation: The product itself and its products of degradation are not toxic.
Special Remarks on the Products of Biodegradation: Not available.
Section 13: Disposal Considerations
Waste Disposal:
Waste must be disposed of in accordance with federal, state and local environmental
control regulations.
Section 14: Transport Information
DOT Classification: Not a DOT controlled material (United States).
Identification: Not applicable.
Special Provisions for Transport: Not applicable.
Section 15: Other Regulatory Information
Federal and State Regulations:
California prop. 65: This product contains the following ingredients for which the State of California has found to
cause birth defects which would require a warning under the statute: No products were found.
California prop. 65: This product contains the following ingredients for which the State of California has found to
cause cancer which would require a warning under the statute: No products were found.
Illinois toxic substances disclosure to employee act: Sodium hydroxide
Illinois chemical safety act: Sodium hydroxide
New York release reporting list: Sodium hydroxide
Rhode Island RTK hazardous substances: Sodium hydroxide
Pennsylvania RTK: Sodium hydroxide
Minnesota: Sodium hydroxide
Massachusetts RTK: Sodium hydroxide
New Jersey: Sodium hydroxide
Louisiana spill reporting: Sodium hydroxide
California Director's List of Hazardous Substances: Sodium Hydroxide
TSCA 8(b) inventory: Sodium hydroxide; Water
CERCLA: Hazardous substances.: Sodium hydroxide: 1000 lbs. (453.6 kg);
Other Regulations: OSHA: Hazardous by definition of Hazard Communication Standard (29 CFR 1910.1200).
Other Classifications:
WHMIS (Canada): Not controlled under WHMIS (Canada).
DSCL (EEC):
R36/38- Irritating to eyes and skin.
S24/25- Avoid contact with skin and eyes.
S36/37/39- Wear suitable protective clothing,
gloves and eye/face protection.
HMIS (U.S.A.):
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Health Hazard: 1
Fire Hazard: 0
Reactivity: 0
Personal Protection: j
National Fire Protection Association (U.S.A.):
Health: 1
Flammability: 0
Reactivity: 1
Specific hazard:
Protective Equipment:
Gloves.
Lab coat.
Not applicable.
Splash goggles.
Section 16: Other Information
References: Not available.
Other Special Considerations: Not available.
Created: 10/10/2005 01:05 AM
Last Updated: 11/06/2008 12:00 PM
The information above is believed to be accurate and represents the best information currently available to us. However, we
make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we
assume no liability resulting from its use. Users should make their own investigations to determine the suitability of the
information for their particular purposes. In no event shall ScienceLab.com be liable for any claims, losses, or damages of any
third party or for lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even
if ScienceLab.com has been advised of the possibility of such damages.
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Material Safety Data Sheet
Dextrose anhydrous MSDS
Section 1: Chemical Product and Company Identification
Product Name: Dextrose anhydrous
Catalog Codes: SLD3880, SLD4483
CAS#: 50-99-7
RTECS: LZ6600000
TSCA: TSCA 8(b) inventory: Dextrose anhydrous
CI#: Not available.
Synonym: D-Glucose
Chemical Name: Not available.
Chemical Formula: C6H12O6
Contact Information:
Sciencelab.com, Inc.
14025 Smith Rd.
Houston, Texas 77396
US Sales: 1-800-901-7247
International Sales: 1-281-441-4400
Order Online: ScienceLab.com
CHEMTREC (24HR Emergency Telephone), call:
1-800-424-9300
International CHEMTREC, call: 1-703-527-3887
For non-emergency assistance, call: 1-281-441-4400
Section 2: Composition and Information on Ingredients
Composition:
Name CAS # % by Weight
Dextrose anhydrous 50-99-7 100
Toxicological Data on Ingredients: Not applicable.
Section 3: Hazards Identification
Potential Acute Health Effects: Slightly hazardous in case of eye contact (irritant), of ingestion, of inhalation.
Potential Chronic Health Effects:
CARCINOGENIC EFFECTS: Not available.
MUTAGENIC EFFECTS: Not available.
TERATOGENIC EFFECTS: Not available.
DEVELOPMENTAL TOXICITY: Not available.
Repeated or prolonged exposure is not known to aggravate medical condition.
Section 4: First Aid Measures
Eye Contact: Immediately flush eyes with running water for at least 15 minutes, keeping eyelids open. Cold water may be
used.
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Skin Contact: No known effect on skin contact, rinse with water for a few minutes.
Serious Skin Contact: Not available.
Inhalation: Allow the victim to rest in a well ventilated area. Seek immediate medical attention.
Serious Inhalation: Not available.
Ingestion:
Do not induce vomiting. Loosen tight clothing such as a collar, tie, belt or waistband. If the victim is not
breathing, perform mouth-to-mouth resuscitation. Seek immediate medical attention.
Serious Ingestion: Not available.
Section 5: Fire and Explosion Data
Flammability of the Product: May be combustible at high temperature.
Auto-Ignition Temperature: Not available.
Flash Points: Not available.
Flammable Limits: Not available.
Products of Combustion: These products are carbon oxides (CO, CO2).
Fire Hazards in Presence of Various Substances: Not available.
Explosion Hazards in Presence of Various Substances:
Risks of explosion of the product in presence of mechanical impact: Not available.
Risks of explosion of the product in presence of static discharge: Not available.
Fire Fighting Media and Instructions:
SMALL FIRE: Use DRY chemical powder.
LARGE FIRE: Use water spray, fog or foam. Do not use water jet.
Special Remarks on Fire Hazards: Not available.
Special Remarks on Explosion Hazards: Not available.
Section 6: Accidental Release Measures
Small Spill:
Use appropriate tools to put the spilled solid in a convenient waste disposal container. Finish cleaning by
spreading water on the contaminated surface and dispose of according to local and regional authority
requirements.
Large Spill:
Use a shovel to put the material into a convenient waste disposal container. Finish cleaning by spreading water
on the contaminated surface and allow to evacuate through the sanitary system. Be careful that the product is not
present at a concentration level above TLV. Check TLV on the MSDS and with local authorities.
Section 7: Handling and Storage
Precautions:
Keep away from heat. Keep away from sources of ignition. Empty containers pose a fire risk, evaporate the
residue under a fume hood. Ground all equipment containing material. Do not ingest. Do not breathe dust. If
ingested, seek medical advice immediately and show the container or the label.
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Storage:
Keep container dry. Keep in a cool place. Ground all equipment containing material. Keep container tightly
closed. Keep in a cool, well-ventilated place. Combustible materials should be stored away from extreme heat
and away from strong oxidizing agents.
Section 8: Exposure Controls/Personal Protection
Engineering Controls:
Use process enclosures, local exhaust ventilation, or other engineering controls to keep airborne levels below
recommended exposure limits. If user operations generate dust, fume or mist, use ventilation to keep exposure to
airborne contaminants below the exposure limit.
Personal Protection: Safety glasses. Lab coat.
Personal Protection in Case of a Large Spill:
Splash goggles. Full suit. Boots. Gloves. Suggested protective clothing might not be sufficient; consult a
specialist BEFORE handling this product.
Exposure Limits:
TWA: 300 (ppm)
Consult local authorities for acceptable exposure limits.
Section 9: Physical and Chemical Properties
Physical state and appearance: Solid.
Odor: Not available.
Taste: Not available.
Molecular Weight: 180.16 g/mole
Color: Not available.
pH (1% soln/water): Not available.
Boiling Point: Decomposes.
Melting Point: 146°C (294.8°F)
Critical Temperature: Not available.
Specific Gravity: 1.562 (Water = 1)
Vapor Pressure: Not applicable.
Vapor Density: Not available.
Volatility: Not available.
Odor Threshold: Not available.
Water/Oil Dist. Coeff.: Not available.
Ionicity (in Water): Not available.
Dispersion Properties: See solubility in water.
Solubility: Easily soluble in cold water.
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Section 10: Stability and Reactivity Data
Stability: The product is stable.
Instability Temperature: Not available.
Conditions of Instability: Not available.
Incompatibility with various substances: Not available.
Corrosivity: Non-corrosive in presence of glass.
Special Remarks on Reactivity: Not available.
Special Remarks on Corrosivity: Not available.
Polymerization: No.
Section 11: Toxicological Information
Routes of Entry: Not available.
Toxicity to Animals: Acute oral toxicity (LD50): 25800 mg/kg [Rat].
Chronic Effects on Humans: Not available.
Other Toxic Effects on Humans: Slightly hazardous in case of ingestion, of inhalation.
Special Remarks on Toxicity to Animals: Not available.
Special Remarks on Chronic Effects on Humans: Passes through the placental barrier in human.
Special Remarks on other Toxic Effects on Humans: Not available.
Section 12: Ecological Information
Ecotoxicity: Not available.
BOD5 and COD: Not available.
Products of Biodegradation:
Possibly hazardous short term degradation products are not likely. However, long term degradation products may
arise.
Toxicity of the Products of Biodegradation: The products of degradation are more toxic.
Special Remarks on the Products of Biodegradation: Not available.
Section 13: Disposal Considerations
Waste Disposal:
Section 14: Transport Information
DOT Classification: Not a DOT controlled material (United States).
Identification: Not applicable.
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Special Provisions for Transport: Not applicable.
Section 15: Other Regulatory Information
Federal and State Regulations: TSCA 8(b) inventory: Dextrose anhydrous
Other Regulations: Not available..
Other Classifications:
WHMIS (Canada): Not controlled under WHMIS (Canada).
DSCL (EEC):
This product is not classified according
to the EU regulations.
HMIS (U.S.A.):
Health Hazard: 1
Fire Hazard: 1
Reactivity: 0
Personal Protection: a
National Fire Protection Association (U.S.A.):
Health: 1
Flammability: 1
Reactivity: 0
Specific hazard:
Protective Equipment:
Not applicable.
Lab coat.
Not applicable.
Safety glasses.
Section 16: Other Information
References: Not available.
Other Special Considerations: Not available.
Created: 10/11/2005 11:46 AM
Last Updated: 11/06/2008 12:00 PM
The information above is believed to be accurate and represents the best information currently available to us. However, we
make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we
assume no liability resulting from its use. Users should make their own investigations to determine the suitability of the
information for their particular purposes. In no event shall ScienceLab.com be liable for any claims, losses, or damages of any
third party or for lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even
if ScienceLab.com has been advised of the possibility of such damages.
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Material Safety Data Sheet
Hydrochloric acid MSDS
Section 1: Chemical Product and Company Identification
Product Name: Hydrochloric acid
Catalog Codes: SLH1462, SLH3154
CAS#: Mixture.
RTECS: MW4025000
TSCA: TSCA 8(b) inventory: Hydrochloric acid
CI#: Not applicable.
Synonym: Hydrochloric Acid; Muriatic Acid
Chemical Name: Not applicable.
Chemical Formula: Not applicable.
Contact Information:
Sciencelab.com, Inc.
14025 Smith Rd.
Houston, Texas 77396
US Sales: 1-800-901-7247
International Sales: 1-281-441-4400
Order Online: ScienceLab.com
CHEMTREC (24HR Emergency Telephone), call:
1-800-424-9300
International CHEMTREC, call: 1-703-527-3887
For non-emergency assistance, call: 1-281-441-4400
Section 2: Composition and Information on Ingredients
Composition:
Name CAS # % by Weight
Hydrogen chloride 7647-01-0 20-38
Water 7732-18-5 62-80
Toxicological Data on Ingredients: Hydrogen chloride: GAS (LC50): Acute: 4701 ppm 0.5 hours [Rat].
Section 3: Hazards Identification
Potential Acute Health Effects:
Very hazardous in case of skin contact (corrosive, irritant, permeator), of eye contact (irritant, corrosive), of
ingestion, . Slightly hazardous in case of inhalation (lung sensitizer). Non-corrosive for lungs. Liquid or spray
mist may produce tissue damage particularly on mucous membranes of eyes, mouth and respiratory tract. Skin
contact may produce burns. Inhalation of the spray mist may produce severe irritation of respiratory tract,
characterized by coughing, choking, or shortness of breath. Severe over-exposure can result in death.
Inflammation of the eye is characterized by redness, watering, and itching. Skin inflammation is characterized by
itching, scaling, reddening, or, occasionally, blistering.
Potential Chronic Health Effects:
Slightly hazardous in case of skin contact (sensitizer).
CARCINOGENIC EFFECTS: Classified 3 (Not classifiable for human.) by IARC [Hydrochloric acid].
MUTAGENIC EFFECTS: Not available.
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TERATOGENIC EFFECTS: Not available.
DEVELOPMENTAL TOXICITY: Not available.
The substance may be toxic to kidneys, liver, mucous membranes, upper respiratory tract, skin, eyes, Circulatory
System, teeth.
Repeated or prolonged exposure to the substance can produce target organs damage. Repeated or prolonged
contact with spray mist may produce chronic eye irritation and severe skin irritation. Repeated or prolonged
exposure to spray mist may produce respiratory tract irritation leading to frequent attacks of bronchial infection.
Repeated exposure to a highly toxic material may produce general deterioration of health by an accumulation in
one or many human organs.
Section 4: First Aid Measures
Eye Contact:
Check for and remove any contact lenses. In case of contact, immediately flush eyes with plenty of water for at
least 15 minutes. Cold water may be used. Get medical attention immediately.
Skin Contact:
In case of contact, immediately flush skin with plenty of water for at least 15 minutes while removing contaminated
clothing and shoes. Cover the irritated skin with an emollient. Cold water may be used.Wash clothing before
reuse. Thoroughly clean shoes before reuse. Get medical attention immediately.
Serious Skin Contact:
Wash with a disinfectant soap and cover the contaminated skin with an anti-bacterial cream. Seek immediate
medical attention.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get
medical attention immediately.
Serious Inhalation:
Evacuate the victim to a safe area as soon as possible. Loosen tight clothing such as a collar, tie, belt or
waistband. If breathing is difficult, administer oxygen. If the victim is not breathing, perform mouth-to-mouth
resuscitation. WARNING: It may be hazardous to the person providing aid to give mouth-to-mouth resuscitation
when the inhaled material is toxic, infectious or corrosive. Seek immediate medical attention.
Ingestion:
If swallowed, do not induce vomiting unless directed to do so by medical personnel. Never give anything by
mouth to an unconscious person. Loosen tight clothing such as a collar, tie, belt or waistband. Get medical
attention immediately.
Serious Ingestion: Not available.
Section 5: Fire and Explosion Data
Flammability of the Product: Non-flammable.
Auto-Ignition Temperature: Not applicable.
Flash Points: Not applicable.
Flammable Limits: Not applicable.
Products of Combustion: Not available.
Fire Hazards in Presence of Various Substances: of metals
Explosion Hazards in Presence of Various Substances: Non-explosive in presence of open flames and sparks, of shocks.
Fire Fighting Media and Instructions: Not applicable.
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Special Remarks on Fire Hazards:
Non combustible.
Calcium carbide reacts with hydrogen chloride gas with incandescence.
Uranium phosphide reacts with hydrochloric acid to release spontaneously flammable phosphine.
Rubidium acetylene carbides burns with slightly warm hydrochloric acid.
Lithium silicide in contact with hydrogen chloride becomes incandescent. When dilute hydrochloric acid is used,
gas spontaneously flammable in air is evolved.
Magnesium boride treated with concentrated hydrochloric acid produces spontaneously flammble gas.
Cesium acetylene carbide burns hydrogen chloride gas.
Cesium carbide ignites in contact with hydrochloric acid unless acid is dilute.
Reacts with most metals to produce flammable Hydrodgen gas.
Special Remarks on Explosion Hazards:
Hydrogen chloride in contact with the following can cause an explosion, ignition on contact, or other
violent/vigorous reaction: Acetic anhydride AgClO + CCl4 Alcohols + hydrogen cyanide, Aluminum
Aluminum-titanium alloys (with HCl vapor), 2-Amino ethanol, Ammonium hydroxide, Calcium carbide Ca3P2
Chlorine + dinitroanilines (evolves gas), Chlorosulfonic acid Cesium carbide Cesium acetylene carbide,
1,1-Difluoroethylene Ethylene diamine Ethylene imine, Fluorine, HClO4 Hexalithium disilicide H2SO4 Metal
acetylides or carbides, Magnesium boride, Mercuric sulfate, Oleum, Potassium permanganate,
beta-Propiolactone Propylene oxide Rubidium carbide, Rubidium, acetylene carbide Sodium (with aqueous HCl),
Sodium hydroxide Sodium tetraselenium, Sulfonic acid, Tetraselenium tetranitride, U3P4 , Vinyl acetate.
Silver perchlorate with carbon tetrachloride in the presence of hydrochloric acid produces trichloromethyl
perchlorate which detonates at 40 deg. C.
Section 6: Accidental Release Measures
Small Spill:
Dilute with water and mop up, or absorb with an inert dry material and place in an appropriate waste disposal
container. If necessary: Neutralize the residue with a dilute solution of sodium carbonate.
Large Spill:
Corrosive liquid. Poisonous liquid.
Stop leak if without risk. Absorb with DRY earth, sand or other non-combustible material. Do not get water inside
container. Do not touch spilled material. Use water spray curtain to divert vapor drift. Use water spray to reduce
vapors. Prevent entry into sewers, basements or confined areas; dike if needed. Call for assistance on disposal.
Neutralize the residue with a dilute solution of sodium carbonate. Be careful that the product is not present at
a concentration level above TLV. Check TLV on the MSDS and with local authorities.
Section 7: Handling and Storage
Precautions:
Keep locked up.. Keep container dry. Do not ingest. Do not breathe gas/fumes/ vapor/spray. Never add water
to this product. In case of insufficient ventilation, wear suitable respiratory equipment. If ingested, seek medical
advice immediately and show the container or the label. Avoid contact with skin and eyes. Keep away from
incompatibles such as oxidizing agents, organic materials, metals, alkalis, moisture.
May corrode metallic surfaces. Store in a metallic or coated fiberboard drum using a strong polyethylene inner
package.
Storage: Keep container tightly closed. Keep container in a cool, well-ventilated area.
Section 8: Exposure Controls/Personal Protection
Engineering Controls:
Provide exhaust ventilation or other engineering controls to keep the airborne concentrations of vapors below their
respective threshold limit value. Ensure that eyewash stations and safety showers are proximal to the
work-station location.
Personal Protection:
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Face shield. Full suit. Vapor respirator. Be sure to use an approved/certified respirator or equivalent. Gloves.
Boots.
Personal Protection in Case of a Large Spill:
Splash goggles. Full suit. Vapor respirator. Boots. Gloves. A self contained breathing apparatus should be
used to avoid inhalation of the product. Suggested protective clothing might not be sufficient; consult a specialist
BEFORE handling this product.
Exposure Limits:
CEIL: 5 (ppm) from OSHA (PEL) [United States]
CEIL: 7 (mg/m3) from OSHA (PEL) [United States]
CEIL: 5 from NIOSH
CEIL: 7 (mg/m3) from NIOSH
TWA: 1 STEL: 5 (ppm) [United Kingdom (UK)]
TWA: 2 STEL: 8 (mg/m3) [United Kingdom (UK)]Consult local authorities for acceptable exposure limits.
Section 9: Physical and Chemical Properties
Physical state and appearance: Liquid.
Odor: Pungent. Irritating (Strong.)
Taste: Not available.
Molecular Weight: Not applicable.
Color: Colorless to light yellow.
pH (1% soln/water): Acidic.
Boiling Point:
108.58 C @ 760 mm Hg (for 20.22% HCl in water)
83 C @ 760 mm Hg (for 31% HCl in water)
50.5 C (for 37% HCl in water)
Melting Point:
-62.25°C (-80°F) (20.69% HCl in water)
-46.2 C (31.24% HCl in water)
-25.4 C (39.17% HCl in water)
Critical Temperature: Not available.
Specific Gravity:
1.1- 1.19 (Water = 1)
1.10 (20%and 22% HCl solutions)
1.12 (24% HCl solution)
1.15 (29.57% HCl solution)
1.16 (32% HCl solution)
1.19 (37% and 38%HCl solutions)
Vapor Pressure: 16 kPa (@ 20°C) average
Vapor Density: 1.267 (Air = 1)
Volatility: Not available.
Odor Threshold: 0.25 to 10 ppm
Water/Oil Dist. Coeff.: Not available.
Ionicity (in Water): Not available.
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Dispersion Properties: See solubility in water, diethyl ether.
Solubility: Soluble in cold water, hot water, diethyl ether.
Section 10: Stability and Reactivity Data
Stability: The product is stable.
Instability Temperature: Not available.
Conditions of Instability: Incompatible materials, water
Incompatibility with various substances:
Highly reactive with metals.
Reactive with oxidizing agents, organic materials, alkalis, water.
Corrosivity:
Extremely corrosive in presence of aluminum, of copper, of stainless steel(304), of stainless steel(316).
Non-corrosive in presence of glass.
Special Remarks on Reactivity:
Reacts with water especially when water is added to the product.
Absorption of gaseous hydrogen chloride on mercuric sulfate becomes violent @ 125 deg. C.
Sodium reacts very violently with gaseous hydrogen chloride.
Calcium phosphide and hydrochloric acid undergo very energetic reaction.
It reacts with oxidizers releasing chlorine gas.
Incompatible with, alkali metals, carbides, borides, metal oxides, vinyl acetate, acetylides, sulphides, phosphides,
cyanides, carbonates.
Reacts with most metals to produce flammable Hydrogen gas.
Reacts violently (moderate reaction with heat of evolution) with water especially when water is added to the
product. Isolate hydrogen chloride from heat, direct sunlight, alkalies (reacts vigorously), organic materials, and
oxidizers (especially nitric acid and chlorates), amines, metals, copper and alloys (e.g. brass), hydroxides, zinc
(galvanized materials), lithium silicide (incandescence), sulfuric acid(increase in temperature and pressure)
Hydrogen chloride gas is emitted when this product is in contact with sulfuric acid.
Adsorption of Hydrochloric Acid onto silicon dioxide results in exothmeric reaction.
Hydrogen chloride causes aldehydes and epoxides to violently polymerize.
Hydrogen chloride or Hydrochloric Acid in contact with the folloiwng can cause explosion or ignition on contact or
Special Remarks on Corrosivity:
Highly corrosive. Incompatible with copper and copper alloys. It attacks nearly all metals (mercury, gold,
platinium, tantalum, silver, and certain alloys are exceptions).
It is one of the most corrosive of the nonoxidizing acids in contact with copper alloys.
No corrosivity data on zinc, steel.
Severe Corrosive effect on brass and bronze
Polymerization: Will not occur.
Section 11: Toxicological Information
Routes of Entry: Absorbed through skin. Dermal contact. Eye contact. Inhalation.
Toxicity to Animals:
Acute oral toxicity (LD50): 900 mg/kg [Rabbit].
Acute toxicity of the vapor (LC50): 1108 ppm, 1 hours [Mouse].
Acute toxicity of the vapor (LC50): 3124 ppm, 1 hours [Rat].
Chronic Effects on Humans:
CARCINOGENIC EFFECTS: Classified 3 (Not classifiable for human.) by IARC [Hydrochloric acid].
May cause damage to the following organs: kidneys, liver, mucous membranes, upper respiratory tract, skin,
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eyes, Circulatory System, teeth.
Other Toxic Effects on Humans:
Very hazardous in case of skin contact (corrosive, irritant, permeator), of ingestion, .
Hazardous in case of eye contact (corrosive), of inhalation (lung corrosive).
Special Remarks on Toxicity to Animals:
Lowest Published Lethal Doses (LDL/LCL)
LDL [Man] -Route: Oral; 2857 ug/kg
LCL [Human] - Route: Inhalation; Dose: 1300 ppm/30M
LCL [Rabbit] - Route: Inhalation; Dose: 4413 ppm/30M
Special Remarks on Chronic Effects on Humans:
May cause adverse reproductive effects (fetoxicity).
May affect genetic material.
Special Remarks on other Toxic Effects on Humans:
Acute Potential Health Effects:
Skin: Corrosive. Causes severe skin irritation and burns.
Eyes: Corrosive. Causes severe eye irritation/conjuntivitis, burns, corneal necrosis.
Inhalation: May be fatal if inhaled. Material is extremely destructive to tissue of the mucous membranes and
upper respiratory tract. Inhalation of hydrochloric acid fumes produces nose, throat, and larryngeal burning, and
irritation, pain and inflammation, coughing, sneezing, choking sensation, hoarseness, laryngeal spasms, upper
respiratory tract edema, chest pains, as well has headache, and palpitations. Inhalation of high concentrations
can result in corrosive burns, necrosis of bronchial epithelium, constriction of the larynx and bronchi, nasospetal
perforation, glottal closure,
occur, particularly if exposure is prolonged. May affect the liver.
Ingestion: May be fatal if swallowed. Causes irritation and burning, ulceration, or perforation of the
gastrointestinal tract and resultant peritonitis, gastric hemorrhage and infection. Can also cause nausea, vomitting
(with "coffee ground" emesis), diarrhea, thirst, difficulty swallowing, salivation, chills, fever, uneasiness, shock,
strictures and stenosis (esophogeal, gastric, pyloric). May affect behavior (excitement), the cardiovascular
system (weak rapid pulse, tachycardia), respiration (shallow respiration), and urinary system (kidneys- renal
failure, nephritis).
Acute exposure via inhalation or ingestion can also cause erosion of tooth enamel.
Chronic Potential Health Effects:
dyspnea, bronchitis. Chemical pneumonitis and pulmonary edema can also
Section 12: Ecological Information
Ecotoxicity: Not available.
BOD5 and COD: Not available.
Products of Biodegradation:
Possibly hazardous short term degradation products are not likely. However, long term degradation products may
arise.
Toxicity of the Products of Biodegradation: The products of degradation are less toxic than the product itself.
Special Remarks on the Products of Biodegradation: Not available.
Section 13: Disposal Considerations
Waste Disposal:
Waste must be disposed of in accordance with federal, state and local environmental
control regulations.
Section 14: Transport Information
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DOT Classification: Class 8: Corrosive material
Identification: : Hydrochloric acid, solution UNNA: 1789 PG: II
Special Provisions for Transport: Not available.
Section 15: Other Regulatory Information
Federal and State Regulations:
Connecticut hazardous material survey.: Hydrochloric acid
Illinois toxic substances disclosure to employee act: Hydrochloric acid
Illinois chemical safety act: Hydrochloric acid
New York release reporting list: Hydrochloric acid
Rhode Island RTK hazardous substances: Hydrochloric acid
Pennsylvania RTK: Hydrochloric acid
Minnesota: Hydrochloric acid
Massachusetts RTK: Hydrochloric acid
Massachusetts spill list: Hydrochloric acid
New Jersey: Hydrochloric acid
New Jersey spill list: Hydrochloric acid
Louisiana RTK reporting list: Hydrochloric acid
Louisiana spill reporting: Hydrochloric acid
California Director's List of Hazardous Substances: Hydrochloric acid
TSCA 8(b) inventory: Hydrochloric acid
TSCA 4(a) proposed test rules: Hydrochloric acid
SARA 302/304/311/312 extremely hazardous substances: Hydrochloric acid
SARA 313 toxic chemical notification and release reporting: Hydrochloric acid
CERCLA: Hazardous substances.: Hydrochloric acid: 5000 lbs. (2268 kg)
Other Regulations:
OSHA: Hazardous by definition of Hazard Communication Standard (29 CFR 1910.1200).
EINECS: This product is on the European Inventory of Existing Commercial Chemical Substances.
Other Classifications:
WHMIS (Canada):
CLASS D-2A: Material causing other toxic effects (VERY TOXIC).
CLASS E: Corrosive liquid.
DSCL (EEC):
R34- Causes burns.
R37- Irritating to respiratory system.
S26- In case of contact with eyes, rinse
immediately with plenty of water and seek
medical advice.
S45- In case of accident or if you feel unwell,
seek medical advice immediately (show the
label where possible).
HMIS (U.S.A.):
Health Hazard: 3
Fire Hazard: 0
Reactivity: 1
Personal Protection:
National Fire Protection Association (U.S.A.):
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Health: 3
Flammability: 0
Reactivity: 1
Specific hazard:
Protective Equipment:
Gloves.
Full suit.
Vapor respirator. Be sure to use an
approved/certified respirator or
equivalent. Wear appropriate respirator
when ventilation is inadequate.
Face shield.
Section 16: Other Information
References:
-Hawley, G.G.. The Condensed Chemical Dictionary, 11e ed., New York N.Y., Van Nostrand Reinold, 1987.
-SAX, N.I. Dangerous Properties of Indutrial Materials. Toronto, Van Nostrand Reinold, 6e ed. 1984.
-The Sigma-Aldrich Library of Chemical Safety Data, Edition II.
-Guide de la loi et du règlement sur le transport des marchandises dangeureuses au canada. Centre de conformité
internatinal Ltée. 1986.
Other Special Considerations: Not available.
Created: 10/09/2005 05:45 PM
Last Updated: 10/09/2005 05:45 PM
The information above is believed to be accurate and represents the best information currently available to us. However, we
make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we
assume no liability resulting from its use. Users should make their own investigations to determine the suitability of the
information for their particular purposes. In no event shall ScienceLab.com be liable for any claims, losses, or damages of any
third party or for lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even
if ScienceLab.com has been advised of the possibility of such damages.
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Material Safety Data Sheet
Product name
Manufacturer
Product No.
MSDS #
Validation date
Print date
In case of emergency
Product and company identification
Responsible name MSDS (Regulatory Affairs)
Immobilized Papain
:
:
:
:
:
:
:
1 .
CHEMTREC:
800.424.9300
OUTSIDE US:
202.483.7616
Supplier : Thermo Fisher Scientific
Pierce Biotechnology
P.O. Box 117
Rockford, IL 61105
United States
815.968.0747 or
800.874.3723
:Use of
Substance/Preparation
Refer to the instruction booklet for
proper and intended use.
Otherwise, contact supplier for
specific applications.
: Thermo Fisher Scientific
Pierce Biotechnology
P.O. Box 117
Rockford, IL 61105
United States
815.968.0747
800.874.3723
Eye contact. Inhalation. Ingestion.
Emergency overview
Hazards identification
Routes of entry
Potential acute health effects
Irritating to respiratory system.
Irritating to eyes.
No known significant effects or critical hazards.
Irritating to skin.
Eyes
Skin
Inhalation
Ingestion
Physical state Liquid. [Suspension.]
WARNING !
CAUSES RESPIRATORY TRACT, EYE AND SKIN IRRITATION.  CONTAINS
MATERIAL THAT CAN CAUSE TARGET ORGAN DAMAGE.
Irritating to eyes, respiratory system and skin.  Avoid exposure - obtain special
instructions before use.  Do not breathe vapor or mist.  Avoid contact with eyes, skin and
clothing.  Contains material that can cause target organ damage.  Use only with
adequate ventilation.  Keep container tightly closed and sealed until ready for use.  Wash
thoroughly after handling.
:
:
:
:
:
:
:
OSHA/HCS status : This material is considered hazardous by the OSHA Hazard Communication Standard
(29 CFR 1910.1200).
2 .
Potential chronic health effects
Carcinogenicity : No known significant effects or critical hazards.
Mutagenicity : No known significant effects or critical hazards.
Teratogenicity : No known significant effects or critical hazards.
Developmental effects : No known significant effects or critical hazards.
Chronic effects : Contains material that can cause target organ damage.
Fertility effects : No known significant effects or critical hazards.
Over-exposure signs/symptoms
Target organs : Contains material which may cause damage to the following organs: kidneys, upper
respiratory tract, skin, eye, lens or cornea.
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Immobilized Papain
Hazards identification2 .
See toxicological information (section 11)
Medical conditions
aggravated by over-
exposure
Pre-existing disorders involving any target organs mentioned in this MSDS as being at
risk may be aggravated by over-exposure to this product.
:
Ingestion : No specific data.
Skin : Adverse symptoms may include the following:
irritation
redness
Eyes : Adverse symptoms may include the following:
pain or irritation
watering
redness
Inhalation : Adverse symptoms may include the following:
respiratory tract irritation
coughing
The preparation is classified as dangerous according to Directive 1999/45/EC and its amendments.
Classification Xi; R36/37/38:
Human health hazards : Irritating to eyes, respiratory system and skin.
Glycerol 56-81-5 20 - 25
Composition/information on ingredients
Name CAS number %
United States
3 .
There are no ingredients or additional ingredients present which, within the current knowledge of the supplier and
in the concentrations applicable, are classified as hazardous to health or the environment and hence require
reporting in this section.
Substance/preparation Preparation:
Ingredient name CAS
number
% ClassificationEC number
Glycerol 56-81-5 20 - 25 200-289-5 Xi;
R36/37/38
[1] [2]
Europe
[1] Substance classified with a health or environmental hazard
[2] Substance with a workplace exposure limit
Occupational exposure limits, if available, are listed in section 8.
Move exposed person to fresh air.  If it is suspected that fumes are still present, the
rescuer should wear an appropriate mask or self-contained breathing apparatus.  Keep
person warm and at rest.  If not breathing, if breathing is irregular or if respiratory arrest
occurs, provide artificial respiration or oxygen by trained personnel.  It may be dangerous
to the person providing aid to give mouth-to-mouth resuscitation.  Get medical attention.
If unconscious, place in recovery position and get medical attention immediately.
Maintain an open airway.  Loosen tight clothing such as a collar, tie, belt or waistband.
First aid measures
Inhalation :
4 .
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First aid measures4 .
Wash out mouth with water.  Remove dentures if any.  Move exposed person to fresh
air.  Keep person warm and at rest.  If material has been swallowed and the exposed
person is conscious, give small quantities of water to drink.  Stop if the exposed person
feels sick as vomiting may be dangerous.  Do not induce vomiting unless directed to do
so by medical personnel.  If vomiting occurs, the head should be kept low so that vomit
does not enter the lungs.  Get medical attention.  Never give anything by mouth to an
unconscious person.  If unconscious, place in recovery position and get medical
attention immediately.  Maintain an open airway.  Loosen tight clothing such as a collar,
tie, belt or waistband.
Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting
the upper and lower eyelids.  Check for and remove any contact lenses.  Get medical
attention.
Flush contaminated skin with plenty of water.  Remove contaminated clothing and
shoes.  Continue to rinse for at least 10 minutes.  Get medical attention.  Wash clothing
before reuse.  Clean shoes thoroughly before reuse.
Eye contact
Skin contact
Ingestion
:
:
:
Protection of first-aiders : No action shall be taken involving any personal risk or without suitable training.  If it is
suspected that fumes are still present, the rescuer should wear an appropriate mask or
self-contained breathing apparatus.  It may be dangerous to the person providing aid to
give mouth-to-mouth resuscitation.
See section 11 for more detailed information on health effects and symptoms.
Use an extinguishing agent suitable for the surrounding fire.
Fire-fighting measures
Extinguishing media
Promptly isolate the scene by removing all persons from the vicinity of the incident if
there is a fire.  No action shall be taken involving any personal risk or without suitable
training.
In a fire or if heated, a pressure increase will occur and the container may burst.
Special protective
equipment for fire-fighters
Fire-fighters should wear appropriate protective equipment and self-contained breathing
apparatus (SCBA) with a full face-piece operated in positive pressure mode.
:
5 .
Special exposure hazards :
None known.
Suitable :
Not suitable :
Hazardous combustion
products
: Decomposition products may include the following materials:
carbon oxides
Flammability of the product :
No action shall be taken involving any personal risk or without suitable training.
Evacuate surrounding areas.  Keep unnecessary and unprotected personnel from
entering.  Do not touch or walk through spilled material.  Avoid breathing vapor or mist.
Provide adequate ventilation.  Wear appropriate respirator when ventilation is
inadequate.  Put on appropriate personal protective equipment (see section 8).
Stop leak if without risk.  Move containers from spill area.  Approach release from
upwind.  Prevent entry into sewers, water courses, basements or confined areas.  Wash
spillages into an effluent treatment plant or proceed as follows.  Contain and collect
spillage with non-combustible, absorbent material e.g. sand, earth, vermiculite or
diatomaceous earth and place in container for disposal according to local regulations
(see section 13).  Dispose of via a licensed waste disposal contractor.  Contaminated
absorbent material may pose the same hazard as the spilled product.  Note: see section
1 for emergency contact information and section 13 for waste disposal.
Environmental precautions
Accidental release measures
: Avoid dispersal of spilled material and runoff and contact with soil, waterways, drains
and sewers.  Inform the relevant authorities if the product has caused environmental
pollution (sewers, waterways, soil or air).
Personal precautions :
Large spill :
6 .
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Accidental release measures6 .
Stop leak if without risk.  Move containers from spill area.  Dilute with water and mop up
if water-soluble or absorb with an inert dry material and place in an appropriate waste
disposal container.  Dispose of via a licensed waste disposal contractor.
Small spill :
Store between the following temperatures: 2 to 8°C (35.6 to 46.4°F).  Store in
accordance with local regulations.  Store in original container protected from direct
sunlight in a dry, cool and well-ventilated area, away from incompatible materials (see
section 10) and food and drink.  Keep container tightly closed and sealed until ready for
use.  Containers that have been opened must be carefully resealed and kept upright to
prevent leakage.  Do not store in unlabeled containers.  Use appropriate containment to
avoid environmental contamination.
Put on appropriate personal protective equipment (see section 8).  Eating, drinking and
smoking should be prohibited in areas where this material is handled, stored and
processed.  Workers should wash hands and face before eating, drinking and smoking.
Do not get in eyes or on skin or clothing.  Do not breathe vapor or mist.  Do not ingest.
Use only with adequate ventilation.  Wear appropriate respirator when ventilation is
inadequate.  Keep in the original container or an approved alternative made from a
compatible material, kept tightly closed when not in use.  Empty containers retain
product residue and can be hazardous.  Do not reuse container.
Handling and storage
Handling
Storage
:
:
7 .
glycerin ACGIH (United States).
  TWA: 10 mg/m³
ACGIH TLV (United States).
  TWA: 10 mg/m³ 8 hour(s). Form: Total particulates
OSHA PEL (United States).
  TWA: 15 mg/m³ 8 hour(s). Form: Total dust
ACGIH TLV (United States, 1/2007).
  TWA: 10 mg/m³ 8 hour(s). Form: Mist
OSHA PEL (United States, 11/2006).
  TWA: 5 mg/m³ 8 hour(s). Form: Respirable fraction
  TWA: 15 mg/m³ 8 hour(s). Form: Total dust
OSHA PEL 1989 (United States, 3/1989).
  TWA: 5 mg/m³ 8 hour(s). Form: Respirable fraction
  TWA: 10 mg/m³ 8 hour(s). Form: Total dust
ACGIH TLV (United States).
  TWA: 10 mg/m³ 8 hour(s). Form: Total particulates
OSHA PEL (United States).
  TWA: 15 mg/m³ 8 hour(s). Form: Total dust
OSHA PEL  (United States). Notes: Respirable
  TWA: 15 mg/m³ 8 hour(s).
Exposure controls/personal protection
Product name Exposure limits
Consult local authorities for acceptable exposure limits.
United States
8 .
Recommended monitoring
procedures
: If this product contains ingredients with exposure limits, personal, workplace atmosphere
or biological monitoring may be required to determine the effectiveness of the ventilation
or other control measures and/or the necessity to use respiratory protective equipment.
Europe
glycerin ACGIH (United States).
  TWA: 10 mg/m³
ACGIH TLV (United States).
  TWA: 10 mg/m³ 8 hour(s). Form: Total particulates
  TWA: 10 mg/m³ 8 hour(s). Form: Mist
  TWA: 10 mg/m³ 8 hour(s). Form: Total particulates
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Exposure controls/personal protection8 .
Use a properly fitted, air-purifying or air-fed respirator complying with an approved
standard if a risk assessment indicates this is necessary.  Respirator selection must be
based on known or anticipated exposure levels, the hazards of the product and the safe
working limits of the selected respirator.
Safety eyewear complying with an approved standard should be used when a risk
assessment indicates this is necessary to avoid exposure to liquid splashes, mists,
gases or dusts.
Personal protective equipment for the body should be selected based on the task being
performed and the risks involved and should be approved by a specialist before handling
this product.
Personal protection
Eyes
Skin
Respiratory
:
:
:
Chemical-resistant, impervious gloves complying with an approved standard should be
worn at all times when handling chemical products if a risk assessment indicates this is
necessary.
Hands :
Engineering measures : Use only with adequate ventilation.  If user operations generate dust, fumes, gas, vapor
or mist, use process enclosures, local exhaust ventilation or other engineering controls
to keep worker exposure to airborne contaminants below any recommended or statutory
limits.
Hygiene measures : Wash hands, forearms and face thoroughly after handling chemical products, before
eating, smoking and using the lavatory and at the end of the working period.  Appropriate
techniques should be used to remove potentially contaminated clothing.  Wash
contaminated clothing before reusing.  Ensure that eyewash stations and safety showers
are close to the workstation location.
Environmental exposure
controls
: Emissions from ventilation or work process equipment should be checked to ensure they
comply with the requirements of environmental protection legislation.  In some cases,
fume scrubbers, filters or engineering modifications to the process equipment will be
necessary to reduce emissions to acceptable levels.
Liquid. [Suspension.]
4.4
Easily dispersible in the following materials: cold water and hot water.
White.
Physical and chemical properties
Physical state
pH
Dispersibility properties
Color
:
:
:
:
9 .
The product is stable.  Under normal conditions of storage and use, hazardous
polymerization will not occur.
No specific data.
Will not occur.
Under normal conditions of storage and use, hazardous decomposition products should
not be produced.
No specific data.
Stability and reactivity
Chemical stability
Conditions to avoid
Incompatible materials
Hazardous decomposition
products
Possibility of hazardous
reactions
:
:
:
:
:
10 .
Toxicological information
United States
11 .
Acute toxicity
Product/ingredient name Result Species Dose Exposure
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Toxicological information11 .
glycerin LD50 Dermal Rabbit >10 g/kg -
LD50
Intraperitoneal
Rat 4420 mg/kg -
LD50 Intravenous Rat 5566 mg/kg -
LD50 Oral Rat 12600 mg/kg -
LD50 Oral Rat 12600 mg/kg -
LD50 Oral Mouse 4090 mg/kg -
LD50
Subcutaneous
Rat 100 mg/kg -
LDLo
Intramuscular
Rat 10 mg/kg -
TDLo
Intramuscular
Rat 8 mL/kg -
TDLo
Intramuscular
Rat 5000 mg/kg -
Conclusion/Summary : Not available.
Chronic toxicity
Conclusion/Summary : Not available.
Carcinogenicity
Conclusion/Summary : Not available.
Mutagenicity
Conclusion/Summary : Not available.
Teratogenicity
Conclusion/Summary : Not available.
Reproductive toxicity
Classification
glycerin - - - - - None.
Product/ingredient name ACGIH EPA NIOSH NTPIARC OSHA
No known significant effects or critical hazards.Chronic effects :
No known significant effects or critical hazards.Carcinogenicity :
No known significant effects or critical hazards.Mutagenicity
No known significant effects or critical hazards.Teratogenicity
Developmental effects : No known significant effects or critical hazards.
Fertility effects : No known significant effects or critical hazards.
:
:
Europe
Not available.Conclusion/Summary :
Ecological information
United States
Environmental effects : No known significant effects or critical hazards.
12 .
Aquatic ecotoxicity
Conclusion/Summary : Not available.
Other adverse effects : No known significant effects or critical hazards.
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The generation of waste should be avoided or minimized wherever possible.  Dispose of
surplus and non-recyclable products via a licensed waste disposal contractor.  Disposal
of this product, solutions and any by-products should at all times comply with the
requirements of environmental protection and waste disposal legislation and any regional
local authority requirements.  Avoid dispersal of spilled material and runoff and contact
with soil, waterways, drains and sewers.
Waste disposal
Disposal considerations
Disposal should be in accordance with applicable regional, national and local laws and regulations.
:
13 .
Refer to Section 7: HANDLING AND STORAGE and Section 8: EXPOSURE CONTROLS/PERSONAL PROTECTION
for additional handling information and protection of employees.
Hazardous waste : The classification of the product may meet the criteria for a hazardous waste.
Transport information
-DOT Classification - -
Not available.Not available.IATA-DGR Class Not available.
Regulatory
information
UN number Proper shipping
name
Classes PG*
-
Not
regulated.
14 .
PG* : Packing group
Irritating material
Target organ effects
HCS Classification
Regulatory information
U.S. Federal regulations United States inventory (TSCA 8b): All components are listed or exempted.
Clean Water Act (CWA) 307: No products were found.
Clean Water Act (CWA) 311: No products were found.
Clean Air Act (CAA) 112 accidental release prevention: No products were found.
Clean Air Act (CAA) 112 regulated flammable substances: No products were found.
Clean Air Act (CAA) 112 regulated toxic substances: No products were found.
CEPA Toxic substances: None of the components are listed.
Canadian ARET: None of the components are listed.
Canadian NPRI: None of the components are listed.
Alberta Designated Substances: None of the components are listed.
Ontario Designated Substances: None of the components are listed.
Quebec Designated Substances: None of the components are listed.
WHMIS (Canada) Class D-2B: Material causing other toxic effects (Toxic).
SARA 302/304/311/312 extremely hazardous substances: No products were found.
SARA 302/304 emergency planning and notification: No products were found.
SARA 302/304/311/312 hazardous chemicals: glycerin
SARA 311/312 MSDS distribution - chemical inventory - hazard identification:
glycerin: Immediate (acute) health hazard, Delayed (chronic) health hazard
:
:
:
Canada
United States
EU regulations
15 .
Canadian lists :
Canada inventory : Canada inventory: At least one component is not listed.
Hazard symbol or symbols :
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Regulatory information15 .
Australia inventory (AICS): All components are listed or exempted.
China inventory (IECSC): All components are listed or exempted.
Korea inventory (KECI): All components are listed or exempted.
Philippines inventory (PICCS): All components are listed or exempted.
Japan inventory (ENCS): Not determined.
International regulations
International lists :
R36/37/38- Irritating to eyes, respiratory system and skin.Risk phrases
:
Irritant
:
Other information
Hazardous Material
Information System (U.S.A.)
2
0
0
0
0
2
National Fire Protection
Association (U.S.A.)
Health
Special
Instability
Flammability
Health
Flammability
Physical hazards
CAUSES RESPIRATORY TRACT, EYE AND SKIN IRRITATION.  CONTAINS
MATERIAL THAT CAN CAUSE TARGET ORGAN DAMAGE.
Label requirements :
Notice to reader
To the best of our knowledge, the information contained herein is accurate. However, neither the above-named
supplier, nor any of its subsidiaries, assumes any liability whatsoever for the accuracy or completeness of the
information contained herein.
Final determination of suitability of any material is the sole responsibility of the user. All materials may present
unknown hazards and should be used with caution. Although certain hazards are described herein, we cannot
guarantee that these are the only hazards that exist.
Date of printing
Date of issue
Date of previous issue
Version
6/2/2008.
6/2/2008.
1
No previous validation.
:
:
:
:
:
:
16 .
The customer is responsible for determining the PPE code for this material.
Indicates information that has changed from previously issued version.
Full text of R-phrases
referred to in sections 2 and
3  -  Europe
: R36/37/38- Irritating to eyes, respiratory system and skin.
Full text of classifications
referred to in sections 2 and
3  -  Europe
: Xi - Irritant
This product has been classified according to the hazard criteria of the CPR and the MSDS contains all the information required by the CPR.
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Material Safety Data Sheet
Product name
Manufacturer
Product No.
MSDS #
Validation date
Print date
In case of emergency
Product and company identification
Responsible name MSDS (Regulatory Affairs)
Immobilized Pepsin
:
:
:
:
:
:
:
1 .
CHEMTREC:
800.424.9300
OUTSIDE US:
202.483.7616
Supplier : Thermo Fisher Scientific
Pierce Biotechnology
P.O. Box 117
Rockford, IL 61105
United States
815.968.0747 or
800.874.3723
:Use of
Substance/Preparation
Refer to the instruction booklet for
proper and intended use.
Otherwise, contact supplier for
specific applications.
: Thermo Fisher Scientific
Pierce Biotechnology
P.O. Box 117
Rockford, IL 61105
United States
815.968.0747
800.874.3723
Eye contact. Inhalation. Ingestion.
Emergency overview
Hazards identification
Routes of entry
Potential acute health effects
Irritating to respiratory system.
Irritating to eyes.
No known significant effects or critical hazards.
Irritating to skin.
Eyes
Skin
Inhalation
Ingestion
Physical state Liquid. [Gelatinous precipitate.]
WARNING !
CAUSES RESPIRATORY TRACT, EYE AND SKIN IRRITATION.  CONTAINS
MATERIAL THAT CAN CAUSE TARGET ORGAN DAMAGE.
Irritating to eyes, respiratory system and skin.  Avoid exposure - obtain special
instructions before use.  Do not breathe vapor or mist.  Avoid contact with eyes, skin and
clothing.  Contains material that can cause target organ damage.  Use only with
adequate ventilation.  Keep container tightly closed and sealed until ready for use.  Wash
thoroughly after handling.
:
:
:
:
:
:
:
OSHA/HCS status : This material is considered hazardous by the OSHA Hazard Communication Standard
(29 CFR 1910.1200).
2 .
Potential chronic health effects
Carcinogenicity : No known significant effects or critical hazards.
Mutagenicity : No known significant effects or critical hazards.
Teratogenicity : No known significant effects or critical hazards.
Developmental effects : No known significant effects or critical hazards.
Chronic effects : Contains material that can cause target organ damage.
Fertility effects : No known significant effects or critical hazards.
Target organs : Contains material which causes damage to the following organs: kidneys, bladder.
Contains material which may cause damage to the following organs: upper respiratory
tract, skin, eye, lens or cornea.
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Hazards identification2 .
See toxicological information (section 11)
Medical conditions
aggravated by over-
exposure
Pre-existing disorders involving any target organs mentioned in this MSDS as being at
risk may be aggravated by over-exposure to this product.
:
Over-exposure signs/symptoms
Ingestion : No specific data.
Skin : Adverse symptoms may include the following:
irritation
redness
Eyes : Adverse symptoms may include the following:
pain or irritation
watering
redness
Inhalation : Adverse symptoms may include the following:
respiratory tract irritation
coughing
The preparation is classified as dangerous according to Directive 1999/45/EC and its amendments.
Classification Xi; R36/37/38
R42
:
Human health hazards : Irritating to eyes, respiratory system and skin.  May cause sensitization by inhalation.
Glycerol 56-81-5 20 - 25
Sodium Acetate 127-09-3 1 - 3
Composition/information on ingredients
Name CAS number %
United States
3 .
There are no ingredients or additional ingredients present which, within the current knowledge of the supplier and
in the concentrations applicable, are classified as hazardous to health or the environment and hence require
reporting in this section.
Substance/preparation Preparation:
Ingredient name CAS
number
% ClassificationEC number
Glycerol 56-81-5 20 - 25 200-289-5 Xi;
R36/37/38
[1] [2]
Sodium Acetate 127-09-3 1 - 3 204-823-8 Not
classified.
[2]
Pepsin 9001-75-6 0.1 - 1 232-629-3 Xi;
R36/37/38
R42
[1]
Europe
[1] Substance classified with a health or environmental hazard
[2] Substance with a workplace exposure limit
Occupational exposure limits, if available, are listed in section 8.
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Wash out mouth with water.  Remove dentures if any.  Move exposed person to fresh
air.  Keep person warm and at rest.  If material has been swallowed and the exposed
person is conscious, give small quantities of water to drink.  Stop if the exposed person
feels sick as vomiting may be dangerous.  Do not induce vomiting unless directed to do
so by medical personnel.  If vomiting occurs, the head should be kept low so that vomit
does not enter the lungs.  Get medical attention.  Never give anything by mouth to an
unconscious person.  If unconscious, place in recovery position and get medical
attention immediately.  Maintain an open airway.  Loosen tight clothing such as a collar,
tie, belt or waistband.
Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting
the upper and lower eyelids.  Check for and remove any contact lenses.  Get medical
attention.
Flush contaminated skin with plenty of water.  Remove contaminated clothing and
shoes.  Continue to rinse for at least 10 minutes.  Get medical attention.  Wash clothing
before reuse.  Clean shoes thoroughly before reuse.
Move exposed person to fresh air.  If it is suspected that fumes are still present, the
rescuer should wear an appropriate mask or self-contained breathing apparatus.  Keep
person warm and at rest.  If not breathing, if breathing is irregular or if respiratory arrest
occurs, provide artificial respiration or oxygen by trained personnel.  It may be dangerous
to the person providing aid to give mouth-to-mouth resuscitation.  Get medical attention.
If unconscious, place in recovery position and get medical attention immediately.
Maintain an open airway.  Loosen tight clothing such as a collar, tie, belt or waistband.
First aid measures
Eye contact
Skin contact
Inhalation
Ingestion
:
:
:
:
4 .
Protection of first-aiders : No action shall be taken involving any personal risk or without suitable training.  If it is
suspected that fumes are still present, the rescuer should wear an appropriate mask or
self-contained breathing apparatus.  It may be dangerous to the person providing aid to
give mouth-to-mouth resuscitation.
See section 11 for more detailed information on health effects and symptoms.
Use an extinguishing agent suitable for the surrounding fire.
Fire-fighting measures
Extinguishing media
Promptly isolate the scene by removing all persons from the vicinity of the incident if
there is a fire.  No action shall be taken involving any personal risk or without suitable
training.
In a fire or if heated, a pressure increase will occur and the container may burst.
Special protective
equipment for fire-fighters
Fire-fighters should wear appropriate protective equipment and self-contained breathing
apparatus (SCBA) with a full face-piece operated in positive pressure mode.
:
5 .
Special exposure hazards :
None known.
Suitable :
Not suitable :
Hazardous combustion
products
: Decomposition products may include the following materials:
carbon oxides
metal oxide/oxides
Flammability of the product :
No action shall be taken involving any personal risk or without suitable training.
Evacuate surrounding areas.  Keep unnecessary and unprotected personnel from
entering.  Do not touch or walk through spilled material.  Avoid breathing vapor or mist.
Provide adequate ventilation.  Wear appropriate respirator when ventilation is
inadequate.  Put on appropriate personal protective equipment (see section 8).
Environmental precautions
Accidental release measures
: Avoid dispersal of spilled material and runoff and contact with soil, waterways, drains
and sewers.  Inform the relevant authorities if the product has caused environmental
pollution (sewers, waterways, soil or air).
Personal precautions :
6 .
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Accidental release measures6 .
Stop leak if without risk.  Move containers from spill area.  Approach release from
upwind.  Prevent entry into sewers, water courses, basements or confined areas.  Wash
spillages into an effluent treatment plant or proceed as follows.  Contain and collect
spillage with non-combustible, absorbent material e.g. sand, earth, vermiculite or
diatomaceous earth and place in container for disposal according to local regulations
(see section 13).  Dispose of via a licensed waste disposal contractor.  Contaminated
absorbent material may pose the same hazard as the spilled product.  Note: see section
1 for emergency contact information and section 13 for waste disposal.
Large spill :
Stop leak if without risk.  Move containers from spill area.  Dilute with water and mop up
if water-soluble or absorb with an inert dry material and place in an appropriate waste
disposal container.  Dispose of via a licensed waste disposal contractor.
Small spill :
Store between the following temperatures: 2 to 8°C (35.6 to 46.4°F).  Store in
accordance with local regulations.  Store in original container protected from direct
sunlight in a dry, cool and well-ventilated area, away from incompatible materials (see
section 10) and food and drink.  Keep container tightly closed and sealed until ready for
use.  Containers that have been opened must be carefully resealed and kept upright to
prevent leakage.  Do not store in unlabeled containers.  Use appropriate containment to
avoid environmental contamination.
Put on appropriate personal protective equipment (see section 8).  Eating, drinking and
smoking should be prohibited in areas where this material is handled, stored and
processed.  Workers should wash hands and face before eating, drinking and smoking.
Do not get in eyes or on skin or clothing.  Do not breathe vapor or mist.  Do not ingest.
Use only with adequate ventilation.  Wear appropriate respirator when ventilation is
inadequate.  Keep in the original container or an approved alternative made from a
compatible material, kept tightly closed when not in use.  Empty containers retain
product residue and can be hazardous.  Do not reuse container.
Handling and storage
Handling
Storage
:
:
7 .
glycerin ACGIH (United States).
  TWA: 10 mg/m³
ACGIH TLV (United States).
  TWA: 10 mg/m³ 8 hour(s). Form: Total particulates
OSHA PEL (United States).
  TWA: 15 mg/m³ 8 hour(s). Form: Total dust
ACGIH TLV (United States, 1/2007).
  TWA: 10 mg/m³ 8 hour(s). Form: Mist
OSHA PEL (United States, 11/2006).
  TWA: 5 mg/m³ 8 hour(s). Form: Respirable fraction
  TWA: 15 mg/m³ 8 hour(s). Form: Total dust
OSHA PEL 1989 (United States, 3/1989).
  TWA: 5 mg/m³ 8 hour(s). Form: Respirable fraction
  TWA: 10 mg/m³ 8 hour(s). Form: Total dust
ACGIH TLV (United States).
  TWA: 10 mg/m³ 8 hour(s). Form: Total particulates
OSHA PEL (United States).
  TWA: 15 mg/m³ 8 hour(s). Form: Total dust
OSHA PEL  (United States). Notes: Respirable
  TWA: 15 mg/m³ 8 hour(s).
acetic acid, sodium salt OSHA  (United States).
  PEL: 15 mg/m³ Form: Total dust
  PEL: 5 mg/m³ Form: Respirable fraction
ACGIH  (United States).
Exposure controls/personal protection
Product name Exposure limits
United States
8 .
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Exposure controls/personal protection8 .
  TLV: 10 mg/m³ Form: Dust Containing no Abestos
Use a properly fitted, air-purifying or air-fed respirator complying with an approved
standard if a risk assessment indicates this is necessary.  Respirator selection must be
based on known or anticipated exposure levels, the hazards of the product and the safe
working limits of the selected respirator.
Safety eyewear complying with an approved standard should be used when a risk
assessment indicates this is necessary to avoid exposure to liquid splashes, mists,
gases or dusts.
Personal protective equipment for the body should be selected based on the task being
performed and the risks involved and should be approved by a specialist before handling
this product.
Personal protection
Eyes
Skin
Respiratory
Consult local authorities for acceptable exposure limits.
:
:
:
Chemical-resistant, impervious gloves complying with an approved standard should be
worn at all times when handling chemical products if a risk assessment indicates this is
necessary.
Hands :
Engineering measures : Use only with adequate ventilation.  If user operations generate dust, fumes, gas, vapor
or mist, use process enclosures, local exhaust ventilation or other engineering controls
to keep worker exposure to airborne contaminants below any recommended or statutory
limits.
Hygiene measures : Wash hands, forearms and face thoroughly after handling chemical products, before
eating, smoking and using the lavatory and at the end of the working period.  Appropriate
techniques should be used to remove potentially contaminated clothing.  Wash
contaminated clothing before reusing.  Ensure that eyewash stations and safety showers
are close to the workstation location.
Recommended monitoring
procedures
: If this product contains ingredients with exposure limits, personal, workplace atmosphere
or biological monitoring may be required to determine the effectiveness of the ventilation
or other control measures and/or the necessity to use respiratory protective equipment.
Environmental exposure
controls
: Emissions from ventilation or work process equipment should be checked to ensure they
comply with the requirements of environmental protection legislation.  In some cases,
fume scrubbers, filters or engineering modifications to the process equipment will be
necessary to reduce emissions to acceptable levels.
Europe
glycerin ACGIH (United States).
  TWA: 10 mg/m³
ACGIH TLV (United States).
  TWA: 10 mg/m³ 8 hour(s). Form: Total particulates
  TWA: 10 mg/m³ 8 hour(s). Form: Mist
  TWA: 10 mg/m³ 8 hour(s). Form: Total particulates
acetic acid, sodium salt ACGIH  (United States).
  TLV: 10 mg/m³ Form: Dust Containing no Abestos
Liquid. [Gelatinous precipitate.]
Easily dispersible in the following materials: cold water and hot water.
White.
Physical and chemical properties
Physical state
Dispersibility properties
Color
:
:
:
9 .
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The product is stable.  Under normal conditions of storage and use, hazardous
polymerization will not occur.
No specific data.
Will not occur.
Under normal conditions of storage and use, hazardous decomposition products should
not be produced.
No specific data.
Stability and reactivity
Chemical stability
Conditions to avoid
Incompatible materials
Hazardous decomposition
products
Possibility of hazardous
reactions
:
:
:
:
:
10 .
Toxicological information
United States
11 .
Acute toxicity
glycerin LD50 Dermal Rabbit >10 g/kg -
LD50
Intraperitoneal
Rat 4420 mg/kg -
LD50 Intravenous Rat 5566 mg/kg -
LD50 Oral Rat 12600 mg/kg -
LD50 Oral Rat 12600 mg/kg -
LD50 Oral Mouse 4090 mg/kg -
LD50
Subcutaneous
Rat 100 mg/kg -
LDLo
Intramuscular
Rat 10 mg/kg -
TDLo
Intramuscular
Rat 8 mL/kg -
TDLo
Intramuscular
Rat 5000 mg/kg -
acetic acid, sodium salt LD50 Dermal Rabbit >10 g/kg -
LD50 Dermal Rabbit >10000 mg/kg -
LD50 Oral Rat 3530 mg/kg -
LD50 Oral Mouse 6891 mg/kg -
LD50 Oral Rat 3530 mg/kg -
Product/ingredient name Result Species Dose Exposure
Conclusion/Summary : Not available.
Chronic toxicity
Conclusion/Summary : Not available.
Carcinogenicity
Conclusion/Summary : Not available.
Mutagenicity
Conclusion/Summary : Not available.
Teratogenicity
Conclusion/Summary : Not available.
Reproductive toxicity
Classification
glycerin - - - - - None.
acetic acid, sodium salt - - - None. - None.
Product/ingredient name ACGIH EPA NIOSH NTPIARC OSHA
Once sensitized, a severe allergic reaction may occur when subsequently exposed
to very low levels.
Chronic effects :
Europe
Not available.Conclusion/Summary :
6/96/2/2008.
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Immobilized Pepsin
Toxicological information11 .
No known significant effects or critical hazards.Carcinogenicity :
No known significant effects or critical hazards.Mutagenicity
No known significant effects or critical hazards.Teratogenicity
Developmental effects : No known significant effects or critical hazards.
Fertility effects : No known significant effects or critical hazards.
:
:
Ecological information
United States
Environmental effects : No known significant effects or critical hazards.
12 .
Aquatic ecotoxicity
Conclusion/Summary : Not available.
Other adverse effects : No known significant effects or critical hazards.
The generation of waste should be avoided or minimized wherever possible.  Dispose of
surplus and non-recyclable products via a licensed waste disposal contractor.  Disposal
of this product, solutions and any by-products should at all times comply with the
requirements of environmental protection and waste disposal legislation and any regional
local authority requirements.  Avoid dispersal of spilled material and runoff and contact
with soil, waterways, drains and sewers.
Waste disposal
Disposal considerations
Disposal should be in accordance with applicable regional, national and local laws and regulations.
:
13 .
Refer to Section 7: HANDLING AND STORAGE and Section 8: EXPOSURE CONTROLS/PERSONAL PROTECTION
for additional handling information and protection of employees.
Hazardous waste : The classification of the product may meet the criteria for a hazardous waste.
Transport information
-DOT Classification - -
Not available.Not available.IATA-DGR Class Not available.
Regulatory
information
UN number Proper shipping
name
Classes PG*
-
Not
regulated.
14 .
PG* : Packing group
Irritating material
Target organ effects
HCS Classification
Regulatory information
U.S. Federal regulations United States inventory (TSCA 8b): All components are listed or exempted.
Clean Water Act (CWA) 307: No products were found.
Clean Water Act (CWA) 311: No products were found.
Clean Air Act (CAA) 112 accidental release prevention: No products were found.
SARA 302/304/311/312 extremely hazardous substances: No products were found.
SARA 302/304 emergency planning and notification: No products were found.
SARA 302/304/311/312 hazardous chemicals: glycerin; acetic acid, sodium salt
SARA 311/312 MSDS distribution - chemical inventory - hazard identification:
glycerin: Immediate (acute) health hazard, Delayed (chronic) health hazard; acetic acid,
sodium salt: Immediate (acute) health hazard
:
:
United States
15 .
7/96/2/2008.
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Immobilized Pepsin
Regulatory information15 .
Clean Air Act (CAA) 112 regulated flammable substances: No products were found.
Clean Air Act (CAA) 112 regulated toxic substances: No products were found.
CEPA Toxic substances: None of the components are listed.
Canadian ARET: None of the components are listed.
Canadian NPRI: None of the components are listed.
Alberta Designated Substances: None of the components are listed.
Ontario Designated Substances: None of the components are listed.
Quebec Designated Substances: None of the components are listed.
Australia inventory (AICS): All components are listed or exempted.
China inventory (IECSC): All components are listed or exempted.
Korea inventory (KECI): All components are listed or exempted.
Philippines inventory (PICCS): All components are listed or exempted.
Japan inventory (ENCS): Not determined.
WHMIS (Canada) Class D-2B: Material causing other toxic effects (Toxic).
International regulations
International lists
:
:
Canada
EU regulations
Canadian lists :
Canada inventory : Canada inventory: All components are listed or exempted.
Safety phrases S23- Do not breathe [***].
S45- In case of accident or if you feel unwell, seek medical advice immediately
(show the label where possible).
R36/37/38- Irritating to eyes, respiratory system and skin.
R42- May cause sensitization by inhalation.
Hazard symbol or symbols
Risk phrases
:
:
Harmful
:
Other information
Hazardous Material
Information System (U.S.A.)
2
0
0
0
0
2
National Fire Protection
Association (U.S.A.)
Health
Special
Instability
Flammability
Health
Flammability
Physical hazards
CAUSES RESPIRATORY TRACT, EYE AND SKIN IRRITATION.  CONTAINS
MATERIAL THAT CAN CAUSE TARGET ORGAN DAMAGE.
Label requirements :
Date of printing
Date of issue
Date of previous issue
6/2/2008.
6/2/2008.
2/29/2008.
:
:
:
:
:
16 .
The customer is responsible for determining the PPE code for this material.
8/96/2/2008.
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Immobilized Pepsin
Other information16 .
Notice to reader
To the best of our knowledge, the information contained herein is accurate. However, neither the above-named
supplier, nor any of its subsidiaries, assumes any liability whatsoever for the accuracy or completeness of the
information contained herein.
Final determination of suitability of any material is the sole responsibility of the user. All materials may present
unknown hazards and should be used with caution. Although certain hazards are described herein, we cannot
guarantee that these are the only hazards that exist.
Version 1.01:
Indicates information that has changed from previously issued version.
Full text of R-phrases
referred to in sections 2 and
3  -  Europe
: R36/37/38- Irritating to eyes, respiratory system and skin.
R42- May cause sensitization by inhalation.
Full text of classifications
referred to in sections 2 and
3  -  Europe
: Xi - Irritant
This product has been classified according to the hazard criteria of the CPR and the MSDS contains all the information required by the CPR.
9/96/2/2008.
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Material Safety Data Sheet
L-Glutamine MSDS
Section 1: Chemical Product and Company Identification
Product Name: L-Glutamine
Catalog Codes: SLG1462, SLG1963
CAS#: 56-85-9
RTECS: MA2275100
TSCA: TSCA 8(b) inventory: L-Glutamine
CI#: Not available.
Synonym: L-2-Aminoglutaramic acid
Chemical Formula: C5H10N2O3
Contact Information:
Sciencelab.com, Inc.
14025 Smith Rd.
Houston, Texas 77396
US Sales: 1-800-901-7247
International Sales: 1-281-441-4400
Order Online: ScienceLab.com
CHEMTREC (24HR Emergency Telephone), call:
1-800-424-9300
International CHEMTREC, call: 1-703-527-3887
For non-emergency assistance, call: 1-281-441-4400
Section 2: Composition and Information on Ingredients
Composition:
Name CAS # % by Weight
{L-}Glutamine 56-85-9 100
Toxicological Data on Ingredients: L-Glutamine: ORAL (LD50): Acute: 7500 mg/kg [Rat]. 21700 mg/kg [Mouse].
Section 3: Hazards Identification
Potential Acute Health Effects: Hazardous in case of ingestion. Slightly hazardous in case of eye contact (irritant), of
inhalation.
Potential Chronic Health Effects:
Hazardous in case of ingestion.
Slightly hazardous in case of eye contact (irritant), of inhalation.
CARCINOGENIC EFFECTS: Not available.
MUTAGENIC EFFECTS: Not available.
TERATOGENIC EFFECTS: Not available.
DEVELOPMENTAL TOXICITY: Not available.
The substance is toxic to lungs, mucous membranes.
Repeated or prolonged exposure to the substance can produce target organs damage.
Section 4: First Aid Measures
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Eye Contact: Immediately flush eyes with running water for at least 15 minutes, keeping eyelids open. Cold water may be
used.
Skin Contact: No known effect on skin contact, rinse with water for a few minutes.
Serious Skin Contact: Not available.
Inhalation: Allow the victim to rest in a well ventilated area. Seek immediate medical attention.
Serious Inhalation: Not available.
Ingestion:
Do not induce vomiting. Loosen tight clothing such as a collar, tie, belt or waistband. If the victim is not
breathing, perform mouth-to-mouth resuscitation. Seek immediate medical attention.
Serious Ingestion: Not available.
Section 5: Fire and Explosion Data
Flammability of the Product: May be combustible at high temperature.
Auto-Ignition Temperature: Not available.
Flash Points: Not available.
Flammable Limits: Not available.
Products of Combustion: These products are carbon oxides (CO, CO2), nitrogen oxides (NO, NO2...).
Fire Hazards in Presence of Various Substances: Not available.
Explosion Hazards in Presence of Various Substances:
Risks of explosion of the product in presence of mechanical impact: Not available.
Risks of explosion of the product in presence of static discharge: Not available.
Fire Fighting Media and Instructions:
SMALL FIRE: Use DRY chemical powder.
LARGE FIRE: Use water spray, fog or foam. Do not use water jet.
Special Remarks on Fire Hazards: Not available.
Special Remarks on Explosion Hazards: Not available.
Section 6: Accidental Release Measures
Small Spill:
Use appropriate tools to put the spilled solid in a convenient waste disposal container. Finish cleaning by
spreading water on the contaminated surface and dispose of according to local and regional authority
requirements.
Large Spill:
Use a shovel to put the material into a convenient waste disposal container. Finish cleaning by spreading water
on the contaminated surface and allow to evacuate through the sanitary system.
Section 7: Handling and Storage
Precautions:
Keep away from heat. Keep away from sources of ignition. Empty containers pose a fire risk, evaporate the
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residue under a fume hood. Ground all equipment containing material. Do not ingest. Do not breathe dust. If
ingested, seek medical advice immediately and show the container or the label.
Storage:
Keep container dry. Keep in a cool place. Ground all equipment containing material. Keep container tightly
closed. Keep in a cool, well-ventilated place. Combustible materials should be stored away from extreme heat
and away from strong oxidizing agents.
Section 8: Exposure Controls/Personal Protection
Engineering Controls:
Use process enclosures, local exhaust ventilation, or other engineering controls to keep airborne levels below
recommended exposure limits. If user operations generate dust, fume or mist, use ventilation to keep exposure to
airborne contaminants below the exposure limit.
Personal Protection: Safety glasses. Lab coat.
Personal Protection in Case of a Large Spill:
Splash goggles. Full suit. Boots. Gloves. Suggested protective clothing might not be sufficient; consult a
specialist BEFORE handling this product.
Exposure Limits: Not available.
Section 9: Physical and Chemical Properties
Physical state and appearance: Solid. (Solid crystalline powder.)
Odor: Not available.
Taste: Not available.
Molecular Weight: 146.15 g/mole
Color: White.
pH (1% soln/water): 7 [Neutral.]
Boiling Point: Not available.
Melting Point: Decomposes. (185°C or 365°F)
Critical Temperature: Not available.
Specific Gravity: Not available.
Vapor Pressure: Not applicable.
Vapor Density: Not available.
Volatility: Not available.
Odor Threshold: Not available.
Water/Oil Dist. Coeff.: Not available.
Ionicity (in Water): Not available.
Dispersion Properties: See solubility in water.
Solubility: Soluble in cold water.
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Section 10: Stability and Reactivity Data
Stability: The product is stable.
Instability Temperature: Not available.
Conditions of Instability: Not available.
Incompatibility with various substances: Not available.
Corrosivity: Not available.
Special Remarks on Reactivity: Not available.
Special Remarks on Corrosivity: Not available.
Polymerization: No.
Section 11: Toxicological Information
Routes of Entry: Ingestion.
Toxicity to Animals: Acute oral toxicity (LD50): 7500 mg/kg [Rat].
Chronic Effects on Humans: The substance is toxic to lungs, mucous membranes.
Other Toxic Effects on Humans:
Hazardous in case of ingestion.
Slightly hazardous in case of inhalation.
Special Remarks on Toxicity to Animals: Not available.
Special Remarks on Chronic Effects on Humans: Passes through the placental barrier in animal.
Special Remarks on other Toxic Effects on Humans: Nuisance dust.
Section 12: Ecological Information
Ecotoxicity: Not available.
BOD5 and COD: Not available.
Products of Biodegradation:
Possibly hazardous short term degradation products are not likely. However, long term degradation products may
arise.
Toxicity of the Products of Biodegradation: The products of degradation are more toxic.
Special Remarks on the Products of Biodegradation: Not available.
Section 13: Disposal Considerations
Waste Disposal:
Section 14: Transport Information
DOT Classification: Not a DOT controlled material (United States).
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Identification: Not applicable.
Special Provisions for Transport: Not applicable.
Section 15: Other Regulatory Information
Federal and State Regulations: TSCA 8(b) inventory: L-Glutamine
Other Regulations: OSHA: Hazardous by definition of Hazard Communication Standard (29 CFR 1910.1200).
Other Classifications:
WHMIS (Canada): CLASS D-2A: Material causing other toxic effects (VERY TOXIC).
DSCL (EEC):
This product is not classified according
to the EU regulations.
HMIS (U.S.A.):
Health Hazard: 1
Fire Hazard: 1
Reactivity: 0
Personal Protection: a
National Fire Protection Association (U.S.A.):
Health: 1
Flammability: 1
Reactivity: 0
Specific hazard:
Protective Equipment:
Not applicable.
Lab coat.
Wear appropriate respirator when ventilation
is inadequate.
Safety glasses.
Section 16: Other Information
References: Not available.
Other Special Considerations: Not available.
Created: 10/09/2005 05:38 PM
Last Updated: 11/06/2008 12:00 PM
The information above is believed to be accurate and represents the best information currently available to us. However, we
make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we
assume no liability resulting from its use. Users should make their own investigations to determine the suitability of the
information for their particular purposes. In no event shall ScienceLab.com be liable for any claims, losses, or damages of any
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third party or for lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even
if ScienceLab.com has been advised of the possibility of such damages.
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                                  SIGMA-ALDRICH
      
                           MATERIAL SAFETY DATA SHEET
      
                                                    Date Printed: 03/30/2009
                                                    Date Updated: 01/27/2006
                                                               Version  1.7
      
      
      Section 1 - Product and Company Information
      
      Product Name                 EX-CELL(TM) ACF CHO MEDIUM
      Product Number               C9098
      Brand                        SIGMA
      
      Company                      Sigma-Aldrich
      Address                      3050 Spruce Street
                                   SAINT LOUIS MO 63103 US
      Technical Phone:             800-325-5832
      Fax:                         800-325-5052
      Emergency Phone:             314-776-6555
      
      Section 2 - Composition/Information on Ingredient
      
      Substance Name                          CAS #                 SARA 313
      EX-CELL ACF CHO MEDIUM                  None                  No
      
      Ingredient Name                         CAS #       Percent   SARA 313
      Information regarding the specific      None
        chemical identity of this material is
        being withheld as a trade secret of
        the manufacturer.
      
      Section 3 - Hazards Identification
      
      EMERGENCY OVERVIEW
         Irritant.
         Irritating to eyes, respiratory system and skin.
      
      HMIS RATING
         HEALTH: 2
         FLAMMABILITY: 0
         REACTIVITY: 0
      
      NFPA RATING
         HEALTH: 2
         FLAMMABILITY: 0
         REACTIVITY: 0
      
      For additional information on toxicity, please refer to Section 11.
      
      Section 4 - First Aid Measures
      
      ORAL EXPOSURE
         If swallowed, wash out mouth with water provided person is
         conscious. Call a physician.
      
      INHALATION EXPOSURE
         If inhaled, remove to fresh air. If not breathing give
         artificial respiration. If breathing is difficult, give oxygen.
      
      DERMAL EXPOSURE
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         In case of contact, immediately wash skin with soap and copious
         amounts of water.
      
      EYE EXPOSURE
         In case of contact, immediately flush eyes with copious amounts
         of water for at least 15 minutes.
      
      Section 5 - Fire Fighting Measures
      
      FLASH POINT
         N/A
      
      AUTOIGNITION TEMP
         N/A
      
      FLAMMABILITY
         N/A
      
      EXTINGUISHING MEDIA
         Suitable: Water spray. Carbon dioxide, dry chemical powder, or
         appropriate foam.
      
      FIREFIGHTING
         Protective Equipment: Wear self-contained breathing apparatus
         and protective clothing to prevent contact with skin and eyes.
         Specific Hazard(s): Emits toxic fumes under fire conditions.
      
      Section 6 - Accidental Release Measures
      
      PROCEDURE(S) OF PERSONAL PRECAUTION(S)
         Wear respirator, chemical safety goggles, rubber boots, and
         heavy rubber gloves.
      
      METHODS FOR CLEANING UP
         Sweep up, place in a bag and hold for waste disposal. Avoid
         raising dust. Ventilate area and wash spill site after material
         pickup is complete.
      
      Section 7 - Handling and Storage
      
      HANDLING
         User Exposure: Do not breathe dust. Avoid contact with eyes,
         skin, and clothing. Avoid prolonged or repeated exposure.
      
      STORAGE
         Suitable: Keep tightly closed.
         Store at 2-8°C
      
      Section 8 - Exposure Controls / PPE
      
      ENGINEERING CONTROLS
         Safety shower and eye bath. Mechanical exhaust required.
      
      PERSONAL PROTECTIVE EQUIPMENT
         Respiratory: Use respirators and components tested and approved
         under appropriate government standards such as NIOSH (US) or CEN
         (EU). Where risk assessment shows air-purifying respirators are
         appropriate use a dust mask type N95 (US) or type P1 (EN 143)
         respirator.
         Hand: Compatible chemical-resistant gloves.
         Eye: Chemical safety goggles.
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      GENERAL HYGIENE MEASURES
         Wash thoroughly after handling.
      
      Section 9 - Physical/Chemical Properties
      
      Appearance              Physical State: Solid
      
      Property                Value               At Temperature or Pressure
      
      Molecular Weight        N/A
      pH                      N/A
      BP/BP Range             N/A
      MP/MP Range             N/A
      Freezing Point          N/A
      Vapor Pressure          N/A
      Vapor Density           N/A
      Saturated Vapor Conc.   N/A
      SG/Density              N/A
      Bulk Density            N/A
      Odor Threshold          N/A
      Volatile%               N/A
      VOC Content             N/A
      Water Content           N/A
      Solvent Content         N/A
      Evaporation Rate        N/A
      Viscosity               N/A
      Surface Tension         N/A
      Partition Coefficient   N/A
      Decomposition Temp.     N/A
      Flash Point             N/A
      Explosion Limits        N/A
      Flammability            N/A
      Autoignition Temp       N/A
      Refractive Index        N/A
      Optical Rotation        N/A
      Miscellaneous Data      N/A
      Solubility              N/A
      
      N/A = not available
      
      Section 10 - Stability and Reactivity
      
      STABILITY
         Stable: Stable.
         Materials to Avoid: Strong oxidizing agents.
      
      HAZARDOUS DECOMPOSITION PRODUCTS
         Hazardous Decomposition Products: Nature of decomposition products
         not known.
      
      HAZARDOUS POLYMERIZATION
         Hazardous Polymerization: Will not occur
      
      Section 11 - Toxicological Information
      
      ROUTE OF EXPOSURE
         Skin Contact: Causes skin irritation.
         Skin Absorption: May be harmful if absorbed through the skin.
         Eye Contact: Causes eye irritation.
         Inhalation: May be harmful if inhaled. Material is irritating to
         mucous membranes and upper respiratory tract.
         Ingestion: May be harmful if swallowed.
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      SIGNS AND SYMPTOMS OF EXPOSURE
         To the best of our knowledge, the chemical, physical, and
         toxicological properties have not been thoroughly investigated.
      
      Section 12 - Ecological Information
      
      No data available.
      
      Section 13 - Disposal Considerations
      
      APPROPRIATE METHOD OF DISPOSAL OF SUBSTANCE OR PREPARATION
         Contact a licensed professional waste disposal service to dispose
         of this material. Dissolve or mix the material with a combustible
         solvent and burn in a chemical incinerator equipped with an
         afterburner and scrubber. Observe all federal, state, and local
         environmental regulations.
      
      Section 14 - Transport Information
      
      DOT
         Proper Shipping Name: None
         Non-Hazardous for Transport: This substance is
         considered to be non-hazardous for transport.
      
      IATA
         Non-Hazardous for Air Transport: Non-hazardous for air
         transport.
      
      Section 15 - Regulatory Information
      
      EU ADDITIONAL CLASSIFICATION
         Symbol of Danger: Xi
         Indication of Danger: Irritant.
         R: 36/37/38
         Risk Statements: Irritating to eyes, respiratory system and skin.
         S: 26-36
         Safety Statements: In case of contact with eyes, rinse
         immediately with plenty of water and seek medical advice. Wear
         suitable protective clothing.
      
      US CLASSIFICATION AND LABEL TEXT
         Indication of Danger: Irritant.
         Risk Statements: Irritating to eyes, respiratory system and skin.
         Safety Statements: After contact with skin, wash immediately
         with plenty of water. Wear suitable protective clothing.
      
      UNITED STATES REGULATORY INFORMATION
         SARA LISTED: No
      
      CANADA REGULATORY INFORMATION
         WHMIS Classification: This product has been classified in
         accordance with the hazard criteria of the CPR, and the MSDS
         contains all the information required by the CPR.
         DSL: No
         NDSL: No
      
      Section 16 - Other Information
      
      DISCLAIMER
         For Research or For Further Manufacturing Use
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      WARRANTY
         The above information is believed to be correct but does not
         purport to be all inclusive and shall be used only as a guide. The
         information in this document is based on the present state of our
         knowledge and is applicable to the product with regard to
         appropriate safety precautions. It does not represent any
         guarantee of the properties of the product. Sigma-Aldrich Inc.,
         shall not be held liable for any damage resulting from handling or
         from contact with the above product. See reverse side of invoice
         or packing slip for additional terms and conditions of sale.
         Copyright 2009 Sigma-Aldrich Co. License granted to make unlimited
         paper copies for internal use only.
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      SIGMA - C9098                  www.sigma-aldrich.com          Page   5
-389-
Material Safety Data Sheet
MES MSDS
Section 1: Chemical Product and Company Identification
Product Name: MES
Catalog Codes: SLM3343, SLM1198
CAS#: 4432-31-9
RTECS: KI7970000
TSCA: TSCA 8(b) inventory: MES
CI#: Not available.
Synonym: 2-(N-Morpholino)ethanesulfonic acid
Chemical Name: Not available.
Chemical Formula: C6H13NO4S.H2O
Contact Information:
Sciencelab.com, Inc.
14025 Smith Rd.
Houston, Texas 77396
US Sales: 1-800-901-7247
International Sales: 1-281-441-4400
Order Online: ScienceLab.com
CHEMTREC (24HR Emergency Telephone), call:
1-800-424-9300
International CHEMTREC, call: 1-703-527-3887
For non-emergency assistance, call: 1-281-441-4400
Section 2: Composition and Information on Ingredients
Composition:
Name CAS # % by Weight
MES 4432-31-9 100
Toxicological Data on Ingredients: MES LD50: Not available. LC50: Not available.
Section 3: Hazards Identification
Potential Acute Health Effects: Very hazardous in case of ingestion. Hazardous in case of skin contact (irritant), of eye
contact (irritant).
Potential Chronic Health Effects:
Hazardous in case of skin contact (irritant), of eye contact (irritant), of ingestion, of inhalation.
CARCINOGENIC EFFECTS: Not available.
MUTAGENIC EFFECTS: Not available.
TERATOGENIC EFFECTS: Not available.
DEVELOPMENTAL TOXICITY: Not available.
The substance is toxic to lungs, mucous membranes.
Repeated or prolonged exposure to the substance can produce target organs damage.
Section 4: First Aid Measures
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Eye Contact: Check for and remove any contact lenses. Do not use an eye ointment. Seek medical attention.
Skin Contact:
After contact with skin, wash immediately with plenty of water. Gently and thoroughly wash the contaminated skin
with running water and non-abrasive soap. Be particularly careful to clean folds, crevices, creases and groin.
Cover the irritated skin with an emollient. If irritation persists, seek medical attention. Wash contaminated
clothing before reusing.
Serious Skin Contact:
Wash with a disinfectant soap and cover the contaminated skin with an anti-bacterial cream. Seek medical
attention.
Inhalation: Allow the victim to rest in a well ventilated area. Seek immediate medical attention.
Serious Inhalation: Not available.
Ingestion:
Do not induce vomiting. Loosen tight clothing such as a collar, tie, belt or waistband. If the victim is not
breathing, perform mouth-to-mouth resuscitation. Seek immediate medical attention.
Serious Ingestion: Not available.
Section 5: Fire and Explosion Data
Flammability of the Product: May be combustible at high temperature.
Auto-Ignition Temperature: Not available.
Flash Points: Not available.
Flammable Limits: Not available.
Products of Combustion: These products are carbon oxides (CO, CO2), nitrogen oxides (NO, NO2...), sulfur oxides (SO2,
SO3...).
Fire Hazards in Presence of Various Substances: Not available.
Explosion Hazards in Presence of Various Substances:
Risks of explosion of the product in presence of mechanical impact: Not available.
Risks of explosion of the product in presence of static discharge: Not available.
Fire Fighting Media and Instructions:
SMALL FIRE: Use DRY chemical powder.
LARGE FIRE: Use water spray, fog or foam. Do not use water jet.
Special Remarks on Fire Hazards: Not available.
Special Remarks on Explosion Hazards: Not available.
Section 6: Accidental Release Measures
Small Spill:
Use appropriate tools to put the spilled solid in a convenient waste disposal container. Finish cleaning by
spreading water on the contaminated surface and dispose of according to local and regional authority
requirements.
Large Spill:
Use a shovel to put the material into a convenient waste disposal container. Finish cleaning by spreading water
on the contaminated surface and allow to evacuate through the sanitary system.
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Section 7: Handling and Storage
Precautions:
Keep away from heat. Keep away from sources of ignition. Empty containers pose a fire risk, evaporate the
residue under a fume hood. Ground all equipment containing material. Do not breathe dust. Wear suitable
protective clothing If you feel unwell, seek medical attention and show the label when possible. Avoid contact
with skin and eyes
Storage:
Keep container dry. Keep in a cool place. Ground all equipment containing material. Keep container tightly
closed. Keep in a cool, well-ventilated place. Combustible materials should be stored away from extreme heat
and away from strong oxidizing agents.
Section 8: Exposure Controls/Personal Protection
Engineering Controls:
Use process enclosures, local exhaust ventilation, or other engineering controls to keep airborne levels below
recommended exposure limits. If user operations generate dust, fume or mist, use ventilation to keep exposure to
airborne contaminants below the exposure limit.
Personal Protection:
Splash goggles. Lab coat. Dust respirator. Be sure to use an approved/certified respirator or equivalent.
Gloves.
Personal Protection in Case of a Large Spill:
Splash goggles. Full suit. Dust respirator. Boots. Gloves. A self contained breathing apparatus should be used
to avoid inhalation of the product. Suggested protective clothing might not be sufficient; consult a specialist
BEFORE handling this product.
Exposure Limits: Not available.
Section 9: Physical and Chemical Properties
Physical state and appearance: Solid. (Powdered solid.)
Odor: Not available.
Taste: Not available.
Molecular Weight: 213.26 g/mole
Color: Colorless.
pH (1% soln/water): Not available.
Boiling Point: Not available.
Melting Point: Not available.
Critical Temperature: Not available.
Specific Gravity: Not available.
Vapor Pressure: Not applicable.
Vapor Density: Not available.
Volatility: Not available.
Odor Threshold: Not available.
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Water/Oil Dist. Coeff.: Not available.
Ionicity (in Water): Not available.
Dispersion Properties: Not available.
Solubility: Not available.
Section 10: Stability and Reactivity Data
Stability: The product is stable.
Instability Temperature: Not available.
Conditions of Instability: Not available.
Incompatibility with various substances: Not available.
Corrosivity: Non-corrosive in presence of glass.
Special Remarks on Reactivity: Not available.
Special Remarks on Corrosivity: Not available.
Polymerization: No.
Section 11: Toxicological Information
Routes of Entry: Eye contact. Ingestion.
Toxicity to Animals:
LD50: Not available.
LC50: Not available.
Chronic Effects on Humans: The substance is toxic to lungs, mucous membranes.
Other Toxic Effects on Humans:
Very hazardous in case of ingestion.
Hazardous in case of skin contact (irritant).
Special Remarks on Toxicity to Animals: Not available.
Special Remarks on Chronic Effects on Humans: Not available.
Special Remarks on other Toxic Effects on Humans: Not available.
Section 12: Ecological Information
Ecotoxicity: Not available.
BOD5 and COD: Not available.
Products of Biodegradation:
Possibly hazardous short term degradation products are not likely. However, long term degradation products may
arise.
Toxicity of the Products of Biodegradation: The products of degradation are more toxic.
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Special Remarks on the Products of Biodegradation: Not available.
Section 13: Disposal Considerations
Waste Disposal:
Section 14: Transport Information
DOT Classification: Not a DOT controlled material (United States).
Identification: Not applicable.
Special Provisions for Transport: Not applicable.
Section 15: Other Regulatory Information
Federal and State Regulations: TSCA 8(b) inventory: MES
Other Regulations: OSHA: Hazardous by definition of Hazard Communication Standard (29 CFR 1910.1200).
Other Classifications:
WHMIS (Canada): CLASS D-2A: Material causing other toxic effects (VERY TOXIC).
DSCL (EEC): R36/38- Irritating to eyes and skin.
HMIS (U.S.A.):
Health Hazard: 2
Fire Hazard: 1
Reactivity: 0
Personal Protection: E
National Fire Protection Association (U.S.A.):
Health: 2
Flammability: 1
Reactivity: 0
Specific hazard:
Protective Equipment:
Gloves.
Lab coat.
Dust respirator. Be sure to use an
approved/certified respirator or
equivalent. Wear appropriate respirator
when ventilation is inadequate.
Splash goggles.
Section 16: Other Information
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References: Not available.
Other Special Considerations: Not available.
Created: 10/09/2005 06:06 PM
Last Updated: 11/06/2008 12:00 PM
The information above is believed to be accurate and represents the best information currently available to us. However, we
make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we
assume no liability resulting from its use. Users should make their own investigations to determine the suitability of the
information for their particular purposes. In no event shall ScienceLab.com be liable for any claims, losses, or damages of any
third party or for lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even
if ScienceLab.com has been advised of the possibility of such damages.
p. 6-395-
Material Safety Data Sheet
Sodium chloride MSDS
Section 1: Chemical Product and Company Identification
Product Name: Sodium chloride
Catalog Codes: SLS3262, SLS1045, SLS3889, SLS1669,
SLS3091
CAS#: 7647-14-5
RTECS: VZ4725000
TSCA: TSCA 8(b) inventory: Sodium chloride
CI#: Not applicable.
Synonym: Salt; Sea Salt
Chemical Name: Sodium chloride
Chemical Formula: NaCl
Contact Information:
Sciencelab.com, Inc.
14025 Smith Rd.
Houston, Texas 77396
US Sales: 1-800-901-7247
International Sales: 1-281-441-4400
Order Online: ScienceLab.com
CHEMTREC (24HR Emergency Telephone), call:
1-800-424-9300
International CHEMTREC, call: 1-703-527-3887
For non-emergency assistance, call: 1-281-441-4400
Section 2: Composition and Information on Ingredients
Composition:
Name CAS # % by Weight
Sodium chloride 7647-14-5 100
Toxicological Data on Ingredients: Sodium chloride: ORAL (LD50): Acute: 3000 mg/kg [Rat.]. 4000 mg/kg [Mouse].
DERMAL (LD50): Acute: &gt;10000 mg/kg [Rabbit]. DUST (LC50): Acute: &gt;42000 mg/m 1 hours [Rat].
Section 3: Hazards Identification
Potential Acute Health Effects: Slightly hazardous in case of skin contact (irritant), of eye contact (irritant), of ingestion, of
inhalation.
Potential Chronic Health Effects:
CARCINOGENIC EFFECTS: Not available.
MUTAGENIC EFFECTS: Mutagenic for mammalian somatic cells. Mutagenic for bacteria and/or yeast.
TERATOGENIC EFFECTS: Not available.
DEVELOPMENTAL TOXICITY: Not available.
Repeated or prolonged exposure is not known to aggravate medical condition.
Section 4: First Aid Measures
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Eye Contact:
Check for and remove any contact lenses. In case of contact, immediately flush eyes with plenty of water for at
least 15 minutes. Cold water may be used. Get medical attention.
Skin Contact:
Wash with soap and water. Cover the irritated skin with an emollient. Get medical attention if irritation develops.
Cold water may be used.
Serious Skin Contact: Not available.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get
medical attention if symptoms appear.
Serious Inhalation: Not available.
Ingestion:
Do NOT induce vomiting unless directed to do so by medical personnel. Never give anything by mouth to an
unconscious person. Loosen tight clothing such as a collar, tie, belt or waistband. Get medical attention if
symptoms appear.
Serious Ingestion: Not available.
Section 5: Fire and Explosion Data
Flammability of the Product: Non-flammable.
Auto-Ignition Temperature: Not applicable.
Flash Points: Not applicable.
Flammable Limits: Not applicable.
Products of Combustion: Not available.
Fire Hazards in Presence of Various Substances: Not applicable.
Explosion Hazards in Presence of Various Substances:
Risks of explosion of the product in presence of mechanical impact: Not available.
Risks of explosion of the product in presence of static discharge: Not available.
Fire Fighting Media and Instructions: Not applicable.
Special Remarks on Fire Hazards: When heated to decomposition it emits toxic fumes.
Special Remarks on Explosion Hazards:
Electrolysis of sodium chloride in presence of nitrogenous compounds to produce chlorine may lead to formation
of explosive nitrogen trichloride.
Potentially explosive reaction with dichloromaleic anhydride + urea.
Section 6: Accidental Release Measures
Small Spill:
Use appropriate tools to put the spilled solid in a convenient waste disposal container. Finish cleaning by
spreading water on the contaminated surface and dispose of according to local and regional authority
requirements.
Large Spill:
Use a shovel to put the material into a convenient waste disposal container. Finish cleaning by spreading water
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on the contaminated surface and allow to evacuate through the sanitary system.
Section 7: Handling and Storage
Precautions:
Keep locked up.. Do not ingest. Do not breathe dust. Avoid contact with eyes. Wear suitable protective
clothing. If ingested, seek medical advice immediately and show the container or the label. Keep away from
incompatibles such as oxidizing agents, acids.
Storage: Keep container tightly closed. Keep container in a cool, well-ventilated area. Hygroscopic
Section 8: Exposure Controls/Personal Protection
Engineering Controls:
Use process enclosures, local exhaust ventilation, or other engineering controls to keep airborne levels below
recommended exposure limits. If user operations generate dust, fume or mist, use ventilation to keep exposure to
airborne contaminants below the exposure limit.
Personal Protection:
Splash goggles. Lab coat. Dust respirator. Be sure to use an approved/certified respirator or equivalent.
Gloves.
Personal Protection in Case of a Large Spill:
Splash goggles. Full suit. Dust respirator. Boots. Gloves. A self contained breathing apparatus should be used
to avoid inhalation of the product. Suggested protective clothing might not be sufficient; consult a specialist
BEFORE handling this product.
Exposure Limits: Not available.
Section 9: Physical and Chemical Properties
Physical state and appearance: Solid. (Solid crystalline powder.)
Odor: Slight.
Taste: Saline.
Molecular Weight: 58.44 g/mole
Color: White.
pH (1% soln/water): 7 [Neutral.]
Boiling Point: 1413°C (2575.4°F)
Melting Point: 801°C (1473.8°F)
Critical Temperature: Not available.
Specific Gravity: 2.165 (Water = 1)
Vapor Pressure: Not applicable.
Vapor Density: Not available.
Volatility: Not available.
Odor Threshold: Not available.
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Water/Oil Dist. Coeff.: Not available.
Ionicity (in Water): Not available.
Dispersion Properties: See solubility in water.
Solubility:
Easily soluble in cold water, hot water.
Soluble in glycerol, and ammonia.
Very slightly soluble in alcohol.
Insoluble in Hydrochloric Acid.
Section 10: Stability and Reactivity Data
Stability: The product is stable.
Instability Temperature: Not available.
Conditions of Instability: Incompatible materials, high temperatures.
Incompatibility with various substances: Reactive with oxidizing agents, metals, acids.
Corrosivity: Not considered to be corrosive for metals and glass.
Special Remarks on Reactivity:
Hygroscopic.
Reacts with most nonnoble metals such as iron or steel, building materials (such as cement)
Sodium chloride is rapidly attacked by bromine trifluoride.
Violent reaction with lithium.
Special Remarks on Corrosivity: Not available.
Polymerization: Will not occur.
Section 11: Toxicological Information
Routes of Entry: Inhalation. Ingestion.
Toxicity to Animals:
WARNING: THE LC50 VALUES HEREUNDER ARE ESTIMATED ON THE BASIS OF A 4-HOUR EXPOSURE.
Acute oral toxicity (LD50): 3000 mg/kg [Rat.].
Acute dermal toxicity (LD50): >10000 mg/kg [Rabbit].
Acute toxicity of the dust (LC50): >42000 mg/m3 1 hours [Rat].
Chronic Effects on Humans: MUTAGENIC EFFECTS: Mutagenic for mammalian somatic cells. Mutagenic for bacteria
and/or yeast.
Other Toxic Effects on Humans: Slightly hazardous in case of skin contact (irritant), of ingestion, of inhalation.
Special Remarks on Toxicity to Animals: Lowest Published Lethal Dose (LDL) [Man] - Route: Oral; Dose: 1000 mg/kg
Special Remarks on Chronic Effects on Humans:
Causes adverse reproductive effects in humans (fetotoxicity, abortion, ) by intraplacental route.
High intake of sodium chloride, whether from occupational exposure or in the diet, may increase risk of TOXEMIA
OF PREGNANCY in susceptible women (Bishop, 1978). Hypertonic sodium chloride solutions have been
used to induce abortion in late pregnancy by direct infusion into the uterus (Brown et al, 1972), but this route of
administration is not relevant to occupational exposures.
May cause adverse reproductive effects and birth defects in animals, particularly rats and mice (fetotoxicity,
abortion, musculoskeletal abnormalities, and maternal effects (effects on ovaries, fallopian tubes) by oral,
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intraperitoneal, intraplacental, intrauterine, parenteral, and subcutaneous routes. While sodium chloride has been
used as a negative control n some reproductive studies, it has also been used as an example that almost any
chemical can cause birth defects in experimental animals if studied under the right conditions (Nishimura &
Miyamoto, 1969). In experimental animals, sodium chloride has caused delayed effects on newborns, has been
fetotoxic, and has caused birth defects and abortions in rats and mice (RTECS, 1997).
May affect genetic material (mutagenic)
Special Remarks on other Toxic Effects on Humans:
Acute Potential Health Effects:
Skin: May cause skin irritation.
Eyes: Causes eye irritation.
Ingestion: Ingestion of large quantities can irritate the stomach (as in overuse of salt tablets) with nausea and
vomiting. May affect behavior (muscle spasicity/contraction, somnolence), sense organs, metabolism, and
cardiovascular system. Continued exposure may produce dehydration, internal organ congestion, and coma.
Inhalation: Material is irritating to mucous membranes and upper respiratory tract.
Section 12: Ecological Information
Ecotoxicity: Not available.
BOD5 and COD: Not available.
Products of Biodegradation:
Possibly hazardous short term degradation products are not likely. However, long term degradation products may
arise.
Toxicity of the Products of Biodegradation: The product itself and its products of degradation are not toxic.
Special Remarks on the Products of Biodegradation: Not available.
Section 13: Disposal Considerations
Waste Disposal:
Waste must be disposed of in accordance with federal, state and local environmental
control regulations.
Section 14: Transport Information
DOT Classification: Not a DOT controlled material (United States).
Identification: Not applicable.
Special Provisions for Transport: Not applicable.
Section 15: Other Regulatory Information
Federal and State Regulations: TSCA 8(b) inventory: Sodium chloride
Other Regulations: EINECS: This product is on the European Inventory of Existing Commercial Chemical Substances.
Other Classifications:
WHMIS (Canada): Not controlled under WHMIS (Canada).
DSCL (EEC):
R40- Possible risks of irreversible
effects.
p. 5-400-
S24/25- Avoid contact with skin and eyes.
HMIS (U.S.A.):
Health Hazard: 1
Fire Hazard: 0
Reactivity: 0
Personal Protection: E
National Fire Protection Association (U.S.A.):
Health: 1
Flammability: 0
Reactivity: 0
Specific hazard:
Protective Equipment:
Gloves.
Lab coat.
Dust respirator. Be sure to use an
approved/certified respirator or
equivalent.
Splash goggles.
Section 16: Other Information
References:
-Hawley, G.G.. The Condensed Chemical Dictionary, 11e ed., New York N.Y., Van Nostrand Reinold, 1987.
-SAX, N.I. Dangerous Properties of Indutrial Materials. Toronto, Van Nostrand Reinold, 6e ed. 1984.
-The Sigma-Aldrich Library of Chemical Safety Data, Edition II.
Other Special Considerations: Not available.
Created: 10/11/2005 12:33 PM
Last Updated: 11/06/2008 12:00 PM
The information above is believed to be accurate and represents the best information currently available to us. However, we
make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we
assume no liability resulting from its use. Users should make their own investigations to determine the suitability of the
information for their particular purposes. In no event shall ScienceLab.com be liable for any claims, losses, or damages of any
third party or for lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even
if ScienceLab.com has been advised of the possibility of such damages.
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Material Safety Data Sheet
PBS Phosphate Buffered Saline
ACC# 89342
Section 1 - Chemical Product and Company Identification
MSDS Name: PBS Phosphate Buffered Saline 
Catalog Numbers: BP661-10, BP661-50, BP665-1 
Synonyms: None. 
Company Identification:
              Fisher Scientific
              1 Reagent Lane
              Fair Lawn, NJ 07410 
For information, call: 201-796-7100 
Emergency Number: 201-796-7100 
For CHEMTREC assistance, call: 800-424-9300 
For International CHEMTREC assistance, call: 703-527-3887
Section 2 - Composition, Information on Ingredients
CAS# Chemical Name Percent EINECS/ELINCS
7647-14-5 Sodium Chloride 81.0 231-598-3
7558-79-4 Sodium phosphate, dibasic ~14 231-448-7
7778-77-0 Potassium phosphate, Monobasic ~3.0 231-913-4
7447-40-7 Potassium chloride ~2.0 231-211-8
Section 3 - Hazards Identification
EMERGENCY OVERVIEW
Appearance: white solid.
Warning! Causes eye irritation. May cause skin and respiratory tract irritation. 
Target Organs: Eyes. 
Potential Health Effects 
Eye: Causes eye irritation. 
Skin: May cause skin irritation. 
Ingestion: Ingestion of large amounts may cause gastrointestinal irritation. May cause gastric
disturbances and electrolytic imbalance. Ingestion of large amounts of sodium chloride may cause
nausea, and vomiting, rigidity or convulsions. Continued exposure can produce coma, dehydration and
internal organ congestion. 
Inhalation: Inhalation of dust may cause respiratory tract irritation. 
Chronic: No information found.
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Section 4 - First Aid Measures
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower
eyelids. Get medical aid. 
Skin: Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and
shoes. Get medical aid if irritation develops or persists. Wash clothing before reuse. 
Ingestion: Do not induce vomiting. If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Never give anything by mouth to an unconscious person. Get medical aid. 
Inhalation: Remove from exposure and move to fresh air immediately. If not breathing, give artificial
respiration. If breathing is difficult, give oxygen. Get medical aid. 
Notes to Physician: Treat symptomatically and supportively.
Section 5 - Fire Fighting Measures
General Information: As in any fire, wear a self-contained breathing apparatus in pressure-demand,
MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic
gases may be generated by thermal decomposition or combustion. Substance is noncombustible. 
Extinguishing Media: Use water spray, dry chemical, carbon dioxide, or chemical foam. 
Flash Point: Not applicable. 
Autoignition Temperature: Not applicable. 
Explosion Limits, Lower:Not available. 
Upper: Not available. 
NFPA Rating: (estimated) Health: 2; Flammability: 0; Instability: 0
Section 6 - Accidental Release Measures
General Information: Use proper personal protective equipment as indicated in Section 8. 
Spills/Leaks: Vacuum or sweep up material and place into a suitable disposal container. Clean up spills
immediately, observing precautions in the Protective Equipment section. Avoid generating dusty
conditions. Provide ventilation.
Section 7 - Handling and Storage
Handling: Wash thoroughly after handling. Use with adequate ventilation. Avoid contact with eyes, skin,
and clothing. Avoid ingestion and inhalation. 
Storage: Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from
incompatible substances.
Section 8 - Exposure Controls, Personal Protection
Engineering Controls: Facilities storing or utilizing this material should be equipped with an eyewash
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facility and a safety shower. Use adequate ventilation to keep airborne concentrations low. 
Exposure Limits
Chemical Name ACGIH NIOSH OSHA - Final PELs
Sodium Chloride none listed none listed none listed
Sodium phosphate, dibasic none listed none listed none listed
Potassium phosphate,
Monobasic
none listed none listed none listed
Potassium chloride none listed none listed none listed
OSHA Vacated PELs: Sodium Chloride: No OSHA Vacated PELs are listed for this chemical. Sodium
phosphate, dibasic: No OSHA Vacated PELs are listed for this chemical. Potassium phosphate,
Monobasic: No OSHA Vacated PELs are listed for this chemical. Potassium chloride: No OSHA Vacated
PELs are listed for this chemical. 
Personal Protective Equipment 
Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye
and face protection regulations in 29 CFR 1910.133 or European Standard EN166. 
Skin: Wear appropriate protective gloves to prevent skin exposure. 
Clothing: Wear appropriate protective clothing to prevent skin exposure. 
Respirators: Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard
EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are
exceeded or if irritation or other symptoms are experienced.
Section 9 - Physical and Chemical Properties
Physical State: Solid 
Appearance: white 
Odor: none reported 
pH: Not available. 
Vapor Pressure: Not available. 
Vapor Density: Not available. 
Evaporation Rate:Not available. 
Viscosity: Not available. 
Boiling Point: Not available. 
Freezing/Melting Point:Not available. 
Decomposition Temperature:Not available. 
Solubility: Soluble. 
Specific Gravity/Density:Not available. 
Molecular Formula:Mixture 
Molecular Weight:Not available.
Section 10 - Stability and Reactivity
Chemical Stability: Stable. 
Conditions to Avoid: Dust generation, excess heat. 
Incompatibilities with Other Materials: Potassium chloride is incompatible with potassium
permanganate. Sodium chloride is incompatible with dichloromaleic anhydride + urea, lithium, and
nitrogen compounds. Potassium phosphate dibasic and monobasic may react violently with strong acids. 
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Hazardous Decomposition Products: Oxides of phosphorus, sodium oxide, oxides of potassium. 
Hazardous Polymerization: Will not occur.
Section 11 - Toxicological Information
RTECS#:      
CAS# 7647-14-5: VZ4725000      
CAS# 7558-79-4: WC4500000      
CAS# 7778-77-0: TC6615500      
CAS# 7447-40-7: TS8050000 
LD50/LC50:
CAS# 7647-14-5:
     Draize test, rabbit, eye: 100 mg Mild;
     Draize test, rabbit, eye: 100 mg/24H Moderate;
     Draize test, rabbit, eye: 10 mg Moderate;
     Draize test, rabbit, skin: 50 mg/24H Mild;
     Draize test, rabbit, skin: 500 mg/24H Mild;
     Inhalation, rat: LC50 = >42 gm/m3/1H;
     Oral, mouse: LD50 = 4 gm/kg;
     Oral, rat: LD50 = 3000 mg/kg;
     Skin, rabbit: LD50 = >10 gm/kg; 
CAS# 7558-79-4:
     Draize test, rabbit, eye: 500 mg/24H Mild;
     Draize test, rabbit, skin: 500 mg/24H Mild;
     Oral, rat: LD50 = 17 gm/kg; 
CAS# 7778-77-0:
     Skin, rabbit: LD50 = >4640 mg/kg; 
CAS# 7447-40-7:
     Draize test, rabbit, eye: 500 mg/24H Mild;
     Oral, mouse: LD50 = 1500 mg/kg;
     Oral, rat: LD50 = 2600 mg/kg; 
Carcinogenicity:
CAS# 7647-14-5: Not listed by ACGIH, IARC, NTP, or CA Prop 65.
CAS# 7558-79-4: Not listed by ACGIH, IARC, NTP, or CA Prop 65.
CAS# 7778-77-0: Not listed by ACGIH, IARC, NTP, or CA Prop 65.
CAS# 7447-40-7: Not listed by ACGIH, IARC, NTP, or CA Prop 65.
Epidemiology: No information found. 
Teratogenicity: No information found. 
Reproductive Effects: No information found. 
Mutagenicity: No information found. 
Neurotoxicity: No information found. 
Other Studies:
Section 12 - Ecological Information
No information available.
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Section 13 - Disposal Considerations
Chemical waste generators must determine whether a discarded chemical is classified as a hazardous
waste. US EPA guidelines for the classification determination are listed in 40 CFR Parts 261.3.
Additionally, waste generators must consult state and local hazardous waste regulations to ensure
complete and accurate classification. 
RCRA P-Series: None listed. 
RCRA U-Series: None listed.
Section 14 - Transport Information
US DOT Canada TDG
Shipping Name: Not regulated as a hazardous material No information available.
Hazard Class:
UN Number:
Packing Group:
Section 15 - Regulatory Information
US FEDERAL
TSCA 
     CAS# 7647-14-5 is listed on the TSCA inventory. 
     CAS# 7558-79-4 is listed on the TSCA inventory. 
     CAS# 7778-77-0 is listed on the TSCA inventory. 
     CAS# 7447-40-7 is listed on the TSCA inventory. 
Health & Safety Reporting List
     None of the chemicals are on the Health & Safety Reporting List. 
Chemical Test Rules
     None of the chemicals in this product are under a Chemical Test Rule. 
Section 12b
     None of the chemicals are listed under TSCA Section 12b. 
TSCA Significant New Use Rule
     None of the chemicals in this material have a SNUR under TSCA. 
CERCLA Hazardous Substances and corresponding RQs
     CAS# 7558-79-4: 5000 lb final RQ; 2270 kg final RQ 
SARA Section 302 Extremely Hazardous Substances
     None of the chemicals in this product have a TPQ. 
SARA Codes
     CAS # 7647-14-5: acute. 
     CAS # 7778-77-0: acute. 
     CAS # 7447-40-7: acute. 
Section 313 
     This material contains Potassium phosphate, Monobasic (listed as Water Dissociable Nitrate
Compounds), ~3.0%, (CAS# 7778-77-0) which is subject to the reporting requirements of Section 313
of SARA Title III and 40 CFR 
     This material contains Potassium chloride (listed as Water Dissociable Nitrate Compounds), ~2.0%,
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(CAS# 7447-40-7) which is subject to the reporting requirements of Section 313 of SARA Title III and
40 CFR Part 373. 
Clean Air Act:
     This material does not contain any hazardous air pollutants. 
     This material does not contain any Class 1 Ozone depletors. 
     This material does not contain any Class 2 Ozone depletors. 
Clean Water Act:
CAS# 7558-79-4 is listed as a Hazardous Substance under the CWA. 
     None of the chemicals in this product are listed as Priority Pollutants under the CWA. 
     None of the chemicals in this product are listed as Toxic Pollutants under the CWA. 
OSHA:
     None of the chemicals in this product are considered highly hazardous by OSHA. 
STATE
     CAS# 7647-14-5 is not present on state lists from CA, PA, MN, MA, FL, or NJ. 
     CAS# 7558-79-4 can be found on the following state right to know lists: California, New Jersey,
Pennsylvania, Massachusetts. 
     CAS# 7778-77-0 is not present on state lists from CA, PA, MN, MA, FL, or NJ. 
     CAS# 7447-40-7 is not present on state lists from CA, PA, MN, MA, FL, or NJ. 
California Prop 65
California No Significant Risk Level: None of the chemicals in this product are listed. 
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols:
      Not available. 
Risk Phrases:
Safety Phrases:
WGK (Water Danger/Protection)
     CAS# 7647-14-5: 0 
     CAS# 7558-79-4: 1 
     CAS# 7778-77-0: 1 
     CAS# 7447-40-7: 1 
Canada - DSL/NDSL
     CAS# 7647-14-5 is listed on Canada's DSL List. 
     CAS# 7558-79-4 is listed on Canada's DSL List. 
     CAS# 7778-77-0 is listed on Canada's DSL List. 
     CAS# 7447-40-7 is listed on Canada's DSL List. 
Canada - WHMIS
     This product has a WHMIS classification of D2B. 
Canadian Ingredient Disclosure List
     CAS# 7778-77-0 is not listed on the Canadian Ingredient Disclosure List.
     CAS# 7447-40-7 is not listed on the Canadian Ingredient Disclosure List.
Section 16 - Additional Information
MSDS Creation Date: 7/16/1999 
Revision #3 Date: 3/05/2003 
-407-
09/06/2005 05:20 PMhttps://fscimage.fishersci.com/msds/89342.htm
Page 7 of 7https://fscimage.fishersci.com/msds/89342.htm
The information above is believed to be accurate and represents the best information currently available to us. However, we make no
warranty of merchantability or any other warranty, express or implied, with respect to such information, and we assume no liability
resulting from its use. Users should make their own investigations to determine the suitability of the information for their particular
purposes. In no event shall Fisher be liable for any claims, losses, or damages of any third party or for lost profits or any special,
indirect, incidental, consequential or exemplary damages, howsoever arising, even if Fisher has been advised of the possibility of such
damages.
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Material Safety Data Sheet
Phosphoric acid, 85% MSDS
Section 1: Chemical Product and Company Identification
Product Name: Phosphoric acid, 85%
Catalog Codes: SLP5569, SLP4555, SLP1732
CAS#: Mixture.
RTECS: Not applicable.
TSCA: TSCA 8(b) inventory: Phosphoric Acid; Water
CI#: Not available.
Synonym: Phosphoric Acid 85%; Phosphoric Acid;
Orthophosphoric acid
Chemical Name: Not applicable.
Chemical Formula: Not applicable.
Contact Information:
Sciencelab.com, Inc.
14025 Smith Rd.
Houston, Texas 77396
US Sales: 1-800-901-7247
International Sales: 1-281-441-4400
Order Online: ScienceLab.com
CHEMTREC (24HR Emergency Telephone), call:
1-800-424-9300
International CHEMTREC, call: 1-703-527-3887
For non-emergency assistance, call: 1-281-441-4400
Section 2: Composition and Information on Ingredients
Composition:
Name CAS # % by Weight
Phosphoric Acid 7664-38-2 85-88
Water 7732-18-5 12-15
Toxicological Data on Ingredients: Phosphoric Acid: ORAL (LD50): Acute: 1530 mg/kg [Rat]. DERMAL (LD50): Acute: 2740
mg/kg [Rabbit]. DUST (LC50): Acute: &gt;850 mg/m 1 hours [Rat].
Section 3: Hazards Identification
Potential Acute Health Effects:
Very hazardous in case of skin contact (irritant), of eye contact (irritant), of ingestion, . Hazardous in case of skin
contact (corrosive, permeator), of eye contact (corrosive). Slightly hazardous in case of inhalation (lung
sensitizer). Liquid or spray mist may produce tissue damage particularly on mucous membranes of eyes, mouth
and respiratory tract. Skin contact may produce burns. Inhalation of the spray mist may produce severe irritation
of respiratory tract, characterized by coughing, choking, or shortness of breath. Severe over-exposure can result
in death. Inflammation of the eye is characterized by redness, watering, and itching. Skin inflammation is
characterized by itching, scaling, reddening, or, occasionally, blistering.
Potential Chronic Health Effects:
CARCINOGENIC EFFECTS: Not available.
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MUTAGENIC EFFECTS: Not available.
TERATOGENIC EFFECTS: Not available.
DEVELOPMENTAL TOXICITY: Not available.
The substance may be toxic to blood, liver, skin, eyes, bone marrow.
Repeated or prolonged exposure to the substance can produce target organs damage. Repeated or prolonged
contact with spray mist may produce chronic eye irritation and severe skin irritation. Repeated or prolonged
exposure to spray mist may produce respiratory tract irritation leading to frequent attacks of bronchial infection.
Repeated exposure to a highly toxic material may produce general deterioration of health by an accumulation in
one or many human organs.
Section 4: First Aid Measures
Eye Contact:
Check for and remove any contact lenses. In case of contact, immediately flush eyes with plenty of water for at
least 15 minutes. Cold water may be used. Get medical attention immediately.
Skin Contact:
In case of contact, immediately flush skin with plenty of water for at least 15 minutes while removing contaminated
clothing and shoes. Cover the irritated skin with an emollient. Cold water may be used.Wash clothing before
reuse. Thoroughly clean shoes before reuse. Get medical attention immediately.
Serious Skin Contact:
Wash with a disinfectant soap and cover the contaminated skin with an anti-bacterial cream. Seek immediate
medical attention.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get
medical attention immediately.
Serious Inhalation:
Evacuate the victim to a safe area as soon as possible. Loosen tight clothing such as a collar, tie, belt or
waistband. If breathing is difficult, administer oxygen. If the victim is not breathing, perform mouth-to-mouth
resuscitation. WARNING: It may be hazardous to the person providing aid to give mouth-to-mouth resuscitation
when the inhaled material is toxic, infectious or corrosive. Seek immediate medical attention.
Ingestion:
Do NOT induce vomiting unless directed to do so by medical personnel. Never give anything by mouth to an
unconscious person. If large quantities of this material are swallowed, call a physician immediately. Loosen tight
clothing such as a collar, tie, belt or waistband.
Serious Ingestion: Not available.
Section 5: Fire and Explosion Data
Flammability of the Product: Non-flammable.
Auto-Ignition Temperature: Not applicable.
Flash Points: Not applicable.
Flammable Limits: Not applicable.
Products of Combustion: Not available.
Fire Hazards in Presence of Various Substances: of metals
Explosion Hazards in Presence of Various Substances: Non-explosive in presence of open flames and sparks, of shocks.
Fire Fighting Media and Instructions: Not applicable.
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Special Remarks on Fire Hazards:
Reacts with metals to liberate flammable hydrogen gas.
Formation of flammable gases with aldehydes, cyanides, mercaptins, and sulfides.
Special Remarks on Explosion Hazards: Mixtures with nitromethane are explosive. (Phosphoric Acid)
Section 6: Accidental Release Measures
Small Spill:
Dilute with water and mop up, or absorb with an inert dry material and place in an appropriate waste disposal
container. If necessary: Neutralize the residue with a dilute solution of sodium carbonate.
Large Spill:
Corrosive liquid. Poisonous liquid.
Stop leak if without risk. Absorb with DRY earth, sand or other non-combustible material. Do not get water inside
container. Do not touch spilled material. Use water spray curtain to divert vapor drift. Use water spray to reduce
vapors. Prevent entry into sewers, basements or confined areas; dike if needed. Call for assistance on disposal.
Neutralize the residue with a dilute solution of sodium carbonate. Be careful that the product is not present at
a concentration level above TLV. Check TLV on the MSDS and with local authorities.
Section 7: Handling and Storage
Precautions:
Do not ingest. Do not breathe gas/fumes/ vapor/spray. Never add water to this product. In case of insufficient
ventilation, wear suitable respiratory equipment. If ingested, seek medical advice immediately and show the
container or the label. Avoid contact with skin and eyes. Keep away from incompatibles such as oxidizing agents,
combustible materials, metals, alkalis.
May corrode metallic surfaces. Store in a metallic or coated fiberboard drum using a strong polyethylene inner
package.
Storage: Keep container tightly closed. Keep container in a cool, well-ventilated area.
Section 8: Exposure Controls/Personal Protection
Engineering Controls:
Provide exhaust ventilation or other engineering controls to keep the airborne concentrations of vapors below their
respective threshold limit value. Ensure that eyewash stations and safety showers are proximal to the
work-station location.
Personal Protection:
Face shield. Full suit. Vapor respirator. Be sure to use an approved/certified respirator or equivalent. Gloves.
Boots.
Personal Protection in Case of a Large Spill:
Splash goggles. Full suit. Vapor respirator. Boots. Gloves. A self contained breathing apparatus should be
used to avoid inhalation of the product. Suggested protective clothing might not be sufficient; consult a specialist
BEFORE handling this product.
Exposure Limits:
Phosphoric Acid
TWA: 1 STEL: 3 (mg/m3) from ACGIH (TLV) [United States]
TWA: 1 STEL: 3 (mg/m3) from OSHA (PEL) [United States]
TWA: 1 STEL: 3 (mg/m3) from NIOSH
TWA: 1 STEL: 3 (mg/m3) [Mexico]Consult local authorities for acceptable exposure limits.
Section 9: Physical and Chemical Properties
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Physical state and appearance: Liquid. (Syrupy liquid Viscous liquid.)
Odor: Odorless.
Taste: Acid.
Molecular Weight: Not applicable.
Color: Clear Colorless.
pH (1% soln/water): Acidic.
Boiling Point: 158°C (316.4°F)
Melting Point: 21°C (69.8°F)
Critical Temperature: Not available.
Specific Gravity: 1.685 @ 25 C (Water = 1)
Vapor Pressure: 0.3 kPa (@ 20°C)
Vapor Density: 3.4 (Air = 1)
Volatility: Not available.
Odor Threshold: Not available.
Water/Oil Dist. Coeff.: Not available.
Ionicity (in Water): Not available.
Dispersion Properties: See solubility in water.
Solubility:
Easily soluble in hot water.
Soluble in cold water.
Section 10: Stability and Reactivity Data
Stability: The product is stable.
Instability Temperature: Not available.
Conditions of Instability: Incompatible materials
Incompatibility with various substances: Reactive with oxidizing agents, combustible materials, metals, alkalis.
Corrosivity:
Extremely corrosive in presence of copper, of stainless steel(304), of stainless steel(316).
Highly corrosive in presence of aluminum.
Non-corrosive in presence of glass.
Special Remarks on Reactivity:
Reacts with metals to liberate flammable hydrogen gas.
Incompatible with sodium tetrahydroborate producing a violent exothermic reaction.
Heat generated with: alcohols, glycols, aldehydes, amides, amines, azo-compounds, carbamates, caustics,
esters, ketones, phenols and cresols, organophosphates, epoxides, combustible materials, unsaturated halides,
organic peroxides.
Formation of flammable gases, with aldehydes, cyanides, mercaptins, and sulfides.
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Formation of toxic fumes with cyanides, fluorides, halogenated organics, sulfides, and organic peroxides.
Do not mix with solutions containing bleach or ammonia.
Incompatible with nitromethane, chlorides + staiinless steel.
(Phosphoric Acid)
Special Remarks on Corrosivity:
Minor corrosive effect on bronze.
Severe corrosive effect on brass.
Corrosive to ferrous metals and alloys.
Polymerization: Will not occur.
Section 11: Toxicological Information
Routes of Entry: Absorbed through skin. Dermal contact. Eye contact. Inhalation. Ingestion.
Toxicity to Animals:
Acute oral toxicity (LD50): 1530 mg/kg [Rat].
Acute dermal toxicity (LD50): 2740 mg/kg [Rabbit].
Chronic Effects on Humans: May cause damage to the following organs: blood, liver, skin, eyes, bone marrow.
Other Toxic Effects on Humans:
Extremely hazardous in case of inhalation (lung corrosive).
Very hazardous in case of skin contact (irritant), of ingestion, .
Hazardous in case of skin contact (corrosive, permeator), of eye contact (corrosive).
Special Remarks on Toxicity to Animals: Not available.
Special Remarks on Chronic Effects on Humans: Not available.
Special Remarks on other Toxic Effects on Humans:
Acute Potential Health Effects:
Skin: Corrosive and causes severe skin irritation and can cause severe skin burns. May affect behavior
(somnolence or excitement) if absorbed through skin.
Eyes: Corrosive. Liquid or vapor causes severe eye irritation and can cause severe eye burns leading to
permanent corneal damage or chemical conjunctivitis.
Ingestion: May be harmful if swallowed. Causes irritation and burns of the gastrointestinal (digestive) tract.
Causes severe pain, nausea, vomiting, diarrhea hematemesis, gastrointestinal hemmorrhaging, and shock. May
cause corrosion and permanent tissue destruction of the esophagus and digestive tract. May affect behavior and
urinary system, liver (hepatocellular damage, hepatic enzymes increased), blood (blood dyscrasia). May also
Section 12: Ecological Information
Ecotoxicity: Not available.
BOD5 and COD: Not available.
Products of Biodegradation:
Possibly hazardous short term degradation products are not likely. However, long term degradation products may
arise.
Toxicity of the Products of Biodegradation: The products of degradation are less toxic than the product itself.
Special Remarks on the Products of Biodegradation: Not available.
Section 13: Disposal Considerations
Waste Disposal:
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Waste must be disposed of in accordance with federal, state and local environmental
control regulations.
Section 14: Transport Information
DOT Classification: Class 8: Corrosive material
Identification: : Phosphoric acid (Phosphoric Acid) UNNA: 1805 PG: III
Special Provisions for Transport: Not available.
Section 15: Other Regulatory Information
Federal and State Regulations:
Connecticut hazardous material survey.: Phosphoric Acid
Illinois toxic substances disclosure to employee act: Phosphoric acid
Illinois chemical safety act: Phosphoric acid
New York release reporting list: Phosphoric acid
Rhode Island RTK hazardous substances: Phosphoric acid
Pennsylvania RTK: Phosphoric acid
Minnesota: Phosphoric acid
Massachusetts RTK: Phosphoric acid
Massachusetts spill list: Phosphoric acid
New Jersey: Phosphoric acid
New Jersey spill list: Phosphoric acid
Louisiana spill reporting: Phosphoric acid
California Director's list of hazardous substances: Phosphoric acid
TSCA 8(b) inventory: Phosphoric Acid; Water
SARA 313 toxic chemical notification and release reporting: Phosphoric acid
CERCLA: Hazardous substances.: Phosphoric acid: 5000 lbs. (2268 kg)
Other Regulations: OSHA: Hazardous by definition of Hazard Communication Standard (29 CFR 1910.1200).
Other Classifications:
WHMIS (Canada): CLASS E: Corrosive liquid.
DSCL (EEC):
R34- Causes burns.
S26- In case of contact with eyes, rinse
immediately with plenty of water and seek
medical advice.
S45- In case of accident or if you feel unwell,
seek medical advice immediately (show the
label where possible).
HMIS (U.S.A.):
Health Hazard: 3
Fire Hazard: 0
Reactivity: 0
Personal Protection:
National Fire Protection Association (U.S.A.):
Health: 3
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Flammability: 0
Reactivity: 0
Specific hazard:
Protective Equipment:
Gloves.
Full suit.
Vapor respirator. Be sure to use an
approved/certified respirator or
equivalent. Wear appropriate respirator
when ventilation is inadequate.
Face shield.
Section 16: Other Information
References: Not available.
Other Special Considerations: Not available.
Created: 10/10/2005 08:47 PM
Last Updated: 11/06/2008 12:00 PM
The information above is believed to be accurate and represents the best information currently available to us. However, we
make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we
assume no liability resulting from its use. Users should make their own investigations to determine the suitability of the
information for their particular purposes. In no event shall ScienceLab.com be liable for any claims, losses, or damages of any
third party or for lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even
if ScienceLab.com has been advised of the possibility of such damages.
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MSDS Number: P5029 * * * * * Effective Date: 08/10/04 * * * * * Supercedes: 11/02/01
POLYETHYLENE GLYCOL
1. Product Identification
Synonyms: PEG; Carbowax®; Polyglycol; Polyethylene glycol 200, 300, 400, 600,1000,1450, 3350, 4000, 6000, 8000 and 20000. 
CAS No.: 25322-68-3 
Molecular Weight: Not applicable to mixtures. 
Chemical Formula: (C2H4O) n.H2O 
Product Codes: 
J.T. Baker: U204, U214, U215, U216, U218, U220, U221, U222 
Mallinckrodt: 7755, H273
2. Composition/Information on Ingredients
  Ingredient                                CAS No         Percent        Hazardous                                  
  ---------------------------------------   ------------   ------------   ---------   
 
  Polyethylene Glycol                       25322-68-3       90 - 100%       No                                                                     
 
3. Hazards Identification
Emergency Overview 
-------------------------- 
As part of good industrial and personal hygiene and safety procedure, avoid all unnecessary exposure to the chemical substance and ensure prompt
removal from skin, eyes and clothing. 
J.T. Baker SAF-T-DATA(tm) Ratings (Provided here for your convenience) 
----------------------------------------------------------------------------------------------------------- 
Health Rating: 0 - None 
Flammability Rating: 1 - Slight 
Reactivity Rating: 0 - None 
Contact Rating: 1 - Slight 
Lab Protective Equip: GOGGLES; LAB COAT 
Storage Color Code: Orange (General Storage) 
----------------------------------------------------------------------------------------------------------- 
Potential Health Effects 
---------------------------------- 
Inhalation: 
No adverse health effects expected from inhalation. (May be a mechanical irritant.) 
Ingestion: 
Large doses of the lower molecular weight products may cause gastro-intestinal upset. 
Skin Contact: 
No adverse effects expected. 
Eye Contact: 
No adverse effects expected. 
Chronic Exposure: 
No information found. 
Aggravation of Pre-existing Conditions: 
Damaged skin.
-416-
09/06/2005 05:21 PMPOLYETHYLENE GLYCOL
Page 2 of 4http://www.jtbaker.com/msds/englishhtml/p5029.htm
4. First Aid Measures
Inhalation: 
Not expected to require first aid measures. 
Ingestion: 
If large amounts were swallowed, give water to drink and get medical advice. 
Skin Contact: 
In case of contact, immediately flush skin with plenty of soap and water for at least 15 minutes. Remove contaminated clothing and shoes. Wash clothing before
reuse. Get medical attention if irritation develops or persists. 
Eye Contact: 
In case of contact, flush eyes with plenty of water for at least 15 minutes. Get medical advice if irritation develops. 
5. Fire Fighting Measures
Fire: 
As with most organic solids, fire is possible at elevated temperatures or by contact with an ignition source. (increases as molecular weight increases). Flash point:
182 - 287 C. 
Explosion: 
Fine dust dispersed in air in sufficient concentrations, and in the presence of an ignition source is a potential dust explosion hazard. 
Fire Extinguishing Media: 
Water spray, dry chemical, alcohol foam, or carbon dioxide. 
Special Information: 
In the event of a fire, wear full protective clothing and NIOSH-approved self-contained breathing apparatus with full facepiece operated in the pressure demand
or other positive pressure mode.
6. Accidental Release Measures
Remove all sources of ignition. Ventilate area of leak or spill. Wear appropriate personal protective equipment as specified in Section 8.
Solid Spills: Clean up spills in a manner that does not disperse dust into the air. Use non-sparking tools and equipment. Reduce airborne dust and prevent
scattering by moistening with water. Pick up spill for recovery or disposal and place in a closed container.
Liquid Spills: Absorb with vermiculite, dry sand, earth or similar material and place in a chemical waste container. Do not use combustible materials, such as saw
dust. Do not flush to sewer.
7. Handling and Storage
Keep in a tightly closed container, stored in a cool, dry, ventilated area. Protect against physical damage. Containers of this material may be hazardous when
empty since they retain product residues (dust, solids, vapors, liquid); observe all warnings and precautions listed for the product.
8. Exposure Controls/Personal Protection
Airborne Exposure Limits: 
AIHA Workplace Environmental Exposure Level (WEEL):
Polypropylene glycols: 8-hour TWA: 10 mg/m3, as an aerosol 
Ventilation System: 
A system of local and/or general exhaust is recommended to keep employee exposures below the Airborne Exposure Limits. Local exhaust ventilation is generally
preferred because it can control the emissions of the contaminant at its source, preventing dispersion of it into the general work area. Please refer to the ACGIH
document, Industrial Ventilation, A Manual of Recommended Practices, most recent edition, for details. 
Personal Respirators (NIOSH Approved): 
For use with solids (not required for liquids): If the exposure limit is exceeded and engineering controls are not feasible, a half facepiece particulate respirator
(NIOSH type N95 or better filters) may be worn for up to ten times the exposure limit or the maximum use concentration specified by the appropriate regulatory
agency or respirator supplier, whichever is lowest.. A full-face piece particulate respirator (NIOSH type N100 filters) may be worn up to 50 times the exposure
limit, or the maximum use concentration specified by the appropriate regulatory agency, or respirator supplier, whichever is lowest. If oil particles (e.g. lubricants,
cutting fluids, glycerine, etc.) are present, use a NIOSH type R or P filter. For emergencies or instances where the exposure levels are not known, use a full-
facepiece positive-pressure, air-supplied respirator. WARNING: Air-purifying respirators do not protect workers in oxygen-deficient atmospheres. 
Skin Protection: 
Wear protective gloves and clean body-covering clothing. 
Eye Protection: 
Use chemical safety goggles. Maintain eye wash fountain and quick-drench facilities in work area. 
-417-
09/06/2005 05:21 PMPOLYETHYLENE GLYCOL
Page 3 of 4http://www.jtbaker.com/msds/englishhtml/p5029.htm
9. Physical and Chemical Properties
Appearance: 
Clear liquid or white solid. 
Odor: 
Mild odor. 
Solubility: 
Soluble in water. 
Density: 
range: 1.1 to 1.2 (increases as molecular weight increases) 
pH: 
No information found. 
% Volatiles by volume @ 21C (70F): 
No information found. 
Boiling Point: 
No information found. 
Melting Point: 
Melting point increases as molecular weight increases: PEG 400 = 4-8C (39-46F) PEG 600 = 20-25C (68-77F) PEG1500 = 44-48C (111-118F) PEG 4000 = 54-
58C (129-136F) PEG 6000 = 56-63C (133-145F) 
Vapor Density (Air=1): 
No information found. 
Vapor Pressure (mm Hg): 
Vapor pressure is very low; as molecular weight increases, vapor pressure decreases. 
Evaporation Rate (BuAc=1): 
No information found. 
10. Stability and Reactivity
Stability: 
Stable under ordinary conditions of use and storage. 
Hazardous Decomposition Products: 
Carbon dioxide and carbon monoxide may form when heated to decomposition. 
Hazardous Polymerization: 
Will not occur. 
Incompatibilities: 
Incompatible with polymerization catalysts (peroxides, persulfates) and accelerators, strong oxidizers, strong bases and strong acids. 
Conditions to Avoid: 
Incompatibles.
11. Toxicological Information
Oral Rat LD50 for: 
PEG 200 = 28gm/kg; PEG 300 = 27.5gm/kg; PEG 400 = 30.2gm/kg; PEG 600 = 30gm/kg; PEG 1000 = 32gm/kg; PEG 1450 = > 4gm/kg; PEG 4000 = 50gm/kg;
PEG 6000 = > 50gm/kg; PEG 20000 = 31.6gm/kg
Polyethylene glycol has been investigated as a mutagen; PEG 1000 has been investigated as a tumorigen. 
  --------\Cancer Lists\------------------------------------------------------
                                         ---NTP Carcinogen---
  Ingredient                             Known    Anticipated    IARC Category
  ------------------------------------   -----    -----------    -------------
  Polyethylene Glycol (25322-68-3)        No          No            None
12. Ecological Information
Environmental Fate: 
No information found. 
Environmental Toxicity: 
No information found.
13. Disposal Considerations
Whatever cannot be saved for recovery or recycling should be managed in an appropriate and approved waste disposal facility. Processing, use or contamination
of this product may change the waste management options. State and local disposal regulations may differ from federal disposal regulations. Dispose of container
and unused contents in accordance with federal, state and local requirements.
14. Transport Information
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Not regulated. 
15. Regulatory Information
  --------\Chemical Inventory Status - Part 1\---------------------------------
  Ingredient                                       TSCA  EC   Japan  Australia
  -----------------------------------------------  ----  ---  -----  ---------
  Polyethylene Glycol (25322-68-3)                  Yes  No    Yes      Yes                                      
 
  --------\Chemical Inventory Status - Part 2\---------------------------------
                                                          --Canada--
  Ingredient                                       Korea  DSL   NDSL  Phil.
  -----------------------------------------------  -----  ---   ----  -----
  Polyethylene Glycol (25322-68-3)                  Yes   Yes   No     Yes             
 
  --------\Federal, State & International Regulations - Part 1\----------------
                                             -SARA 302-    ------SARA 313------
  Ingredient                                 RQ    TPQ     List  Chemical Catg.
  -----------------------------------------  ---   -----   ----  --------------
  Polyethylene Glycol (25322-68-3)           No    No      No         No
 
  --------\Federal, State & International Regulations - Part 2\----------------
                                                        -RCRA-    -TSCA-
  Ingredient                                 CERCLA     261.33     8(d) 
  -----------------------------------------  ------     ------    ------
  Polyethylene Glycol (25322-68-3)           No         No         No           
 
 
Chemical Weapons Convention:  No     TSCA 12(b):  No     CDTA:  No
SARA 311/312:  Acute: No       Chronic: No   Fire: No  Pressure: No
Reactivity: No          (Pure / Solid) 
Australian Hazchem Code: None allocated. 
Poison Schedule: None allocated. 
WHMIS: 
This MSDS has been prepared according to the hazard criteria of the Controlled Products Regulations (CPR) and the MSDS contains all of the information
required by the CPR. 
16. Other Information
NFPA Ratings: Health: 0 Flammability: 1 Reactivity: 0 
Label Hazard Warning: 
As part of good industrial and personal hygiene and safety procedure, avoid all unnecessary exposure to the chemical substance and ensure prompt removal from
skin, eyes and clothing. 
Label Precautions: 
None. 
Label First Aid: 
Not applicable. 
Product Use: 
Laboratory Reagent. 
Revision Information: 
No Changes. 
Disclaimer: 
************************************************************************************************ 
Mallinckrodt Baker, Inc. provides the information contained herein in good faith but makes no representation as to its comprehensiveness or accuracy.
This document is intended only as a guide to the appropriate precautionary handling of the material by a properly trained person using this product.
Individuals receiving the information must exercise their independent judgment in determining its appropriateness for a particular purpose.
MALLINCKRODT BAKER, INC. MAKES NO REPRESENTATIONS OR WARRANTIES, EITHER EXPRESS OR IMPLIED, INCLUDING
WITHOUT LIMITATION ANY WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE WITH RESPECT TO THE
INFORMATION SET FORTH HEREIN OR THE PRODUCT TO WHICH THE INFORMATION REFERS. ACCORDINGLY, MALLINCKRODT
BAKER, INC. WILL NOT BE RESPONSIBLE FOR DAMAGES RESULTING FROM USE OF OR RELIANCE UPON THIS INFORMATION. 
************************************************************************************************ 
Prepared by: Environmental Health & Safety
Phone Number: (314) 654-1600 (U.S.A.)
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Material Safety Data Sheet
POLYSORBATE 80 MSDS
Section 1: Chemical Product and Company Identification
Product Name: POLYSORBATE 80
Catalog Codes: SLP4093
CAS#: 9005-65-6
RTECS: WG2935000
TSCA: TSCA 8(b) inventory: POLYSORBATE 80
CI#: Not available.
Synonym: TWEEN 80; Polyoxyethylene 20 sorbitan
monooleate; Polyethylene oxide sorbitan mono-oleate;
Polyoxyethylene sorbitan monooleate; Polyoxyethylene
sorbitan oleate; Sorbitan mono-9-octadecenoate
poly(oxy-1,2-ethanediyl) derivatives; Sorethytan (20)
monooleate
Chemical Name: Sorbitan, monooleate polyoxyethylene
deriv.
Chemical Formula: Not available.
Contact Information:
Sciencelab.com, Inc.
14025 Smith Rd.
Houston, Texas 77396
US Sales: 1-800-901-7247
International Sales: 1-281-441-4400
Order Online: ScienceLab.com
CHEMTREC (24HR Emergency Telephone), call:
1-800-424-9300
International CHEMTREC, call: 1-703-527-3887
For non-emergency assistance, call: 1-281-441-4400
Section 2: Composition and Information on Ingredients
Composition:
Name CAS # % by Weight
POLYSORBATE 80 9005-65-6 100
Toxicological Data on Ingredients: Not applicable.
Section 3: Hazards Identification
Potential Acute Health Effects: Slightly hazardous in case of skin contact (irritant), of eye contact (irritant), of ingestion, of
inhalation.
Potential Chronic Health Effects:
CARCINOGENIC EFFECTS: Not available.
MUTAGENIC EFFECTS: Not available.
TERATOGENIC EFFECTS: Not available.
DEVELOPMENTAL TOXICITY: Not available.
Repeated or prolonged exposure is not known to aggravate medical condition.
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Section 4: First Aid Measures
Eye Contact:
Check for and remove any contact lenses. In case of contact, immediately flush eyes with plenty of water for at
least 15 minutes. Cold water may be used. Get medical attention if irritation occurs.
Skin Contact:
Wash with soap and water. Cover the irritated skin with an emollient. Get medical attention if irritation develops.
Cold water may be used.
Serious Skin Contact: Not available.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get
medical attention.
Serious Inhalation: Not available.
Ingestion:
Do NOT induce vomiting unless directed to do so by medical personnel. Never give anything by mouth to an
unconscious person. Loosen tight clothing such as a collar, tie, belt or waistband. Get medical attention if
symptoms appear.
Serious Ingestion: Not available.
Section 5: Fire and Explosion Data
Flammability of the Product: May be combustible at high temperature.
Auto-Ignition Temperature: Not available.
Flash Points: CLOSED CUP: >148.89°C (300°F).
Flammable Limits: Not available.
Products of Combustion: Not available.
Fire Hazards in Presence of Various Substances: Slightly flammable to flammable in presence of heat.
Explosion Hazards in Presence of Various Substances:
Risks of explosion of the product in presence of mechanical impact: Not available.
Risks of explosion of the product in presence of static discharge: Not available.
Fire Fighting Media and Instructions:
SMALL FIRE: Use DRY chemical powder.
LARGE FIRE: Use water spray, fog or foam. Do not use water jet.
Special Remarks on Fire Hazards: Not available.
Special Remarks on Explosion Hazards: Not available.
Section 6: Accidental Release Measures
Small Spill:
Dilute with water and mop up, or absorb with an inert dry material and place in an appropriate waste disposal
container. Finish cleaning by spreading water on the contaminated surface and dispose of according to local and
regional authority requirements.
Large Spill:
Absorb with an inert material and put the spilled material in an appropriate waste disposal. Finish cleaning by
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spreading water on the contaminated surface and allow to evacuate through the sanitary system.
Section 7: Handling and Storage
Precautions:
Keep away from heat. Keep away from sources of ignition. Empty containers pose a fire risk, evaporate the
residue under a fume hood. Ground all equipment containing material. Do not ingest. Do not breathe gas/fumes/
vapor/spray. If ingested, seek medical advice immediately and show the container or the label. Keep away from
incompatibles such as oxidizing agents.
Storage:
Keep container tightly closed. Keep container in a cool, well-ventilated area. Do not store above 32.2°C (90°F).
Preferably store at temperatures between 50 deg F to 90 deg. F.
Section 8: Exposure Controls/Personal Protection
Engineering Controls:
Provide exhaust ventilation or other engineering controls to keep the airborne concentrations of vapors below their
respective threshold limit value. Ensure that eyewash stations and safety showers are proximal to the
work-station location.
Personal Protection: Safety glasses. Lab coat.
Personal Protection in Case of a Large Spill:
Splash goggles. Full suit. Boots. Gloves. Suggested protective clothing might not be sufficient; consult a
specialist BEFORE handling this product.
Exposure Limits: Not available.
Section 9: Physical and Chemical Properties
Physical state and appearance: Liquid. (Oily liquid.)
Odor: fatty (Slight.)
Taste: Not available.
Molecular Weight: Not available.
Color: Clear Amber. Yellow.
pH (1% soln/water): 7 [Neutral.]
Boiling Point: >100°C (212°F)
Melting Point: -20.556°C (-5°F)
Critical Temperature: Not available.
Specific Gravity: 1.06 - 1.10 (Water = 1)
Vapor Pressure: <0.1 kPa (@ 20°C)
Vapor Density: Not available.
Volatility: Not available.
Odor Threshold: Not available.
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Water/Oil Dist. Coeff.: Not available.
Ionicity (in Water): Not available.
Dispersion Properties: See solubility in water, methanol.
Solubility:
Easily soluble in cold water, hot water.
Soluble in methanol.
Soluble in Toluene, alcohol, cottonseed oil, corn oil, Ethyl Acetate.
Insoluble in mineral oil.
Section 10: Stability and Reactivity Data
Stability: The product is stable.
Instability Temperature: Not available.
Conditions of Instability: Excess heat, incompatible materials
Incompatibility with various substances: Reactive with oxidizing agents.
Corrosivity: Non-corrosive in presence of glass, of stainless steel(304), of stainless steel(316).
Special Remarks on Reactivity: Not available.
Special Remarks on Corrosivity: Not available.
Polymerization: Will not occur.
Section 11: Toxicological Information
Routes of Entry: Inhalation. Ingestion.
Toxicity to Animals: Acute oral toxicity (LD50): 25000 mg/kg [Mouse].
Chronic Effects on Humans: Not available.
Other Toxic Effects on Humans: Slightly hazardous in case of skin contact (irritant), of ingestion, of inhalation.
Special Remarks on Toxicity to Animals:
Lethal Dose/Conc 50% Kill:
LD50 [Rat] - Route: Oral; Dose: 34500 ul/kg
Special Remarks on Chronic Effects on Humans:
May cause adverse reproductive effects based on animal test data. No human data found.
May cause cancer based on animal test data. No human data found.
May affect genetic material (mutagenic)
Special Remarks on other Toxic Effects on Humans:
Acute Potential Health Effects:
Skin: No irritation is expected, but it may cause mild/slight irritation in more sensitive individuals. It will probably
not be absorbed through the skin.
Eyes: It may cause eye irritation.
Inhalation: No expected to be a health hazard. No irritation is expected to be associated with the inhalation of this
material. No toxic effects are known to be associated with the inhalation of this material.
Ingestion: This material is not likely to cause irritation upon ingestion. It is classified as "relatively harmless" by
ingestion and considered to be a low ingestion hazard. Ingestion of very large doses may cause abdominal
spasms and diarrhea. Animal studies have shown it to cause cardiac changes, changes in behavior (altered sleep
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time) and weight loss (upon repeated or prolonged ingestion). However, no similar human data has been
reported.
Section 12: Ecological Information
Ecotoxicity: Not available.
BOD5 and COD: Not available.
Products of Biodegradation:
Possibly hazardous short term degradation products are not likely. However, long term degradation products may
arise.
Toxicity of the Products of Biodegradation: Not available.
Special Remarks on the Products of Biodegradation: Not available.
Section 13: Disposal Considerations
Waste Disposal:
Waste must be disposed of in accordance with federal, state and local environmental
control regulations.
Section 14: Transport Information
DOT Classification: Not a DOT controlled material (United States).
Identification: Not applicable.
Special Provisions for Transport: Not applicable.
Section 15: Other Regulatory Information
Federal and State Regulations: TSCA 8(b) inventory: POLYSORBATE 80
Other Regulations: EINECS: This product is on the European Inventory of Existing Commercial Chemical Substances.
Other Classifications:
WHMIS (Canada): Not controlled under WHMIS (Canada).
DSCL (EEC):
This product is not classified according
to the EU regulations.
Not applicable.
HMIS (U.S.A.):
Health Hazard: 1
Fire Hazard: 1
Reactivity: 0
Personal Protection: a
National Fire Protection Association (U.S.A.):
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Health: 1
Flammability: 1
Reactivity: 0
Specific hazard:
Protective Equipment:
Not applicable.
Lab coat.
Not applicable.
Safety glasses.
Section 16: Other Information
References: Not available.
Other Special Considerations: Not available.
Created: 10/10/2005 11:35 AM
Last Updated: 11/06/2008 12:00 PM
The information above is believed to be accurate and represents the best information currently available to us. However, we
make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we
assume no liability resulting from its use. Users should make their own investigations to determine the suitability of the
information for their particular purposes. In no event shall ScienceLab.com be liable for any claims, losses, or damages of any
third party or for lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even
if ScienceLab.com has been advised of the possibility of such damages.
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Material Safety Data Sheet
Sodium acetate anhydrous MSDS
Section 1: Chemical Product and Company Identification
Product Name: Sodium acetate anhydrous
Catalog Codes: SLS2710, SLS1918, SLS1123
CAS#: 127-09-3
RTECS: AJ4300010
TSCA: TSCA 8(b) inventory: Sodium acetate anhydrous
CI#: Not applicable.
Synonym: Acetic acid, sodium salt
Chemical Name: Sodium acetate
Chemical Formula: CH3COONa
Contact Information:
Sciencelab.com, Inc.
14025 Smith Rd.
Houston, Texas 77396
US Sales: 1-800-901-7247
International Sales: 1-281-441-4400
Order Online: ScienceLab.com
CHEMTREC (24HR Emergency Telephone), call:
1-800-424-9300
International CHEMTREC, call: 1-703-527-3887
For non-emergency assistance, call: 1-281-441-4400
Section 2: Composition and Information on Ingredients
Composition:
Name CAS # % by Weight
Sodium acetate anhydrous 127-09-3 100
Toxicological Data on Ingredients: Not applicable.
Section 3: Hazards Identification
Potential Acute Health Effects:
Hazardous in case of ingestion, of inhalation. Slightly hazardous in case of skin contact (irritant), of eye contact
(irritant).
Potential Chronic Health Effects:
CARCINOGENIC EFFECTS: Not available.
MUTAGENIC EFFECTS: Not available.
TERATOGENIC EFFECTS: Not available.
DEVELOPMENTAL TOXICITY: Not available.
Repeated or prolonged exposure is not known to aggravate medical condition.
Section 4: First Aid Measures
Eye Contact:
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Check for and remove any contact lenses. In case of contact, immediately flush eyes with plenty of water for at
least 15 minutes. Cold water may be used. Get medical attention if irritation occurs.
Skin Contact:
Wash with soap and water. Cover the irritated skin with an emollient. Get medical attention if irritation develops.
Cold water may be used.
Serious Skin Contact: Not available.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get
medical attention if symptoms appear.
Serious Inhalation: Not available.
Ingestion:
Do NOT induce vomiting unless directed to do so by medical personnel. Never give anything by mouth to an
unconscious person. Loosen tight clothing such as a collar, tie, belt or waistband. Get medical attention if
symptoms appear.
Serious Ingestion: Not available.
Section 5: Fire and Explosion Data
Flammability of the Product: May be combustible at high temperature.
Auto-Ignition Temperature: Not available.
Flash Points: Not available.
Flammable Limits: Not available.
Products of Combustion: These products are carbon oxides (CO, CO2).
Fire Hazards in Presence of Various Substances:
Slightly flammable to flammable in presence of open flames and sparks, of heat.
Non-flammable in presence of shocks.
Explosion Hazards in Presence of Various Substances:
Risks of explosion of the product in presence of mechanical impact: Not available.
Risks of explosion of the product in presence of static discharge: Not available.
Fire Fighting Media and Instructions:
SMALL FIRE: Use DRY chemical powder.
LARGE FIRE: Use water spray, fog or foam. Do not use water jet.
Special Remarks on Fire Hazards: Combustible when exposed to heat or flame.
Special Remarks on Explosion Hazards: Not available.
Section 6: Accidental Release Measures
Small Spill:
Use appropriate tools to put the spilled solid in a convenient waste disposal container. If necessary: Neutralize
the residue with a dilute solution of acetic acid. Finish cleaning by spreading water on the contaminated
surface and dispose of according to local and regional authority requirements.
Large Spill:
Use a shovel to put the material into a convenient waste disposal container. Neutralize the residue with a dilute
solution of acetic acid. Finish cleaning by spreading water on the contaminated surface and allow to evacuate
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through the sanitary system.
Section 7: Handling and Storage
Precautions:
Keep away from heat. Keep away from sources of ignition. Empty containers pose a fire risk, evaporate the
residue under a fume hood. Ground all equipment containing material. Do not ingest. Do not breathe dust.
Wear suitable protective clothing. In case of insufficient ventilation, wear suitable respiratory equipment. If
ingested, seek medical advice immediately and show the container or the label. Keep away from incompatibles
such as oxidizing agents, acids.
Storage: Keep container tightly closed. Keep container in a cool, well-ventilated area.
Section 8: Exposure Controls/Personal Protection
Engineering Controls:
Use process enclosures, local exhaust ventilation, or other engineering controls to keep airborne levels below
recommended exposure limits. If user operations generate dust, fume or mist, use ventilation to keep exposure to
airborne contaminants below the exposure limit.
Personal Protection: Safety glasses. Lab coat. Dust respirator. Be sure to use an approved/certified respirator or equivalent.
Gloves.
Personal Protection in Case of a Large Spill:
Splash goggles. Full suit. Dust respirator. Boots. Gloves. A self contained breathing apparatus should be used
to avoid inhalation of the product. Suggested protective clothing might not be sufficient; consult a specialist
BEFORE handling this product.
Exposure Limits: Not available.
Section 9: Physical and Chemical Properties
Physical state and appearance: Solid. (Granular, crystalline powder.)
Odor: Odorless to acetic (Slight.)
Taste: Not available.
Molecular Weight: 82.03 g/mole
Color: Colorless. White.
pH (1% soln/water): 11 [Basic.]
Boiling Point: Not available.
Melting Point: 324°C (615.2°F)
Critical Temperature: Not available.
Specific Gravity: 1.528 (Water = 1)
Vapor Pressure: Not applicable.
Vapor Density: Not available.
Volatility: Not available.
Odor Threshold: Not available.
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Water/Oil Dist. Coeff.: Not available.
Ionicity (in Water): Not available.
Dispersion Properties: See solubility in water.
Solubility: Easily soluble in cold water, hot water.
Section 10: Stability and Reactivity Data
Stability: The product is stable.
Instability Temperature: Not available.
Conditions of Instability: Excess heat, incompatible materials, moisture.
Incompatibility with various substances: Reactive with oxidizing agents, acids.
Corrosivity: Non-corrosive in presence of glass.
Special Remarks on Reactivity:
Hygroscopic; keep container tightly closed.
Incompatible (violent reaction) with fluorine diketene, potassium nitrate. Also incompatible wth nitric acid.
Emits fumes of acetic acid upon heating and on contact with strong acids.
Special Remarks on Corrosivity: Not available.
Polymerization: Will not occur.
Section 11: Toxicological Information
Routes of Entry: Inhalation. Ingestion.
Toxicity to Animals:
WARNING: THE LC50 VALUES HEREUNDER ARE ESTIMATED ON THE BASIS OF A 4-HOUR EXPOSURE.
Acute oral toxicity (LD50): 3530 mg/kg [Rat].
Acute dermal toxicity (LD50): >10000 mg/kg [Rabbit].
Acute toxicity of the dust (LC50): >30000 mg/m
1 hours [Rat].
3
Chronic Effects on Humans: Not available.
Other Toxic Effects on Humans:
Hazardous in case of ingestion, of inhalation.
Slightly hazardous in case of skin contact (irritant).
Special Remarks on Toxicity to Animals: Not available.
Special Remarks on Chronic Effects on Humans: Not available.
Special Remarks on other Toxic Effects on Humans:
Acute Potential Health Effects:
Skin: May cause skin irritation.
Eyes: May cause eye irritation.
Ingestion: May cause digestive tract irritation with abdominal pain, nausea, and vomiting. May affect behavior,
and urinary system.
Inhalation: May cause respiratory tract irritation. Symptoms may include coughing, sore throat, labored
breathing, and chest pain.
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Section 12: Ecological Information
Ecotoxicity: Not available.
BOD5 and COD: Not available.
Products of Biodegradation:
Possibly hazardous short term degradation products are not likely. However, long term degradation products may
arise.
Toxicity of the Products of Biodegradation: The product itself and its products of degradation are not toxic.
Special Remarks on the Products of Biodegradation: Not available.
Section 13: Disposal Considerations
Waste Disposal:
Waste must be disposed of in accordance with federal, state and local environmental
control regulations.
Section 14: Transport Information
DOT Classification: Not a DOT controlled material (United States).
Identification: Not applicable.
Special Provisions for Transport: Not applicable.
Section 15: Other Regulatory Information
Federal and State Regulations: TSCA 8(b) inventory: Sodium acetate anhydrous
Other Regulations: EINECS: This product is on the European Inventory of Existing Commercial Chemical Substances.
Other Classifications:
WHMIS (Canada): Not controlled under WHMIS (Canada).
DSCL (EEC):
This product is not classified according
to the EU regulations.
Not applicable.
HMIS (U.S.A.):
Health Hazard: 2
Fire Hazard: 1
Reactivity: 0
Personal Protection: E
National Fire Protection Association (U.S.A.):
Health: 2
Flammability: 1
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Reactivity: 0
Specific hazard:
Protective Equipment:
Gloves.
Lab coat.
Dust respirator. Be sure to use an
approved/certified respirator or
equivalent.
Safety glasses.
Section 16: Other Information
References:
-Hawley, G.G.. The Condensed Chemical Dictionary, 11e ed., New York N.Y., Van Nostrand Reinold, 1987.
-SAX, N.I. Dangerous Properties of Indutrial Materials. Toronto, Van Nostrand Reinold, 6e ed. 1984.
-The Sigma-Aldrich Library of Chemical Safety Data, Edition II.
Registery of Toxic Effects of Chemical Substances.
Hazardous Substance Data Bank.
Other Special Considerations: Not available.
Created: 10/09/2005 06:28 PM
Last Updated: 10/09/2005 06:28 PM
The information above is believed to be accurate and represents the best information currently available to us. However, we
make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we
assume no liability resulting from its use. Users should make their own investigations to determine the suitability of the
information for their particular purposes. In no event shall ScienceLab.com be liable for any claims, losses, or damages of any
third party or for lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even
if ScienceLab.com has been advised of the possibility of such damages.
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Material Safety Data Sheet
Sodium bicarbonate MSDS
Section 1: Chemical Product and Company Identification
Product Name: Sodium bicarbonate
Catalog Codes: SLS3241, SLS2446, SLS3868
CAS#: 144-55-8
RTECS: VZ0950000
TSCA: TSCA 8(b) inventory: Sodium bicarbonate
CI#: Not available.
Synonym: Baking Soda; Bicarbonate of soda; Sodium acid
carbonate; Monosodium carbonate; Sodium hydrogen
carbonate; Carbonic acid monosodium salt
Chemical Name: Sodium Bicarbonate
Chemical Formula: NaHCO3
Contact Information:
Sciencelab.com, Inc.
14025 Smith Rd.
Houston, Texas 77396
US Sales: 1-800-901-7247
International Sales: 1-281-441-4400
Order Online: ScienceLab.com
CHEMTREC (24HR Emergency Telephone), call:
1-800-424-9300
International CHEMTREC, call: 1-703-527-3887
For non-emergency assistance, call: 1-281-441-4400
Section 2: Composition and Information on Ingredients
Composition:
Name CAS # % by Weight
Sodium bicarbonate 144-55-8 100
Toxicological Data on Ingredients: Not applicable.
Section 3: Hazards Identification
Potential Acute Health Effects: Slightly hazardous in case of skin contact (irritant), of eye contact (irritant), of ingestion, of
inhalation.
Potential Chronic Health Effects:
CARCINOGENIC EFFECTS: Not available.
MUTAGENIC EFFECTS: Not available.
TERATOGENIC EFFECTS: Not available.
DEVELOPMENTAL TOXICITY: Not available.
Repeated or prolonged exposure is not known to aggravate medical condition.
Section 4: First Aid Measures
p. 1-432-
Eye Contact:
Check for and remove any contact lenses. In case of contact, immediately flush eyes with plenty of water for at
least 15 minutes. Cold water may be used. Get medical attention if irritation occurs.
Skin Contact:
Wash with soap and water. Cover the irritated skin with an emollient. Get medical attention if irritation develops.
Cold water may be used.
Serious Skin Contact: Not available.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get
medical attention.
Serious Inhalation: Not available.
Ingestion:
Do NOT induce vomiting unless directed to do so by medical personnel. Never give anything by mouth to an
unconscious person. Loosen tight clothing such as a collar, tie, belt or waistband. Get medical attention if
symptoms appear.
Serious Ingestion: Not available.
Section 5: Fire and Explosion Data
Flammability of the Product: Non-flammable.
Auto-Ignition Temperature: Not applicable.
Flash Points: Not applicable.
Flammable Limits: Not applicable.
Products of Combustion: Not available.
Fire Hazards in Presence of Various Substances: Not applicable.
Explosion Hazards in Presence of Various Substances:
Risks of explosion of the product in presence of mechanical impact: Not available.
Risks of explosion of the product in presence of static discharge: Not available.
Fire Fighting Media and Instructions: Not applicable.
Special Remarks on Fire Hazards: When heated to decomposition it emits acrid smoke and irritating fumes.
Special Remarks on Explosion Hazards: Not available.
Section 6: Accidental Release Measures
Small Spill:
Use appropriate tools to put the spilled solid in a convenient waste disposal container. Finish cleaning by
spreading water on the contaminated surface and dispose of according to local and regional authority
requirements.
Large Spill:
Use a shovel to put the material into a convenient waste disposal container. Finish cleaning by spreading water
on the contaminated surface and allow to evacuate through the sanitary system.
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Section 7: Handling and Storage
Precautions:
Do not ingest. Do not breathe dust. If ingested, seek medical advice immediately and show the container or the
label. Keep away from incompatibles such as acids.
Storage: Keep container tightly closed. Keep container in a cool, well-ventilated area.
Section 8: Exposure Controls/Personal Protection
Engineering Controls:
Use process enclosures, local exhaust ventilation, or other engineering controls to keep airborne levels below
recommended exposure limits. If user operations generate dust, fume or mist, use ventilation to keep exposure to
airborne contaminants below the exposure limit.
Personal Protection: Safety glasses. Lab coat. Dust respirator. Be sure to use an approved/certified respirator or equivalent.
Gloves.
Personal Protection in Case of a Large Spill:
Splash goggles. Full suit. Dust respirator. Boots. Gloves. A self contained breathing apparatus should be used
to avoid inhalation of the product. Suggested protective clothing might not be sufficient; consult a specialist
BEFORE handling this product.
Exposure Limits: Not available.
Section 9: Physical and Chemical Properties
Physical state and appearance: Solid.
Odor: Odorless.
Taste: Saline. Alkaline.
Molecular Weight: 84.01g/mole
Color: White.
pH (1% soln/water): Not available.
Boiling Point: Not available.
Melting Point: Not available.
Critical Temperature: Not available.
Specific Gravity: Density: 2.159 (Water = 1)
Vapor Pressure: Not applicable.
Vapor Density: Not available.
Volatility: Not available.
Odor Threshold: Not available.
Water/Oil Dist. Coeff.: Not available.
Ionicity (in Water): Not available.
Dispersion Properties: See solubility in water.
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Solubility:
Soluble in cold water.
Slightly soluble in alcohol.
Solubility in Water: 6.4, 7.6, 8.7, 10.0, 11.3, 12.7, 14.2, 16.5, 19.1 g/100 solution at 0, 10, 20, 30, 40, 50, 60, 80,
adn 100 deg. C, respectively.
Solubility in Water: 6.9, 8,2, 9.6, 11.1, 12.7, 14.5, 16.5, 19.7, and 23.6 g/100g water at 0, 10, 20, 30, 40, 50, 60,
80, 100 deg. C, respectively.
Section 10: Stability and Reactivity Data
Stability: The product is stable.
Instability Temperature: Not available.
Conditions of Instability: Incompatible materials, Moisture. Stable in dry air, but slowly decomposes in moist air.
Incompatibility with various substances: Reactive with acids.
Corrosivity: Non-corrosive in presence of glass.
Special Remarks on Reactivity:
Reacts with acids to form carbon dioxide.
Dangerous reaction with monoammonium phosphate or a sodium-potassium alloy.
Special Remarks on Corrosivity: Not available.
Polymerization: Will not occur.
Section 11: Toxicological Information
Routes of Entry: Inhalation. Ingestion.
Toxicity to Animals: Acute oral toxicity (LD50): 3360 mg/kg [Mouse].
Chronic Effects on Humans: Not available.
Other Toxic Effects on Humans: Slightly hazardous in case of skin contact (irritant), of ingestion, of inhalation.
Special Remarks on Toxicity to Animals: Not available.
Special Remarks on Chronic Effects on Humans:
Sodium Bicarbonate as produced genetic effects in rats (unscheduled DNA synthesis). However, no affects have
been found in humans.
Special Remarks on other Toxic Effects on Humans:
Acute Potential Health Effects:
Skin: May cause mild skin irritation.
Eyes: May cause mild eye irritation.
Inhalation: May cause respiratory tract irritation. Symptoms may include coughing and sneezing.
Ingestion: Symptoms of overexposure to Sodium Bicarbonate include thirst, abdominal pain, gastroenteritis, and
inflammation of the digestive tract.
Chronic Potential Health Effects:
Skin: Repeated or prolonged skin contact may cause irritation, drying or cracking of the skin.
Ingestion and Inhalation: Chronic toxicity usually occurs within 4 to 10 days following ingestion of very large
amounts. Repeated or prolonged ingestion or inhalation of large amounts may cause metabolic abnormalities, and
sodium retention. Metabolic abnormalities such as acidosis, hypernatremia, hypochloremia, alkalosis,
hypocalcemia, or sodium retention may affect the blood, kidneys, respiration (cyanosis, apnea secondary to
metabolic acidosis or pulmonary edema), and cardiovascular system (tachycardia, hypotension).
Severe toxicity may also affect behavior/central nervous system/nervous system. Neurological changes may
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result from metabolic abnormalities. These may include fatigue, irritability, dizziness, mental confusion,
paresthesia, seizures, tetany, cerebral edema
Medical Conditions Aggravated by Exposure: Persons with pre-existing skin conditions might have increased
sensitivity. Predisposing conditions that contribute to a mild alkali syndrome include, renal disease, dehydration,
adn electrolyte imbalance, hypertension, sarcoidosis, congestive heart failure, edema, or other sodium retaining
conditions.
Section 12: Ecological Information
Ecotoxicity: Not available.
BOD5 and COD: Not available.
Products of Biodegradation:
Possibly hazardous short term degradation products are not likely. However, long term degradation products may
arise.
Toxicity of the Products of Biodegradation: The product itself and its products of degradation are not toxic.
Special Remarks on the Products of Biodegradation: Not available.
Section 13: Disposal Considerations
Waste Disposal:
Waste must be disposed of in accordance with federal, state and local environmental
control regulations.
Section 14: Transport Information
DOT Classification: Not a DOT controlled material (United States).
Identification: Not applicable.
Special Provisions for Transport: Not applicable.
Section 15: Other Regulatory Information
Federal and State Regulations: TSCA 8(b) inventory: Sodium bicarbonate
Other Regulations: Not available.
Other Classifications:
WHMIS (Canada): Not controlled under WHMIS (Canada).
DSCL (EEC):
This product is not classified according
to the EU regulations.
Not applicable.
HMIS (U.S.A.):
Health Hazard: 1
Fire Hazard: 0
Reactivity: 0
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Personal Protection: E
National Fire Protection Association (U.S.A.):
Health: 1
Flammability: 0
Reactivity: 0
Specific hazard:
Protective Equipment:
Gloves.
Lab coat.
Dust respirator. Be sure to use an
approved/certified respirator or
equivalent.
Safety glasses.
Section 16: Other Information
References: Not available.
Other Special Considerations: Not available.
Created: 10/10/2005 08:26 PM
Last Updated: 11/06/2008 12:00 PM
The information above is believed to be accurate and represents the best information currently available to us. However, we
make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we
assume no liability resulting from its use. Users should make their own investigations to determine the suitability of the
information for their particular purposes. In no event shall ScienceLab.com be liable for any claims, losses, or damages of any
third party or for lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even
if ScienceLab.com has been advised of the possibility of such damages.
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Material Safety Data Sheet
Sodium citrate dihydrate MSDS
Section 1: Chemical Product and Company Identification
Product Name: Sodium citrate dihydrate
Catalog Codes: SLS4237, SLS3442, SLS1225
CAS#: 6132-04-3
RTECS: GE8300000 (Sodium Citrate, anhydrous)
TSCA: TSCA 8(b) inventory: No products were found.
CI#: Not available.
Synonym: Citnatin, Citreme, Citrosoedine, Citrosodna,
Natrocitral; Trisodium citrate dihydrate;
1,2,3-Propanetricarboxylic acid, 2-hydroxy-, trisodium salt,
dihydrate
Chemical Name: Citric acid, trisodium salt, dihydrate
Chemical Formula: C6H5Na3O7.2H2O
Contact Information:
Sciencelab.com, Inc.
14025 Smith Rd.
Houston, Texas 77396
US Sales: 1-800-901-7247
International Sales: 1-281-441-4400
Order Online: ScienceLab.com
CHEMTREC (24HR Emergency Telephone), call:
1-800-424-9300
International CHEMTREC, call: 1-703-527-3887
For non-emergency assistance, call: 1-281-441-4400
Section 2: Composition and Information on Ingredients
Composition:
Name CAS # % by Weight
Sodium citrate dihydrate 6132-04-3 100
Toxicological Data on Ingredients: Not applicable.
Section 3: Hazards Identification
Potential Acute Health Effects: Slightly hazardous in case of skin contact (irritant), of eye contact (irritant), of ingestion, of
inhalation.
Potential Chronic Health Effects:
CARCINOGENIC EFFECTS: Not available.
MUTAGENIC EFFECTS: Not available.
TERATOGENIC EFFECTS: Not available.
DEVELOPMENTAL TOXICITY: Not available.
Repeated or prolonged exposure is not known to aggravate medical condition.
Section 4: First Aid Measures
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Eye Contact:
Check for and remove any contact lenses. In case of contact, immediately flush eyes with plenty of water for at
least 15 minutes. Cold water may be used. Get medical attention if irritation occurs.
Skin Contact:
Wash with soap and water. Cover the irritated skin with an emollient. Get medical attention if irritation develops.
Cold water may be used.
Serious Skin Contact: Not available.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get
medical attention.
Serious Inhalation: Not available.
Ingestion:
Do NOT induce vomiting unless directed to do so by medical personnel. Never give anything by mouth to an
unconscious person. If large quantities of this material are swallowed, call a physician immediately. Loosen tight
clothing such as a collar, tie, belt or waistband.
Serious Ingestion: Not available.
Section 5: Fire and Explosion Data
Flammability of the Product: May be combustible at high temperature.
Auto-Ignition Temperature: Not available.
Flash Points: Not available.
Flammable Limits: Not available.
Products of Combustion: These products are carbon oxides (CO, CO2). Some metallic oxides.
Fire Hazards in Presence of Various Substances:
Slightly flammable to flammable in presence of heat.
Non-flammable in presence of shocks.
Explosion Hazards in Presence of Various Substances:
Slightly explosive in presence of open flames and sparks.
Non-explosive in presence of shocks.
Fire Fighting Media and Instructions:
SMALL FIRE: Use DRY chemical powder.
LARGE FIRE: Use water spray, fog or foam. Do not use water jet.
Special Remarks on Fire Hazards: As with most organic solids, fire is possible at elevated temperatures
Special Remarks on Explosion Hazards:
Fine dust dispersed in air in sufficient concentrations, and in the presences of an ignition source is a potential dust
explosion hazard.
Section 6: Accidental Release Measures
Small Spill:
Use appropriate tools to put the spilled solid in a convenient waste disposal container. Finish cleaning by
spreading water on the contaminated surface and dispose of according to local and regional authority
requirements.
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Large Spill:
Use a shovel to put the material into a convenient waste disposal container. Finish cleaning by spreading water
on the contaminated surface and allow to evacuate through the sanitary system.
Section 7: Handling and Storage
Precautions:
Keep away from heat. Keep away from sources of ignition. Do not breathe dust. Keep away from incompatibles
such as oxidizing agents.
Storage: Keep container tightly closed. Keep container in a cool, well-ventilated area.
Section 8: Exposure Controls/Personal Protection
Engineering Controls:
Use process enclosures, local exhaust ventilation, or other engineering controls to keep airborne levels below
recommended exposure limits. If user operations generate dust, fume or mist, use ventilation to keep exposure to
airborne contaminants below the exposure limit.
Personal Protection: Safety glasses. Lab coat. Dust respirator. Be sure to use an approved/certified respirator or equivalent.
Gloves.
Personal Protection in Case of a Large Spill:
Splash goggles. Full suit. Dust respirator. Boots. Gloves. A self contained breathing apparatus should be used
to avoid inhalation of the product. Suggested protective clothing might not be sufficient; consult a specialist
BEFORE handling this product.
Exposure Limits: Not available.
Section 9: Physical and Chemical Properties
Physical state and appearance: Solid. (Crystalline granules solid.)
Odor: Odorless.
Taste: Cool, Saline.
Molecular Weight: 294.1 g/mole
Color: White.
pH (1% soln/water):
8 [Basic.] The aqueous solution is slightly alkaline
to litmus; pH about 8
Boiling Point: Not available.
Melting Point: Not available.
Critical Temperature: Not available.
Specific Gravity: Not available.
Vapor Pressure: Not applicable.
Vapor Density: Not available.
Volatility: Not available.
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Odor Threshold: Not available.
Water/Oil Dist. Coeff.: Not available.
Ionicity (in Water): Not available.
Dispersion Properties: See solubility in water.
Solubility:
Easily soluble in hot water.
Soluble in cold water.
Insoluble in alcohol.
Soluble in 1.3 parts water.
Soluble in 0.6 parts boiling water.
Section 10: Stability and Reactivity Data
Stability: The product is stable.
Instability Temperature: Not available.
Conditions of Instability: Excess heat, dust generation, incompatible materials
Incompatibility with various substances: Reactive with oxidizing agents.
Corrosivity: Non-corrosive in presence of glass.
Special Remarks on Reactivity: Decomposes at red heat. Becomes anhydrous at 150 deg. C
Special Remarks on Corrosivity: Not available.
Polymerization: Will not occur.
Section 11: Toxicological Information
Routes of Entry: Inhalation. Ingestion.
Toxicity to Animals:
LD50: Not available.
LC50: Not available.
Chronic Effects on Humans: Not available.
Other Toxic Effects on Humans: Slightly hazardous in case of skin contact (irritant), of ingestion, of inhalation.
Special Remarks on Toxicity to Animals: Not available.
Special Remarks on Chronic Effects on Humans: Not available.
Special Remarks on other Toxic Effects on Humans:
Potential Health Effects:
Skin: Possible irritation on prolonged contact with moist or sensitive areas of the skin.
Eyes: No adverse effects expected, but dust may casue mechanical irritation.
Inhalation: Inhalation of large amounts of dust may cause irritation to the respiratory tract. Low hazard for usual
industrial handling.
Ingestion: Ingestion of large amounts may cause gastrointestinal tract irritation/disturbances.
May affect behavior (convulsions), respiration (cyanosis).
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Section 12: Ecological Information
Ecotoxicity: Not available.
BOD5 and COD: Not available.
Products of Biodegradation:
Possibly hazardous short term degradation products are not likely. However, long term degradation products may
arise.
Toxicity of the Products of Biodegradation: The product itself and its products of degradation are not toxic.
Special Remarks on the Products of Biodegradation: Not available.
Section 13: Disposal Considerations
Waste Disposal:
Waste must be disposed of in accordance with federal, state and local environmental
control regulations.
Section 14: Transport Information
DOT Classification: Not a DOT controlled material (United States).
Identification: Not applicable.
Special Provisions for Transport: Not applicable.
Section 15: Other Regulatory Information
Federal and State Regulations: No products were found.
Other Regulations: Not available.
Other Classifications:
WHMIS (Canada): Not controlled under WHMIS (Canada).
DSCL (EEC):
This product is not classified according
to the EU regulations.
S24/25- Avoid contact with skin and eyes.
HMIS (U.S.A.):
Health Hazard: 1
Fire Hazard: 1
Reactivity: 0
Personal Protection: E
National Fire Protection Association (U.S.A.):
Health: 1
Flammability: 0
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Reactivity: 0
Specific hazard:
Protective Equipment:
Gloves.
Lab coat.
Dust respirator. Be sure to use an
approved/certified respirator or
equivalent.
Safety glasses.
Section 16: Other Information
References: Not available.
Other Special Considerations: Not available.
Created: 10/10/2005 08:27 PM
Last Updated: 11/06/2008 12:00 PM
The information above is believed to be accurate and represents the best information currently available to us. However, we
make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we
assume no liability resulting from its use. Users should make their own investigations to determine the suitability of the
information for their particular purposes. In no event shall ScienceLab.com be liable for any claims, losses, or damages of any
third party or for lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even
if ScienceLab.com has been advised of the possibility of such damages.
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Material Safety Data Sheet
Sodium hydroxide MSDS
Section 1: Chemical Product and Company Identification
Product Name: Sodium hydroxide
Catalog Codes: SLS3298, SLS1081, SLS2503, SLS3925,
SLS1705
CAS#: 1310-73-2
RTECS:WB4900000
TSCA: TSCA 8(b) inventory: Sodium hydroxide
CI#: Not available.
Synonym: Caustic Soda
Chemical Name: Sodium Hydroxide
Chemical Formula: NaOH
Contact Information:
Sciencelab.com, Inc.
14025 Smith Rd.
Houston, Texas 77396
US Sales: 1-800-901-7247
International Sales: 1-281-441-4400
Order Online: ScienceLab.com
CHEMTREC (24HR Emergency Telephone), call:
1-800-424-9300
International CHEMTREC, call: 1-703-527-3887
For non-emergency assistance, call: 1-281-441-4400
Section 2: Composition and Information on Ingredients
Composition:
Name CAS # % by Weight
Sodium hydroxide 1310-73-2 100
Toxicological Data on Ingredients: Sodium hydroxide LD50: Not available. LC50: Not available.
Section 3: Hazards Identification
Potential Acute Health Effects:
Very hazardous in case of skin contact (corrosive, irritant, permeator), of eye contact (irritant, corrosive), of
ingestion, of inhalation. The amount of tissue damage depends on length of contact. Eye contact can result in
corneal damage or blindness. Skin contact can produce inflammation and blistering. Inhalation of dust will
produce irritation to gastro-intestinal or respiratory tract, characterized by burning, sneezing and coughing.
Severe over-exposure can produce lung damage, choking, unconsciousness or death. Inflammation of the eye is
characterized by redness, watering, and itching. Skin inflammation is characterized by itching, scaling, reddening,
or, occasionally, blistering.
Potential Chronic Health Effects:
CARCINOGENIC EFFECTS: Not available.
MUTAGENIC EFFECTS: Mutagenic for mammalian somatic cells.
TERATOGENIC EFFECTS: Not available.
DEVELOPMENTAL TOXICITY: Not available.
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The substance may be toxic to mucous membranes, upper respiratory tract, skin, eyes.
Repeated or prolonged exposure to the substance can produce target organs damage. Repeated exposure of the
eyes to a low level of dust can produce eye irritation. Repeated skin exposure can produce local skin destruction,
or dermatitis. Repeated inhalation of dust can produce varying degree of respiratory irritation or lung damage.
Section 4: First Aid Measures
Eye Contact:
Check for and remove any contact lenses. In case of contact, immediately flush eyes with plenty of water for at
least 15 minutes. Cold water may be used. Get medical attention immediately.
Skin Contact:
In case of contact, immediately flush skin with plenty of water for at least 15 minutes while removing contaminated
clothing and shoes. Cover the irritated skin with an emollient. Cold water may be used.Wash clothing before
reuse. Thoroughly clean shoes before reuse. Get medical attention immediately.
Serious Skin Contact:
Wash with a disinfectant soap and cover the contaminated skin with an anti-bacterial cream. Seek medical
attention.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get
medical attention immediately.
Serious Inhalation:
Evacuate the victim to a safe area as soon as possible. Loosen tight clothing such as a collar, tie, belt or
waistband. If breathing is difficult, administer oxygen. If the victim is not breathing, perform mouth-to-mouth
resuscitation. WARNING: It may be hazardous to the person providing aid to give mouth-to-mouth resuscitation
when the inhaled material is toxic, infectious or corrosive. Seek immediate medical attention.
Ingestion:
Do NOT induce vomiting unless directed to do so by medical personnel. Never give anything by mouth to an
unconscious person. If large quantities of this material are swallowed, call a physician immediately. Loosen tight
clothing such as a collar, tie, belt or waistband.
Serious Ingestion: Not available.
Section 5: Fire and Explosion Data
Flammability of the Product: Non-flammable.
Auto-Ignition Temperature: Not applicable.
Flash Points: Not applicable.
Flammable Limits: Not applicable.
Products of Combustion: Not available.
Fire Hazards in Presence of Various Substances: metals
Explosion Hazards in Presence of Various Substances:
Risks of explosion of the product in presence of mechanical impact: Not available.
Risks of explosion of the product in presence of static discharge: Not available.
Slightly explosive in presence of heat.
Fire Fighting Media and Instructions: Not available
Special Remarks on Fire Hazards:
sodium hydroxide + zinc metal dust causes ignition of the latter.
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Under proper conditions of temperature, pressure and state of division, it can ignite or react violently with
acetaldehyde, ally alcohol, allyl chloride, benzene-1,4-diol, chlorine trifluoride, 1,2 dichlorethylene, nitroethane,
nitromethane, nitroparaffins, nitropropane, cinnamaldehyde, 2,2-dichloro-3,3-dimethylbutane.
Sodium hydroxide in contact with water may generate enough heat to ignite adjacent combustible materials.
Phosphorous boiled with NaOH yields mixed phosphines which may ignite spontanously in air.
sodium hydroxide and cinnamaldehyde + heat may cause ignition.
Reaction with certain metals releases flammable and explosive hydrogen gas.
Special Remarks on Explosion Hazards:
Sodium hydroxide reacts to form explosive products with ammonia + silver nitrate.
Benzene extract of allyl benzenesulfonate prepared from allyl alcohol, and benzene sulfonyl chloride in presence of
aquesous sodium hydroxide, under vacuum distillation, residue darkened and exploded.
Sodium Hydroxde + impure tetrahydrofuran, which can contain peroxides, can cause serious explosions.
Dry mixtures of sodium hydroxide and sodium tetrahydroborate liberate hydrogen explosively at 230-270 deg. C.
Sodium Hydroxide reacts with sodium salt of trichlorophenol + methyl alcohol + trichlorobenzene + heat to cause
an explosion.
Section 6: Accidental Release Measures
Small Spill:
Use appropriate tools to put the spilled solid in a convenient waste disposal container. If necessary: Neutralize
the residue with a dilute solution of acetic acid.
Large Spill:
Corrosive solid.
Stop leak if without risk. Do not get water inside container. Do not touch spilled material. Use water spray to
reduce vapors. Prevent entry into sewers, basements or confined areas; dike if needed. Call for assistance on
disposal. Neutralize the residue with a dilute solution of acetic acid. Be careful that the product is not present
at a concentration level above TLV. Check TLV on the MSDS and with local authorities.
Section 7: Handling and Storage
Precautions:
Keep container dry. Do not breathe dust. Never add water to this product. In case of insufficient ventilation, wear
suitable respiratory equipment. If you feel unwell, seek medical attention and show the label when possible. Avoid
contact with skin and eyes. Keep away from incompatibles such as oxidizing agents, reducing agents, metals,
acids, alkalis, moisture.
Storage: Keep container tightly closed. Keep container in a cool, well-ventilated area. Hygroscopic. Deliquescent.
Section 8: Exposure Controls/Personal Protection
Engineering Controls:
Use process enclosures, local exhaust ventilation, or other engineering controls to keep airborne levels below
recommended exposure limits. If user operations generate dust, fume or mist, use ventilation to keep exposure to
airborne contaminants below the exposure limit.
Personal Protection:
Splash goggles. Synthetic apron. Vapor and dust respirator. Be sure to use an approved/certified respirator or
equivalent. Gloves.
Personal Protection in Case of a Large Spill:
Splash goggles. Full suit. Vapor and dust respirator. Boots. Gloves. A self contained breathing apparatus
should be used to avoid inhalation of the product. Suggested protective clothing might not be sufficient; consult a
specialist BEFORE handling this product.
Exposure Limits:
STEL: 2 (mg/m3) from ACGIH (TLV) [United States]
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TWA: 2 CEIL: 2 (mg/m3) from OSHA (PEL) [United States]
CEIL: 2 (mg/m3) from NIOSHConsult local authorities for acceptable exposure limits.
Section 9: Physical and Chemical Properties
Physical state and appearance: Solid. (Deliquescent solid.)
Odor: Odorless.
Taste: Not available.
Molecular Weight: 40 g/mole
Color:White.
pH (1% soln/water): 13.5 [Basic.]
Boiling Point: 1388°C (2530.4°F)
Melting Point: 323°C (613.4°F)
Critical Temperature: Not available.
Specific Gravity: 2.13 (Water = 1)
Vapor Pressure: Not applicable.
Vapor Density: Not available.
Volatility: Not available.
Odor Threshold: Not available.
Water/Oil Dist. Coeff.: Not available.
Ionicity (in Water): Not available.
Dispersion Properties: See solubility in water.
Solubility: Easily soluble in cold water.
Section 10: Stability and Reactivity Data
Stability: The product is stable.
Instability Temperature: Not available.
Conditions of Instability: Incompatible materials, moisture, moist air
Incompatibility with various substances:
Highly reactive with metals.
Reactive with oxidizing agents, reducing agents, acids, alkalis, moisture.
Corrosivity: Not available.
Special Remarks on Reactivity:
Hygroscopic. Much heat is evolved when solid material is dissolved in water. Therefore cold water and caution
must be used for this process.
Sodium hydroxide solution and octanol + diborane during a work-up of a reaction mixture of oxime and diborane in
tetrahyrofuran is very exothermic, a mild explosion being noted on one occassion.
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Reactive with water, acids (mineral, non-oxidizing, e.g. hydrochloric, hydrofluoric acid, muriatic acid, phosphoric),
acids (mineral, oxidizing e.g. chromic acid, hypochlorous acid, nitric acid, sulfuric acid), acids (organic e.g. acetic
acid, benzoic acid, formic acid, methanoic acid, oxalic acid), aldehydes (e.g. acetaldehyde, acrolein, chloral
hydrate, foraldehyde), carbamates (e.g. carbanolate, carbofuran), esters (e.g. butyl acetate, ethyl acetate, propyl
formate), halogenated organics (dibromoethane, hexachlorobenzene, methyl chloride, trichloroethylene),
isocyanates (e.g. methyl isocyanate), ketones (acetone, acetophenone, MEK, MIBK), acid chlorides, strong
bases, strong oxidizing agents, strong reducing agents, flammable liquids, powdered metals and metals (i.e
aluminum, tin, zinc, hafnium, raney nickel), metals (alkali and alkaline e.g. cesium, potassium, sodium), metal
compounds (toxic e.g. berylium, lead acetate, nickel carbonyl, tetraethyl lead), mitrides (e.g. potassium nitride,
sodium nitride), nitriles (e.g. acetonitrile, methyl cyanide), nitro compounds (organic e.g. nitrobenzene,
nitromethane), acetic anhydride, chlorohydrin, chlorosulfonic acid, ethylene cyanohydrin, glyoxal, hydrosulfuric
acid, oleum, propiolactone, acylonitrile, phorosous pentoxide, chloroethanol, chloroform-methanol,
tetrahydroborate, cyanogen azide, 1,2,4,5 tetrachlorobenzene, cinnamaldehyde.
Reacts with formaldehyde hydroxide to yield formic acid, and hydrogen.
Special Remarks on Corrosivity: Very caustic to aluminum and other metals in presence of moisture.
Polymerization:Will not occur.
Section 11: Toxicological Information
Routes of Entry: Absorbed through skin. Dermal contact. Eye contact. Inhalation. Ingestion.
Toxicity to Animals:
LD50: Not available.
LC50: Not available.
Chronic Effects on Humans:
MUTAGENIC EFFECTS: Mutagenic for mammalian somatic cells.
May cause damage to the following organs: mucous membranes, upper respiratory tract, skin, eyes.
Other Toxic Effects on Humans:
Extremely hazardous in case of inhalation (lung corrosive).
Very hazardous in case of skin contact (corrosive, irritant, permeator), of eye contact (corrosive), of ingestion, .
Special Remarks on Toxicity to Animals:
Lowest Published Lethal Dose:
LDL [Rabbit] - Route: Oral; Dose: 500 mg/kg
Special Remarks on Chronic Effects on Humans: May affect genetic material. Investigation as a mutagen (cytogenetic
analysis)
Special Remarks on other Toxic Effects on Humans:
Section 12: Ecological Information
Ecotoxicity: Not available.
BOD5 and COD: Not available.
Products of Biodegradation:
Possibly hazardous short term degradation products are not likely. However, long term degradation products may
arise.
Toxicity of the Products of Biodegradation: The product itself and its products of degradation are not toxic.
Special Remarks on the Products of Biodegradation: Not available.
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Section 13: Disposal Considerations
Waste Disposal:
Waste must be disposed of in accordance with federal, state and local environmental
control regulations.
Section 14: Transport Information
DOT Classification: Class 8: Corrosive material
Identification: : Sodium hydroxide, solid UNNA: 1823 PG: II
Special Provisions for Transport: Not available.
Section 15: Other Regulatory Information
Federal and State Regulations:
Illinois toxic substances disclosure to employee act: Sodium hydroxide
Illinois chemical safety act: Sodium hydroxide
New York release reporting list: Sodium hydroxide
Rhode Island RTK hazardous substances: Sodium hydroxide
Pennsylvania RTK: Sodium hydroxide
Minnesota: Sodium hydroxide
Massachusetts RTK: Sodium hydroxide
New Jersey: Sodium hydroxide
Louisiana spill reporting: Sodium hydroxide
California Director's List of Hazardous Substances: Sodium hydroxide
TSCA 8(b) inventory: Sodium hydroxide
CERCLA: Hazardous substances.: Sodium hydroxide: 1000 lbs. (453.6 kg)
Other Regulations:
OSHA: Hazardous by definition of Hazard Communication Standard (29 CFR 1910.1200).
EINECS: This product is on the European Inventory of Existing Commercial Chemical Substances.
Other Classifications:
WHMIS (Canada): CLASS E: Corrosive solid.
DSCL (EEC):
R35- Causes severe burns.
S26- In case of contact with eyes, rinse
immediately with plenty of water and seek
medical advice.
S37/39- Wear suitable gloves and eye/face
protection.
S45- In case of accident or if you feel unwell,
seek medical advice immediately (show the
label where possible).
HMIS (U.S.A.):
Health Hazard: 3
Fire Hazard: 0
Reactivity: 2
Personal Protection: j
National Fire Protection Association (U.S.A.):
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Health: 3
Flammability: 0
Reactivity: 1
Specific hazard:
Protective Equipment:
Gloves.
Synthetic apron.
Vapor and dust respirator. Be sure to
use an approved/certified respirator or
equivalent. Wear appropriate respirator
when ventilation is inadequate.
Splash goggles.
Section 16: Other Information
References: Not available.
Other Special Considerations: Not available.
Created: 10/09/2005 06:32 PM
Last Updated: 10/09/2005 06:32 PM
The information above is believed to be accurate and represents the best information currently available to us. However, we
make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we
assume no liability resulting from its use. Users should make their own investigations to determine the suitability of the
information for their particular purposes. In no event shall ScienceLab.com be liable for any claims, losses, or damages of any
third party or for lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even
if ScienceLab.com has been advised of the possibility of such damages.
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Material Safety Data Sheet
Sodium phosphate tribasic MSDS
Section 1: Chemical Product and Company Identification
Product Name: Sodium phosphate tribasic
Catalog Codes: SLS2650, SLS4072
CAS#: 7601-54-9
RTECS: TC9490000
TSCA: TSCA 8(b) inventory: Sodium phosphate tribasic
CI#: Not available.
Synonym: Trisodium Phosphate Anhydrous; Phosphoric
Acid, Trisodium Salt; Trisodium Orthophosphate
Chemical Name: Sodium Phosphate Tribasic
Chemical Formula: Na3PO4
Contact Information:
Sciencelab.com, Inc.
14025 Smith Rd.
Houston, Texas 77396
US Sales: 1-800-901-7247
International Sales: 1-281-441-4400
Order Online: ScienceLab.com
CHEMTREC (24HR Emergency Telephone), call:
1-800-424-9300
International CHEMTREC, call: 1-703-527-3887
For non-emergency assistance, call: 1-281-441-4400
Section 2: Composition and Information on Ingredients
Composition:
Name CAS # % by Weight
Sodium phosphate tribasic 7601-54-9 100
Toxicological Data on Ingredients: Sodium phosphate tribasic: ORAL (LD50): Acute: 4150 mg/kg [Rat [information from
other supplier]]. DERMAL (LD50): Acute: &gt;7940 mg/kg [Rabbit [information from other supplier]]. &gt;300 mg/kg [Rabbit
[Registry of Toxic Effects of Chemical Substances database]].
Section 3: Hazards Identification
Potential Acute Health Effects:
Hazardous in case of skin contact (irritant), of eye contact (irritant), of ingestion, of inhalation. Slightly hazardous
in case of skin contact (permeator). Corrosive to eyes and skin. The amount of tissue damage depends on
length of contact. Eye contact can result in corneal damage or blindness. Skin contact can produce inflammation
and blistering. Inhalation of dust will produce irritation to gastro-intestinal or respiratory tract, characterized by
burning, sneezing and coughing. Severe over-exposure can produce lung damage, choking, unconsciousness or
death.
Potential Chronic Health Effects:
CARCINOGENIC EFFECTS: Not available.
MUTAGENIC EFFECTS: Not available.
TERATOGENIC EFFECTS: Not available.
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DEVELOPMENTAL TOXICITY: Not available.
Repeated exposure of the eyes to a low level of dust can produce eye irritation. Repeated skin exposure can
produce local skin destruction, or dermatitis. Repeated inhalation of dust can produce varying degree of
respiratory irritation or lung damage.
Section 4: First Aid Measures
Eye Contact:
Check for and remove any contact lenses. In case of contact, immediately flush eyes with plenty of water for at
least 15 minutes. Cold water may be used. Get medical attention immediately.
Skin Contact:
In case of contact, immediately flush skin with plenty of water for at least 15 minutes while removing contaminated
clothing and shoes. Cover the irritated skin with an emollient. Cold water may be used.Wash clothing before
reuse. Thoroughly clean shoes before reuse. Get medical attention immediately.
Serious Skin Contact:
Wash with a disinfectant soap and cover the contaminated skin with an anti-bacterial cream. Seek medical
attention.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get
medical attention immediately.
Serious Inhalation: Not available.
Ingestion:
Do NOT induce vomiting unless directed to do so by medical personnel. Never give anything by mouth to an
unconscious person. Loosen tight clothing such as a collar, tie, belt or waistband. Get medical attention if
symptoms appear.
Serious Ingestion: Not available.
Section 5: Fire and Explosion Data
Flammability of the Product: Non-flammable.
Auto-Ignition Temperature: Not applicable.
Flash Points: Not applicable.
Flammable Limits: Not applicable.
Products of Combustion: Not available.
Fire Hazards in Presence of Various Substances: Not applicable.
Explosion Hazards in Presence of Various Substances:
Risks of explosion of the product in presence of mechanical impact: Not available.
Risks of explosion of the product in presence of static discharge: Not available.
Slightly explosive in presence of heat.
Fire Fighting Media and Instructions: Not applicable.
Special Remarks on Fire Hazards: Not available.
Special Remarks on Explosion Hazards: Containers may explode when heated
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Section 6: Accidental Release Measures
Small Spill:
Use appropriate tools to put the spilled solid in a convenient waste disposal container. If necessary: Neutralize
the residue with a dilute solution of acetic acid. Finish cleaning by spreading water on the contaminated
surface and dispose of according to local and regional authority requirements.
Large Spill:
Corrosive solid.
Stop leak if without risk. Do not get water inside container. Do not touch spilled material. Use water spray to
reduce vapors. Prevent entry into sewers, basements or confined areas; dike if needed. Call for assistance on
disposal. Neutralize the residue with a dilute solution of acetic acid. Be careful that the product is not present
at a concentration level above TLV. Check TLV on the MSDS and with local authorities.
Section 7: Handling and Storage
Precautions:
Keep container dry. Do not ingest. Do not breathe dust. Never add water to this product. Wear suitable
protective clothing. In case of insufficient ventilation, wear suitable respiratory equipment. If ingested, seek
medical advice immediately and show the container or the label. Avoid contact with skin and eyes. Keep away
from incompatibles such as moisture.
Storage: Keep container tightly closed. Keep container in a cool, well-ventilated area. Do not store above 23°C (73.4°F).
Section 8: Exposure Controls/Personal Protection
Engineering Controls:
Use process enclosures, local exhaust ventilation, or other engineering controls to keep airborne levels below
recommended exposure limits. If user operations generate dust, fume or mist, use ventilation to keep exposure to
airborne contaminants below the exposure limit.
Personal Protection: Safety glasses. Synthetic apron. Gloves (impervious).
Personal Protection in Case of a Large Spill:
Splash goggles. Full suit. Boots. Gloves. Suggested protective clothing might not be sufficient; consult a
specialist BEFORE handling this product.
Exposure Limits:
TWA: 15 (mg/m3) from OSHA (PEL) [United States] Inhalation Total.
TWA: 5 (mg/m3) from OSHA (PEL) [United States] Inhalation Respirable.
TWA: 5 STEL: 5 (mg/m3) from AIHA InhalationConsult local authorities for acceptable exposure limits.
Section 9: Physical and Chemical Properties
Physical state and appearance: Solid.
Odor: Odorless.
Taste: Not available.
Molecular Weight: 163.94 g/mole
Color: White.
pH (1% soln/water): 11.9 [Basic.]
Boiling Point: Not available.
Melting Point: 75°C (167°F)
p. 3-453-
Critical Temperature: Not available.
Specific Gravity: 1.62 (Water = 1)
Vapor Pressure: Not applicable.
Vapor Density: Not available.
Volatility: Not available.
Odor Threshold: Not available.
Water/Oil Dist. Coeff.: Not available.
Ionicity (in Water): Not available.
Dispersion Properties: See solubility in water.
Solubility:
Easily soluble in hot water.
Soluble in cold water.
Section 10: Stability and Reactivity Data
Stability: The product is stable.
Instability Temperature: Not available.
Conditions of Instability: Moisture
Incompatibility with various substances: Reactive with moisture.
Corrosivity: Non-corrosive in presence of glass.
Special Remarks on Reactivity: Hygroscopic. Sodium Phosphate Tribasic forms a strong caustic solution similar to soda lye
Special Remarks on Corrosivity: When wet, mild steel and brass may be corroded by sodium phosphate tribasic.
Polymerization: Will not occur.
Section 11: Toxicological Information
Routes of Entry: Absorbed through skin. Inhalation. Ingestion.
Toxicity to Animals:
Acute oral toxicity (LD50): 4150 mg/kg [Rat [information from other supplier]].
Acute dermal toxicity (LD50): >300 mg/kg [Rabbit [Registry of Toxic Effects of Chemical Substances database]].
Chronic Effects on Humans: Not available.
Other Toxic Effects on Humans:
Extremely hazardous in case of skin contact (corrosive), of eye contact (corrosive), of inhalation (lung corrosive).
Hazardous in case of skin contact (irritant), of ingestion, .
Slightly hazardous in case of skin contact (permeator).
Special Remarks on Toxicity to Animals: Not available.
Special Remarks on Chronic Effects on Humans: May affect genetic material (mutagenic)
Special Remarks on other Toxic Effects on Humans:
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Acute Potential Health Effects:
Skin: Causes skin irritation with possible burning pain and corrosive damage. It may be absorbed through the
skin.
Eyes: Causes eye irritation. It causes immediate and severe pain followed by conjunctival edema and corneal
clouding. Later cataract formation may occur. This substance may cause eye burns.
Inhalation: May be harmful if inhaled. Inhalation of dust may Cause respiratory tract and mucous membrane
irritation with coughing, sneezing, choking, difficulty breathing, and pulmonary edema.
Ingestion: May be harmful if swallowed. May cause severe gastrointestinal (digestive) tract irritation with severe
nausea, vomiting, abdominal discomfort, violent purging, diarrhea, and burning sensation. Ingestion of large
amounts may induce hypcalcemia or hypnatremia characterized by tetanus-like spasms, due to the sequestration
of calcium ions by the phosphate moiety. It may also cause caustic burns of the mouth oropharnyx, esophagus,
or gastrointestinal tract.
Section 12: Ecological Information
Ecotoxicity:
Ecotoxicity in water (LC50): 220 mg/l 96 hours [Bluegill sunfish]. 120 mg/l 96 hours [Rainbow Trout]. 177 mg/l
50 hours [Daphnia].
BOD5 and COD: Not available.
Products of Biodegradation:
Possibly hazardous short term degradation products are not likely. However, long term degradation products may
arise.
Toxicity of the Products of Biodegradation: The products of degradation are as toxic as the original product.
Special Remarks on the Products of Biodegradation: Not available.
Section 13: Disposal Considerations
Waste Disposal:
Waste must be disposed of in accordance with federal, state and local environmental
control regulations.
Section 14: Transport Information
DOT Classification: Not a DOT controlled material (United States).
Identification: : Not available. UNNA: 9148 PG: III
Special Provisions for Transport: Not applicable.
Section 15: Other Regulatory Information
Federal and State Regulations:
New York release reporting list: Sodium phosphate tribasic
Pennsylvania RTK: Sodium phosphate tribasic
Minnesota: Sodium phosphate tribasic
Massachusetts RTK: Sodium phosphate tribasic
New Jersey: Sodium phosphate tribasic
California Director's List of Hazardous Substances: Sodium phosphate tribasic
TSCA 8(b) inventory: Sodium phosphate tribasic
CERCLA: Hazardous substances.: Sodium phosphate tribasic: 5000 lbs. (2268 kg)
Other Regulations:
OSHA: Hazardous by definition of Hazard Communication Standard (29 CFR 1910.1200).
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EINECS: This product is on the European Inventory of Existing Commercial Chemical Substances.
Other Classifications:
WHMIS (Canada): CLASS E: Corrosive solid.
DSCL (EEC):
R35- Causes severe burns.
S1/2- Keep locked up and out of the reach of
children.
S26- In case of contact with eyes, rinse
immediately with plenty of water and seek
medical advice.
S36/37- Wear suitable protective clothing and
gloves.
S39- Wear eye/face protection.
S45- In case of accident or if you feel unwell,
seek medical advice immediately (show the
label where possible).
HMIS (U.S.A.):
Health Hazard: 2
Fire Hazard: 0
Reactivity: 0
Personal Protection: C
National Fire Protection Association (U.S.A.):
Health: 2
Flammability: 0
Reactivity: 2
Specific hazard:
Protective Equipment:
Gloves (impervious).
Synthetic apron.
Wear appropriate respirator when
ventilation is inadequate.
Safety glasses.
Section 16: Other Information
References: Not available.
Other Special Considerations: Not available.
Created: 10/09/2005 06:35 PM
Last Updated: 11/06/2008 12:00 PM
The information above is believed to be accurate and represents the best information currently available to us. However, we
make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we
assume no liability resulting from its use. Users should make their own investigations to determine the suitability of the
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information for their particular purposes. In no event shall ScienceLab.com be liable for any claims, losses, or damages of any
third party or for lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even
if ScienceLab.com has been advised of the possibility of such damages.
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Material Safety Data Sheet
Tris(hydroxymethyl)amino methane HCl MSDS
Section 1: Chemical Product and Company Identification
Product Name: Tris(hydroxymethyl)amino methane HCl
Catalog Codes: SLT1672
CAS#: 1185-53-1
RTECS: Not available.
TSCA: TSCA 8(b) inventory: Tris(hydroxymethyl)amino
methane HCl
CI#: Not available.
Synonym: Spectris Hydrochloride Trismat Hydrochloride;
2-Amino-2-(hydroxymethyl)propane-1,3-diol hydrochloride
Chemical Name: 1,3-Propanediol,
2-amino-2-(hydroxymethyl)-, hydrochloride
Chemical Formula: C4-H11-N-O3.HCl
Contact Information:
Sciencelab.com, Inc.
14025 Smith Rd.
Houston, Texas 77396
US Sales: 1-800-901-7247
International Sales: 1-281-441-4400
Order Online: ScienceLab.com
CHEMTREC (24HR Emergency Telephone), call:
1-800-424-9300
International CHEMTREC, call: 1-703-527-3887
For non-emergency assistance, call: 1-281-441-4400
Section 2: Composition and Information on Ingredients
Composition:
Name CAS # % by Weight
Tris(hydroxymethyl)amino methane HCl 1185-53-1 100
Toxicological Data on Ingredients: Not applicable.
Section 3: Hazards Identification
Potential Acute Health Effects: Slightly hazardous in case of skin contact (irritant), of eye contact (irritant), of ingestion, of
inhalation.
Potential Chronic Health Effects:
CARCINOGENIC EFFECTS: Not available.
MUTAGENIC EFFECTS: Not available.
TERATOGENIC EFFECTS: Not available.
DEVELOPMENTAL TOXICITY: Not available.
Repeated or prolonged exposure is not known to aggravate medical condition.
Section 4: First Aid Measures
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Eye Contact:
Check for and remove any contact lenses. In case of contact, immediately flush eyes with plenty of water for at
least 15 minutes. Cold water may be used. Get medical attention if irritation occurs.
Skin Contact:
Wash with soap and water. Cover the irritated skin with an emollient. Get medical attention if irritation develops.
Cold water may be used.
Serious Skin Contact: Not available.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get
medical attention.
Serious Inhalation: Not available.
Ingestion:
Do NOT induce vomiting unless directed to do so by medical personnel. Never give anything by mouth to an
unconscious person. If large quantities of this material are swallowed, call a physician immediately. Loosen tight
clothing such as a collar, tie, belt or waistband.
Serious Ingestion: Not available.
Section 5: Fire and Explosion Data
Flammability of the Product: May be combustible at high temperature.
Auto-Ignition Temperature: Not available.
Flash Points: Not available.
Flammable Limits: Not available.
Products of Combustion: These products are carbon oxides (CO, CO2), nitrogen oxides (NO, NO2...).
Fire Hazards in Presence of Various Substances:
Slightly flammable to flammable in presence of heat.
Non-flammable in presence of shocks.
Explosion Hazards in Presence of Various Substances:
Risks of explosion of the product in presence of mechanical impact: Not available.
Risks of explosion of the product in presence of static discharge: Not available.
Fire Fighting Media and Instructions:
SMALL FIRE: Use DRY chemical powder.
LARGE FIRE: Use water spray, fog or foam. Do not use water jet.
Special Remarks on Fire Hazards: As with most organic solids, fire is possible at elevated temperatures
Special Remarks on Explosion Hazards: Not available.
Section 6: Accidental Release Measures
Small Spill:
Use appropriate tools to put the spilled solid in a convenient waste disposal container. Finish cleaning by
spreading water on the contaminated surface and dispose of according to local and regional authority
requirements.
Large Spill:
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Use a shovel to put the material into a convenient waste disposal container. Finish cleaning by spreading water
on the contaminated surface and allow to evacuate through the sanitary system.
Section 7: Handling and Storage
Precautions:
Keep away from heat. Keep away from sources of ignition. Ground all equipment containing material. Do not
breathe dust. Keep away from incompatibles such as oxidizing agents.
Storage: Keep container tightly closed. Keep container in a cool, well-ventilated area.
Section 8: Exposure Controls/Personal Protection
Engineering Controls:
Use process enclosures, local exhaust ventilation, or other engineering controls to keep airborne levels below
recommended exposure limits. If user operations generate dust, fume or mist, use ventilation to keep exposure to
airborne contaminants below the exposure limit.
Personal Protection: Safety glasses. Lab coat. Dust respirator. Be sure to use an approved/certified respirator or equivalent.
Gloves.
Personal Protection in Case of a Large Spill:
Splash goggles. Full suit. Dust respirator. Boots. Gloves. A self contained breathing apparatus should be used
to avoid inhalation of the product. Suggested protective clothing might not be sufficient; consult a specialist
BEFORE handling this product.
Exposure Limits: Not available.
Section 9: Physical and Chemical Properties
Physical state and appearance: Solid. (Crystals solid.)
Odor: Not available.
Taste: Not available.
Molecular Weight: 157.59 g/mole
Color: White.
pH (1% soln/water): Not available.
Boiling Point: Not available.
Melting Point: 150°C (302°F)
Critical Temperature: Not available.
Specific Gravity: Not available.
Vapor Pressure: Not applicable.
Vapor Density: Not available.
Volatility: Not available.
Odor Threshold: Not available.
Water/Oil Dist. Coeff.: Not available.
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Ionicity (in Water): Not available.
Dispersion Properties: See solubility in water.
Solubility: Soluble in cold water.
Section 10: Stability and Reactivity Data
Stability: The product is stable.
Instability Temperature: Not available.
Conditions of Instability: Excess heat, incompatible materials, moisture
Incompatibility with various substances: Reactive with oxidizing agents.
Corrosivity: Non-corrosive in presence of glass.
Special Remarks on Reactivity: Hygroscopic; keep container tightly closed.
Special Remarks on Corrosivity: Not available.
Polymerization: Will not occur.
Section 11: Toxicological Information
Routes of Entry: Inhalation. Ingestion.
Toxicity to Animals:
LD50: Not available.
LC50: Not available.
Chronic Effects on Humans: Not available.
Other Toxic Effects on Humans: Slightly hazardous in case of skin contact (irritant), of ingestion, of inhalation.
Special Remarks on Toxicity to Animals: Not available.
Special Remarks on Chronic Effects on Humans: Not available.
Special Remarks on other Toxic Effects on Humans:
Acute Potential Health Effects:
Skin: May cause skin irritation with redness, and skin inflammation.
Eyes: May cause eye irritation.
Inhalation: Excessive inhalation may cause respiratory tract and mucous membrane irritation, coughing, adn
shortness of breath. No toxicity expected from inhalation.
Ingestion: Ingestion of excessive amounts may cause nausea, vomiting, diarrhea. It may also cause weakness,
collapse and coma.
Section 12: Ecological Information
Ecotoxicity: Not available.
BOD5 and COD: Not available.
Products of Biodegradation:
Possibly hazardous short term degradation products are not likely. However, long term degradation products may
arise.
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Toxicity of the Products of Biodegradation: The product itself and its products of degradation are not toxic.
Special Remarks on the Products of Biodegradation: Not available.
Section 13: Disposal Considerations
Waste Disposal:
Waste must be disposed of in accordance with federal, state and local environmental
control regulations.
Section 14: Transport Information
DOT Classification: Not a DOT controlled material (United States).
Identification: Not applicable.
Special Provisions for Transport: Not applicable.
Section 15: Other Regulatory Information
Federal and State Regulations: TSCA 8(b) inventory: Tris(hydroxymethyl)amino methane HCl
Other Regulations: EINECS: This product is on the European Inventory of Existing Commercial Chemical Substances.
Other Classifications:
WHMIS (Canada): Not controlled under WHMIS (Canada).
DSCL (EEC):
R36/37/38- Irritating to eyes,
respiratory system and skin.
S22- Do not breathe dust.
S24/25- Avoid contact with skin and eyes.
S36/37- Wear suitable protective clothing and
gloves.
HMIS (U.S.A.):
Health Hazard: 1
Fire Hazard: 1
Reactivity: 0
Personal Protection: E
National Fire Protection Association (U.S.A.):
Health: 1
Flammability: 1
Reactivity: 0
Specific hazard:
Protective Equipment:
Gloves.
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Lab coat.
Dust respirator. Be sure to use an
approved/certified respirator or
equivalent.
Safety glasses.
Section 16: Other Information
References: Not available.
Other Special Considerations: Not available.
Created: 10/10/2005 12:10 AM
Last Updated: 11/06/2008 12:00 PM
The information above is believed to be accurate and represents the best information currently available to us. However, we
make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we
assume no liability resulting from its use. Users should make their own investigations to determine the suitability of the
information for their particular purposes. In no event shall ScienceLab.com be liable for any claims, losses, or damages of any
third party or for lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even
if ScienceLab.com has been advised of the possibility of such damages.
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SECTION 1 - MATERIAL IDENTIFICATION AND INFORMATION
MANUFACTURER’S NAME: GENOMIC SOLUTIONS, INC.
ADDRESS: 4355 VARSITY DR.
ANN ARBOR, MI 48108
TELEPHONE NUMBER: (734) 975-4800
US EMERGENCY PHONE: (800) 535-5053
INTERNATIONAL EMERGENCY PHONE: 1(352) 323-3500 (Call Collect)
CAS NUMBER: 77-86-1
RTECS NUMBER: TY2900000
SUBSTANCE: TRIS BASE
TRADE NAMES/SYNONYMS:
80-0077, TRIS BASE, 500G; 80-0160, TRIS BASE, 2500G; 2-AMINO-2- (HYDROXYMETHYL) -1,3-
PROPANEDIOL; AMINOTRIMETHYLOLMETHANE; AMINOTRIS (HYDROXYMETHYL) METHANE;
TRIMETHYLOLAMINOMETHANE; TRIS (BUFFERING AGENT); TRIS BUFFER; TRIS
(HYDROXYMETHYL) METHANAMINE; TRIS (HYDROXYMETHYL) METHYLAMINE;
TRIS (METHYLOLAMINO) METHANE; TROMETHAMINE; TROMETHANE; TROMETHANMIN;
TRISAMINE; TRIS (HYDROXYMETHYL) AMINOMETHANE; 1,3-PROPANEDIOL,
2-AMINO-2- (HYDROXYMETHYL) -; TRIS (HYDROXYMETHYL) AMINOMETHANE; C4H11NO3.
CHEMICAL FAMILY: AMINE, HYDROXYL, ALIPHATIC
CREATION DATE: 6/14/95
REVISED: 2/20/98
SECTION 2 - PHYSICAL / CHEMICAL CHARACTERISTICS
COMPONENT: TRIS(HYDROXYMETHYL)AMINOMETHANE
CAS NUMBER: 77-86-1
PERCENTAGE: 100
OTHER CONTAMINANTS: NONE
PHYSICAL AND CHEMICAL PROPERTIES
DESCRIPTION: Odorless, hygroscopic, crystalline mass or white crystalline powder
MOLECULAR WEIGHT: 121.14
MOLECULAR FORMULA: (H-O-C-H2)3-C-N-H2
MELTING POINT: 340-342 F (171-172 C)
BOILING POINT: 426-428 F (219-220 C) @ 10 mmHg
VAPOR PRESSURE: no data available
VAPOR DENSITY: N/A
SPECIFIC GRAVITY: not available
WATER SOLUBILITY: 55%
VOLATILITY:
pH: 10.4 @ 1.2% solution
ODOR THRESHOLD: no data available
EVAPORATION RATE: N/A
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SOLVENT SOLUBILITY: Moderately soluble in methanol, ethanol, ethylene glycol, dimethylformamide;
slightly soluble in acetone, ether; very slightly soluble in ethyl acetate, cyclohexane, chloroform, carbon
tetrachloride.
SECTION 3 - FIRE AND EXPLOSION HAZARD DATA
CERCLA RATINGS (SCALE 0-3): HEALTH = 2 FIRE = 1 REACTIVITY = 0 PERSISTENCE = 0
NFPA RATINGS (SCALE 0-4): HEALTH = 2 FIRE = 1 REACTIVITY = 0
EMERGENCY OVERVIEW:
Odorless, hygroscopic, crystalline mass or white crystalline powder. Causes respiratory tract, skin and eye irritation.
Avoid breathing dust. Avoid contact with eyes, skin and clothing. Keep container tightly closed. Wash thoroughly
after handling. Use only with adequate ventilation.
POTENTIAL HEALTH EFFECTS
INHALATION:
Short Term Effects: May cause irritation. Additional effects may include coughing, chest pain and
difficulty breathing.
Long Term Effects: No information is available.
SKIN CONTACT:
Short Term Effects: May cause irritation.
Long Term Effects: Same effects as short term exposure.
EYE CONTACT:
Short Term Effects: May cause irritation. Additional effects may include eye damage.
Long Term Effects: Same effects as short term exposure.
INGESTION:
Short Term Effects: May cause gastrointestinal irritation. Additional effects may include burns, digestive
disorders and weakness.
Long Term Effects: No information is available.
CARCINOGEN STATUS:
OSHA: N
NTP: N
IARC: N
FIRE FIGHTING MEASURES
FIRE AND EXPLOSION HAZARD:
Slight fire hazard when exposed to heat or flame.
EXTINGUISHING MEDIA:
Dry chemical, carbon dioxide, water spray or regular foam (1993 Emergency Response Guidebook, RSPA P
5800.6).
For larger fires, use water spray, fog or regular foam (1993 Emergency Response Guidebook, RSPA P 5800.6).
FIREFIGHTING:
Move container from fire area if you can do it without risk. Do not scatter spilled material with high-pressure water
streams. Dike fire-control water for later disposal (1993 Emergency Response Guidebook, RSPA P 5800.6,
Guide Page 31).
Use agents suitable for type of surrounding fire. Avoid breathing hazardous vapors, keep upwind.
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FLASH POINT: no data available
LOWER FLAMMABLE LIMIT: no data available
UPPER FLAMMABLE LIMIT: no data available
AUTOIGNITION: no data available
HAZARDOUS COMBUSTION PRODUCTS:
Thermal decomposition products may include toxic oxides of carbon and nitrogen.
SECTION 4 - REACTIVITY HAZARD DATA
STABILITY AND REACTIVITY
REACTIVITY:
Stable under normal temperatures and pressures.
CONDITIONS TO AVOID:
May burn but does not ignite readily. Avoid contact with strong oxidizers, excessive heat, sparks, or open flame.
INCOMPATIBILITIES:
TRIS(HYDROXYMETHYL)AMINOMETHANE:
ACIDS: Vigorous reaction
ALKALIES (STRONG): Incompatible
ALUMINUM: Corrosive
BRASS: Corrosive
COPPER: Corrosive
OXIDIZERS (STRONG): Fire and explosion hazard
HAZARDOUS DECOMPOSITION:
Thermal decomposition products may include toxic oxides of carbon and nitrogen.
POLYMERIZATION:
Hazardous polymerization has not been reported to occur under normal temperatures and pressures.
SECTION 5 - HEALTH HAZARD DATA
EMERGENCY FIRST AID
INHALATION:
First Aid - Remove from exposure area to fresh air immediately. Perform artificial respiration if necessary. Keep
person warm and at rest. Treat symptomatically and supportively. Get medical attention immediately.
SKIN CONTACT:
First Aid - Remove contaminated clothing and shoes immediately. Wash with soap or mild detergent and large
amounts of water until no evidence of chemical remains (at least 15-20 minutes). Get medical attention
immediately.
EYE CONTACT:
First Aid - Wash eyes immediately with large amounts of water or normal saline, occasionally lifting upper and
lower lids, until no evidence of chemical remains (at least 15-20 minutes). Get medical attention immediately.
-466-
MATERIAL SAFETY DATA SHEET
TRIS BASE
PAGE 4 MSDS 70-2562
INGESTION:
First Aid - If vomiting occurs, keep head lower than hips to help prevent aspiration. Treat symptomatically and
supportively. Get medical attention if needed.
NOTE TO PHYSICIAN
ANTIDOTE: No specific antidote. Treat symptomatically and supportively.
TOXICOLOGY INFORMATION
TRIS(HYDROXYMETHYL)AMINOMETHANE:
TOXICITY DATA:
5900 mg/kg oral-rat LD50 1800 mg/kg intravenous-rat LD50
1000 mg/kg oral-rabbit LDLo 1210 mg/kg intravenous-mouse LD50
CARCINOGEN STATUS: None
LOCAL EFFECTS: Irritant- inhalation, skin, eye
ACUTE TOXICITY LEVEL: Slightly toxic by ingestion
TARGET EFFECTS: No data available
HEALTH EFFECTS
INHALATION:
TRIS(HYDROXYMETHYL)AMINOMETHANE:
IRRITANT.
Acute Exposure: May cause irritation of the mucous membranes with tightness and pain in the chest,
coughing, and difficulty breathing.
Chronic Exposure: No data available.
SKIN CONTACT:
TRIS(HYDROXYMETHYL)AMINOMETHANE:
IRRITANT.
Acute Exposure: May cause irritation with redness, pain, and possibly sensitization.
Chronic Exposure: May cause dermatitis due to irritation or sensitization.
EYE CONTACT:
TRIS(HYDROXYMETHYL)AMINOMETHANE:
IRRITANT.
Acute Exposure: May cause irritation with redness, pain, and possibly corneal damage.
Chronic Exposure: Prolonged or repeated exposure to irritants may cause conjunctivitis.
INGESTION:
TRIS(HYDROXYMETHYL)AMINOMETHANE:
Acute Exposure: May cause gastrointestinal irritation and possibly burns to the mouth and stomach. Large
doses to laboratory animals caused weakness, collapse and death. The estimated fatal dose is 50 grams.
Chronic Exposure: No data available.
SECTION 6 - CONTROL AND PROTECTIVE MEASURES
EXPOSURE LIMITS:
No occupational exposure limits established by OSHA, ACGIH, or NIOSH.
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VENTILATION:
Provide local exhaust ventilation. Ventilation equipment should be explosion-proof if explosive concentrations of
dust, vapor or fume are present.
EYE PROTECTION:
Employee must wear splash-proof or dust-resistant safety goggles to prevent contact with this substance.
EMERGENCY WASH FACILITIES:
Where there is any possibility that an employee's eyes and/or skin may be exposed to this substance, the employer
should provide an eye wash fountain and quick drench shower within the immediate work area for emergency use.
CLOTHING:
Employee must wear appropriate protective (impervious) clothing and equipment to prevent repeated or prolonged
skin contact with this substance.
GLOVES:
Employee must wear appropriate protective gloves to prevent contact with this substance.
RESPIRATOR:
The following respirators are recommended based on information found in the physical data, toxicity and health
effects sections. They are ranked in order from minimum to maximum respiratory protection.
The specific respirator selected must be based on contamination levels found in the work place, must be based on
the specific operation, must not exceed the working limits of the respirator and must be jointly approved by the
National Institute for Occupational Safety and Health and the Mine Safety and Health Administration (NIOSH-
MSHA).
Any dust and mist respirator.
Any air-purifying respirator with a high-efficiency particulate filter.
Any powered air-purifying respirator with a dust and mist filter.
Any powered air-purifying respirator with a high-efficiency particulate filter.
Any type 'C' supplied-air respirator operated in the pressure-demand or other positive pressure or continuous-flow
mode.
Any self-contained breathing apparatus.
FOR FIREFIGHTING AND OTHER IMMEDIATELY DANGEROUS TO LIFE OR HEALTH
CONDITIONS:
Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other
positive-pressure mode.
Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure
mode in combination with an auxiliary self-contained breathing apparatus operated in pressure-demand or other
positive-pressure mode.
SECTION 7 - PRECAUTIONS FOR SAFE HANDLING & USE/LEAK PROCEDURES
ACCIDENTAL RELEASE MEASURES
OCCUPATIONAL SPILL:
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Sweep up and place in suitable clean, dry containers for reclamation or later disposal. Do not flush spilled material
into sewer. Keep unnecessary people away.
HANDLING AND STORAGE
Observe all federal, state and local regulations when storing this substance. Store away from incompatible
substances. Store in a cool, dry place; keep container tightly closed when not in use.
DISPOSAL INFORMATION
Observe all federal, state and local regulations when disposing of this substance.
SECTION 8 - TRANSPORTATION AND REGULATORY INFORMATION
TRANSPORTATION INFORMATION:
No classification currently assigned
REGULATORY INFORMATION:
TSCA STATUS: Y
CERCLA SECTION 103 (40CFR302.4): N
SARA SECTION 302 (40CFR355.30): N
SARA SECTION 304 (40CFR355.40): N
SARA SECTION 313 (40CFR372..65): N
OSHA PROCESS SAFETY (29CFR1910.119): N
CALIFORNIA PROPOSITION 65: N
SARA HAZARD CATEGORIES, SARA SECTIONS 311/312 (40 CFR 370.21)
ACUTE HAZARD: Y
CHRONIC HAZARD: N
FIRE HAZARD: N
REACTIVITY HAZARD: N
SUDDEN RELEASE HAZARD: N
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While the information and recommendations set forth herein are believed to be accurate as of the date hereof,
ESA, Inc. makes no warranty with respect thereto and disclaims all liability from reliance thereon.
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TM
EasYFlaskTM Family
225 cm
2
New to 
the
Family!
For more information or samples, please call
1-800-446-2543 x7261 or
E-mail: cellculture@nunc.us
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Complete product range
• Available in 25, 75, 175 and now 225 cm2
Ergonomic closure
• Easy open-and-close cap takes only 1/3 turn
• Distinctive “Y” shaped mark on the vent/close cap allows      
visual verification of the cap position
Low profile design
• Maximizes incubator space in the same footprint as convential flasks
• Allows viewing of entire growth surface when estimating 
confluency using a standard microscope
Angled neck
• Large opening and angled neck allow for easy access to the entire growth surface with both 
pipettes and cell scrapers
Volume graduations
• Graduations are both printed and molded on the side wall of the flasks for easy use
Consistent performance
• Nunclon® ∆ treated surface ensures optimal cell attachment and growth
• Certified non-pyrogenic and is tested for both monolayer formation and cloning efficiency 
employing primary cells as well as repeating cell lines
Maximum airflow
• Air flows under the flask to optimize temperature equilibration during incubation, even when stacked
Nunc EasYFlask – Nunclon ∆, radiation sterilized
Catalog Number 156340 156367 156472 156499 159920 159910 159933 159934
Culture area, cm2 25 25 75 75 175 175 225 225
Closure Vent/close Filter Vent/close Filter Vent/close Filter Vent/close Filter
Cap Material HDPE HDPE HDPE HDPE HDPE HDPE HDPE HDPE
Sug. working
volume, ml 7 7 25 25 55 55 70 70
Units per 
sleeve/case 10/200 10/200 5/100 5/100 5/30 5/30 5/30 5/30
Bulk closures for EasYFlask
Catalog Number 158892 158523 158240 157527 133002 133001
Closure Vent/Close Filter Vent/Close Filter Vent/Close Filter
Culture area, cm2 25 25 75 75 175/225 175/225
Units per sleeve/case 1/100 1/100 1/100 1/100 1/100 1/100
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PETG Roller Bottles
Features:
•   Surface areas range from 1050 cm2 to 4200 cm2
     - Fewer interventions, lower contamination risk
•    Expanded Surface (XPS) Bottles have increased 
surface-to-volume ratios  
      -  Increases production without expanding 
facilities
•   Molded of durable PETG 
      -  Stronger than glass under normal laboratory 
use
•   Ergonomic vented and non-vented closures
      -  Reduces wrist strain and increases 
productivity
InVitro Roller Bottles from Nalge Nunc International are available in surface areas from 1050 cm2 to 
4200 cm2. All InVitro Roller Bottles are molded from PETG (polyethylene terephthalate G copolyester) 
and feature HDPE Quick-Action vented and non-vented ergonomic closures. 
The patented* InVitro Expanded Surface (XPS) Roller Bottles greatly increase the capacity of existing 
roller apparatus without expanding your capital or labor costs.
*US Pat. Off. Nos. 4,824,787; 4,962,033 and 5,010,013
The Art of 
CellCulture
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Standard Roller Bottles - 1050 and 1800 cm2
The 1050 cm2 1.2X bottle is similar in overall size to  
standard 850 cm2 bottles, but has 23% greater surface 
area for adherent or suspension cell cultures. It will 
accept approximately 800 ml of cell suspension in the 
horizontal position and is excellent for freezing to -40°C. 
Twice as long as the 1.2X bottle, the 1800 cm2 1XL bottle 
reduces labor and sterile interventions by reducing the 
number of bottles required.
Expanded Surface Roller Bottles - 1700, 2100 
and 4200 cm2
Patented* InVitro Expanded Surface (XPS) Roller Bottles 
provide up to 250% more growth area than same- 
volume standard bottles. XPS Bottles can conveniently 
expand existing production capacity and reduce inter-
ventions per bottle, resulting in lower risk of contamina-
tion.
InVitro XPS Roller Bottles have specially designed pleats 
that dramatically expand the available growth surface. 
The pleats are oriented in the direction of rotation to 
minimize turbulence. Flat panels between sections allow 
microscopic viewing and expedite drainage during 
medium replacement and cell harvest.
Cat. No. Description
Closure
type
Culture
area, cm2
Working
volume, ml
Units
sleeve/case
Standard Roller Bottles
106005 1.2X PETG Roller Bottle Standard 1050 100-500 5/20
106085 1.2X PETG Roller Bottle Vent 1050 100-500 5/20
106020 1.2X PETG Roller Bottle Standard 1050 100-500 20/20
186022 1XL PETG Roller Bottle Standard 1800 200-1000 22/22
Expanded Surface (XPS) Roller Bottles
176020 2X PETG Roller Bottle Standard 1700 200-600 20/20
216005 2.5X PETG Roller Bottle Standard 2100 200-600 5/20
216020 2.5X PETG Roller Bottle Standard 2100 200-600 20/20
426022  5X PETG Roller Bottle Standard 4200 400-1000 22/22
Replacement Closures
308001 48 mm HDPE Vented Quick-Action Closure, Sterile 1/300
The 2X (1700 cm2) bottle’s pleat profile provides faster 
drainage because of expanded pleats. 
Both the 2.5X (2100 cm2) and 5X (4200 cm2) bottles have 
a shorter and tighter pleat design which allows for com-
plete wetting of the surface with less volume.  
Common Features
    •   Molded of durable PETG; an excellent substrate   
         for adherent cell cultures
    •   Wide range of sizes; surface areas from 1050 cm2   
         to 4200 cm2
    •   Expanded Surface (XPS) Bottles have improved   
         surface-to-volume ratios for increased production  
         without expanding facilities
    •   Ergonomic closure reduces wrist strain and   
         increases productivity
    •    Vented closures available on the 1.2X standard size  
         and as replacement closures
    •   Easy-to-read graduations for medium fills
    •   Lot number is printed on each bottle for traceability
*US Pat. Off. Nos. 4,824,787; 4,962,033 and 5,010,013
N
o.
 7
70
28
 V
er
si
o
n
 1
.1
 Y
N
I/
C
T 
-  
11
-2
00
4
www.nuncbrand.comNunc A/S · Denmark · Tel +45 4631 2000 · infociety@nunc.dk · www.nuncbrand.com
Nalge Nunc International · USA · Tel +1 585 586 8800 · nnitech@nalgenunc.com · www.nuncbrand.com
Nunc GmbH & Co. KG · Germany · Tel +49 6111 86740 · nunc@nunc.de · www.nunc.de
Nalge Nunc International KK · Japan · Tel +81 3381 63355 · info@nalgenunc.co.jp · www.nalgenunc.co.jp
-469-
U.S. Toll-free: 800-323-4340       •      Outside the U.S.: 847-549-7600       •      www.coleparmer.com     
Canada 800-363-5900  •  India 91-22-6716-2222  •  UK 0500-345-300
2132
Tissue & Cell CultureTI
NUNC™ OptiCell™ Cell Culture System
Unique format for growing, monitoring, and transporting live cells
● Total growing area of 100 cm2
● Thin profile maximizes incubator space and reduces media consumption
● Barcoded for easy tracking and automation handling
System consists of two parallel gas-permeable, cell culture treated polystyrene 
membranes—2 mm apart—attached to a standard microtiter plate-sized frame. Two 
resealing access ports provide closed growth environment with a sterile fluid path 
to reduce the risk of contamination. Typical applications for these systems include 
transportation of live cells, hybridoma antibody production, biomagnetic cell separation, 
cell imaging and staining, and transfection.
Accessories
R-01931-58 OptiMag cell separation 
magnet .....................................................  /ea
R-01931-60 OptiCell mailer. 
Case of 10 .................................................. /cs
R-01931-61 OptiCell mailer. 
Case of 25 .................................................. /cs
R-01931-62 OptiCell rack .........................  /ea
R-01931-63 OptiCell insertion tips. 
Case of 100 ................................................ /cs
R-01931-64 OptiCell knife. 
Case of 3 .................................................... /cs
Catalog number Description Contents Price
R-01931-50 OptiCell 1100 starter kit 20 OptiCell 1100 chambers, 1 rack, 1 knife, 50 insertion tips, 2 caps, 1 optical shield, and 1 mini-CD  
R-01931-54 OptiCell MAX 2100 starter kit 5 OptiCell MAX 2100 chambers, 1 rack, 50 insertion tips, and hybridoma Ab production protocol  
R-01931-57 OptiMag cell separation kit 5 OptiCell 1100 chambers, 1 magnet, 50 insertion tips,1 rack, and OptiMag cell separation protocol  
R-01931-59 OptiCell mailer kit 5 OptiCell 1100 chambers, 50 insertion tips, 5 OptiCell mailers, and shipping protocol  
Replacement Chambers
Catalog number Description Culture area/chamber Working volume/chamber Qty/cs Price/cs
R-01931-51
OptiCell 1100 100 cm² 10 mL
20   
R-01931-52 100  
R-01931-53 500  
R-01931-55 OptiCell 2100 100 cm² 30 mL 20  R-01931-56 100  
OptiCell 1100 starter kit 01931-50
Resealing access ports provide 
closed growth environment.
Low-Profile Bottle Roller
Lightweight and portable—easy to transport from lab to lab
● Use from 0 to 60°C–operates in CO2 and high humidity incubators
● Accommodates tubes from 10 mL up to 850 cm2
Use this low-profile bottle roller for growing bacteria and cell cultures. The low-profile 
shape saves benchtop and incubator shelf space. The thin, flat power cord reaches external 
outlets without damaging incubator gaskets. Adjust roller speed from 1 to 30 rpm. The unit 
comes with 6 rollers to accommodate tubes from 10 mL to 50 mL or up to three 850 cm2 
growth area culture bottles with a total of 11⁄2 liters of liquid. The low-profile roller 
measures 15"L x 141⁄4"W x 23⁄8"H.
What’s included: low-profile bottle roller, six rollers, and 6-ft power cord.
R-36202-50 Additional bottle roller ................................................................................................  
Catalog number Power (50/60 Hz) Price
R-36202-02 115 VAC  
R-36202-04 220 VAC  
36202-02
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Thermo Scientific Precision Incubators
Performance, Quality and Value for Your Incubation Needs
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Global Leader in
Quality and Reliability
For more than 50 years, Thermo Scientific products have been
trusted by the world’s leading biotechnology, pharmaceutical,
academic, industrial and clinical laboratories. Our solutions deliver
the performance, quality and reliability required by researchers
and clinicians worldwide.
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Our new Thermo Scientific Precision incubator series
delivers excellent temperature uniformity, performance
and value for a wide range of microbiological incubation
applications – from everyday needs to demanding
incubation and storage tasks.
Precision® High-Performance Incubators pg. 3-6
> Superior Temperature Uniformity
Precision Standard Incubators pg. 7
> For Everyday Incubation Applications
Precision Compact Incubators pg. 8
> Space-Saving Design for Basic Applications
Precision Refrigerated Incubators pg. 9-10
> For Various Applications at Temperatures
Below and Above Ambient
APPLICATIONS
Precision
High-Performance
Incubators
Precision
Standard
Incubators
Precision
Compact
Incubators
Precision
Refrigerated
Incubators
Bacterial Research • • •
Biochemical Oxygen Demand (BOD) •
Chemical Storage • • •
Chick Embryo Studies • •
Coliform Determinations • • • •
Crystallization Studies • •
Drying And Staining Procedures • • •
Entomological Studies •
Enzyme Digestion Studies • • •
Hematological Testing • • • •
Microbiological Determinations • • • •
Paraffin Embedding • •
Pharmaceutical Stability Testing •
Sample Storage • •
Tissue Culturing • • • •
Plant Growth Studies •
Thermo Scientific
Precision
Incubators
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Thermo Scientific Precision High-Performance Incubators
Choice of Mechanical or
Gravity Convection
• Mechanical convection provides
uniform heating and precise
temperature control. A blower
circulates heated air in a horizontal
airflow pattern for efficient heat
distribution with tight temperature
tolerances of up to ±0.3°C
• Gravity convection offers safe
incubation with reduced air changes,
minimizing drying-out of samples
while providing a stable environment
Advanced Microprocessor
Controls
• Sophisticated microprocessor
controls feature easy-to-view digital
LED readout and reliable temperature
control
• Fixed setpoints on control panel
eliminate the need for tuning and off-
set feature enables easy calibration
• Temperature is displayed on large,
three-character screen and can be
easily set from 5°C above ambient
to 75°C in 0.1°C increments using
touch-sensitive arrow keys
Built-In Safety
• Built-in safety back-up maintains
control at 3°C above setpoint if
primary heater control fails
• Visual alarm indicates when
temperature exceeds 3°C setpoint
• Silicone gasket on outer door
and 3” thick fiberglass insulation
prevents heat loss and ensures
excellent temperature uniformity
• Circuit breaker protects against
power surges.
Simplicity and Flexibility
• Inner glass door permits viewing
of samples without disturbing the
chamber environment
• Internal electrical outlet allows
operation of a shaker, stirrer or
other lab apparatus
Durable and Robust
• Cabinet has durable, enamel-coated
steel exterior. Interior chamber
features easy-to-clean stainless steel
• Low-watt density heater elements
are designed for long life and energy
efficiency
Featuring advanced microprocessor controls, our Precision
high-performance incubators are available with mechanical
or gravity convection for your most important applications that
require excellent temperature distribution or gentle sample
incubation and handling between 5°C above ambient to 75°C.
Mechanical or
Gravity Convection
Mechanical Convention Models
• Stackable, table-top units
• Outer door opens to 180˚ for unhindered access
• Double door unit and large capacity units also available
• Choice of 120V and 240V versions
• Internal electrical outlet in all models
3
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High-Performance Mechanical Convection Double Doors Large Capacity
Chamber Volume 2.2 cu. ft./62 L 3.4 cu. ft./96 L 4.5 cu. ft. /127 L 11.2 cu. ft./317 L 30 cu. ft./850 L
Temperature Control Microprocessor PID Microprocessor PID Microprocessor PID Hydraulic Thermostat Hydraulic Thermostat
Temperature Display LED LED LED LED Thermometer
Temperature Range ambient +5° to 75°C ambient +5° to 75°C ambient +5° to 75°C ambient +5° to 65°C ambient +5° to 70°C
Uniformity @37˚C ±0.5°C ±0.5°C ±0.5°C ± 0.6°C ±0.5°C
Dimensions (W x H x D)
Chamber 18 x 12.5 x 18 in. 18 x 19 x 18 in. 18 x 25.5 x 18 in. 37 x 25 x 21 in. 30 x 72 x 24.25 in.
(46 x 32 x 46 cm) (46 x 48 x 46 cm) (46 x 65 x 46 cm) (94 x 64 x 53 cm) (72.2 x 182.9 x 61.6 cm)
Exterior 25 x 26 x 23.5 in. 25 x 33 x 23.5 in. 25 x 39 x 23.5 in. 39.8 x 34.5 x 25 in. 36 x 88.5 x 31.5 in.
(64 x 66 x 60 cm) (64 x 84 x 60 cm) (64 x 99 x 60 cm) (101 x 88 x 64 cm) (91.4 x 224.5 x 74.3 cm)
Electrical Specs
120 V (60Hz) 330 watts/8.3 amps 330 watts/8.3 amps 410 watts /8.9 amps 520 watts/4.3 amps 450 watts/12.1 amps
240 V (50/60Hz) 330 watts/6.6 amps 330 watts/6.6 amps 410 watts/7.0 amps 520 watts/2.2 amps —
Shelves 1 supplied, 3 max 1 supplied, 6 max 2 supplied, 10 max 6 supplied, 36 max* 6 supplied, 30 max
Catalog Number
120 V PR205045M PR205055M PR205065M PR205075M
3971, solid door
3973, glass door
240 V PR205040M PR205050M PR205060M PR205070M
Shipping Weight 150 lb/68 kg 165 lb/74.5 kg 190 lb/86.2 kg 215 lb/98 kg 685 lb/310.7 kg
*18 shelves per door opening
Additional shelf kits for table top units: Catalog Number 13247S
Additional shelf kits for double door units: Catalog Number AY2076X1
Additional shelf kits for large capacity units: Catalog Number 3166190
All 120V table top units are UL/cUL listed.
12 month warranty (parts and labor)
4
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Gravity Convection Models
• Three stackable, table-top units
• Outer door opens to 180° for unhindered access
• Choice of 120 V and 240 V versions
• Electrical outlet in all models
5
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High-Performance Gravity Convection Double-Door
Chamber Volume 2.5 cu. ft./71 L 3.75 cu. ft./106 L 5 cu. ft./142 L 11.2 cu. ft./317 L
Temperature Control Microprocessor PID Microprocessor PID Microprocessor PID Microprocessor PID
Temperature Display LED LED LED LED
Temperature Range ambient +5° to 75°C ambient +5° to 75°C ambient +5° to 75°C ambient +5° to 65°C
Uniformity @37˚C ±0.7°C ±0.7°C ±0.7°C ±0.4°C
Sensitivity ±0.1°C ±0.1°C ±0.1°C ±0.2°C
Dimensions (W x H x D)
Chamber 18 x 13.5 x 18 in. 18 x 20 x 18 in. 18 x 26.5 x 18 in. 37 x 25 x 21 in.
(46 x 34 x 46 cm) (46 x 51 x 46 cm) (46 x 67 x 46 cm) (94 x 64 x 53 cm)
Exterior 25 x 26 x 23.5 in. 25 x 33 x 23.5 in. 25 x 39 x 23.5 in. 40 x 35 x 25 in.
(64 x 66 x 60 cm) (64 x 84 x 60 cm) (64 x 99 x 60 cm) (101 x 88 x 64 cm)
Electrical Specs (50/60Hz)
120 V (60Hz) 260 watts/2.2 amps 260 watts/2.2 amps 320 watts/2.7 amps 450 watts/3.8 amps
240 V (50/60Hz) 260 watts/1.1 amps 260 watts/1.1 amps 320 watts/1.4 amps 450 watts/1.9 amps
Shelves 1 supplied, 5 max 1 supplied, 8 max 2 supplied, 11 max 6 supplied, 36 max*
Catalog Number
120 V PR205045G PR205055G PR205065G PR205075G
240 V PR205040G PR205050G PR205060G PR205070G
Shipping Weight 115 lb/ 52 kg 130 lb/59 kg 145 lb/66 kg 215 lb/98 kg
Thermo Scientific Precision High-Performance Incubators (continued)
* 18 shelves per door opening
Additional shelf kits for table top units: Catalog Number 13247S
Additional shelf kits for double door units: Catalog Number AY2076X1
All table top units (120 V and 240 V) are UL/cUL listed.
12 month warranty (parts and labor)
6
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Economy and Value Our Precision standard incubators are ideal for
everyday applications that require temperatures between
5°C above ambient to 65°C and feature gravity convection
for uniform heat distribution and reduced air movement
to protect samples from drying out.
Thermo Scientific Precision Standard Incubators
Two Chamber Sizes
• 1.3 cu. ft. (37L) includes two
adjustable aluminum shelves
• 5.1 cu. ft. (144L) includes two
adjustable aluminum shelves
(*Additional shelves are sold separately)
Standard Incubators
Chamber Volume 1.3 cu. ft. /37 L 5.1 cu. ft. /144 L
Temperature Control Hydraulic Thermostat Hydraulic Thermostat
Temperature Display Thermometer Thermometer
Temperature Range ambient +5° to 65°C ambient +5° to 65°C
Uniformity @37˚C ±1°C ±1.3°C
Dimensions (W x H x D)
Chamber 13 x 13 x 13 in. 18 x 27 x 18 in.
(33 x 33 x 33 cm) (46 x 69 x 46 cm)
Exterior 15.7 x 21 x 15 in. 21 x 33 x 21 in.
(40 x 53 x 38 cm) (53 x 84 x 53 cm)
Electrical Specs
120 V (60Hz) 200 watts/1.7 amps 400 watts/3.3 amps
240 V (50/60Hz) 200 watts/0.8 amps 400 watts/1.7 amps
Shelves 2 supplied, 5 max 2 supplied, 9 max
Catalog Numbers
120 V PR205125G PR205165G
240 V PR205120G PR205160G
Shipping Weight 51 lb/23 kg 90 lb/41 kg
Uniform Temperature
Protects Samples
• Gravity convection permits heat to
enter from all points on the wall and
floor of incubator for uniform heat
distribution and reduced air move-
ment to prevent drying out
• Adjustable hydraulic thermostat
ensures stable temperature through-
out chamber
• Superior heat distribution eliminates
hot spots and provides temperature
uniformity of up to ±1°C at 37°C
Excellent Safety
• Radiant wall heaters outside
chamber eliminate safety hazards
of exposed heaters
• Environmentally friendly, mercury-
free thermometer included
• Pilot light indicates when heaters
are energized for safe operation
Durability and Easy Cleaning
• Corrosion-resistant aluminum
chamber is easy to clean
• Powder-coated exterior steel
construction ensures durability
• Shelves are perforated for optimized
temperature transfer to samples and
can easily be removed for thorough
cleaning
7
Additional shelf kits for the 1.3 cu. ft. models:
Catalog Number 203-8Q
Additional shelf kits for the 5.1 cu. ft. models:
Catalog Number 403-8Q
All 120V units are UL/cUL listed.
12 month warranty (parts and labor)
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Space-Saving
Design
Featuring a space-savings footprint for maximizing workspace,
our Precision compact incubators are ideal for small clinics
and laboratories that require temperatures between
5°C above ambient to 40°C or 60°C for basic applications.
Thermo Scientific Precision Compact Incubators
Three Convenient Sizes
• 0.67 cu. ft. (19L) includes
thermometer and one
fixed shelf
• 1 cu. ft. (28L) includes
thermometer and one
removable shelf
• 1.32 cu. ft (37L) includes
thermometer and two
fixed shelves*
* Unit comes with plexiglass door
for unobstructed viewing. For egg
incubation, not for clinical use,
microbiological or biochemical studies.
Space-Efficient Design
• Small footprint saves valuable
bench space
Temperature Uniformity
• Easily adjustable bi-metallic thermo-
stat controls and aluminum chamber
ensure excellent temperature
uniformity
• Rugged metal door with positive
latch provides excellent seal for
temperature stability
• 1” thick fiberglass insulation prevents
heat loss (0.67 cu. ft. and 1.0 cu. ft.
units only)
Safe Operation
• Shielded heating elements eliminate
safety hazards caused by spills
• Pilot light indicates when heaters
are energized for safe operation
• Environmentally, mercury-free
thermometer included
Durability and Easy Cleaning
• Corrosion-resistant aluminum
chamber is easy to clean
• Powder-coated paint and exterior
steel construction ensure durability
All 120V units are UL/cUL listed.
12 month warranty (parts and labor)
Compact Incubators
Chamber Volume 0.67 cu. ft./19 L 1 cu. ft./28 1.32 cu. ft./37 L
Temperature Control Bimetallic Thermostat Bimetallic Thermostat Bimetallic Thermostat
Temperature Display Thermometer Thermometer Thermometer
Temperature Range ambient +5° to 40°C ambient +5° to 60°C ambient +5° to 45°C
Uniformity @37˚C ±1°C ±1°C ±3°C
Dimensions (W x H x D)
Chamber 12 x 8 x 12 in. 12 x 12 x 12 in. 13.44 x 12.68 x 12.65 in.
(30 x 20 x 30 cm) (30 x 30 x 30 cm) (35 x 32 x 35 cm)
Exterior 13.5 x 11.8 x 14.5 in. 13.5 x 15.7 x 13.9 in. 13.5 x 15.7 x 13.9 in.
(34 x 30 x 37 cm) (34 x 40 x 35 cm) (37 x 40 x 35 cm)
Electrical Specs (50/60Hz)
120 V 100 watts/0.8 amps 100 watts/0.8 amps 150 watts/1.3 amps
240 V 100 watts/0.4 amps 100 watts/0.4 amps 150 watts/0.6 amps
Shelves 1 supplied, 1 max 1 supplied, 1 max 2 supplied, 2 max
Catalog Numbers
120 V PR205215G PR205225G PR205235G
240 V PR205210G PR205220G PR205230G
Shipping Weight 15 lb/7 kg 27 lb/12 kg 33 lb/15 kg
8
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Thermo Scientific Precision Refrigerated Incubators
Broad Temperature
Range
Featuring microprocessor controls and forced air circulation,
our Precision refrigerated incubators are ideal for applications
that require temperatures ranging from -15°C to 60°C with
excellent stability.
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Model 818
Model 815
20 cu. ft. Model 815
Refrigerated Incubator:
• Ideal for BOD applications and
temperature settings at or below
ambient
• Advanced microprocessor controlled
with easy-to-use push buttons and
set-points
• Connection for external chart recorder
and RS-232 interface for data logging
• Holds up to 333 BOD bottles (300 ml)
Efficient, Dependable Design
• Easy-to-clean, corrosion resistant
construction
• Compressor relay conserves energy
• 2A outlet easily supports apparatus
inside the unit
Excellent Temperature Uniformity
• Microprocessor control with
easy-to-read display shows actual
temperature within 0.1°C
• Push-button controls feature
temperature set-point selection
• Forced air circulation delivers
excellent temperature stability
• CFC-free, foamed polyurethane
insulation prevents heat loss
• RTD temperature probe and pro-
tected setpoint mode prevent acci-
dental temperature change
• Door key lock protects samples from
unauthorized access
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Refrigerated Incubators Model 815 Model 818/Plant Growth
Chamber Volume 6.1 cu. ft./173 L 30.4 cu. ft./861 L 20 cu. ft./566 L 17.8 cu. ft./504 L
Temperature Control Microprocessor Controlled Microprocessor Controlled Microprocessor Controlled Microprocessor Controlled
Temperature Display LED LED LED LED
Temperature Range -10°C to +60°C -15 C to 50 C -10°C to +50°C -10°C to +50°C /+10°C to +50°C*
Uniformity @37˚C ±1.0°C ±1.0°C ±0.5°C ±1.5°C @ 20°C
Sensitivity @37˚C ±0.1°C ±0.1°C ±0.1°C ±0.2°C
Dimensions (W x H x D)
Chamber 20.5 x 28 x 20.5 in. 32 x 65.6 x 25 in. 26.5 x 57 x 20 in. 26.5 x 57 x 20 in.
(52 x 53 x70 cm) (81 x 166 x 64 cm) (67.3 x144.8 x 50.8 cm) (67.3 x 144.8 x 50.8 cm)
Exterior 24 x 34.5 x24.5 in 35 x 74 x 33 in. 32 x 75 x 29 in. 32 x 75 x 29 in.
(61 x 88 x 62 cm) (89 x 188 x 84 cm) (82 x 191 x 74 cm) (82 x 191 x 74 cm)
Electrical Specs
115 V 860 watts/9.5 amps 1600 watts/16 amps 800 watts/ 7.0 amps 860 watts/7.5 amps
230 V 860 watts/5.8 amps 1600 watt/9 amps 800 watts/3.5 amps 860 watts/3.75 amps
Shelves 2 supplied, 4 max 4 supplied, 7 max 6 supplied, 6 max 6 supplied, 6 max
Catalog Number
115 V PR205745R PR205795R 3721 3759
230 V PR205740R PR205790R 3722 3758
Shipping Weight 126 lb/57 kg 360 lb/163 kg 315 lb/142.9 kg 347 lb/157.4 kg
All 115V units are cCSAus listed.
* with illumination
12 month warranty (parts and labor)
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17.8 cu. ft. Model 818
Plant Growth Chamber:
• Ideal for applications requiring
night/day simulation, precise
temperature control and uniformity
over a broad temperature range
• Dual-lamp fluorescent lighting
provides 300 foot candles for
uniform illumination
• Programmable heating and lighting
cycles: 7-day program with 2 light
cycles per day
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BIOSTAT® CultiBag RM 
Culturing Convenience
turning science into solutions
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Culturing Convenience
The BIOSTAT® CultiBag RM is
the new generation of dispos-
able bioreactors utilizing rock-
ing motion for mixing with 
low shear. The combination of 
a new generation of Sartorius
Stedim Biotech engineered
control capabilities launches
the disposable bioreactor
system into a new era of
cultivation. The disposable culti-
vation chamber CultiBag RM is
specially designed for shear
sensitive cells and any single-
use applications. A comprehen-
sive validation and extractables
report is available for the bags
and can also be designed for
your process.
Maintenance and overhead
expenses are reduced, eliminat-
ing the need for:
– Sterilization in Place (SIP)
– Cleaning In Place (CIP)
– Reduction in WFI
– Reduction in user time |
effort
– Reduction in validation 
requirements
The measurement and control
capabilities supplied by
Sartorius Stedim Biotech are
second to none. Utilizing
proven technology and expert
engineering, we have developed
our existing in-house systems 
to bring powerful control 
capabilities to the disposable
market. The BIOSTAT® RM
Control Tower presents an
easy-to-use touch screen
control with integrated
measurement and control hard-
ware, pumps, temperature and
gassing systems, for excellent
process control.
The application-driven, config-
ured packages for basic, optical
and perfusion provide every-
thing needed to get started
immediately. The BIOSTAT®
CultiBag RM is available in
scalable working volumes from
0.1 L to 100 L. Just select the
size that meets your needs
today. Each basic, optical and
perfusion package also includes
our BioPAT® MFCS/DA data
logging software. A large
variety of operation modes
facilitates a batch-oriented
bioprocessing.
Technical Specifications
Dimensions Weight (kg)
W + H + D (mm)
BIOSTAT® RM
Control Tower 320 + 735 + 565 mm 60 kg
Rocker 2 with Holder 2 330 + 400 + 430 mm 7 kg
Rocker 2 with Holder 10 550 + 200 + 430 mm 8 kg
Rocker 20/50 with 
Holder 20 710 + 400 + 560 mm 27 kg
Rocker 20/50 with 
Holder 50 1030 + 450 + 580 mm 32 kg
200 L Optical System 1998 + 1241 + 830 mm 272 kg
Utilities
Power supply 120 VAC and 230 VAC
208 VAC and 400 VAC
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The BIOSTAT® CultiBag RM 
is ideal for
– Cell culture, growth of ani-
mal, insect and plant cells
– Shear sensitive cells or 
anaerobic bacteria
– Transition from shake 
or tissue culture flasks
– Seed Cultivation for large
sclae Bioreactors
– Production scale up to 100 L
– For all your disposable 
applications
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The BIOSTAT® CultiBag RM packages are specially configured 
to meet your disposable needs
Basic Packages –
Used for simple and easy
cultivations. The rocker is used as
a standalone unit with the heater
blanket for temperature control
and is equipped with an integrat-
ed air pump and flow controller
for bag inflation and supply to
cells. Alternatively the unit may
be placed inside an incubator for
temperature control and air
supply to the cells. Additionally, 
a pressure relief valve and flow
controller are included for
attachment to your own gas 
mixing device. Rocking rate and
rocking angle can be adjusted
individually.
Optical Packages –
Designed for batch and fed-batch
processes. Process control is
achieved through disposable
optical chemical pH and DO
sensors. Feedback control of 
both values is available for your
process. Two integrated pumps
are included.
Perfusion Packages –
Designed for continuous
cultivation. Two additional
integrated pumps are supplied 
for feed| harvest control by
weight. Balances are included 
for excellent perfusion control.
BioPAT® MFCS/DA
All packages are equipped with
BioPAT® MFCS/DA software for
external data logging. All batch
related data can be stored in an
individual folder allowing batch-
oriented bioprocessing. Its
plotting module together with
the integrated export function to
MS Excel is both user friendly and
highly flexible. 
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Basic Packages
– Standalone Unit
– Rocker only
– Integrated pump or external
airation module for inflation
of bag and supply of ambient
air to the cells
– Pressure relief and flow
controller for connection to
an external gas supply device
– Rocking angle and rocking
rate control
– Temperature control heater
blanket included
– Rocker may alternatively be
placed into a CO2 incubator
– BioPAT® MFCS/DA data log-
ging software included
Optical Packages
– Standalone Unit
– Rocker with Optical 
Control Tower
Optical Tower
– Disposable optical chemical
pH and DO sensors are
included
– Feedback control of pH
– Feedback control of DO
– Intuitive touchscreen
– Trend display
– 2 integrated pumps
– Pressure control for
overpressure safety
– Gassing by 4 + rotameters
and 2 + mass flow controllers
to overlay aeration
– BioPAT® MFCS/DA data
logging software included
Perfusion Packages
– Standalone Unit
– Rocker with Perfusion 
Control Tower
Perfusion  Tower
– Balances for feed| harvest
flow control are included
– Disposable optical chemical
pH and DO sensors are
included
– Feedback control of pH
– Feedback control of DO
– Intuitive touchscreen
– Trend display
– 4 integrated pumps
– Pressure control for
overpressure safety
– Gassing by 4 + rotameters
and 2 + mass flow controllers
to overlay aeration
– BioPAT® MFCS/DA data
logging software included
Packages
Basic Bags* 
– Air inlet | air outlet filter
– Sample port
– Fill | drain and spare ports
– Female luer, female MPC 
or male MPC connectors
– Ports with dip tubes
Optical Bags*
– Air inlet | air outlet filter
– Sample port
– Fill | drain and spare ports
– Female luer, female MPC 
or male MPC connectors
– Ports with dip tubes
– Optical chemical DO sensor
– Optical chemical pH sensor
Perfusion Pro Bags*
– Air inlet | air outlet filter
– Sample port
– Fill | drain and spare ports
– Female luer, female MPC or
male MPC connectors
– Ports with dip tubes 
– Optical chemical DO sensor
– Optical chemical pH sensor
– Feed | harvest ports
– Acid | base port
– Internal fixed perfusion
membrane
Bag Designs
Customized bags also available
* Bags not included in packages 
Disposable optical chemical 
pH and DO sensors assure total
process control in your
application  
An easy to use touch screen
interface makes the operation
of your BIOSTAT® CultiBag RM
system very convenient and
keeps training to a minimum
The needleless Septum port in
all standard CultiBags RM
faciliates your sampling process
and keeps it safe at all times.
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Hardware Technical Specifications
Description Rockers and Controllers
Rocker 2 Rocker 20/50 Rocker 200
Bag Sizes 1 L, 2 L, 10 L 2 L, 10 L, 20 L, 50 L 100 L, 200 L
Power Supply
120 VAC|208 VAC* • • •
230 VAC|400 VAC* • • •
Rocker Includes
Air Pump • • •
Pressure Regulator • • •
Rocking Angle (degrees) 5–10 5–10 4–10
Rocking Rate (rocks/min) 6–42 8–42 3–20
Basic Package Rocker only Rocker only n/a
Heater Plate • • –
Bag Holder • • –
Filter Heater • • –
Tinted Lid • • –
Control Tower – – –
BioPAT® MFCS/DA • • –
Optical Package n/a Rocker + Rocker + 
Optical Control Tower Optical Control Tower
Heater Plate – • •
Optical Control Tower – • •
Rotameter for air, 
O2, N2, CO2 – • •
MFC for Total Flow – • •
MFC for CO2 – • •
Temperature Control 
(°C) – 20–40 20–40
pH Control – 5.5–9 5.5–9
DO Control – 0–100 % 0–100 %
Cascade Control on Controller – • •
Aeration Module on Controller – • •
Peristaltic pumps (integrated) – 2 2
BioPAT® MFCS/DA – • •
Perfusion Package n/a Rocker + Rocker +
Perfusion Control Tower Perfusion Control Tower
In addition to Optical Package:
Peristaltic pumps – 2 2 per side
Balances – 2 2 per side
For additional information and order codes please refer to our datasheets BIOSTAT® CultiBag RM 2, 
BIOSTAT® CultiBag RM 20/50 and BIOSTAT® CultiBag RM 200.
• or value = included
– = not included
* Rocker 200 only
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Bag Technical Specifications
Description Standard Bags
Sizes
CultiBag Basic 1L 2L 10L 20L 50L 100L 200L
CultiBag Optical – 2L 10L 20L 50L 100L 200L
CultiBag Perfusion Pro – 2L 10L 20L 50L 100L 200L
Total Volume (L) 1 2 10 20 50 100 200 
Min Working 
Volume (L) 0.1* 0.2* 1* 2* 5* 10* 20*
Max Working 
Volume (L) 0.5 1 5 10 25 50 100 
Fittings (ID + OD)
Air Inlet Filter 1 1 1 1 1 2 2
Air Outlet Filter 1 1 1 1 1 1 1
Sample port 1 1 1 1 1 2 2
Female Luer, C-Flex 
1/8"+1/4", dip tube 1 1 – – – – –
– 1 – – – – –
– – – – – – –
Female Luer, C-Flex 
1/8"+1/4" – – 1 1 1 1 1
– – 1 1 1 1 1
– 1 1 1 1 1 1
Female Luer, Silicone 
3/16"+5/16" 1 2 1 2 2 2 2
– 2 1 1 1 1 1
– 1 – – – – –
Female MPC, C-Flex
1/4"+7/16", dip tube – – 1 1 1 – –
Male MPC, C-Flex
1/4"+7/16" - – – – 1 – –
Male MPC,
C-Flex 3/8"+5/8" – – – – – 1 1
Male MPC, C-Flex
3/8"+5/8", dip tube – – – – – 1 1
pH and DO optical 
chemical sensor – – – – – – –
– • • • • • •
– • • • • • •
Fittings CultiBag RM
Perfusion Pro only:
Perfusion membrane 1.2 μm – • • • • • •
Perfusion membrane 5 μm – • • • • • •
Female Luer, 
Pharmed 1/16" x 3/16",  
C-Flex 1/8" x 1/4", dip tube – 1 1 – – – –
Female Luer, 
Pharmed 1/16" x 3/16",  
C-Flex 1/8" x 1/4" – 1 1 – – – –
Female Luer, 
Pharmed 1/8" x 1/4",  
C-Flex 1/8" x 1/4", dip tube – – – 1 1 – –
Female Luer, 
Pharmed 1/8" x 1/4",  
C-Flex 1/8" x 1/4" – – – 1 1 – –
Female Luer, 
Pharmed 3/16" x 5/16",  
C-Flex 1/4" x 7/16", dip tube – – – – – 1 1
Female Luer, 
Pharmed 3/16" x 5/16",  
C-Flex 1/4" x 7/16" – – – – – 1 1
• or number = included
– = not included
= applies to all 
Bag types
= applies to basic 
Bags only
= applies to optical 
Bags only
= applies to perfusion 
Bags only
* Bags with sensors require 
a higher minimum working
volume than indicated
For additional information and
order codes please refer to our
datasheet CultiBag RM.
-489-
Sp
ec
if
ic
at
io
ns
 s
ub
je
ct
 to
 c
ha
ng
e 
w
it
ho
ut
 n
ot
ic
e.
 P
rin
te
d 
in
 G
er
m
an
y 
on
 p
ap
er
 th
at
 h
as
 b
ee
n 
bl
ea
ch
ed
 w
it
ho
ut
 a
ny
 u
se
 o
f c
hl
or
in
e.
 W
/s
ar
t-
00
0
· G
.
Pu
bl
ic
at
io
n 
N
o.
: S
BT
15
01
-e
08
06
4 
· O
rd
er
 N
o.
: 8
50
30
-5
32
-2
0
Sales and Service Contacts
For further contacts, visit www.sartorius-stedim.com
Europe
Germany
Sartorius Stedim Biotech GmbH
August-Spindler-Strasse 11
37079 Goettingen
Phone +49.551.308.0
Fax +49.551.308.3289
www.sartorius-stedim.com 
Sartorius Stedim Systems GmbH
Schwarzenberger Weg 73–79
34212 Melsungen
Phone +49.5661.71.3400
Fax +49.5661.71.3702
www.sartorius-stedim.com
France
Sartorius Stedim Biotech S.A.
Z.I. des Paluds
Avenue de Jouques – BP 1051
13781 Aubagne Cedex
Phone +33.442.845600
Fax +33.442.845619
Sartorius Stedim France
4, rue Emile Baudot
91127 Palaiseau Cedex
Phone +33.1.6919.2100
Fax +33.1.6920.0922
Austria
Sartorius Stedim Austria GmbH
Franzosengraben 12
A-1030 Vienna
Phone +43.1.7965763.18
Fax +43.1.796576344
Belgium
Sartorius Stedim Belgium N.V.
Leuvensesteenweg, 248/B
1800 Vilvoorde
Phone +32.2.756.06.80
Fax +32.2.756.06.81
Denmark
Sartorius Stedim Nordic A/S
Hoerskaetten 6D, 1.
DK-2630 Taastrup
Phone +45.7023.4400
Fax +45.4630.4030
Italy
Sartorius Stedim Italy S.p.A.
Via dell’Antella, 76/A
50012 Antella-Bagno a Ripoli (FI)
Phone +39.055.63.40.41
Fax +39.055.63.40.526
Netherlands
Sartorius Stedim Netherlands B.V.
Edisonbaan 24
3439 MN Nieuwegein
Phone +31.30.6025080
Fax +31.30.6025099
Spain
Sartorius Stedim Spain SA
C/Isabel Colbrand 10–12, 
Planta 4, Oficina 121
Polígono Industrial de Fuencarral
28050 Madrid
Phone +34.91.3586102
Fax +34.91.3588804
Switzerland
Sartorius Stedim Switzerland GmbH
Lerzenstrasse 21
8953 Dietikon
Phone +41.44.741.05.00
Fax +41.44.741.05.09
U.K.
Sartorius Stedim UK Limited
Longmead Business Park
Blenheim Road, Epsom
Surrey KT19 9 QQ
Phone +44.1372.737159
Fax +44.1372.726171
America
USA
Sartorius Stedim North America Inc.
131 Heartland Blvd.
Edgewood, NY 11717
Toll-Free +1.800.368.7178
Fax +1.631.254.4253
Sartorius Stedim SUS Inc.
1910 Mark Court
Concord, CA 94520
Phone +1.925.689.6650
Toll Free +1.800.914.6644
Fax +1.925.689.6988
Sartorius Stedim Systems Inc. 
201 South Ingram Mill Road
Springfield, MO 65802
Phone +1.417.873.9636
Fax +1.417.873.9275 
Asia|Pacific
India
Sartorius Stedim India Pvt. Ltd.
10, 6th Main, 3rd Phase Peenya
KIADB Industrial Area
Bangalore – 560 058
Phone +91.80.2839.1963|0461
Fax +91.80.2839.8262
Japan
Sartorius Stedim Japan K.K.
KY Building, 8–11 
Kita Shinagawa 1-chome
Shinagawa-ku
Tokyo 140-0001
Phone +81.3.3740.5407
Fax +81.3.3740.5406
Malaysia
Sartorius Stedim Malaysia Sdn. Bhd.
Lot L3-E-3B, Enterprise 4
Technology Park Malaysia
Bukit Jalil
57000 Kuala Lumpur
Phone +60.3.8996.0622
Fax +60.3.8996.0755
Singapore
Sartorius Stedim Singapore Pte. Ltd.
10, Science Park Road, The Alpha
#02-25, Singapore Science Park 2
Singapore 117684
Phone +65.6872.3966
Fax +65.6778.2494
Australia
Sartorius Stedim Australia Pty. Ltd.
Unit 17/104 Ferntree Gully Road
Waverley Business Park
East Oakleigh, Victoria 3166
Phone +61.3.9590.8800
Fax +61.3.9590.8828
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Specifications
Materials of Construction
Prefilter Membrane: Polyethersulfone,
asymmetric
Endfilter Membrane: Polyethersulfone,
asymmetric
Support Fleece: Polypropylene
Core: Polypropylene
End Caps: Polypropylene
O-Rings: Silicone (optional
EPDM or Viton)
Pore Size 
0.45 μm + 0.2 μm
Available Sizes |Filtration Area
Size 1 10” 0.6 m2|6 ft2
Size 2 20” 1.2 m2|12 ft2
Size 3 30” 1.8 m2|18 ft2
Available Adapters | Connectors
21, 25, 27, 28
Operating Parameters
Max. Allowable 5 bar|75 psi at 20°C
Differential Pressure: 2 bar|29 psi at 80°C
Max. Allowable Back 2 bar|29 psi at 20°C
Pressure:
Sartopore® 2  0.2 μm
Sterilizing Grade Filter Cartridges
Description
Sartopore® 2 0.2 μm rated sterilizing grade 
filter cartridges are designed for filtration 
of a broad range of pharmaceutical products
where compliance with cGMP requirements
has to be fulfilled. Sartopore® 2 cartridges 
feature a unique hydrophilic heterogeneous
double layer Polyethersulfone membrane
with broad chemical compatibility, high 
thermal resistance and higher throughput
and flow-rate than any other sterilizing 
grade filter cartridge. 
Applications
Typical applications include sterilizing 
grade filtration of:
– Therapeutics
– Biological Fluids
– Opthalmics
– SVPs, LVPs
– Antibiotics
– WFI
– Chemicals
– Cleaning and sanitizing agents 
– Bulk pharmaceutical products
Compatibility
The polyethersulfone membrane is compatible
with a pH range from pH 1 to pH 14 and
unaffected by steam sterilization cycles 
making Sartopore® 2 cartridges ideal for 
filtration of solutions with high| low pH and
for SIP|CIP-cycles.
Performance
Sartopore® 2 cartridges provide an exception-
ally high total throughput by fractionated 
filtration due to the "built-in prefiltration" of
the 0.45 μm membrane. The asymmetric pore
structure of the polyethersulfone membrane
provides high flow rates at low pressure
drops.
Wettability
Sartopore® 2 cartridges can be easily wetted
out for integrity testing even after drying 
at 80°C for 12 hours.
Microbiological Retention
Sartopore® 2 filter cartridges are fully 
validated as sterilizing grade filter elements
according to HIMA and ASTM F-838-83
guidelines. 
Quality Control
Each individual element is integrity tested 
by diffusion and bubble point test prior 
to release, assuring absolute reliability.
Documentation
Sartopore® 2 cartridges are designed, devel-
oped and manufactured in accordance with
an ISO 9001 certified Quality Management
System. A Validation Guide and Extractables
Guide are available for compliance with 
regulatory requirements.
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Sartorius Stedim Biotech GmbH
August-Spindler-Strasse 11
37079 Goettingen, Germany
Phone +49.551.308.0
Fax +49.551.308.3289
www.sartorius-stedim.com 
USA Toll-Free +1.800.368.7178
UK +44.1372.737159
France +33.442.845600
Italy +39.055.63.40.41
Spain +34.91.3586102
Japan +81.3.3740.5407
Specifications subject to change 
without notice. Printed and copyrighted 
by Sartorius Stedim Biotech GmbH
W/sart-000 · G
Publication No.: SPK2030-e08066
Order No.: 85030-511-67
Specifications 
Extractables
Sartopore® 2 0.2 μm rated filter cartridges
meet, or exceed the requirements for WFI
quality standards set by the current USP.
Regulatory Compliance
100% Individually integrity tested
Integrity test correlated to HIMA/ASTM 
F 838-83 Bacteria Challenge Test
Non-pyrogenic according to USP Bacterial
Endotoxins
Passes USP Plastics Class VI Test
Non-fiber releasing according to 21 CFR
Sterilization
In-Line Steam Sterilization:
134°C, 20 min. at max differential pressure 
of 0.5 bar|7.25 psi
Autoclaving:
134°C, 2 bar|29 psi, 30 min
Sterilization Cycles
In-Line Sterilization: Min. 25
Autoclaving: Min. 25
Technical References
Validation Guide:
SPK 5732-e
Extractables Guide:
SPK 5731-e
Water Flow Rates for 10″, 20″ and 30″ Cartridges
Differential pressure [bar]
1
0.75
0.5
0.25
0
15
7.5
0
0           2,000        4,000        6,000        8,000      10,000      12,000      14,000
Flow [l/h]
10″                           20″                            30″
[psi]
Total Throughput Comparison
100
80
60
40
20
0
Total throughput [kg at 95 % blockage]
Sartopore 2
0.45 | 0.2 μm
PVDF
0.2 μm
PVDF
0.22 μm
Nylon
0.2 | 0.2 μm
PESU
0.8 | 0.2 μm
Standardized at 20°C
10″ Cartridge format
Ordering Information
Order Code. Pore size Test Max. Min. B.P.
[μm] Pressure Diffusion [bar|psi]
[bar|psi] [ml/min]
544**07H1 0.2 2.5|36 18 3.2|46
544**07H2 0.2 2.5|36 36 3.2|46
544**07H3 0.2 2.5|36 54 3.2|46
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PERISTALTIC PUMPS
ARE IDEAL FOR
 Abrasive and aggressive fluids
 Beverage dispensing
 Cell culture
 Fermentation
 Filtration and separation
 Food processing
 Industrial chemicals
 Inks and pigments
 Pharmaceuticals
 Photographic solutions
 Water treatment
The benefits of peristaltic pumping
Compared to lobe pumps, diaphragm
pumps, gear pumps and piston pumps,
and every other type of pump, these
are the advantages of Watson-Marlow
pumps: 
1 No contamination of the fluid.
2 No contamination of the pump.
3 Ideal for shear-sensitive and aggressive
fluids.
4 Self-priming, dry-running.
5 No valves, seals or glands.
6 Automatic check valve action prevents
backflow.
Watson-Marlow leads the world in
solving fluid handling problems with
peristaltic pumping technology. The
company is accredited for design and
manufacture to ISO9001, and
provides its customers with nothing
less than the best products, service and
knowledge. Watson-Marlow conducts
its business ethically, and stands by 
its word, its recommendations and 
its products.
Put Watson-Marlow to work
on your pumping problems
 Watson-Marlow peristaltic pumps are problem
solving pumps, best applied where other pump
types fail or frustrate.Watson-Marlow works only
through trained engineers, and, wherever you are,
they will work with you, using the experience of
meeting and solving literally thousands of pumping
problems.
 As the largest peristaltic pump 
manufacturer, with a range of pumps
and tubing for flow rates from
microlitres per hour to thousands of
litres per hour, we stand every
chance of helping you, but if we
cannot we will tell you. 
 If we can help, we will do whatever
is necessary to prove to you that it will
do the job. Any product we
recommend, we will stand by
completely, and if it fails to meet the
agreed need, then that will be our
problem and not yours. 
800 Brochure 1996 (inposed)  6/8/01  11:48 am  Page 1
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Purchasers in the EU please note
825 and 840 pumpheads are specially designed
for connection by the user to gearboxes of the
users choice and they do not carry the CE mark.
These pumpheads are supplied with
“Declarations of Incorporation” as required by
the EU Machinery Directive.
The B/RA and the RA bare shaft pumps carry
the CE mark, but the complete motorised pump
assembly must also carry the assembler's CE
mark in addition to the Watson-Marlow CE
mark.
Customers in EU member States must note that
self assembly of machines carries with it the
responsibility to ensure that the final working
assembly complies with all the relevant EU
safety directives and the assembler’s CE mark
is affixed on completion.
Standards
CE Conforms to all relevant Directives
IEC 335-1 is the International Electrotechnical
Commission standard dealing with the
“Safety of household and similar appliances,
general requirements”. Equivalents are
BS3456: Part 101 and DIN VDE 0700: Part 1).
EN60529 is the European Norm standard
dealing with the “Classification of degrees of
protection provided by enclosures for
rotating machines. Equivalents are BS 4999:
Part 105, IEN 60034: Part 5, and DIN VDE
0530: Part 5. IP numbers (such as IP34, IP42,
IP55) indicate the degree of ingress
protection of the product, with the first digit
indicating protection against the ingress of
objects, and the second digit indicating the
degree of protection against the ingress of
water.
EN60204-1 is the European Norm covering
“The Safety of Machines - Electrical
Equipment of Machines”.
EN61010-1 is the European Norm covering
“Safety requirements for electrical
equipment for measurement, control and
laboratory use”.
EN50081-1 is the European Norm covering
“Electromagnetic compatibility - Generic
Emission standard - Residential, commercial
and light industry”.
EN50082 - 1 is the European Norm covering
“Electromagnetic compatibility - Generic
Immunity standard - Residential, commercial
and light industry”.
Spare parts availability
Watson-Marlow’s policy is to provide spare
parts for all products for a minimum of eight
years from discontinuation. For major
products, this period is extended to twelve
years. The ability to implement this policy is
not entirely within Watson-Marlow’s control
and cannot be guaranteed, but every effort
will be made to honour this policy.
Common conversions
To go from Multiply by To get to
bar 14.50377 psi
inches 25.4 mm
deg C (1.8 x C) + 32 deg F
gal (IMP) 4.5460 litres
gal (US) 3.7854 litres
gal (IMP) 1.20095 gal (US)
gpm (US) 0.22712 m3/hr
gpm (IMP) 0.27276 m3/hr
inches Hg 1.1329 ft H2O
inches Hg 0.4912 psi
kg/cm2 14.22334 psi
kW 1.341 hp
kPa 0.14504 psi
N/m2 1.0 Pa
Pa 0.00001 bar
litre 0.0001 m3
kgcm 0.098 Nm
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25mm High-flow, hygienic pump
Provides 2000 litre/hr 
(0.33 litre/rev)
Twin stainless steel rollers
Hinged door with only two
captive bolts makes
changing tube extremely
simple and safe
Use USP Class VI Bioprene
tubing for 2 bar (29 psi) and
3.5 bar (51 psi) operation
Tube elements complete
with hygienic connectors
Tubing in extended element
lengths for fitting customers
own connectors
Bareshaft pumpheads to
take a range of foot-
mounted motors with
flexible couplings
Pumpheads to accept IEC B5
output flange-mounted gear
motors
Pumps
825B/R Baseplate mounted bareshaft pumphead 080.2500.000
825RA Pumphead with bareshaft adaptor (no baseplate) 083.2510.000
Bioprene tubing for 825 pumps
Tube bore
25mm 1” 2 bar TM tube element 770mm length 088.0250.E0M
25mm 1” 3.5 bar TH tube element 770mm length 088.0250.E0H
25mm 1” 2 bar TM tube element 2.3m length 088.0250.00M
25mm 1” 3.5 bar TH tube element 2.3m length 088.0250.00H
Connectors for 825 pumps
825CT Triclamp hygienic connector 1” 089.0250.00T
825CS SMS hygienic connector 089.0250.00S
825CI IDF/ISS hygienic connector 089.0250.00R
825CQ Quick coupling (MIL-C-2748F) 1” 089.0250.00Q
825CR Quick RJT (BS1864) connector 089.0250.00R
Tube lubricant
400g Translucent food machinery grease (USDA-H1) approved 098.0005.000
BS800, IEC 335-1, 
EN60529 (IP55) CE
Ordering information
Standards
800 SERIES2
825R or B/R Motor power/tube life
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Configurations
All 800 series pumps are available
from Watson-Marlow as complete,
ready to run, motorised pumps
with a two year warranty.
Each pump supplied by Watson-
Marlow is a fully assembled,
ready-to-run unit, or a B/RA or an
RA bare shaft, ready-to-drive
pumphead, which complies with
all relevant EU (European Union)
safety directives and carries the 
relevant CE mark or declaration of
incorporation.
Fixed speed pumps
825 and 840 pumps can be supplied as a
complete speed units fitted with an IP55 motor
and gearbox in 4 different speeds.
825FB/R pump speeds are 22, 38, 68 and 98
rpm. 840FB/R pump speeds are 22, 39, 62 and
100 rpm.
Variable speed inverter controlled pumps
We supply complete electronically variable
speed pumps with two maximum speeds with a
5:1 reduction ratio. The minimum flow rate will
be approximately 20% of the maximum
achievable.
Watson-Marlow have selected as standard
accessories, single phase input/three phase
output inverters for use with the 800 series
pumps (maximum power requirement 1.5KW,
for use with the 825 pumps and 2.2KW for use
with 840 pumps).
All Watson-Marlow pumps are available fitted
with motorised geared units to suit the users
own choice of inverter.
Mechanically variable speed pumps
All Zone 1 Exd 800 series pumps and those
rated above 2.2KW are fitted with belt driven
mechanically variable speed gearboxes and
IP55 standard motors.
Accessories
Pulsation dampers will be required for certain
applications. Watson-Marlow will supply
pulsation dampers from the Flowguard
range. 
Tube failure detectors are available to order.
A choice of feet or castors for fitting to 825
and 840 pump frames are available.
Explosion-proof pumps
All pumps are available fitted with Exd IIB T4
specification explosion-proof motors that
meet all EU explosion-proof standards.
Specially selected combinations of explosion-
proof motors and electronic inverters are
available. These inverters are not fitted with
explosion-proof casework and therefore must
be sited outside the hazardous area.
800 SERIES 7
Drive options
A number of motor/gearbox
options and control options are
available for these pumps
including fixed and variable speed
with mechanical variatiors. The
options include inverter control
enabling 4-20mA and 0-10V
process control, remote stop/start
and reverse, and frequency output.
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40mm High-flow, hygienic pump
Pumps
840B/RA Baseplate mounted bareshaft pumphead 080.4000.000
840RA Pumphead with bareshaft adaptor (no baseplate) 083.4010.000
Bioprene tubing for 840 pumps
Tube bore
40mm 15/8” 2 bar TM tube element 1.25m length 088.0400.E0M
40mm 15/8” 3.5 bar TH tube element 1.25m length 088.0400.E0H
40mm 15/8” 2 bar TM tube element 2.5m length 088.0400.00M
40mm 15/8” 3.5 bar TH tube element 2.5m length 088.0400.00H
Connectors for 840 pumps
840CT Triclamp hygienic connector 2” 089.0400.00T
840CS SMS hygienic connector 089.0400.00S
840CI IDF/ISS hygienic connector 2” 089.0400.00R
840CQ Quick coupling (MIL-C-2748F) 089.0400.00Q
840CR Quick RJT (BS1864) connector 089.0400.00R
Tube lubricant
400g Translucent food machinery grease (USDA-H1) approved 098.0005.000
BS800, IEC 335-1, 
EN60529 (IP55) CE
Ordering information
Standards
Provides 8000 litre/h 
(1.33 litre/rev)
Twin stainless steel rollers
Hinged door with two
captive bolts makes
changing tube extremely
simple and safe
Use USP Class VI Bioprene
tubing for 2 bar (29 psi) and
3.5 bar (51 psi) operation
Tube elements complete
with hygienic connectors or
Tubing in extended element
lengths for fitting customers
own connectors
Bareshaft pumpheads to
take a range of foot-
mounted motors with
flexible couplings
Pumpheads to accept IEC B5
output flange-mounted gear
motors
800 SERIES4
840R or B/R Motor power/tube life
800 Brochure 1996 (inposed)  6/8/01  11:48 am  Page 5
-498-
800 SERIES 5
840RA 840B/RA 840FB/R or DFB/R 840VBI/R 840VB/R or DVB/R
840B/RA
840FB/R, 840VBI/R, 840DFB/R, 840DVB/R
Dimensions mm
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800
Tube life High pressure tube life
800 SERIES6
Operating and storage
temperatures
Unless otherwise stated, all
pumps listed in this brochure may
be operated at ambient
temperatures between 5C and 40C
(41F and 104F). They may be
stored at temperatures between 
-40C and 70C (-40F and 158F), but
allow time for acclimatisation
before operating.
Flow rates
All flow rates quoted in this brochure were obtained
pumping water at 20C (68F) with zero suction and
delivery heads. 
The Watson-Marlow 800 series pumps use a
Bioprene tube which meets USP and NFS Class
VI requirements. Bioprene also complies with
FDA 21 CFR 177.260 and meets USDA
standards for food handling.
High pressure applications
For specific higher pressure
applications, use 3.5 bar “TH” tubing
elements for intermittent periods only.
Do not use quick connectors for this
process. Tubing previously used as a
pumping element should not be used
as a transfer section.
Tube lubricant
Translucent food machinery grease
(USDA-H1 approved for food contact)
is available for 800 series tubing to
prolong tube life.
Connectors
800 series pumps may be used
with either tube elements fitted
with hygienic  connectors or
extended element lengths. A
choice of connector types is
offered, including Triclamp
(Triclover and 3A compatible), IDF
and SMS sanitary, and RJT. These
are constructed from 316 stainless
steel and are totally autoclavable.
Tubing
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825RA 825B/RA 825FB/R or DFB/R 825VBI/R 825VB/R or DVB/R
825B/RA
825FB/R, 825VBI/R, 825DFB/R, 825DVB/R
Dimensions mm
800 SERIES 3
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800
Paint specification
The 800 series epoxy polyester powder coating
is based on a mixed polymer thermosetting
resin designed to combine the durability
associated with epoxies with the enhanced UV
and heat stability associated with polyesters.
This results in a high quality finish which is
abrasive and impact resistant.
Installation drawings
Installation drawings of all 800 series pumps
are available on request in A3 size.
Reproducible drawings are also available for a
modest fee.
Custom-built pumps
Watson-Marlow Limited’s team of technical
support engineers is available to advise and
quote for your custom-built pumps with
electric, hydraulic or pneumatic motors, trolley
mounting, stainless steel baseplates etc.
800 SERIES8
Description Material
Pumphead body Aluminium alloy with epoxy polyester powder coat finish
Pumphead door Aluminium alloy with epoxy polyester powder coat finish
Pumphead rotor Aluminium alloy
Rotor rollers 316 stainless steel
Frame Stainless steel 304L
Optional motor housing Stainless-steel 304L
Door fixings Stainless steel
Motor fixings Zinc plated high tensile steel bolts, stainless steel nuts and washers
Frame fixings Stainless steel
Materials of construction
CIP
The 800 series pumphead incorporates
retractable roller mechanisms which allow
clean-in-place or steam-in-place hose cleaning.
The roller mechanisms are simply unlocked and
disengaged from the standard pumping
position, providing maximum cleaning capacity
via a free flow of cleaning agents through the
hose.
SIP
The 800 series can be steamed-in-place at 
135°C (2 bar) for a duration of one hour. Allow
15 minutes for pump to return to ambient
temperature prior to restarting pump.
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Unmatched warranties
The high quality of the design and
manufacture of Watson-Marlow
products allows us to offer
international warranties far
exceeding those available for
other pump types. 
All 800 series pumps carry a two
year warranty.
25mm hygienic pumps
40mm hygienic pumps
Flow rates
Up to 8,000 litres/hour depending
upon motor speed.
Pressures
Up to 3.5 bar continuous operation
governed by motor sizing.
Drive options
Fixed speed, variable speed
(inverter or mechanical variator),
all drives available with Exd
options. Contact Watson-Marlow
Technical Support for further
information.
Duty rating
24 hour governed by motor sizing.
The 800 series pumps have been designed for hygienic
pumping up to 8000 litre/hour and pressures to 3.5
bar (51 psi), in the biotechnology, pharmaceutical and
food industries. Pumpheads are constructed of
aluminium with an epoxy powder coated white finish
and they offer true CIP (clean-in-place) and SIP
(steam-in-place) as the rollers retract to a non-
occluding position, allowing a complete flow-through
for cleaning.
All pumps are mounted on a stainless steel frame with
the option of a brushed stainless steel motor housing,
where belt variators are not required.
Watson-Marlow’s focus has been to minimise the total
cost of ownership over the lifetime of the pumps by
making them reliable, long-lasting, and simple to use
and maintain. Downtime is the true enemy of
productivity, and so minimising downtime and
whatever essential maintenance is required rewards
our care and your choice of pump.
For instance and (uniquely), access to the tube is
through a hinged door rather than a lift-off cover, and
the door is secured by two captive bolts rather than
sixteen or twenty loose ones, making tube changing
fast, simple and safe. 
Bioprene tube elements with hygienic connectors are
autoclavable and can be fitted quickly and cleanly.
Where hygiene and system up-time is valued,
there is no better pump than a Watson-Marlow 800
series.
800 SERIES 1
years
W
2
warranty
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
ST DESIGN 
Belgium
Telephone 02 529 5858
Fax 02 529 5861
Web www.watson-marlow.com/watson-marlow/
Email bs.support@watson-marlow.com
France
Telephone (1) 30 62 12 47
Fax (1) 30 66 11 22
Web www.watson-marlow.com/watson-marlow/
Email fs.support@watson-marlow.com
Germany
Telephone 02183 42040
Fax 02183 82592
Web www.watson-marlow.com/watson-marlow/
Email ds.upport@watson-marlow.com
Italy
Telephone (03) 0687 1184
Fax (03) 0687 1352
Korea
Telephone 02 525 5755
Telex K26177
Fax 02 525 5764
Web www.watson-marlow.com/watson-marlow/
Email k.support@watson-marlow.com
Watson-Marlow Limited
The Netherlands
Telephone 010 462 1688
Fax 010 462 3486
Web www.watson-marlow.com/watson-marlow/
Email nl.support@watson-marlow.com
Singapore
Telephone (65) 456 7274
Fax (65) 457 5912
United Kingdom
Telephone +44 1326 370370
Fax +44 1326 376009
www.watson-marlow.com/watson-marlow/
Email support@watson-marlow.co.uk
United States of America
Telephone 800 282 8823
Fax 508 658 0041
Web www.watson-marlow.com/watson-marlow/
Email us.support@watson-marlow.com
Members of the Spirax-Sarco Engineering Group
Watson-Marlow is a registered trademark of
Watson-Marlow Limited.
Publication ref: HB 0057
The information contained in this document is
believed to be correct but Watson-Marlow Limited
accepts no liability for any errors it contains, and
reserves the right to alter specifications without
notice.
600
Mid flow pumps
Cased pumps or baseplate-mounted
pumps for flows up to 15.8 litre/min
(4.2 US gpm). Fixed or variable speed
and single channel. 
 HB 0063           
300
Low-cost pumps
Flow rates from 0.2  to 2,000 ml/min.
Fixed and variable speeds.
 HB 0060
500
Microprocessor controlled
pumps
Flow rates from 0.01 to 2,200 ml/min. 
1 to 48 channels. Manual, auto and
digital control.
IP55 rated pumps
Washdown pumps for tough
environments, and pneumatic or
baseplate-mounted pumps with Exd
motors for hazardous areas. Flow
rates to 2.2litre/min. 
 HB 0062
100/200
Low-flow pumps
100 series flow rates from 0.01 to 53
ml/min. Single channel. Fixed and
variable flow rates.
Multi-channel pumps
200 series flow rates from microlitres
to 32 ml/min. through up to 32
channels. Manual and auto-control.
 HB 0065
700
High-flow pumps
IP55 rated pumps with manual or auto
control and baseplate-mounted
industrial pumps provide flows to 2,000
litre/hr (8.8 US gpm). Single or twin
channel. 
 HB 0060
800
High-flow hygienic pumps
Use Bioprene USP Class VI tubing for
flow rates up to 8,000 litre/hr (35 US
gpm). and pressures up to 3.5 bar (50
psi). True CIP and SIP facilities ideal
for biotech, pharmaceutical and food
industries. Single channel.
 HB 0057
900
High-flow, high-pressure
pumps
Use reinforced tubing in five different
materials for flow rates up to 10,000
litre/hr and pressures up to 15 bar
(210 psi). Single channel.
 HB 0056
Dispensers &
Robotic fillers
For repetitive and accurate dosing and
dispensing duties. Straightforward
stop/start volumes up to one litre in
five seconds or precision, balance-
controlled dispensing.
 HB 0039
OEM pumps
Pumpheads for use with customers’
own drives or plate-mounted
pumpheads and motors. Compact,
easy to install and to use. Single and
multi-channel with flow rates up to
2,700 ml/min.
 HB 0076
Tubing
Twelve different materials and over 50
sizes of tubing for the complete range
of Watson-Marlow pumps. Full
chemical compatibility tables with 450
fluids tabulated. Performance and
physical data.
 HB 0065
 These brochures describe the full Watson-Marlow range
of peristaltic pumps, tubing and accessories.
S       E        R        I        E        S
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BIOPRENE TUBING
Thermoplastic elastomer tubing
USP, ISO and FDA approvals matter in maintaining 
validated processes. Bioprene peristaltic pump tubing
offers long life and chemical resistance, and carries 
the widest range of safety approvals
 USP Class VI FDA approvals
 Fully documented bio-compatibility and comprehensive 
validation pack
 Safe for use in biomedical applications
 Ex-stock availability
 Comprehensive stock of a wide range of sizes
 UV opaque
 Fully weldable
 No odour
 Low extractables
 Suitable for repeated autoclave cycles
Highly resistant to oxidising
agents


Watson-Marlow Bioprene: the best peristaltic pump tube
life with excellent chemical resistance
Bioprene peristaltic pump
tubing is fully approved for
food and pharmaceutical
applications. Validated
processes are supported.
Like Marprene, Bioprene
lasts at least 10 times as
long as tubing in other
materials. Long-life tubing
means stoppages for a
tube change are rare
events, easily fitted in with
general maintenance. 
Validated
processes
Clean-in-place and
steam-in-place (with 
tubing elements) are no
problem for the tube that
has everything.
Easy sterilisation
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For long life and chemical compatibility
Meeting or exceeding FDA regulations
Bioprene for validation
Bore Wall
Coil size Part number Coil size Part number Coil size Part number
inch mm inch mm
1/50 0.5 1/16 1.6
50ft / 15m
903.0005.016
16ft / 5m
903.0005.J16
500ft / 152m
903.0005.R16
1/32 0.8 1/16 1.6 903.0008.016 903.0008.J16 903.0008.R16
1/16 1.6 1/16 1.6 903.0016.016 903.0016.J16 903.0016.R16
3/32 2.4 1/16 1.6 903.0024.016 903.0024.J16 903.0024.R16
1/8 3.2 1/16 1.6 903.0032.016 903.0032.J16 903.0032.R16
3/16 4.8 1/16 1.6 903.0048.016 903.0048.J16 903.0048.R16
1/4 6.4 1/16 1.6 903.0064.016 903.0064.J16 903.0064.R16
5/16 8.0 1/16 1.6 903.0080.016 903.0080.J16 903.0080.R16
903.0005.024 903.0005.J24
903.0008.024 903.0008.J24
1/16 1.6 3/32 2.4 903.0016.024 903.0016.J24 903.0016.R24
1/8 3.2 3/32 2.4 903.0032.024 903.0032.J24 903.0032.R24
3/16 4.8 3/32 2.4 903.0048.024 903.0048.J24 400ft / 122m 903.0048.R24
1/4 6.4 3/32 2.4 903.0064.024 903.0064.J24 300ft / 91m 903.0064.R24
5/16 8.0 3/32 2.4 903.0080.024 903.0080.J24 200ft / 61m 903.0080.R24
3/8 9.6 3/32 2.4 903.0096.024 903.0096.J24 150ft / 46m 903.0096.R24
903.0048.032 903.0048.I32
1/4 6.4 1/8 3.2 903.0064.032
10ft / 3m
903.0064.I32 200ft / 61m 903.0064.R32
3/8 9.6 1/8 3.2 903.0096.032 903.0096.I32 150ft / 46m 903.0096.R32
1/2 12.7 1/8 3.2 903.0127.032 903.0127.I32
5/8 15.9 1/8 3.2 903.0159.032 903.0159.I32
- 8.0 - 4.0 903.0080.040 903.0080.I40
- 12.0 - 4.0 903.0120.040 903.0120.I40
- 16.0 - 4.0 903.0160.040 903.0160.I40
3/8 9.6 3/16 4.8 903.0096.048 903.0096.I48
1/2 12.7 3/16 4.8 903.0127.048 903.0127.I48
5/8 15.9 3/16 4.8 903.0159.048 903.0159.I48
3/4 19.0 3/16 4.8 903.0190.048 903.0190.I48
1 25.4 3/16 4.8 903.0254.048 903.0254.I48
H
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Custom sizes are
available to order, as
are other specific
requirements
Bioprene Typical values
Material Thermoplastic elastomer
Colour / transparency Beige / opaque
Spallation Fair
Life, hours 313/314, 520R pumpheads: 10,000; 620R pumphead: 6,000
Certification FDA regulations 21 CFR 177.2600 for contactwith aqueous food
Sterilisation methods Gamma, autoclave, EtO. CIP, SIP: refer toWatson-Marlow for details
Operating temperature 5C-80C
Hardness, shore A (5 sec) 64 shore: 66; 73 shore: 74; 87 shore: 88
Specific gravity 64 shore: 0.97; 73 shore: 0.96; 87 shore: 0.95
Tear B, ppi -
Ultimate tensile 
strength, psi 64 shore: 1007; 73 shore: 1410; 87 shore: 2263
Elongation at break, % 64 shore: 473; 73 shore: 510; 87 shore: 547
Tensile stress at 100% 
elongation, psi 64 shore: 367; 73 shore: 525; 87 shore: 987
Compression set, % -
Weather resistance Excellent
Sunlight resistance Excellent
Gas permeability, 
O2cc.cm x 10-8 /
cm2.sec.atm
5.8
Gas permeability rating Fair
Water absorption Good
Odour Excellent
ASTM methods   Hardness: ASTM D 2240; Specific gravity: ASTM D 792; Tear B, Ultimate
tensile strength, Elongation at break, Tensile stress at 100% elongation: ASTM D 412
Bioprene offers exceptionally long life and resistance
to a wide range of chemicals. It is a first choice for
applications including metering tablet-coating materi-
als, pH control and media feed in fermentation and
bioreactor metering, as well as pharmaceutical han-
dling, dispensing, metering, transfer and filtration.
General industrial long-life transfer
tube. Highly resistant to oxidising 
agensts such as ozone, peroxides 
and sodium hypochlorite.
Netherlands
Telephone +31 (0) 10 462 1688
Fax: +31 (0) 10 462 3486
Email info@watson-marlow.nl
www.watson-marlow.nl
South Africa
Telephone +27 11 796 2960
Fax: +27 11 794 1250
Email info@wmbpumps.co.za
www.watson-marlow.co.za
Sweden
Telephone +46 8 556 556 00
Fax: +46 8 556 556 19
Email info@watson-marlow.se
www.watson-marlow.se
United States of America
Telephone 800 282 8823
Fax: +1 978 658 0041
Email support@wmbpumps.com
www.watson-marlow.com
United Kingdom
Telephone +44 (0) 1326 370370
Fax: +44 (0) 1326 376009
Email info@watson-marlow.co.uk
www.watson-marlow.co.uk
Belgium
Telephone +32 (0) 9 225 94 57
Fax: +32 (0) 9 233 06 49
Email info@watson-marlow.be
Brazil
Telephone +55 (11) 2155 4000
Fax: +55 (11) 2155 4001
Email info4brazil@watson-marlow.com
www.watson-marlow.com.br
China
Telephone +86 21 6485 4898
Fax: +86 21 6485 7366
Email mingshao@cn.spiraxsarco.com
www.watson-marlow.cn
Denmark
Telephone +45 43 94 00 65
Fax: +45 43 94 00 85
Email info@watson-marlow.dk
www.watson-marlow.dk
France
Telephone +33 (0) 1 34 87 12 12
Fax: +33 (0) 1 34 87 12 13
Email info@watson-marlow.fr
www.watson-marlow.fr
Germany
Telephone +49 (0) 2183 42040
Fax: +49 (0) 2183 82592
Email info@watson-marlow.de
www.watson-marlow.de
Italy
Telephone +39 03 06871184
Fax: +39 03 06871352
Email info@watson-marlow.it
www.watson-marlow.it
Korea
Telephone +82 (0) 32 820 3973
Fax: +82 (0) 32 811 0321
Email changwoo-
jang@kr.spiraxsarco.com
www.watson-marlow.co.kr
Malaysia
Telephone +60 (3) 5635 3323
Fax: +60 (3) 5635 7717
Email sales@my.spiraxsarco.com
www.watson-marlow.com
www.watson-marlow.co.uk
Members of the Spirax-Sarco Engineering Group
The information contained in this document is believed to be
correct, but Watson-Marlow Bredel accepts no 
liability for any errors it contains, and reserves the right to
alter specifications without notice.
WARNING These products are not designed 
for use in, and should not be used for, patient-
connected applications.
Watson-Marlow, Pumpsil, LoadSure, LaserTraceability,
Bioprene and Marprene are registered trademarks of 
Watson-Marlow Limited. STA-PURE and CHEM-SURE are
trademarks of WL Gore and Associates INC. Fluorel is a
trademark of 3M.
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Jacketed Tanks
Features at a glance:
• Standard sizes 18 to 7,000 gallon
• 304, 304L, 316, 316L stainless steel
• 2B, #4/180, #7/320, and electropolish available
• Flat, sloped, dished, or 15 ° cone bottom
• ASME or non-ASME code stamped designs
• Jackets available:  embossed, dimple, half pipe, laser
• Jacket design:  pressure 150 psi, temperature 366° F
Our cylindrical jacketed tanks are custom made to satisfy your
process, mixing, and temperature control requirements.  Built
from 304, 304L, 316, or 316L stainless steel.  Our jacketed
tanks can be easily adapted to meet your dimensional
requirements.  All standard sizes have optional features that
allow for made-to-order applications.
Ja
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ISO 9001 Certified
600 Main Street
Sharpsville, PA 16150
office:  724-962-1100
fax:  724-962-1226
email:  Sales@scacon.com
www.sharpsvillecontainer.com
Sharpsville Container is known for high quality fabrication in
stainless steel and exotic alloys.  Our vessels, whether they are
process or transport, ASME, UN, or Heat Transfer are
manufactured for the Food, Chemical, Beverage, Petro-
Chemical and Pharmaceutical markets.  The size of vessels that
we manufacture range from 1 gallon to 25,000 gallons.  With
our standard line and custom design expertise, we are capable
of meeting or exceeding your fabrication requirements.  Our
reputation for quality and service continues to exceed our
customers’ expectations.
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Separation system for Pharmaceutical and Biotechnical applications
BTAX 215 
The BTAX centrifuge is specially designed for biotechnical 
processes such as cell harvesting, broth clarification and 
the separation of cell debris. The centrifuge has a very high 
separation efficiency and can be installed in a closed system. 
To ensure cleanliness, the BTAX can be heat pasteurised to 
100oC.
Available models
The BTAX centrifuge is available in four versions
• BTAX 215S-31 CEP
 Paring disc version.
• BTAX 215S-31 CEFP
 Paring disc version, explosion protected.
• BTAX 215H-31 CEP
 Hermetic version.
• BTAX 215H-31 CEFP
 Hermetic version, explosion protected.
All BTAX models are gastight. The complete system can be 
supplied in an explosion-protected version when required.
Throughput capacity
Actual throughput is in the range of 0-12 m3/h depending on 
paring disc size and design, as well as on the amount and 
type of solids in the feed, temperature, viscosity, required 
degree of clarification etc. Max hydraulic capacity of disc 
stack is much higher.
Efficient solids ejection
During separation, solids collect in pockets recessed in 
the bowl wall which avoids undesirable solids build-up, 
and minimizes disturbances during solids ejection. The 
pneumatically operated solids-ejecting system ensures fast 
and efficient discharges resulting in a clean bowl. 
Axial discharge channels lead from the solids pockets to 
valves, which are held closed by a spring loaded valve slide. 
To eject solids from the bowl during operation the slide is 
lowered momentarily by a very short injection of compressed 
air or gas through the hollow bowl spindle. This opens the 
valves and the solids are ejected.
High separation efficiency
The high speed of the bowl creates a peripheral centrifugal 
acceleration of 12,000 gravities. This gives the BTAX an 
extremely high separation efficiency that can capture particles 
down to 0.1 µ in diameter.
Large solids space
Long periods between ejections is possible thanks to the large 
(14 l) solids space, which results in better separation and drier 
solids.
Paring disc design
In this version the clarified liquid is continuously discharged 
under pressure by a paring disc, which is a stationary impeller 
that converts the rotational energy of the liquid into pressure. 
With the paring disc design there is no need for a down-
stream pump.
Hermetic inlet and outlet
The bowl is always completely filled with liquid in the hermetic 
version. This eliminates the risk for oxidation and airborne 
infections and ensures gentle treatment of the product.
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Efficient cooling
The frame hood and bowl casing are jacketed for cooling. 
When separated solids need to be cooled, a jacketed cyclone 
can be supplied.
Totally contained system
To protect both the product and environment, the BTAX 215 is 
provided with a special water cooled axial seal under the bowl 
to prevent contamination of the drive system.
Sturdy frame and belt drive
Power is transmitted from the vertically mounted motor to the 
spindle cartridge by the flat-belt drive inside the sturdy frame. 
The vertical bowl spindle which supports and drives the 
separator bowl is designed as a replaceable cartridge unit.
Material
All liquid-wetted parts are made of high-grade stainless steel. 
The bowl body and the valve slide are made of steel quality, 
specially developed to resist corrosion and with the high 
tensile strength needed for the high g-force generated in 
the BTAX centrifuge. The frame hood, solids receptacle and 
cyclone as well as bowl casing are of stainless steel and the 
frame is epoxy-enamelled cast iron. Gaskets are of EPDM, 
Viton or Nitrile.
Standard equipment
Centrifuge with electric motor, small or large cyclone. The 
large cyclone has cooling jacket, sight glass and connections 
for level transmitter. Foundation frame and vibration dampers, 
tank for compressed air with solenoid valve for discharge, 
vibration monitor and speed transmitter, oil pressure gauge 
and switches, one set of tools and one intermediate service 
kit.
Optional equipment
Cover interlock switch, special tools for cartridge, intermediate 
and major service kit, cartridge service kit and service kit for 
foundation feet.
1. Feed valve
2. Centrate out
3. Pneumatic butterfly valve
4. Cooling jacket
5. Bowl
6. Cooling water
7. Axial seal
8. Check valve
9. Spindle cartridge
10. Oil filler and gauge
11. Flat driving belt
12. Cyclone with recirculation tube
13. Solids pockets
14. Pneumatically operated slide
15. Motor
16. Unibase frame
17. Foundation
16
17
6
15
14
13
12
1
6
2
3
4
5
6
7
4
8
9
10
11
Cross-section of BTAX 215 paring disc version
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Ancillary equipment necessary for operation
Electrical and pneumatic system consisting of
• Starting equipment with y/d-starter, DC-brake and main  
 switch.
• Control equipment:
 A. Not explosion protected version with built-in operator´s  
  control pannel. A remote control panel is available as an  
  option, or
 B. explosion protected version including a simple control  
  cabinet to be placed outside the hazardous area and an  
  operator´s control panel to be placed in the hazardous  
  area.
 C. Pneumatic unit with solenoid valves, pressure reducing  
  valves and pressure switch. Normal and explosion- 
  protected versions are available.
Valve module including inlet valves for either safety liquid or 
process feed, and outlet valves to direct the centrifugate to 
either drain or process outlet. Also included is a flow trans-
mitter and regulating valve for the feed and a counter  
pressure regulating valve for the outlet.
Service liquid unit with valves to control flushing, cooling 
and sealing liquid. Flow switches for the sealing liquid are 
also included.
For centrifuges explosion protected with inert gas the follow-
ing additional units are needed:
 A. Inert gas regulating unit with valves and flow-switches 
  for flow control.
 B. Seal pot unit to give slight overpressure in the whole  
  system.
 C. Solids receiving unit with pneumatic pump to handle 
  the discharged solids.
Technical data
Motor size                                                                           
  Standard                                     30 kW, controlled torque
  Explosion protected                    30 kW, controlled torque
  EEx de IIB T4
Throughput and power consumption
Paring disc version
  Small paring disc                                0-5 m3/h, 10-17 kW 
  Large paring disc                             2-12 m3/h, 15-25 kW
Hermetic version                                0-12 m3/h, 13-28 kW
Starting time                                            approx 7 minutes
Stopping time                                                                     
  With DC brake                                     approx 20 minutes
Max bowl speed                                                 6,065 rpm
Solids space volume                                               14 litres
Caulk thickness                                                       0.4 mm
Cooling water consumption
  Cooling jacket                                                 200-400 l/h
  Hermetic seal                                                      60-80 l/h
  Axial seal                                                                  30 l/h
  Cyclone with cooling jacket                             200-400 l/h
Gas consumption for solids discharge        20 Nl/discharge
Max. pasteurization temperature                               100oC
Discharge valve          24 VDC, 24 VAC, 48 VAC, 110 VAC,
                                                                        EEx d IIC T5
Inert gas consumption
  For purging                                                        20 Nm3/h
  For normal operation                                    100-400 Nl/h
Control and starting equipment (not 
explosion-protected).
Inert gas regulating unit. Valve module and service liquid unit.
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Specifications 
Materials of construction
Membrane Hydrosart 
(stabilized cellulose
based membrane)
Gaskets PVDF
Spacer Polypropylene
Sealing compound Silicone
Pore size|Retention rate
Hydrosart ultrafiltration cassettes are 
available in a choice of the following 
nominal molecular weight cut offs: 
10 kD|30 kD
Available sizes
Sartorius Crossflow Cassettes are available in
Standard Cassette size for pilot-|production
scale and in Sartocon Slice format for
reduced volume handling.
Available filterholder
Sartorius Crossflow Cassettes are designed 
for Sartorius filter holders like, Sartocon,
Sartocon 2 Plus, Sartocon 3, and different
Sartoflow holder.
Filtration area
Filter area Sartocube® Cassette is 3.0 m2
Operating parameters 
Feed pressure, Pin 58 psi |4 bar
maximum
Operating temperature 50°C maximum, 
at 20°C
Max. air diffusion 50 ml air/min for
rates at 3.0 m2 filter area
Pin = 15 psi |1 bar
Cleaning NaOH, 1 M, 40°C
Disinfection NaOH, 1 M, 40°C, 
30 min
Storage NaOH, 0.1 M
Sartocube® – Hydrosart® Ultrafilter Cassette
Protein purification, concentration and diafiltration
Sartorius Crossflow Filter
Description
The Hydrosart® Membrane
Hydrosart is a stabilized cellulose based 
membrane that has been optimized for 
the biotechnological and pharmaceutical
industry. The Hydrosart membrane is a stable 
polymer that features a broad pH range.
Hydrosart is also extremely hydrophilic, 
making it non-protein binding, virtually non-
foul, and has extremely high flux. Membrane
regeneration, storage and depyrogenation
can be accomplished by using NaOH even at
elevated temperatures. These features make
Hydrosart an ideal membrane for biological
applications. Hydrosart ultrafiltration 
Sartocube® cassettes are available in the 
following nominal molecular weight 
cutoffs: 10 kD|30 kD
Applications
Hydrosart ultrafiltration membranes are
designed for use in the biotechnological 
and pharmaceutical industries. They can 
be used for the following applications: 
– Oligonucleotide
– Proteins
Albumin, even with 40% EtOH
Hemoglobin 
– Coagulation factors
Factor VIII
Factor III 
– Vaccines 
Tetanus
Diphteria 
– Monoklonal Antibodies
Product profile 
Hydrosart shows minimal adsorption of 
proteins, viruses, etc. Membrane retention 
is unaffected by repeated re-use. 
The Hydrosart ultrafiltration membrane 
can be re-used without any less cleaning 
loss of integrity or performance.
Feature Benefits
Non-adsorptive No loss of proteins,
easy to clean, 
sustained flux
Non-protein binding High product yield
Wide pH and More choices in 
temperature range sanitizing agents
High flow rates Economical filtration
runs
Self sealing cassette No gaskets needed
Silicone sealing No glue
compound
Enlarged inlet and Lower pressure drop
outlet holes
Better solvent resistance than 
Polyethersulfone and Cellulose Triacetate
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Sterilization
NaOH, 1 M, 40°C, 30 min 
Regulatory compliance
All materials have passed the current USP
Biological Test. The filtrate meets or exeeds
USP and EP requirements for Sterile Water
for Injection with respect to total solids,
oxidizable substances, particulate matter,
ammonia, chloride, nitrate, sulfate and 
heavy metals.
Quality control
Each filter cassette is individually assigned a
serial number, integrity tested and certified.
It complies with cGMP requirements for 
non-fiber-releasing filters and is filed under
the Drug Master File Number DMF 5967 
by the Food and Drug Administration,
Washington, DC. Validation information 
is available upon request.
If you use holding devices from other
suppliers, please contact our Applications
Department. A different torque might be
needed due to specific variations in design.
For further assistance, please contact 
your local Sartorius field engineer or 
our Goettingen- based Applications
Department in Germany.
Technical references:
Validation Guide 
Publication No.: SPC5704-e
Directions for Use (Sartocube® Cassettes)
Publication No.: SPC6018-a
Typical water flux release data*
Nominal molecular Sartocube® Cassettes 
weight cutoff 3.0 m2 filter area 
(kD) Permeate* [l/h]
10 kD 190
30 kD 600
* (Feed pressure, Pin = 22 psi |1.5 bar; Retentate pressure, Pout = closed valve; PFiltrate = open valve)
Retention rates Hydrosart®
Substance Approx. Mol. Wt. 2 kD 5 kD 10 kD 30 kD 100 kD
Vitamin B12 1.200 >88% – – –
Inulin 5.000 – >97% – –
Cytochrome C 12.400 – – >97,5% –
Albumin 67.000 – – – >97,5% <60%
γ Globulin 169.000 – – – >97,5% >96%
Order information 
Available types and order numbers
Type Filter area Cut off Order no.
Sartocon Cassettes 3.0 m2 10 kD 302 144 39 30 E–BSW
Sartocon Cassettes 3.0 m2 30 kD 302 144 59 30 E–BSW
Sartorius Crossflow Filter
Sartorius AG
Weender Landstrasse 94–108
37075 Goettingen, Germany
Phone +49.551.308.0
Fax +49.551.308.3289
www.sartorius.com
USA +1.631.2544249
UK +44.1372.737159
France +33.1.69192100
Italy +39.055.634041
Spain +34.91.3586100
Japan +81.3.33293366
Specifications subject to change without notice. 
Printed in Germany on paper thas been bleached 
without any use of chlorine.
by Sartorius · W/sart-228 · G
Publication No.: SPC2047-e05121
Order No.: 85030-523-55
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Specifications 
Materials of construction
Membrane Hydrosart 
(stabilized cellulose
based membrane)
Gaskets PVDF
Spacer Polypropylene
Sealing compound Silicone
Pore size|Retention rate
Hydrosart ultrafiltration cassettes are 
available in a choice of the following nominal
molecular weight cut offs: 5 k|10 k|30 k
Available sizes
Sartorius Crossflow Cassettes are available in
Standard Cassette size for pilot-|production
scale and in Sartocon Slice format for
reduced volume handling.
Available filterholder
Sartorius Crossflow Cassettes are designed 
for Sartorius filter holders like SartoconSlice
(0.1 m2 Cassettes only), Sartocon, Sartocon 2
Plus, Sartocon 3, and different Sartoflow
holder.
Filtration area
Filter area Sartocon Cassette 0.6 m2
Filter area Sartocon Slice Cassette 0.1 m2
Operating parameters 
Feed pressure, Pin 58 psi |4 bar
maximum
Operating temperature 50°C maximum, 
at 20°C
Max. air diffusion 15 ml air/min for
rates at 0.6 m2 filter area
Pin = 15 psi |1 bar 5 ml air/min for 
0.1 m2 filter area
Cleaning NaOH, 1 M, 40°C
Disinfection NaOH, 1 M, 40°C, 
30 min
Storage NaOH, 0.1 M
Hydrosart® Ultrafiltration Cassettes
Protein purification, concentration and diafiltration
Sartorius Crossflow Filter
Description
The Hydrosart® Membrane
Hydrosart is a stabilized cellulose based 
membrane that has been optimized for 
the biotechnological and pharmaceutical
industry. The Hydrosart membrane is a stable
polymer that features a broad pH range.
Hydrosart is also extremely hydrophilic, 
making it non-protein binding, virtually 
non-foul, and has extremely high flux. 
Membrane regeneration, storage and 
depyrogenation can be accomplished by 
using NaOH even at elevated temperatures.
These features make Hydrosart an ideal 
membrane for biological applications.
Hydrosart ultrafiltration cassettes are 
available in the following nominal molecular
weight cutoffs: 2 k|5 k|10 k|30 k 
Applications
Hydrosart ultrafiltration membranes are
designed for use in the biotechnological 
and pharmaceutical industries. They can 
be used for the following applications: 
– Oligonucleotide
– Proteins
Albumin, even with 40% EtOH
Hemoglobin 
– Coagulation factors
Factor VIII
Factor III 
– Vaccines 
Tetanus
Diphteria 
– Monoklonal Antibodies
Product profile 
Hydrosart shows minimal adsorption of 
proteins, viruses, etc. Membrane retention 
is unaffected by repeated re-use. 
The Hydrosart ultrafiltration membrane 
can be re-used without any less cleaning 
loss of integrity or performance.
Feature Benefits
Non-adsorptive No loss of proteins,
easy to clean, 
sustained flux
Non-protein binding High product yield
Wide pH and More choices in 
temperature range sanitizing agents
High flow rates Economical filtration
runs
Self sealing cassette No gaskets needed
Silicone sealing No glue
compound
Enlarged inlet and Lower pressure drop
outlet holes
Better solvent resistance than 
Polyethersulfone and Cellulose Triacetate
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Sterilization
NaOH, 1 M, 40°C, 30 min 
Regulatory compliance
All materials have passed the current USP
Biological Test. The filtrate meets or exeeds
USP and EP requirements for Sterile Water
for Injection with respect to total solids,
oxidizable substances, particulate matter,
ammonia, chloride, nitrate, sulfate and 
heavy metals.
Quality control
Each filter cassette is individually assigned a
serial number, integrity tested and certified.
It complies with cGMP requirements for 
non-fiber-releasing filters and is filed under
the Drug Master File Number DMF 5967 
by the Food and Drug Administration,
Washington, DC. Validation information 
is available upon request.
If you use holding devices from other
suppliers, please contact our Applications
Department. A different torque might be
needed due to specific variations in design.
For further assistance, please contact 
your local Sartorius field engineer or 
our Goettingen- based Applications
Department in Germany.
Technical references:
Validation Guide 
Publication No.: SPC5701-e
Directions for Use (Sartocon Cassettes
and Sartocon Slice Cassettes)
Publication No.: SPC6001-a
Typical water flux release data*
Nominal molecular Sartocon Cassettes Sartocon Slice Cassettes 
weight cutoff 0.6 m2 filter area 0.1 m2 filter area
(k) Permeate* [l/h] Permeate* [l/h]
2 k 7 1.5
5 k 12 3
10 k 35 8
30 k 120 25
* (Feed pressure, Pin = 22 psi |1.5 bar; Retentate pressure, Pout = closed valve; PFiltrate = open valve)
Retention rates Hydrosart®
Substance Approx. Mol. Wt. 2 k 5 k 10 k 30 k
Vitamin B12 1.200 >88% – – –
Inulin 5.000 – >97% – –
Cytochrome C 12.400 – – >97,5% –
Albumin 67.000 – – – >97,5%
Order information 
Available types and order numbers
Type Filter area Cut off Order no.
Sartocon Cassettes 0.6 m2 2 k 302 144 19 06 E––SG
Sartocon Cassettes 0.6 m2 5 k 302 144 29 06 E––SG
Sartocon Cassettes 0.6 m2 10 k 302 144 39 06 E––SG
Sartocon Cassettes 0.6 m2 30 k 302 144 59 06 E––SG
Sartocon Slice Cassettes 0.1 m2 2 k 305 144 19 01 E––SG
Sartocon Slice Cassettes 0.1 m2 5 k 305 144 29 01 E––SG
Sartocon Slice Cassettes 0.1 m2 10 k 305 144 39 01 E––SG
Sartocon Slice Cassettes 0.1 m2 30 k 305 144 59 01 E––SG
Sartorius Crossflow Filter
Sartorius AG
Weender Landstrasse 94–108
37075 Goettingen, Germany
Phone +49.551.308.0
Fax +49.551.308.3289
www.sartorius.com
USA +1.631.2544249
UK +44.1372.737159
France +33.1.69192100
Italy +39.055.634041
Spain +34.91.3586100
Japan +81.3.33293366
Specifications subject to change without notice. 
Printed in Germany on paper thas been bleached 
without any use of chlorine.
by Sartorius · W/sart-000 · G
Publication No.: SPC2027-e04046
Order No.: 85030-509-91
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The feed and retentate connectors are 
located on one side of the plate. This allows
easy integration into any skid design and
assures a compact system with low minimum
working volume.
Connectors are situated to eliminate potential
air locks and to assure thorough cleaning and
total product recovery.
The Sartocon 2Plus device is available in 
a grinded and an electro polished surface 
version.
Feature Benefits
Cassettes in vertical self draining
position
Tri-clamp connectors safe fit of accessories
No welds no corrosion
Steamable no cross 
contamination
Fits up to ten high flexibility for
Sartocon cassettes up to 1000 l working
volume
Specifications
Materials of Construction
Filter and Clamping 316L (1.4404)
plate Stainless steel
Connectors 1”–11” sanitary Tri
Clamp flange (DN25)
Nuts for tie rods Nickel coated bronze
Other components 316L Stainless steel
Sartocon® 2Plus Stainless Steel Holder
Crossflow holder for Sartocon® cassettes
Sartorius Crossflow Holder
Description
Sartocon 2Plus Holder
The Sartocon 2Plus stainless steel holder is
optimized for the use with up to ten Sartocon
production scale Crossflow cassettes (max.
7 m2). It is designed for applications from 30 l
to 1000 l volume.
Target use:
– process development
– preclinical trials
– clinical trials
– pilot lots
Sartocon cassettes with a filter area of up to
0.7 m2 each, are available with Polyethersul-
fone, Hydrosart, Polypropylene and Cellulose
Triacetate membrane types.
The Sartocon 2Plus system covers the whole
range of pharmaceutical and biotechnologi-
cal crossflow applications like concentration
and diafiltration of proteins, vaccines, viruses,
antibodies, oligo nucleotides, endotoxin
removal etc. The system is also suitable for
cell harvesting and clarification processes.
The family of Sartorius Crossflow holders 
feature the latest advances in crossflow
design:
– vertical orientation of cassettes
– self draining systems
– autoclavable and inline steamable
– no welds
– minimized hold up volume
The Sartocon 2Plus holding device is part of 
a modular micro- and ultrafiltration system
and fits up to ten Sartocon filter cassettes. 
It is designed for process development and
pilot scale production in pharmaceutical and
biotechnology applications. Easy handling
design and high quality materials make this
holder the perfect tool. 
The Sartocon cassettes are placed between
filter and clamping plate without a need for
additional gaskets. It´s not even necessary to
remove the clamping plate for installation of
the cassettes. Just place the cassettes on the
guide rods and close the holder with a torque
wrench. 
The vertical positioning of the cassettes
allows complete draining of retentate 
and permeate channels by gravity during 
harvesting and steaming procedures. 
Thermal sterilisation in an autoclave or
steaming in place even with cassettes
installed is possible. A special pressure 
compensation tool was designed to allow
thermal sterilisation of Sartocon filter 
cassettes in the Sartocon 2Plus device.
The Sartocon 2Plus´s flow distribution plate 
is machined from a single piece of stainless
steel. It´s sanitary 11” tri-clamp connections
are not welded but machined from the same
plate. This eliminates potentially problems
associated with welds and ensures long 
service life and safe and reliable connection
to other equipment. 
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Technical Data 
Surface finish Ra < 0.6 µm
Maximum number 10 Sartocon
of cassettes cassettes
Dimensions (L+W+H) 371+270+348 mm
Weight approx. 50 kg
Ordering Informations and Accessories
Sartocon 2Plus stainless 17546---002
steel holder, grinded
Sartocon 2Plus 17546---201
microfiltration set
Sartocon 2Plus 17546---202
ultrafiltration set
Sartocon 2Plus 17546E--002
stainless steel holder, 
electro polished
Torque wrench for 17128
Sartocon 2Plus holder
Socket, 27 mm 6986135
Pressure gauge, 0-6 bar, 17546---003
1–11" autoclavable
Diaphragm valve, 1–11" 17546---005
Silicone gasket (FDA), 17546---012
1–11"
Clamp for 1–11" 17033
Tri Clamp 
Sartocon 2Plus manifold 17546---016
for permeate outlet
Hose connector to 17546---018
1–11" Tri Clamp flange
Pressure compensation 17625
tool for steaming and 
autoclaving
Ultrasart Cassettes
Membrane Material Nominal Molecular Order Numbers
Weight Cutoff Sartocon®
[NMWCO]
Cellulose triacetate 5 kD 3021452907E--SG 
20 kD 3021454907E--SG
Polyethersulfone (PESU) 1 kD 3021460907E--SG
5 kD 3021462907E--SG
8 kD 3021463407E--SG
10 kD 3021463907E--SG
Albumin 302146AL07K--SG
Albumin (New) 302146AL07K--SW
30 kD 3021465907E--SG
50 kD 3021465007E--SG
100 kD 3021466807E--SG
300 kD 3021467907E--SG
Hydrosart® 2 kD 3021441906E--SG
5 kD 3021442906E--SG
10 kD 3021443906E--SG
30 kD 3021445906E--SG
100 kD 3021446806E--SG
Microsart Cassettes
Membrane Material Pore Size Order Numbers
[µm] Sartocon®
Polyethersulfone (PESU) 0.1 µm 3021545806W--SG 
Polypropylene 0.2 µm 3021750706W--SG
Hydrosart® 0.2 µm 3021860706W--SG
0.45 µm 3021860606W--SG 
Hydrosart® 0.2 µm 3021860704O--SG
Open Channel 0.45 µm 3021860604O--SG
Sartorius Crossflow Holder
Sartorius AG
Weender Landstrasse 94–108
37075 Goettingen, Germany
Phone +49.551.308.0
Fax +49.551.308.3289
www.sartorius.com
USA +1.631.2544249
UK +44.1372.737100
France +33.1.69192100
Italy +39.055.634041
Spain +34.91.3586100
Japan +81.3.33293366
Specifications subject to change without notice. 
Printed in Germany on paper thas been bleached
without any use of chlorine. 
W/sart-000 · G
Publication No.: SPC2052-e05061
Order No.: 85030-530-84
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Specifications
Pump Output >50 L/min @ 60 psi
____________________________________
Filter Area 4 to 70 ft2
____________________________________
Tank Volume 20L____________________________________
Min. Operating Volume <1L____________________________________
Max. Inlet Pressure 60 psi____________________________________
Piping Connections Tri-clamp
____________________________________
Electrical Req 115 VAC/15 Amps
____________________________________ 
Dimensions 2.5 feet X  3 feet
Components
316L SS Sartocon 2 Plus Holder____________________________________
316L SS Feed Tank____________________________________
316L SS Rotary Lobe Pump____________________________________
316L SS Tubular Frame____________________________________
316L SS Sanitary Pressure Gauges____________________________________
316L SS Fractional Diaphragm Valves
____________________________________ 
316L SS Temperature Gauge
Sartocon 2 Plus Benchtop Crossflow System
Sartorius Crossflow Filter
Description
The Sartocon 2 Plus Benchtop is a basic cost
effective Crossflow filtration system for small to
intermediate scale Micro and Ultrafiltration
pharmaceutical and biotech applications.
The Sartocon 2 Plus Benchtop is mainly used
in Process Development laboratories and Pilot
plants to run small production and clinical
lots. The system is designed for membrane
areas of 0.4 to 2.5 m2 but can accommodate
upto 10 Sartorius Sartocon Cassettes.
The Sartocon 2 Plus Benchtop is supplied
complete with a tank, CIP sprayball, sanitary
diaphragm valves , temperature and pressure
gauges. The design and engineering of the
system is equivalent to a large scale
production system.
Sartocon filter cassettes utilize a parallel leaf
design which provides the user with linear
scale-up and predictable performance for
future production needs. Therefore, the flow
characteristics of a 5 square foot system are
the sames as the flow characteristics of a 500
square foot system.
Sartorius offers standard systems like the
Sartocon Benchtop as well as custom designs
for laboratory, pilot plant and manufacturing.
Sartocon Benchtop System Advantages
• Compact foot print means you can locate
the system almost anywhere
• Low operating volumes let you concentrate
to < 1L
• Sanitary design makes this system ideal for 
cGMP production
• Low point drain facilitates recovery all of 
your product
• Integrity test port provides quick confirma-
tion of the system’s “ready status”
• Every unit is designed for easy cleaning in 
place
Documentation provided:
The system is supplied complete with a cGMP
turn over package.
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Quality and Documentation
Sartorius Crossflow filtration systems are
manufactured from high quality components
and designed to meet the strict requirements
of cGMP operating environments.
All valves, tubing, instruments and filter 
holder wetted surfaces are 316 L SS electro-
polished with a surface finish < 20µ inch Ra.
All non wetted surfaces have a 150 grit
electropolish finish and all welds are ground
smooth to prevent corrosion.
Standards and Codes
All fluid pathway components and manufac-
turing methods meet or exceed the current
3A Sanitary Standards “Accepted Practices for
Permanently Installed Sanitary Proudcts -
Pipelines and Cleaning Systems”.
All electrical enclosures are NEMA 4 and all
elctrical components are UL and CSA listed.
Ordering Information
Sartocon 2 Plus U1-SYS17546BT1-P3
Sartorius Crossflow Filter
Sartorius AG
Weender Landstrasse 94–108
37075 Goettingen, Germany
Phone +49.551.308.0
Fax +49.551.308.3289
www.sartorius.com
USA +1.631.2544274
UK +44.1372.737100
France +33.1.69192100
Italy +39.055.634041
Spain +34.91.3586100
Japan +81.3.33293366
Specifications subject to change 
without notice. 
Printed and copyrighted 
by Sartorius · W/sart-000 · G
Publication No.: S--2037-am04051
Order No.: 85030-520-33
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MEMBRAplan® DG(M) – Safer Production 
and Higher Profitability
Life Sciences
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The Best Solution for the Pharmaceutical and 
Biotechnological Production
Lead by innovation
Pall SeitzSchenk Filtersystems GmbH located in Bad Kreuznach
and Waldstetten is a modern company for the filtration of chemical,
pharmaceutical, and biotechnological products on an international
scale. Due to its high performance level and worldwide presence
Pall SeitzSchenk Filtersystems belongs to the leading companies
in the field of filtration. 
A row of basic inventions and fundamental product developments
brought worldwide appreciation and contributes to the high standards
of the Pall SeitzSchenk filtration technique.
Safety, efficiency, delivery readiness, service, technical consultancy,
and high quality have always been the corner stones for Pall Seitz-
Schenk. The Pall SeitzSchenk filter systems are used around the
world providing reliable and economical filtration.
With the MEMBRAplan® a completely new generation of sheet filters
was developed, setting new standards for the modern pharmaceu-
tical and biotechnological production. This new filtration method
not only meets today's requirements, but also the requirements on
future pharmaceutical processes.
Life Sciences
-523-
2_3Life Sciences
The reason for the development of the MEMBRAplan® DG(M) was
the need for a new type of filter for the treatment of parenteral phar-
maceutics with a high yield of the active ingredients. The result
was a system which can be used for both a quantitative solid/liquid
separation as well as for clarifying and final filtration.
The scope of potential applications is wide. For this reason only 
a few are mentioned:
 Plasma fractionation
 Biomass separation
 Removal of absorbents
 Removal of filter aids
 Removal of extraction residues
 Removal of catalysts
 Filtration of nutrients filtration of cell cultures
 Filtration of therapeutical proteins, vaccines, diagnostics, 
enzymes
 Filtration of antibiotics
 Adsorptive filtration
MEMBRAplan® DG(M) is the first system of its kind allowing a com-
plete CIP cleaning and sterilization and thus meets all requirements
of pharmaceutical equipment.
-524-
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Technical Data MEMBRAplan DGM... P (with stainless steel filter plates)
Chassis size No. of
MEMBRAplan DGM Depth filters 15 mm frames Filter plates Membrane plates Filter area m2 Filter cake volume * L
400 P 30 8 8 4 4 1,0 11,2
16 16 8 8 1,9 22,9
400 P 60 20 20 10 10 2,4 28
30 30 15 15 3,6 42
400 P 100 40 40 20 20 4 60
50 50 25 25 5 75
600 P 50 6 6 3 3 1,9 22,3
18 18 9 9 5,6 67,0
26 26 13 13 8,1 97,0
600 P 100 36 36 18 18 11,2 134
50 50 25 25 15,5 186
600 P 150 58 58 29 29 18,0 216
76 76 38 38 23,6 273
600 P 200 88 88 44 44 27,3 327
100 100 50 50 25 372
800 P 50 6 6 3 3 3 36
18 18 9 9 9 108
26 26 13 13 13 156
800 P 100 36 36 18 18 18 216
50 50 25 25 25 300
800 P 150 58 58 29 29 29 348
76 76 38 38 38 456
800 P 200 88 88 44 44 44 528
100 100 50 50 50 600
*) Only usable to 90%
16_17
Chassis, parts in contact with product Aisi 316 L
Filter pack Polypropylene + Stainless steel 
Membrane Thermoplastic rubber
Gaskets (O-ring) Silicone / EPDM / Viton™
™ Trademark Dupont
Materials
Materials
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Dimensions (in mm)
MEMBRAplan DG(M) with PP-plates L1 L2min L2max L3 B1 B2 H1*
MEMBRAplan DG(M) 400 K   30 1200 520 920 1920 470 550 1000
MEMBRAplan DG(M) 400 K 60 1950 1150 1650 2750 470 550 1000
MEMBRAplan DG(M) 400 K 100 2870 1970 2570 3760 470 550 1000
MEMBRAplan DG(M) 600 K 50 1900 940 1440 2660 720 940 1090
MEMBRAplan DG(M) 600 K 100 3100 1860 2660 4160 720 940 1090
MEMBRAplan DG(M) 600 K 150 4250 2810 3810 5510 720 940 1090
MEMBRAplan DG(M) 600 K 200 5450 4010 5010 6760 720 940 1090
MEMBRAplan DG(M) 800 K   50 2040 940 1440 2775 950 1150 1400
MEMBRAplan DG(M) 800 K 100 3270 1970 2670 4155 950 1150 1400
MEMBRAplan DG(M) 800 K 150 4420 2820 3820 5600 950 1150 1400
MEMBRAplan DG(M) 800 K 200 5620 4020 5020 6800 950 1150 1400
MEMBRAplan DG(M) 400 P  30 920 220 620 1610 470 550 1000
MEMBRAplan DG(M) 400 P  60 1420 620 1120 2210 470 550 1000
MEMBRAplan DG(M) 400 P 100 2020 1120 1720 2910 470 550 1000
MEMBRAplan DG(M) 600 P 50 1370 530 930 1990 720 940 1090
MEMBRAplan DG(M) 600 P 100 2160 1220 1720 2820 720 940 1090
MEMBRAplan DG(M) 600 P 150 2900 1670 2470 3970 720 940 1090
MEMBRAplan DG(M) 600 P 200 3660 2220 3220 4920 720 940 1090
MEMBRAplan DG(M) 800 P 50 1530 520 920 2270 950 1150 1400
MEMBRAplan DG(M) 800 P 100 2330 1120 1720 3580 950 1150 1400
MEMBRAplan DG(M) 800 P 150 3080 1670 2470 4430 950 1150 1400
MEMBRAplan DG(M) 800 P 200 3880 2270 3270 5430 950 1150 1400
MEMBRAplan DG(M) with stainles steel-plates L1 L2min L2max L3 B1 B2 H1*
*Height without air distributor
Air distributor only for MEMBRAplan type DGM
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Filter pack Plate thickness Filter area per filter plate m2 Cake volume L Weight
(mm) (kg)
MEMBRAplan DG(M) 400 P Filter plate 10 0,24 - 3,8
Membrane plate 14 - - -
Frame 12 - 1,44 3,8
Frame 25 - 3,0 7,9
Frame 40 - 4,8 12,7
MEMBRAplan DG(M) 400 K Filter plate 25 0,2 - 3,5
Membrane plate 34 - - 5,5
Frame 15 - 1,5 1,5
Frame 20 - 2,0 2,0
Frame 25 - 2,5 2,5
Frame 40 - 4,0 4,0
MEMBRAplan DG(M) 600 P Filter plate 10 0,62 - 8,0
Membrane plate 14 - - -
Frame 12 - 3,72 6,5
Frame 25 - 7,75 13,5
Frame 40 - 12,40 21,7
MEMBRAplan DG(M) 600 K Filter plate 25 0,5 - 7,7
Membrane plate 34 - - 10,0
Frame 15 - 3,75 2,0
Frame 20 - 5,0 2,7
Frame 25 6,25 3,4
Frame 40 - 10,0 5,4
MEMBRAplan DG(M) 800 P Filter plate 10 1,0 - 12,0
Membrane plate 14 - - -
Rahmen 12 - 6,0 10,0
Rahmen 25 - 12,5 20,8
Rahmen 40 - 20,0 33,3
MEMBRAplan DG(M) 800 K Filter plate 25 0,84 - 12,5
Membrane plate 34 - - 15,5
Rahmen 15 - 6,3 3,0
Frame 20 - 8,4 4,0
Frame 25 - 10,5 5,0
Frame 40 - 16,8 8,0
Enclosed filter system with O-ring G = enclosed filter system with O-ring
sealing arranged on the periphery of the plate
Membrane retightening M = Membrane plate
optional: execution for the chemical industry
Depth filter sizes: 300 = 30 x 30 cm (on request)
400 = 40 x 40 cm
600 = 60 x 60 cm
800 = 80 x 80 cm
1000 = 100 x 100 cm (on request)
Filter plates: K = Polypropylene
P = Stainless steel
Chassis size: 30, 50, 60, 100, 150, 200 (for 600/800 depth filter format)
EXAMPLE: MEMBRAplan DGM DG 800 K 100M C
18_19
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New York - USA
+1 516 484 5400 phone
+1 516 625 3610 fax
pharmafilter@pall.com e-mail
Portsmouth - Europe
+44 (0)23 9230 3303 phone
+44 (0)23 9230 2506 fax
BioPharmUK@pall.com e-mail
Pall Seitzschenk - Germany
+49 (0)671 88220 phone
+49 (0)671 8822200 fax
Pall Corporation has offices and plants throughout the world in locations including:
Argentina, Australia, Austria, Belgium, Brazil, Canada, China, France, Germany, India,
Indonesia, Ireland, Italy, Japan, Korea, Malaysia, Mexico, the Netherlands, New Zealand,
Norway, Poland, Puerto Rico, Russia, Singapore, South Africa, Spain, Sweden, Switzerland,
Taiwan, Thailand, United Kingdom, United States, and Venezuela.  Distributors are located
in all major industrial areas of the world.
Visit us on the Web at www.pall.com
Reorder Code. PLS-P124 engl. 3 07/03 
© Copyright 2002, Pall Corporation. Pall,            , are trademarks of Pall Corporation. ® Indicates a Pall
trademark registered in the USA.                                                             is a service mark of Pall Corporation.
*Select-A-FAX is a registered trademark of CyberData, Inc. 
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                                  Intelligent BioProcessing Systems 
 
Automated, Aseptic Transfer of Liquids into Multiple, 
Single-use Storage Bags 
Summary: 
 
The Fill Master aseptically transfers solution into multiple, plastic storage bags. The Fill 
Master controls up to twelve, pneumatically operated tube pinch valves to direct the 
liquid flow from the reservoir into sterile storage bags.  Only the internal tube walls and 
the inside bag surfaces are in contact with the liquid. The high-accuracy, low-shear 
peristaltic pump action provides gentle and reproducible bag filling. In the 
programmable, volume dispensing mode, the Fill Master meters a user-defined volume 
of liquid, then automatically switches to the next empty storage bag to be filled. Up to 12 
storage bags can be serially filled in this fashion. Once filled, the bags can be 
aseptically sealed using a sterile tube welder. 
Features: 
 
There are several Fill Master models to choose from.  For example, the Fill Master 104B 
peristaltic pump head (max. pump rate is 14.6 liters/min with #184 Silicone tubing) 
allows for a continuous tube connection to be made between the reservoir and the 
storage bag manifold. A typical sterile fluid handling bag manifold, which may include 
multiple storage bags, as well as integral tubing, QC bags, sterilizing filter and 
connectors, are available pre-sterilized (i.e. gamma irradiated).  Contact SciLog for info.   
 
When ordering a sterile fluid handling bag manifold, the size and material of the integral 
tubing must be specified. The Fill Master 104B peristaltic pump head can accommodate 
the following tubing sizes: #26, 6.4 mm ID (0.15 to 2.60 liters/min); #73, 9.6mm ID (0.31 
to 5.94 liters/min); #82, 12.7 mm ID (0.53 to 9.25 liters/min) and #184, 15.9 mm ID (0.80 
to 14.50 liters/min) A range of tube materials can be used: Silicone, Pharmed, PVC and 
C-Flex (heat sealable).  Other Fill Master models accommodate additional sizes. 
 
An optional, disposable pressure transmitter can be placed in front of the in-line 
sterilizing filter to monitor filter backpressure. With the pressure transmitter connected to 
the Fill Master, excessive pressure build-up as well as associated leaks and bag failures 
are prevented. The Fill Master will stop all pumping action when a user-defined safe 
pressure limit is exceeded. 
SciLog Inc, 8845 S. Greenview Drive #4, Middleton, WI 53562-2562 
Web: www.scilog.com Tel: 800-955-1993 Fax: 608-824-0509 
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Automated Bag Filling Operation: Fill Master Metering Program 
 
The Fill Master Volume-Flow mode (Mode 30) allows you to enter (in “EDIT”) and store an 
automated metering program. The following is a simple program to fill three, 20 liter storage 
bags. Change the RATE and TIME program steps to suit your storage bag volume. Add 
additional “RUN” program blocks to increase the number of bags (up to 12) you want to fill. 
 
000         START   The following program steps have been entered in Mode 30: 
001 CW   Motor Runs Clock-wise 
002 RUN   Motor is turned “ON” 
003 V  100000  Pinch Valve V1 is Energized, other V-valves are De-energized 
004 RATE: 5.0L/min   Pump Rate 5 liters per minute 
005 TIME: 00:04:00   Pump Runs 4 minutes, Bag #1 is filled with 20 Liters 
 
006 STOP   Pump “Off” 
007         V  020000  Pinch Valve V2 is Energized, other V-valve are De-energized 
008 TIME: 00:00:02  2 Second Time delay 
 
009 RUN   Pump “ON” 
010         RATE: 5.0 L/min  Pump Rate 5 liters per minute 
011 TIME: 00:04:00  Pump Runs 4 Minutes, Bag #2 is filled with 20 Liters 
 
012 STOP   Pump “Off” 
013  V  003000  Pinch Valve V3 is Energized, other V-valves are De-energized 
014 TIME: 00:00:02  2 Second Time Delay 
 
015         RUN   Pump “ON” 
016 RATE: 5.0 L/min  Pump Rate 5.0 liters per minute 
017 TIME: 00:04:00  Pump Runs 4 Minutes, Bag #3 is filled with 20 Liters 
018 STOP   Pump “Off” 
019         V 000000  All V-Valves are De-energized 
020         COUNT: 1  The Program Steps 000 to 020 are executed once 
021 END 
 
ORDERING INFORMATION:    SciLog Customer Service: 1-800-955-1993 
 
 Catalog #: Description: 
 
800-104BFILL Fill Master 104B mounted with a Watson-Marlow 620R peristaltic pump head, 0.5 HP motor; 
90VDC; 250 RPM max.; 7.8: 1 Speed Reducer. The 620R peristaltic pump head has two (2) 
pump rollers and accommodates continuous pump tubing of the following sizes: 6.4mm ID (#26), 
0.15 to 2.60 L/M); 9.6mm ID (#73) 0.31 to 5.94 L/M; 12.7mm ID (#82), 0.53 to 9.25 L/M; and 
15.9mm ID (#184), 0.80 to 14.5 L/M, wall thickness is 3.2mm (0.125”) for all tube sizes 
 
800-450 Multiple-Valve Controller: Remote control of twelve (12) electrically actuated air flow valves 
(Clippard) for automated pneumatic operation of twelve (12) pinch valves or sanitary diaphragm 
valves. Fully programmable from the Fill Master via dedicated serial port or manual control from 
front panel of the multi-Valve Box. Optional inputs for valve position sensors. 
 
934-VALVE Tubing Pinch Valve: Specify Tubing OD: 0.125”, 0.250”, 0.375”, 0.50”, 0.75”, and wall thickness. 
The valve is pneumatically actuated. Ideal for maintaining sterility, only tubing comes in contact 
with your process solution. Requires a Multi-Valve Controller for actuation and control. The Multi-
Valve Controller is fully programmable from the Fill Master via dedicated serial port or manual 
control from front panel of multi-Valve Box. Optional inputs for valve position sensors. 
 
  
 
 
 
 
AN 8002, Copyrighted. Last Revision: 12/22/05 
SciLog Inc, 8845 S. Greenview Drive #4, Middleton, WI 53562-2562 
Web: www.scilog.com Tel: 800-955-1993 Fax: 608-824-0509 
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HyQ®CX5-14 Film
• Regulatory friendly due to ADCF 
status and low extractables
• Improved shelf life of media due to 
superior barrier properties
• Scalability from 50 mL–2500 L in 
same film
Flexible and Secure Containers
• Save storage space
• Safer than carboys
• Easy to handle (handling systems 
available)
Single-Use; Arrive Sterile and  
Ready-to-use
• No cleaning or sterilization
• Minimize validation requirements
• Labor and cost saving
Range of Standard Products
• Integrate with most industry 
standard connection systems
Labtainer™ System
BioProcess Container™ Systems for small volume liquid handling
applications in bioresearch and biopharma production.
Animal Derived Component Free (ADCF™) Film • Sizes range from 50 mL–50 L
Applications:
•   Collection, storage, and transport of sterile liquids
•   Delivery of media to small-scale biotechnology production systems
•   Formulation and filling of sterile media, buffers, and other process liquids
•   Chromatography feed and fraction collection
•   Bioreactor and fermentation feed and harvest
•   Transportation and storage of bulk intermediate product
•   Freezing/thawing, heat inactivation, and irradiation of product
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B Ordering Information
B Consumable (single-use, reordered on demand)
In the Americas and Asia:
Tel: +1 (435) 792 8000 Fax: +1 (435) 792 8001
Toll-free: +1 (800) HyClone www.hyclone.com
           or +1 (800) 492 5663 info@hyclone.com
In Europe: Perbio Science Europe
Tel: +32 53 83 44 04
Fax: +32 53 83 76 38
euromarketing@perbio.com
SM0478
bioprocess containers • media • buffers • reagents • serum-free media • FBS replacements • sera
B Technical Information
Additional technical information 
(HyQ®CX5-14 fact sheet, film white 
paper, and the BPC Capabilities and 
Products Brochure) is available upon 
request. Please contact your HyClone 
customer service representative.
B Customization
For orders that require a customized 
solution, please contact your HyClone 
sales representative to initiate a 
Product Brief, defining your intended 
application and requirements.
2-D, Hanging Pillow
3 ports, end dispense 
Line 1 3/8" (9.5 mm) QC Insert
 (tube length: 12"/ 30.4 cm)
Line 2 3/8" (9.5 mm) QC Insert
 (tube length: 12"/ 30.4 cm)
Line 3 1/4" (6.4 mm) Plugged
 
Single-pk Part# Size
SH30714.01 5 L
SH30714.02 10 L
SH30714.03 20 L
SH30714.04 50 L
�������
2-D, Hanging Pillow
2 ports, end dispense 
Line 1 1⁄8" (3.2 mm) Female LL
 (tube length: 12"/ 30.5 cm)
Line 2 1⁄4" (6..4 mm) QC Insert
 (fitting directly attached to BPC)
Single-pk Part# 10-pk Part# Size
SH30662.01 SH30662.11 50 mL
SH30662.02 SH30662.12 100 mL
SH30662.03 SH30662.13 250 mL
SH30662.04 SH30662.14 500 mL
SH30662.05 SH30662.15 1000 mL
SH30662.06 SH30662.16 2000 mL
2-D, Hanging Pillow
3 ports, end dispense 
Line 1 1/4" (6.4 mm) Male LL
 (tube length: 12"/ 30.4 cm)
Line 2 1/4" (6.4 mm) Female LL
 (tube length: 12"/ 30.4 cm)
Line 3 1/8" (3.2 mm) Female LL
 (tube length: 12"/ 30.4 cm)
Single-pk Part# Size
SH30713.01 5 L
SH30713.02 10 L
SH30713.03 20 L
SH30713.04 50 L
�������
2-D, Hanging Pillow
2 ports, end dispense 
Line 1 1⁄4" (6.4 mm) Male LL
(fitting directly attached to BPC)
Line 2 1⁄4" (6.4 mm) Female LL
(fitting directly attached to BPC)
Single-pk Part# 10-pk Part# Size
SH30657.01 SH30657.11 50 mL
SH30657.02 SH30657.12 100 mL
SH30657.03 SH30657.13 250 mL
SH30657.04 SH30657.14 500 mL
SH30657.05 SH30657.15 1000 mL
SH30657.06 SH30657.16 2000 mL
�������
2-D, Hanging Pillow
2 ports, end dispense 
Line 1 1⁄8" (3.2 mm) Male LL
 (tube length: 12"/ 30.5 cm)
Line 2 1⁄8" (3.2 mm) Female LL
 (tube length: 12"/ 30.5 cm)
Single-pk Part# 10-pk Part# Size
SH30658.01 SH30658.11 50 mL
SH30658.02 SH30658.12 100 mL
SH30658.03 SH30658.13 250 mL
SH30658.04 SH30658.14 500 mL
SH30658.05 SH30658.15 1000 mL
SH30658.06 SH30658.16 2000 mL
2-D, Hanging Pillow
3 ports, end dispense 
Line 1 3/8" (9.5 mm) QC Insert
 (tube length: 24"/ 61 cm)
Line 2 3/8" (9.5 mm) QC Body
 (tube length: 24"/ 61 cm)
Line 3 1/8" (3.2 mm) Female LL
 (tube length: 24"/ 61 cm)
Single-pk Part# Size
SH30712.01 5 L
SH30712.02 10 L
SH30712.03 20 L
SH30712.04 50 L
>  All end fittings are capped or plugged.
> All tubing lines are C-Flex® and provided with clamps. (C-Flex is a registered trademark of Consolidated 
Polymer Technologies.)
> LL = Luer Lock 
> QC = Quick Connect
B Accessories
•  Hanging Rack—assists in the handling of product.
•  Totes/Tote Rack—assists in the handling of product.
•  Adapter Tube Sets—extend functionality of product by using adapter tube sets.
Additional information available on request.
2-D, Hanging Pillow
3 ports, end dispense 
Line 1 3/8" (9.5 mm) QC Insert
 (fitting directly attached to BPC)
Line 2 3/8" (9.5 mm) QC Insert
 (fitting directly attached to BPC)
Line 3 Injection Port
  (fitting directly attached to BPC)
Single-pk Part# Size
SH30709.01 5 L
SH30709.02 10 L
SH30709.03 20 L
SH30709.04 50 L
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CUSTOMER QUOTATION
DATE
4/2/2009
QUOTE NO.
9002-1655
NAME / ADDRESS
UNIVERSITY OF PENNSYLVANIA
SHIP TO
Kevin Hsu
QUALITY BIORESOURCES, INC
          QUOTED PRICES ARE VALID FOR SIXTY (60) DAYS FROM QUOTATION DATE SHOWN ABOVE.                                 
PLEASE REFER TO QUOTATION NUMBER ON ALL ORDERS.
PAYMENT TERMS:  NET 30 DAYS SHIPMENT TERMS:  FOB SEGUIN, TEXAS
1015 N. AUSTIN STREET
SEGUIN, TEXAS   78155
( 830)  372-4797
ITEM DESCRIPTIONQTY SPECIAL QUOTE
CUSTOM MONOCLONAL ANTIBODY, LYOPHILIZED, 1ML PER VIAL, CLEAR
GLASS SERUM VIAL, BUTYL RUBBER STOPPER, NATURAL
ALUMINUM CRIMP, PACKAGED IN SHRINK-WRAPPED TRAYS
225,000 225,000
OR
CUSTOM MONOCLONAL ANTIBODY, LYOPHILIZED, 1ML PER VIAL, CLEAR
GLASS SERUM VIAL, BUTYL RUBBER STOPPER, NATURAL
ALUMINUM CRIMP, LABELED, PACKAGED IN SHRINK-WRAPPED
TRAYS
225,000 270,000
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CIP Washers
Clean-In-Place Systems
B i o - P h a r m
Sani-Matic Clean-In-Place Systems for the Bio-Pharm 
industry are custom engineered to specific plant 
application and utility requirements to ensure  
effective and efficient cleaning of process 
equipment automatically.
Proper CIP design and sizing will not only ensure 
sufficient flow and pressure to remove residue 
adequately, and rinse thoroughly. Sani-Matic 
CIP designs will also save cycle time, reduce 
water and chemical usage, and minimize 
discharge and utility costs. Balancing all  
factors to create an optimum system is 
our goal. CIP Systems can be designed to 
recirculate or provide “once-through” 
cleaning, depending on the product residue. 
Multi-tank systems can provide additional 
benefits of faster turnaround time if cleaning 
processes are more frequent.
WhAT mAkeS uS 
DIFFereNT?
Sani-Matic has the expertise to engineer an effective 
solution for your cleaning application. Specialists in cleaning 
technology, the Sani-Matic team will provide valuable 
insight and guidance during your project from beginning 
to end. Developing a creative design concept based on 
decades of practical experience, we can ensure you are 
purchasing a system which is dependable and cost-effective 
for the long term. Sani-Matic has in-house programming 
staff and field technical service with the expertise to develop 
and optimize your cleaning cycles and integrate the CIP 
functions with your plant Process control systems. 
Because the Sani-Matic team understands the unique 
challenges of cleaning, we add value to your CIP projects.
Our manufacturing 
facilities and processes are 
controlled and efficient,  
ensuring that your system is com-
pliant and on-schedule. Project  
management and documentation 
is detailed and complete, saving 
you time and resources while 
achieving your project’s 
budget and target  
start-up date.
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CIP:  Clean-In-PlaCe
• Single-use source of wash solution and rinse water
• lower space requirement
• Portable or stationary design is available
• Once through or recirculated
One Tank
Single-use System
Two Tank
Detergent & Rinse System
• Permits once through or recirculated flow of wash solution
• Used where water utilities are limited
• Reduced wash cycle times
CIP system sizing is determined by dimensions of the vessels 
and pipelines to be cleaned.
Supply pump flow is determined by the vessel size and the 
largest pipeline diameter. Turbulent cleaning action requires 
5-7 fps flow in lines. Proper cascading cleaning action by 
a sprayball is 3 gpm per ft of tank circumference.  
Pressure is determined by the spray device requirement 
(typically 25psi, plus any line loss). 
Sizing the wash and rinse tank volume is determined by the 
pipeline holdup volume (gal per 100ft) and the available inlet 
water capacity and the estimated cleaning program time. 
CIP DeSIgN SIzINg FACTOrS
®
 Clean-In-PlaCe
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Controls
The IDeAL SOLuTION FOr:
• Vessels with low and/or small outlets
• Variable supply and return flow (1 to 100 GPM)
• Portable - avoid investment in permanent supply & return lines
• locations with limited/low water volume available
• economical replacement for an existing or outdated CIP
• Installations where available floor space is limited
• not appropriate for “once through” non-recirculated processes
ADVANTAGES
• Reduce water usage • lower chemical consumption
• eliminate installation costs • Increase flexibility
Sani-Matic has in-house programmers and authorized Ul 
panel shop who design, manufacture, pre-test, startup and 
support of all types of Control Systems for cleaning systems. 
Because the team specializes in cleaning applications,  
Sani-Matic has developed expertise and efficiencies that have 
advantages over other fabricators or process integrators.  
Sani-Matic has designed, manufactured and supported  
thousands of CIP systems and other cleaning related systems.
Understanding the unique aspects of an effective cleaning 
program, Sani-Matic developed a very flexible & easy-to- 
understand OP-Code Recipe editor that allows the customer 
to manipulate the system hardware to optimize their cleaning 
programs. This can result shorter total cycle time, lower water 
& chemical usage, more precise control to setpoints and  
detailed alarms which reduce troubleshooting time.
Soon to be released, the new Sani-Trend Data acquisition 
System collects and stores cleaning cycle data, events/alarms, 
and operator information onto a PC. Operating usage of 
water, chemical, and utilities may be calculated and trended. 
Sani-Trend reports are in easy to use excel format, and provide 
reliable, secure information giving you valuable insight on your 
cleaning process.
CIP Washers
ultraFlow
The Sani-Matic UltraFlow CIP is patented technology which 
uses an eductor, vortex air separation chamber and modulating 
valves to control the CIP supply and return flows. This unique 
CIP design successfully brings air & water back in the return 
flow, separates the air, keeping the supply pump primed. The 
UltraFlow uses much less water than traditional CIPs and is 
flexible to clean a wide variety of circuits.
 O
PC
O
DE
 N
UM
BE
R
OPCODE CHART  OPC
O
DE
 N
UM
BE
R
 T
EM
PE
RA
TU
RE
 H
O
LD
 C
O
ND
UC
TI
V
IT
Y 
HO
LD
 D
ET
ER
GE
NT
 T
A
NK
 O
UT
LE
T 
 D
ET
ER
GE
NT
 T
A
NK
 R
ET
UR
N
 R
IN
SE
 T
A
NK
 O
UT
LE
T 
 R
IN
SE
 T
A
NK
 R
ET
UR
N
 S
UC
TI
O
N 
DR
A
IN
 V
al
ve
 D
ET
ER
GE
NT
 T
A
NK
 F
IL
L 
O
FF
 
 F
IL
E
 W
O
R
D
 1
, N
14
:0
 D
E
S
T
IN
A
T
IO
N
 W
O
R
D
 N
7:
2
 O
PC
O
DE
 N
UM
BE
R
 S
UP
PL
Y 
PU
M
P 
 R
ET
UR
N 
PU
M
P 
 B
UR
ST
 S
UP
PL
Y 
PU
M
P
 T
EM
P 
1 
(P
RE
RI
NS
E)
 T
EM
P 
2 
(R
IN
SE
)
 T
EM
P 
3 
(D
ET
ER
GE
NT
 W
A
SH
)
 T
EM
P 
4
 R
EC
O
V
ER
 D
ET
ER
GE
NT
 T
A
NK
 R
EC
O
V
ER
 R
IN
SE
 T
A
NK
 S
A
NI
TI
ZE
R 
PU
M
P
 D
ET
ER
GE
NT
 C
O
ND
UC
TI
V
IT
Y
 F
IL
E
 W
O
RD
 2
, N
15
:0
 D
ES
TI
NA
TI
O
N 
W
O
RD
 N
7:
3
 O
PC
O
DE
 N
UM
BE
R
 R
IN
SE
 R
EC
O
V
ER
YT
A
NK
 O
UT
LE
T
 R
IN
SE
 R
EC
O
V
ER
Y 
 T
A
NK
 R
ET
UR
N
 R
IN
SE
 R
EC
O
V
ER
Y 
TA
NK
 R
EC
O
V
ER
Y
CL
EA
R 
RI
NS
E 
HO
LD
DE
TE
RG
EN
T 
CH
A
SE
 C
O
ND
UC
TI
V
IT
Y 
HO
LD
 F
IL
E
 W
O
RD
 3
, N
16
:0
 D
ES
TI
NA
TI
O
N 
W
O
RD
 N
7:
4
DESCRIPTION 12 11 10 9 8 7 6 2 15 14 12 11 10 9 8 6 5 2 1 14 13 11 9 8
1 **PROGRAM  END** 1 0 0 0 0 1 0 0 0 0 1 0 0 0 0
2 **SAN PROGRAM START** 2 0 0 0 0 2 0 0 0 0 2 0 0 0 0
3 **CIP PROGRAM END** 3 0 0 0 0 3 0 0 0 0 3 0 0 0 0
4 4 0 0 0 0 4 0 0 0 0 4 0 0 0 0
5 PRE RINSE TO DRAIN 5 1 0 1 0 0 5 1 1 1 C 8 0 0 5 0 0 0 0
6 6 0 0 0 0 6 0 0 0 0 6 0 0 0 0
7 BURST PRE RINSE TO DRAIN 7 1 0 1 0 0 7 1 1 1 1 D 8 0 0 7 0 0 0 0
8 8 0 0 0 0 8 0 0 0 0 8 0 0 0 0
9 DETERGENT WASH 9 1 1 1 1 1 C 0 4 9 1 1 1 1 C 2 0 2 9 0 0 0 0
10 ACID WASH 10 1 1 1 8 0 0 10 1 1 1 C 1 0 0 10 1 1 6 0 0 0
11 CHASE RINSE TO DRAIN W/ DETERGENT 11 1 1 0 4 0 4 11 1 1 1 1 C 2 0 2 11 0 0 0 0
12 CHASE RINSE TO DRAIN W/ ACID 12 0 0 0 0 12 1 1 1 C 1 0 0 12 1 4 0 0 0
13 CHASE RINSE TO DRAIN W/ DETERGENT AND CONDUCTIVITY HOLD 13 1 1 0 4 0 4 13 1 1 1 1 C 2 0 2 13 1 0 1 0 0
14 CHASE RINSE TO DRAIN W/ ACID AND CONDUCTIVITY HOLD 14 0 0 0 0 14 1 1 1 C 1 0 0 14 1 4 0 0 0
15 CHEMICAL SANITIZE 15 1 0 1 0 0 15 1 1 1 C 0 0 4 15 0 0 0 0
16 16 0 0 0 0 16 0 0 0 0 16 0 0 0 0
17 17 0 0 0 0 17 0 0 0 0 17 0 0 0 0
18 18 0 0 0 0 18 0 0 0 0 18 0 0 0 0
19 19 0 0 0 0 19 0 0 0 0 19 0 0 0 0
20 20 0 0 0 0 20 0 0 0 0 20 0 0 0 0
21 PUMPBACK TO DRAIN 21 0 0 0 0 21 1 4 0 0 0 21 0 0 0 0
22 PUMPBACK W/ DETERGENT RECOVERY 22 1 0 0 0 4 22 1 1 4 0 4 0 22 0 0 0 0
23 PUMPBACK W/ ACID RECOVERY 23 0 0 0 0 23 1 4 0 0 0 23 1 0 8 0 0
24 RINSE TO DRAIN 24 1 0 1 0 0 24 1 1 1 C 4 0 0 24 0 0 0 0
25 RINSE TO DRAIN WITH RETURN CONDUCTIVITY HOLD 25 1 0 1 0 0 25 1 1 1 C 4 0 0 25 1 0 2 0 0
26 RINSE WITH DET RECOVERY AND RETURN CONDUCTIIVITY HOLD 26 1 1 0 1 0 4 26 1 1 1 1 C 4 4 0 26 1 0 2 0 0
27 RINSE WITH ACID RECOVERY AND RETURN CONDUCTIVITY HOLD 27 1 0 1 0 0 27 1 1 1 C 4 0 0 27 1 1 0 A 0 0
28 RINSE W/ DETERGENT RECOVERY 28 1 1 0 1 0 4 28 1 1 1 1 C 4 4 0 28 0 0 0 0
29 RINSE W/ ACID RECOVERY 29 1 0 1 0 0 29 1 1 1 C 4 0 0 29 1 0 8 0 0
UltraFlow technical 
brochure available 
separately.
Easier/Faster to Validate
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1915 S. Stoughton Road  •  P.O. Box 8662  •  Madison, WI  53708 
Phone: 608-222-2399  •  Fax: 608-222-5348  •  info@sanimatic.com
www.sanimatic.com
CIP Clean-In-PlaCe
CIP Features
Spray Devices
Custom Engineered  
and Precision Drilled
• Operation and maintenance manuals
• Recommended spare parts list
• Instrument lists
• Instrumentation calibration procedures
• Performance data
• Material certificates
• Weld qualification and inspection records
• Inspection test results, reports and certificates
• aSMe data
• Component catalog cut sheets
• as built assembly drawings
• as built process and instrumentation diagrams 
• as built electrical drawings
• annotated PlC ladder diagrams
OPTIONAL  
• (FRS/FDS) Functional Design Specifications 
• Control System Design Specification (HRS and SRS)
• (FaT) Factory acceptance Test report
• (SaT) Site acceptance Test document
• IQ/OQ installation and operation qualification
• Cleaning and passivation report
• Weld video record (Boroscope)
• Custom engineered in 3D
• Precision drilled 
• Pass Riboflavin testing first time
• Documented for future replacement without re-validating
Sani-Matic personnel are  
active participants in the  
following organizations:
ISPE-International Society of  
Pharmaceutical Engineers
Co-developer & Co-leader of    
“Cleaning Technology” course
ASME-American Society of  
Mechanical Engineers
BPE (Bio Processing Equipment) 
CIP task group
AWS-American Welding Society 
D18 Team committee for sanitary 
welding
3A-Sanitary Standards
Member of board of directors 
and task committees
In-house engineering and opera-
tions
Custom engineered to order 
– solidworks 3D Cadd designs
Electrical design and program-
ming in-house
Manufacturing work team dedi-
cated to Bio-Pharm
Authorized UL panel shop
ASME certified shop – welding 
inspector and trainer
Project Management – manage 
Gantt scheduling, change orders, 
FAT
Complete Technical  
Service Staff offering:
Documentation
Field start-up and training
Factory support after start-up
Pharm CIP-5536 3/07
®
Sani-Matic designs and manufactures a complete range of 
sprayballs and associated solution tubes and tank fittings.
Utilizing the latest technology, Sani-Matic has engineered 
a method to model a process vessel in 3D and design the 
most effective spray device and drill pattern to ensure 
proper coverage of all ports and surfaces. With decades of 
experience in spray technology and Bio-Pharm CIP applications, 
the Sani-Matic team understands the spray dynamics required 
to ensure adequate flows, pressures and geometries will 
dependably clean your process equipment. 
Sani-Matic provides complete documentation and ID marking 
for ease of validation and future replacement. Responsive 
service and reliable delivery make Sani-Matic the preferred 
supplier of Spray Devices in the market today.
Documentation
Faster & Easier Validation
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